However RB O
, , O
if IN O
EMPD NNP O
involves VBZ O
the DT O
glans NNS O
penis VBP O
or CC O
perianal JJ O
area NN O
, , O
a DT O
search NN O
for IN O
internal JJ O
malignancy NN O
is VBZ O
still RB O
warranted VBN O
. . O

The DT O
ESEG NNP O
' POS O
s NN O
are VBP O
a DT O
direct JJ O
result NN O
of IN O
the DT O
NEXT NNP O
study NN O
. . O

The DT O
patient NN O
was VBD O
treated VBN O
with IN O
benzathine NN O
penicillin NN O
, , O
2 CD O
, , O
400 CD O
, , O
0 CD O
U NNP O
weekly NN O
for IN O
three CD O
weeks NNS O
. . O

On IN O
line NN O
calculation NN O
of IN O
steroid JJ O
concentrations NNS O
by IN O
radioimmunoassay NN O

Molecular JJ O
mimicry NN O
of IN O
human JJ O
cytokine NN O
and CC O
cytokine NN O
response NN O
pathway NN O
genes NNS O
by IN O
KSHV NNP O
. . O

Petko NNP O
, , O
and CC O
S NNP O
. . O

The DT O
sensitivity NN O
of IN O
the DT O
vas NN O
deferens VBZ O
to TO O
adrenaline VB O
was VBD O
also RB O
reduced VBN O
in IN O
scorbutic JJ O
guinea NN O
pigs NNS O
, , O
thus RB O
decreasing VBG O
their PRP$ O
fertility NN O
rate NN O
. . O

In IN O
addition NN O
, , O
the DT O
hGCSFR NN B-Gene
gene NN I-Gene
was VBD O
chromosomally RB O
localized VBN O
by IN O
Southern NNP O
blot NN O
analysis NN O
of IN O
its PRP$ O
segregation NN O
pattern NN O
in IN O
a DT O
panel NN O
of IN O
rodent JJ O
- : O
human JJ O
hybrid JJ O
DNAs NNP O
using VBG O
the DT O
radiolabeled VBN O
cDNA NN O
probe NN O
. . O

In IN O
contrast NN O
, , O
when WRB O
the DT O
isoform NN O
containing VBG O
the DT O
C NNP O
epsilon4 NN O
domain NN O
joined VBD O
directly RB O
to TO O
the DT O
M2 NNP O
exon NN O
( ( O
IgE NNP B-Gene
grande NN I-Gene
) ) O
is VBZ O
expressed VBN O
in IN O
the DT O
J558L NNP O
cell NN O
line NN O
, , O
it PRP O
is VBZ O
degraded VBN O
intracellularly RB O
, , O
suggesting VBG O
a DT O
cell NN O
line NN O
- : O
dependent JJ O
regulation NN O
of IN O
secretion NN O
. . O

No DT O
consistent JJ O
correlation NN O
between IN O
blood NN O
pressure NN O
change NN O
and CC O
SCR NNP O
- : O
change NN O
was VBD O
seen VBN O
. . O

Modification NN O
of IN O
dopamine NN B-Gene
D2 NNP I-Gene
receptor NN I-Gene
activity NN O
by IN O
pergolide NN O
in IN O
Parkinson NNP O
' POS O
s JJ O
disease NN O
: : O
an DT O
in IN O
vivo NN O
study NN O
by IN O
PET NNP O
. . O

The DT O
Cut9 NNP B-Gene
subunit NN I-Gene
is VBZ O
likely JJ O
to TO O
be VB O
a DT O
target NN O
for IN O
regulating VBG O
APC NNP B-Gene
/ NNP I-Gene
cyclosome NN I-Gene
function NN O
through IN O
protein NN O
- : O
protein NN O
interactions NNS O
and CC O
phosphorylation NN O
. . O

Sequence NN O
comparisons NNS O
have VBP O
shown VBN O
that IN O
Aps1p NNP B-Gene
is VBZ O
more RBR O
similar JJ O
to TO O
the DT O
sigma NN O
subunit NN O
of IN O
the DT O
Golgi NNP O
- : O
localized JJ O
mammalian JJ O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
complex JJ I-Gene
than IN O
Aps2p NNP B-Gene
, , O
which WDT O
is VBZ O
more RBR O
related JJ O
to TO O
the DT O
plasma NN O
membrane NN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
sigma NN I-Gene
subunit NN O
. . O

The DT O
IE13 NNP O
. . O
1 CD O
cell NN O
line NN O
was VBD O
able JJ O
to TO O
complement VB O
a DT O
recombinant JJ O
virus NN O
in IN O
which WDT O
both DT O
copies NNS O
of IN O
the DT O
IE NNP B-Gene
gene NN I-Gene
were VBD O
replaced VBN O
by IN O
insertion NN O
of IN O
the DT O
Escherichia NNP B-Gene
coli NN I-Gene
lacZ NN I-Gene
gene NN I-Gene
. . O

Frequency NN O
of IN O
seeing VBG O
curves NNS O
were VBD O
examined VBN O
for IN O
the DT O
method NN O
most RBS O
similar JJ O
to TO O
FDT NNP O
. . O

The DT O
human JJ B-Gene
CD38 NNP I-Gene
gene NN I-Gene
consists VBZ O
of IN O
8 CD O
exons NNS O
that WDT O
extend VBP O
more JJR O
than IN O
77 CD O
kb NN O
on IN O
the DT O
human JJ O
genome NN O
. . O

The DT O
TA NNP O
muscle NN O
was VBD O
fatigued VBN O
by IN O
four CD O
forms NNS O
of IN O
repeated JJ O
isometric JJ O
contractions NNS O
: : O
( ( O
1 CD O
) ) O
maximal NN O
voluntary JJ O
contractions NNS O
( ( O
MVC NNP O
) ) O
, , O
( ( O
2 CD O
) ) O
MVC NN O
with IN O
circulation NN O
occluded VBN O
, , O
( ( O
3 CD O
) ) O
electrically RB O
evoked VBD O
contractions NNS O
with IN O
20 CD O
Hz NNP O
supramaximal JJ O
voltage NN O
stimulation NN O
and CC O
( ( O
4 CD O
) ) O
electrically RB O
evoked VBD O
contractions NNS O
with IN O
circulation NN O
occluded VBN O
. . O

The DT O
strategies NNS O
by IN O
which WDT O
hepatitis NN O
B NNP O
and CC O
hepatitis NN O
D NNP O
can MD O
be VB O
diminished VBN O
and CC O
eventually RB O
eliminated VBN O
are VBP O
: : O
immunization NN O
, , O
measures NNS O
to TO O
prevent VB O
exposure NN O
to TO O
infective VB O
blood NN O
or CC O
blood NN O
derivatives NNS O
and CC O
education NN O
( ( O
in IN O
particular JJ O
awareness NN O
that WDT O
hepatitis NN O
B NNP O
is VBZ O
a DT O
sexually RB O
transmitted JJ O
disease NN O
) ) O
. . O

Mature NN O
and CC O
old JJ O
B6AF1 NNP O
and CC O
B6D2F1 NNP O
mice NN O
were VBD O
given VBN O
acidified JJ O
tap JJ O
water NN O
or CC O
promethazine NN O
HCl NNP O
( ( O
a DT O
phenothiazine NN O
with IN O
H1 NNP B-Gene
receptor NN I-Gene
blocking VBG O
activity NN O
) ) O
, , O
chlorpheniramine NN O
( ( O
an DT O
H1 NNP B-Gene
blocker NN O
) ) O
or CC O
trifluoperazine NN O
( ( O
a DT O
phenothiazine NN O
with IN O
no DT O
H1 NNP B-Gene
blocking VBG O
activity NN O
) ) O
in IN O
their PRP$ O
drinking NN O
water NN O
, , O
and CC O
the DT O
effects NNS O
of IN O
these DT O
agents NNS O
on IN O
bone JJ O
mineral JJ O
content NN O
were VBD O
assessed VBN O
by IN O
intermittently RB O
measuring VBG O
the DT O
24 CD O
- : O
h NN O
whole JJ O
body NN O
retention NN O
of IN O
Tc NNP O
99m CD O
methylene NN O
diphosphonate NN O
( ( O
Tc NNP O
99m CD O
MDP NNP O
, , O
an DT O
indicator NN O
of IN O
bone NN O
metabolism NN O
) ) O
and CC O
at IN O
the DT O
end NN O
of IN O
the DT O
studies NNS O
by IN O
determining VBG O
ash JJ O
weights NNS O
of IN O
femur NN O
, , O
ilium NN O
and CC O
sacrum NN O
. . O

For IN O
colostral JJ O
milk NN O
there EX O
was VBD O
a DT O
significant JJ O
correlation NN O
of IN O
vitamin NN O
K1 NNP O
to TO O
cholesterol VB O
( ( O
r VB O
= RB O
0 CD O
. . O
62 CD O
) ) O
but CC O
not RB O
to TO O
total JJ O
lipid JJ O
or CC O
phospholipid JJ O
suggesting VBG O
a DT O
role NN O
for IN O
cholesterol NN O
in IN O
the DT O
secretion NN O
of IN O
vitamin NN O
K1 NNP O
into IN O
colostral JJ O
milk NN O
. . O

These DT O
results NNS O
illuminate VBP O
a DT O
hitherto NN O
unanticipated JJ O
function NN O
of IN O
U6 NNP B-Gene
RNA NNP I-Gene
: : O
the DT O
modulation NN O
of IN O
a DT O
phosphorylation NN O
- : O
dephosphorylation NN O
cycle NN O
of IN O
C1 NNP B-Gene
hnRNP NN I-Gene
protein NN I-Gene
that WDT O
influences VBZ O
the DT O
binding VBG O
affinity NN O
of IN O
this DT O
protein NN O
for IN O
pre JJ O
- : O
mRNA NN O
. . O

The DT O
prognosis NN O
of IN O
seven CD O
patients NNS O
who WP O
received VBD O
ABSCT NNP O
was VBD O
significantly RB O
better JJR O
than IN O
that DT O
of IN O
13 CD O
patients NNS O
who WP O
received VBD O
conventional JJ O
therapy NN O
alone RB O
. . O

The DT O
C NNP O
- : O
terminal JJ O
end NN O
of IN O
this DT O
polypeptide NN O
harbors VBZ O
three CD O
types NNS O
of IN O
repeated JJ O
sequences NNS O
. . O

Enzyme NNP B-Gene
I PRP I-Gene
of IN O
the DT O
phosphoenolpyruvate NN B-Gene
: : I-Gene
sugar NN I-Gene
phosphotransferase NN I-Gene
system NN O
. . O

By IN O
contrast NN O
, , O
mTRAP100 NN B-Gene
coprecipitates NNS O
in IN O
vivo NN O
with IN O
another DT O
component NN O
of IN O
the DT O
TRAP NNP B-Gene
complex NN I-Gene
( ( O
TRAP220 NNP B-Gene
) ) O
, , O
which WDT O
directly RB O
contacts VBZ O
TR NNP B-Gene
and CC O
the DT O
vitamin NN B-Gene
D NNP I-Gene
receptor NN I-Gene
in IN O
a DT O
ligand NN O
- : O
dependent JJ O
manner NN O
. . O

Value NNP O
of IN O
determination NN O
of IN O
alkaline JJ B-Gene
phosphatase NN I-Gene
isoenzymes NNS I-Gene
for IN O
differential JJ O
diagnosis NN O
of IN O
obstructive JJ O
jaundice NN O
and CC O
biliary JJ O
liver NN O
cirrhosis NN O

We PRP O
studied VBD O
the DT O
role NN O
of IN O
prostaglandins NNS O
in IN O
acid JJ O
- : O
induced JJ O
esophagitis NN O
and CC O
the DT O
associated JJ O
LES NNP O
hypotension NN O
by IN O
simultaneous JJ O
treatment NN O
of IN O
some DT O
animals NNS O
with IN O
indomethacin NN O
( ( O
150 CD O
micrograms NNS O
/ VBP O
kg RB O
intravenous JJ O
) ) O
, , O
a DT O
specific JJ O
inhibitor NN O
of IN O
prostaglandin JJ O
synthesis NN O
, , O
either CC O
during IN O
production NN O
of IN O
esophagitis NN O
or CC O
during IN O
recovery NN O
. . O

All DT O
lambs VBZ O
with IN O
B NNP O
breeding NN O
had VBD O
significantly RB O
higher JJR O
Hb NNP B-Gene
levels NNS O
at IN O
the DT O
end NN O
of IN O
the DT O
experiment NN O
than IN O
did VBD O
NB NNP O
lambs NN O
. . O

Molecular JJ O
cloning NN O
and CC O
characterisation NN O
of IN O
the DT O
two CD O
homologous JJ O
genes NNS O
coding VBG O
for IN O
nitrate JJ B-Gene
reductase NN I-Gene
in IN I-Gene
tobacco NN I-Gene
. . O

These DT O
findings NNS O
demonstrate VBP O
that IN O
signature NN O
- : O
tagged VBN O
mutagenesis NN O
is VBZ O
a DT O
viable JJ O
approach NN O
to TO O
identify VB O
bacterial JJ O
genes NNS O
associated VBN O
with IN O
the DT O
ability NN O
to TO O
infect VB O
the DT O
urinary JJ O
tract NN O
. . O

Judicious JJ O
use NN O
of IN O
laboratory NN O
testing NN O
, , O
including VBG O
monitoring NN O
of IN O
CD4 NNP B-Gene
cell NN O
counts NNS O
, , O
is VBZ O
recommended VBN O
. . O

Nonreturn NNP O
rates NNS O
can MD O
be VB O
used VBN O
to TO O
derive VB O
more JJR O
elementary JJ O
biological JJ O
measures NNS O
for IN O
reproductive JJ O
efficiency NN O
, , O
such JJ O
as IN O
conception NN O
rate NN O
and CC O
calving VBG O
rate NN O
, , O
which WDT O
separately RB O
might MD O
be VB O
more RBR O
reliable JJ O
than IN O
nonreturn NN O
rate NN O
itself PRP O
to TO O
evaluate VB O
the DT O
fertility NN O
of IN O
a DT O
bull NN O
or CC O
the DT O
performance NN O
of IN O
an DT O
AI NNP O
technician NN O
. . O

When WRB O
examined VBN O
as IN O
adults NNS O
( ( O
8 CD O
weeks NNS O
old JJ O
) ) O
, , O
the DT O
external JJ O
genitalia NN O
of IN O
TA NNP O
- : O
exposed VBD O
offspring VBG O
were VBD O
normal JJ O
. . O

Patients NNS O
with IN O
antibody JJ O
peaks NNS O
, , O
defined VBD O
as IN O
fivefold NN O
or CC O
higher JJR O
increase NN O
in IN O
antibody NN O
titer NN O
compared VBN O
to TO O
the DT O
lowest JJS O
antibody NN O
titer NN O
over IN O
the DT O
course NN O
of IN O
GBS NNP O
, , O
had VBD O
higher JJR O
disability NN O
scores NNS O
during IN O
the DT O
first JJ O
two CD O
weeks NNS O
of IN O
GBS NNP O
and CC O
a DT O
worse JJR O
clinical JJ O
outcome NN O
( ( O
anti JJ B-Gene
- : I-Gene
GM1 NNP I-Gene
IgG NNP I-Gene
and CC O
anti SYM B-Gene
- : I-Gene
GD1a NNP I-Gene
IgM NNP I-Gene
antibody NN I-Gene
peaks NNS O
) ) O
and CC O
axonal JJ O
damage NN O
( ( O
anti JJ B-Gene
- : I-Gene
GD1a NNP I-Gene
IgM NNP I-Gene
antibody NN I-Gene
peaks NNS O
) ) O
, , O
compared VBN O
to TO O
patients NNS O
without IN O
peak JJ O
antibody NN O
titers NNS O
. . O

Indeed RB O
, , O
mutation NN O
of IN O
two CD O
of IN O
these DT O
motifs NNS O
, , O
known VBN O
to TO O
be VB O
important JJ O
to TO O
regulation NN O
of IN O
sid1 NN B-Gene
, , O
altered VBD O
the DT O
differential JJ O
regulation NN O
of IN O
sid2 NN B-Gene
by IN O
iron NN O
. . O

In IN O
infected JJ O
mammalian JJ O
cells NNS O
, , O
the DT O
ARV NNP B-Gene
G NNP I-Gene
and CC O
GNS NNP B-Gene
genes NNS I-Gene
are VBP O
transcribed VBN O
primarily RB O
as IN O
a DT O
polycistronic NN O
mRNA NN O
which WDT O
appears VBZ O
to TO O
extend VB O
from IN O
the DT O
consensus NN O
sequence NN O
( ( O
AACAG NNP O
) ) O
at IN O
the DT O
start NN O
of IN O
the DT O
G NNP B-Gene
gene NN I-Gene
to TO O
the DT O
next JJ O
recognized VBN O
polyadenylation NN O
signal NN O
( ( O
CATG NNP O
[ VBZ O
A NNP O
] NNP O
7 CD O
) ) O
located VBD O
697 CD O
nucleotides NNS O
downstream NN O
of IN O
the DT O
GNS NNP B-Gene
protein NN I-Gene
termination NN O
codon NN O
. . O

Deletion NN O
of IN O
the DT O
proximal JJ O
octanucleotide NN O
motif NN O
from IN O
the DT O
plasmid NN O
containing VBG O
the DT O
- : O
461 CD O
fragment NN O
of IN O
the DT O
LPL NNP B-Gene
promoter NN I-Gene
, , O
resulted VBD O
in IN O
a DT O
79 CD O
and CC O
76 CD O
% NN O
decrease NN O
in IN O
the DT O
level NN O
of IN O
expression NN O
in IN O
transfected JJ O
3T3 CD O
- : O
L1 NN O
adipocytes NNS O
and CC O
HepG2 NNP O
hepatocytes NNS O
, , O
respectively RB O
. . O

Toward NNP O
absolute NN O
methods NNS O
in IN O
clinical JJ O
chemistry NN O
: : O
application NN O
of IN O
mass NN O
fragmentography NN O
to TO O
high JJ O
- : O
accuracy NN O
analyses NNS O
. . O

The DT O
defined JJ O
length NN O
of IN O
the DT O
mRNA NN O
, , O
1 CD O
, , O
838 CD O
nucleotides NNS O
, , O
was VBD O
in IN O
agreement NN O
with IN O
that DT O
of IN O
a DT O
1 CD O
. . O
9 CD O
- : O
kb NN O
RNA NNP O
expressed VBD O
throughout IN O
the DT O
replication NN O
cycle NN O
, , O
starting VBG O
at IN O
the DT O
early JJ O
stages NNS O
of IN O
infection NN O
. . O

2 CD O
. . O

Animals NNS O
that WDT O
received VBD O
DSP NNP O
- : O
4 CD O
were VBD O
significantly RB O
retarded VBN O
in IN O
motor NN O
recovery NN O
compared VBN O
with IN O
the DT O
saline NN O
group NN O
. . O

EXERCISE NN O
IN NNP O
THE NNP O
TERRESTRIAL NNP O
CHRISTMAS NNP O
ISLAND NNP O
RED NNP O
CRAB NNP O
GECARCOIDEA NNP O
NATALIS NNP O
- : O
ENERGETICS NN O
OF IN O
LOCOMOTION NNP O

Insulin NNP B-Gene
- : O
regulated VBD O
events NNS O
, , O
however RB O
, , O
occur VBP O
in IN O
all DT O
cells NNS O
. . O

Neither DT O
model NN O
, , O
as IN O
applied VBN O
, , O
provided VBD O
a DT O
satisfactory JJ O
account NN O
of IN O
the DT O
effects NNS O
of IN O
the DT O
main JJ O
variables NNS O
of IN O
number NN O
of IN O
tones NNS O
and CC O
amount NN O
of IN O
perturbation NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
400 CD O
WORDS NNP O
) ) O

Overproduction NN O
, , O
purification NN O
and CC O
characterization NN O
of IN O
M NNP B-Gene
. . I-Gene
HinfI NNP I-Gene
methyltransferase NN I-Gene
and CC O
its PRP$ O
deletion NN O
mutant NN O
. . O

HFA $ O
134a CD O
had VBD O
a DT O
greater JJR O
tendency NN O
to TO O
take VB O
up RP O
moisture NN O
from IN O
the DT O
environment NN O
than IN O
did VBD O
HFA NNP O
227 CD O
. . O

An DT O
association NN O
was VBD O
demonstrated VBN O
between IN O
the DT O
expression NN O
of IN O
aberrantly RB O
and CC O
/ VB O
or CC O
alternatively RB O
spliced JJ O
mdm2 NN B-Gene
mRNAs NN I-Gene
and CC O
a DT O
lack NN O
of IN O
progesterone NN B-Gene
receptor NN I-Gene
. . O

For IN O
oral JJ O
administration NN O
, , O
AUC0 NNP O
- : O
infinity NN O
was VBD O
58 CD O
. . O
47 CD O
+ JJ O
/ NNP O
- : O
16 CD O
. . O
37 CD O
microg JJ O
x NN O
h NN O
/ NNP O
ml NN O
, , O
t1 EX O
/ $ O
2beta CD O
was VBD O
18 CD O
. . O
39 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
6 CD O
hours NNS O
, , O
maximum JJ O
concentration NN O
( ( O
Cmax NNP O
) ) O
was VBD O
2 CD O
. . O
12 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
51 CD O
microg JJ O
/ NNP O
ml NN O
, , O
time NN O
to TO O
Cmax NNP O
was VBD O
2 CD O
. . O
20 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O
17 CD O
hours NNS O
, , O
mean JJ O
absorption NN O
time NN O
was VBD O
2 CD O
. . O
9 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
51 CD O
hours NNS O
, , O
and CC O
bioavailability NN O
was VBD O
42 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
42 CD O
% NN O
. . O

In IN O
contrast NN O
, , O
high JJ O
COUP NNP B-Gene
- : I-Gene
TFI NNP I-Gene
expression NN O
impeded VBD O
the DT O
neuronal JJ O
differentiation NN O
of IN O
P19 NNP O
cells NNS O
induced VBD O
with IN O
RA NNP O
, , O
resulting VBG O
in IN O
cell NN O
cultures NNS O
lacking VBG O
neurons NNS O
. . O

The DT O
greatest JJS O
difference NN O
between IN O
the DT O
Ad7 NNP B-Gene
and CC I-Gene
Ad5 NNP I-Gene
DBPs NNP I-Gene
is VBZ O
the DT O
absence NN O
, , O
in IN O
the DT O
Ad7 NNP O
protein NN O
, , O
of IN O
12 CD O
amino JJ O
acids NNS O
located VBN O
between IN O
the DT O
two CD O
functional JJ O
domains NNS O
in IN O
the DT O
Ad5 NNP O
protein NN O
( ( O
amino JJ O
acids NNS O
151 CD O
- : O
162 CD O
) ) O
. . O

Newcastle NNP O
disease NN O
virus NN O
surveillance NN O
in IN O
Hong NNP O
Kong NNP O
on IN O
local JJ O
and CC O
imported JJ O
poultry NN O
. . O

A DT O
value NN O
of IN O
1 CD O
. . O
1 CD O
l JJ O
/ NNP O
kg NN O
was VBD O
used VBN O
for IN O
V NNP O
in IN O
calculating VBG O
all DT O
single JJ O
sample NN O
estimates NNS O
of IN O
clearance NN O
( ( O
CL NNP O
) ) O
, , O
and CC O
a DT O
value NN O
of IN O
4 CD O
. . O
3 CD O
l JJ O
/ NNP O
kg NN O
was VBD O
used VBN O
to TO O
calculate VB O
single JJ O
sample NN O
estimates NNS O
of IN O
clearance NN O
of IN O
plasma JJ O
unbound JJ O
drug NN O
( ( O
CLunb NNP O
) ) O
. . O

Injection NN O
of IN O
double JJ O
- : O
stranded VBN O
RNA NNP O
into IN O
C NNP O
. . O
elegans NNS O
results NNS O
in IN O
embryonic JJ O
lethality NN O
; : O
thus RB O
, , O
the DT O
SF1 NNP B-Gene
gene NN I-Gene
is VBZ O
essential JJ O
not RB O
only RB O
in IN O
yeast NN O
but CC O
also RB O
in IN O
at IN O
least JJS O
one CD O
metazoan NN O
. . O

Bioplastique NNP O
granuloma NN O
presents NNS O
with IN O
irregularly JJ O
shaped VBN O
cystic JJ O
spaces NNS O
of IN O
varying VBG O
size NN O
containing VBG O
jagged VBN O
, , O
translucent NN O
, , O
nonbirefringent JJ O
foreign JJ O
bodies NNS O
whereas VBP O
Artecoll NNP O
granuloma NN O
shows VBZ O
numerous JJ O
round NN O
vacuoles NNS O
nearly RB O
identical JJ O
in IN O
size NN O
and CC O
shape NN O
enclosing VBG O
round NN O
and CC O
sharply RB O
circumscribed JJ O
, , O
translucent JJ O
, , O
nonbirefringent JJ O
foreign JJ O
bodies NNS O
. . O

Deadenylation NN O
and CC O
decay NN O
of IN O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
mRNA NN I-Gene
in IN O
K562 NNP O
cells NNS O
is VBZ O
extraordinarily RB O
slow JJ O
compared VBN O
with IN O
NIH NNP O
3T3 CD O
cells NNS O
, , O
suggesting VBG O
that IN O
the DT O
increased VBN O
stability NN O
gained VBN O
by IN O
beta NN B-Gene
- : I-Gene
globin NN I-Gene
mRNA NN I-Gene
in IN O
K562 NNP O
cells NNS O
is VBZ O
mainly RB O
controlled VBN O
at IN O
the DT O
deadenylation NN O
step NN O
. . O

The DT O
P NNP B-Gene
mRNA NN I-Gene
also RB O
contains VBZ O
a DT O
third JJ O
ORF NNP O
for IN O
the DT O
V NNP B-Gene
protein NN I-Gene
, , O
although IN O
it PRP O
is VBZ O
unclear JJ O
how WRB O
or CC O
whether IN O
this DT O
ORF NNP O
is VBZ O
accessed VBN O
. . O

We PRP O
examined VBD O
Akt NNP B-Gene
activation NN O
in IN O
Lyn NNP B-Gene
- : O
, , O
Syk NNP B-Gene
- : O
and CC O
Btk NNP B-Gene
- : O
deficient NN O
DT40 NNP O
cells NNS O
and CC O
B NNP O
cells NNS O
from IN O
Lyn NNP B-Gene
( ( I-Gene
- : I-Gene
/ SYM I-Gene
- : I-Gene
) ) I-Gene
mice NN O
. . O

Hypoglycemic NNP O
action NN O
of IN O
"""" NN O
he PRP O
xiang VBD O
zhuang NNP O
qi NN O
gong NN O
"""" NN O
and CC O
its PRP$ O
mechanism NN O
on IN O
diabetes NNS O
mellitus NNS O

Initial JJ O
estimates NNS O
indicate VBP O
that IN O
27 CD O
, , O
193 CD O
people NNS O
are VBP O
either RB O
in IN O
receipt NN O
of IN O
or CC O
in IN O
need NN O
of IN O
mental JJ O
handicap NN O
services NNS O
. . O

Previous JJ O
experimental JJ O
evidence NN O
had VBD O
indicated VBN O
that IN O
Reg1 NNP B-Gene
might MD O
target VB O
Glc7 NNP B-Gene
to TO O
nuclear JJ O
substrates NNS O
such JJ O
as IN O
the DT O
Snf1 NNP B-Gene
kinase NN I-Gene
complex NN I-Gene
. . O

This DT O
region NN O
constitutes VBZ O
the DT O
DNA NNP O
- : O
binding NN O
domain NN O
with IN O
basic JJ O
- : O
helix NN O
- : O
loop NN O
- : O
helix NN O
and CC O
leucine JJ O
- : O
zipper NN O
motifs NNS O
, , O
features NNS O
common JJ O
to TO O
the DT O
myc NN B-Gene
- : I-Gene
related JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
family NN I-Gene
. . O

The DT O
relative JJ O
toxicity NN O
of IN O
nickel JJ O
oxide NN O
( ( O
NiO NNP O
) ) O
, , O
nickel JJ O
sulfate NN O
hexahydrate NN O
( ( O
NiSO4 NNP O
. . O
6H2O CD O
) ) O
, , O
and CC O
nickel JJ O
subsulfide NN O
( ( O
Ni3S2 NNP O
) ) O
was VBD O
studied VBN O
in IN O
F344 NNP O
/ NNP O
N NNP O
rats NNS O
and CC O
B6C3F1 NNP O
mice NN O
after IN O
inhalation NN O
exposure NN O
for IN O
6 CD O
hr JJ O
/ NNP O
day NN O
, , O
5 CD O
days NNS O
/ JJ O
week NN O
, , O
for IN O
13 CD O
weeks NNS O
. . O

Two CD O
estrogen NN B-Gene
receptor NN I-Gene
( ( O
ER NNP B-Gene
) ) O
isoforms VBZ O
with IN O
different JJ O
estrogen NN O
dependencies NNS O
are VBP O
generated VBN O
from IN O
the DT O
trout NN B-Gene
ER NNP I-Gene
gene NN I-Gene
. . O

Copyright JJ O
1999 CD O
Academic NNP O
Press NNP O
. . O

Selection NN O
was VBD O
based VBN O
on IN O
expression NN O
of IN O
an DT O
integrated VBN O
DNA NNP O
fragment NN O
containing VBG O
the DT O
con NN B-Gene
- : I-Gene
10 CD I-Gene
promoter NN I-Gene
- : I-Gene
regulatory JJ I-Gene
region NN I-Gene
followed VBN O
by IN O
the DT O
initial JJ O
segment NN O
of IN O
the DT O
con NN B-Gene
- : I-Gene
10 CD I-Gene
open JJ I-Gene
reading NN I-Gene
frame NN I-Gene
fused VBN O
in IN O
frame NN O
with IN O
the DT O
bacterial JJ B-Gene
hygromycin NN I-Gene
B NNP I-Gene
phosphotransferase NN I-Gene
structural JJ I-Gene
gene NN I-Gene
( ( O
con10 NN B-Gene
' '' I-Gene
- : I-Gene
' POS I-Gene
hph NN I-Gene
) ) O
. . O

Antidromic NNP O
invasion NN O
of IN O
impulses NNS O
and CC O
recurrent JJ O
collateral NN O
inhibition NN O
in IN O
pyramidal JJ O
tract NN O
neurones NNS O
. . O

Upstream NN O
of IN O
the DT O
dra NN B-Gene
gene NN I-Gene
an DT O
open JJ O
reading NN O
frame NN O
of IN O
313 CD O
amino JJ O
acids NNS O
was VBD O
identified VBN O
. . O

METHODS NNS O
: : O
Four CD O
hundred VBD O
fifty JJ O
patients NNS O
with IN O
the DT O
diagnosis NN O
of IN O
squamous JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
oral JJ O
cavity NN O
received VBD O
their PRP$ O
primary JJ O
treatment NN O
at IN O
Roswell NNP O
Park NNP O
Cancer NNP O
Center NNP O
( ( O
RPCI NNP O
) ) O
from IN O
1971 CD O
to TO O
1991 CD O
. . O

Significance NN O
of IN O
the DT O
biopsy NN O
site NN O
of IN O
the DT O
latissimus NN O
dorsi NN O
muscle NN O
for IN O
fiber NN O
typing NN O
. . O

The DT O
plant NN O
protein NN O
maintains VBZ O
all PDT O
the DT O
functional JJ O
domains NNS O
found VBN O
in IN O
the DT O
other JJ O
proteins NNS O
, , O
including VBG O
nuclear JJ O
localization NN O
signal NN O
, , O
DNA NNP O
- : O
binding NN O
domain NN O
and CC O
helicase NN B-Gene
motifs NNS I-Gene
, , O
suggesting VBG O
that IN O
it PRP O
might MD O
also RB O
act VB O
as IN O
part NN O
of IN O
the DT O
RNA NNP O
transcription NN O
apparatus NN O
, , O
as RB O
well RB O
as IN O
nucleotide JJ O
excision NN O
repair NN O
in IN O
plant NN O
cells NNS O
. . O

Based VBN O
on IN O
this DT O
analysis NN O
, , O
we PRP O
propose VBP O
that IN O
the DT O
interactions NNS O
of IN O
Sos NNP B-Gene
with IN O
the DT O
switch NN O
1 CD O
and CC O
switch VB O
2 CD O
regions NNS O
of IN O
Ras NNP B-Gene
have VBP O
distinct JJ O
functional JJ O
consequences NNS O
: : O
the DT O
interaction NN O
with IN O
switch NN O
2 CD O
mediates VBZ O
the DT O
anchoring NN O
of IN O
Ras NNP B-Gene
to TO O
Sos NNP B-Gene
, , O
whereas IN O
the DT O
interaction NN O
with IN O
switch NN O
1 CD O
leads VBZ O
to TO O
disruption NN O
of IN O
the DT O
nucleotide JJ O
- : O
binding NN O
site NN O
and CC O
GDP NNP O
dissociation NN O
. . O

To TO O
our PRP$ O
knowledge NN O
, , O
type NN O
IV NNP O
renal JJ O
tubular NN O
acidosis NN O
has VBZ O
not RB O
been VBN O
reported VBN O
previously RB O
in IN O
association NN O
with IN O
Alport NNP O
' POS O
s JJ O
syndrome NN O
in IN O
an DT O
adult NN O
patient NN O
. . O

In IN O
the DT O
present JJ O
report NN O
, , O
66 CD O
hemochromatosis NN O
families NNS O
yielding VBG O
151 CD O
hemochromatosis NN O
chromosomes NNS O
and CC O
182 CD O
normal JJ O
chromosomes NNS O
were VBD O
RFLP NNP O
- : O
typed VBD O
with IN O
a DT O
battery NN O
of IN O
probes NNS O
, , O
including VBG O
two CD O
newly RB O
derived VBN O
polymorphic JJ O
markers NNS O
from IN O
the DT O
6 CD O
. . O
7 CD O
and CC O
HLA NNP B-Gene
- : I-Gene
F NNP I-Gene
loci NN I-Gene
located VBD O
150 CD O
and CC O
250 CD O
kb NNS O
telomeric JJ O
to TO O
HLA NNP B-Gene
- : I-Gene
A NN I-Gene
, , O
respectively RB O
. . O

cDNA NN O
clones NNS O
encoding VBG O
Arabidopsis NNP O
thaliana NN O
and CC O
Zea NNP B-Gene
mays VBZ I-Gene
mitochondrial JJ I-Gene
chaperonin NN I-Gene
HSP60 NNP B-Gene
and CC O
gene NN O
expression NN O
during IN O
seed NN O
germination NN O
and CC O
heat NN O
shock NN O
. . O

When WRB O
the DT O
entire JJ O
diet NN O
consisted VBD O
of IN O
SBF NNP O
, , O
voluntary JJ O
feed NN O
intake NN O
was VBD O
reduced VBN O
, , O
indicating VBG O
that IN O
SBF NNP O
should MD O
not RB O
be VB O
fed VBN O
to TO O
ponies NNS O
as IN O
the DT O
sole JJ O
dietary JJ O
ingredient NN O
. . O

Both DT O
EWS NNP B-Gene
- : O
FLI NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
FLI NNP B-Gene
- : I-Gene
1 CD I-Gene
proteins NNS I-Gene
function NN O
as IN O
transcription NN O
factors NNS O
that WDT O
bind VBP O
specifically RB O
to TO O
ets NNS B-Gene
sequences NNS O
( ( O
the DT O
ets NNS B-Gene
boxes NNS O
) ) O
present VBP O
in IN O
promoter NN O
elements NNS O
. . O

Introduction NN O
of IN O
v JJ B-Gene
- : I-Gene
fms NN I-Gene
into IN O
a DT O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
dependent JJ O
murine NN O
macrophage NN O
cell NN O
line NN O
induced VBN O
factor NN O
independence NN O
and CC O
tumorigenicity NN O
by IN O
a DT O
nonautocrine JJ O
mechanism NN O
. . O

The DT O
other JJ O
element NN O
bound IN O
RBP NNP B-Gene
- : I-Gene
J NNP I-Gene
kappa VBZ I-Gene
with IN O
low JJ O
affinity NN O
. . O

Atheroma NNP O
appears VBZ O
as IN O
a DT O
very RB O
low JJ O
signal NN O
intensity NN O
area NN O
on IN O
2 CD O
- : O
dimensional JJ O
time NN O
- : O
of IN O
- : O
flight NN O
( ( O
TOF NNP O
) ) O
magnetic JJ O
resonance NN O
( ( O
MR NNP O
) ) O
images VBZ O
, , O
and CC O
its PRP$ O
components NNS O
have VBP O
various JJ O
signal JJ O
intensities NNS O
on IN O
spin NN O
- : O
echo NN O
( ( O
SE NNP O
) ) O
images NNS O
. . O

Clones NNS O
33F CD O
and CC O
34B CD O
encoded VBD O
identical JJ O
aromatase NN B-Gene
proteins NNS I-Gene
of IN O
503 CD O
amino NN O
acids NNS O
, , O
but CC O
differed VBD O
in IN O
size NN O
due JJ O
to TO O
alternative JJ O
polyadenylation NN O
signal JJ O
usage NN O
for IN O
the DT O
corresponding JJ O
mRNAs NN O
. . O

Total JJ O
cumulative JJ O
doses NNS O
of IN O
doxorubicin NNS O
ranged VBN O
from IN O
145 CD O
to TO O
625 CD O
mg NN O
. . O
/ JJ O
m NN O
. . O
2 CD O
. . O

The DT O
missing VBG O
5 CD O
' '' O
sequences NNS O
were VBD O
obtained VBN O
by IN O
5 CD O
' POS O
- : O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
and CC O
by IN O
analysis NN O
of IN O
an DT O
NHE5 NNP B-Gene
genomic JJ I-Gene
clone NN I-Gene
, , O
and CC O
the DT O
missing VBG O
3 CD O
' '' O
sequences NNS O
were VBD O
obtained VBN O
by IN O
3 CD O
' POS O
- : O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
. . O

Resistance NN O
to TO O
thyroid VB O
hormone NN O
: : O
implications NNS O
for IN O
neurodevelopmental JJ O
research NN O
on IN O
the DT O
effects NNS O
of IN O
thyroid JJ O
hormone NN O
disruptors NNS O
. . O

Both DT O
neural JJ O
and CC O
hormonal JJ O
pathways NNS O
and CC O
both DT O
opiate NN O
and CC O
nonopiate NN O
substances NNS O
play VBP O
roles NNS O
in IN O
the DT O
complex JJ O
modulation NN O
of IN O
pain NN O
transmission NN O
. . O

Rams NNS O
were VBD O
weighed VBN O
and CC O
testis JJ O
size NN O
was VBD O
estimated VBN O
by IN O
orchimetry NN O
at IN O
each DT O
time NN O
period NN O
. . O

Private JJ O
hospital NN O
accreditation NN O
. . O

Such JJ O
multisensory JJ O
interactions NNS O
can MD O
be VB O
significant JJ O
for IN O
behavior NN O
. . O

Linear JJ O
extrapolation NN O
is VBZ O
used VBN O
below IN O
the DT O
experimental JJ O
data NN O
range NN O
to TO O
establish VB O
an DT O
upper JJ O
bound NN O
on IN O
carcinogenic JJ O
risk NN O
at IN O
low JJ O
doses NNS O
. . O

Regression NN O
analyses NNS O
identified VBD O
7 CD O
risk NN O
and CC O
7 CD O
protective JJ O
factors NNS O
with IN O
minimal JJ O
overlap NN O
. . O

The DT O
incidence NN O
of IN O
hepatitis NN B-Gene
B NNP I-Gene
antigen NN I-Gene
following VBG O
transfusion NN O
was VBD O
about IN O
2 CD O
. . O
8 CD O
per IN O
cent NN O
. . O

Efficacy NN O
was VBD O
determined VBN O
by IN O
responses NNS O
to TO O
question VB O
3 CD O
( ( O
ability NN O
to TO O
achieve VB O
an DT O
erection NN O
) ) O
and CC O
question $ O
4 CD O
( ( O
ability NN O
to TO O
maintain VB O
an DT O
erection NN O
) ) O
of IN O
the DT O
15 CD O
- : O
item NN O
International NNP O
Index NNP O
of IN O
Erectile NNP O
Function NNP O
( ( O
IIEF NNP O
) ) O
. . O

Potential JJ O
treatments NNS O
include VBP O
dobutamine NN O
, , O
KATP NNP O
channel NN O
activators NNS O
, , O
and CC O
21 CD O
- : O
aminosteroids NNS O
. . O

By IN O
order NN O
of IN O
decreasing VBG O
rate NN O
, , O
finger NN O
flexors NNS O
, , O
jaw NN O
, , O
crossed VBD O
adductors NNS O
, , O
and CC O
triceps NNS O
reflexes NNS O
were VBD O
less RBR O
frequently RB O
elicited VBN O
in IN O
both DT O
groups NNS O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
D NNP O
( ( O
4 CD O
) ) O
and CC O
D NNP O
( ( O
2L CD O
) ) O
receptors NNS O
activate VBP O
the DT O
ERK NNP B-Gene
kinase NN I-Gene
cascade NN O
by IN O
first JJ O
mobilizing VBG O
signaling NN O
by IN O
the DT O
PDGF NNP B-Gene
receptor NN I-Gene
, , O
followed VBN O
by IN O
the DT O
subsequent JJ O
activation NN O
of IN O
ERK1 NNP B-Gene
/ NNP I-Gene
2 CD I-Gene
by IN O
pathways NNS O
associated VBN O
with IN O
this DT O
receptor NN B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
. . O

Two CD O
promoters NNS O
were VBD O
identified VBN O
by IN O
S1 NNP B-Gene
nuclease NN I-Gene
mapping NN O
: : O
P1 NNP O
, , O
which WDT O
lies VBZ O
about IN O
72 CD O
bp NNS O
upstream RB O
from IN O
the DT O
structural JJ O
gene NN O
; : O
and CC O
P2 NNP O
, , O
which WDT O
lies VBZ O
about IN O
35 CD O
bp NN O
upstream NN O
. . O

For IN O
smaller JJR O
vessels NNS O
up IN O
to TO O
a DT O
diameter NN O
of IN O
0 CD O
. . O
5 CD O
mm NN O
, , O
treatments NNS O
at IN O
16 CD O
and CC O
18 CD O
J NNP O
/ NNP O
cm2 NN O
showed VBD O
good JJ O
results NNS O
in IN O
60 CD O
and CC O
82 CD O
% NN O
respectively RB O
; : O
for IN O
vessels NNS O
up RB O
to TO O
1 CD O
mm NNS O
in IN O
27 CD O
and CC O
33 CD O
% NN O
. . O

UV NNP O
cross SYM O
- : O
linking VBG O
experiments NNS O
demonstrated VBD O
that IN O
HSV NNP O
infection NN O
caused VBD O
enhanced JJ O
binding NN O
of IN O
protein NN O
factors NNS O
, , O
including VBG O
the DT O
64 CD B-Gene
- : I-Gene
kDa NN I-Gene
component NN I-Gene
of IN I-Gene
cleavage NN I-Gene
stimulation NN I-Gene
factor NN I-Gene
( ( O
CstF NNP B-Gene
) ) O
, , O
to TO O
poly VB O
( ( O
A DT O
) ) O
site NN O
RNAs NNP O
from IN O
virus NN O
genes NNS O
of IN O
all DT O
temporal JJ O
classes NNS O
and CC O
that IN O
this DT O
enhanced VBD O
binding NN O
required VBN O
expression NN O
of IN O
IE63 NNP B-Gene
. . O

Accurate NNP O
pathologic NN O
staging VBG O
identifies NNS O
patients NNS O
who WP O
are VBP O
potentially RB O
curable JJ O
with IN O
radiotherapy NN O
. . O

Mutational JJ O
analysis NN O
shows VBZ O
that IN O
both DT O
an DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
like IN I-Gene
sequence NN I-Gene
( ( O
- : O
294 CD O
/ SYM O
- : O
285 CD O
, , O
TGAATCATCA NNP O
) ) O
and CC O
an DT O
A NNP O
/ NN O
T NNP O
- : O
rich JJ O
myocyte NN B-Gene
enhancer NN I-Gene
factor NN I-Gene
( ( I-Gene
MEF NNP I-Gene
) ) I-Gene
- : I-Gene
2 CD I-Gene
like IN I-Gene
sequence NN I-Gene
( ( O
- : O
310 CD O
/ SYM O
- : O
298 CD O
, , O
TTAAAAATAAAAA NNP O
) ) O
in IN O
the DT O
33 CD O
- : O
bp NN O
region NN O
are VBP O
necessary JJ O
for IN O
the DT O
OP NNP B-Gene
- : I-Gene
1 CD I-Gene
effect NN O
. . O

The DT O
strategy NN O
has VBZ O
been VBN O
used VBN O
to TO O
determine VB O
2 CD O
. . O
6 CD O
kilobases NNS O
of IN O
nucleotide JJ O
sequence NN O
in IN O
the DT O
Saccharomyces NNP B-Gene
cerevisiae NN I-Gene
ADE NNP I-Gene
1 CD I-Gene
locus NN I-Gene
. . O

To TO O
examine VB O
the DT O
possibility NN O
that WDT O
LNNB NNP O
performance NN O
of IN O
the DT O
schizophrenic JJ O
groups NNS O
may MD O
have VB O
been VBN O
related VBN O
to TO O
neuroleptic JJ O
medication NN O
, , O
analyses NNS O
were VBD O
completed VBN O
on IN O
the DT O
relationship NN O
between IN O
medication NN O
levels NNS O
and CC O
LNNB NNP O
scores NNS O
. . O

The DT O
viral JJ B-Gene
oncoprotein NN I-Gene
E1A NNP I-Gene
inhibits VBZ O
NFAT NNP B-Gene
- : O
dependent JJ O
transactivation NN O
in IN O
a DT O
p300 NN B-Gene
- : O
dependent JJ O
manner NN O
. . O

A DT O
multi NN O
- : O
centre JJ O
evaluation NN O
of IN O
the DT O
card NN O
indirect JJ O
agglutination NN O
test NN O
for IN O
trypanosomiasis NN O
( ( O
TrypTect NNP O
CIATT NNP O
) ) O
. . O

Secretory JJ O
function NN O
of IN O
the DT O
prostate NN O
gland NN O
. . O

The DT O
transforming VBG O
protein NN O
of IN O
Rous NNP O
sarcoma NN O
virus NN O
, , O
pp60v SYM B-Gene
- : I-Gene
src NN I-Gene
, , O
and CC O
its PRP$ O
normal JJ O
cellular JJ O
homolog NN O
, , O
pp60c SYM B-Gene
- : I-Gene
src NN I-Gene
, , O
differ NN O
not RB O
only RB O
in IN O
oncogenic JJ O
potential NN O
but CC O
also RB O
in IN O
their PRP$ O
subcellular JJ O
localization NN O
and CC O
cytoskeletal JJ O
binding NN O
ability NN O
. . O

A DT O
list NN O
of IN O
12 CD O
names NNS O
for IN O
the DT O
disease NN O
and CC O
37 CD O
diagnostic JJ O
criteria NNS O
were VBD O
proposed VBN O
to TO O
a DT O
Consensus NNP O
Panel NNP O
of IN O
12 CD O
Italian JJ O
experts NNS O
who WP O
ranked VBD O
them PRP O
in IN O
order NN O
so RB O
as IN O
to TO O
identify VB O
a DT O
core NN O
set NN O
of IN O
criteria NNS O
. . O

Northern NNP O
analysis NN O
revealed VBD O
no DT O
detectable JJ O
expression NN O
of IN O
the DT O
transcript NN O
in IN O
diapause NN O
- : O
or CC O
nondiapause IN O
- : O
programmed JJ O
wandering NN O
larvae NN O
, , O
and CC O
only RB O
trace JJ O
expression NN O
in IN O
nondiapausing VBG O
pupae NN O
. . O

Latexin NNP B-Gene
, , O
a DT O
carboxypeptidase NN B-Gene
A NNP I-Gene
inhibitor NN O
, , O
is VBZ O
expressed VBN O
in IN O
a DT O
cell NN O
type NN O
- : O
specific JJ O
manner NN O
in IN O
both DT O
central JJ O
and CC O
peripheral JJ O
nervous JJ O
systems NNS O
in IN O
the DT O
rat NN O
. . O

HIV NNP O
- : O
1 CD O
and CC O
hepatitis NN O
B NNP O
virus NN O
infections NNS O
in IN O
adolescents NNS O
lodged VBN O
in IN O
security NN O
institutes NNS O
of IN O
Buenos NNP O
Aires NNP O
. . O

The DT O
amount NN O
of IN O
these DT O
factors NNS O
was VBD O
reduced VBN O
in IN O
GEO NNP O
cells NNS O
in IN O
which WDT O
the DT O
u JJ B-Gene
- : I-Gene
PAR NNP I-Gene
gene NN I-Gene
is VBZ O
only RB O
weakly JJ O
transcriptionally RB O
activated VBN O
. . O

Insulin NNP B-Gene
regulation NN O
of IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
kinase NN I-Gene
( ( O
MEK NNP B-Gene
) ) O
, , O
mitogen SYM B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
and CC O
casein NN B-Gene
kinase NN I-Gene
in IN O
the DT O
cell NN O
nucleus NN O
: : O
a DT O
possible JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
gene NN O
expression NN O
. . O

Expression NN O
of IN O
this DT O
protein NN O
in IN O
E NNP O
. . O
coli NN O
demonstrated VBD O
that IN O
tyrosine NN O
was VBD O
incorporated VBN O
during IN O
suppression NN O
and CC O
that IN O
yeast JJ B-Gene
cytoplasmic JJ I-Gene
TyrRS NNP I-Gene
activity NN O
was VBD O
produced VBN O
. . O

In IN O
most JJS O
cases NNS O
of IN O
acute JJ O
transmural JJ O
infarction NN O
, , O
the DT O
reciprocal JJ O
ST NNP O
segment NN O
depressions NNS O
observed VBD O
in IN O
contralateral JJ O
leads NNS O
are VBP O
less RBR O
marked JJ O
than IN O
the DT O
primary JJ O
ST NNP O
segment NN O
elevations NNS O
. . O

i NN O
. . O

Ras NNP B-Gene
is VBZ O
not RB O
associated VBN O
with IN O
the DT O
tegument NN O
. . O

On IN O
the DT O
other JJ O
side NN O
, , O
when WRB O
the DT O
aortic JJ O
ring NN O
was VBD O
perfused VBN O
with IN O
L NNP O
- : O
NNA NNP O
( ( O
NO NNP O
- : O
synthesis NN O
inhibitor NN O
) ) O
or CC O
methylene JJ O
blue NN O
( ( O
soluble JJ O
cGMPase NN B-Gene
inhibitor NN O
) ) O
, , O
the DT O
changes NNS O
could MD O
be VB O
attenuated VBN O
. . O

D NNP O
. . O

Testing VBG O
for IN O
serum NN B-Gene
IgM NNP I-Gene
binding NN O
to TO O
GM1 NNP O
ganglioside NN O
in IN O
clinical JJ O
practice NN O
. . O

The DT O
initial JJ O
patients NNS O
treated VBN O
with IN O
AZQ NNP O
and CC O
mitroxantrone NN O
experienced VBD O
prolonged JJ O
bone NN O
marrow NN O
suppression NN O
and CC O
, , O
therefore RB O
, , O
subsequent JJ O
cohorts NNS O
were VBD O
treated VBN O
with IN O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
, , O
5 CD O
micrograms NNS O
/ JJ O
kg NN O
, , O
beginning VBG O
the DT O
day NN O
after IN O
completion NN O
of IN O
the DT O
third JJ O
cycle NN O
of IN O
chemotherapy NN O
. . O

Antibodies NNS O
raised VBN O
against IN O
a DT O
C NNP O
- : O
terminal JJ O
portion NN O
of IN O
Sec31A NNP B-Gene
co SYM O
- : O
precipitate NN O
Sec13 NNP B-Gene
and CC O
inhibit VB O
ER NNP O
- : O
Golgi NNP O
transport NN O
of IN O
temperature NN O
- : O
arrested VBN O
vesicular JJ O
stomatitis NN B-Gene
G NNP I-Gene
protein NN I-Gene
in IN O
a DT O
semi JJ O
- : O
intact JJ O
cell NN O
assay NN O
. . O

Decreased VBN O
cardiac JJ O
glycogen NN O
following VBG O
phenformin JJ O
injection NN O
in IN O
hyperglycemic JJ O
, , O
hyperinsulinemic JJ O
anaesthetized JJ O
rats NNS O
. . O

Ultrastructure NN O
of IN O
the DT O
tumor NN O
in IN O
1 CD O
patient NN O
in IN O
whom WP O
transurethral JJ O
resection NN O
was VBD O
performed VBN O
2 CD O
weeks NNS O
after IN O
alum JJ O
irrigation NN O
revealed VBD O
well RB O
preserved VBN O
nuclear JJ O
chromatin NN O
, , O
thus RB O
, , O
suggesting VBG O
that IN O
whatever WDT O
changes NNS O
occur VBP O
after IN O
alum NN O
irrigation NN O
are VBP O
short JJ O
- : O
lived VBD O
. . O

To TO O
investigate VB O
the DT O
potential JJ O
role NN O
of IN O
SP1 NNP B-Gene
, , O
we PRP O
examined VBD O
nuclear JJ O
extracts NNS O
from IN O
HCMV NNP O
- : O
infected JJ O
cells NNS O
. . O

The DT O
ZNF274 NNP B-Gene
gene NN I-Gene
is VBZ O
mapped VBN O
distal JJ O
to TO O
marker VB O
RP NNP O
S28 NNP O
1 CD O
in IN O
the DT O
human JJ O
chromosome NN O
19qter CD O
region NN O
, , O
by IN O
RH NNP O
mapping NN O
. . O

Molecular JJ O
and CC O
genetic JJ O
analysis NN O
of IN O
the DT O
yeast JJS B-Gene
early JJ I-Gene
meiotic JJ I-Gene
recombination NN I-Gene
genes NNS I-Gene
REC102 NNP I-Gene
and CC O
REC107 NNP B-Gene
/ NNP O
MER2 NNP B-Gene
. . O

The DT O
E NNP O
- : O
box NN O
sequence NN O
in IN O
the DT O
SE2 NNP B-Gene
fragment NN I-Gene
of IN O
the DT O
transferrin NN B-Gene
promoter NN I-Gene
was VBD O
CATCTG NNP O
and CC O
was VBD O
similar JJ O
in IN O
gel JJ O
shifts NNS O
to TO O
the DT O
consensus NN O
E NNP O
- : O
box NN O
elements NNS O
( ( O
CANNTG NNP O
) ) O
previously RB O
characterized VBN O
. . O

Removal NN O
of IN O
each DT O
of IN O
three CD O
contiguous JJ O
segments NNS O
from IN O
the DT O
N NNP O
- : O
terminal JJ O
half NN O
specifically RB O
inhibits VBZ O
the DT O
formation NN O
of IN O
5 CD B-Gene
. . I-Gene
8Ss CD I-Gene
rRNA NN I-Gene
, , O
whereas IN O
deleting VBG O
part NN O
of IN O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
of IN O
the DT O
protein NN O
only RB O
blocks VBZ O
the DT O
production NN O
of IN O
18S CD B-Gene
rRNA NN I-Gene
. . O

Prenatal JJ O
exposure NN O
to TO O
the DT O
fungicide NN O
dinocap NN O
causes VBZ O
behavioral JJ O
torticollis NNS O
, , O
ballooning NN O
and CC O
cleft NN O
palate NN O
in IN O
mice NN O
, , O
but CC O
not RB O
rats NNS O
or CC O
hamsters NNS O
. . O

SELECTION NNP O
CRITERIA NNP O
: : O
Randomised VBN O
controlled JJ O
trials NNS O
of IN O
cabergoline NN O
versus NN O
placebo NN O
in IN O
patients NNS O
with IN O
a DT O
clinical JJ O
diagnosis NN O
of IN O
idiopathic JJ O
Parkinson NNP O
' POS O
s JJ O
disease NN O
and CC O
long JJ O
- : O
term NN O
complications NNS O
of IN O
levodopa JJ O
therapy NN O
. . O

Inhibition NN O
of IN O
JNK1 NNP B-Gene
and CC O
ERK NNP B-Gene
kinase NNP O
activities NNS O
either CC O
by IN O
expression NN O
of IN O
the DT O
dominant JJ O
negative JJ O
mutant NN O
JNK1 NNP B-Gene
or CC O
by IN O
treatment NN O
with IN O
a DT O
selective JJ O
chemical NN O
inhibitor NN O
of IN O
ERK NNP B-Gene
( ( O
PD098059 NNP O
) ) O
substantially RB O
abrogates VBZ O
the DT O
UV NNP O
induction NN O
of IN O
the DT O
GADD45 NNP B-Gene
promoter NN I-Gene
. . O

RESULTS NN O
: : O
Auditory JJ O
thresholds NNS O
collected VBN O
during IN O
audiometric JJ O
tests NNS O
increased VBD O
gradually RB O
in IN O
proportion NN O
with IN O
age NN O
, , O
especially RB O
in IN O
the DT O
hypertensive JJ O
group NN O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
. . O

The DT O
healing VBG O
rate NN O
in IN O
HIV NNP O
- : O
positive JJ O
patients NNS O
was VBD O
66 CD O
percent NN O
after IN O
14 CD O
weeks NNS O
and CC O
100 CD O
percent NN O
after IN O
32 CD O
weeks NNS O
; : O
the DT O
corresponding JJ O
figures NNS O
for IN O
patients NNS O
with IN O
acquired JJ O
immunodeficiency NN O
syndrome NN O
were VBD O
0 CD O
and CC O
50 CD O
percent NN O
. . O

Deletion NN O
analysis NN O
showed VBD O
that IN O
the DT O
- : O
321 CD O
/ JJ O
+ $ O
41 CD O
sequence NN O
was VBD O
sufficient JJ O
for IN O
both DT O
the DT O
constitutive JJ O
promoter NN O
activity NN O
and CC O
auto NN O
- : O
activation NN O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
identified VBD O
the DT O
interaction NN O
of IN O
C NNP B-Gene
/ NNP I-Gene
EBPs NNP I-Gene
and CC O
Sp1 NNP B-Gene
to TO O
this DT O
region NN O
. . O

The DT O
pen NN O
can MD O
heal VB O
. . O

The DT O
levels NNS O
of IN O
both DT O
MAP1 NNP B-Gene
- : I-Gene
specific NN I-Gene
and CC I-Gene
MAP2 NNP I-Gene
- : I-Gene
specific JJ I-Gene
mRNAs JJ I-Gene
decline NN O
in IN O
the DT O
postnatal JJ O
developing NN O
brain NN O
; : O
the DT O
level NN O
of IN O
MAP1 NNP B-Gene
- : I-Gene
specific JJ I-Gene
mRNA NN I-Gene
also RB O
increases VBZ O
slightly RB O
in IN O
rat NN O
PC12 NNP O
cells NNS O
upon IN O
exposure NN O
to TO O
nerve VB B-Gene
growth NN I-Gene
factor NN I-Gene
. . O

No DT O
reflow NN O
occurred VBD O
in IN O
approximately RB O
30 CD O
percent NN O
of IN O
the DT O
muscle NN O
microvasculature NN O
upon IN O
reperfusion NN O
. . O

Serine NNP O
phosphorylation NN O
of IN O
STAT3 NNP B-Gene
was VBD O
only RB O
apparent JJ O
after IN O
somatostatin JJ B-Gene
treatment NN O
and CC O
was VBD O
abolished VBN O
by IN O
pertussis NN B-Gene
toxin NN I-Gene
or CC O
PD NNP O
98059 CD O
, , O
together RB O
with IN O
the DT O
associated JJ O
increases NNS O
in IN O
proliferation NN O
. . O

In IN O
Experiment NNP O
II NNP O
, , O
as IN O
performing VBG O
moderate JJ O
supine NN O
cycling NN O
( ( O
55 CD O
% NN O
VO2 NNP O
max NN O
) ) O
for IN O
50 CD O
minutes NNS O
under IN O
several JJ O
LBNP NNP O
conditions NNS O
in IN O
5 CD O
sedentary JJ O
women NNS O
, , O
there EX O
were VBD O
correspondingly RB O
similar JJ O
changing VBG O
manners NNS O
of IN O
the DT O
cardiovascular JJ O
adjustments NNS O
to TO O
each DT O
of IN O
the DT O
phases NNS O
given VBN O
in IN O
Experiment NNP O
I PRP O
. . O

Therefore RB O
, , O
ICSBP NNP B-Gene
may MD O
be VB O
involved VBN O
in IN O
maintaining VBG O
submaximal JJ O
transcriptional JJ O
activity NN O
of IN O
IFN NNP B-Gene
- : O
inducible JJ O
genes NNS O
in IN O
hematopoietic JJ O
cells NNS O
. . O

There EX O
is VBZ O
growing VBG O
evidence NN O
that IN O
mammalian JJ B-Gene
AMP NNP I-Gene
- : I-Gene
activated VBD I-Gene
protein JJ I-Gene
kinase NN I-Gene
( ( O
AMPK NNP B-Gene
) ) O
plays VBZ O
a DT O
role NN O
in IN O
protecting VBG O
cells NNS O
from IN O
stresses NNS O
that WDT O
cause VBP O
ATP NNP O
depletion NN O
by IN O
switching VBG O
off RP O
ATP NNP O
- : O
consuming VBG O
biosynthetic JJ O
pathways NNS O
. . O

In IN O
literature NN O
, , O
the DT O
HBE NNP O
has VBZ O
been VBN O
displayed VBN O
by IN O
application NN O
of IN O
the DT O
averaging VBG O
method NN O
. . O

Ethylene NNP O
glycol NN O
and CC O
diethylene NN O
glycol NNS O
were VBD O
each DT O
administered VBN O
once RB O
weekly JJ O
subcutaneously RB O
to TO O
groups NNS O
of IN O
100 CD O
female JJ O
NMRI NNP O
mice NN O
at IN O
3 CD O
dosages NNS O
( ( O
30 CD O
; : O
10 CD O
und IN O
3 CD O
mg NNS O
single JJ O
dose JJ O
per IN O
mouse NN O
) ) O
. . O

Lauciello NNP O
describes VBZ O
a DT O
technique NN O
for IN O
the DT O
placement NN O
of IN O
functionally RB O
generated VBN O
amalgam JJ O
stops NNS O
as IN O
restorations NNS O
within IN O
mandibular JJ O
acrylic JJ O
teeth NNS O
. . O

Enzyme NNP O
histochemical JJ O
findings NNS O
in IN O
the DT O
ultimobranchial JJ O
body NN O
of IN O
the DT O
horse NN O

The DT O
corresponding JJ O
differences NNS O
in IN O
FVIIa NNP B-Gene
and CC O
PAI NNP B-Gene
- : I-Gene
1 CD I-Gene
were VBD O
not RB O
statistically RB O
significant JJ O
. . O

These DT O
results NNS O
were VBD O
robust JJ O
to TO O
changes NNS O
in IN O
the DT O
baseline NN O
assumptions NNS O
of IN O
the DT O
model NN O
. . O

Four CD O
of IN O
these DT O
five CD O
subjects NNS O
also RB O
performed VBD O
mixed JJ O
sequences NNS O
under IN O
conditional JJ O
control NN O
of IN O
the DT O
words NNS O
( ( O
e NN O
. . O
g NN O
. . O
, , O
A1 NNP O
- : O
- : O
- : O
- : O
B2 SYM O
- : O
- : O
- : O
- : O
A3 SYM O
- : O
- : O
- : O
- : O
B4 NNP O
- : O
- : O
- : O
- : O
A5 NN O
and CC O
its PRP$ O
reversal NN O
) ) O
, , O
verifying VBG O
that IN O
the DT O
stimuli NN O
which WDT O
occupied VBD O
the DT O
same JJ O
position NN O
in IN O
each DT O
sequence NN O
were VBD O
members NNS O
of IN O
the DT O
same JJ O
class NN O
. . O

The DT O
present JJ O
study NN O
investigates VBZ O
whether IN O
prostaglandins NNS O
"""" VBP O
cytoprotect JJ O
"""" IN O
the DT O
gastric JJ O
mucosa NN O
against IN O
hemorrhage NN O
- : O
induced JJ O
stress NN O
ulceration NN O
by IN O
assessing VBG O
the DT O
influence NN O
of IN O
16 CD O
, , O
16 CD O
- : O
dimethyl NN O
prostaglandin NN O
E2 NNP O
( ( O
16 CD O
, , O
16 CD O
- : O
dm NN O
PGE2 NNP O
) ) O
on IN O
gross JJ O
and CC O
microscopic JJ O
lesion NN O
formation NN O
, , O
intramucosal JJ O
tissue NN O
pH NN O
, , O
H NNP O
+ NNP O
back RB O
- : O
diffusion NN O
, , O
and CC O
mucosal NN O
blood NN O
flow NN O
in IN O
rat NN O
gastric JJ O
mucosa NN O
exposed VBD O
to TO O
luminal JJ O
acid NN O
( ( O
100 CD O
mM RB O
HCl NNP O
) ) O
during IN O
hemorrhagic NN O
shock NN O
( ( O
13 CD O
ml NN O
/ NNP O
kg NN O
for IN O
20 CD O
min NN O
) ) O
. . O

Genetic JJ O
studies NNS O
in IN O
Drosophila NNP O
have VBP O
led VBN O
to TO O
the DT O
identification NN O
of IN O
several JJ O
components NNS O
of IN O
the DT O
Notch NNP B-Gene
pathway NN O
. . O

An DT O
in IN O
vivo NN O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
substrate NN O
, , O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
, , O
implicated VBN O
in IN O
Erk NNP B-Gene
activation NN O
, , O
also RB O
became VBD O
rapidly RB O
tyrosine JJ O
- : O
phosphorylated VBN O
in IN O
Jurkat NNP O
cells NNS O
, , O
but CC O
not RB O
in IN O
P116 NNP O
cells NNS O
, , O
upon IN O
treatment NN O
with IN O
H2O2 NNP O
. . O

One CD O
of IN O
these DT O
, , O
an DT O
AACA NNP O
motif NN O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
negative JJ O
regulator NN O
in IN O
non JJ O
- : O
seed NN O
tissues NNS O
and CC O
has VBZ O
a DT O
similarity NN O
to TO O
the DT O
barley NN O
gibberellin NN O
responsive JJ O
element NN O
recognized VBN O
by IN O
MYB NNP B-Gene
- : I-Gene
like IN I-Gene
DNA NNP I-Gene
binding VBG I-Gene
proteins NNS I-Gene
. . O

CD3 NNP B-Gene
cross SYM O
- : O
linking VBG O
induced JJ O
tyrosine JJ O
phosphorylation NN O
of IN O
Sam68 NNP B-Gene
in IN O
uninfected JJ O
T NNP O
cells NNS O
. . O

The DT O
genomic JJ O
structure NN O
of IN O
the DT O
human JJ B-Gene
SPEC1 NNP I-Gene
gene NN I-Gene
reveals NNS O
complex JJ O
splicing NN O
and CC O
close JJ O
promoter NN O
proximity NN O
to TO O
the DT O
AF1q NNP B-Gene
translocation NN I-Gene
gene NN I-Gene
. . O

In IN O
addition NN O
, , O
we PRP O
did VBD O
not RB O
detect VB O
significant JJ O
differences NNS O
in IN O
CDR3 NNP B-Gene
sequences NNS I-Gene
of IN O
endogenous JJ B-Gene
Ig NNP I-Gene
lambdaL NN I-Gene
and CC O
kappaL NN B-Gene
chain NN I-Gene
gene NN I-Gene
loci NN I-Gene
cloned VBN O
from IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
of IN O
an DT O
NBS NNP O
patient NN O
and CC O
of IN O
healthy JJ O
individuals NNS O
. . O

The DT O
maximum JJ O
amplitude NN O
of IN O
evoked JJ O
responses NNS O
in IN O
the DT O
cervical JJ O
sympathetic JJ O
trunk NN O
was VBD O
obtained VBN O
when WRB O
the DT O
T2 NNP O
white JJ O
ramus NN O
was VBD O
stimulated VBN O
and CC O
decreased VBN O
gradually RB O
when WRB O
followed VBN O
by IN O
the DT O
stimulation NN O
of IN O
T1 NNP O
, , O
T3 NNP O
, , O
T4 NNP O
and CC O
T5 NNP O
white JJ O
rami NN O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
contact NN O
allergy NN O
to TO O
K NNP O
- : O
CG NN O
is VBZ O
common JJ O
. . O

Therefore RB O
, , O
Mxi1 NNP B-Gene
and CC O
Mad NNP B-Gene
might MD O
antagonize VB O
Myc NNP B-Gene
function NN O
and CC O
are VBP O
candidate JJ O
tumor NN O
suppressor NN O
genes NNS O
. . O

The DT O
most RBS O
common JJ O
grade NN O
3 CD O
toxicity NN O
was VBD O
neutropenia RB O
, , O
thrombocytopenia NN O
, , O
and CC O
parasthesias NN O
( ( O
observed VBN O
in IN O
< JJ O
10 CD O
% NN O
of IN O
cycles NNS O
) ) O
. . O

When WRB O
the DT O
PHT NNP O
and CC O
CSA NNP O
groups NNS O
were VBD O
compared VBN O
, , O
Hyp NNP O
levels NNS O
were VBD O
significantly RB O
higher JJR O
in IN O
the DT O
PHT NNP O
- : O
GO NNP O
+ NNP O
group NN O
than IN O
in IN O
the DT O
CSA NNP O
- : O
GO NNP O
+ NNP O
group NN O
. . O

Most JJS O
patients NNS O
with IN O
high JJ O
blood NN O
pressure NN O
( ( O
BP NNP O
) ) O
can MD O
be VB O
managed VBN O
by IN O
using VBG O
one CD O
of IN O
4 CD O
classes NNS O
of IN O
compounds NNS O
: : O
a DT O
diuretic JJ O
, , O
beta JJ O
blocker NN O
, , O
converting VBG O
enzyme JJ O
inhibitor NN O
or CC O
calcium NN O
antagonist NN O
. . O

Bulbar NN O
pouches NNS O
were VBD O
perfused VBN O
with IN O
solutions NNS O
of IN O
0 CD O
. . O
9 CD O
% NN O
Na NNP O
C1 NNP O
, , O
0 CD O
. . O
1 CD O
N NNP O
HC1 NNP O
, , O
40 CD O
% NN O
glucose NN O
, , O
40 CD O
% NN O
NaC1 NNP O
, , O
and CC O
40 CD O
% NN O
peptone NN O
or CC O
with IN O
0 CD O
. . O
1 CD O
% NN O
solutions NNS O
of IN O
acetylcholine JJ O
chloride NN O
. . O

In IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
, , O
copper NN O
levels NNS O
exert VBP O
some DT O
control NN O
over IN O
the DT O
level NN O
of IN O
SOD1 NNP B-Gene
expression NN O
. . O

The DT O
secondary JJ O
, , O
but CC O
not RB O
the DT O
primary JJ O
, , O
antibody JJ O
responses NNS O
of IN O
male JJ O
C57Bl NNP O
/ NNP O
6 CD O
mice NN O
were VBD O
higher JJR O
among IN O
mice NNS O
housed VBD O
alone RB O
compared VBN O
to TO O
mice NNS O
housed VBN O
in IN O
groups NNS O
; : O
differences NNS O
were VBD O
observed VBN O
for IN O
both DT O
IgM NNP B-Gene
and CC O
IgG NNP B-Gene
anti VBP I-Gene
- : I-Gene
KLH NNP I-Gene
antibodies NNS I-Gene
. . O

This DT O
slope NN O
was VBD O
further RBR O
significantly RB O
decreased VBN O
at IN O
5 CD O
min NN O
ischemia NN O
( ( O
- : O
26 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
8 CD O
. . O
8 CD O
microm NN O
/ NNP O
mmHg NN O
) ) O
but CC O
returned VBN O
toward IN O
control NN O
values NNS O
in IN O
short JJ O
- : O
term NN O
hibernating VBG O
myocardium NN O
at IN O
90 CD O
min NN O
ischemia NN O
( ( O
- : O
17 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
6 CD O
. . O
6 CD O
microm NN O
/ NNP O
mmHg NN O
) ) O
. . O

These DT O
women NNS O
should MD O
not RB O
be VB O
given VBN O
the DT O
current JJ O
estrogen NN O
PPI NNP O
, , O
which WDT O
was VBD O
designed VBN O
to TO O
warn VB O
women NNS O
of IN O
the DT O
risks NNS O
of IN O
long JJ O
- : O
term NN O
estrogen NN O
use NN O
; : O
a DT O
PPI NNP O
should MD O
be VB O
written VBN O
specifically RB O
for IN O
patients NNS O
receiving VBG O
short JJ O
courses NNS O
. . O

Northern NNP O
blot NN O
analysis NN O
indicates VBZ O
that IN O
AHA2 NNP B-Gene
mRNA RBS I-Gene
relative JJ O
to TO O
total JJ O
cellular JJ O
RNA NNP O
is VBZ O
expressed VBN O
at IN O
significantly RB O
higher JJR O
levels NNS O
in IN O
root NN O
tissue NN O
as IN O
compared VBN O
with IN O
shoot JJ O
tissue NN O
. . O

A DT O
total NN O
of IN O
1459 CD O
men NNS O
aged VBD O
48 CD O
to TO O
84 CD O
years NNS O
, , O
who WP O
were VBD O
diagnosed VBN O
for IN O
the DT O
first JJ O
time NN O
by IN O
physicians NNS O
as IN O
having VBG O
BPH NNP O
in IN O
1994 CD O
and CC O
who WP O
had VBD O
not RB O
received VBN O
treatment NN O
, , O
participated VBN O
in IN O
the DT O
study NN O
. . O

Thirty NNP O
cadaver NN O
brains NNS O
were VBD O
examined VBN O
under IN O
X $ O
6 CD O
to TO O
16 CD O
magnification NN O
in IN O
order NN O
to TO O
define VB O
the DT O
microsurgical JJ O
anatomy NN O
of IN O
the DT O
pineal JJ O
region NN O
, , O
particularly RB O
the DT O
relationship NN O
of IN O
the DT O
pineal NN O
body NN O
, , O
posterior JJ O
cerebral JJ O
artery NN O
, , O
superior JJ O
cerebellar JJ O
artery NN O
, , O
vein NN O
of IN O
Galen NNP O
, , O
basal NN O
vein NN O
of IN O
Rosenthal NNP O
, , O
internal JJ O
cerebral JJ O
vein NN O
, , O
straight JJ O
sinus NN O
, , O
bridging VBG O
vein NN O
, , O
the DT O
size NN O
of IN O
the DT O
tentorial JJ O
notch NN O
, , O
and CC O
the DT O
third JJ O
and CC O
the DT O
fourth JJ O
cranial JJ O
nerves NNS O
. . O

The DT O
proteins NNS O
differ VBP O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
a DT O
21 CD O
- : O
amino NN O
- : O
acid NN O
sequence NN O
located VBD O
24 CD O
amino NN O
acids NNS O
C NNP O
terminal NN O
of IN O
the DT O
translational JJ O
initiation NN O
codon NN O
. . O

Mapping NN O
of IN O
the DT O
DNA NNP O
binding VBG O
domain NN O
of IN O
the DT O
copper NN O
- : O
responsive JJ O
transcription NN O
factor NN O
Mac1 NNP B-Gene
from IN I-Gene
Saccharomyces NNP I-Gene
cerevisiae NN I-Gene
. . O

Compared VBN O
to TO O
controls NNS O
, , O
both DT O
UB NNP O
and CC O
OCS NNP O
rats NNS O
showed VBD O
a DT O
small JJ O
but CC O
significant JJ O
post NN O
- : O
operative JJ O
reduction NN O
in IN O
the DT O
nocturnality NN O
of IN O
drinking NN O
. . O

To TO O
identify VB O
critical JJ O
regions NNS O
mediating VBG O
growth NN O
signal JJ O
transduction NN O
by IN O
hG JJ B-Gene
- : I-Gene
CSFR NN I-Gene
, , O
deletions NNS O
or CC O
site NN O
- : O
directed VBN O
amino NN O
acid JJ O
substitutions NNS O
were VBD O
introduced VBN O
into IN O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
hG JJ B-Gene
- : I-Gene
CSFR NN I-Gene
, , O
and CC O
the DT O
mutant JJ O
cDNAs NN O
were VBD O
transfected VBN O
into IN O
the DT O
murine NN B-Gene
interleukin SYM I-Gene
- : I-Gene
3 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
3 CD I-Gene
) ) O
- : O
dependent JJ O
Ba NNP O
/ NNP O
F3 NNP O
and CC O
FDCP NNP O
cell NN O
lines NNS O
. . O

Abstracts NNS O
. . O

Thirty NNP O
- : O
five CD O
patients NNS O
were VBD O
included VBN O
. . O

In IN O
the DT O
IA NNP O
task NN O
, , O
post NN O
- : O
training NN O
intraperitoneal JJ O
injections NNS O
of IN O
picrotoxin NN O
and CC O
bicuculline NN O
induced VBD O
a DT O
dose JJ O
- : O
dependent JJ O
enhancement NN O
of IN O
retention NN O
measured VBD O
24 CD O
h NN O
after IN O
the DT O
training NN O
, , O
while IN O
retention NN O
was VBD O
not RB O
affected VBN O
by IN O
bicuculline NN O
methiodide NN O
( ( O
a DT O
GABA NNP B-Gene
receptor NN I-Gene
antagonist NN O
that WDT O
does VBZ O
not RB O
readily RB O
cross VB O
the DT O
blood NN O
- : O
brain NN O
barrier NN O
) ) O
. . O

To TO O
determine VB O
if IN O
CYC2 NNP B-Gene
is VBZ O
found VBN O
in IN O
a DT O
complex JJ O
with IN O
previously RB O
identified VBN O
trypanosome NN B-Gene
cdc2 SYM I-Gene
- : I-Gene
related JJ I-Gene
kinases NNS I-Gene
( ( O
CRKs NNP B-Gene
) ) O
, , O
the DT O
CYC2 NNP B-Gene
gene NN I-Gene
was VBD O
fused VBN O
to TO O
the DT O
TY NNP B-Gene
epitope NN I-Gene
tag NN O
, , O
integrated VBN O
into IN O
the DT O
trypanosome JJ O
genome NN O
, , O
and CC O
expressed VBD O
under IN O
inducible JJ O
control NN O
. . O

A DT O
major JJ O
mechanism NN O
whereby WRB O
steroid JJ B-Gene
hydroxylase NN I-Gene
gene NN I-Gene
transcription NN O
is VBZ O
regulated VBN O
in IN O
the DT O
adrenal JJ O
cortex NN O
requires VBZ O
the DT O
pituitary JJ O
peptide NN O
hormone NN O
, , O
ACTH NNP B-Gene
, , O
which WDT O
acts VBZ O
via IN O
cAMP NN O
. . O

ALT NNP B-Gene
levels NNS O
in IN O
responders NNS O
were VBD O
lowered VBN O
by IN O
46 CD O
% NN O
and CC O
AST NNP B-Gene
levels NNS O
were VBD O
lowered VBN O
by IN O
35 CD O
% NN O
after IN O
12 CD O
weeks NNS O
of IN O
vitamin JJ O
E NNP O
treatment NN O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
pathway NN O
activation NN O
occurs VBZ O
during IN O
transformation NN O
induced VBN O
by IN O
a DT O
number NN O
of IN O
classical JJ O
oncogenes NNS O
, , O
including VBG O
Bcr NNP B-Gene
/ NNP O
Abl NNP B-Gene
, , O
Ras NNP B-Gene
and CC O
Rac NNP B-Gene
, , O
and CC O
is VBZ O
necessary JJ O
for IN O
full JJ O
transforming VBG O
potential JJ O
. . O

Surprisingly RB O
, , O
TFIIIC NNP B-Gene
alpha NN I-Gene
has VBZ O
no DT O
homology NN O
to TO O
any DT O
of IN O
the DT O
yeast NN B-Gene
TFIIIC NNP I-Gene
subunits VBZ I-Gene
already RB O
cloned VBN O
, , O
suggesting VBG O
a DT O
significant JJ O
degree NN O
of IN O
evolutionary JJ O
divergence NN O
for IN O
RNA NNP B-Gene
polymerase NN I-Gene
III NNP I-Gene
factors NNS I-Gene
. . O

9 CD O
, , O
1498 CD O
- : O
1506 CD O
) ) O
. . O

Retention NNP O
behavior NN O
of IN O
steroids NNS O
in IN O
gas NN O
chromatography NN O
with IN O
a DT O
series NN O
of IN O
combination NN O
columns NN O
. . O

Immunological JJ O
and CC O
biochemical JJ O
characterization NN O
of IN O
streptococcal JJ B-Gene
pyrogenic NN I-Gene
exotoxins NNS I-Gene
I PRP I-Gene
and CC I-Gene
J NNP I-Gene
( ( O
SPE NNP B-Gene
- : I-Gene
I PRP I-Gene
and CC O
SPE NNP B-Gene
- : I-Gene
J NN I-Gene
) ) O
from IN O
Streptococcus NNP O
pyogenes NNS O
. . O

Trypanosoma NNP O
cruzi NN O
. . O

On IN O
Day NNP O
8 CD O
, , O
the DT O
CIDR NNP O
- : O
B NN O
was VBD O
removed VBN O
and CC O
500 CD O
micrograms NNS O
cloprostenol RB O
injected VBN O
, , O
IM NNP O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
sought VBD O
to TO O
identify VB O
mechanisms NNS O
that WDT O
could MD O
account VB O
for IN O
the DT O
antimitogenic JJ O
effects NNS O
of IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
. . O

Steal NNP O
is VBZ O
a DT O
pathophysiological JJ O
process NN O
in IN O
which WDT O
increased VBD O
blood NN O
flow NN O
through IN O
a DT O
low JJ O
- : O
resistance NN O
vascular JJ O
bed NN O
is VBZ O
sufficient JJ O
to TO O
divert VB O
flow VB O
away RB O
from IN O
a DT O
region NN O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

In IN O
the DT O
absence NN O
of IN O
other JJ O
stabilizers NNS O
, , O
increased VBD O
sucrose RB O
can MD O
provide VB O
increased VBD O
thermoresistance NN O
to TO O
the DT O
virus NN O
in IN O
2 CD O
. . O
5 CD O
% NN O
albumin NN B-Gene
. . O

It PRP O
was VBD O
found VBN O
that IN O
increase NN O
in IN O
the DT O
RH NNP O
level NN O
boosts VBZ O
the DT O
current JJ O
values NNS O
by IN O
2 CD O
- : O
3 CD O
orders NNS O
of IN O
magnitude NN O
; : O
contrariwise NN O
, , O
the DT O
voltage NN O
values NNS O
rise VB O
by IN O
about RB O
three CD O
times NNS O
with IN O
drop NN O
in IN O
the DT O
RH NNP O
. . O

The DT O
hydropathy NN O
plot NN O
revealed VBD O
a DT O
rather RB O
hydrophilic JJ O
N NNP O
- : O
terminal JJ O
region NN O
and CC O
the DT O
absence NN O
of IN O
a DT O
hydrophobic JJ O
signal JJ O
peptide NN O
. . O

As IN O
stands NNS O
shifted VBN O
in IN O
dominance NN O
from IN O
pine NN O
to TO O
fir VB O
with IN O
age NN O
, , O
subalpine JJ O
fir NN O
appeared VBD O
to TO O
maintain VB O
gradually RB O
increasing VBG O
rates NNS O
of IN O
whole JJ O
- : O
forest JJS O
productivity NN O
until IN O
stands NNS O
were VBD O
approximately RB O
400 CD O
years NNS O
old JJ O
. . O

Patients NNS O
enrolled VBN O
in IN O
the DT O
Integrilin NNP O
to TO O
Minimize VB O
Platelet NNP O
Aggregation NNP O
and CC O
Coronary NNP O
Thrombosis NNP O
- : O
II NNP O
( ( O
IMPACT NNP O
- : O
II NN O
) ) O
trial NN O
were VBD O
analyzed VBN O
. . O

A DT O
small JJ O
amount NN O
of IN O
HSP81 NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
was VBD O
detected VBN O
only RB O
in IN O
roots NNS O
. . O

is VBZ O
a DT O
safe JJ O
, , O
well RB O
tolerated VBN O
combination NN O
that WDT O
achieves VBZ O
a DT O
80 CD O
. . O
6 CD O
% NN O
eradication NN O
rate NN O
of IN O
H NNP O
. . O
pylori NN O
and CC O
duodenal JJ O
ulcer NN O
healing VBG O
rates NNS O
as RB O
good JJ O
as IN O
those DT O
achieved VBN O
by IN O
omeprazole JJ O
20 CD O
mg NN O
/ NNP O
d NN O
when WRB O
given VBN O
for IN O
4 CD O
wk NN O
. . O

At IN O
physiological JJ O
doses NNS O
, , O
either CC O
insulin SYM B-Gene
- : I-Gene
like IN I-Gene
growth NN I-Gene
factor NN I-Gene
I PRP I-Gene
( ( O
IGF NNP B-Gene
- : I-Gene
I PRP I-Gene
) ) O
or CC O
insulin NN B-Gene
turned VBD O
out RP O
to TO O
be VB O
as RB O
potent JJ O
as IN O
dibutyryl NN O
cAMP NN O
( ( O
dbcAMP NN O
) ) O
in IN O
increasing VBG O
UCP1 NNP B-Gene
gene NN I-Gene
transcription NN O
rate NN O
( ( O
1 CD O
h NN O
) ) O
and CC O
also RB O
UCP1 NNP B-Gene
mRNA NN I-Gene
accumulation NN O
( ( O
3 CD O
h NN O
) ) O
, , O
their PRP$ O
maximal JJ O
effect NN O
( ( O
15 CD O
- : O
fold JJ O
increase NN O
) ) O
reached VBD O
upon IN O
treatment NN O
for IN O
24 CD O
h NN O
. . O

Amiodarone NNP O
, , O
seldom RB O
used VBD O
as IN O
first JJ O
- : O
line NN O
treatment NN O
, , O
appears VBZ O
to TO O
be VB O
the DT O
most RBS O
effective JJ O
drug NN O
. . O

The DT O
presence NN O
of IN O
visna JJ O
- : O
maedi NN O
in IN O
Italy NNP O
is VBZ O
reported VBN O
for IN O
the DT O
first JJ O
time NN O
. . O

The DT O
cloned VBN O
alcR NN B-Gene
gene NN I-Gene
provided VBN O
in IN O
trans NNS O
restored VBN O
these DT O
siderophore NN O
system NN O
activities NNS O
to TO O
the DT O
mutants NNS O
. . O

Instead RB O
, , O
the DT O
results NNS O
support VBP O
the DT O
idea NN O
that IN O
Pc NNP B-Gene
group NN I-Gene
products NNS I-Gene
provide VBP O
stable JJ O
memory NN O
or CC O
imprinting NN O
of IN O
boundaries NNS O
which WDT O
are VBP O
initially RB O
specified VBN O
by IN O
gap NN O
and CC O
pair NN O
- : O
rule NN O
regulators NNS O
. . O

Family RB O
planning VBG O
continues VBZ O
to TO O
play VB O
a DT O
minor JJ O
role NN O
, , O
and CC O
only RB O
25 CD O
. . O
3 CD O
per IN O
cent NN O
of IN O
all DT O
patients NNS O
reviewed VBD O
took VBD O
to TO O
oral JJ O
contraceptives NNS O
for IN O
shorter JJR O
or CC O
longer JJR O
periods NNS O
of IN O
time NN O
. . O

They PRP O
share NN O
many JJ O
downstream NN O
targets NNS O
, , O
including VBG O
remodeling NN O
of IN O
the DT O
actin JJ B-Gene
cytoskeleton NN O
, , O
activation NN O
of IN O
p70 NN B-Gene
( ( I-Gene
S6 NNP I-Gene
) ) I-Gene
kinase NN I-Gene
and CC O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
N NNP I-Gene
- : I-Gene
terminal JJ I-Gene
kinase NN I-Gene
( ( O
JNK NNP B-Gene
) ) O
, , O
and CC O
regulation NN O
of IN O
transcription NN O
and CC O
cell NN O
proliferation NN O
. . O

Functional JJ O
recognition NN O
of IN O
5 CD O
' POS O
splice NN O
site NN O
by IN O
U4 NNP B-Gene
/ NNP O
U6 NNP B-Gene
. . O
U5 NNP B-Gene
tri SYM O
- : O
snRNP NN O
defines VBZ O
a DT O
novel JJ O
ATP NNP O
- : O
dependent JJ O
step NN O
in IN O
early JJ O
spliceosome NN O
assembly NN O
. . O

The DT O
function NN O
of IN O
the DT O
C NNP O
- : O
terminal JJ O
tail NN O
in IN O
telomere JJ O
maintenance NN O
is VBZ O
not RB O
mediated VBN O
through IN O
the DT O
RAP1 NNP B-Gene
interacting NN I-Gene
factor NN I-Gene
RIF1 NNP B-Gene
: : O
rap1 NN B-Gene
alleles NNS I-Gene
defective VBP O
in IN O
both CC O
the DT O
C NNP O
- : O
terminal JJ O
tail NN O
and CC O
RIF1 NNP B-Gene
interaction NN I-Gene
domains NNS I-Gene
have VBP O
additive JJ O
effects NNS O
on IN O
telomere JJ O
length NN O
. . O

Clinical JJ O
aspects NNS O
of IN O
early JJ O
increase NN O
in IN O
serum JJ O
gamma NN B-Gene
- : I-Gene
glutamyl NN I-Gene
transferase NN I-Gene
in IN O
cerebral JJ O
infarction NN O
. . O

Blood NNP O
sampling NN O
procedures NNS O
were VBD O
videotaped VBN O
. . O

Epithelial JJ O
cytotoxicity NN O
of IN O
combined JJ O
antibiotics NNS O
was VBD O
additive JJ O
, , O
with IN O
no DT O
evidence NN O
of IN O
competition NN O
or CC O
synergism NN O
. . O

Molecule NNP O
( ( O
s PRP O
) ) O
secreted VBN O
by IN O
neuronal JJ O
cultures NNS O
contribute VBP O
to TO O
this DT O
induction NN O
of IN O
GLT NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
but CC O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
signaling NN O
pathways VBZ O
mediating VBG O
this DT O
regulation NN O
. . O

STUDY NNP O
OBJECTIVE NNP O
: : O
This DT O
study NN O
assessed VBD O
several JJ O
methodological JJ O
aspects NNS O
related VBN O
to TO O
the DT O
quality NN O
of IN O
published VBN O
controlled JJ O
clinical JJ O
trials NNS O
( ( O
CCTs NNP O
) ) O
in IN O
relation NN O
to TO O
the DT O
participation NN O
of IN O
an DT O
epidemiologist NN O
/ NN O
biostatistician NN O
( ( O
E NNP O
/ NNP O
B NNP O
) ) O
. . O

Furthermore RB O
, , O
no DT O
Shine NNP O
- : O
Dalgarno NN O
sequences NNS O
are VBP O
present JJ O
upstream NN O
of IN O
the DT O
presumed JJ O
translational JJ O
start NN O
codons NNS O
. . O

Krox NNP B-Gene
- : I-Gene
24 CD I-Gene
is VBZ O
therefore RB O
a DT O
sequence NN O
- : O
specific JJ O
transcriptional JJ O
activator NN O
. . O

In IN O
this DT O
study NN O
we PRP O
describe VBP O
that IN O
platelet NN B-Gene
- : I-Gene
derived JJ I-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
PDGF NNP B-Gene
) ) O
, , O
12 CD O
- : O
O NNP O
- : O
tetradecanoyl NN O
- : O
phorbol NN O
- : O
acetate NN O
( ( O
TPA NNP O
) ) O
, , O
and CC O
forskolin NN O
induced VBN O
CREB NNP B-Gene
( ( O
cAMP SYM B-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
) ) O
Ser NNP O
- : O
133 CD O
phosphorylation NN O
with IN O
comparable JJ O
magnitude NN O
and CC O
kinetics NNS O
in IN O
NIH NNP O
3T3 CD O
cells NNS O
. . O

Northern NNP O
blot NN O
analysis NN O
demonstrated VBD O
that IN O
the DT O
STORP NNP B-Gene
gene NN I-Gene
has VBZ O
a DT O
ubiquitous JJ O
pattern NN O
of IN O
expression NN O
similar JJ O
to TO O
that DT O
of IN O
the DT O
PML NNP B-Gene
gene NN I-Gene
. . O

However RB O
, , O
there EX O
were VBD O
some DT O
properties NNS O
of IN O
Rak NNP B-Gene
that WDT O
are VBP O
distinct JJ O
from IN O
Src NNP B-Gene
- : I-Gene
like JJ I-Gene
kinases NNS I-Gene
: : O
( ( O
a DT O
) ) O
expression NN O
of IN O
Rak NNP B-Gene
was VBD O
predominantly RB O
in IN O
epithelial JJ O
- : O
derived VBN O
cell NN O
lines NNS O
and CC O
tissues NNS O
, , O
especially RB O
normal JJ O
liver NN O
and CC O
kidney NN O
, , O
and CC O
cell NN O
lines NNS O
of IN O
breast NN O
and CC O
colon NN O
origin NN O
; : O
( ( O
b NN O
) ) O
Rak NN B-Gene
does VBZ O
not RB O
harbor VB O
the DT O
NH2 NNP O
- : O
terminal JJ O
glycine NN O
essential JJ O
for IN O
myristylation NN O
and CC O
membrane NN O
localization NN O
; : O
and CC O
( ( O
c NN O
) ) O
Rak NNP B-Gene
possesses VBZ O
a DT O
putative JJ O
bipartite NN O
nuclear JJ O
localization NN O
signal NN O
in IN O
the DT O
SH2 NNP B-Gene
domain NN I-Gene
, , O
and CC O
subcellular JJ O
fractionation NN O
studies NNS O
revealed VBD O
that IN O
p54rak NN B-Gene
resides NNS O
predominantly RB O
in IN O
the DT O
nucleus NN O
. . O

The DT O
mechanism NN O
by IN O
which WDT O
E2 NNP B-Gene
- : I-Gene
C NNP I-Gene
represses VBZ O
E2 NNP B-Gene
- : I-Gene
dependent JJ I-Gene
enhancer NN I-Gene
activity NN O
most RBS O
likely JJ O
involves VBZ O
competition NN O
with IN O
E2 NNP B-Gene
for IN O
binding VBG O
to TO O
a DT O
common JJ O
transcriptional JJ O
regulatory JJ O
site NN O
. . O
( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
400 CD O
WORDS NNP O
) ) O

These DT O
included VBD O
HNF NNP B-Gene
- : I-Gene
3 CD I-Gene
beta NN I-Gene
, , O
HFH NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
HFH NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
HFH NNP B-Gene
- : I-Gene
3 CD I-Gene
, , O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
, , O
and CC O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
, , O
all DT O
of IN O
which WDT O
are VBP O
consistent JJ O
with IN O
the DT O
tissue NN O
- : O
specific JJ O
expression NN O
profiles NNS O
of IN O
the DT O
gene NN O
. . O

Pharmacokinetic JJ O
parameters NNS O
were VBD O
similar JJ O
to TO O
values VB O
given VBN O
in IN O
the DT O
literature NN O
for IN O
intravenous JJ O
( ( O
IV NNP O
) ) O
or CC O
intraarterial JJ O
( ( O
IA NNP O
) ) O
bolus NN O
MMC NNP O
injections NNS O
( ( O
Tmax NNP O
= VBZ O
7 CD O
. . O
0 CD O
min NN O
following VBG O
the DT O
beginning NN O
of IN O
MMC NNP O
infusion NN O
, , O
Vss NNP O
= VBZ O
0 CD O
. . O
57 CD O
1 CD O
/ NN O
kg NN O
, , O
C1 NNP O
= VBZ O
8 CD O
. . O
9 CD O
ml JJ O
/ NNP O
min NN O
. . O
kg NN O
, , O
T1 NNP O
/ VBZ O
2 CD O
alpha NN O
= VBD O
8 CD O
. . O
3 CD O
min NN O
, , O
T1 NNP O
/ VBZ O
2 CD O
beta NN O
= NN O
58 CD O
. . O
6 CD O
min NN O
) ) O
. . O

The DT O
1 CD O
. . O
9 CD O
- : O
kb NN O
C NNP B-Gene
mu NN I-Gene
RNA NNP O
contains VBZ O
the DT O
3 CD O
' POS O
sequence NN O
characteristic NN O
of IN O
secreted JJ O
mu NN B-Gene
chain NN I-Gene
, , O
whereas IN O
the DT O
longer JJR O
species NNS O
bear VBP O
that IN O
of IN O
membrane NN O
- : O
bound NN O
mu NN B-Gene
chin NN O
. . O

Chem NNP O
. . O

Most JJS O
of IN O
the DT O
patients NNS O
had VBD O
locally RB O
advanced JJ O
lesions NNS O
( ( O
63 CD O
T3 NNP O
- : O
4 CD O
: : O
91 CD O
. . O
5 CD O
% NN O
) ) O
according VBG O
to TO O
the DT O
adopted VBN O
TNM NNP O
system NN O
( ( O
Lederman NNP O
- : O
Gadeberg NNP O
, , O
Sisson NNP O
- : O
Jesse NN O
) ) O
. . O

Characterization NN O
of IN O
a DT O
Xenopus NNP B-Gene
laevis NN I-Gene
CXC NNP I-Gene
chemokine NN I-Gene
receptor NN I-Gene
4 CD I-Gene
: : O
implications NNS O
for IN O
hematopoietic JJ O
cell NN O
development NN O
in IN O
the DT O
vertebrate NN O
embryo NN O
. . O

Characterization NN O
of IN O
the DT O
3 CD O
' POS O
ends NNS O
of IN O
the DT O
plus JJ O
- : O
strand NN O
DNA NN O
fragments NNS O
reveals NNS O
( ( O
1 CD O
) ) O
that IN O
the DT O
upstream JJ O
fragment NN O
is VBZ O
elongated VBN O
beyond IN O
PPT2 NNP B-Gene
creating VBG O
a DT O
plus JJ O
- : O
strand NN O
overlap NN O
and CC O
( ( O
2 CD O
) ) O
that IN O
the DT O
majority NN O
of IN O
plus CC O
- : O
strand NN O
strong JJ O
- : O
stop NN O
DNA NN O
fragments NNS O
bear VBP O
a DT O
copy NN O
of IN O
the DT O
minus NN O
- : O
strand NN O
primer NN O
binding VBG O
site NN O
in IN O
agreement NN O
with IN O
the DT O
accepted JJ O
model NN O
of IN O
retroviral JJ O
genomic JJ O
RNA NNP O
reverse NN O
transcription NN O
. . O

Another DT O
segment NN O
of IN O
CRL3 NNP B-Gene
( ( O
- : O
296 CD O
to TO O
- : O
184 CD O
) ) O
, , O
also RB O
displaying VBG O
enhancer NN O
function NN O
, , O
contained VBN O
tandem NN O
repeated VBN O
sequences NNS O
( ( O
DR NNP O
- : O
A1 NNP O
and CC O
DR NNP O
- : O
A2 NN O
) ) O
. . O

After IN O
successful JJ O
subtotal JJ O
parathyroidectomy NN O
, , O
evident JJ O
by IN O
the DT O
decrease NN O
of IN O
serum NN O
iPTH NN B-Gene
levels NNS O
, , O
both CC O
the DT O
CL NNP O
of IN O
group NN O
2 CD O
PMNs NNP O
and CC O
the DT O
ability NN O
of IN O
group NN O
2 CD O
sera NN O
to TO O
induce VB O
augmented JJ O
CL NNP O
in IN O
normal JJ O
PMNs NNP O
decreased VBD O
( ( O
p JJ O
< NN O
0 CD O
. . O
25 CD O
) ) O
. . O

Induced NNP O
expression NN O
of IN O
Rnd3 NNP B-Gene
is VBZ O
associated VBN O
with IN O
transformation NN O
of IN O
polarized JJ O
epithelial JJ O
cells NNS O
by IN O
the DT O
Raf NNP B-Gene
- : O
MEK NNP B-Gene
- : O
extracellular JJ O
signal JJ O
- : O
regulated JJ O
kinase NN O
pathway NN O
. . O

Acad NNP O
. . O

The DT O
distribution NN O
of IN O
patients NNS O
was VBD O
as IN O
follows VBZ O
: : O
group NN O
1 CD O
- : O
- : O
complex JJ O
gamma NN O
- : O
therapy NN O
( ( O
55 CD O
cases NNS O
) ) O
, , O
group NN O
2 CD O
- : O
- : O
complex JJ O
gamma NN O
- : O
therapy NN O
plus CC O
iliac JJ O
lymphadenectomy NN O
( ( O
50 CD O
cases NNS O
) ) O
and CC O
group NN O
3 CD O
- : O
- : O
complex JJ O
radiation NN O
treatment NN O
with IN O
megavolt NN O
bremsstrahlung NN O
beam NN O
from IN O
the DT O
luc NN O
type NN O
installation NN O
and CC O
iliac JJ O
lymphadenectomy NN O
( ( O
50 CD O
cases NNS O
) ) O
. . O

This DT O
sequence NN O
similarity NN O
raises VBZ O
the DT O
possibility NN O
that IN O
GCN1 NNP B-Gene
interacts VBZ O
with IN O
ribosomes NNS O
or CC O
tRNA NN O
molecules NNS O
and CC O
functions NNS O
in IN O
conjunction NN O
with IN O
GCN2 NNP B-Gene
in IN O
monitoring VBG O
uncharged JJ O
tRNA NN O
levels NNS O
during IN O
the DT O
process NN O
of IN O
translation NN O
elongation NN O
. . O

The DT O
cis NN O
- : O
acting VBG O
regulatory JJ O
properties NNS O
of IN O
an DT O
872 CD O
bp NN O
promoter NN O
fragment NN O
of IN O
a DT O
B NNP O
. . O
napus NN O
oleosin IN B-Gene
gene NN I-Gene
were VBD O
examined VBN O
by IN O
analysis NN O
of IN O
beta NN B-Gene
- : I-Gene
glucuronidase NN I-Gene
( ( O
GUS NNP B-Gene
) ) O
expression NN O
in IN O
transgenic JJ O
tobacco NN O
plants NNS O
containing VBG O
an DT O
oleosin NN B-Gene
promoter NN I-Gene
- : O
GUS NNP B-Gene
transcriptional JJ O
fusion NN O
. . O

The DT O
presence NN O
of IN O
AS NNP O
- : O
oligo NN O
had VBD O
no DT O
further JJ O
effect NN O
on IN O
the DT O
FSH NNP B-Gene
- : O
mediated VBD O
activation NN O
of IN O
the DT O
EB NNP O
* NNP O
- : O
mTf NN B-Gene
- : O
CAT NNP B-Gene
construct NN O
but CC O
reduced VBD O
cAMP SYM O
- : O
mediated VBN O
activation NN O
. . O

Several JJ O
nuclear JJ O
factors NNS O
that IN O
interact NN O
with IN O
sequences NNS O
in IN O
the DT O
5 CD O
' POS O
flanking JJ O
region NN O
of IN O
the DT O
mouse NN B-Gene
tyrosinase NN I-Gene
gene NN I-Gene
were VBD O
identified VBN O
using VBG O
band NN O
shift NN O
and CC O
methylation NN O
interference NN O
assays NNS O
. . O

Our PRP$ O
data NNS O
show VBP O
that IN O
multiple JJ O
MLSN1 NNP B-Gene
transcripts NNS I-Gene
, , O
both DT O
constitutively RB O
expressed VBN O
and CC O
inducible JJ O
, , O
are VBP O
present JJ O
in IN O
cultured JJ O
pigmented JJ O
melanoma NN O
cells NNS O
, , O
and CC O
suggest VBP O
that IN O
MLSN1 NNP B-Gene
expression NN O
can MD O
be VB O
regulated VBN O
at IN O
the DT O
level NN O
of IN O
both DT O
transcription NN O
and CC O
mRNA NN O
processing NN O
. . O

NDRF NNP B-Gene
/ NNP O
NeuroD2 NNP B-Gene
was VBD O
co JJ O
- : O
precipitated VBN O
with IN O
PKN NNP B-Gene
from IN O
the DT O
lysate NN O
of IN O
COS NNP O
- : O
7 CD O
cells NNS O
transfected VBN O
with IN O
both DT O
expression NN O
constructs NNS O
for IN O
NDRF NNP B-Gene
/ NNP O
NeuroD2 NNP B-Gene
and CC O
PKN NNP B-Gene
. . O

Clinical JJ O
and CC O
haematological JJ O
signs NNS O
are VBP O
not RB O
specific JJ O
in IN O
this DT O
setting NN O
, , O
and CC O
the DT O
diagnosis NN O
relies NNS O
on IN O
histological JJ O
features NNS O
, , O
mainly RB O
bone NN O
marrow NN O
examination NN O
. . O

The DT O
effect NN O
of IN O
MIB NNP O
on IN O
the DT O
dose JJ O
- : O
response NN O
curve NN O
of IN O
externally RB O
applied VBN O
noradrenaline NN O
was VBD O
also RB O
studied VBN O
. . O

Exon NNP O
A NNP O
is VBZ O
located VBN O
approximately RB O
7 CD O
kb VBD O
5 CD O
' '' O
to TO O
the DT O
HSL NNP B-Gene
translation NN I-Gene
start NN I-Gene
site NN I-Gene
. . O

An DT O
association NN O
between IN O
hSIE NN B-Gene
and CC O
Stat NNP B-Gene
- : I-Gene
3 CD I-Gene
after IN O
MHC NNP B-Gene
- : I-Gene
I PRP I-Gene
ligation NN O
was VBD O
directly RB O
demonstrated VBN O
by IN O
precipitating VBG O
Stat NNP B-Gene
- : I-Gene
3 CD I-Gene
from IN O
nuclear JJ O
extracts NNS O
with IN O
biotinylated JJ O
hSIE NN B-Gene
probe NN O
and CC O
avidin JJ B-Gene
- : O
coupled VBN O
agarose RB O
. . O

In IN O
addition NN O
, , O
the DT O
ketamine NN O
- : O
treated JJ O
rats NNS O
had VBD O
more JJR O
neurons NNS O
and CC O
glial JJ O
cells NNS O
surrounding VBG O
the DT O
ventricles NNS O
. . O

IdB NN O
1031 CD O
was VBD O
first RB O
extracted VBN O
by IN O
liquid JJ O
- : O
solid JJ O
partition NN O
and CC O
the DT O
extracts NNS O
were VBD O
evaporated VBN O
and CC O
analysed VBN O
on IN O
a DT O
reversed JJ O
- : O
phase NN O
column NN O
under IN O
isocratic JJ O
conditions NNS O
, , O
using VBG O
either CC O
an DT O
electrochemical JJ O
or CC O
a DT O
UV NNP O
detector NN O
. . O

Absorption NN O
of IN O
electrolytes NNS O
from IN O
the DT O
colon NN O
in IN O
cases NNS O
of IN O
ulcerative JJ O
colitis NN O
and CC O
in IN O
control NN O
subjects NNS O
. . O

Ultraviolet NNP O
light VBD O
- : O
induced JJ O
kinin NN B-Gene
formation NN O
in IN O
human JJ O
skin NN O
. . O

First RB O
, , O
a DT O
pet54 NN B-Gene
: : O
: : O
LEU2 NNP B-Gene
cytoductant NN O
bearing VBG O
the DT O
' '' O
short JJ O
' POS O
mitochondrial JJ O
genome NN O
that WDT O
lacks VBZ O
both DT O
COX1 NNP B-Gene
introns NNS I-Gene
aI5 VBP B-Gene
alpha NN I-Gene
and CC O
aI5 NN B-Gene
beta NN I-Gene
is VBZ O
defective JJ O
only RB O
in IN O
COX3 NNP B-Gene
gene NN I-Gene
expression NN O
and CC O
not RB O
in IN O
COX1 NNP B-Gene
mRNA NN I-Gene
splicing NN O
or CC O
mRNA JJ O
translation NN O
. . O

A DT O
stable JJ O
interface NN O
depends VBZ O
on IN O
overall JJ O
stress NN O
and CC O
microstress NN O
distribution NN O
on IN O
the DT O
bone NN O
, , O
particularly RB O
trabecular JJ O
bone NN O
. . O

In IN O
contrast NN O
, , O
the DT O
failure NN O
of IN O
the DT O
QKTT NNP O
motif NN O
and CC O
TGN46 NNP O
cytoplasmic JJ O
tail NN O
to TO O
induce VB O
steady JJ O
- : O
state NN O
ER NNP O
localization NN O
of IN O
vesicular JJ B-Gene
stomatitis NN I-Gene
virus NN I-Gene
glycoprotein NN I-Gene
( ( O
VSVG NNP B-Gene
) ) O
chimeras NN O
in IN O
HeLa NNP O
and CC O
NRK NNP O
cells NNS O
indicates VBZ O
that IN O
significant JJ O
differences NNS O
in IN O
early JJ O
secretory NN O
trafficking NN O
also RB O
exist VBP O
. . O

The DT O
positive JJ O
- : O
acting VBG O
global JJ O
sulfur NN O
regulatory JJ O
protein NN O
, , O
CYS3 NNP B-Gene
, , O
of IN O
Neurospora NNP O
crassa NN O
turns VBZ O
on IN O
the DT O
expression NN O
of IN O
a DT O
family NN O
of IN O
unlinked JJ O
structural JJ O
genes NNS O
that WDT O
encode VBP O
enzymes NNS O
of IN O
sulfur JJ O
catabolism NN O
. . O

They PRP O
include VBP O
genes NNS O
encoding VBG O
three CD O
subunits NNS O
of IN O
the DT O
cytochrome JJ B-Gene
oxidase NN I-Gene
( ( O
cox1 NN B-Gene
to TO I-Gene
3 CD I-Gene
) ) O
, , O
apocytochrome JJ B-Gene
b NN I-Gene
( ( O
cob NN B-Gene
) ) O
, , O
seven CD O
subunits NNS O
of IN O
the DT O
NADH NNP B-Gene
dehydrogenase NN I-Gene
complex NN I-Gene
( ( O
nad1 UH B-Gene
to TO I-Gene
6 CD I-Gene
, , O
nad4L NN B-Gene
) ) O
, , O
two CD O
ATPase NNP B-Gene
subunits NNS O
( ( O
atp6 NN B-Gene
and CC O
atp9 NN B-Gene
) ) O
, , O
three CD O
ribosomal JJ O
RNAs NNP O
( ( O
rrn5 NN B-Gene
, , O
srn NN B-Gene
and CC O
lrn NN B-Gene
) ) O
, , O
23 CD O
tRNAs NN O
and CC O
four CD O
ribosomal NN O
proteins NNS O
( ( O
rps3 NN B-Gene
, , O
rps11 NN B-Gene
, , O
rps12 NN B-Gene
and CC O
rpl16 NN B-Gene
) ) O
. . O

UVA NNP O
- : O
induced VBD O
melanocytic JJ O
lesions NNS O
. . O

These DT O
findings NNS O
were VBD O
reinforced VBN O
by IN O
an DT O
analysis NN O
that WDT O
was VBD O
restricted VBN O
to TO O
living VBG O
donor JJ O
transplants NNS O
without IN O
acute JJ O
rejection NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
retroplasmid JJ O
reverse NN B-Gene
transcriptase NN I-Gene
is VBZ O
uniquely RB O
adapted VBN O
to TO O
initiate VB O
cDNA NN O
synthesis NN O
by IN O
recognizing VBG O
a DT O
3 CD O
' POS O
CCA NNP O
sequence NN O
. . O

METHODS NN O
: : O
Between NNP O
August NNP O
1991 CD O
and CC O
June NNP O
1994 CD O
, , O
198 CD O
men NNS O
with IN O
clinical JJ O
T2 NNP O
or CC O
T3 NNP O
classified VBD O
( ( O
TNM NNP O
) ) O
prostate NN O
carcinoma NN O
( ( O
bone JJ O
scan JJ O
negative NN O
) ) O
who WP O
were VBD O
at IN O
high JJ O
risk NN O
of IN O
lymph JJ O
node JJ O
involvement NN O
underwent VBD O
a DT O
111In CD O
- : O
capromab NN O
pendetide JJ O
scan JJ O
prior NN O
to TO O
staging VBG O
lymphadenectomy NN O
. . O

Nodal NNP O
domains NNS O
are VBP O
regions NNS O
where WRB O
a DT O
function NN O
has VBZ O
definite VBN O
sign NN O
. . O

The DT O
data NN O
suggest NN O
that IN O
like IN O
in IN O
yeast NN O
, , O
in IN O
plants NNS O
a DT O
certain JJ O
subfamily NN O
of IN O
UBC NNP B-Gene
is VBZ O
specifically RB O
involved VBN O
in IN O
the DT O
proteolytic JJ O
degradation NN O
of IN O
abnormal JJ O
proteins NNS O
as IN O
result NN O
of IN O
stress NN O
. . O

Chagas NNP O
' POS O
disease NN O
, , O
visceral JJ O
leishmaniasis NN O
, , O
anti SYM B-Gene
- : I-Gene
nuclear JJ I-Gene
factor NN I-Gene
, , O
schistosomiasis NN O
, , O
rheumatoid JJ B-Gene
factor NN I-Gene
and CC O
normal JJ O
controls NNS O
. . O

The DT O
viral JJ B-Gene
LTR NNP I-Gene
was VBD O
used VBN O
as IN O
the DT O
promoter NN O
. . O

Percent NNP O
identities NNS O
of IN O
the DT O
mouse NN B-Gene
PP2 NNP I-Gene
to TO O
mouse VB B-Gene
Y1 NNP I-Gene
, , O
mouse NN O
Y4 NNP B-Gene
/ NNP O
PP1 NNP B-Gene
and CC O
human JJ B-Gene
Y2 NNP I-Gene
receptors NNS I-Gene
are VBP O
53 CD O
, , O
42 CD O
, , O
and CC O
31 CD O
, , O
respectively RB O
. . O

Raman NNP O
investigation NN O
of IN O
YBa2 NNP O
- : O
xLaxCu3O7 NN O
ceramics NNS O
. . O

However RB O
, , O
unlike IN O
the DT O
SIN3 NNP B-Gene
gene NN I-Gene
of IN O
Saccharomyces NNP O
cerevisiae NN O
, , O
pst1 NN B-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
is VBZ O
essential JJ O
for IN O
cell NN O
viability NN O
. . O

The DT O
effect NN O
of IN O
calcitonin NN B-Gene
, , O
a DT O
large JJ O
amount NN O
of IN O
calcium NN O
given VBN O
orally RB O
, , O
pentagastrin NN O
and CC O
glucagon NN B-Gene
on IN O
plasma NN O
47Ca CD O
radioactivity NN O
curves NNS O
in IN O
subjects NNS O
pretreated VBN O
with IN O
47Ca CD O
was VBD O
examined VBN O
. . O

A DT O
dose NN O
of IN O
3 CD O
and CC O
6 CD O
micrograms NNS O
/ VBP O
kg JJ O
/ NNP O
day NN O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
reduces VBZ O
the DT O
severity NN O
of IN O
neutropenia NN O
and CC O
thrombocytopenia NN O
after IN O
carboplatin NN O
- : O
cyclophosphamide NN O
chemotherapy NN O
, , O
which WDT O
may MD O
lead VB O
to TO O
more RBR O
effective JJ O
chemotherapy NN O
for IN O
ovarian JJ O
cancer NN O
in IN O
the DT O
future NN O
. . O

Mitomycin NNP O
- : O
C NN O
can MD O
cause VB O
severe JJ O
necrosis NN O
and CC O
ulceration NN O
when WRB O
extravasated VBN O
inadvertently RB O
into IN O
skin NN O
and CC O
soft JJ O
tissues NNS O
following VBG O
IV NNP O
drug NN O
administration NN O
. . O

DNA NNP O
strand VBP O
exchange NN O
catalyzed VBN O
by IN O
Rad51 NNP B-Gene
protein NN I-Gene
is VBZ O
also RB O
greatly RB O
stimulated VBN O
by IN O
RPA NNP B-Gene
. . O

To TO O
define VB O
transcriptional JJ O
control NN O
elements VBZ O
responsible JJ O
for IN O
muscle NN O
- : O
specific JJ O
expression NN O
of IN O
the DT O
human JJ B-Gene
myoglobin NN I-Gene
gene NN I-Gene
, , O
we PRP O
performed VBD O
mutational JJ O
analysis NN O
of IN O
upstream JJ O
sequences NNS O
( ( O
nucleotide JJ O
positions NNS O
- : O
373 CD O
to TO O
+ VB O
7 CD O
relative JJ O
to TO O
the DT O
transcriptional JJ O
start NN O
site NN O
) ) O
linked VBD O
to TO O
a DT O
firefly JJ B-Gene
luciferase NN I-Gene
gene NN I-Gene
. . O

FLP NNP B-Gene
and CC O
Cre NNP B-Gene
recombinase NN I-Gene
function NN O
in IN O
Xenopus NNP O
embryos NN O
. . O

Emergency NNP O
treatment NN O
of IN O
facial JJ O
and CC O
maxillary JJ O
/ NNP O
mandibular NN O
injuries NNS O

Only RB O
17 CD O
% NN O
of IN O
all DT O
patients NNS O
admitted VBD O
it PRP O
at IN O
all DT O
times NNS O
. . O

Adenylosuccinate NNP B-Gene
synthetase NN I-Gene
( ( O
IMP NNP O
: : O
L NNP B-Gene
- : I-Gene
aspartate NN I-Gene
ligase NN I-Gene
( ( O
GDP NNP O
) ) O
, , O
EC NNP B-Gene
6 CD I-Gene
. . I-Gene
3 CD I-Gene
. . I-Gene
4 CD I-Gene
. . I-Gene
4 CD I-Gene
) ) O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
purine JJ O
biosynthesis NN O
catalyzing VBG O
the DT O
GTP NNP O
- : O
dependent JJ O
conversion NN O
of IN O
IMP NNP O
to TO O
AMP NNP O
. . O

These DT O
results NNS O
illustrate VBP O
an DT O
important JJ O
role NN O
for IN O
La NNP B-Gene
in IN O
RNA NNP O
production NN O
by IN O
demonstrating VBG O
its PRP$ O
ability NN O
to TO O
clear VB O
the DT O
termination NN O
sites VBZ O
of IN O
class NN O
III NNP O
templates VBZ O
, , O
thereby RB O
promoting VBG O
efficient JJ O
use NN O
of IN O
transcription NN O
complexes NNS O
by IN O
pol NN B-Gene
III NNP I-Gene
. . O

We PRP O
tested VBD O
10 CD O
rats NNS O
with IN O
electrophysiologically RB O
guided VBN O
, , O
ibotenic JJ O
acid NN O
lesions NNS O
of IN O
the DT O
PBN NNP O
( ( O
PBNx NNP O
) ) O
to TO O
determine VB O
whether IN O
they PRP O
could MD O
acquire VB O
a DT O
LiCl NNP O
- : O
induced VBD O
CTA NNP O
to TO O
l VB O
- : O
alanine NN O
( ( O
0 CD O
. . O
3 CD O
M NNP O
) ) O
or CC O
demonstrate VB O
a DT O
sodium NN O
appetite NN O
following VBG O
furosemide JJ O
treatment NN O
and CC O
overnight JJ O
access NN O
to TO O
sodium VB O
deficient JJ O
chow NN O
. . O

Distal NNP O
tubular JJ O
acidification NN O
and CC O
the DT O
threshold NN O
for IN O
proximal JJ O
tubular JJ O
bicarbonate NN O
reabsorption NN O
were VBD O
normal JJ O
, , O
as IN O
was VBD O
urine JJ O
concentrating NN O
capacity NN O
. . O

Vascular JJ O
endothelial JJ O
cells NNS O
undergo JJ O
profound NN O
changes NNS O
upon IN O
cellular JJ O
activation NN O
including VBG O
expression NN O
of IN O
a DT O
spectrum NN O
of IN O
cell NN O
activation NN O
- : O
associated VBN O
genes NNS O
. . O

Furthermore RB O
, , O
binding VBG O
of IN O
recombinant JJ B-Gene
Myb NNP I-Gene
and CC O
Ets NNP B-Gene
- : I-Gene
2 CD I-Gene
protein NN I-Gene
to TO O
these DT O
fragments NNS O
could MD O
be VB O
competed VBN O
with IN O
an DT O
excess NN O
of IN O
double JJ O
stranded JJ O
oligodeoxynucleotides NNS O
containing VBG O
canonical JJ O
, , O
but CC O
not RB O
mutated VBN O
, , O
Myb NNP B-Gene
- : O
or CC O
Ets NNP B-Gene
- : I-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Effect NN O
of IN O
heat NN O
treatments NNS O
on IN O
the DT O
meltability NN O
of IN O
cheeses NNS O
. . O

We PRP O
describe VBP O
here RB O
a DT O
Drosophila NNP B-Gene
melanogaster NN I-Gene
FAK NNP I-Gene
homologue NN I-Gene
, , O
DFak56 NNP B-Gene
, , O
which WDT O
maps VBZ O
to TO O
band VB O
56D CD O
on IN O
the DT O
right JJ O
arm NN O
of IN O
the DT O
second JJ O
chromosome NN O
. . O

Antenatal JJ O
diagnosis NN O
of IN O
haematological JJ O
disorders NNS O
- : O
- : O
' '' O
1978 CD O
' POS O
. . O

sp NN O
. . O
pisi NN O
, , O
and CC O
beta SYM B-Gene
- : I-Gene
glucuronidase NN I-Gene
activities NNS O
of IN O
the DT O
transformants NNS O
were VBD O
measured VBN O
. . O

An DT O
extensive JJ O
literature NN O
review NN O
is VBZ O
used VBN O
in IN O
an DT O
attempt NN O
to TO O
answer VB O
these DT O
queries NNS O
, , O
from IN O
which WDT O
questions NNS O
for IN O
further JJ O
study NN O
are VBP O
posed VBN O
. . O

Posttranslational NNP O
regulation NN O
of IN O
Ty1 NNP B-Gene
retrotransposition NN O
by IN O
mitogen NN B-Gene
- : I-Gene
activated VBN I-Gene
protein JJ I-Gene
kinase NN I-Gene
Fus3 NNP I-Gene
. . O

In IN O
mice NN O
, , O
three CD O
major JJ O
families NNS O
of IN O
L1 NNP O
elements NNS O
, , O
termed VBN O
"""" IN O
A NNP O
, , O
"""" NNP O
"""" NNP O
F NNP O
, , O
"""" NNP O
and CC O
"""" NNP O
V NNP O
, , O
"""" NNP O
have VBP O
been VBN O
defined VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
sequence NN O
found VBD O
at IN O
the DT O
5 CD O
' POS O
terminus NN O
. . O

Despite IN O
these DT O
limitations NNS O
the DT O
CHIME NNP O
monitor NN O
provides VBZ O
an DT O
opportunity NN O
to TO O
record VB O
physiological JJ O
data NNS O
previously RB O
unavailable JJ O
in IN O
the DT O
home NN O
. . O

INTERVENTIONS NN O
: : O
Subcutaneous JJ O
tissue NN O
PO2 NNP O
and CC O
PCO2 NNP O
tensions NNS O
were VBD O
measured VBN O
directly RB O
in IN O
patients NNS O
with IN O
necrotising JJ O
fasciitis NN O
and CC O
in IN O
healthy JJ O
volunteers NNS O
during IN O
normobaric JJ O
and CC O
hyperbaric JJ O
conditions NNS O
. . O

The DT O
unique JJ O
nature NN O
and CC O
arrangement NN O
of IN O
the DT O
ANT1 NNP B-Gene
transcriptional JJ I-Gene
control NN I-Gene
elements NNS I-Gene
may MD O
account VB O
for IN O
this DT O
differential JJ O
expression NN O
. . O

Plate NNP O
luting NN O
, , O
a DT O
technique NN O
that WDT O
uses VBZ O
polymethylmethacrylate NN O
( ( O
PMMA NNP O
) ) O
interposed VBD O
between IN O
the DT O
plate NN O
and CC O
the DT O
bone NN O
, , O
as RB O
well RB O
as IN O
between IN O
the DT O
screw NN O
heads NNS O
and CC O
the DT O
plate NN O
, , O
to TO O
improve VB O
the DT O
stability NN O
of IN O
internal JJ O
fixation NN O
was VBD O
tested VBN O
in IN O
vitro NN O
using VBG O
20 CD O
paired JJ O
equine JJ O
third JJ O
metacarpal JJ O
bones NNS O
with IN O
mid JJ O
- : O
diaphyseal NN O
osteotomies NNS O
plated VBN O
with IN O
six CD O
- : O
hole NN O
broad JJ O
ASIF NNP O
compression NN O
plates NNS O
. . O

The DT O
most RBS O
common JJ O
characteristics NNS O
of IN O
VRE NNP O
patients NNS O
were VBD O
recent JJ O
prior RB O
vancomycin NN O
use NN O
, , O
recent JJ O
prior RB O
susceptible JJ O
enterococcal JJ O
infection NN O
, , O
coinfection NN O
with IN O
other JJ O
microbial JJ O
pathogens NNS O
, , O
and CC O
concurrent JJ O
fungal JJ O
infection NN O
. . O

RBP56 NNP B-Gene
protein NN I-Gene
turned VBD O
out RP O
to TO O
be VB O
hTAFII68 JJ B-Gene
which WDT O
was VBD O
isolated VBN O
as IN O
a DT O
TATA NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
associated VBN I-Gene
factor NN I-Gene
( ( O
TAF NNP B-Gene
) ) O
from IN O
a DT O
sub JJ O
- : O
population NN O
of IN O
TFIID NNP B-Gene
complexes NNS I-Gene
( ( O
Bertolotti NNP O
A NNP O
. . O
, , O
Lutz NNP O
, , O
Y NNP O
. . O
, , O
Heard NNP O
, , O
D NNP O
. . O
J NNP O
. . O
, , O
Chambon NNP O
, , O
P NNP O
. . O
, , O
Tora NNP O
, , O
L NNP O
. . O
, , O
1996 CD O
. . O

RESULTS NN O
: : O
Horses VBZ O
with IN O
colic NN O
had VBD O
significantly RB O
higher JJR O
fibrinogen NN B-Gene
concentration NN O
, , O
greater JJR O
alpha NN B-Gene
2AP CD I-Gene
and CC O
protein VB B-Gene
C NNP I-Gene
activities NNS O
, , O
and CC O
longer JJR O
PT NNP O
and CC O
APTT NNP O
than IN O
did VBD O
healthy JJ O
horses NNS O
. . O

Three CD O
different JJ O
site NN O
- : O
directed JJ O
mutations NNS O
of IN O
the DT O
cyclic JJ O
AMP NNP O
response NN O
element NN O
each DT O
reduced VBD O
the DT O
nerve NN B-Gene
growth NN I-Gene
factor NN I-Gene
effect NN O
by IN O
> $ O
90 CD O
% NN O
. . O

To TO O
address VB O
mechanisms NNS O
that WDT O
define VBP O
interactions NNS O
of IN O
Site NNP B-Gene
II NNP I-Gene
regulatory JJ I-Gene
factors NNS I-Gene
with IN O
this DT O
cell NN O
cycle NN O
control NN O
element NN O
, , O
we PRP O
have VBP O
investigated VBN O
these DT O
determinants NNS O
of IN O
transcriptional JJ O
regulation NN O
at IN O
the DT O
G1 NNP O
/ NNP O
S NNP O
phase NN O
transition NN O
in IN O
FDC NNP O
- : O
P1 NNP O
hematopoietic JJ O
progenitor NN O
cells NNS O
. . O

Fortunately RB O
DDT NNP O
- : O
, , O
HCH NNP O
- : O
and CC O
HCB NNP O
- : O
levels NNS O
decreased VBN O
in IN O
breast NN O
milk NN O
during IN O
the DT O
last JJ O
years NNS O
. . O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
primary JJ O
visual JJ O
cortex NN O
of IN O
the DT O
rat NN O
is VBZ O
asymmetrical JJ O
in IN O
volume NN O
, , O
and CC O
that IN O
the DT O
asymmetry NN O
reflects VBZ O
side JJ O
differences NNS O
in IN O
the DT O
number NN O
of IN O
neurons NNS O
. . O

Despite IN O
the DT O
absence NN O
of IN O
exercise NN O
- : O
induced VBN O
asthma NN O
( ( O
EIA NNP O
) ) O
while IN O
breathing VBG O
WH NNP O
air NN O
, , O
asthmatic JJ O
patients NNS O
still RB O
had VBD O
significantly RB O
higher JJR O
mean JJ O
GH NNP O
increments NNS O
than IN O
normal JJ O
subjects NNS O
( ( O
9 CD O
. . O
2 CD O
vs JJ O
2 CD O
. . O
3 CD O
ng JJ O
/ NNP O
ml NN O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

The DT O
30 CD O
- : O
day NN O
mortality NN O
in IN O
the DT O
CPB NNP O
group NN O
and CC O
the DT O
non JJ O
- : O
CPB NNP O
group NN O
were VBD O
20 CD O
% NN O
and CC O
4 CD O
. . O
6 CD O
% NN O
, , O
respectively RB O
which WDT O
was VBD O
not RB O
statistically RB O
significant JJ O
( ( O
p JJ O
= NN O
0 CD O
. . O
6 CD O
) ) O
. . O

Furthermore RB O
, , O
interactions NNS O
were VBD O
identified VBN O
between IN O
endogenous JJ B-Gene
E NNP I-Gene
- : I-Gene
cadherin NN I-Gene
and CC O
the DT O
chimera NN O
containing VBG O
the DT O
E NNP B-Gene
- : I-Gene
cadherin NN I-Gene
extracellular JJ I-Gene
domain NN I-Gene
and CC O
the DT O
desmoglein NN B-Gene
1 CD I-Gene
intracellular JJ I-Gene
domain NN I-Gene
providing VBG O
in IN O
vivo JJ O
evidence NN O
for IN O
previously RB O
predicted VBN O
lateral JJ O
interactions NNS O
of IN O
E NNP B-Gene
- : I-Gene
cadherin NN I-Gene
extracellular JJ I-Gene
domains NNS I-Gene
. . O

Identification NN O
of IN O
this DT O
region NN O
as IN O
the DT O
E NNP B-Gene
. . I-Gene
coli NN I-Gene
tmk JJ I-Gene
gene NN I-Gene
was VBD O
confirmed VBN O
by IN O
functional JJ O
complementation NN O
of IN O
a DT O
yeast NN B-Gene
dTMP NN I-Gene
kinase NN I-Gene
temperature NN O
- : O
sensitive JJ O
mutant NN O
and CC O
by IN O
in IN O
vitro NN O
enzyme NNS O
assay VBP O
of IN O
the DT O
thymidylate JJ B-Gene
kinase NN I-Gene
activity NN O
in IN O
cell NN O
extracts NNS O
of IN O
E NNP O
. . O
coli NN O
by IN O
use NN O
of IN O
tmk NN B-Gene
- : O
overproducing NN O
plasmids NNS O
. . O

A DT O
recently RB O
described VBN O
protein NN O
, , O
metaxin NN B-Gene
1 CD I-Gene
, , O
serves VBZ O
as IN O
a DT O
component NN O
of IN O
a DT O
preprotein JJ O
import NN O
complex NN O
in IN O
the DT O
outer NN O
membrane NN O
of IN O
the DT O
mammalian JJ O
mitochondrion NN O
. . O

Subsequently RB O
, , O
we PRP O
show VBP O
that IN O
the DT O
reexpression NN O
of IN O
the DT O
r NN B-Gene
- : I-Gene
PTPeta NNP I-Gene
gene NN I-Gene
in IN O
highly RB O
malignant JJ O
rat NN O
thyroid NN O
cells NNS O
transformed VBN O
by IN O
retroviruses NNS O
carrying VBG O
the DT O
v NN B-Gene
- : I-Gene
mos NN I-Gene
and CC O
v NN B-Gene
- : I-Gene
ras NN I-Gene
- : I-Gene
Ki NNP I-Gene
oncogenes NNS I-Gene
suppresses VBZ O
their PRP$ O
malignant JJ O
phenotype NN O
. . O

Roux NNP O
- : O
en SYM O
- : O
Y JJ O
gastroenterostomy NN O
severely RB O
disturbs JJ O
emptying NN O
of IN O
the DT O
gallbladder NN O
. . O

In IN O
all DT O
cases NNS O
the DT O
antigenemia NN O
was VBD O
transient JJ O
and CC O
cleared VBN O
by IN O
28th CD O
day NN O
post VBD O
- : O
vaccination NN O
. . O

This DT O
distribution NN O
parallels VBZ O
that IN O
of IN O
the DT O
neurotransmitters NNS O
glutamate VBP O
and CC O
aspartate VBP O
; : O
however RB O
, , O
neither DT O
of IN O
these DT O
excitatory JJ O
amino NN O
acids NNS O
is VBZ O
a DT O
substrate NN O
for IN O
transport NN O
. . O

Although IN O
a DT O
great JJ O
deal NN O
is VBZ O
understood VBN O
about IN O
how WRB O
bHLH JJ B-Gene
factors NNS I-Gene
activate VBP O
gene NN O
transcription NN O
via IN O
E NNP O
- : O
box NN O
DNA NNP O
consensus NN O
sequences NNS O
, , O
studies NNS O
of IN O
bHLH JJ B-Gene
factor NN I-Gene
function NN O
in IN O
higher JJR O
eukaryotes NNS O
often RB O
have VBP O
been VBN O
hindered VBN O
by IN O
the DT O
presence NN O
of IN O
multiple JJ O
family NN O
members NNS O
. . O

These DT O
results NNS O
imply VBP O
that IN O
the DT O
GCN3 NNP B-Gene
product NN I-Gene
can MD O
promote VB O
either DT O
repression NN O
or CC O
activation NN O
of IN O
GCN4 NNP B-Gene
expression NN O
depending VBG O
on IN O
amino NN O
acid JJ O
availability NN O
. . O

The DT O
coding VBG O
region NN O
of IN O
mkh1 NN B-Gene
is VBZ O
contained VBN O
within IN O
a DT O
single JJ O
exon NN O
encoding VBG O
a DT O
1 CD O
, , O
116 CD O
- : O
amino NN O
- : O
acid NN O
protein NN O
. . O

The DT O
goal NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
determine VB O
the DT O
feasibility NN O
of IN O
retrovirus NN O
mediated VBN O
expression NN O
of IN O
rp47phox NN B-Gene
in IN O
the DT O
HL60 NNP O
and CC O
U937 NNP O
human JJ O
hematopoietic NN O
cell NN O
lines NNS O
, , O
and CC O
in IN O
an DT O
Epstein NNP O
- : O
Barr NNP O
virus NN O
transformed VBD O
B NNP O
- : O
lymphocyte NN O
cell NN O
line NN O
( ( O
EBV NNP O
- : O
BCL NNP O
) ) O
derived VBD O
from IN O
a DT O
p47phox NN B-Gene
- : O
deficient NN O
CGD NNP O
patient NN O
. . O

The DT O
absence NN O
of IN O
H4PteGlun NNP O
bound NN O
to TO O
the DT O
T NNP B-Gene
protein NN I-Gene
in IN O
our PRP$ O
experimental JJ O
conditions NNS O
demonstrates VBZ O
that IN O
H4PteGlun NNP O
is VBZ O
not RB O
covalently RB O
linked VBN O
to TO O
the DT O
T NNP B-Gene
protein NN I-Gene
. . O

Phosphorylation NN O
and CC O
spindle JJ O
pole NN O
body NN O
localization NN O
of IN O
the DT O
Cdc15p NNP B-Gene
mitotic JJ I-Gene
regulatory JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
in IN I-Gene
budding VBG I-Gene
yeast NN I-Gene
. . O

1 CD O
in IN O
Ho NNP O
Chi NNP O
Minh NNP O
City NNP O
was VBD O
studied VBN O
by IN O
culture NN O
and CC O
latex JJ O
agglutination NN O
of IN O
blood NN O
, , O
cerebrospinal JJ O
fluid NN O
, , O
urine JJ O
and CC O
pleural JJ O
fluid NN O
. . O

Western JJ O
blot NN O
analyses NNS O
detect VBP O
anti JJ B-Gene
- : I-Gene
E NN I-Gene
- : O
specific JJ O
immunoreactivity NN O
in IN O
affinity NN O
- : O
purified JJ O
extracts NNS O
derived VBN O
from IN O
the DT O
bacterial JJ O
expression NN O
of IN O
a DT O
truncated JJ B-Gene
AMPD3 NNP I-Gene
cDNA NN I-Gene
. . O

Thirty NNP O
minutes NNS O
of IN O
supine JJ O
restraint NN O
decreased VBD O
DOPAC NNP O
concentrations NNS O
in IN O
the DT O
median JJ O
eminence NN O
of IN O
female JJ O
rats NNS O
that WDT O
were VBD O
not RB O
exposed VBN O
to TO O
ether VB O
, , O
and CC O
brief JJ O
exposure NN O
to TO O
ether VB O
enhanced VB O
this DT O
effect NN O
. . O

Amino NNP O
acid NN O
residues VBZ O
147 CD O
- : O
167 CD O
of IN O
the DT O
previously RB O
reported VBN O
sequence NN O
are VBP O
replaced VBN O
by IN O
new JJ O
residues NNS O
147 CD O
to TO O
150 CD O
. . O

Constantly RB O
rectilinear JJ O
pressure NN O
curves NNS O
without IN O
uterine JJ O
activities NNS O
are VBP O
interpreted VBN O
as IN O
characteristic JJ O
tocographic JJ O
criteria NNS O
of IN O
an DT O
advanced JJ O
ectopic NN O
gravidity NN O
. . O

After IN O
clofelin JJ O
administration NN O
the DT O
autoregulation NN O
borders NNS O
shifted VBD O
to TO O
the DT O
right NN O
i NN O
. . O
e NN O
. . O
towards NNS O
higher RBR O
AP NNP O
levels NNS O
. . O

These DT O
patients NNS O
appear VBP O
to TO O
have VB O
slightly RB O
better JJR O
pulmonary JJ O
function NN O
and CC O
nutritional JJ O
status NN O
; : O
yet RB O
, , O
they PRP O
seem VBP O
to TO O
have VB O
a DT O
higher JJR O
degree NN O
of IN O
health NN O
care NN O
utilization NN O
. . O

The DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
of IN O
the DT O
human JJ B-Gene
lactoferrin NN I-Gene
gene NN I-Gene
was VBD O
isolated VBN O
from IN O
a DT O
human JJ O
placental JJ O
genomic JJ O
library NN O
. . O

Thus RB O
, , O
cibenzoline NN O
is VBZ O
an DT O
effective JJ O
antiarrhythmic JJ O
agent NN O
with IN O
a DT O
favourable JJ O
pharmacokinetic JJ O
profile NN O
that WDT O
may MD O
be VB O
considered VBN O
with IN O
other JJ O
class NN O
I PRP O
drugs NNS O
in IN O
patients NNS O
requiring VBG O
therapy NN O
for IN O
high JJ O
risk NN O
arrhythmias NNS O
. . O

SV1 NNP B-Gene
has VBZ O
a DT O
33 CD O
- : O
amino NN O
acid NN O
insert NN O
in IN O
the DT O
S1 NNP O
transmembrane NN O
domain NN O
that WDT O
does VBZ O
not RB O
alter VB O
S1 NNP O
overall JJ O
hydrophobicity NN O
, , O
but CC O
makes VBZ O
the DT O
S0 NNP O
- : O
S1 NN O
linker NN O
longer RBR O
. . O

All DT O
of IN O
the DT O
elements NNS O
exhibited VBD O
a DT O
uniform JJ O
structure NN O
. . O

Melatonin NNP O
and CC O
seasonality NN O
: : O
filling VBG O
the DT O
gap NN O
. . O

The DT O
catalytic JJ O
site NN O
has VBZ O
an DT O
S1 NNP O
pocket NN O
lined VBD O
with IN O
conserved JJ O
hydrophobic NN O
residues NNS O
to TO O
accommodate VB O
the DT O
pyroglutamyl NN O
residue NN O
. . O

The DT O
mode NN O
of IN O
resistance NN O
to TO O
quinupristin VB O
/ JJ O
dalfopristin NN O
was VBD O
not RB O
evident JJ O
( ( O
sat VB O
A NNP O
- : O
negative JJ O
by IN O
PCR NNP O
) ) O
; : O
and CC O
these DT O
cases NNS O
illustrate VBP O
the DT O
existence NN O
of IN O
streptogramin JJ O
- : O
resistant JJ O
isolates NNS O
before IN O
the DT O
introduction NN O
of IN O
this DT O
antimicrobial JJ O
class NN O
into IN O
human JJ O
clinical JJ O
practice NN O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
DNA NNP O
methylation NN O
, , O
chromatin NN O
structure NN O
, , O
and CC O
transactivation NN O
at IN O
an DT O
Sp1 NNP B-Gene
site NN I-Gene
contribute NN O
to TO O
the DT O
highly RB O
restricted JJ O
expression NN O
of IN O
this DT O
myelomonocytic JJ O
lineage NN O
specific JJ O
gene NN O
. . O

This DT O
resulted VBD O
in IN O
a DT O
complete JJ O
inhibition NN O
of IN O
Site NNP O
- : O
1 CD O
cleavage NN O
that WDT O
was VBD O
restored VBN O
by IN O
concomitant JJ O
overexpression NN O
of IN O
full JJ O
- : O
length NN O
SCAP NNP B-Gene
. . O

A DT O
genomic JJ O
clone NN O
for IN O
the DT O
cyc07 NN B-Gene
gene NN I-Gene
, , O
which WDT O
is VBZ O
expressed VBN O
specifically RB O
at IN O
the DT O
S NNP O
phase NN O
during IN O
the DT O
cell NN O
cycle NN O
in IN O
synchronous JJ O
cultures NNS O
of IN O
periwinkle NN O
( ( O
Catharanthus NNP O
roseus NN O
) ) O
cells NNS O
, , O
was VBD O
isolated VBN O
. . O

The DT O
UCR NNP O
core NN O
sequence NN O
, , O
CGCCATTTT NNP O
, , O
binds VBZ O
a DT O
ubiquitous JJ O
nuclear JJ O
factor NN O
and CC O
mediates NNS O
negative JJ O
regulation NN O
of IN O
MuLV NNP O
promoter NN O
activity NN O
. . O

The DT O
measurement NN O
of IN O
the DT O
areas NNS O
of IN O
fibrin NN B-Gene
, , O
of IN O
tissue NN O
and CC O
fibrinolysis NN O
, , O
at IN O
the DT O
above NN O
mentioned VBD O
times NNS O
, , O
has VBZ O
been VBN O
effected VBN O
at IN O
standard JJ O
magnification NN O
( ( O
15 CD O
X NN O
) ) O
by IN O
an DT O
image NN O
analyser NN O
( ( O
Videoplan NNP O
) ) O
scale VBD O
1 CD O
: : O
8 CD O
. . O

Overexpression NN O
of IN O
POG1 NNP B-Gene
inhibits NNS O
alpha VBP B-Gene
- : I-Gene
factor NN I-Gene
- : O
induced JJ O
G1 NNP O
arrest NN O
and CC O
transcriptional JJ O
repression NN O
of IN O
the DT O
CLN1 NNP B-Gene
and CC O
CLN2 NNP B-Gene
genes NNS I-Gene
. . O

A DT O
new JJ O
hemagglutination NN O
test NN O
for IN O
the DT O
on IN O
- : O
slide NN O
assay NN O
of IN O
rheumatoid JJ B-Gene
factor NN I-Gene

Using VBG O
a DT O
series NN O
of IN O
mutant JJ B-Gene
T NNP I-Gene
antigens NNS I-Gene
expressed VBN O
by IN O
recombinant JJ O
baculoviruses NNS O
in IN O
Sf9 NNP O
cells NNS O
, , O
we PRP O
find VBP O
that IN O
the DT O
origin NN O
unwinding VBG O
activities NNS O
of IN O
both DT O
TS677 NNP O
- : O
- : O
> VB O
A DT O
and CC O
TS677 NNP O
, , O
679 CD O
- : O
- : O
> NN O
A DT O
are VBP O
inhibited VBN O
by IN O
the DT O
T NNP B-Gene
- : I-Gene
antigen NN I-Gene
kinase NN I-Gene
, , O
as IN O
is VBZ O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
T NNP I-Gene
antigen NN I-Gene
. . O

On IN O
the DT O
basis NN O
of IN O
serological JJ O
studies NNS O
, , O
the DT O
highly RB O
conserved VBN O
A NNP O
domain NN O
of IN O
HspA NNP B-Gene
was VBD O
found VBN O
to TO O
be VB O
the DT O
immunodominant JJ O
domain NN O
. . O

OBJECTIVE NN O
: : O
To TO O
compare VB O
pregnancy NN O
complications NNS O
in IN O
women NNS O
having VBG O
genetic JJ O
amniocentesis NN O
at IN O
11 CD O
- : O
14 CD O
weeks NNS O
versus VBP O
those DT O
undergoing JJ O
amniocentesis NN O
at IN O
16 CD O
- : O
19 CD O
weeks NNS O
' POS O
gestation NN O
. . O

Proteasomes NNS O
are VBP O
the DT O
multisubunit JJ O
protease NN O
involved VBN O
in IN O
the DT O
generation NN O
of IN O
peptides NNS O
presented VBN O
by IN O
MHC NNP B-Gene
class NN I-Gene
I PRP I-Gene
molecules NNS I-Gene
. . O

Finally RB O
, , O
profiling VBG O
of IN O
a DT O
gcn4Delta NN B-Gene
mutant NN I-Gene
uncovered VBD O
an DT O
alternative JJ O
induction NN O
pathway NN O
operating VBG O
at IN O
many JJ O
Gcn4p NNP B-Gene
target NN I-Gene
genes NNS I-Gene
in IN O
histidine NN O
- : O
starved JJ O
cells NNS O
. . O

Either DT O
two CD O
or CC O
more JJR O
different JJ O
sequences NNS O
can MD O
promote VB O
cleavage NN O
, , O
or CC O
a DT O
single JJ O
element NN O
exists NNS O
which WDT O
is VBZ O
long JJ O
and CC O
diffuse NN O
. . O

In IN O
contrast NN O
, , O
resensitization NN O
of IN O
a DT O
sequestration NN O
- : O
impaired JJ O
beta2AR NN B-Gene
mutant NN O
( ( O
Y326A NNP O
) ) O
was VBD O
reestablished VBN O
following VBG O
the DT O
overexpression NN O
of IN O
either DT O
GRK2 NNP B-Gene
or CC O
beta SYM B-Gene
- : I-Gene
arrestin NN I-Gene
1 CD I-Gene
. . O

The DT O
tissue NN O
- : O
specific JJ O
expression NN O
of IN O
DP NNP B-Gene
family NN I-Gene
members NNS I-Gene
suggests VBZ O
that IN O
the DT O
combination NN O
of IN O
DP NNP B-Gene
/ NNP O
E2F NNP B-Gene
heterodimers NNS O
that WDT O
constitute VBP O
DRTF1 NNP B-Gene
/ NNP O
E2F NNP B-Gene
is VBZ O
influenced VBN O
by IN O
the DT O
phenotype NN O
of IN O
the DT O
cell NN O
. . O

Comparative JJ O
DNA NNP O
sequence NN O
analysis NN O
showed VBD O
the DT O
Genethon NNP O
microsatellite NN B-Gene
D19S596 NNP I-Gene
lies VBZ O
2 CD O
. . O
2 CD O
kb JJ O
downstream NN O
of IN O
the DT O
coding VBG O
region NN O
of IN O
FUT1 NNP B-Gene
, , O
indicating VBG O
that IN O
the DT O
cluster NN O
comprising VBG O
the DT O
closely RB O
linked VBN O
FUT1 NNP B-Gene
and CC O
FUT2 NNP B-Gene
genes NNS I-Gene
is VBZ O
located VBN O
4 CD O
cM JJ O
distal NN O
to TO O
D19S412 NNP B-Gene
( ( O
lod JJ O
score NN O
13 CD O
. . O
7 CD O
) ) O
and CC O
9 CD O
cM NN O
proximal NN O
to TO O
D19S571 NNP B-Gene
( ( O
lod JJ O
score NN O
11 CD O
. . O
7 CD O
) ) O
. . O

CBT NNP O
is VBZ O
discussed VBN O
in IN O
comparison NN O
with IN O
the DT O
Wisconsin NNP O
Card NNP O
Sorting NNP O
Test NNP O
as IN O
a DT O
potential JJ O
cognitive JJ O
activation NN O
task NN O
for IN O
functional JJ O
neuroimaging NN O
of IN O
the DT O
frontal JJ O
lobes NN O
. . O

Both DT O
increasing VBG O
basal NN O
FSH NNP B-Gene
and CC O
age NN O
were VBD O
associated VBN O
significantly RB O
with IN O
increased JJ O
total NN O
gonadotrophin NN B-Gene
dose NN O
, , O
and CC O
reduced JJ O
number NN O
of IN O
oocytes NNS O
collected VBN O
and CC O
pregnancy NN O
rate NN O
. . O

Site NNP O
- : O
directed VBD O
mutagenesis NN O
of IN O
residues NNS O
in IN O
this DT O
domain NN O
( ( O
R82A NNP O
, , O
K85A NNP O
, , O
K88A NNP O
, , O
and CC O
V89A NNP O
) ) O
resulted VBD O
in IN O
proteins NNS O
which WDT O
failed VBD O
to TO O
transactivate VB O
from IN O
the DT O
HTLV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
in IN O
vivo NN O
. . O

Lysosomal JJ O
enzymes NNS O
that WDT O
degrade VBP O
cartilage NN O
are VBP O
released VBN O
. . O

These DT O
data NNS O
may MD O
also RB O
aid VB O
in IN O
the DT O
localization NN O
of IN O
other JJ O
disease NN O
loci NN O
mapped VBD O
to TO O
this DT O
region NN O
, , O
including VBG O
the DT O
gene NN O
for IN O
tricho JJ O
- : O
dento NN O
- : O
osseous JJ O
syndrome NN O
and CC O
a DT O
murine NN O
locus NN O
for IN O
susceptibility NN O
to TO O
ozone VB O
- : O
induced VBN O
acute JJ O
lung NN O
injury NN O
. . O

XXI NN O
. . O

Thus RB O
, , O
both DT O
the DT O
hyperplasia NN O
and CC O
thrombotic JJ O
complications NNS O
which WDT O
often RB O
follow VBP O
stenting VBG O
might MD O
be VB O
minimized VBN O
by IN O
employing VBG O
gold NN O
stents NNS O
, , O
which WDT O
have VBP O
a DT O
greater JJR O
capacity NN O
than IN O
steel NN O
in IN O
supporting VBG O
a DT O
functional JJ O
neo NN O
- : O
endothelium NN O
. . O

Aortic JJ O
diameters NNS O
in IN O
infants NNS O
and CC O
young JJ O
children NNS O
: : O
normative JJ O
angiographic JJ O
data NNS O
. . O

However RB O
, , O
when WRB O
a DT O
second JJ O
, , O
upstream JJ B-Gene
IRE NNP I-Gene
- : I-Gene
like IN I-Gene
sequence NN I-Gene
was VBD O
evaluated VBN O
by IN O
EMSA NNP O
, , O
a DT O
DNA NN O
binding VBG O
pattern JJ O
distinct NN O
from IN O
that DT O
seen VBN O
following VBG O
exposure NN O
to TO O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
alone RB O
was VBD O
observed VBN O
after IN O
prolonged JJ O
stimulation NN O
with IN O
both DT O
IFN NNP B-Gene
- : I-Gene
alpha NN I-Gene
and CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
. . O

Comparison NNP O
of IN O
sequences NNS O
from IN O
- : O
215 CD O
to TO O
+ VB O
1 CD O
bp NNS O
identified VBN O
consensus NN O
binding VBG O
sites NNS O
for IN O
the DT O
homeodomain NN B-Gene
transcription NN I-Gene
factor NN I-Gene
thyroid JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
TTF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
. . O

In IN O
Mv1Lu NNP O
lung NN O
epithelial JJ O
cells NNS O
, , O
ActR NNP B-Gene
- : I-Gene
IB NN I-Gene
and CC O
T NNP B-Gene
beta NN I-Gene
R NNP I-Gene
- : I-Gene
I PRP I-Gene
signal VBP O
a DT O
common JJ O
set NN O
of IN O
growth NN O
- : O
inhibitory NN O
and CC O
transcriptional JJ O
responses NNS O
in IN O
association NN O
with IN O
their PRP$ O
corresponding JJ O
ligands NNS O
and CC O
type NN B-Gene
II NNP I-Gene
receptors NNS I-Gene
. . O

The DT O
UV NNP O
induction NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
is VBZ O
mediated VBN O
by IN O
two CD O
UV NNP O
response NN O
elements NNS O
consisting VBG O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
- : I-Gene
like IN I-Gene
sequences NNS I-Gene
within IN O
its PRP$ O
5 CD O
' '' O
control NN O
region NN O
. . O

Nine NNP O
DNA NNP O
fragments NNS O
that WDT O
were VBD O
specifically RB O
recognized VBN O
and CC O
bound VBN O
by IN O
histidine NN O
- : O
tagged VBN O
AdpA NNP B-Gene
were VBD O
isolated VBN O
by IN O
cycles NNS O
of IN O
a DT O
gel JJ O
mobility NN O
shift NN O
- : O
PCR NNP O
method NN O
. . O

A DT O
rabbit NN O
antiserum NN O
was VBD O
raised VBN O
against IN O
a DT O
synthetic JJ O
peptide NN O
corresponding VBG O
to TO O
a DT O
hydrophilic JJ O
portion NN O
of IN O
the DT O
translated JJ O
murine NN O
cDNA NN O
sequence NN O
. . O

Copyright JJ O
1998 CD O
Elsevier NNP O
Science NNP O
B NNP O
. . O
V NNP O
. . O

To TO O
evaluate VB O
the DT O
hepatic JJ O
regenerative JJ O
response NN O
in IN O
patients NNS O
with IN O
alcoholic JJ O
liver NN O
disease NN O
, , O
sera NN O
from IN O
263 CD O
patients NNS O
with IN O
severe JJ O
alcoholic JJ O
hepatitis NN O
and CC O
/ NN O
or CC O
cirrhosis NN O
were VBD O
analyzed VBN O
for IN O
hepatocyte NN B-Gene
growth NN I-Gene
factor NN I-Gene
( ( O
HGF NNP B-Gene
) ) O
and CC O
alpha $ B-Gene
- : I-Gene
fetoprotein NN I-Gene
( ( O
AFP NNP B-Gene
) ) O
. . O

Neuronal JJ O
mechanisms NNS O
underlying VBG O
stimulus JJ O
- : O
response NN O
( ( O
S NNP O
- : O
R NN O
) ) O
associations NNS O
in IN O
S NNP O
- : O
R NNP O
compatibility NN O
tasks NNS O
were VBD O
identified VBN O
in IN O
2 CD O
experiments NNS O
with IN O
monkeys NNS O
. . O

Identification NN O
of IN O
a DT O
proline NN O
- : O
rich JJ O
sequence NN O
in IN O
the DT O
CD2 NNP B-Gene
cytoplasmic JJ I-Gene
domain NN I-Gene
critical JJ O
for IN O
regulation NN O
of IN O
integrin JJ B-Gene
- : O
mediated VBN O
adhesion NN O
and CC O
activation NN O
of IN O
phosphoinositide NN B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
. . O

Interestingly RB O
, , O
the DT O
activated JJ O
PDGF NNP B-Gene
beta NN I-Gene
- : I-Gene
receptor NN I-Gene
was VBD O
found VBN O
not RB O
to TO O
bind VB O
Crk NNP B-Gene
proteins NNS I-Gene
. . O

Interestingly RB O
, , O
virions NNS O
also RB O
contained VBD O
smaller JJR O
proteins NNS O
that WDT O
reacted VBD O
with IN O
antibodies NNS O
specific VBP O
for IN O
the DT O
accessory JJ O
proteins NNS O
as RB O
well RB O
as IN O
SN NNP B-Gene
and CC O
CAT NNP B-Gene
fusion NN I-Gene
partners NNS O
. . O

In IN O
order NN O
to TO O
investigate VB O
how WRB O
these DT O
expression NN O
patterns NNS O
are VBP O
established VBN O
, , O
we PRP O
fused VBD O
promoter NN O
regions NNS O
of IN O
an DT O
acidic JJ O
and CC O
a DT O
basic JJ O
glucanase NN B-Gene
gene NN I-Gene
to TO O
the DT O
beta NN B-Gene
- : I-Gene
glucuronidase NN I-Gene
( ( O
GUS NNP B-Gene
) ) O
reporter NN O
gene NN O
and CC O
examined JJ O
expression NN O
of IN O
these DT O
constructs NNS O
in IN O
transgenic JJ O
tobacco NN O
plants NNS O
. . O

This DT O
report NN O
has VBZ O
reviewed VBN O
some DT O
of IN O
the DT O
reasons NNS O
for IN O
treatment NN O
failures NNS O
and CC O
has VBZ O
presented VBN O
a DT O
philosophy NN O
for IN O
their PRP$ O
management NN O
. . O

The DT O
experimental JJ O
results NNS O
showed VBD O
that IN O
the DT O
coagulation NN O
- : O
electrooxidation NN O
process NN O
could MD O
efficiently RB O
remove VB O
the DT O
color NN O
and CC O
the DT O
COD NNP O
from IN O
the DT O
simulated JJ O
dye NN O
wastewater NN O
. . O

To TO O
study VB O
the DT O
regulation NN O
of IN O
mdr2 JJ B-Gene
expression NN O
, , O
the DT O
promoter NN O
of IN O
the DT O
mdr2 NN B-Gene
gene NN I-Gene
has VBZ O
been VBN O
isolated VBN O
from IN O
a DT O
murine NN O
vinblastine NN O
- : O
resistant NN O
cell NN O
line NN O
, , O
J7 NNP O
. . O
V2 NNP O
- : O
1 CD O
, , O
and CC O
characterized VBD O
. . O

Thus RB O
, , O
replication NN O
fork NN O
movement NN O
near IN O
HML NNP B-Gene
pauses VBZ O
at IN O
a DT O
silent JJ O
origin NN O
which WDT O
is VBZ O
competent NN O
for IN O
replication NN O
initiation NN O
but CC O
kept VBD O
silent JJ O
through IN O
Orc2p NNP B-Gene
, , O
a DT O
component NN O
of IN O
the DT O
replication NN O
initiator NN O
. . O

The DT O
hypothesis NN O
of IN O
Geisler NNP O
( ( O
Brain NNP O
Res NNP O
. . O

Moreover RB O
, , O
elderly JJ O
men NNS O
with IN O
bioavailable JJ O
estradiol NN O
levels NNS O
below IN O
the DT O
median JJ O
[ NN O
40 CD O
pmol NN O
/ NN O
liter NN O
( ( O
11 CD O
pg NN O
/ NNP O
ml NN O
) ) O
] NN O
had VBD O
significantly RB O
higher JJR O
rates NNS O
of IN O
bone NN O
loss NN O
and CC O
levels NNS O
of IN O
bone NN O
resorption NN O
markers NNS O
than IN O
men NNS O
with IN O
bioavailable JJ O
estradiol NN O
levels NNS O
above IN O
40 CD O
pmol NN O
/ NN O
liter NN O
. . O

Marrow NNP O
dysplasia NN O
is VBZ O
a DT O
major JJ O
characteristic NN O
of IN O
patients NNS O
with IN O
myelodysplastic JJ O
syndrome NN O
( ( O
MDS NNP O
) ) O
, , O
along IN O
with IN O
marrow JJ O
blastosis NN O
, , O
cytopenia NN O
and CC O
cytogenetic JJ O
anomalies NNS O
. . O

c SYM B-Gene
- : I-Gene
Myc NNP I-Gene
- : O
induced JJ O
apoptosis NN O
appears VBZ O
to TO O
be VB O
deficient JJ O
in IN O
bax JJ B-Gene
- : O
null NN O
as IN O
compared VBN O
with IN O
bax JJ B-Gene
- : O
wild JJ O
- : O
type NN O
mouse NN O
embryonic JJ O
fibroblasts NNS O
. . O

Sulfhydryl NNP O
titration NN O
with IN O
iodoacetamide NN O
, , O
monitored VBN O
by IN O
quantitating VBG O
the DT O
residual JJ O
thiols NNS O
after IN O
reaction NN O
with IN O
a DT O
maleimide JJ O
derivative NN O
of IN O
biotin NN O
, , O
revealed VBD O
a DT O
striking JJ O
difference NN O
in IN O
the DT O
apparent JJ O
pK NN O
( ( O
a DT O
) ) O
values NNS O
of IN O
the DT O
cysteines NNS O
at IN O
the DT O
two CD O
splice NN O
junctions NNS O
. . O

ECM NNP O
disruption NN O
in IN O
Lytechinus NNP O
embryos NN O
caused VBD O
a DT O
relative JJ O
drop NN O
in IN O
USF NNP B-Gene
RNA NNP I-Gene
accumulation NN O
levels NNS O
to TO O
approximately RB O
60 CD O
% NN O
of IN O
control NN O
embryos NN O
, , O
while IN O
LpS1 NNP B-Gene
RNA NNP I-Gene
accumulation NN O
levels NNS O
dropped VBD O
to TO O
less JJR O
than IN O
5 CD O
% NN O
. . O

An DT O
N NNP O
- : O
terminal JJ O
arm NN O
from IN O
each DT O
subunit NN O
wraps VBZ O
around IN O
the DT O
dinucleotide NN O
- : O
binding NN O
domain NN O
of IN O
an DT O
adjacent JJ O
subunit NN O
, , O
covering VBG O
the DT O
adenine JJ O
ring NN O
of IN O
NADP NNP O
. . O

Our PRP$ O
results NNS O
are VBP O
reassuring VBG O
and CC O
we PRP O
therefore VBP O
advise RP O
that DT O
in IN O
patients NNS O
undergoing JJ O
free JJ O
jejunum NN O
flap JJ O
reconstruction NN O
of IN O
the DT O
hypopharyngo NN O
- : O
esophageal NN O
tract JJ O
voice NN O
restoration NN O
should MD O
be VB O
attempted VBN O
by IN O
placing VBG O
a DT O
voice NN O
prosthesis NN O
through IN O
a DT O
secondary JJ O
tracheo NN O
- : O
esophageal JJ O
puncture NN O
and CC O
providing VBG O
intensive JJ O
speech NN O
training NN O
. . O

In IN O
a DT O
series NN O
of IN O
patients NNS O
with IN O
neuroinfection NN O
, , O
Lyme NNP O
disease NN O
, , O
Guillain NNP O
Barre NNP O
syndrome NN O
, , O
demyelinization NN O
, , O
partial JJ O
or CC O
generalized VBN O
, , O
epilepsy RB O
, , O
we PRP O
have VBP O
investigated VBN O
antiphospholipid JJ O
antibodies NNS O
of IN O
IgG NNP B-Gene
and CC O
IgM NNP B-Gene
subtypes NNS O
, , O
together RB O
with IN O
anticoagulant JJ O
factors NNS O
, , O
member NN O
of IN O
thrombocytes NNS O
, , O
sedimentation NN O
rate NN O
of IN O
erythrocytes NNS O
. . O

When WRB O
CSF NNP O
[ NNP O
HCO3 NNP O
- : O
] NN O
is VBZ O
shown VBN O
as IN O
a DT O
function NN O
of IN O
CSF NNP O
PCO2 NNP O
the DT O
data NN O
of IN O
K NNP O
- : O
depleted VBN O
rats NNS O
are VBP O
no RB O
longer RB O
displaced VBD O
when WRB O
compared VBN O
to TO O
controls NNS O
but CC O
still RB O
have VBP O
a DT O
significantly RB O
greater JJR O
slope NN O
( ( O
1 CD O
. . O
21 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
23 CD O
vs NN O
. . O

The DT O
following JJ O
aspects NNS O
were VBD O
assessed VBN O
: : O
( ( O
1 CD O
) ) O
The DT O
effect NN O
on IN O
the DT O
cardiovascular JJ O
system NN O
in IN O
terms NNS O
of IN O
brachial JJ O
arterial JJ O
pressure NN O
, , O
pulse JJ O
rate NN O
, , O
and CC O
oxygen NN O
consumption NN O
( ( O
VO2 NNP O
) ) O
during IN O
exercise NN O
in IN O
5 CD O
health NN O
volunteers NNS O
; : O
( ( O
2 CD O
) ) O
emg NN O
activity NN O
of IN O
the DT O
tibialis NN O
anterior NN O
and CC O
gastrocnemius NN O
muscles NNS O
during IN O
exercise NN O
in IN O
the DT O
same JJ O
5 CD O
volunteers NNS O
; : O
and CC O
( ( O
3 CD O
) ) O
postexercise NN O
ankle JJ O
pressure NN O
changes NNS O
in IN O
10 CD O
subjects NNS O
with IN O
angiographically RB O
proven JJ O
occlusive JJ O
arterial JJ O
diseases NNS O
of IN O
the DT O
lower JJR O
extremities NNS O
. . O

The DT O
initial JJ O
translation NN O
protein NN O
encoded VBN O
by IN O
the DT O
cDNA NN O
is VBZ O
53 CD O
, , O
932 CD O
kDa NN O
and CC O
possesses VBZ O
a DT O
hydrophilic JJ O
amino NN O
acid JJ O
composition NN O
with IN O
glutamic JJ O
acid NN O
comprising VBG O
22 CD O
% NN O
of IN O
the DT O
total JJ O
amino NN O
acid NN O
residues NNS O
. . O

Furthermore RB O
, , O
in IN O
vivo NN O
and CC O
in IN O
vitro JJ O
protein NN O
- : O
protein NN O
interaction NN O
experiments NNS O
have VBP O
shown VBN O
that IN O
SR33 NNP B-Gene
protein NN I-Gene
interacts VBZ O
with IN O
itself PRP O
and CC O
with IN O
SR45 NNP B-Gene
protein NNS I-Gene
but CC O
not RB O
with IN O
two CD O
other JJ O
members NNS O
( ( O
SRZ21 NNP B-Gene
and CC O
SRZ22 NNP B-Gene
) ) O
of IN O
the DT O
SR NNP B-Gene
family NN I-Gene
that WDT O
are VBP O
known VBN O
to TO O
interact VB O
with IN O
the DT O
Arabidopsis NNP O
full JJ O
- : O
length NN O
U NNP B-Gene
- : I-Gene
70K CD I-Gene
only RB O
. . O

Using VBG O
an DT O
opsonophagocytic JJ O
bacterial JJ O
assay NN O
and CC O
a DT O
suckling JJ O
rat NN O
model NN O
of IN O
GBS NNP O
sepsis NN O
, , O
we PRP O
analyzed VBD O
a DT O
modified JJ O
human JJ B-Gene
immunoglobulin NN I-Gene
for IN O
opsonic JJ O
and CC O
protective JJ O
antibody NN O
. . O

Cloning NNP O
, , O
sequencing VBG O
and CC O
expression NN O
of IN O
the DT O
3 CD B-Gene
- : I-Gene
phosphoglycerate NN I-Gene
kinase NN I-Gene
gene NN I-Gene
of IN O
Pyrococcus NNP O
woesei NN O
in IN O
Escherichia NNP O
coli NN O
and CC O
characterization NN O
of IN O
the DT O
protein NN O
. . O

Pneumothorax NN O
following VBG O
lung NN O
abscess NN O
in IN O
the DT O
renal JJ O
transplant NN O
patient NN O
. . O

Expense NN O
limits VBZ O
the DT O
use NN O
of IN O
hepatitis NN O
B NNP O
vaccines NNS O
, , O
but CC O
low JJ O
- : O
dose NN O
intradermal JJ O
immunization NN O
has VBZ O
been VBN O
evaluated VBN O
as IN O
a DT O
cost NN O
- : O
saving VBG O
strategy NN O
in IN O
numerous JJ O
studies NNS O
. . O

During IN O
coronary JJ O
stenosis NN O
, , O
on IN O
the DT O
contrary JJ O
, , O
intracoronary JJ O
procaterol NN O
at IN O
the DT O
same JJ O
dose NN O
significantly RB O
deteriorated VBD O
regional JJ O
myocardial JJ O
dysfunction NN O
without IN O
changing VBG O
LCX NNP O
flow NN O
, , O
global JJ O
hemodynamics NNS O
and CC O
cardiac JJ O
lactate NN O
metabolism NN O
. . O

In IN O
addition NN O
, , O
narZ JJ B-Gene
expression NN O
was VBD O
induced VBN O
approximately RB O
20 CD O
- : O
fold NN O
intracellularly RB O
in IN O
Madin NNP O
- : O
Darby NNP O
canine NN O
kidney NN O
epithelial JJ O
cells NNS O
and CC O
16 CD O
- : O
fold NN O
in IN O
intracellular JJ O
salts NNS O
medium NN O
, , O
which WDT O
is VBZ O
believed VBN O
to TO O
mimic VB O
the DT O
intracellular JJ O
milieu NN O
. . O

We PRP O
further VBP O
found VBD O
that IN O
KmMig1p NNP B-Gene
is VBZ O
fully RB O
functional JJ O
when WRB O
expressed VBN O
in IN O
S NNP O
. . O
cerevisiae NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
HIV NNP O
- : O
1 CD O
Gag NNP B-Gene
sequences NNS I-Gene
can MD O
influence VB O
the DT O
viral JJ B-Gene
PR NNP I-Gene
- : O
mediated VBD O
processing NN O
of IN O
the DT O
MuLV NNP O
TM NNP B-Gene
Env NNP I-Gene
protein NN I-Gene
p15 NN B-Gene
( ( I-Gene
E NNP I-Gene
) ) I-Gene
. . O

Recombinant NNP O
plasmid NN O
pFV100 NN O
was VBD O
subsequently RB O
isolated VBN O
by IN O
its PRP$ O
ability NN O
to TO O
complement NN O
B NNP O
- : O
band NN O
expression NN O
in IN O
ge6 NN B-Gene
. . O

The DT O
prevalence NN O
of IN O
malnutrition NN O
was VBD O
30 CD O
% NN O
in IN O
the DT O
47 CD O
patients NNS O
without IN O
CVD NNP O
and CC O
was VBD O
significantly RB O
higher JJR O
( ( O
70 CD O
% NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
in IN O
the DT O
70 CD O
patients NNS O
with IN O
CVD NNP O
, , O
who WP O
also RB O
had VBD O
lower JJR O
tHcy NN O
, , O
SAlb NNP O
, , O
plasma NN B-Gene
IGF NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
serum NN O
creatinine NN O
( ( O
SCr NNP O
) ) O
, , O
and CC O
blood NN B-Gene
hemoglobin NN I-Gene
. . O

The DT O
effects NNS O
of IN O
procedural JJ O
variations NNS O
on IN O
lateralized JJ O
Stroop NNP O
effects NNS O
. . O

Measurement NN O
of IN O
gastric JJ O
acid JJ O
secretion NN O
by IN O
conductivity NN O
. . O

In IN O
summary JJ O
, , O
the DT O
data NNS O
establish VB O
that IN O
the DT O
previously RB O
reported VBN O
human JJ B-Gene
MAdCAM NNP I-Gene
- : I-Gene
1 CD I-Gene
cDNA NN I-Gene
does VBZ O
indeed RB O
encode VB O
the DT O
human JJ O
homologue NN O
of IN O
mouse NN B-Gene
MAdCAM NNP I-Gene
- : I-Gene
1 CD I-Gene
, , O
despite IN O
gross JJ O
dissimilarities NNS O
in IN O
the DT O
MAdCAM NNP B-Gene
- : I-Gene
1 CD I-Gene
C NNP O
- : O
terminal JJ O
structures NNS O
. . O

Is VBZ O
criticism NN O
of IN O
patient NN O
care NN O
justified JJ O
and CC O
does VBZ O
it PRP O
have VB O
educational JJ O
value NN O
? . O

The DT O
activity NN O
of IN O
6 CD O
- : O
fluoroquinolones NNS O
and CC O
their PRP$ O
nonfluorinated JJ O
derivatives NNS O
is VBZ O
compared VBN O
in IN O
general JJ O
. . O

High JJ O
radial JJ O
r NN O
values NNS O
with IN O
small JJ O
standard JJ O
deviations NNS O
were VBD O
observed VBN O
in IN O
normal JJ O
LV NNP O
( ( O
0 CD O
. . O
972 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
16 CD O
) ) O
and CC O
in IN O
non JJ O
- : O
MI NN O
regions NNS O
( ( O
0 CD O
. . O
964 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
18 CD O
) ) O
, , O
indicating VBG O
temporally RB O
homogeneous JJ O
radial JJ O
shortening NN O
. . O

The DT O
role NN O
of IN O
protein JJ B-Gene
kinase NNP I-Gene
C NNP I-Gene
signaling VBG O
in IN O
activated JJ O
DRA NNP B-Gene
transcription NN O
. . O

Results NNS O
showed VBD O
that IN O
the DT O
mean JJ O
bond NN O
strength NN O
of IN O
H NNP O
. . O
T NNP O
. . O
V NNP O
. . O
specimens NNS O
ranged VBD O
from IN O
9 CD O
. . O
6 CD O
to TO O
13 CD O
. . O
12 CD O
kg JJ O
/ NNP O
cm2 NN O
, , O
while IN O
the DT O
mean JJ O
bond NN O
strength NN O
of IN O
R NNP O
. . O
T NNP O
. . O
V NNP O
. . O
specimens NNS O
ranged VBD O
from IN O
0 CD O
. . O
36 CD O
to TO O
1 CD O
. . O
75 CD O
kg JJ O
/ NNP O
cm2 NN O
. . O

Plasma NNP O
, , O
LDL NNP B-Gene
and CC O
liver RB O
cholesterol NN O
concentrations NNS O
were VBD O
higher JJR O
in IN O
the DT O
hyperlipidemic NN O
control NN O
than IN O
the DT O
nonhyperlipidemic JJ O
control NN O
and CC O
lower JJR O
in IN O
the DT O
groups NNS O
fed VBP O
diets NNS O
containing VBG O
pectin NN B-Gene
or CC O
prune NN O
fiber NN O
than IN O
in IN O
the DT O
hyperlipidemic JJ O
control NN O
group NN O
. . O

Conversely RB O
, , O
the DT O
inactive JJ O
dAK NN B-Gene
subunit NN I-Gene
is VBZ O
progressively RB O
activated VBN O
by IN O
1 CD O
) ) O
association NN O
with IN O
a DT O
dGK NN B-Gene
or CC O
dCK NN B-Gene
subunit NN I-Gene
and CC O
2 CD O
) ) O
the DT O
conformationally RB O
driven JJ O
heterotropic NNS O
affect NN O
of IN O
dGuo NN B-Gene
or CC O
dCyd NN B-Gene
bound NN O
to TO O
the DT O
opposing VBG O
subunit NN O
. . O

The DT O
transcription NN O
of IN O
most JJS O
RP NNP B-Gene
genes NNS I-Gene
is VBZ O
activated VBN O
by IN O
two CD O
Rap1p NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
, , O
250 CD O
to TO O
400 CD O
bp NNS O
upstream RB O
from IN O
the DT O
initiation NN O
of IN O
transcription NN O
. . O

In IN O
addition NN O
, , O
a DT O
21 CD O
- : O
mer NN O
subrepeat NN O
structure NN O
is VBZ O
also RB O
present JJ O
in IN O
each DT O
unit NN O
. . O

In IN O
a DT O
prospective JJ O
, , O
multicentre JJ O
trial NN O
the DT O
efficacy NN O
of IN O
an DT O
Vitex NNP O
agnus NN O
castus NN O
L NNP O
extract NN O
Ze NNP O
440 CD O
was VBD O
investigated VBN O
in IN O
50 CD O
patients NNS O
with IN O
pre JJ O
- : O
menstrual JJ O
syndrome NN O
( ( O
PMS NNP O
) ) O
. . O

One CD O
form NN O
of IN O
the DT O
SBEI NNP B-Gene
gene NN I-Gene
transcript NN I-Gene
in IN O
12 CD O
- : O
day NN O
old JJ O
kernels NNS O
contained VBD O
the DT O
exon NN O
I PRP O
+ VBP O
II NNP O
+ NNP O
III NNP O
combination NN O
at IN O
the DT O
5 CD O
' POS O
end NN O
, , O
whereas IN O
other JJ O
forms NNS O
differed VBN O
by IN O
inclusion NN O
of IN O
intron NN O
1 CD O
or CC O
exclusion NN O
of IN O
exon JJ O
II NNP O
sequences NNS O
. . O

Selected VBN O
topics NNS O
in IN O
laboratory NN O
animal JJ O
medicine NN O
. . O

A DT O
combined JJ O
series NN O
of IN O
patients NNS O
experienced VBD O
a DT O
TOL NNP O
after IN O
two CD O
or CC O
more JJR O
previous JJ O
cesarean NN O
deliveries NNS O
; : O
the DT O
rate NN O
of IN O
vaginal JJ O
delivery NN O
was VBD O
66 CD O
% NN O
, , O
and CC O
there RB O
was VBD O
virtually RB O
no DT O
morbidity NN O
. . O

CPT NNP O
- : O
11 CD O
was VBD O
administered VBN O
as IN O
a DT O
30 CD O
- : O
minute NN O
i NN O
. . O
v NN O
. . O
infusion NN O
at IN O
a DT O
dose NN O
of IN O
350 CD O
mg NNS O
/ JJ O
m2 NN O
diluted VBN O
in IN O
250 CD O
ml NNS O
normal JJ O
saline JJ O
every DT O
3 CD O
weeks NNS O
. . O

Net JJ O
lift NN O
and CC O
combined VBN O
drag NN O
from IN O
all DT O
8 CD O
bearings NNS O
of IN O
the DT O
4 CD O
- : O
bladed VBN O
impeller NN O
are VBP O
compared VBN O
with IN O
predictions NNS O
based VBN O
on IN O
2 CD O
- : O
D NNP O
theory NN O
. . O

Increased VBN O
dietary JJ O
energy NN O
decreased VBD O
PAB NNP O
and CC O
the DT O
use NN O
of IN O
added JJ O
dietary JJ O
CO NNP O
rather RB O
than IN O
PF NNP O
decreased VBD O
PSHL NNP O
in IN O
broiler NN O
breeders NNS O
between IN O
26 CD O
and CC O
47 CD O
wk NN O
of IN O
age NN O
. . O

The DT O
homozygous JJ O
C2 NNP B-Disease
- : I-Disease
deficient NN I-Disease
propositus NN O
and CC O
brother NN O
were VBD O
HLA NNP O
- : O
A DT O
and CC O
B NNP O
homozygous JJ O
but CC O
heterozygous JJ O
at IN O
the DT O
HLA NNP O
- : O
D NN O
and CC O
glyoxalase NN O
I PRP O
loci VBP O
. . O

One CD O
mutation NN O
, , O
detected VBN O
by IN O
the DT O
abnormal JJ O
pattern NN O
of IN O
migration NN O
of IN O
an DT O
amplified JJ O
fragment NN O
, , O
is VBZ O
a DT O
C NNP O
to TO O
T NNP O
transition NN O
in IN O
the DT O
splice NN O
acceptor NN O
site NN O
of IN O
intron NN O
10 CD O
, , O
which WDT O
resulted VBD O
in IN O
the DT O
skipping NN O
of IN O
exon $ O
11 CD O
with IN O
the DT O
premature JJ O
termination NN O
of IN O
RNA NNP O
translation NN O
downstream NN O
from IN O
exon JJ O
12 CD O
( ( O
- : O
3 CD O
IVS10 NNP O
) ) O
. . O

Wild NNP O
- : O
type NN O
APC NNP B-Disease
activity NN O
in IN O
beta NN O
- : O
catenin NN O
- : O
/ NN O
Tcf NNP O
- : O
mediated VBD O
transcription NN O
was VBD O
strongly RB O
inhibited VBN O
by IN O
a DT O
mutant JJ O
APC NNP B-Disease
that WDT O
is VBZ O
truncated VBN O
at IN O
codon NN O
1309 CD O
. . O

To TO O
date NN O
we PRP O
have VBP O
identified VBN O
65 CD O
missense JJ O
mutations NNS O
in IN O
the DT O
GALNS NNP O
gene NN O
from IN O
MPS NNP B-Disease
IVA NNP I-Disease
patients NNS O
, , O
but CC O
the DT O
correlation NN O
between IN O
genotype NN O
and CC O
phenotype NN O
has VBZ O
remained VBN O
unclear JJ O
. . O

Forty NNP O
- : O
six CD O
per IN O
cent NN O
of IN O
patients NNS O
with IN O
mutations NNS O
5 CD O
of IN O
the DT O
Dp260 NNP O
transcript JJ O
start NN O
site NN O
have VBP O
abnormal JJ O
ERGs NNP O
, , O
as IN O
opposed VBN O
to TO O
94 CD O
% NN O
with IN O
more JJR O
distal JJ O
mutations NNS O
. . O

We PRP O
have VBP O
determined VBN O
that IN O
the DT O
human JJ O
gene NN O
( ( O
PDEB NNP O
) ) O
maps VBZ O
to TO O
4p16 CD O
. . O

We PRP O
describe VBP O
three CD O
novel JJ O
mutations NNS O
( ( O
R58fs NNP O
, , O
R330S NNP O
, , O
and CC O
H371R NNP O
) ) O
and CC O
one CD O
common JJ O
AKU NNP B-Disease
mutation NN O
( ( O
M368V NNP O
) ) O
, , O
detected VBN O
by IN O
mutational JJ O
and CC O
polymorphism NN O
analysis NN O
of IN O
the DT O
HGO NNP O
gene NN O
in IN O
five CD O
Finnish JJ O
AKU NNP B-Disease
pedigrees NNS O
. . O

Haplotyping VBG O
showed VBD O
that IN O
they PRP O
are VBP O
likely JJ O
to TO O
derive VB O
from IN O
a DT O
common JJ O
ancestor NN O
, , O
possibly RB O
of IN O
northern JJ O
British JJ O
origin NN O
. . O

DTD NNP B-Disease
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
recently RB O
identified VBN O
diastrophic JJ B-Disease
dysplasia NN I-Disease
sulfate NN O
- : O
transporter NN O
gene NN O
( ( O
DTDST NNP O
) ) O
. . O

PCR NNP O
- : O
amplified VBD O
VLCAD NNP O
cDNAs NN O
were VBD O
sequenced VBN O
in IN O
cultured JJ O
fibroblasts NNS O
from IN O
two CD O
VLCAD NNP B-Disease
- : I-Disease
deficient NN I-Disease
patients NNS O
. . O

We PRP O
had VBD O
not RB O
seen VBN O
a DT O
case NN O
of IN O
homozygosity NN O
for IN O
c862t NN O
( ( O
R279W NNP O
) ) O
until IN O
we PRP O
analysed VBD O
DNA NNP O
from IN O
a DT O
36 CD O
year NN O
old JJ O
male NN O
with IN O
tall JJ O
- : O
normal JJ O
stature NN O
( ( O
180 CD O
cm NN O
) ) O
who WP O
asked VBD O
for IN O
genetic JJ O
counselling NN O
for IN O
suspected JJ O
multiple JJ B-Disease
epiphyseal NN I-Disease
dysplasia NN I-Disease
. . O

A DT O
physical JJ O
map NN O
and CC O
candidate NN O
genes NNS O
in IN O
the DT O
BRCA1 NNP O
region NN O
on IN O
chromosome NN O
17q12 CD O
- : O
21 CD O
. . O

These DT O
results NNS O
show VBP O
that IN O
the DT O
former JJ O
five CD O
mutations NNS O
account VBP O
for IN O
more JJR O
than IN O
90 CD O
% NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
cases NNS O
in IN O
Taiwan NNP O
. . O

The DT O
BRCA1 NNP O
Exon NNP O
13 CD O
Duplication NNP O
Screening NNP O
Group NNP O
. . O

A DT O
new JJ O
mutation NN O
in IN O
the DT O
proteolipid JJ O
protein NN O
( ( O
PLP NNP O
) ) O
gene NN O
in IN O
a DT O
German JJ O
family NN O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
. . O

Splice NNP O
- : O
site NN O
mutation NN O
in IN O
the DT O
PDS NNP B-Disease
gene NN O
may MD O
result VB O
in IN O
intrafamilial JJ O
variability NN O
for IN O
deafness NN B-Disease
in IN O
Pendred NNP B-Disease
syndrome NN I-Disease
. . O

Treatment NN O
of IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
: : O
effects NNS O
of IN O
chenodeoxycholic JJ O
acid NN O
, , O
pravastatin NN O
, , O
and CC O
combined VBN O
use NN O
. . O

All DT O
types NNS O
of IN O
point NN O
mutations NNS O
are VBP O
represented VBN O
and CC O
are VBP O
found VBN O
unequally RB O
distributed VBN O
along IN O
the DT O
RB1 NNP O
gene NN O
sequence NN O
. . O

Three CD O
novel JJ O
mutations NNS O
were VBD O
identified VBN O
a DT O
C NNP O
- : O
T NNP O
substitution NN O
in IN O
exon JJ O
5 CD O
, , O
and CC O
a DT O
G NNP O
- : O
T NNP O
substitution NN O
and CC O
single JJ O
cytosine NN O
deletion NN O
in IN O
exon JJ O
6 CD O
, , O
confirming VBG O
the DT O
existence NN O
of IN O
extensive JJ O
allelic JJ O
heterogeneity NN O
in IN O
this DT O
condition NN O
. . O

Analysis NN O
of IN O
17q CD O
haplotypes NNS O
shows VBZ O
a DT O
recombination NN O
event NN O
in IN O
a DT O
bilateral JJ O
breast NN B-Disease
cancer NN I-Disease
case NN O
which WDT O
suggests VBZ O
that IN O
the DT O
BRCA1 NNP O
gene NN O
lies VBZ O
distal JJ O
to TO O
D17S857 NNP O
; : O
D17S857 NNP O
is VBZ O
thus RB O
the DT O
new JJ O
proximal JJ O
boundary NN O
for IN O
the DT O
region NN O
containing VBG O
BRCA1 NNP O
. . O

Mutational JJ O
analysis NN O
of IN O
the DT O
HGO NNP O
gene NN O
in IN O
Finnish JJ O
alkaptonuria NN B-Disease
patients NNS O
. . O

97 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O

Of IN O
these DT O
four CD O
rearrangements NNS O
, , O
one CD O
resulted VBD O
in IN O
the DT O
deletion NN O
of IN O
exons NNS O
11 CD O
and CC O
12 CD O
and CC O
two CD O
others NNS O
resulted VBD O
in IN O
either CC O
complete JJ O
or CC O
partial JJ O
deletion NN O
of IN O
exon $ O
14 CD O
. . O

A DT O
new JJ O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
variant NN O
associated VBN O
with IN O
chronic JJ B-Disease
nonspherocytic JJ I-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
was VBD O
reported VBN O
. . O

These DT O
results NNS O
support VBD O
the DT O
finding NN O
of IN O
a DT O
prostate NN B-Disease
cancer NN I-Disease
- : O
susceptibility NN O
gene NN O
linked VBD O
to TO O
1q24 CD O
- : O
25 CD O
, , O
albeit NN O
in IN O
a DT O
defined JJ O
subset NN O
of IN O
prostate NN B-Disease
cancer NN I-Disease
families NNS O
. . O

The DT O
third JJ O
mutation NN O
( ( O
1376 CD O
G NNP O
- : O
- : O
- : O
- : O
T NN O
) ) O
was VBD O
found VBN O
in IN O
four CD O
affected JJ O
Chinese NNP O
. . O

The DT O
Na NNP O
+ NNP O
/ NNP O
glucose VBP O
cotransporter NN O
gene NN O
SGLT1 NNP O
encodes VBZ O
the DT O
primary JJ O
carrier NN O
protein NN O
responsible JJ O
for IN O
the DT O
uptake NN O
of IN O
the DT O
dietary JJ O
sugars NNS O
glucose JJ O
and CC O
galactose JJ O
from IN O
the DT O
intestinal JJ O
lumen NNS O
. . O

In IN O
comparison NN O
with IN O
the DT O
usual JJ O
EDMD NNP B-Disease
phenotype NN O
, , O
patients NNS O
with IN O
P183 NNP O
missense NN O
mutations NNS O
have VBP O
a DT O
later JJ O
age NN O
at IN O
onset NN O
of IN O
first JJ O
symptoms NNS O
, , O
elbow NN B-Disease
contractures NNS I-Disease
, , O
ankle NN B-Disease
contractures NNS I-Disease
, , O
upper JJ B-Disease
limb NN I-Disease
weakness NN I-Disease
and CC O
lower JJR B-Disease
limb NN I-Disease
weakness NN I-Disease
, , O
but CC O
there EX O
is VBZ O
no DT O
difference NN O
for IN O
the DT O
age NN O
at IN O
onset NN O
of IN O
cardiac JJ B-Disease
involvement NN I-Disease
. . O

3 CD O
region NN O
between IN O
DXS155 NNP O
and CC O
DXS294 NNP O
/ NNP O
DXS730 NNP O
. . O

Another DT O
C NNP O
- : O
- : O
> NN O
T NNP O
transition NN O
converted VBD O
a DT O
CAG NNP O
- : O
glutamine NN O
to TO O
a DT O
TAG NNP O
- : O
stop NN O
in IN O
exon JJ O
7 CD O
. . O

In IN O
two CD O
unrelated JJ O
families NNS O
, , O
males NNS O
have VBP O
been VBN O
identified VBN O
who WP O
suffer VBP O
from IN O
choroideremia NN B-Disease
and CC O
at IN O
the DT O
same JJ O
time NN O
have VBP O
an DT O
interstitial JJ O
deletion NN O
on IN O
the DT O
proximal NN O
long JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
. . O

The DT O
latter JJ O
three CD O
mutations NNS O
are VBP O
predicted VBN O
to TO O
result VB O
in IN O
exon NN O
skipping NN O
in IN O
the DT O
mRNA NN O
encoded VBD O
from IN O
the DT O
mutant JJ O
allele NN O
. . O

Aniridia NNP B-Disease
( ( O
iris JJ B-Disease
hypoplasia NN I-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
congenital JJ I-Disease
disorder NN I-Disease
of IN I-Disease
the DT I-Disease
eye NN I-Disease
. . O

Thus RB O
, , O
PRAD1 NNP O
is VBZ O
an DT O
excellent JJ O
candidate NN O
"""" NNP O
BCL1 NNP O
oncogene NN O
. . O

We PRP O
determined VBD O
the DT O
AGA NNP O
activity NN O
in IN O
cultured JJ O
fibroblasts NNS O
of IN O
a DT O
girl NN O
with IN O
a DT O
46 CD O
, , O
XX NNP O
, , O
del NN O
( ( O
4 CD O
) ) O
( ( O
q33 NN O
) ) O
karyotype NN O
. . O

Among IN O
503 CD O
subjects NNS O
, , O
43 CD O
showed VBD O
an DT O
enzyme JJ O
deficiency NN O
; : O
in IN O
39 CD O
the DT O
defect NN O
was VBD O
of IN O
the DT O
Mediterranean NNP O
type NN O
. . O

Antibodies NNS O
to TO O
PTS1R NNP O
inhibit NN O
peroxisomal JJ O
protein NN O
- : O
import NN O
of IN O
PTS1 NNP O
- : O
containing VBG O
proteins NNS O
in IN O
a DT O
permeabilized JJ O
CHO NNP O
cell NN O
system NN O
. . O

II NNP O
. . O

A DT O
common JJ O
human JJ O
skin FW B-Disease
tumour NN I-Disease
is VBZ O
caused VBN O
by IN O
activating VBG O
mutations NNS O
in IN O
beta NN O
- : O
catenin NN O
. . O

Combined VBN O
treatment NN O
with IN O
CDCA NNP O
and CC O
pravastatin NN O
showed VBD O
good JJ O
overlapping NN O
of IN O
the DT O
effects NNS O
of IN O
each DT O
drug NN O
alone RB O
. . O

We PRP O
analyzed VBD O
genomic JJ O
DNA NN O
from IN O
one CD O
affected VBD O
individual JJ O
from IN O
each DT O
of IN O
24 CD O
families NNS O
with IN O
at IN O
least JJS O
three CD O
cases NNS O
of IN O
ovarian JJ B-Disease
or CC I-Disease
breast NN I-Disease
cancer NN I-Disease
, , O
using VBG O
SSCP NNP O
assays NNS O
. . O

An DT O
amelogenin JJ O
gene NN O
, , O
AMGX NNP O
, , O
has VBZ O
been VBN O
mapped VBN O
to TO O
the DT O
short JJ O
of IN O
the DT O
X NNP O
chromosome NN O
( ( O
Xp22 NNP O
. . O
1 CD O
- : O
p22 NN O
. . O
3 CD O
) ) O
and CC O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
molecular JJ O
pathology NN O
of IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
amelogenesis NN I-Disease
imperfecta NN I-Disease
( ( O
AIH1 NNP B-Disease
) ) O
. . O

Renal NNP B-Disease
cell NN I-Disease
carcinomas NNS I-Disease
constitute VBP O
a DT O
particularly RB O
frequent JJ O
cause NN O
of IN O
death NN O
in IN O
this DT O
disorder NN O
, , O
occurring VBG O
as IN O
bilateral JJ B-Disease
and CC I-Disease
multifocal JJ I-Disease
tumours NNS I-Disease
, , O
and CC O
presenting VBG O
at IN O
an DT O
earlier JJR O
age NN O
than IN O
in IN O
sporadic JJ O
, , O
non JJ O
- : O
familial JJ O
cases NNS O
of IN O
this DT O
tumour NN B-Disease
type NN O
. . O

We PRP O
have VBP O
used VBN O
the DT O
Xq25 NNP O
breakpoint NN O
in IN O
this DT O
patient NN O
to TO O
determine VB O
the DT O
position NN O
of IN O
OCRL NNP O
relative NN O
to TO O
the DT O
two CD O
linked VBD O
markers NNS O
. . O

HFE NNP O
mutations NNS O
analysis NN O
in IN O
711 CD O
hemochromatosis NN B-Disease
probands NNS O
: : O
evidence NN O
for IN O
S65C NNP O
implication NN O
in IN O
mild JJ O
form NN O
of IN O
hemochromatosis NN B-Disease
. . O

The DT O
C282Y NNP O
mutation NN O
occurs VBZ O
on IN O
a DT O
haplotype NN O
that WDT O
extends VBZ O
< JJ O
/ NNP O
= NNP O
6 CD O
Mb NNP O
, , O
suggesting VBG O
that IN O
this DT O
mutation NN O
has VBZ O
arisen VBN O
during IN O
the DT O
past JJ O
2 CD O
, , O
0 CD O
years NNS O
. . O

A DT O
total NN O
of IN O
63 CD O
families NNS O
with IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
were VBD O
examined VBN O
for IN O
linkage NN O
between IN O
HD NNP B-Disease
and CC O
G8 NNP O
( ( O
D4S10 NNP O
) ) O
. . O

Gc NNP O
- : O
types NNS O
in IN O
the DT O
family NN O
were VBD O
compatible JJ O
with IN O
, , O
but CC O
did VBD O
not RB O
prove VB O
, , O
linkage NN O
of IN O
analbuminemia NN B-Disease
to TO O
the DT O
Gc NNP O
- : O
locus NN O
. . O

The DT O
response NN O
to TO O
treatment NN O
was VBD O
good JJ O
despite IN O
using VBG O
low JJ O
colchicine NN O
dose NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O

We PRP O
have VBP O
utilized VBN O
backcross NN O
analysis NN O
in IN O
mice NN O
to TO O
verify VB O
and CC O
define VB O
more RBR O
precisely RB O
the DT O
location NN O
of IN O
the DT O
Pdeb NNP O
locus NN O
6 CD O
. . O

Centrosome NNP O
amplification NN O
and CC O
a DT O
defective JJ O
G2 NNP O
- : O
M NNP O
cell NN O
cycle NN O
checkpoint NN O
induce VB O
genetic JJ O
instability NN O
in IN O
BRCA1 NNP O
exon VBP O
11 CD O
isoform NN O
- : O
deficient NN O
cells NNS O
. . O

We PRP O
conclude VBP O
that DT O
hypopigmentation NN B-Disease
is VBZ O
found VBN O
in IN O
a DT O
significant JJ O
proportion NN O
of IN O
individuals NNS O
with IN O
PWS NNP B-Disease
and CC O
that IN O
the DT O
hypopigmentation NN B-Disease
may MD O
be VB O
associated VBN O
with IN O
a DT O
deletion NN O
of IN O
the DT O
long JJ O
arm NN O
of IN O
chromosome NN O
15 CD O
. . O

In IN O
sum NN O
, , O
FISH NNP O
was VBD O
found VBN O
to TO O
be VB O
a DT O
simple JJ O
and CC O
reliable JJ O
method NN O
to TO O
detect VB O
VHL NNP B-Disease
germline NN O
deletions NNS O
and CC O
practically RB O
useful JJ O
in IN O
cases NNS O
where WRB O
other JJ O
methods NNS O
of IN O
screening VBG O
have VB O
failed VBN O
to TO O
detect VB O
a DT O
VHL NNP B-Disease
gene NN I-Disease
abnormality NN I-Disease

Both DT O
genes NNS O
are VBP O
intronless JJ O
with IN O
tandem JJ O
direct JJ O
repeat NN O
sequences NNS O
contained VBD O
within IN O
a DT O
CpG NNP O
island NN O
in IN O
the DT O
5 CD O
- : O
untranscribed JJ O
region NN O
. . O

South JJ O
African JJ O
Negroids NNS O
have VBP O
a DT O
CTG NNP O
allelic JJ O
distribution NN O
that WDT O
is VBZ O
significantly RB O
different JJ O
from IN O
that DT O
in IN O
Caucasoids NNP O
and CC O
Japanese JJ O
the DT O
CTG NNP O
repeat NN O
lengths NNS O
of IN O
> NN O
or CC O
= VB O
19 CD O
are VBP O
very RB O
rare JJ O
. . O

While IN O
narrowing VBG O
the DT O
genetic JJ O
interval NN O
containing VBG O
SPG2 NNP O
in IN O
a DT O
large JJ O
pedigree NN O
, , O
we PRP O
found VBD O
that IN O
PLP NNP O
was VBD O
the DT O
closest JJS O
marker NN O
to TO O
the DT O
disease NN O
locus NN O
, , O
implicating VBG O
PLP NNP O
as IN O
a DT O
possible JJ O
candidate NN O
gene NN O
. . O

A DT O
new JJ O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
variant NN O
( ( O
G6PD NNP O
Nagano NNP O
) ) O
associated VBN O
with IN O
congenital JJ B-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
. . O

These DT O
results NNS O
provide VBP O
further JJ O
examples NNS O
of IN O
mutations NNS O
in IN O
PLP NNP O
that IN O
cause NN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
and CC O
illustrate VB O
the DT O
value NN O
of IN O
SSCP NNP O
in IN O
genetic JJ O
analysis NN O
. . O
. . O

Palmitoyl NNP O
- : O
CoA NNP O
dehydrogenase NN O
activity NN O
in IN O
skin JJ O
fibroblasts NNS O
from IN O
seven CD O
patients NNS O
with IN O
unidentified JJ O
defects NNS O
of IN O
fatty JJ O
acid JJ O
oxidation NN O
was VBD O
measured VBN O
in IN O
the DT O
presence NN O
and CC O
absence NN O
of IN O
antibodies NNS O
against IN O
medium NN O
- : O
chain NN O
, , O
long JJ O
- : O
chain NN O
, , O
and CC O
very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NN O
dehydrogenases NNS O
( ( O
VLCAD NNP O
) ) O
. . O

Mutations NNS O
were VBD O
found VBN O
in IN O
35 CD O
( ( O
53 CD O
% NN O
) ) O
of IN O
the DT O
66 CD O
families NNS O
studied VBN O
. . O

To TO O
confirm VB O
these DT O
findings NNS O
, , O
a DT O
large JJ O
linkage NN O
study NN O
was VBD O
performed VBN O
in IN O
twelve JJ O
additional JJ O
families NNS O
segregating VBG O
for IN O
Alstrom NNP B-Disease
syndrome NN I-Disease
. . O

6 CD O
6 CD O
. . O

G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
different JJ O
geographical JJ O
areas NNS O
appears VBZ O
to TO O
have VB O
arisen VBN O
through IN O
independent JJ O
mutational JJ O
events NNS O
, , O
but CC O
within IN O
the DT O
same JJ O
population NN O
it PRP O
may MD O
also RB O
be VB O
heterogeneous JJ O
. . O

There EX O
is VBZ O
mounting VBG O
evidence NN O
to TO O
suggest VB O
that IN O
Friedreich NNP B-Disease
ataxia NN I-Disease
is VBZ O
the DT O
result NN O
of IN O
accumulation NN O
of IN O
iron NN O
in IN O
mitochondria NN O
leading VBG O
to TO O
excess JJ O
production NN O
of IN O
free JJ O
radicals NNS O
, , O
which WDT O
then RB O
results NNS O
in IN O
cellular JJ O
damage NN O
and CC O
death NN O
. . O

A DT O
comparison NN O
of IN O
the DT O
clinical JJ O
manifestations NNS O
of IN O
the DT O
present JJ O
five CD O
patients NNS O
and CC O
reported VBD O
CGKD NNP B-Disease
or CC O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
patients NNS O
with IN O
DNA NNP O
deletion NN O
suggests VBZ O
the DT O
existence NN O
of IN O
a DT O
certain JJ O
gene NN O
responsible JJ O
for IN O
gonadotropin JJ B-Disease
deficiency NN I-Disease
( ( O
GTD NNP B-Disease
) ) O
. . O

A DT O
high JJ O
frequency NN O
of IN O
individuals NNS O
who WP O
appeared VBD O
to TO O
be VB O
TSD NNP B-Disease
heterozygotes NNS O
was VBD O
detected VBN O
( ( O
Kelly NNP O
et VBZ O
al NN O
. . O
, , O
1975 CD O
) ) O
. . O

Disease NNP O
duration NN O
influenced VBD O
the DT O
appearance NN O
and CC O
amount NN O
of IN O
white JJ B-Disease
matter NN I-Disease
lesions NNS I-Disease
on IN O
MRI NNP O
. . O

We PRP O
investigated VBD O
the DT O
mechanism NN O
for IN O
AFAP NNP B-Disease
in IN O
patients NNS O
carrying VBG O
a DT O
mutant JJ O
APC NNP B-Disease
allele NN O
( ( O
APC NNP O
( ( O
AS9 NNP O
) ) O
) ) O
that WDT O
has VBZ O
a DT O
mutation NN O
in IN O
the DT O
alternatively RB O
spliced JJ O
region NN O
of IN O
exon $ O
9 CD O
. . O

Comparison NNP O
of IN O
phage NN O
restriction NN O
maps NNS O
exclude VBP O
the DT O
presence NN O
of IN O
any DT O
sizable JJ O
deletion NN O
in IN O
this DT O
case NN O
. . O

Among IN O
910 CD O
sperm NNS O
analyzed VBN O
, , O
the DT O
allele NN O
linked VBD O
to TO O
the DT O
disease NN O
chromosome NN O
was VBD O
detected VBN O
in IN O
50 CD O
. . O

Mutations NNS O
in IN O
the DT O
HD NNP B-Disease
gene NN O
that WDT O
are VBP O
other JJ O
than IN O
CAG NNP O
expansion NN O
have VBP O
not RB O
been VBN O
excluded VBN O
for IN O
the DT O
remaining VBG O
eight CD O
cases NNS O
; : O
however RB O
, , O
in IN O
as RB O
many JJ O
as IN O
seven CD O
of IN O
these DT O
persons NNS O
, , O
retrospective JJ O
review NN O
of IN O
these DT O
patients NNS O
clinical JJ O
features NNS O
identified VBN O
characteristics NNS O
not RB O
typical JJ O
for IN O
HD NNP B-Disease
. . O

Moreover RB O
, , O
the DT O
exclusive JJ O
maternal JJ O
inheritance NN O
of IN O
the DT O
congenital JJ O
form NN O
remains VBZ O
unexplained JJ O
. . O

These DT O
findings NNS O
, , O
and CC O
the DT O
absence NN O
of IN O
functionally RB O
relevant JJ O
base NN O
changes NNS O
in IN O
healthy JJ O
controls NNS O
, , O
emphasize VB O
the DT O
causal JJ O
role NN O
of IN O
this DT O
candidate NN O
gene NN O
in IN O
Norrie NNP B-Disease
disease NN I-Disease
and CC O
pave VB O
the DT O
way NN O
for IN O
reliable JJ O
diagnosis NN O
and CC O
carrier NN O
detection NN O
. . O
. . O

Amniotic JJ O
- : O
fluid NN O
cells NNS O
from IN O
patient NN O
2 CD O
showed VBD O
normal JJ O
levels NNS O
of IN O
acid JJ O
lipase NN O
with IN O
all DT O
substrates NNS O
tested VBN O
; : O
the DT O
electrophoretic JJ O
pattern NN O
of IN O
acid JJ O
lipase NN O
was VBD O
normal JJ O
. . O

This DT O
response NN O
is VBZ O
abrogated VBN O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
cells NNS O
that IN O
either DT O
do VBP O
not RB O
express VB O
ATM NNP O
protein NN O
or CC O
express NN O
near IN O
full JJ O
- : O
length NN O
mutant JJ O
protein NN O
. . O

The DT O
families NNS O
included VBD O
57 CD O
Caucasian NNP O
, , O
four CD O
Black NNP O
American NNP O
, , O
and CC O
two CD O
Japanese JJ O
. . O

Resemblance NN O
of IN O
the DT O
majority NN O
of IN O
variants NNS O
in IN O
electrophoretic JJ O
mobility NN O
and CC O
the DT O
level NN O
of IN O
erythrocyte JJ O
enzyme JJ O
activity NN O
permit NN O
to TO O
suggest VB O
the DT O
existence NN O
of IN O
a DT O
common JJ O
parental NN O
mutant JJ O
G6PD NNP O
allele NN O
distributed VBN O
in IN O
this DT O
area NN O
. . O

Because IN O
of IN O
absence NN O
of IN O
a DT O
distinctive JJ O
facial JJ O
appearance NN O
, , O
the DT O
degree NN O
of IN O
mental JJ B-Disease
retardation NN I-Disease
, , O
and CC O
short JJ B-Disease
stature NN I-Disease
, , O
the DT O
initially RB O
considered VBN O
clinical JJ O
diagnosis NN O
of IN O
Cohen NNP B-Disease
syndrome NN I-Disease
was VBD O
withdrawn VBN O
and CC O
a DT O
novel JJ O
genetic JJ O
entity NN O
was VBD O
assumed VBN O
. . O

In IN O
contrast NN O
to TO O
other JJ O
Atm NNP O
mutant NN O
mice NN O
, , O
Atm NNP O
( ( O
y JJ O
/ NNP O
y NN O
) ) O
mice NN O
show VBP O
a DT O
lower JJR O
incidence NN O
of IN O
thymic JJ B-Disease
lymphoma NN I-Disease
and CC O
survive JJ O
beyond IN O
a DT O
few JJ O
months NNS O
of IN O
age NN O
. . O

Of IN O
the DT O
177 CD O
, , O
79 CD O
percent NN O
had VBD O
the DT O
exon JJ O
11 CD O
insertion NN O
mutation NN O
, , O
18 CD O
percent NN O
had VBD O
the DT O
intron NN O
12 CD O
splice NN O
- : O
junction NN O
mutation NN O
, , O
and CC O
3 CD O
percent NN O
had VBD O
the DT O
less RBR O
severe JJ O
exon NN O
7 CD O
mutation NN O
associated VBN O
with IN O
adult NN O
- : O
onset NN O
disease NN O
. . O

Because IN O
the DT O
gene NN O
responsible JJ O
for IN O
WAS NNP B-Disease
has VBZ O
been VBN O
sequenced VBN O
, , O
it PRP O
was VBD O
possible JJ O
to TO O
correlate VB O
the DT O
WAS NNP B-Disease
phenotypes NNS O
with IN O
WAS NNP B-Disease
gene NN O
mutations NNS O
. . O

Inherited VBN O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
gene NN O
are VBP O
associated VBN O
with IN O
a DT O
high JJ O
risk NN O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
some DT O
families NNS O
. . O

The DT O
finding NN O
of IN O
a DT O
mutation NN O
in IN O
a DT O
family NN O
with IN O
male JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
, , O
not RB O
previously RB O
thought VBN O
to TO O
be VB O
related VBN O
to TO O
BRCA1 NNP O
, , O
also RB O
illustrates VBZ O
the DT O
potential JJ O
difficulties NNS O
of IN O
genetic JJ O
counseling NN O
for IN O
individuals NNS O
known VBN O
to TO O
carry VB O
mutations NNS O
. . O
. . O

Both DT O
sequences NNS O
map VBP O
to TO O
the DT O
region NN O
of IN O
10 CD O
centimorgan NNS O
lying VBG O
between IN O
the DT O
Tabby NNP O
( ( O
Ta NNP O
) ) O
and CC O
St14 NNP O
- : O
1 CD O
( ( O
DxPas8 NNP O
) ) O
loci NN O
, , O
close RB O
to TO O
the DT O
phosphorylase NN O
b NN O
kinase NN O
locus NN O
( ( O
Phk NNP O
) ) O
. . O

However RB O
, , O
p95 JJ O
/ NNP O
nbs1 NN O
was VBD O
phosphorylated VBN O
on IN O
serine NN O
343 CD O
in IN O
an DT O
ATM NNP O
- : O
dependent JJ O
manner NN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
after IN O
ionizing VBG O
radiation NN O
. . O

We PRP O
suggest VBP O
that IN O
Coats NNP B-Disease
telangiectasis NN I-Disease
is VBZ O
secondary JJ O
to TO O
somatic JJ O
mutation NN O
in IN O
the DT O
NDP NNP O
gene NN O
which WDT O
results NNS O
in IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
norrin NN I-Disease
( ( O
the DT O
protein NN O
product NN O
of IN O
the DT O
NDP NNP O
gene NN O
) ) O
within IN O
the DT O
developing VBG O
retina NN O
. . O

Their PRP$ O
relatives NNS O
were VBD O
described VBN O
with IN O
respect NN O
to TO O
absence VB O
/ JJ O
presence NN O
of IN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

We PRP O
used VBD O
heteroduplex JJ O
analysis NN O
to TO O
identify VB O
sequence NN O
anomalies NNS O
in IN O
five CD O
individuals NNS O
with IN O
Kniest NNP B-Disease
dysplasia NN I-Disease
. . O

In IN O
this DT O
group NN O
of IN O
relatives NNS O
, , O
a DT O
low JJ O
free JJ O
protein NN O
S NNP O
level NN O
was VBD O
the DT O
most RBS O
reliable JJ O
predictor NN O
of IN O
a DT O
PROS1 NNP B-Disease
gene NN I-Disease
defect NN I-Disease
( ( O
sensitivity NN O
97 CD O
. . O
7 CD O
% NN O
, , O
specificity NN O
100 CD O
% NN O
) ) O
. . O

These DT O
data NNS O
uncover RB O
an DT O
essential JJ O
role NN O
of IN O
BRCA1 NNP O
in IN O
maintaining VBG O
genetic JJ O
stability NN O
through IN O
the DT O
regulation NN O
of IN O
centrosome JJ O
duplication NN O
and CC O
the DT O
G2 NNP O
- : O
M NNP O
checkpoint NN O
and CC O
provide VB O
a DT O
molecular JJ O
basis NN O
for IN O
the DT O
role NN O
of IN O
BRCA1 NNP O
in IN O
tumorigenesis NN O
. . O
. . O

The DT O
plasma NN O
of IN O
the DT O
probands NNS O
was VBD O
totally RB O
deficient JJ O
in IN O
CETP NNP O
activity NN O
and CC O
mass NN O
. . O

The DT O
molecular JJ O
mechanisms NNS O
by IN O
which WDT O
the DT O
expanded VBN O
repeat NN O
causes VBZ O
the DT O
clinically RB O
variable JJ O
and CC O
multisystemic JJ B-Disease
disease NN I-Disease
, , O
myotonic JJ B-Disease
dystrophy NN I-Disease
, , O
are VBP O
not RB O
understood JJ O
. . O

We PRP O
have VBP O
characterised VBN O
a DT O
novel JJ O
missense NN O
mutation NN O
, , O
G5260A NNP O
, , O
in IN O
exon JJ O
32 CD O
in IN O
a DT O
family NN O
segregating VBG O
for IN O
EA NNP B-Disease
- : I-Disease
2 CD I-Disease
. . O

The DT O
severity NN O
of IN O
the DT O
phenotype NN O
appears VBZ O
to TO O
be VB O
correlated VBN O
with IN O
the DT O
predicted JJ O
effect NN O
of IN O
the DT O
mutations NNS O
on IN O
the DT O
residual JJ O
activity NN O
of IN O
the DT O
DTDST NNP O
protein NN O
. . O
. . O

Haplotype NNP O
analysis NN O
was VBD O
undertaken VBN O
on IN O
the DT O
four CD O
families NNS O
who WP O
have VBP O
been VBN O
described VBN O
with IN O
this DT O
mutation NN O
. . O

All DT O
affected JJ O
individuals NNS O
presented VBD O
a DT O
missense JJ O
mutation NN O
( ( O
G1757 NNP O
- : O
- : O
> VB O
A DT O
) ) O
that WDT O
replaces VBZ O
glycine NN O
at IN O
position NN O
23 CD O
with IN O
arginine NN O
within IN O
the DT O
NPII NNP O
domain NN O
. . O

Direct JJ O
sequence NN O
analysis NN O
of IN O
cDNA NN O
and CC O
genomic JJ O
DNA NN O
obtained VBN O
from IN O
patient JJ O
- : O
derived VBN O
cell NN O
lines NNS O
showed VBD O
12 CD O
unique JJ O
mutations NNS O
distributed VBN O
throughout IN O
the DT O
WAS NNP B-Disease
gene NN O
, , O
including VBG O
insertions NNS O
, , O
deletions NNS O
, , O
and CC O
point NN O
mutations NNS O
resulting VBG O
in IN O
amino NN O
acid NN O
substitutions NNS O
, , O
termination NN O
, , O
exon FW O
skipping VBG O
, , O
or CC O
splicing VBG O
defects NNS O
. . O

MAIN NNP O
OUTCOME NNP O
MEASURES NNP O
Age NNP O
at IN O
diagnosis NN O
, , O
surgical JJ O
stage NN O
, , O
histologic NN O
cell NN O
type NN O
and CC O
grade NN O
, , O
and CC O
surgical JJ O
outcome NN O
; : O
and CC O
response NN O
to TO O
chemotherapy NN O
and CC O
survival NN O
for IN O
advanced JJ O
- : O
stage NN O
( ( O
II NNP O
and CC O
IV NNP O
) ) O
cases NNS O
. . O

Because IN O
LpA NNP O
- : O
I PRP O
has VBZ O
been VBN O
proposed VBN O
to TO O
be VB O
more RBR O
protective JJ O
than IN O
LpA NNP O
- : O
I PRP O
A VBP O
- : O
II NNP O
against IN O
atherosclerosis NN B-Disease
, , O
this DT O
selective JJ O
effect NN O
on IN O
the DT O
metabolism NN O
of IN O
LpA NNP O
- : O
I PRP O
A VBP O
- : O
II NN O
may MD O
provide VB O
a DT O
potential JJ O
explanation NN O
why WRB O
patients NNS O
with IN O
classic JJ B-Disease
LCAT NNP I-Disease
deficiency NN I-Disease
and CC O
Fish NNP B-Disease
- : I-Disease
eye NN I-Disease
disease NN I-Disease
are VBP O
not RB O
at IN O
increased VBN O
risk NN O
for IN O
premature JJ O
atherosclerosis NN B-Disease
despite IN O
markedly RB O
decreased JJ O
levels NNS O
of IN O
HDL NNP O
cholesterol NN O
and CC O
apoA JJ O
- : O
I PRP O

When WRB O
the DT O
patients NNS O
serum VBP O
or CC O
plasma NN O
was VBD O
used VBN O
, , O
only RB O
a DT O
trace NN O
of IN O
lysis NN O
was VBD O
detected VBN O
. . O

Little JJ O
effort NN O
has VBZ O
yet RB O
been VBN O
made VBN O
to TO O
find VB O
alterations NNS O
involving VBG O
this DT O
gene NN O
in IN O
human JJ O
solid JJ B-Disease
tumors NNS I-Disease
. . O

The DT O
finding NN O
of IN O
jaw NN B-Disease
lesions NNS I-Disease
and CC O
/ NN O
or CC O
pigmented VBN B-Disease
ocular JJ I-Disease
fundus NN I-Disease
lesions NNS I-Disease
in IN O
relatives NNS O
at IN O
risk NN O
are VBP O
indications NNS O
of IN O
the DT O
possible JJ O
presence NN O
of IN O
the DT O
GS NNP B-Disease
gene NN O
. . O

The DT O
fact NN O
that IN O
the DT O
mouse NN O
Snrpn NNP O
gene NN O
is VBZ O
maternally RB O
imprinted VBN O
in IN O
brain NN O
suggests NNS O
that IN O
loss NN O
of IN O
the DT O
paternally RB O
derived VBN O
SNRPN NNP O
allele NN O
may MD O
be VB O
involved VBN O
in IN O
the DT O
PWS NNP B-Disease
phenotype NN O
. . O
. . O

For IN O
the DT O
BRCA1 NNP O
mutations NNS O
studied VBD O
here RB O
, , O
the DT O
individual JJ O
mutations NNS O
are VBP O
estimated VBN O
to TO O
have VB O
arisen VBN O
9 CD O
- : O
170 CD O
generations NNS O
ago RB O
. . O

The DT O
pathophysiological JJ O
interactions NNS O
of IN O
these DT O
two CD O
unlinked VBD O
disorders NNS O
are VBP O
discussed VBN O
at IN O
the DT O
clinical JJ O
and CC O
histopathological JJ O
levels NNS O
. . O
. . O

Using VBG O
both DT O
antisera NN O
, , O
we PRP O
found VBD O
positive JJ O
nuclear JJ O
membrane NN O
staining VBG O
in IN O
skeletal JJ O
, , O
cardiac JJ O
and CC O
smooth JJ O
muscles NNS O
in IN O
the DT O
normal JJ O
controls NNS O
and CC O
in IN O
patients NNS O
with IN O
neuromuscular JJ B-Disease
diseases NNS I-Disease
other JJ O
than IN O
EDMD NNP B-Disease
. . O

A DT O
test NN O
for IN O
the DT O
mutant NN O
allele NN O
based VBN O
on IN O
amplification NN O
of IN O
DNA NN O
by IN O
the DT O
polymerase NN O
chain NN O
rection NN O
and CC O
cleavage NN O
of IN O
a DT O
DdeI NNP O
restriction NN O
site NN O
generated VBN O
by IN O
the DT O
mutation NN O
revealed VBD O
that IN O
this DT O
case NN O
and CC O
two CD O
other JJ O
cases NNS O
of IN O
the DT O
Ashkenazi NNP O
, , O
infantile JJ O
form NN O
of IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
are VBP O
heterozygous JJ O
for IN O
two CD O
different JJ O
mutations NNS O
. . O

The DT O
Norrie NNP B-Disease
disease NN I-Disease
gene NN O
maps NNS O
to TO O
a DT O
150 CD O
kb JJ O
region NN O
on IN O
chromosome NN O
Xp11 NNP O
. . O
3 CD O
. . O

Knobloch NNP B-Disease
syndrome NN I-Disease
involving VBG O
midline NN B-Disease
scalp NN I-Disease
defect NN I-Disease
of IN I-Disease
the DT I-Disease
frontal JJ I-Disease
region NN I-Disease
. . O

Trisomy $ B-Disease
15 CD I-Disease
with IN O
loss NN O
of IN O
the DT O
paternal JJ O
15 CD O
as IN O
a DT O
cause NN O
of IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
due JJ O
to TO O
maternal JJ B-Disease
disomy NN I-Disease
. . O

Changes NNS O
at IN O
P183 NNP O
of IN O
emerin RB O
weaken VB O
its PRP$ O
protein NN O
- : O
protein NN O
interactions NNS O
resulting VBG O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
Emery NNP I-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

Determination NN O
of IN O
30 CD O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
adrenoleukodystrophy JJ I-Disease
mutations NNS O
, , O
including VBG O
15 CD O
not RB O
previously RB O
described VBN O
. . O

Ophthalmic JJ O
examinations NNS O
in IN O
all DT O
five CD O
boys NNS O
had VBD O
normal JJ O
findings NNS O
, , O
yet RB O
an DT O
abnormal JJ O
negative JJ O
ERG NNP O
was VBD O
recorded VBN O
for IN O
each DT O
subject NN O
. . O

The DT O
map NN O
was VBD O
constructed VBN O
employing VBG O
the DT O
LINKAGE NNP O
and CC O
CRIMAP NNP O
computational JJ O
methodologies NNS O
to TO O
build VB O
the DT O
multipoint NN O
map NN O
via IN O
a DT O
stepwise NN O
algorithm NN O
. . O

A DT O
rare JJ O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
dysmyelinating VBG I-Disease
disorder NN I-Disease
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
( ( O
PMD NNP B-Disease
) ) O
, , O
has VBZ O
also RB O
been VBN O
mapped VBN O
to TO O
Xq21 VB O
- : O
q22 NN O
, , O
and CC O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
proteolipid JJ O
protein NN O
gene NN O
( ( O
PLP NNP O
) ) O
which WDT O
encodes VBZ O
two CD O
myelin NN O
proteins NNS O
, , O
PLP NNP O
and CC O
DM20 NNP O
. . O

Three CD O
lines NNS O
of IN O
evidence NN O
now RB O
converge VBZ O
to TO O
implicate VB O
PAX6 NNP O
more RBR O
widely RB O
in IN O
anterior JJ B-Disease
segment NN I-Disease
malformations NNS I-Disease
including VBG O
Peters NNP B-Disease
anomaly NN I-Disease
. . O

Finally RB O
, , O
since IN O
none NN O
of IN O
the DT O
98 CD O
PKU NNP B-Disease
patients NNS O
tested VBN O
were VBD O
found VBN O
to TO O
carry VB O
this DT O
particular JJ O
deletion NN O
, , O
our PRP$ O
study NN O
suggests VBZ O
that IN O
this DT O
molecular JJ O
event NN O
probably RB O
occurred VBD O
recently RB O
on IN O
the DT O
background NN O
of IN O
a DT O
haplotype NN O
2 CD O
gene NN O
in IN O
Portugal NNP O
. . O
. . O

Of IN O
the DT O
31 CD O
variants NNS O
found VBN O
in IN O
this DT O
province NN O
, , O
Gd NNP O
Kaiping NNP O
, , O
Gd NNP O
Taiwan NNP O
- : O
Hakka NNP O
, , O
Gd NNP O
Haad NNP O
Yai NNP O
, , O
Gd NNP O
Haad NNP O
Yai NNP O
- : O
like IN O
and CC O
Gd NNP O
Huiyang NNP O
occurred VBD O
most JJS O
frequently RB O
. . O

The DT O
mutation NN O
can MD O
serve VB O
as IN O
a DT O
marker NN O
for IN O
following VBG O
segregation NN O
of IN O
the DT O
PLP NNP O
gene NN O
. . O
. . O

Mutation NNP O
rate NN O
of IN O
the DT O
VWS NNP B-Disease
gene NN O
is VBZ O
calculated VBN O
to TO O
be VB O
1 CD O
. . O

Targeted VBN O
deletion NN O
of IN O
Dm15 NNP O
, , O
the DT O
mouse NN O
orthologue NN O
of IN O
human JJ O
DMPK NNP O
, , O
produced VBD O
mice NN O
with IN O
a DT O
mild JJ O
myopathy NN B-Disease
and CC O
cardiac JJ B-Disease
conduction NN I-Disease
abnormalities NNS I-Disease
, , O
but CC O
without IN O
other JJ O
features NNS O
of IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
, , O
such JJ O
as IN O
myotonia NN B-Disease
and CC O
cataracts NNS B-Disease
. . O

The DT O
role NN O
of IN O
FMR1 NNP O
remains NNS O
undetermined JJ O
but CC O
the DT O
protein NN O
appears VBZ O
to TO O
be VB O
involved VBN O
in IN O
RNA NNP O
metabolism NN O
. . O

Cell NNP O
fusion NN O
complementation NN O
studies NNS O
demonstrated VBD O
that IN O
these DT O
diseases NNS O
are VBP O
genetically RB O
heterogeneous JJ O
, , O
with IN O
two CD O
- : O
thirds NNS O
of IN O
all DT O
patients NNS O
lying VBG O
within IN O
a DT O
single JJ O
complementation NN O
group NN O
, , O
CG1 NNP O
. . O

Furthermore RB O
, , O
we PRP O
propose VBP O
that IN O
active JJ O
transcription NN O
of IN O
these DT O
repeats NNS O
in IN O
male NN O
and CC O
female JJ O
germ NN O
cells NNS O
may MD O
facilitate VB O
the DT O
homologous JJ O
recombination NN O
process NN O
. . O

A DT O
51 CD O
/ NN O
2 CD O
- : O
year NN O
- : O
old JJ O
black JJ O
girl NN O
with IN O
recurrent JJ O
meningococcal JJ B-Disease
meningitis NN I-Disease
and CC O
absence NN B-Disease
of IN I-Disease
the DT I-Disease
sixth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
( ( O
C6 NNP O
) ) O
is VBZ O
reported VBN O
. . O

The DT O
psiGLDC NN O
gene NN O
has VBZ O
no DT O
intron NN O
and CC O
shares NNS O
97 CD O
. . O

Immunofluorescent JJ O
visualization NN O
of IN O
dystrophin NN O
revealed VBD O
foci NN O
of IN O
dystrophin JJ O
- : O
positive JJ O
fibers NNS O
adjacent JJ O
to TO O
foci VB O
of IN O
dystrophin JJ O
- : O
negative JJ O
fibers NNS O
. . O

The DT O
incidence NN O
of IN O
PKU NNP B-Disease
varies NNS O
widely RB O
across IN O
different JJ O
geographic JJ O
areas NNS O
, , O
and CC O
is VBZ O
highest JJS O
( ( O
about IN O
1 CD O
in IN O
5 CD O
, , O
0 CD O
live JJ O
births NNS O
) ) O
in IN O
Ireland NNP O
and CC O
western JJ O
Scotland NNP O
, , O
and CC O
among IN O
Yemenite JJ O
Jews NNPS O
. . O

Motor NNP O
development NN O
was VBD O
delayed VBN O
. . O

Positions NNS O
of IN O
the DT O
chromosome NN O
22 CD O
breakpoints NNS O
were VBD O
determined VBN O
for IN O
19 CD O
Ewing NNP B-Disease
tumors NNS I-Disease
. . O

These DT O
findings NNS O
underscore VBP O
the DT O
critical JJ O
role NN O
of IN O
C5 NNP O
in IN O
the DT O
generation NN O
of IN O
chemotactic JJ O
activity NN O
and CC O
in IN O
cytolytic JJ O
reactions NNS O
, , O
as IN O
opposed VBN O
to TO O
a DT O
nonobligatory NN O
or CC O
minimal JJ O
role NN O
in IN O
opsonization NN O
, , O
at IN O
least JJS O
for IN O
the DT O
organisms NNS O
under IN O
study NN O
. . O
. . O

Two CD O
new JJ O
arylsulfatase NN O
A NNP O
( ( O
ARSA NNP O
) ) O
mutations NNS O
in IN O
a DT O
juvenile NN O
metachromatic JJ B-Disease
leukodystrophy NN I-Disease
( ( O
MLD NNP B-Disease
) ) O
patient NN O
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
spastic JJ I-Disease
paraplegia NN I-Disease
and CC O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
are VBP O
allelic JJ B-Disease
disorders NNS I-Disease
at IN O
the DT O
proteolipid JJ O
protein NN O
locus NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
of IN O
protein JJ O
studies NNS O
on IN O
patients NNS O
with IN O
missense JJ O
mutations NNS O
resulting VBG O
in IN O
the DT O
clinical JJ O
features NNS O
of IN O
EDMD NNP B-Disease
. . O

Canavan NNP B-Disease
disease NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
recessive NN I-Disease
leukodystrophy NN I-Disease
caused VBN O
by IN O
the DT O
deficiency NN B-Disease
of IN I-Disease
aspartoacylase NN I-Disease
( ( O
ASPA NNP O
) ) O
. . O

The DT O
patient NN O
responded VBD O
positively RB O
to TO O
treatment NN O
with IN O
L NNP O
- : O
dopa NN O
. . O

In IN O
the DT O
other JJ O
allele NN O
a DT O
single JJ O
T NNP O
insertion NN O
in IN O
codon JJ O
- : O
25 CD O
was VBD O
found VBN O
. . O

Most RBS O
important JJ O
, , O
the DT O
enzyme NN O
converts VBZ O
phosphatidylinositol RB O
4 CD O
, , O
5 CD O
- : O
bisphosphate NN O
to TO O
phosphatidylinositol VB O
4 CD O
- : O
phosphate NN O
. . O

In IN O
response NN O
to TO O
this DT O
stimulus NN O
, , O
cytoplasmic JJ O
beta NN O
- : O
catenin NN O
( ( O
encoded VBN O
by IN O
CTNNB1 NNP O
) ) O
is VBZ O
stabilized VBN O
, , O
enabling VBG O
downstream JJ O
transcriptional JJ O
activation NN O
by IN O
members NNS O
of IN O
the DT O
LEF NNP O
/ NNP O
TCF NNP O
family NN O
. . O

Despite IN O
the DT O
ubiquitous JJ O
expression NN O
of IN O
the DT O
truncated JJ O
HMG NNP O
I PRP O
- : O
C NNP O
protein NN O
, , O
the DT O
transgenic JJ O
mice NN O
develop VB O
a DT O
selective JJ O
abundance NN O
of IN O
fat JJ O
tissue NN O
early RB O
in IN O
life NN O
, , O
show VBP O
marked VBN O
adipose JJ B-Disease
tissue NN I-Disease
inflammation NN I-Disease
, , O
and CC O
have VBP O
an DT O
abnormally RB O
high JJ O
incidence NN O
of IN O
lipomas NN B-Disease
. . O

With IN O
each DT O
single JJ O
mutation NN O
we PRP O
found VBD O
a DT O
slight JJ O
decrease NN O
in IN O
both CC O
the DT O
specific JJ O
activity NN O
and CC O
the DT O
yield NN O
of IN O
enzyme NN O
when WRB O
compared VBN O
to TO O
G6PD NNP O
B NNP O
. . O

One CD O
of IN O
these DT O
patients NNS O
subsequently RB O
developed VBD O
progressive JJ O
renal JJ B-Disease
failure NN I-Disease
requiring VBG O
dialysis NN O
beginning VBG O
5 CD O
1 CD O
/ JJ O
2 CD O
years NNS O
after IN O
TF NNP O
therapy NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
mutation NN O
of IN O
BRCA1 NNP O
may MD O
not RB O
be VB O
critical JJ O
in IN O
the DT O
development NN O
of IN O
the DT O
majority NN O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
that WDT O
arise VBP O
in IN O
the DT O
absence NN O
of IN O
a DT O
mutant JJ O
germline NN O
allele NN O
. . O
. . O

The DT O
oculocerebrorenal JJ B-Disease
syndrome NN I-Disease
of IN I-Disease
Lowe NNP I-Disease
( ( O
OCRL NNP B-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
major JJ O
abnormalities NNS B-Disease
of IN I-Disease
eyes NNS I-Disease
, , I-Disease
nervous JJ I-Disease
system NN I-Disease
, , I-Disease
and CC I-Disease
kidneys NNS I-Disease
. . O

A DT O
candidate NN O
Wilms NNP B-Disease
tumor NN I-Disease
gene NN O
, , O
WT1 NNP O
, , O
from IN O
the DT O
11p13 CD O
chromosome NN O
region NN O
has VBZ O
recently RB O
been VBN O
cloned VBN O
. . O

We PRP O
report VBP O
two CD O
de IN O
novo FW O
cases NNS O
of IN O
del NN O
( ( O
8 CD O
) ) O
( ( O
pter JJ O
- : O
- : O
- : O
- : O
q24 NN O
. . O
1 CD O
) ) O
with IN O
breakpoints NNS O
involving VBG O
the DT O
distal JJ O
part NN O
of IN O
band NN O
8q24 CD O
. . O

Markers NNS O
that WDT O
have VBP O
been VBN O
isolated VBN O
from IN O
the DT O
chromosome NN O
11p13 CD O
region NN O
were VBD O
then RB O
analyzed VBN O
in IN O
this DT O
aniridia JJ B-Disease
family NN O
. . O

To TO O
determine VB O
the DT O
molecular JJ O
basis NN O
of IN O
type NN B-Disease
I PRP I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
, , O
the DT O
C2 NNP O
gene NN O
and CC O
cDNA NN O
were VBD O
characterized VBN O
from IN O
a DT O
homozygous JJ O
type NN B-Disease
I PRP I-Disease
C2 NNP I-Disease
- : I-Disease
deficient NN I-Disease
individual NN O
with IN O
the DT O
common JJ O
associated VBN O
haplotype JJ O
/ NN O
complotype NN O
. . O

Allele NNP O
- : O
specific JJ O
oligonucleotide JJ O
hybridization NN O
confirmed VBD O
homozygosity NN O
in IN O
the DT O
proband NN O
. . O

MAGEL2 NNP O
is VBZ O
expressed VBN O
predominantly RB O
in IN O
brain NN O
, , O
the DT O
primary JJ O
tissue NN O
affected VBD O
in IN O
PWS NNP B-Disease
and CC O
in IN O
several JJ O
fetal JJ O
tissues NNS O
as IN O
shown VBN O
by IN O
northern JJ O
blot NN O
analysis NN O
. . O

This DT O
implies VBZ O
a DT O
size NN O
- : O
and CC O
sex NN O
- : O
dependent JJ O
meiotic JJ O
instability NN O
. . O

De NNP O
novo FW O
deletions NNS O
of IN O
SNRPN NNP O
exon VBP O
1 CD O
in IN O
early JJ O
human NN O
and CC O
mouse NN O
embryos NN O
result NN O
in IN O
a DT O
paternal JJ O
to TO O
maternal JJ O
imprint NN O
switch NN O
. . O

C25 NNP O
, , O
C24 NNP O
, , O
and CC O
C23 NNP O
fatty JJ O
acids NNS O
were VBD O
also RB O
increased VBN O
, , O
but CC O
the DT O
C22 NNP O
and CC O
C20 NNP O
fatty JJ O
acids NNS O
were VBD O
normal JJ O
. . O

The DT O
human JJ O
genotype NN O
- : O
phenotype NN O
correlations NNS O
are VBP O
consistent JJ O
with IN O
a DT O
role NN O
for IN O
Dp260 NNP O
in IN O
normal JJ O
retinal JJ O
electrophysiology NN O
and CC O
may MD O
also RB O
reflect VB O
the DT O
expression NN O
of IN O
other JJ O
C NNP O
- : O
terminal NN O
dystrophin NN O
isoforms NNS O
and CC O
their PRP$ O
contributions NNS O
to TO O
retinal JJ O
signal JJ O
transmission NN O
. . O
. . O

This DT O
made VBD O
a DT O
prenatal JJ O
or CC O
presymptomatic JJ O
diagnosis NN O
and CC O
heterozygote NN O
detection NN O
by IN O
DNA NNP O
analysis NN O
with IN O
this DT O
marker NN O
reliable NN O
. . O

We PRP O
postulate VBP O
that IN O
altered VBD O
metabolism NN O
of IN O
a DT O
natural JJ O
toxin NN O
or CC O
antigen NN O
by IN O
the DT O
CYP2D6 NNP O
gene NN O
may MD O
increase VB O
susceptibility NN O
to TO O
AS NNP B-Disease
. . O

Normal NNP O
glucose JJ O
absorption NN O
is VBZ O
mediated VBN O
by IN O
the DT O
Na NNP O
+ NNP O
/ NNP O
glucose VBP O
cotransporter NN O
in IN O
the DT O
brush NN O
border NN O
membrane NN O
of IN O
the DT O
intestinal JJ O
epithelium NN O
. . O

Mapping NN O
of IN O
the DT O
mouse NN O
homologue NN O
of IN O
the DT O
Wilson NNP B-Disease
disease NN I-Disease
gene NN O
to TO O
mouse VB O
chromosome NN O
8 CD O
. . O

A DT O
29 CD O
- : O
year NN O
- : O
old JJ O
woman NN O
with IN O
discoid JJ B-Disease
lupus NN I-Disease
erythematosus NN I-Disease
had VBD O
undetectable JJ O
classic JJ O
pathway NN O
complement NN O
activity NN O
. . O

Subjects NNS O
with IN O
homozygous JJ O
CETP NNP B-Disease
deficiency NN I-Disease
caused VBN O
by IN O
a DT O
gene NN O
splicing VBG O
defect NNS O
have VBP O
markedly RB O
elevated VBN O
HDL NNP O
; : O
however RB O
, , O
heterozygotes NNS O
have VBP O
only RB O
mild JJ O
increases NNS O
in IN O
HDL NNP O
. . O

Ectopic NNP O
expression NN O
of IN O
wild JJ O
- : O
type NN O
, , O
but CC O
not RB O
mutated VBN O
, , O
BRCA1 NNP O
in IN O
these DT O
cells NNS O
rendered VBD O
them PRP O
less RBR O
sensitive JJ O
to TO O
the DT O
DNA NNP O
damage NN O
agent NN O
, , O
methyl JJ O
methanesulfonate NN O
. . O

After IN O
crossbreeding VBG O
with IN O
female JJ O
mice NN O
of IN O
the DT O
EIIa NNP O
- : O
cre NN O
strain NN O
, , O
the DT O
floxed JJ O
allele NN O
undergoes NNS O
Cre NNP O
- : O
mediated VBD O
recombination NN O
with IN O
high JJ O
efficiency NN O
during IN O
early JJ O
embryonic JJ O
development NN O
. . O

A DT O
potential JJ O
animal NN O
model NN O
for IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome VBP I-Disease
through IN O
introduction NN O
of IN O
HPRT NNP O
mutations NNS O
into IN O
mice NN O
. . O

Counselling NN O
was VBD O
given VBN O
for IN O
a DT O
recessive JJ B-Disease
disorder NN I-Disease
, , O
thereby RB O
considerably RB O
reducing VBG O
the DT O
probability NN O
of IN O
affected JJ O
offspring NN O
. . O

Genet NNP O
. . O

All DT O
donor NN O
and CC O
acceptor NN O
sites NNS O
adhere RB O
to TO O
the DT O
canonical JJ O
GT NNP O
- : O
AG NNP O
rule NN O
, , O
except IN O
for IN O
the DT O
donor JJ O
site NN O
of IN O
intron NN O
21 CD O
, , O
where WRB O
a DT O
variant JJ O
form NN O
GC NNP O
is VBZ O
used VBN O
instead RB O
of IN O
GT NNP O
. . O

For IN O
case NN O
- : O
control NN O
studies NNS O
, , O
617 CD O
unrelated JJ O
individuals NNS O
with IN O
AS NNP B-Disease
( ( O
361 CD O
probands NNS O
from IN O
sibling VBG O
- : O
pair NN O
and CC O
parent NN O
- : O
case NN O
trio NN O
families NNS O
and CC O
256 CD O
unrelated JJ O
non SYM O
- : O
familial JJ O
sporadic JJ O
cases NNS O
) ) O
and CC O
402 CD O
healthy JJ O
ethnically RB O
matched VBN O
controls NNS O
were VBD O
employed VBN O
. . O

Electron NNP O
photomicrographs NN O
revealed VBD O
that IN O
the DT O
diameters NNS O
of IN O
particles NNS O
in IN O
the DT O
d NN O
less JJR O
than IN O
1 CD O
. . O

The DT O
protein NN O
truncation NN O
test NN O
promises VBZ O
to TO O
become VB O
a DT O
valuable JJ O
technique NN O
in IN O
detecting VBG O
BRCA1 NNP O
mutations NNS O
. . O
. . O

Homozygosity NN O
for IN O
M1V NNP O
and CC O
codominant JJ O
inheritance NN O
of IN O
I65T NNP O
/ NNP O
R408W NNP O
were VBD O
both DT O
associated VBN O
with IN O
classical JJ B-Disease
phenylketonuria NN I-Disease
. . O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
ataxin NN O
- : O
3 CD O
, , O
the DT O
disease NN O
protein NN O
in IN O
SCA3 NNP B-Disease
/ NNP O
MJD NNP B-Disease
, , O
adopts VBZ O
a DT O
unique JJ O
conformation NN O
when WRB O
expressed VBN O
within IN O
the DT O
nucleus NN O
of IN O
transfected JJ O
cells NNS O
. . O

Infected VBN O
cells NNS O
express RBR O
PAH NNP O
mRNA NN O
, , O
immunoreactive JJ O
PAH NNP O
protein NN O
, , O
and CC O
exhibit NN O
pterin JJ O
- : O
dependent JJ O
phenylalanine JJ O
hydroxylase NN O
activity NN O
. . O

Point NN O
mutations NNS O
, , O
the DT O
majority NN O
of IN O
which WDT O
were VBD O
C NNP O
- : O
- : O
> NN O
T NNP O
transitions NNS O
, , O
were VBD O
the DT O
most RBS O
common JJ O
abnormality NN O
and CC O
usually RB O
resulted VBN O
in IN O
the DT O
conversion NN O
of IN O
an DT O
arginine JJ O
codon NN O
to TO O
a DT O
stop JJ O
codon NN O
. . O

Hereditary JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
the DT I-Disease
fifth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
in IN O
man NN O
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
was VBD O
found VBN O
in IN O
3 CD O
. . O

Fatal NNP O
pyoderma NN B-Disease
gangrenosum NN I-Disease
in IN O
association NN O
with IN O
C7 NNP B-Disease
deficiency NN I-Disease
. . O

Detailed JJ O
analysis NN O
of IN O
genomic JJ O
deletions NNS O
in IN O
Norrie NNP B-Disease
patients NNS O
shows VBZ O
that IN O
they PRP O
are VBP O
heterogeneous JJ O
, , O
both DT O
in IN O
size NN O
and CC O
in IN O
position NN O
. . O

Adrenoleukodystrophy NN B-Disease
: : O
survey NN O
of IN O
303 CD O
cases NNS O
: : O
biochemistry NN O
, , O
diagnosis NN O
, , O
and CC O
therapy NN O
. . O

We PRP O
thus RB O
predicted VBD O
that IN O
the DT O
abnormal JJ O
C6 NNP O
molecule NN O
might MD O
be VB O
carboxy JJ O
- : O
terminally RB O
truncated VBN O
and CC O
sought VBD O
a DT O
mutation NN O
in IN O
an DT O
area NN O
approximately RB O
14 CD O
% NN O
from IN O
the DT O
carboxy JJ O
- : O
terminal JJ O
end NN O
of IN O
the DT O
coding NN O
sequence NN O
. . O

We PRP O
have VBP O
now RB O
used VBN O
DNA NNP O
polymorphisms NNS O
associated VBN O
with IN O
the DT O
AAT NNP O
gene NN O
to TO O
investigate VB O
the DT O
origin NN O
of IN O
the DT O
PI NNP O
Z NNP O
allele NN O
. . O

This DT O
substitution NN O
accounted VBD O
for IN O
7 CD O
. . O

Radiolabelled VBN O
precursor NN O
C5 NNP O
was VBD O
contained VBN O
within IN O
the DT O
cells NNS O
and CC O
was VBD O
secreted VBN O
into IN O
the DT O
tissue NN O
culture NN O
media NNS O
. . O

Clinical JJ O
manifestation NN O
of IN O
DM NNP B-Disease
may MD O
be VB O
caused VBN O
by IN O
the DT O
expanded VBN O
CTG NNP O
- : O
repeat NN O
compromising VBG O
the DT O
( ( O
alternative JJ O
) ) O
expression NN O
of IN O
DM NNP O
- : O
kinase NN O
or CC O
DMR NNP O
- : O
N9 NN O
proteins NNS O
. . O
. . O

The DT O
splice NN O
- : O
site NN O
mutation NN O
following VBG O
exon $ O
7 CD O
produces NNS O
late JJ O
- : O
infantile NN O
MLD NNP B-Disease
when WRB O
combined VBN O
with IN O
other JJ O
enzyme JJ O
- : O
null JJ O
mutations NNS O
, , O
implying VBG O
that IN O
it PRP O
is VBZ O
completely RB O
silent JJ O
enzymatically RB O
. . O
. . O

The DT O
clinical JJ O
classification NN O
is VBZ O
increasingly RB O
being VBG O
replaced VBN O
by IN O
a DT O
genetic JJ O
one NN O
. . O

Both DT O
the DT O
deciduous JJ O
and CC O
permanent JJ O
dentitions NNS O
are VBP O
affected VBN O
, , O
resulting VBG O
in IN O
premature NN O
tooth JJ B-Disease
loss NN I-Disease
. . O

Predictions NNS O
about IN O
allelic JJ O
homogeneity NN O
in IN O
Finland NNP O
and CC O
mutation NN O
rates NNS O
in IN O
simple JJ O
sequence NN O
repeats NNS O
are VBP O
confirmed VBN O
by IN O
independent JJ O
observations NNS O
. . O

Studies NNS O
of IN O
biopsied JJ O
tissue NN O
for IN O
the DT O
presence NN O
of IN O
Epstein NNP B-Disease
- : I-Disease
Barr NNP I-Disease
virus NN I-Disease
and CC O
cytomegalovirus NN B-Disease
were VBD O
negative JJ O
, , O
as IN O
were VBD O
studies NNS O
of IN O
blood NN O
, , O
including VBG O
the DT O
polymerase NN O
chain NN O
reaction NN O
, , O
for IN O
the DT O
presence NN O
of IN O
the DT O
human JJ B-Disease
immunodeficiency NN I-Disease
virus NN I-Disease
( ( O
HIV NNP B-Disease
) ) O
. . O

We PRP O
propose VBP O
that IN O
iron NN O
- : O
dependent NN O
self PRP O
- : O
assembly NN O
of IN O
recombinant JJ O
mYfh1p NN O
reflects VBZ O
a DT O
physiological JJ O
role NN O
for IN O
frataxin NN O
in IN O
mitochondrial JJ O
iron NN O
sequestration NN O
and CC O
bioavailability NN O
. . O
. . O

We PRP O
hypothesize VBP O
that IN O
large JJ O
expansions NNS O
also RB O
occur VBP O
in IN O
the DT O
female JJ O
germline NN O
and CC O
that IN O
a DT O
negative JJ O
selection NN O
of IN O
oocytes NNS O
with IN O
long JJ O
repeats NNS O
might MD O
explain VB O
the DT O
different JJ O
instability NN O
behavior NN O
of IN O
the DT O
male NN O
and CC O
the DT O
female JJ O
germlines NNS O
. . O
. . O

62 CD O
- : O
APC NNP O
- : O
EF5 NN O
62 CD O
- : O
APC NNP O
- : O
EF5 NN O
. . O

38T LS O
- : O
- : O
> NN O
C NNP O
( ( O
L13P NNP O
) ) O
and CC O
c $ O
. . O

Restoration NN O
of IN O
photoreceptor NN O
ultrastructure NN O
and CC O
function NN O
in IN O
retinal JJ B-Disease
degeneration NN I-Disease
slow JJ O
mice NN O
by IN O
gene NN O
therapy NN O
. . O

We PRP O
have VBP O
isolated VBN O
murine JJ O
genomic JJ O
clones NNS O
containing VBG O
Brca1 NNP O
as IN O
a DT O
first JJ O
step NN O
in IN O
generating VBG O
a DT O
mouse NN O
model NN O
for IN O
the DT O
loss NN O
of IN O
BRCA1 NNP O
function NN O
. . O

Erythrocyte NNP O
indices NNS O
did VBD O
not RB O
show VB O
differences NNS O
between IN O
mutants NNS O
and CC O
wild JJ O
types NNS O
. . O

In IN O
six CD O
kindreds NNS O
, , O
platelet NN O
vWF NN O
Ag NNP O
and CC O
RiCof NNP O
were VBD O
equally RB O
low JJ O
( ( O
platelet VB O
low JJ O
) ) O
; : O
after IN O
DDAVP NNP O
, , O
plasma NN O
vWF NN O
Ag NNP O
and CC O
RiCof NNP O
remained VBD O
low JJ O
, , O
and CC O
the DT O
BT NNP O
was VBD O
prolonged VBN O
. . O

Linkage NNP O
disequilibrium NN O
mapping NN O
in IN O
isolated JJ O
populations NNS O
provides VBZ O
a DT O
powerful JJ O
tool NN O
for IN O
fine JJ O
structure NN O
localization NN O
of IN O
disease NN O
genes NNS O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
prenatal JJ O
diagnosis NN O
of IN O
Wolman NNP B-Disease
disease NN I-Disease
be VB O
made VBN O
using VBG O
the DT O
radioassay NN O
of IN O
acid JJ O
lipase NN O
and CC O
/ NN O
or CC O
electrophoresis NN O
. . O
. . O

However RB O
, , O
this DT O
mutation NN O
also RB O
occurs VBZ O
near IN O
a DT O
potential JJ O
cryptic JJ O
splice NN O
acceptor NN O
site NN O
, , O
raising VBG O
the DT O
possibility NN O
of IN O
alternative JJ O
splicing VBG O
resulting VBG O
in IN O
a DT O
less RBR O
severely RB O
disrupted VBN O
protein NN O
. . O
. . O

Comparison NNP O
of IN O
G6PD NNP O
spectra NN O
in IN O
two CD O
subpopulations NNS O
and CC O
in IN O
a DT O
mixed JJ O
group NN O
permits VBZ O
to TO O
make VB O
a DT O
conclusion NN O
about IN O
existence NN O
of IN O
common JJ O
and CC O
rare JJ O
G6PD NNP O
alleles NNS O
in IN O
examined JJ O
population NN O
. . O

METHODS NNP O
Affected NNP O
individuals NNS O
underwent JJ O
ophthalmic JJ O
examination NN O
, , O
scotopic JJ O
perimetry NN O
, , O
dark JJ O
adaptometry NN O
, , O
measurement NN O
of IN O
color NN O
- : O
contrast NN O
sensitivity NN O
, , O
and CC O
electroretinography NN O
to TO O
characterize VB O
the DT O
photoreceptor NN O
dysfunction NN O
. . O

Comparable JJ O
results NNS O
were VBD O
produced VBN O
when WRB O
the DT O
replacement NN O
119 CD O
Gln NNP O
- : O
- : O
> NN O
Glu NNP O
was VBD O
studied VBN O
instead RB O
of IN O
126 CD O
Asn NNP O
- : O
- : O
> NN O
Asp NNP O
. . O

Here RB O
, , O
it PRP O
is VBZ O
shown VBN O
that IN O
BRCA1 NNP O
interacts NNS O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
with IN O
hRad50 NN O
, , O
which WDT O
forms VBZ O
a DT O
complex JJ O
with IN O
hMre11 NN O
and CC O
p95 NN O
/ NNP O
nibrin NN O
. . O

The DT O
clinical JJ O
use NN O
of IN O
molecular JJ O
analyses NNS O
in IN O
recessive JJ B-Disease
disorders NNS I-Disease
relies NNS O
on IN O
the DT O
exact JJ O
characterization NN O
of IN O
both DT O
mutant JJ O
alleles NNS O
in IN O
the DT O
affected JJ O
patient NN O
. . O

However RB O
, , O
there EX O
was VBD O
no DT O
punctate NN O
staining NN O
in IN O
the DT O
# # O
163 CD O
cells NNS O
. . O

The DT O
expression NN O
of IN O
VWS NNP B-Disease
is VBZ O
significantly RB O
modified VBN O
by IN O
the DT O
genetic JJ O
background NN O
More RBR O
extreme JJ O
phenotypes NNS O
in IN O
parents NNS O
tend VBP O
to TO O
produce VB O
more JJR O
extreme JJ O
expression NN O
in IN O
their PRP$ O
children NNS O
. . O

Cytogenetic JJ O
and CC O
carrier NN O
studies NNS O
revealed VBD O
structurally RB O
normal JJ O
chromosomes NNS O
for IN O
this DT O
patient NN O
and CC O
her PRP$ O
parents NNS O
and CC O
demonstrated VBD O
that IN O
this DT O
mutation NN O
arose VBD O
through IN O
a DT O
de FW O
novo FW O
gametic JJ O
event NN O
. . O

In IN O
47 CD O
D442G NNP O
heterozygotes NNS O
, , O
mean VBP O
HDL NNP O
- : O
C NN O
levels NNS O
were VBD O
91 CD O
+ NNP O
/ NNP O
- : O
23 CD O
mg NN O
/ NNP O
dl NN O
, , O
similar JJ O
to TO O
the DT O
level NN O
in IN O
D442G NNP O
homozygotes NNS O
, , O
and CC O
significantly RB O
greater JJR O
than IN O
mean VB O
HDL NNP O
- : O
C NN O
levels NNS O
in IN O
Int14 NNP O
A NNP O
heterozygotes VBZ O
( ( O
69 CD O
+ NN O
/ NNP O
- : O
15 CD O
mg NN O
/ NNP O
dl NN O
) ) O
. . O

Six NNP O
frameshift NN O
and CC O
two CD O
missense NN O
mutations NNS O
were VBD O
detected VBN O
in IN O
10 CD O
different JJ O
families NNS O
. . O

Heterogeneity NN O
of IN O
type NN B-Disease
I PRP I-Disease
von VBP I-Disease
Willebrand JJ I-Disease
disease NN I-Disease
: : O
evidence NN O
for IN O
a DT O
subgroup NN O
with IN O
an DT O
abnormal JJ O
von NN B-Disease
Willebrand NNP I-Disease
factor NN O
. . O

In IN O
the DT O
family NN O
with IN O
the DT O
missense NN O
mutation NN O
the DT O
phenotype NN O
was VBD O
milder NN O
. . O

Western JJ O
blots NNS O
revealed VBD O
a DT O
protein NN O
with IN O
the DT O
expected JJ O
molecular NN O
weight NN O
which WDT O
is VBZ O
present JJ O
in IN O
the DT O
soluble JJ O
fraction NN O
of IN O
rat NN O
and CC O
monkey NN O
brain NN O
tissues NNS O
and CC O
lymphoblastoid JJ O
cells NNS O
from IN O
control NN O
cases NNS O
. . O

Gaucher NNP B-Disease
disease NN I-Disease
( ( O
GD NNP B-Disease
) ) O
is VBZ O
an DT O
inherited JJ O
deficiency NN B-Disease
of IN I-Disease
beta NN I-Disease
- : I-Disease
glucocerebrosidase NN I-Disease
( ( O
EC NNP O
3 CD O
. . O
1 CD O
. . O
2 CD O
. . O
45 CD O
, , O
gene NN O
symbol NN O
GBA NNP O
) ) O
. . O

Canavan NNP B-Disease
disease NN I-Disease
: : O
genomic JJ O
organization NN O
and CC O
localization NN O
of IN O
human JJ O
ASPA NNP O
to TO O
17p13 CD O
- : O
ter NN O
and CC O
conservation NN O
of IN O
the DT O
ASPA NNP O
gene NN O
during IN O
evolution NN O
. . O

Moreover RB O
, , O
a DT O
high JJ O
level NN O
of IN O
instability NN O
, , O
increasing VBG O
with IN O
age NN O
, , O
can MD O
be VB O
observed VBN O
in IN O
tissues NNS O
and CC O
in IN O
sperm NN O
. . O

These DT O
results NNS O
represent VBP O
a DT O
minimal JJ O
estimate NN O
of IN O
the DT O
frequency NN O
of IN O
BRCA1 NNP O
mutations NNS O
in IN O
this DT O
population NN O
. . O

Among IN O
the DT O
ALPS NNP B-Disease
- : O
associated VBN O
Fas NNP O
mutants NNS O
, , O
dominant JJ O
inhibition NN O
of IN O
apoptosis NN O
was VBD O
much RB O
more JJR O
pronounced JJ O
in IN O
mutants NNS O
affecting VBG O
the DT O
intracellular NN O
, , O
versus NN O
extracellular NN O
, , O
portion NN O
of IN O
the DT O
Fas NNP O
receptor NN O
. . O

Additional JJ O
evidence NN O
of IN O
a DT O
large JJ O
gene NN O
deletion NN O
was VBD O
given VBN O
by IN O
novel JJ O
SfiI NNP O
junction NN O
fragments NNS O
detected VBN O
by IN O
probes NNS O
p20 NNS O
, , O
J NNP O
- : O
Bir NNP O
, , O
and CC O
J NNP O
- : O
66 CD O
on IN O
pulsed JJ O
- : O
field NN O
gel JJ O
electrophoresis NN O
( ( O
PFGE NNP O
) ) O
. . O

Investigation NN O
of IN O
thermoregulatory NN O
characteristics NNS O
in IN O
patients NNS O
with IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
. . O

DNA NN O
analysis NN O
for IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
showed VBD O
no DT O
abnormalities NNS O
. . O

Mice NNP O
carrying VBG O
each DT O
of IN O
the DT O
two CD O
mutations NNS O
were VBD O
bred VBN O
and CC O
analyzed VBN O
. . O

Primary JJ B-Disease
dystonias NNS I-Disease
are VBP O
movement NN B-Disease
disorders NNS I-Disease
with IN O
dystonia NN B-Disease
as IN O
a DT O
major JJ O
symptom NN O
. . O

These DT O
findings NNS O
establish VB O
that IN O
some DT O
neuropathological JJ B-Disease
abnormalities NNS I-Disease
seen VBN O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
also RB O
are VBP O
present JJ O
in IN O
Atm NNP O
mutant JJ O
mice NN O
. . O

Allele NNP O
- : O
specific JJ O
oligonucleotide JJ O
hybridization NN O
was VBD O
used VBN O
to TO O
verify VB O
sequence NN O
changes NNS O
and CC O
to TO O
screen VB O
DNA NNP O
from IN O
control NN O
individuals NNS O
. . O

The DT O
Lowe NNP B-Disease
oculocerebrorenal JJ I-Disease
syndrome NN I-Disease
( ( O
OCRL NNP B-Disease
) ) O
is VBZ O
characterized VBN O
by IN O
congenital JJ O
cataract NN B-Disease
, , O
mental JJ B-Disease
retardation NN I-Disease
, , O
and CC O
defective JJ B-Disease
renal JJ I-Disease
tubular JJ I-Disease
function NN I-Disease
. . O

The DT O
zinc NN O
finger NN O
mutations NNS O
affect VBP O
DNA NNP O
binding NN O
and CC O
the DT O
amount NN O
of IN O
residual JJ O
binding VBG O
directly RB O
correlates VBZ O
with IN O
disease NN O
severity NN O
. . O

Immunologic NNP O
methods NNS O
revealed VBD O
trace NN O
amounts NNS O
( ( O
17 CD O
mg NN O
/ VBD O
100 CD O
ml NN O
) ) O
of IN O
apparently RB O
normal JJ O
serum JJ O
albumin NN O
. . O

Furthermore RB O
, , O
comparison NN O
of IN O
methylation NN O
patterns NNS O
within IN O
a DT O
region NN O
of IN O
the DT O
HPRT NNP O
gene NN O
known VBN O
to TO O
be VB O
important JJ O
in IN O
gene NN O
regulation NN O
revealed VBD O
differences NNS O
between IN O
DNA NN O
from IN O
the DT O
father NN O
and CC O
the DT O
patient NN O
, , O
in IN O
keeping VBG O
with IN O
an DT O
active JJ O
HPRT NNP O
locus NN O
in IN O
the DT O
father NN O
and CC O
an DT O
inactive JJ O
HPRT NNP O
locus NN O
in IN O
the DT O
patient NN O
. . O

Emerin NNP O
was VBD O
not RB O
detected VBN O
in IN O
the DT O
biopsied JJ O
muscle NN O
, , O
and CC O
RT NNP O
- : O
PCR NN O
and CC O
PCR NNP O
- : O
based VBN O
genomic JJ O
DNA NNP O
analyses NNS O
of IN O
the DT O
emerin JJ O
gene NN O
demonstrated VBD O
no DT O
amplification NN O
product NN O
in IN O
the DT O
patient NN O
. . O

Among IN O
the DT O
new JJ O
mutations NNS O
, , O
two CD O
nonsense JJ O
mutations NNS O
( ( O
R317X NNP O
and CC O
E558X NNP O
) ) O
and CC O
three CD O
other JJ O
frameshift NN O
mutations NNS O
caused VBD O
premature JJ O
termination NN O
of IN O
the DT O
protein NN O
. . O

4 CD O
% NN O
( ( O
7 CD O
of IN O
94 CD O
) ) O
were VBD O
A DT O
to TO O
G NNP O
mutation NN O
at IN O
nt JJ O
493 CD O
, , O
7 CD O
. . O

We PRP O
have VBP O
used VBN O
in IN O
situ JJ O
hybridisation NN O
with IN O
MCT112 NNP O
, , O
a DT O
corresponding JJ O
cosmid NN O
MJ1 NNP O
, , O
and CC O
DR47 NNP O
( ( O
D9S5 NNP O
) ) O
, , O
coupled VBN O
with IN O
mapping VBG O
studies NNS O
on IN O
hybrid JJ O
cell NN O
panels NNS O
, , O
to TO O
define VB O
more RBR O
precisely RB O
the DT O
location NN O
of IN O
the DT O
disease NN O
locus NN O
. . O

We PRP O
screened VBD O
49 CD O
potential JJ O
FAP NNP B-Disease
families NNS O
and CC O
identified VBD O
26 CD O
different JJ O
germline NN O
APC NNP B-Disease
mutations NNS O
in IN O
30 CD O
families NNS O
. . O

Although IN O
MHC NNP O
genes NNS O
, , O
including VBG O
HLA NNP O
- : O
B27 NNP O
, , O
contribute VBZ O
only RB O
20 CD O
- : O
50 CD O
% NN O
of IN O
the DT O
genetic JJ O
risk NN O
for IN O
the DT O
disease NN O
, , O
no DT O
non JJ O
- : O
MHC NNP O
gene NN O
has VBZ O
yet RB O
been VBN O
convincingly RB O
demonstrated VBN O
to TO O
influence VB O
either DT O
susceptibility NN O
to TO O
the DT O
disease NN O
or CC O
its PRP$ O
phenotypic JJ O
expression NN O
. . O

Seven NNP O
mutations NNS O
lead VBP O
to TO O
protein VB O
truncations NNS O
at IN O
sites NNS O
throughout IN O
the DT O
gene NN O
. . O

METHODS NNP O
Ten CD O
patients NNS O
with IN O
XLRS NNP B-Disease
underwent JJ O
full JJ O
ophthalmologic NN O
examination NN O
, , O
including VBG O
slitlamp JJ O
biomicroscopy NN O
and CC O
dilated VBD O
funduscopy NN O
. . O

The DT O
mutation NN O
introduces VBZ O
a DT O
termination NN O
codon NN O
within IN O
exon $ O
8 CD O
of IN O
the DT O
dystrophin JJ O
gene NN O
. . O

It PRP O
mainly RB O
involves VBZ O
the DT O
nervous JJ O
system NN O
white JJ O
matter NN O
, , O
adrenal JJ O
cortex NN O
and CC O
testes NNS O
. . O

A DT O
domain NN O
of IN O
exclusive JJ O
paternal JJ O
expression NN O
surrounding VBG O
the DT O
imprinting NN O
center NN O
suggests VBZ O
strong JJ O
regional JJ O
control NN O
of IN O
the DT O
imprinting NN O
process NN O
. . O

Discovery NN O
of IN O
other JJ O
cases NNS O
with IN O
both DT O
disorders NNS O
may MD O
provide VB O
clues NNS O
to TO O
the DT O
pathophysiology NN O
of IN O
both DT O
conditions NNS O
. . O
. . O

Historically RB O
, , O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
has VBZ O
encompassed VBN O
a DT O
host NN O
of IN O
neurologic JJ B-Disease
disorders NNS I-Disease
that WDT O
present VBP O
with IN O
a DT O
deficit NN B-Disease
of IN I-Disease
myelin NN I-Disease
, , O
the DT O
membrane NN O
elaborated VBN O
by IN O
glial JJ O
cells NNS O
that IN O
encircles NNS O
and CC O
successively RB O
enwraps JJ O
axons NNS O
. . O

One CD O
of IN O
the DT O
twins NNS O
received VBD O
2 CD O
mg NN O
of IN O
mazindol JJ O
daily JJ O
, , O
while IN O
the DT O
other JJ O
received VBD O
a DT O
placebo NN O
. . O

The DT O
clinical JJ O
features NNS O
were VBD O
similar JJ O
and CC O
there EX O
were VBD O
no DT O
obvious JJ O
stigmata NN O
of IN O
Langer NNP B-Disease
- : I-Disease
Giedion NN I-Disease
syndrome NN I-Disease
( ( O
LGS NNP B-Disease
) ) O
. . O

OBJECTIVES IN O
A NNP O
Japanese JJ O
family NN O
with IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
( ( O
CTX NNP B-Disease
) ) O
was VBD O
investigated VBN O
for IN O
a DT O
sequence NN O
alteration NN O
in IN O
the DT O
sterol NN O
27 CD O
- : O
hydroxylase NN O
gene NN O
( ( O
CYP27 NNP O
) ) O
. . O

2 CD O
shows NNS O
that IN O
the DT O
DM NNP B-Disease
locus NN O
is VBZ O
distal JJ O
to TO O
APOC2 NNP O
. . O

Cognitive JJ O
performance NN O
( ( O
IQ NNP O
) ) O
was VBD O
also RB O
significantly RB O
related VBN O
to TO O
genotype NN O
. . O

The DT O
FRDA NNP B-Disease
gene NN O
encodes VBZ O
a DT O
widely RB O
expressed VBN O
210 CD O
- : O
aa NN O
protein NN O
, , O
frataxin NN O
, , O
which WDT O
is VBZ O
located VBN O
in IN O
mitochondria NN O
and CC O
is VBZ O
severely RB O
reduced VBN O
in IN O
FRDA NNP B-Disease
patients NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
these DT O
criteria NNS O
, , O
48 CD O
% NN O
of IN O
the DT O
PWS NNP B-Disease
individuals NNS O
were VBD O
hypopigmented VBN B-Disease
. . O

The DT O
frequency NN O
of IN O
the DT O
deficiency NN O
was VBD O
increasingly RB O
higher JJR O
in IN O
presenile JJ O
cataracts NNS B-Disease
. . O

Subsequently RB O
PAX6 NNP O
intragenic JJ O
mutations NNS O
were VBD O
demonstrated VBN O
in IN O
Smalleye NNP O
, , O
a DT O
mouse NN O
mutant NN O
which WDT O
is VBZ O
an DT O
animal JJ O
model NN O
for IN O
aniridia NN B-Disease
, , O
and CC O
six CD O
human JJ O
aniridia NN B-Disease
patients NNS O
. . O

The DT O
phenotypic JJ O
expressions NNS O
of IN O
the DT O
different JJ O
genetic JJ O
predispositions NNS O
involved VBN O
, , O
include VBP O
sacro JJ B-Disease
- : I-Disease
iliitis NN I-Disease
, , O
psoriasis NN B-Disease
, , O
acute JJ B-Disease
anterior JJ I-Disease
uveitis NN I-Disease
, , O
peripheral JJ O
arthropathy NN B-Disease
and CC O
inflammatory JJ B-Disease
bowel NN I-Disease
disease NN I-Disease
. . O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
hypothesis NN O
of IN O
linkage NN O
to TO O
HPC1 NNP O
in IN O
a DT O
subset NN O
of IN O
families NNS O
with IN O
prostate NN B-Disease
cancer NN I-Disease
, , O
particularly RB O
those DT O
with IN O
an DT O
early JJ O
age NN O
at IN O
diagnosis NN O
. . O

The DT O
exact JJ O
APC NNP B-Disease
mutation NN O
was VBD O
identified VBN O
in IN O
42 CD O
unrelated JJ O
patients NNS O
. . O

The DT O
Christian JJ O
Arabs NNPS O
in IN O
Israel NNP O
also RB O
have VBP O
a DT O
high JJ O
incidence NN O
of IN O
the DT O
disease NN O
( ( O
1 CD O
/ RB O
10 CD O
, , O
0 CD O
live JJ O
births NNS O
) ) O
; : O
the DT O
mutation NN O
in IN O
this DT O
population NN O
is VBZ O
still RB O
unknown JJ O
. . O

The DT O
seizures NNS O
usually RB O
spontaneously RB O
cease NN O
after IN O
one CD O
year NN O
without IN O
treatment NN O
, , O
leaving VBG O
no DT O
neurological JJ B-Disease
abnormalities NNS I-Disease
. . O

The DT O
majority NN O
, , O
but CC O
not RB O
all DT O
, , O
of IN O
breast SYM B-Disease
- : I-Disease
ovary JJ I-Disease
cancer NN I-Disease
families NNS O
show VBP O
linkage NN O
to TO O
this DT O
susceptibility NN O
locus NN O
, , O
designated VBN O
BRCA1 NNP O
. . O

To TO O
better RBR O
understand VB O
the DT O
function NN O
of IN O
the DT O
EWS NNP O
protein NN O
, , O
we PRP O
cloned VBD O
the DT O
EWS NNP O
cDNA NN O
. . O

Spectrum NNP O
of IN O
germline JJ O
mutations NNS O
in IN O
the DT O
RB1 NNP O
gene NN O
: : O
a DT O
study NN O
of IN O
232 CD O
patients NNS O
with IN O
hereditary JJ B-Disease
and CC I-Disease
non JJ I-Disease
hereditary JJ I-Disease
retinoblastoma NN I-Disease
. . O

The DT O
mutations NNS O
were VBD O
not RB O
detected VBN O
in IN O
the DT O
ALD NNP B-Disease
gene NN O
of IN O
30 CD O
healthy JJ O
persons NNS O
. . O
. . O

Patients NNS O
homozygous JJ O
for IN O
a DT O
single JJ O
truncating NN O
mutation NN O
, , O
typically RB O
near IN O
the DT O
N NNP O
- : O
terminal JJ O
end NN O
of IN O
the DT O
gene NN O
, , O
or CC O
heterozygous JJ O
for IN O
the DT O
in IN O
- : O
frame NN O
deletion NN O
2546 CD O
3 CD O
, , O
were VBD O
shorter JJR O
and CC O
had VBD O
significantly RB O
shorter JJR O
survival NN O
than IN O
those DT O
heterozygous JJ O
for IN O
a DT O
splice NN O
site NN O
or CC O
missense JJ O
mutation NN O
, , O
or CC O
heterozygous JJ O
for IN O
two CD O
truncating VBG O
mutations NNS O
. . O

This DT O
mutation NN O
is VBZ O
identical JJ O
to TO O
the DT O
disease NN O
- : O
causing VBG O
mutation NN O
in IN O
patients NNS O
with IN O
hereditary JJ B-Disease
hemochromatosis NN I-Disease
. . O

We PRP O
identified VBD O
a DT O
treatment NN O
regimen NN O
that WDT O
resulted VBD O
in IN O
the DT O
presence NN O
of IN O
dystrophin NN O
in IN O
the DT O
cell NN O
membrane NN O
in IN O
all DT O
striated JJ O
muscles NNS O
examined VBN O
and CC O
that IN O
provided VBD O
functional JJ O
protection NN O
against IN O
muscular JJ B-Disease
injury NN I-Disease
. . O

It PRP O
was VBD O
detected VBN O
in IN O
nine CD O
families NNS O
. . O

We PRP O
discuss VBP O
these DT O
findings NNS O
in IN O
the DT O
context NN O
of IN O
the DT O
hypothesis NN O
that WDT O
abnormal JJ O
development NN O
of IN O
Purkinje NNP O
cells NNS O
and CC O
lymphocytes VBZ O
contributes NNS O
to TO O
the DT O
pathogenesis NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
. . O
. . O

Analysis NN O
with IN O
DNA NNP O
markers NNS O
at IN O
Xq28 NNP O
suggested VBD O
segregation NN O
of IN O
both DT O
ALD NNP B-Disease
and CC O
AMN NNP B-Disease
with IN O
an DT O
identical JJ O
haplotype NN O
. . O

The DT O
growth NN O
of IN O
the DT O
cultured JJ O
fibroblasts NNS O
of IN O
this DT O
patient NN O
was VBD O
intermediate JJ O
in IN O
media NNS O
containing VBG O
hypoxanthine NN O
aminopterin NN O
thymidine NN O
( ( O
HAT NNP O
) ) O
, , O
whereas IN O
the DT O
growth NN O
of IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
cells NNS O
was VBD O
inhibited VBN O
and CC O
normal JJ O
cells NNS O
grew VBD O
normally RB O
. . O

However RB O
, , O
the DT O
mutation NN O
stats NNS O
of IN O
individuals NNS O
unselected VBN O
for IN O
breast NN B-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
has VBZ O
not RB O
been VBN O
determined VBN O
, , O
and CC O
it PRP O
is VBZ O
not RB O
known VBN O
whether IN O
mutations NNS O
in IN O
such JJ O
individuals NNS O
confer VBP O
the DT O
same JJ O
risk NN O
of IN O
cancer NN B-Disease
as IN O
in IN O
individuals NNS O
from IN O
the DT O
high JJ O
- : O
risk NN O
families NNS O
studied VBN O
so RB O
far RB O
. . O

Using VBG O
multipoint NN O
linkage NN O
analysis NN O
, , O
the DT O
combined JJ O
maximum JJ O
lod NN O
score NN O
for IN O
these DT O
two CD O
families NNS O
was VBD O
7 CD O
. . O

The DT O
serum NN O
transferrin NN O
saturation NN O
was VBD O
45 CD O
percent NN O
or CC O
higher JJR O
in IN O
15 CD O
of IN O
the DT O
16 CD O
who WP O
were VBD O
homozygous JJ O
; : O
in IN O
1 CD O
subject JJ O
it PRP O
was VBD O
43 CD O
percent NN O
. . O

324 CD O
( ( O
1 CD O
in IN O
31 CD O
individuals NNS O
) ) O
. . O

We PRP O
have VBP O
searched VBN O
for IN O
hSNF5 NN O
/ NNP O
INI1 NNP O
mutations NNS O
in IN O
229 CD O
tumors NNS B-Disease
of IN O
various JJ O
origins NNS O
using VBG O
a DT O
screening NN O
method NN O
based VBN O
on IN O
denaturing VBG O
high JJ O
- : O
performance NN O
liquid NN O
chromatography NN O
. . O

The DT O
mutation NN O
causing VBG O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
has VBZ O
recently RB O
been VBN O
identified VBN O
as IN O
an DT O
unstable JJ O
CTG NNP O
trinucleotide NN O
repeat NN O
located VBN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
of IN O
a DT O
gene NN O
encoding VBG O
for IN O
a DT O
protein NN O
with IN O
putative JJ O
serine NN O
- : O
threonine NN O
protein JJ O
kinase NN O
activity NN O
. . O

Six5 NNP O
+ NNP O
/ NNP O
- : O
and CC O
Six5 NNP O
- : O
/ SYM O
- : O
mice NN O
show NN O
increased VBD O
steady JJ O
- : O
state NN O
levels NNS O
of IN O
the DT O
Na NNP O
+ NNP O
/ NNP O
K NNP O
+ NNP O
- : O
ATPase NNP O
alpha VBZ O
- : O
1 CD O
subunit NN O
and CC O
decreased VBD O
Dm15 NNP O
mRNA NN O
levels NNS O
. . O

Haplotype NNP O
analysis NN O
supports VBZ O
previous JJ O
data NNS O
which WDT O
suggest VBP O
some DT O
BRCA1 NNP O
mutation NN O
carriers NNS O
have VBP O
common JJ O
ancestors NNS O
; : O
however RB O
, , O
we PRP O
have VBP O
found VBN O
at IN O
least JJS O
two CD O
examples NNS O
where WRB O
recurrent JJ O
mutations NNS O
appear VBP O
to TO O
have VB O
arisen VBN O
independently RB O
. . O
. . O

Analysis NN O
of IN O
information NN O
from IN O
21 CD O
sibships NNS O
in IN O
14 CD O
kindreds NNS O
showed VBD O
a DT O
significant JJ O
tendency NN O
for IN O
sibs NN O
who WP O
have VBP O
similar JJ O
onset VBN O
ages NNS O
to TO O
share NN O
the DT O
same JJ O
D4S10 NNP O
allele NN O
from IN O
the DT O
normal JJ O
parent NN O
. . O

Oocyte NNP O
macropatch NN O
analysis NN O
revealed VBD O
that IN O
the DT O
activation NN O
kinetics NNS O
of IN O
T1620M NNP O
were VBD O
normal JJ O
. . O

It PRP O
is VBZ O
unclear JJ O
whether IN O
the DT O
specific JJ O
molecular JJ O
changes NNS O
that WDT O
distinguish VBP O
the DT O
D1 NNP O
and CC O
D2 NNP O
alleles VBZ O
account NN O
for IN O
the DT O
different JJ O
activities NNS O
. . O

This DT O
mutation NN O
( ( O
R413P NNP O
) ) O
results NNS O
in IN O
negligible JJ O
enzymatic JJ O
activity NN O
when WRB O
expressed VBN O
in IN O
heterologous JJ O
mammalian JJ O
cells NNS O
and CC O
is VBZ O
compatible JJ O
with IN O
a DT O
classic JJ O
PKU NNP B-Disease
phenotype NN O
in IN O
the DT O
patient NN O
. . O

In IN O
general JJ O
, , O
cone NN O
and CC O
rod NN O
thresholds NNS O
were VBD O
elevated VBN O
, , O
and CC O
color NN O
- : O
contrast NN O
sensitivity NN O
was VBD O
absent JJ O
in IN O
the DT O
central JJ O
visual JJ O
field NN O
. . O

We PRP O
have VBP O
determined VBN O
the DT O
parental JJ O
origin NN O
of IN O
the DT O
retained JJ O
allele NN O
in IN O
nine CD O
retinoblastoma NN B-Disease
tumours NNS I-Disease
from IN O
eight CD O
unrelated JJ O
non SYM O
- : O
familial JJ O
cases NNS O
by IN O
using VBG O
RB1 NNP O
- : O
linked VBN O
genetic JJ O
markers NNS O
. . O

Recent JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
this DT O
trinucleotide NN O
motif NN O
forms NNS O
part NN O
of IN O
the DT O
last JJ O
, , O
3 CD O
untranslated JJ O
exon NN O
of IN O
a DT O
gene NN O
which WDT O
potentially RB O
encodes VBZ O
multiple JJ O
protein NN O
isoforms NNS O
of IN O
a DT O
serine NN O
/ NNP O
threonine NN O
protein NN O
kinase NN O
( ( O
myotonic JJ B-Disease
dystrophy NN I-Disease
protein NN O
kinase NN O
, , O
DM NNP O
- : O
PK NN O
) ) O
. . O

We PRP O
have VBP O
now RB O
examined VBN O
the DT O
DNA NN O
of IN O
three CD O
previously RB O
reported VBN O
electrophoretically RB O
fast JJ O
Mexican NNP O
G6PD NNP O
variants NNS O
, , O
- : O
G6PD NNP O
Distrito NNP O
Federal NNP O
, , O
G6PD NNP O
Tepic NNP O
, , O
and CC O
G6PD NNP O
Castilla NNP O
. . O

21 CD O
region NN O
of IN O
the DT O
human JJ O
X NNP O
chromosome NN O
. . O

Cytogenetic JJ O
investigations NNS O
in IN O
families NNS O
with IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
. . O

The DT O
mutation NN O
does VBZ O
not RB O
affect VB O
the DT O
electrophoretic JJ O
migration NN O
, , O
the DT O
isoelectric JJ O
point NN O
, , O
or CC O
the DT O
thermal JJ O
stability NN O
. . O

By IN O
use NN O
of IN O
this DT O
strategy NN O
, , O
carrier NN O
status NN O
was VBD O
accurately RB O
assessed VBN O
in IN O
all DT O
seven CD O
at IN O
- : O
risk NN O
females NNS O
tested VBN O
, , O
whereas JJ O
enzymatic JJ O
dosages NNS O
failed VBD O
to TO O
diagnose VB O
or CC O
exclude VB O
heterozygosity NN O
. . O
. . O

Protein NNP B-Disease
S NNP I-Disease
deficiency NN I-Disease
is VBZ O
a DT O
recognized VBN O
risk NN O
factor NN O
for IN O
venous JJ B-Disease
thrombosis NN I-Disease
. . O

N NNP O
. . O
, , O
Irrinki NNP O
, , O
A NNP O
. . O
, , O
Feder NNP O
, , O
J NNP O
. . O
N NNP O
. . O
, , O
and CC O
Enns NNP O
, , O
C NNP O
. . O
A NNP O
. . O
( ( O
1998 CD O
) ) O
J NNP O
. . O
Biol NNP O
. . O
Chem NNP O
. . O
273 CD O
, , O
22068 CD O
- : O
22074 CD O
; : O
Feder NNP O
, , O
J NNP O
. . O
N NNP O
. . O
, , O
Penny NNP O
, , O
D NNP O
. . O
M NNP O
. . O
, , O
Irrinki NNP O
, , O
A NNP O
. . O
, , O
Lee NNP O
, , O
V NNP O
. . O
K NNP O
. . O
, , O
Lebron NNP O
, , O
J NNP O
. . O
A NNP O
. . O
, , O
Watson NNP O
, , O
N NNP O
. . O
, , O
Tsuchihashi NNP O
, , O
Z NNP O
. . O
, , O
Sigal NNP O
, , O
E NNP O
. . O
, , O
Bjorkman NNP O
, , O
P NNP O
. . O
J NNP O
. . O
, , O
and CC O
Schatzman NNP O
, , O
R NNP O
. . O
C NNP O
. . O
( ( O
1998 CD O
) ) O
Proc NNP O
. . O
Natl NNP O
. . O

Moreover RB O
, , O
we PRP O
observed VBD O
the DT O
occurrence NN O
of IN O
de FW O
novo FW O
mutations NNS O
between IN O
parental JJ O
and CC O
grandparental JJ O
generations NNS O
in IN O
17 CD O
three CD O
- : O
generation NN O
families NNS O
, , O
which WDT O
allowed VBD O
a DT O
direct JJ O
estimation NN O
of IN O
the DT O
k NN O
value NN O
( ( O
k VB O
= NNP O
11 CD O
) ) O
. . O

Differential NNP O
Alu NNP O
PCR NNP O
fingerprint NN O
cloning NN O
was VBD O
used VBN O
to TO O
isolate VB O
a DT O
DNA NN O
probe NN O
from IN O
the DT O
Xp11 NNP O
. . O

In IN O
Sardinians NNPS O
with IN O
the DT O
beta NN O
0 CD O
- : O
thalassemia NN O
trait NN O
, , O
parasite JJ O
growth NN O
was VBD O
normal JJ O
except IN O
when WRB O
G6PD NNP B-Disease
deficiency NN I-Disease
occurred VBD O
together RB O
with IN O
the DT O
thalassemia NN B-Disease
trait NN O
. . O

The DT O
most RBS O
recent JJ O
ancestors NNS O
common JJ O
to TO O
obligate VB O
carriers NNS O
of IN O
this DT O
mutation NN O
were VBD O
from IN O
the DT O
Charlevoix NNP O
region NN O
of IN O
the DT O
province NN O
of IN O
Quebec NNP O
. . O

The DT O
mutations NNS O
include VBP O
an DT O
11 CD O
- : O
base NN O
pair NN O
deletion NN O
, , O
a DT O
1 CD O
- : O
base NN O
pair NN O
insertion NN O
, , O
a DT O
stop NN O
codon NN O
, , O
a DT O
missense NN O
substitution NN O
, , O
and CC O
an DT O
inferred JJ O
regulatory JJ O
mutation NN O
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
in IN O
RBCs NNP O
was VBD O
found VBN O
significantly RB O
more RBR O
frequently RB O
in IN O
210 CD O
male JJ O
cataractous JJ B-Disease
patients NNS O
than IN O
in IN O
672 CD O
control NN O
subjects NNS O
of IN O
Sardinian JJ O
origin NN O
. . O

Lymphocytes NNS O
from IN O
all DT O
WAS NNP B-Disease
patients NNS O
showed VBD O
WASPdim NNP O
instead RB O
of IN O
WASPbright NNP O
. . O

The DT O
ERG NNP O
shows VBZ O
promise NN O
of IN O
becoming VBG O
a DT O
noninvasive JJ O
diagnostic JJ O
tool NN O
for IN O
DMD NNP B-Disease
and CC O
its PRP$ O
milder NN O
allelic NN O
forms NNS O
. . O
. . O

We PRP O
propose VBP O
that IN O
the DT O
PAX6 NNP O
gene NN O
on IN O
the DT O
rearranged VBN O
chromosome NN O
11 CD O
is VBZ O
in IN O
an DT O
inappropriate JJ O
chromatin NN O
environment NN O
for IN O
normal JJ O
expression NN O
and CC O
therefore NN O
that IN O
a DT O
position NN O
effect NN O
is VBZ O
the DT O
underlying VBG O
mechanism NN O
of IN O
disease NN O
in IN O
these DT O
families NNS O
. . O
. . O

Finally RB O
, , O
one CD O
frameshift NN O
mutation NN O
, , O
2799delC CD O
, , O
modifies VBZ O
the DT O
C NNP O
- : O
terminal JJ O
part NN O
of IN O
OCRL1 NNP O
, , O
with IN O
an DT O
extension NN O
of IN O
six CD O
amino JJ O
acids NNS O
. . O

Platelet NNP O
aggregation NN O
responses NNS O
of IN O
Sit NNP O
( ( O
a DT O
) ) O
( ( O
+ $ O
) ) O
individuals NNS O
were VBD O
diminished VBN O
in IN O
response NN O
to TO O
collagen NN O
, , O
indicating VBG O
that IN O
the DT O
Thr NNP O
( ( O
799 CD O
) ) O
Met NNP O
mutation NN O
affects VBZ O
the DT O
function NN O
of IN O
the DT O
GPIa NNP O
/ NNP O
IIa NNP O
complex NN O

The DT O
murine NN O
homolog NN O
of IN O
the DT O
human JJ O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
Brca1 NNP O
maps NNS O
to TO O
mouse VB O
chromosome NN O
11D CD O
. . O

Based VBN O
on IN O
this DT O
idea NN O
, , O
DNAs NNP O
isolated VBD O
from IN O
gastric JJ B-Disease
cancers NNS I-Disease
were VBD O
examined VBN O
by IN O
means NNS O
of IN O
a DT O
RNase NNP O
protection NN O
analysis NN O
coupled VBN O
with IN O
polymerase NN O
chain NN O
reaction NN O
followed VBN O
by IN O
sequencing VBG O
of IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
products NNS O
. . O

Friedreich NNP B-Disease
ataxia NN I-Disease
: : O
an DT O
overview NN O
. . O

The DT O
CTSC NNP O
message NN O
is VBZ O
expressed VBN O
at IN O
high JJ O
levels NNS O
in IN O
a DT O
variety NN O
of IN O
immune JJ O
cells NNS O
including VBG O
polymorphonuclear JJ O
leucocytes NNS O
, , O
macrophages NNS O
, , O
and CC O
their PRP$ O
precursors NNS O
. . O

In IN O
one CD O
large JJ O
family NN O
a DT O
single JJ O
nucleotide NN O
( ( O
T NNP O
) ) O
insertion NN O
into IN O
the DT O
donor JJ O
splice NN O
site NN O
of IN O
exon JJ O
C NNP O
leads VBZ O
to TO O
two CD O
aberrantly RB O
spliced VBN O
mRNAs JJ O
both DT O
producing VBG O
a DT O
premature NN O
stop NN O
codon NN O
. . O

Clinical JJ O
and CC O
biochemical JJ O
analyses NNS O
have VBP O
identified VBN O
many JJ O
variants NNS O
exhibiting VBG O
a DT O
range NN O
of IN O
phenotypes NNS O
, , O
which WDT O
have VBP O
been VBN O
well RB O
characterized VBN O
from IN O
the DT O
hematological JJ O
point NN O
of IN O
view NN O
. . O

Four CD O
amino NN O
acid NN O
substitutions NNS O
, , O
Leu27Phe NNP O
, , O
Thr48Ile NNP O
, , O
Val75Met NNP O
and CC O
Arg477Lys NNP O
, , O
were VBD O
found VBN O
in IN O
patients NNS O
with IN O
congenital JJ B-Disease
thrombocytopenia NN I-Disease
and CC O
no DT O
clinically RB O
evident JJ O
immune NN O
defect NN O
indicating VBG O
that IN O
the DT O
WASP NNP O
gene NN O
is VBZ O
the DT O
site NN O
for IN O
mutations NNS O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
thrombocytopenia NN I-Disease
as RB O
well RB O
as IN O
in IN O
WAS NNP B-Disease
. . O

This DT O
is VBZ O
the DT O
first JJ O
demonstration NN O
of IN O
LOH NNP O
at IN O
the DT O
APC NNP B-Disease
locus NN O
in IN O
adrenocortical JJ B-Disease
tumors NNS I-Disease
. . O

This DT O
agrees VBZ O
with IN O
the DT O
data NNS O
obtained VBN O
from IN O
other JJ O
linkage NN O
studies NNS O
and CC O
from IN O
physical JJ O
mapping NN O
. . O

The DT O
syndrome NN O
inconsistently RB O
associates VBZ O
characteristic JJ O
patches NNS O
of IN O
congenital JJ B-Disease
hypertrophy NN I-Disease
of IN I-Disease
the DT I-Disease
retinal JJ I-Disease
pigment NN I-Disease
epithelium NN I-Disease
( ( O
CHRPE NNP B-Disease
) ) O
. . O

We PRP O
detected VBD O
a DT O
significant JJ O
segregation NN O
distortion NN O
in IN O
the DT O
data NN O
as IN O
a DT O
whole NN O
( ( O
P NNP O
= NNP O
. . O
99 CD O
) ) O
and CC O
a DT O
significant JJ O
heterogeneity NN O
in IN O
the DT O
segregation NN O
rate NN O
across IN O
donors NNS O
( ( O
. . O
92 CD O
) ) O
. . O

This DT O
indicated VBD O
that IN O
nonneonatal JJ O
ALD NNP B-Disease
and CC O
AMN NNP B-Disease
are VBP O
caused VBN O
by IN O
a DT O
mutation NN O
in IN O
the DT O
same JJ O
gene NN O
at IN O
Xq28 NNP O
. . O

Autosomal NNP B-Disease
dominant JJ I-Disease
neurohypophyseal NN I-Disease
diabetes NNS I-Disease
insipidus VBP I-Disease
is VBZ O
a DT O
familial JJ O
form NN O
of IN O
diabetes NNS B-Disease
insipidus VBP I-Disease
. . O

The DT O
molecular JJ O
characteristics NNS O
of IN O
G6PD NNP O
in IN O
the DT O
patient NN O
differed VBD O
from IN O
those DT O
of IN O
all DT O
previously RB O
reported VBN O
variants NNS O
associated VBN O
with IN O
CNSHA NNP B-Disease
, , O
so IN O
the DT O
present JJ O
variant NN O
was VBD O
provisionally RB O
called VBN O
G6PD NNP O
Barcelona NNP O
to TO O
distinguish VB O
it PRP O
from IN O
other JJ O
G6PD NNP O
variants NNS O
previously RB O
described VBN O
. . O

CONCLUSIONS NNP O
. . O

The DT O
mutations NNS O
2871delC CD O
and CC O
R778L NNP O
have VBP O
been VBN O
previously RB O
reported VBN O
in IN O
a DT O
relatively RB O
large JJ O
number NN O
of IN O
Japanese JJ O
patients NNS O
. . O

The DT O
underlying VBG O
DNA NNP O
changes NNS O
associated VBN O
with IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
- : I-Disease
deficient NN I-Disease
Asians NNPS O
have VBP O
not RB O
been VBN O
extensively RB O
investigated VBN O
. . O

Analysis NN O
of IN O
poly NN O
( ( O
A DT O
) ) O
+ NN O
RNA NNP O
showed VBD O
dramatic JJ O
decreases NNS O
of IN O
both DT O
the DT O
mutant NN O
and CC O
normal JJ O
DM NNP B-Disease
kinase NN O
RNAs NNP O
, , O
and CC O
these DT O
changes NNS O
were VBD O
disease JJ O
- : O
specific NN O
. . O

FISH NN O
with IN O
cosmid NN O
probes NNS O
has VBZ O
proved VBN O
to TO O
be VB O
a DT O
fast JJ O
and CC O
reliable JJ O
technique NN O
for IN O
the DT O
molecular JJ O
analysis NN O
of IN O
deletions NNS O
. . O

Residual JJ O
enzyme NN O
activity NN O
was VBD O
about RB O
2 CD O
. . O

Using VBG O
two CD O
genomic JJ O
probes NNS O
extending VBG O
into IN O
the DT O
5 CD O
and CC O
3 CD O
flanking NN O
regions NNS O
, , O
respectively RB O
, , O
we PRP O
have VBP O
identified VBN O
eight CD O
polymorphic JJ O
restriction NN O
sites NNS O
. . O

Genetic JJ O
analysis NN O
in IN O
families NNS O
with IN O
van JJ B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
. . O

After IN O
addition NN O
of IN O
( ( O
55 CD O
) ) O
Fe NNP O
to TO O
the DT O
medium NN O
, , O
immunoprecipitates NNS O
of IN O
this DT O
species NNS O
contain VBP O
> JJ O
16 CD O
atoms NNS O
of IN O
( ( O
55 CD O
) ) O
Fe NNP O
per IN O
molecule NN O
of IN O
mYfh1p NN O
. . O

A DT O
gene NN O
, , O
FGD1 NNP O
, , O
altered VBD O
in IN O
a DT O
patient NN O
with IN O
AAS NNP B-Disease
phenotype NN O
, , O
has VBZ O
been VBN O
identified VBN O
and CC O
found VBN O
to TO O
encode VB O
a DT O
protein NN O
with IN O
homology NN O
to TO O
Rho NNP O
/ NNP O
Rac NNP O
guanine NNP O
nucleotide IN O
exchange NN O
factors NNS O
( ( O
Rho NNP O
/ NNP O
Rac NNP O
GEF NNP O
) ) O
. . O

The DT O
second JJ O
mutation NN O
introduces VBZ O
a DT O
missense JJ O
mutation NN O
( ( O
C282Y NNP O
) ) O
into IN O
the DT O
Hfe NNP O
locus NN O
, , O
but CC O
otherwise RB O
leaves VBZ O
the DT O
gene NN O
intact JJ O
. . O

The DT O
Sit NNP O
( ( O
a DT O
) ) O
alloantigen NN O
is VBZ O
of IN O
low JJ O
frequency NN O
( ( O
1 CD O
/ RB O
400 CD O
) ) O
in IN O
the DT O
German JJ O
population NN O
. . O

Both DT O
alternatively RB O
spliced VBN O
transcripts NNS O
, , O
EWS NNP O
and CC O
EWS NNP O
- : O
b NN O
, , O
are VBP O
expressed VBN O
in IN O
a DT O
variety NN O
of IN O
cells NNS O
. . O

The DT O
mutation NN O
causing VBG O
juvenile NN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
in IN O
two CD O
sibs NN O
of IN O
Lebanese NNP O
- : O
Maronite NNP O
origin NN O
is VBZ O
described VBN O
. . O

Recently RB O
, , O
this DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
was VBD O
shown VBN O
to TO O
be VB O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
PDS NNP B-Disease
gene NN O
, , O
which WDT O
encodes VBZ O
an DT O
anion NN O
transporter NN O
called VBN O
pendrin NN O
. . O

A DT O
5 CD O
bp NN O
deletion NN O
at IN O
codon NN O
1309 CD O
reported VBD O
to TO O
occur VB O
in IN O
10 CD O
- : O
15 CD O
% NN O
of IN O
unselected JJ O
APC NNP B-Disease
patients NNS O
worldwide RB O
, , O
was VBD O
found VBN O
in IN O
5 CD O
of IN O
the DT O
18 CD O
new JJ O
mutation NN O
cases NNS O
and CC O
4 CD O
of IN O
the DT O
27 CD O
familial JJ O
cases NNS O
all DT O
nine CD O
were VBD O
classed VBN O
as IN O
severe JJ O
. . O

Breast NNP B-Disease
cancer NN I-Disease
in IN O
men NNS O
is VBZ O
about IN O
a DT O
hundredfold NN O
less JJR O
common JJ O
than IN O
in IN O
women NNS O
and CC O
this DT O
has VBZ O
hindered VBN O
research NN O
into IN O
its PRP$ O
genetic JJ O
basis NN O
. . O

DiGeorge NNP B-Disease
syndrome NN I-Disease
( ( O
DGS NNP B-Disease
) ) O
, , O
a DT O
developmental JJ O
field NN O
defect NN O
of IN O
the DT O
third JJ O
and CC O
fourth JJ O
pharyngeal NN O
pouches NNS O
, , O
is VBZ O
characterized VBN O
by IN O
aplasia NN B-Disease
or CC I-Disease
hypoplasia NN I-Disease
of IN I-Disease
the DT I-Disease
thymus NN I-Disease
and CC I-Disease
parathyroid JJ I-Disease
glands NNS I-Disease
and CC O
by IN O
conotruncal JJ B-Disease
cardiac JJ I-Disease
malformations NNS I-Disease
. . O

The DT O
identification NN O
of IN O
four CD O
genomic JJ O
rearrangements NNS O
among IN O
30 CD O
mutations NNS O
suggests VBZ O
that IN O
genomic JJ O
rearrangements NNS O
are VBP O
frequent JJ O
germline NN O
APC NNP B-Disease
mutations NNS O
. . O
. . O

4 CD O
kb NN O
of IN O
the DT O
region NN O
of IN O
these DT O
clones NNS O
corresponding VBG O
to TO O
part NN O
of IN O
human JJ O
exon FW O
11 CD O
revealed VBD O
72 CD O
% NN O
nucleic JJ O
acid JJ O
identity NN O
but CC O
only RB O
50 CD O
% NN O
amino NN O
acid NN O
identity NN O
with IN O
the DT O
human JJ O
gene NN O
. . O

We PRP O
report VBP O
on IN O
a DT O
4 CD O
- : O
year NN O
- : O
old JJ O
boy NN O
with IN O
Knobloch NNP B-Disease
syndrome NN I-Disease
. . O

All DT O
five CD O
have VBP O
the DT O
( ( O
NlaIII NNP O
/ NNP O
FokI NNP O
/ NNP O
PvuII NNP O
/ NNP O
PstI NNP O
) ) O
haplotype VBD O
characteristic JJ O
of IN O
G6PD NNP O
A NNP O
- : O
in IN O
Africa NNP O
. . O

The DT O
in IN O
situ JJ O
location NN O
of IN O
all DT O
three CD O
probes NNS O
is VBZ O
9q13 CD O
- : O
- : O
- : O
- : O
q21 NN O
. . O

In IN O
addition NN O
, , O
two CD O
mutations NNS O
, , O
( ( O
G1496 NNP O
to TO O
A NNP O
in IN O
exon JJ O
13 CD O
and CC O
a DT O
4 CD O
- : O
bp NN O
insertion NN O
in IN O
exon $ O
11 CD O
) ) O
that WDT O
have VBP O
previously RB O
been VBN O
reported VBN O
were VBD O
identified VBN O
. . O
. . O

Mapping NN O
of IN O
the DT O
deletion NN O
endpoints NNS O
in IN O
these DT O
four CD O
patients NNS O
and CC O
in IN O
another DT O
11 CD O
male NN O
patients NNS O
with IN O
sizeable JJ O
deletions NNS O
enabled VBD O
us PRP O
to TO O
construct VB O
a DT O
very RB O
detailed JJ O
map NN O
of IN O
intervals NNS O
2 CD O
and CC O
3 CD O
of IN O
Xq21 NN O
. . O

Tumor NNP O
tissue NN O
obtained VBN O
from IN O
the DT O
propositus NN O
with IN O
the DT O
seminoma NN B-Disease
revealed VBD O
loss NN O
of IN O
heterozygosity NN O
in IN O
the DT O
TP53 NNP O
gene NN O
. . O

The DT O
patients NNS O
serum VBP O
lacked VBD O
the DT O
85 CD O
kDa NN O
C7 NNP O
chain NN O
. . O

Mutations NNS O
that WDT O
alter VBP O
splice NN O
sites NNS O
led VBD O
to TO O
the DT O
synthesis NN O
of IN O
several JJ O
types NNS O
of IN O
mRNAs NN O
, , O
a DT O
fraction NN O
of IN O
which WDT O
represented VBD O
the DT O
normally RB O
spliced JJ O
product NN O
. . O

No DT O
mutations NNS O
at IN O
the DT O
Hprt NNP O
locus NN O
leading VBG O
to TO O
loss NN O
of IN O
activity NN O
have VBP O
been VBN O
described VBN O
in IN O
laboratory NN O
animals NNS O
. . O

Patients NNS O
excrete VBP O
large JJ O
amounts NNS O
of IN O
homogentisic JJ O
acid NN O
in IN O
their PRP$ O
urine NN O
and CC O
a DT O
black JJ O
ochronotic JJ O
pigment NN O
is VBZ O
deposited VBN O
in IN O
their PRP$ O
cartilage NN O
and CC O
collagenous JJ O
tissues NNS O
. . O

Genetic JJ O
heterogeneity NN O
at IN O
the DT O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
locus NN O
in IN O
southern JJ O
Italy NNP O
: : O
a DT O
study NN O
on IN O
a DT O
population NN O
from IN O
the DT O
Matera NNP O
district NN O
. . O

A DT B-Disease
- : I-Disease
T NN I-Disease
heterozygotes NNS O
may MD O
comprise VB O
more JJR O
than IN O
5 CD O
% NN O
of IN O
all DT O
persons NNS O
dying VBG O
from IN O
a DT O
cancer NN B-Disease
before IN O
age NN O
45 CD O
. . O

This DT O
is VBZ O
the DT O
first JJ O
population NN O
- : O
based VBN O
ovarian JJ B-Disease
cancer NN I-Disease
study NN O
reporting VBG O
BRCA1 NNP O
alterations NNS O
derived VBD O
from IN O
a DT O
comprehensive JJ O
screen NN O
of IN O
the DT O
entire JJ O
coding NN O
region NN O
. . O

Here RB O
, , O
we PRP O
characterize VBP O
the DT O
altered JJ O
effects NNS O
of IN O
a DT O
human JJ O
beta NN O
( ( O
1 CD O
) ) O
- : O
subunit NN O
( ( O
hbeta NN O
( ( O
1 CD O
) ) O
) ) O
on IN O
the DT O
heterologously RB O
expressed VBN O
hH1 NN O
mutation NN O
( ( O
T1620M NNP O
) ) O
previously RB O
associated VBN O
with IN O
IVF NNP B-Disease
. . O

A DT O
40 CD O
- : O
year NN O
- : O
old JJ O
man NN O
with IN O
childhood NN O
- : O
onset NN O
Tourette NNP B-Disease
syndrome NN I-Disease
( ( O
TS NNP B-Disease
) ) O
developed VBD O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
. . O

Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
associated VBN O
with IN O
an DT O
expanded VBN O
CAG NNP O
repeat NN O
within IN O
a DT O
novel JJ O
gene NN O
on IN O
4p16 CD O
. . O

The DT O
linkage NN O
analysis NN O
also RB O
provides VBZ O
data NNS O
on IN O
the DT O
frequency NN O
of IN O
recombination NN O
along IN O
the DT O
short JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
, , O
and CC O
across IN O
the DT O
centromeric JJ O
region NN O
. . O
. . O

MEFV NNP O
was VBD O
also RB O
expressed VBN O
in IN O
the DT O
monocytic JJ O
cell NN O
lines NNS O
U937 NNP O
and CC O
THP NNP O
- : O
1 CD O
. . O

The DT O
patients NNS O
fibroblasts NNS O
were VBD O
even RB O
more RBR O
efficient JJ O
in IN O
the DT O
metabolism NN O
of IN O
8 CD O
- : O
14C CD O
- : O
guanine NN O
, , O
which WDT O
was VBD O
utilized VBN O
to TO O
the DT O
extent NN O
of IN O
27 CD O
% NN O
, , O
over IN O
80 CD O
% NN O
of IN O
which WDT O
was VBD O
converted VBN O
to TO O
guanine VB O
and CC O
adenine VB O
nucleotides NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
report VBP O
the DT O
use NN O
of IN O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
( ( O
FISH NNP O
) ) O
as IN O
a DT O
method NN O
to TO O
detect VB O
and CC O
characterize VB O
VHL NNP B-Disease
germline JJ O
deletions NNS O
. . O

Three CD O
children NNS O
are VBP O
reported VBN O
with IN O
typical JJ O
cat NN B-Disease
eye NN I-Disease
syndrome NN I-Disease
( ( O
CES NNP B-Disease
) ) O
and CC O
three CD O
more JJR O
children NNS O
with IN O
partial JJ O
CES NNP B-Disease
because IN O
of IN O
absence NN O
of IN O
coloboma NN O
, , O
in IN O
which WDT O
the DT O
supernumerary NN O
marker NN O
chromosome NN O
was VBD O
studied VBN O
by IN O
FISH NNP O
. . O

The DT O
extent NN O
of IN O
these DT O
duplications NNS O
has VBZ O
been VBN O
characterized VBN O
according VBG O
to TO O
the DT O
published VBN O
exon SYM O
- : O
containing VBG O
HindIII NNP O
fragment NN O
map NN O
, , O
and CC O
in IN O
six CD O
of IN O
the DT O
10 CD O
duplications NNS O
a DT O
novel JJ O
restriction NN O
fragment NN O
that WDT O
spanned VBD O
the DT O
duplication NN O
junction NN O
was VBD O
detected VBN O
. . O

The DT O
clinical JJ O
features NNS O
of IN O
eight CD O
cases NNS O
with IN O
15q11 CD O
- : O
12 CD O
deletion NN O
were VBD O
very RB O
similar JJ O
to TO O
those DT O
originally RB O
described VBN O
in IN O
PWS NNP B-Disease
. . O

A DT O
high JJ O
percentage NN O
of IN O
ATM NNP O
germline NN O
mutations NNS O
was VBD O
demonstrated VBN O
among IN O
patients NNS O
with IN O
sporadic JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
. . O

ERGs NNS O
were VBD O
recorded VBN O
in IN O
anesthetized JJ O
mdx NN O
and CC O
control NN O
mice NN O
with IN O
a DT O
modified JJ O
Grass NNP O
photostimulator NN O
( ( O
Grass NNP O
Instrument NNP O
Company NNP O
, , O
Quincy NNP O
, , O
MA NNP O
) ) O
. . O

Familial JJ B-Disease
hypobetalipoproteinemia NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
codominant NN I-Disease
disorder NN I-Disease
resulting VBG O
in IN O
a DT O
dramatic JJ O
reduction NN O
in IN O
plasma JJ O
concentrations NNS O
of IN O
apolipoprotein NN O
( ( O
apo NN O
) ) O
B NNP O
, , O
cholesterol NN O
, , O
and CC O
beta SYM O
- : O
migrating NN O
lipoproteins NNS O
. . O

The DT O
three CD O
glycine NN O
- : O
and CC O
arginine VB O
- : O
rich JJ O
motifs NNS O
of IN O
the DT O
gene NN O
are VBP O
mainly RB O
encoded VBN O
by IN O
exons NNS O
8 CD O
- : O
9 CD O
, , O
14 CD O
, , O
and CC O
16 CD O
. . O

Frequent JJ O
detection NN O
of IN O
codon NN O
877 CD O
mutation NN O
in IN O
the DT O
androgen NN O
receptor NN O
gene NN O
in IN O
advanced JJ B-Disease
prostate NN I-Disease
cancers NNS I-Disease
. . O

Direct JJ O
repeats NNS O
were VBD O
present JJ O
at IN O
the DT O
breakpoint NN O
junctions NNS O
in IN O
the DT O
majority NN O
of IN O
deletions NNS O
, , O
supporting VBG O
a DT O
slipped JJ O
- : O
mispairing NN O
mechanism NN O
. . O

Restriction NNP O
digestion NN O
following VBG O
PCR NNP O
amplification NN O
of IN O
ARG1 NNP O
exon FW O
2 CD O
confirmed VBD O
the DT O
presence NN O
of IN O
the DT O
mutation NN O
. . O

2 CD O
Mb NNP O
. . O

About RB O
98 CD O
% NN O
of IN O
mutant JJ O
alleles NNS O
have VBP O
an DT O
expansion NN O
of IN O
a DT O
GAA NNP O
trinucleotide NN O
repeat NN O
in IN O
intron NN O
1 CD O
of IN O
the DT O
gene NN O
. . O

We PRP O
observed VBD O
a DT O
significant JJ O
correlation NN O
between IN O
the DT O
location NN O
of IN O
the DT O
mutation NN O
in IN O
the DT O
gene NN O
and CC O
the DT O
ratio NN O
of IN O
breast NN B-Disease
to TO I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
incidence NN O
within IN O
each DT O
family NN O
. . O

This DT O
pattern NN O
corresponds VBZ O
to TO O
mutations NNS O
leading VBG O
mainly RB O
to TO O
truncated JJ O
proteins NNS O
with IN O
few JJ O
specific JJ O
missense NN O
mutations NNS O
. . O

We PRP O
report VBP O
here RB O
a DT O
detailed JJ O
characterization NN O
of IN O
the DT O
ALD NNP B-Disease
gene NN O
structure NN O
. . O

While IN O
the DT O
WASP NNP O
gene NN O
defects NNS O
responsible JJ O
for IN O
isolated JJ B-Disease
thrombocytopenia NN I-Disease
and CC O
other JJ O
mild JJ O
presentations NNS O
of IN O
WAS NNP B-Disease
do VBP O
not RB O
appear VB O
distinct JJ O
from IN O
those DT O
resulting VBG O
in IN O
severe NN O
WAS NNP B-Disease
, , O
these DT O
data NNS O
indicate VBP O
that IN O
analysis NN O
of IN O
WASP NNP O
gene NN O
mutation NN O
provides VBZ O
a DT O
valuable JJ O
tool NN O
for IN O
distinguishing VBG O
the DT O
spectrum NN O
of IN O
WAS NNP B-Disease
patients NNS O
and CC O
the DT O
subset NN O
of IN O
males NNS O
with IN O
isolated JJ B-Disease
thrombocytopenia NN I-Disease
who WP O
represent VBP O
mild JJ O
cases NNS O
of IN O
WAS NNP B-Disease
. . O
. . O

Here RB O
we PRP O
report VBP O
that IN O
a DT O
single JJ O
molecular NN O
defect NN O
- : O
- : O
a DT O
deletion NN O
spanning VBG O
the DT O
third JJ O
exon NN O
of IN O
the DT O
PAH NNP O
gene NN O
- : O
- : O
is VBZ O
responsible JJ O
for IN O
all PDT O
the DT O
PKU NNP B-Disease
cases NNS O
among IN O
the DT O
Yemenite NNP O
Jews NNPS O
. . O

Ninety NNP O
- : O
four CD O
Chinese JJ O
males NNS O
with IN O
G6PD NNP B-Disease
deficiency NN I-Disease
were VBD O
studied VBN O
. . O

Subcellular JJ O
localization NN O
of IN O
huntingtin NN O
is VBZ O
consistent JJ O
with IN O
a DT O
cytosolic JJ O
protein NN O
primarily RB O
found VBN O
in IN O
somatodendritic JJ O
regions NNS O
. . O

HFE NNP O
- : O
/ SYM O
- : O
mice NN O
also RB O
demonstrated VBD O
an DT O
increase NN O
in IN O
duodenal JJ O
DMT1 NNP O
( ( O
IRE NNP O
) ) O
mRNA NN O
( ( O
average JJ O
7 CD O
. . O
7 CD O
- : O
fold NN O
) ) O
, , O
despite IN O
their PRP$ O
elevated JJ O
transferrin NN O
saturation NN O
and CC O
hepatic JJ O
iron NN O
content NN O
. . O

Two CD O
novel JJ O
nonsense JJ O
mutations NNS O
led VBD O
to TO O
the DT O
loss NN O
of IN O
mutant JJ O
BRCA1 NNP O
transcript NN O
in IN O
families NNS O
with IN O
10 CD O
and CC O
6 CD O
cases NNS O
of IN O
early JJ O
- : O
onset NN O
breast NN B-Disease
cancer NN I-Disease
and CC O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

The DT O
fragile JJ O
site NN O
is VBZ O
not RB O
associated VBN O
with IN O
mental JJ B-Disease
retardation NN I-Disease
, , O
it PRP O
does VBZ O
not RB O
give VB O
abnormal JJ O
results NNS O
when WRB O
subjected VBN O
to TO O
Southern NNP O
analysis NN O
with IN O
probe NN O
pfxa3 NN O
which WDT O
detects VBZ O
the DT O
unstable JJ O
DNA NNP O
sequence NN O
characteristic NN O
of IN O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
. . O

The DT O
substitutions NNS O
found VBD O
at IN O
cDNA NN O
392 CD O
and CC O
cDNA NN O
1024 CD O
are VBP O
new JJ O
findings NNS O
. . O

Experimental JJ O
inhibition NN O
of IN O
BRCA1 NNP O
expression NN O
with IN O
antisense JJ O
oligonucleotides NNS O
produced VBD O
accelerated JJ O
growth NN O
of IN O
normal JJ O
and CC O
malignant JJ O
mammary JJ O
cells NNS O
, , O
but CC O
had VBD O
no DT O
effect NN O
on IN O
non JJ O
- : O
mammary JJ O
epithelial JJ O
cells NNS O
. . O

In IN O
view NN O
of IN O
the DT O
small JJ O
number NN O
of IN O
CTX NNP B-Disease
patients NNS O
diagnosed VBD O
in IN O
the DT O
world NN O
( ( O
a DT O
total NN O
of IN O
50 CD O
including VBG O
our PRP$ O
6 CD O
patients NNS O
) ) O
, , O
we PRP O
are VBP O
probably RB O
dealing VBG O
with IN O
an DT O
ethnic JJ O
subgroup NN O
with IN O
a DT O
high JJ O
CTX NNP O
gene NN O
frequency NN O
, , O
which WDT O
we PRP O
have VBP O
estimated VBN O
to TO O
be VB O
1 CD O
/ JJ O
108 CD O
. . O

Three CD O
of IN O
these DT O
patients NNS O
had VBD O
pure JJ O
spinal JJ B-Disease
SEP NNP I-Disease
abnormalities NNS I-Disease
and CC O
in IN O
the DT O
remaining VBG O
two CD O
patients NNS O
SEPs VBP O
showed JJ O
signs NNS O
of IN O
involvement NN O
of IN O
both CC O
the DT O
spinal NN O
and CC O
cerebral JJ O
somatosensory NN O
tracts NNS O
. . O

Skewed NNP O
X NNP O
inactivation NN O
in IN O
a DT O
female JJ O
MZ NNP O
twin NN O
results NNS O
in IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

Germline NNP O
mutations NNS O
of IN O
the DT O
Brca1 NNP O
tumor NN B-Disease
suppressor NN O
gene NN O
predispose JJ O
women NNS O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
. . O

The DT O
two CD O
HL NNP O
- : O
A DT O
haplotypes NNS O
closely RB O
linked VBN O
to TO O
C2 NNP B-Disease
deficiency NN I-Disease
are VBP O
different JJ O
2 CD O
, , O
W18 NNP O
and CC O
W24 NNP O
, , O
W18 NNP O
. . O

These DT O
percentages NNS O
differ VBP O
significantly RB O
from IN O
previous JJ O
reports NNS O
, , O
in IN O
which WDT O
25 CD O
to TO O
28 CD O
% NN O
of IN O
the DT O
patients NNS O
developed VBD O
AMN NNP B-Disease
and CC O
53 CD O
to TO O
57 CD O
% NN O
CCALD NNP B-Disease
or CC O
AdolCALD NNP B-Disease
. . O

The DT O
pedigree NN O
and CC O
clinical JJ O
findings NNS O
were VBD O
compatible JJ O
with IN O
autosomal JJ O
recessive JJ O
transmission NN O
of IN O
analbuminemia NN B-Disease
. . O

As IN O
part NN O
of IN O
a DT O
strategy NN O
to TO O
clone VB O
the DT O
HD NNP B-Disease
gene NN O
on IN O
the DT O
basis NN O
of IN O
its PRP$ O
chromosomal JJ O
location NN O
, , O
we PRP O
isolated VBD O
genomic JJ O
DNA NN O
from IN O
the DT O
HD NNP B-Disease
region NN O
as IN O
a DT O
set NN O
of IN O
overlapping VBG O
yeast JJ O
artificial JJ O
chromosome NN O
( ( O
YAC NNP O
) ) O
clones NNS O
. . O

The DT O
gene NN O
for IN O
human JJ O
apolipoprotein NN O
C2 NNP O
( ( O
APOC2 NNP O
) ) O
, , O
situated VBN O
on IN O
the DT O
proximal NN O
long JJ O
arm NN O
of IN O
chromosome NN O
19 CD O
, , O
is VBZ O
closely RB O
linked VBN O
to TO O
the DT O
gene NN O
for IN O
the DT O
most RBS O
common JJ O
form NN O
of IN O
adult NN O
muscular JJ B-Disease
dystrophy NN I-Disease
, , O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
. . O

No DT O
impairment NN B-Disease
of IN I-Disease
cellular JJ I-Disease
immunity NN I-Disease
or CC O
immunoglobulin JJ B-Disease
deficiency NN I-Disease
could MD O
be VB O
found VBN O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
pendrin JJ O
functions NNS O
as IN O
a DT O
transporter NN O
of IN O
chloride NN O
and CC O
iodide NN O
, , O
but CC O
not RB O
sulfate VB O
, , O
and CC O
may MD O
provide VB O
insight NN O
into IN O
thyroid JJ O
physiology NN O
and CC O
the DT O
pathophysiology NN O
of IN O
Pendred NNP B-Disease
syndrome NN I-Disease
. . O
. . O

In IN O
the DT O
third JJ O
group NN O
, , O
no DT O
gene NN O
deletions NNS O
could MD O
be VB O
detected VBN O
. . O

The DT O
gene NN O
Prph2 NNP O
encodes VBZ O
a DT O
photoreceptor NN O
- : O
specific JJ O
membrane NN O
glycoprotein NN O
, , O
peripherin SYM O
- : O
2 CD O
( ( O
also RB O
known VBN O
as IN O
peripherin NN O
/ NNP O
rds NNS O
) ) O
, , O
which WDT O
is VBZ O
inserted VBN O
into IN O
the DT O
rims NNS O
of IN O
photoreceptor NN O
outer NN O
segment NN O
discs NN O
in IN O
a DT O
complex JJ O
with IN O
rom NN O
- : O
1 CD O
( ( O
ref NN O
. . O
2 CD O
) ) O
. . O

We PRP O
then RB O
tested VBD O
six CD O
phenotypically RB O
normal JJ O
offspring VBG O
from IN O
four CD O
of IN O
these DT O
VHL NNP B-Disease
families NNS O
two CD O
were VBD O
found VBN O
to TO O
carry VB O
the DT O
deletion NN O
and CC O
the DT O
other JJ O
four CD O
were VBD O
deletion NN O
- : O
free JJ O
. . O

apoB NN O
DNA NNP O
, , O
RNA NNP O
, , O
and CC O
protein RB O
from IN O
two CD O
patients NNS O
with IN O
homozygous JJ B-Disease
hypobetalipoproteinemia NN I-Disease
( ( O
HBL NNP B-Disease
) ) O
were VBD O
evaluated VBN O
and CC O
compared VBN O
with IN O
normal JJ O
individuals NNS O
. . O

Ataxia NNP B-Disease
- : I-Disease
telangiectasia NN I-Disease
is VBZ O
a DT O
hereditary JJ B-Disease
multisystemic JJ I-Disease
disease NN I-Disease
resulting VBG O
from IN O
mutations NNS O
of IN O
ataxia NN B-Disease
telangiectasia NN I-Disease
, , O
mutated VBN O
( ( O
ATM NNP O
) ) O
and CC O
is VBZ O
characterized VBN O
by IN O
neurodegeneration NN B-Disease
, , O
cancer NN B-Disease
, , O
immune JJ B-Disease
defects NNS I-Disease
, , O
and CC O
hypersensitivity NN B-Disease
to TO I-Disease
ionizing VBG I-Disease
radiation NN I-Disease
. . O

Pedigree NNP O
data NNS O
suggest VBP O
that IN O
this DT O
mutation NN O
has VBZ O
been VBN O
in IN O
the DT O
Cajun NNP O
population NN O
since IN O
its PRP$ O
founding NN O
over IN O
2 CD O
centuries NNS O
ago RB O
and CC O
that IN O
it PRP O
may MD O
be VB O
widely RB O
distributed VBN O
within IN O
the DT O
population NN O
. . O

Some DT O
patients NNS O
have VBP O
only RB O
palmoplantar JJ B-Disease
keratosis NN I-Disease
or CC O
periodontitis NN B-Disease
, , O
and CC O
in IN O
rare JJ O
individuals NNS O
the DT O
periodontitis NN B-Disease
is VBZ O
mild JJ O
and CC O
of IN O
late JJ O
onset NN O
. . O

Further JJ O
evidence NN O
for IN O
heterogeneity NN O
of IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
in IN O
Papua NNP O
New NNP O
Guinea NNP O
. . O

Fifteen NNP O
missense NN O
mutations NNS O
and CC O
two CD O
newly RB O
engineered VBN O
active JJ O
site NN O
mutations NNS O
( ( O
C79S NNP O
, , O
C79T NNP O
) ) O
were VBD O
characterized VBN O
by IN O
transient JJ O
expression NN O
analysis NN O
. . O

2 CD O
2 CD O
. . O

Sequencing VBG O
of IN O
amplified JJ O
cDNA NN O
fragments NNS O
revealed VBD O
a DT O
single JJ O
alteration NN O
, , O
guanine NN O
to TO O
adenine VB O
at IN O
nt JJ O
749 CD O
creating VBG O
a DT O
G250D NNP O
mutation NN O
. . O

Molecular JJ O
detection NN O
of IN O
chromosomal JJ O
translocations NNS O
that WDT O
disrupt VBP O
the DT O
putative JJ O
retinoblastoma NN B-Disease
susceptibility NN O
locus NN O
. . O

On IN O
the DT O
mechanisms NNS O
of IN O
the DT O
development NN O
of IN O
tolerance NN O
to IN O
the DT O
muscular JJ O
rigidity NN O
produced VBN O
by IN O
morphine NN B-Chemical
in IN O
rats NNS O
. . O

Both DT O
compounds NNS O
caused VBD O
deformations NNS O
and CC O
lethality NN O
in IN O
a DT O
dose NN O
- HYPH O
dependent JJ O
manner NN O
. . O

A DT O
detailed JJ O
clinical JJ O
history NN O
, , O
together RB O
with IN O
skin NN O
tests NNS O
, , O
RAST NNP O
( , O
radioallergosorbent NN O
test NN O
) -RRB- O
, , O
and CC O
controlled VBN O
challenge NN O
tests NNS O
, , O
was VBD O
used VBN O
to TO O
establish VB O
whether IN O
patients NNS O
allergic JJ O
to IN O
beta JJ B-Chemical
- HYPH I-Chemical
lactam NN I-Chemical
antibiotics NNS O
had VBD O
selective JJ O
immediate JJ O
allergic JJ O
responses NNS O
to IN O
amoxicillin NN B-Chemical
( , O
AX NNP B-Chemical
) -RRB- O
or CC O
were VBD O
cross NN O
- HYPH O
reacting VBG O
with IN O
other JJ O
penicillin NN B-Chemical
derivatives NNS O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
whether IN O
autophagy NN O
was VBD O
involved VBN O
in IN O
the DT O
progression NN O
of IN O
heart NN O
failure NN O
induced VBN O
by IN O
adriamycin NN B-Chemical
, , O
so IN O
that IN O
we PRP O
can MD O
develop VB O
a DT O
novel JJ O
treatment NN O
strategy NN O
for IN O
heart NN O
failure NN O
. . O

CONCLUSION NN O
: : O
Toxic JJ O
hepatitis NN O
is VBZ O
a DT O
potential JJ O
adverse JJ O
effect NN O
of IN O
antithyroid JJ O
drugs NNS O
which WDT O
warrants VBZ O
, , O
as IN O
for IN O
haematological JJ O
disturbances NNS O
, , O
a DT O
pre JJ O
- HYPH O
therapeutic JJ O
determination NN O
and CC O
a DT O
careful JJ O
follow NN O
- HYPH O
up NN O
of IN O
relevant JJ O
biological JJ O
markers NNS O
. . O

Renal JJ O
damage NN O
as IN O
reflected VBN O
by IN O
an DT O
increase NN O
in IN O
serum NN O
urea NN B-Chemical
and CC O
in IN O
kidney NN O
weight NN O
was VBD O
prevented VBN O
by IN O
Captopril NNP B-Chemical
. . O

A DT O
prospective JJ O
, , O
randomized VBN O
study NN O
was VBD O
conducted VBN O
to TO O
evaluate VB O
the DT O
role NN O
of IN O
vitamin NN B-Chemical
B12 NN I-Chemical
and CC O
folinic JJ B-Chemical
acid NN I-Chemical
supplementation NN O
in IN O
preventing VBG O
zidovudine NN B-Chemical
( -LRB- O
ZDV NNP B-Chemical
) -RRB- O
- HYPH O
induced VBN O
bone NN O
marrow NN O
suppression NN O
. . O

Because IN O
DTIs NNS O
do VBP O
not RB O
have VB O
reversal JJ O
agents NNS O
, , O
surgical JJ O
teams NNS O
and CC O
transfusion NN O
services NNS O
should MD O
remain VB O
aware JJ O
of IN O
the DT O
possibility NN O
of IN O
massive JJ O
transfusion NN O
events NNS O
during IN O
anticoagulation NN O
with IN O
these DT O
agents NNS O
. . O

RESULTS NNS O
: : O
Among IN O
593 CD O
patients NNS O
with IN O
cerebral JJ O
haemorrhage NN O
, , O
59 CD O
( SYM O
10 CD O
% NN O
) CD O
were VBD O
assessed VBN O
as IN O
related VBN O
to IN O
warfarin JJ B-Chemical
treatment NN O
. . O

Lastly RB O
, , O
we PRP O
measured VBD O
PRL NN O
- HYPH O
R NN O
and CC O
suppressor NN O
of IN O
cytokine NN O
signaling NN O
( , O
SOCS NN O
- HYPH O
1 CD O
and CC O
- HYPH O
3 CD O
and CC O
CIS NN O
, , O
which WDT O
reflect VBP O
the DT O
level NN O
of IN O
prolactin NN O
signaling NN O
) , O
mRNAs NNS O
in IN O
response NN O
to IN O
sulpiride NN B-Chemical
and CC O
estradiol NN B-Chemical
. . O

The DT O
results NNS O
evinced VBD O
no DT O
enhancement NN O
of IN O
the DT O
hepatocarcinogenicity NN O
of IN O
the DT O
choline NN B-Chemical
- HYPH O
devoid JJ O
diet NN O
by IN O
phenobarbital NN B-Chemical
. . O

BACKGROUND NN O
: : O
The DT O
widespread JJ O
use NN O
of IN O
benzodiazepines NNS B-Chemical
has VBZ O
led VBN O
to IN O
increasing VBG O
recognition NN O
of IN O
their PRP$ O
unwanted JJ O
effects NNS O
. . O

During IN O
activation NN O
with IN O
Na NNP B-Chemical
+ CC O
, , O
the DT O
Vmax NNP O
remained VBD O
unchanged JJ O
, , O
however RB O
the DT O
K NNP B-Chemical
( , O
Na NNP B-Chemical
) -RRB- O
increased VBD O
by IN O
50 CD O
% NN O
, , O
indicating VBG O
a DT O
profound JJ O
decrease NN O
in IN O
the DT O
affinity NN O
of IN O
the DT O
Na NNP B-Chemical
+ NN O
- HYPH O
binding VBG O
site NN O
in IN O
NO NNP B-Chemical
- HYPH O
deficient JJ O
rats NNS O
. . O

The DT O
aims NNS O
of IN O
this DT O
study NN O
were VBD O
to TO O
confirm VB O
our PRP$ O
previous JJ O
findings NNS O
in IN O
a DT O
separate JJ O
cohort NN O
of IN O
patients NNS O
and CC O
to TO O
determine VB O
the DT O
time NN O
course NN O
of IN O
the DT O
cardiovascular JJ O
consequences NNS O
of IN O
stopping VBG O
selegiline NN B-Chemical
in IN O
the DT O
expectation NN O
that IN O
this DT O
might MD O
shed VB O
light NN O
on IN O
the DT O
mechanisms NNS O
by IN O
which WDT O
the DT O
drug NN O
causes VBZ O
orthostatic JJ O
hypotension NN O
. . O

However RB O
, , O
the DT O
level NN O
in IN O
the DT O
AS NNP O
/ SYM O
KS NNP O
group NN O
remained VBD O
considerably RB O
lower JJR O
than IN O
in IN O
the DT O
A NNP O
group NN O
. . O

The DT O
65 CD O
dogs NNS O
in IN O
the DT O
study NN O
received VBD O
injections NNS O
in IN O
the DT O
subarachnoid NN O
space NN O
as IN O
follows VBZ O
: : O
6 CD O
to TO O
8 CD O
ml NNS O
of IN O
bupivacaine NN B-Chemical
( , O
N NNP O
= SYM O
15 CD O
) -RRB- O
, , O
2 CD B-Chemical
- HYPH I-Chemical
chloroprocaine NN I-Chemical
- HYPH I-Chemical
CE NN I-Chemical
( , O
N NNP O
= SYM O
20 CD O
) -RRB- O
, , O
low JJ O
pH NN O
normal JJ O
saline NN O
( , O
pH NN O
3 CD O
. . O
0 CD O
) -RRB- O
( , O
N CD O
= SYM O
20 CD O
) -RRB- O
, , O
or CC O
normal JJ O
saline NN O
( HYPH O
N NNP O
= SYM O
10 CD O
) -RRB- O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
Li NNP B-Chemical
- HYPH O
induced VBN O
nephropathy NN O
, , O
even RB O
when WRB O
the DT O
GFR NNP O
is VBZ O
only RB O
modestly RB O
reduced VBN O
, , O
is VBZ O
associated VBN O
with IN O
proteinuria NN O
and CC O
arterial JJ O
systolic JJ O
hypertension NN O
. . O

Therefore RB O
the DT O
prophylactic JJ O
use NN O
of IN O
granulocyte NN O
- HYPH O
colony NN O
stimulating VBG O
factor NN O
should MD O
be VB O
considered VBN O
with IN O
this DT O
treatment NN O
. . O

Unlike IN O
DFU NNP B-Chemical
, , O
piroxicam NN B-Chemical
was VBD O
also RB O
highly RB O
toxic JJ O
to IN O
the DT O
dams NNS O
. . O

Low JJ O
- HYPH O
dose NN O
PDTC NNP B-Chemical
treatment NN O
almost RB O
completely RB O
protected VBN O
from IN O
lesions NNS O
in IN O
the DT O
piriform NN O
cortex NN O
. . O

Early JJ O
onset NN O
migraine NN O
attacks NNS O
were VBD O
induced VBN O
by IN O
nitroglycerin NN B-Chemical
in IN O
seven CD O
out IN O
of IN O
10 CD O
patients NNS O
versus IN O
no DT O
patient NN O
in IN O
the DT O
placebo NN O
group NN O
. . O

Pathologically RB O
, , O
granular JJ O
cytoplasmic JJ O
changes NNS O
were VBD O
found VBN O
in IN O
cardiac JJ O
myocytes NNS O
, , O
indicating VBG O
enlarged VBN O
, , O
damaged VBN O
mitochondria NN O
. . O

There EX O
was VBD O
no DT O
correlation NN O
between IN O
vitamin NN B-Chemical
B12 NN I-Chemical
or CC O
folate NN B-Chemical
levels NNS O
and CC O
development NN O
of IN O
myelosuppression NN O
. . O

These DT O
parameters NNS O
remained VBD O
unchanged JJ O
in IN O
controls NNS O
. . O

A DT O
comprehensive JJ O
examination NN O
including VBG O
her PRP$ O
medical JJ O
history NN O
, , O
panoramic JJ O
radiograph NN O
, , O
and CC O
intraoral JJ O
examination NN O
revealed VBD O
19 CD O
carious JJ O
lesions NNS O
, , O
which WDT O
is VBZ O
not RB O
very RB O
common JJ O
for IN O
a DT O
healthy JJ O
adult NN O
. . O

Twenty CD O
- HYPH O
three CD O
of IN O
the DT O
patients NNS O
had VBD O
previously RB O
taken VBN O
appetite NN B-Chemical
suppressants NNS I-Chemical
, , O
mainly RB O
fenfluramines NNS B-Chemical
, , O
as IN O
compared VBN O
with IN O
only RB O
5 CD O
of IN O
the DT O
controls NNS O
( : O
66 CD O
versus IN O
6 CD O
% NN O
, , O
p NN O
< NN O
0 CD O
. . O
0001 CD O
) -RRB- O
. . O

RESULTS NNS O
: : O
Switches NNS O
to IN O
hypomania NN O
or CC O
mania NN O
occurred VBD O
in IN O
27 CD O
% NN O
of IN O
all DT O
patients NNS O
( , O
N NNP O
= SYM O
12 CD O
) -RRB- O
( , O
and CC O
in IN O
24 CD O
% NN O
of IN O
the DT O
subgroup NN O
of IN O
patients NNS O
treated VBN O
with IN O
SSRIs NNP B-Chemical
[ -LRB- O
8 CD O
/ SYM O
33 CD O
] -RRB- O
) CD O
; : O
16 CD O
% NN O
( , O
N CD O
= SYM O
7 CD O
) -RRB- O
experienced VBN O
manic JJ O
episodes NNS O
, , O
and CC O
11 CD O
% NN O
( , O
N NN O
= SYM O
5 CD O
) -RRB- O
experienced VBD O
hypomanic JJ O
episodes NNS O
. . O

The DT O
protective JJ O
effect NN O
of IN O
LY274614 NNP B-Chemical
was VBD O
dose NN O
- HYPH O
dependent JJ O
, , O
being VBG O
maximum JJ O
at IN O
10 CD O
- SYM O
40 CD O
mgkg NNS O
( : O
i PRP O
. . O
p NN O
. . O
) -RRB- O
. . O

Thus RB O
the DT O
migraine NN O
- HYPH O
inducing VBG O
effect NN O
of IN O
nitroglycerin NN B-Chemical
seems VBZ O
to TO O
depend VB O
on IN O
direct JJ O
stimulation NN O
of IN O
the DT O
habitual JJ O
site NN O
of IN O
pain NN O
, , O
suggesting VBG O
that IN O
the DT O
frontotemporal JJ O
region NN O
is VBZ O
of IN O
crucial JJ O
importance NN O
in IN O
the DT O
development NN O
of IN O
a DT O
migraine NN O
crisis NN O
. . O

In IN O
four CD O
patients NNS O
, , O
the DT O
arrhythmia NN O
was VBD O
rapidly RB O
diagnosed VBN O
and CC O
treated VBN O
with IN O
disappearance NN O
of IN O
further JJ O
episodes NNS O
of IN O
the DT O
arrhythmia NN O
. . O

Uni NN O
- HYPH O
and CC O
multivariate JJ O
analyses NNS O
were VBD O
used VBN O
to TO O
test VB O
the DT O
influence NN O
of IN O
the DT O
clinical JJ O
variables NNS O
: : O
age NN O
, , O
sex NN O
, , O
stroke NN O
, , O
myocardiopathy NN O
( , O
MP NN O
) -RRB- O
, , O
duration NN O
of IN O
the DT O
test NN O
, , O
mitral NN O
regurgitation NN O
( , O
MR NN O
) -RRB- O
and CC O
the DT O
MZ NNP B-Chemical
dose NN O
. . O

In IN O
Dahl NNP O
salt NN B-Chemical
- HYPH O
sensitive JJ O
rats NNS O
( , O
DS NNP O
) -RRB- O
, , O
high JJ O
- HYPH O
salt NN B-Chemical
( -LRB- O
HS NN O
) -RRB- O
diet NN O
increases VBZ O
BP NNP O
more JJR O
in IN O
males NNS O
than IN O
females NNS O
. . O

OBJECTIVES NNS O
: : O
Given VBN O
its PRP$ O
preclinical JJ O
success NN O
for IN O
treating VBG O
substance NN O
abuse NN O
and CC O
the DT O
increased VBN O
risk NN O
of IN O
visual JJ O
field NN O
defects NNS O
( , O
VFD NNP O
) -RRB- O
associated VBN O
with IN O
cumulative JJ O
lifetime NN O
exposure NN O
, , O
we PRP O
explored VBD O
the DT O
effects NNS O
of IN O
sub NN O
- HYPH O
chronic JJ O
low JJ O
dose NN O
GVG NN B-Chemical
on IN O
cocaine NN B-Chemical
- HYPH O
induced VBN O
increases NNS O
in IN O
nucleus NN O
accumbens NNS O
( -LRB- O
NAcc NNP O
) -RRB- O
dopamine NN B-Chemical
( -LRB- O
DA NN B-Chemical
) -RRB- O
. . O

CONCLUSION NN O
: : O
Pericarditis NN O
may MD O
be VB O
the DT O
initial JJ O
manifestation NN O
of IN O
drug NN O
- HYPH O
induced VBN O
vasculitis NN O
attributable JJ O
to IN O
propylthio NN B-Chemical
- HYPH I-Chemical
uracil NN I-Chemical
therapy NN O
. . O

Effect NN O
of IN O
aspirin NN B-Chemical
on IN O
N NNP B-Chemical
- HYPH I-Chemical
[ -LRB- I-Chemical
4 CD I-Chemical
- HYPH I-Chemical
( HYPH I-Chemical
5 CD I-Chemical
- HYPH I-Chemical
nitro CD I-Chemical
- HYPH I-Chemical
2 CD I-Chemical
- HYPH I-Chemical
furyl NN I-Chemical
) NFP I-Chemical
- HYPH I-Chemical
2 CD I-Chemical
- HYPH I-Chemical
thiazolyl NN I-Chemical
] -RRB- I-Chemical
- HYPH I-Chemical
formamide NN I-Chemical
- HYPH O
induced VBN O
epithelial JJ O
proliferation NN O
in IN O
the DT O
urinary JJ O
bladder NN O
and CC O
forestomach NN O
of IN O
the DT O
rat NN O
. . O

Sirolimus NNP B-Chemical
represents VBZ O
a DT O
major JJ O
therapeutic JJ O
advance NN O
in IN O
the DT O
prevention NN O
of IN O
acute JJ O
renal JJ O
allograft NN O
rejection NN O
and CC O
chronic JJ O
allograft NN O
nephropathy NN O
. . O

Outcome NN O
improvement NN O
with IN O
more RBR O
intensive JJ O
chemotherapy NN O
has VBZ O
significantly RB O
increased VBN O
the DT O
incidence NN O
and CC O
severity NN O
of IN O
adverse JJ O
events NNS O
. . O

The DT O
correlation NN O
between IN O
neurotoxic JJ O
esterase NN O
inhibition NN O
and CC O
mipafox NN B-Chemical
- HYPH O
induced VBN O
neuropathic JJ O
damage NN O
in IN O
rats NNS O
. . O

They PRP O
had VBD O
been VBN O
taking VBG O
metronidazole NN B-Chemical
( , O
total JJ O
dosage NN O
, , O
45 CD O
- SYM O
120 CD O
g NN O
; : O
duration NN O
, , O
30 CD O
days NNS O
to IN O
2 CD O
months NNS O
) , O
to TO O
treat VB O
the DT O
infection NN O
in IN O
various JJ O
organs NNS O
. . O

Simultaneously RB O
, , O
we PRP O
found VBD O
that IN O
these DT O
two CD O
lemon NN O
essential JJ O
oil NN O
components NNS O
could MD O
inhibit VB O
acetylcholinesterase NN O
activity NN O
in IN O
vitro FW O
using VBG O
the DT O
Ellman NNP O
method NN O
. . O

Sexual JJ O
dysfunctions NNS O
were VBD O
found VBN O
to TO O
be VB O
common JJ O
among IN O
patients NNS O
and CC O
controls NNS O
, , O
the DT O
majority NN O
in IN O
both DT O
groups NNS O
reporting VBG O
one CD O
or CC O
more JJR O
dysfunctions NNS O
. . O

Reactive JJ O
oxygen NN B-Chemical
species NNS O
have VBP O
been VBN O
implicated VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
acute JJ O
puromycin NN B-Chemical
aminonucleoside NN I-Chemical
( , O
PAN NNP B-Chemical
) -RRB- O
- HYPH O
induced VBN O
nephropathy NN O
, , O
with IN O
antioxidants NNS O
significantly RB O
reducing VBG O
the DT O
proteinuria NN O
. . O

Based VBN O
on IN O
these DT O
data NNS O
, , O
it PRP O
can MD O
be VB O
postulated VBN O
that IN O
( : O
+ NFP O
/ SYM O
- HYPH O
) NFP O
- HYPH O
PG NN B-Chemical
- HYPH I-Chemical
9 CD I-Chemical
exerted VBD O
an DT O
antinociceptive JJ O
effect NN O
mediated VBN O
by IN O
a DT O
central JJ O
potentiation NN O
of IN O
cholinergic JJ O
transmission NN O
. . O

Ovariectomy NN O
of IN O
female JJ O
DS NN O
had VBD O
no DT O
effect NN O
on IN O
intrarenal JJ O
angiotensinogen NN O
expression NN O
on IN O
either DT O
diet NN O
. . O

Attenuation NN O
of IN O
the DT O
lithium NN B-Chemical
- HYPH O
induced VBN O
diabetes NN O
- HYPH O
insipidus NN O
- HYPH O
like JJ O
syndrome NN O
by IN O
amiloride NN B-Chemical
in IN O
rats NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
during IN O
concomitant JJ O
treatment NN O
with IN O
cinacalcet NN B-Chemical
, , O
dose NN O
adjustment NN O
may MD O
be VB O
necessary JJ O
for IN O
drugs NNS O
that WDT O
demonstrate VBP O
a DT O
narrow JJ O
therapeutic JJ O
index NN O
and CC O
are VBP O
metabolized VBN O
by IN O
CYP2D6 NNP O
. . O

The DT O
incidence NN O
of IN O
pseudolithiasis NN O
is VBZ O
not RB O
affected VBN O
by IN O
fasting VBG O
. . O

Her PRP$ O
symptoms NNS O
totally RB O
regressed VBD O
after IN O
drug NN O
withdrawal NN O
and CC O
reappeared VBD O
when WRB O
acitretin NN B-Chemical
was VBD O
reintroduced VBN O
. . O

Neurologic JJ O
toxicity NN O
was VBD O
reported VBN O
in IN O
52 CD O
% NN O
of IN O
patients NNS O
. . O

Haemodilution NN O
in IN O
groups NNS O
B NNP O
and CC O
C NN O
was VBD O
produced VBN O
by IN O
withdrawing VBG O
approximately RB O
1000 CD O
mL NN O
of IN O
blood NN O
and CC O
replacing VBG O
it PRP O
with IN O
the DT O
same JJ O
amount NN O
of IN O
dextran JJ B-Chemical
solution NN O
, , O
and CC O
final JJ O
haematocrit NN O
values NNS O
were VBD O
21 CD O
or CC O
22 CD O
% NN O
. . O

However RB O
, , O
at IN O
the DT O
end NN O
of IN O
3 CD O
weeks NNS O
, , O
amphotericin NN B-Chemical
B NN I-Chemical
levels NNS O
in IN O
the DT O
kidneys NNS O
and CC O
liver NN O
were VBD O
significantly RB O
higher JJR O
in IN O
salt NN O
- HYPH O
depleted VBN O
and CC O
normal JJ O
- HYPH O
salt NN O
rats NNS O
than IN O
those DT O
in IN O
salt NN O
- HYPH O
loaded VBN O
rats NNS O
, , O
with IN O
plasma NN O
/ SYM O
kidney NN O
ratios NNS O
of IN O
21 CD O
, , O
14 CD O
, , O
and CC O
8 CD O
in IN O
salt NN O
- HYPH O
depleted VBN O
, , O
normal JJ O
- HYPH O
salt NN O
, , O
and CC O
salt NN O
- HYPH O
loaded VBN O
rats NNS O
, , O
respectively RB O
. . O

This DT O
case NN O
highlights VBZ O
the DT O
need NN O
for IN O
adequate JJ O
labelling NN O
and CC O
regulation NN O
of IN O
such JJ O
products NNS O
. . O

AREAS NNS O
COVERED VBN O
IN IN O
THIS DT O
REVIEW NN O
: : O
This DT O
article NN O
reviews VBZ O
the DT O
pharmacology NN O
and CC O
efficacy NN O
of IN O
capecitabine NN B-Chemical
with IN O
a DT O
special JJ O
emphasis NN O
on IN O
its PRP$ O
safety NN O
. . O

Exposure NN O
to IN O
appetite NN B-Chemical
- HYPH I-Chemical
suppressants NNS I-Chemical
was VBD O
assessed VBN O
on IN O
the DT O
basis NN O
of IN O
hospital NN O
records NNS O
and CC O
standardized VBN O
interview NN O
. . O

Calcineurin NN O
- HYPH O
inhibitor NN O
induced VBN O
pain NN O
syndrome NN O
( -LRB- O
CIPS NNP O
) -RRB- O
: : O
a DT O
severe JJ O
disabling JJ O
complication NN O
after IN O
organ NN O
transplantation NN O
. . O

We PRP O
report VBP O
the DT O
case NN O
of IN O
a DT O
patient NN O
who WP O
developed VBD O
acute JJ O
hepatitis NN O
with IN O
extensive JJ O
hepatocellular JJ O
necrosis NN O
, , O
7 CD O
months NNS O
after IN O
the DT O
onset NN O
of IN O
administration NN O
of IN O
clotiazepam NN B-Chemical
, , O
a DT O
thienodiazepine NN B-Chemical
derivative NN O
. . O

BACKGROUND NN O
: : O
Although IN O
the DT O
prevalence NN O
of IN O
nonsmall JJ O
cell NN O
lung NN O
carcinoma NN O
( -LRB- O
NSCLC NNP O
) -RRB- O
is VBZ O
high JJ O
among IN O
elderly JJ O
patients NNS O
, , O
few JJ O
data NNS O
are VBP O
available JJ O
regarding VBG O
the DT O
efficacy NN O
and CC O
toxicity NN O
of IN O
chemotherapy NN O
in IN O
this DT O
group NN O
of IN O
patients NNS O
. . O

Phenylephrine NN B-Chemical
infusion NN O
increased VBD O
arterial JJ O
pressure NN O
, , O
arteriolar JJ O
diameter NN O
and CC O
clearance NN O
of IN O
fluorescent JJ O
dextran NN B-Chemical
by IN O
a DT O
similar JJ O
magnitude NN O
in IN O
both DT O
groups NNS O
. . O

The DT O
SPV NNP O
during IN O
hypotension NN O
was VBD O
15 CD O
. . O
7 CD O
+ NN O
/ SYM O
- HYPH O
6 CD O
. . O
7 CD O
mm NN O
Hg CD O
in IN O
the DT O
HEM NNP O
group NN O
, , O
compared VBN O
with IN O
9 CD O
. . O
1 CD O
+ NFP O
/ SYM O
- HYPH O
2 CD O
. . O
0 CD O
mm NN O
Hg NN O
in IN O
the DT O
SNP NNP B-Chemical
group NN O
( , O
P NN O
less JJR O
than IN O
0 CD O
. . O
02 CD O
) -RRB- O
. . O

Nine CD O
patients NNS O
with IN O
severe JJ O
pain NN O
in IN O
their PRP$ O
feet NNS O
, , O
which WDT O
was VBD O
registered VBN O
after IN O
transplantation NN O
, , O
were VBD O
investigated VBN O
. . O

Treatment NN O
for IN O
2 CD O
weeks NNS O
with IN O
Warfarin NNP B-Chemical
caused VBD O
massive JJ O
focal JJ O
calcification NN O
of IN O
the DT O
artery NN O
media NNS O
in IN O
20 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
rats NNS O
and CC O
less RBR O
extensive JJ O
focal JJ O
calcification NN O
in IN O
42 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
rats NNS O
. . O

The DT O
present JJ O
study NN O
was VBD O
designed VBN O
to TO O
evaluate VB O
the DT O
cardioprotective JJ O
potential NN O
of IN O
salvianolic NN B-Chemical
acid NN I-Chemical
A NN I-Chemical
on IN O
isoproterenol NN B-Chemical
- HYPH O
induced VBN O
myocardial JJ O
infarction NN O
in IN O
rats NNS O
. . O

Evaluation NN O
of IN O
the DT O
anticocaine JJ O
monoclonal JJ O
antibody NN O
GNC92H2 NNP B-Chemical
as IN O
an DT O
immunotherapy NN O
for IN O
cocaine NN O
overdose NN O
. . O

The DT O
primary JJ O
response NN O
variable NN O
was VBD O
based VBN O
on IN O
central JJ O
reading NN O
of IN O
24 CD O
hour NN O
ambulatory JJ O
electrocardiographic JJ O
recordings NNS O
and CC O
was VBD O
defined VBN O
as IN O
the DT O
occurrence NN O
of IN O
30 CD O
or CC O
more JJR O
single JJ O
premature JJ O
ventricular JJ O
complexes NNS O
in IN O
any DT O
two CD O
consecutive JJ O
30 CD O
minute NN O
blocks NNS O
or CC O
one CD O
or CC O
more JJR O
runs NNS O
of IN O
two CD O
or CC O
more JJR O
premature JJ O
ventricular JJ O
complexes NNS O
in IN O
the DT O
entire JJ O
24 CD O
hour NN O
electrocardiographic JJ O
recording NN O
. . O

Doses NNS O
were VBD O
set VBN O
at IN O
0 CD O
. . O
3 CD O
, , O
3 CD O
. . O
0 CD O
and CC O
30 CD O
. . O
0mg CD O
/ SYM O
kg NN O
for IN O
piroxicam NN B-Chemical
and CC O
0 CD O
. . O
2 CD O
, , O
2 CD O
. . O
0 CD O
and CC O
20 CD O
. . O
0mg CD O
/ SYM O
kg NN O
for IN O
DFU NNP B-Chemical
. . O

METHODS NNS O
: : O
One CD O
hundred CD O
and CC O
four CD O
( SYM O
104 CD O
) , O
patients NNS O
aged VBN O
6 CD O
- SYM O
35 CD O
years NNS O
( , O
mean JJ O
17 CD O
, , O
2 CD O
years NNS O
) -RRB- O
participated VBD O
in IN O
the DT O
study NN O
. . O

After IN O
a DT O
30 CD O
- HYPH O
min NN O
baseline NN O
measure NN O
of IN O
locomotor NN O
activity NN O
( , O
day NN O
0 CD O
) -RRB- O
, , O
animals NNS O
were VBD O
maintained VBN O
on IN O
a DT O
cyclic JJ O
diet NN O
of IN O
12 CD O
- HYPH O
h NN O
deprivation NN O
followed VBN O
by IN O
12 CD O
- HYPH O
h NN O
access NN O
to IN O
10 CD O
% NN O
sucrose NN B-Chemical
solution NN O
and CC O
chow NN O
pellets NNS O
( , O
12 CD O
h NN O
access NN O
starting VBG O
4 CD O
h NN O
after IN O
onset NN O
of IN O
the DT O
dark JJ O
period NN O
) -RRB- O
for IN O
21 CD O
days NNS O
. . O

Therefore RB O
, , O
certain JJ O
limitations NNS O
for IN O
malaria NN O
prophylaxis NN O
and CC O
treatment NN O
with IN O
mefloquine NN B-Chemical
are VBP O
recommended VBN O
. . O

These DT O
observations NNS O
support VBP O
the DT O
hypothesis NN O
that IN O
treatment NN O
with IN O
high JJ O
doses NNS O
of IN O
D NN B-Chemical
- HYPH I-Chemical
pen NN I-Chemical
may MD O
induce VB O
a DT O
fibroproliferative JJ O
response NN O
in IN O
rat NN O
aorta NN O
, , O
possibly RB O
by IN O
an DT O
inhibitory JJ O
effect NN O
on IN O
the DT O
cross NN O
- HYPH O
linking NN O
of IN O
collagen NN O
and CC O
elastin NN O
. . O

Levofloxacin NNP B-Chemical
, , O
a DT O
fluoroquinolone NN B-Chemical
, , O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
commonly RB O
prescribed VBN O
antibiotics NNS O
in IN O
clinical JJ O
practice NN O
and CC O
is VBZ O
effective JJ O
against IN O
Gram NNP O
- HYPH O
positive JJ O
, , O
Gram NNP O
- HYPH O
negative JJ O
, , O
and CC O
atypical JJ O
bacteria NNS O
. . O

In IN O
contrast NN O
, , O
reports NNS O
of IN O
myocardial JJ O
dysfunction NN O
due JJ O
to IN O
acute JJ O
iatrogenic JJ O
overdose NN O
are VBP O
rare JJ O
. . O

Plasma NN O
concentrations NNS O
of IN O
the DT O
drug NN O
were VBD O
estimated VBN O
by IN O
gas NN O
- HYPH O
liquid NN O
chromatography NN O
, , O
in IN O
a DT O
smaller JJR O
number NN O
of IN O
the DT O
subjects NNS O
. . O

Inflammatory JJ O
cells NNS O
are VBP O
postulated VBN O
to TO O
mediate VB O
some DT O
of IN O
the DT O
brain NN O
damage NN O
following VBG O
ischemic JJ O
stroke NN O
. . O

In IN O
7 CD O
of IN O
the DT O
18 CD O
rats NNS O
, , O
degeneration NN O
and CC O
myocyte NN O
vacuolisation NN O
were VBD O
found VBN O
. . O

These DT O
differences NNS O
may MD O
be VB O
caused VBN O
by IN O
timolol NN B-Chemical
- HYPH O
induced VBN O
bradycardia NN O
and CC O
a DT O
compensatory JJ O
increase NN O
in IN O
end NN O
- HYPH O
diastolic JJ O
volume NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
examine VB O
further RB O
the DT O
renal JJ O
function NN O
, , O
including VBG O
morphological JJ O
analysis NN O
of IN O
the DT O
kidneys NNS O
of IN O
male JJ O
Sprague NNP O
- HYPH O
Dawley NNP O
rats NNS O
treated VBN O
with IN O
either CC O
cyclosporine NN B-Chemical
A NN I-Chemical
( , O
CsA NNP B-Chemical
) -RRB- O
, , O
tacrolimus NN B-Chemical
( , O
FK506 NNP B-Chemical
) -RRB- O
or CC O
SRL NN B-Chemical
as IN O
monotherapies NNS O
or CC O
in IN O
different JJ O
combinations NNS O
. . O

We PRP O
describe VBP O
4 CD O
patients NNS O
in IN O
whom WP O
hyperkalemia NN O
ranging VBG O
from IN O
6 CD O
. . O
1 CD O
to IN O
6 CD O
. . O
9 CD O
mEq NNS O
/ SYM O
l NN O
developed VBN O
within IN O
3 CD O
to TO O
8 CD O
days NNS O
of IN O
sulindac NN B-Chemical
administration NN O
. . O

Thermal JJ O
enhancement NN O
ratios NNS O
estimated VBN O
for IN O
"""" `` O
acute JJ O
"""" '' O
hematological JJ O
changes NNS O
were VBD O
1 CD O
. . O
3 CD O
, , O
whereas IN O
those DT O
estimated VBN O
for IN O
"""" `` O
late JJ O
"""" '' O
damage NN O
( , O
based VBN O
on IN O
morphological JJ O
cardiac JJ O
and CC O
renal JJ O
lesions NNS O
) -RRB- O
varied VBD O
between IN O
2 CD O
. . O
4 CD O
and CC O
4 CD O
. . O
3 CD O
. . O

Although IN O
generally RB O
consisted VBN O
safe RB O
when WRB O
given VBN O
intramuscularly RB O
, , O
intravenous JJ O
administration NN O
is VBZ O
known VBN O
to TO O
cause VB O
respiratory JJ O
and CC O
cardiovascular JJ O
depression NN O
. . O

Serologic JJ O
evaluation NN O
revealed VBD O
the DT O
presence NN O
of IN O
perinuclear NN O
- HYPH O
staining VBG O
antineutrophil JJ O
cytoplasmic JJ O
autoantibodies NNS O
( -LRB- O
pANCA NNP O
) -RRB- O
against IN O
myeloperoxidase NN O
( , O
MPO NN O
) -RRB- O
. . O

Patients NNS O
' POS O
mean JJ O
age NN O
was VBD O
53 CD O
. . O
9 CD O
years NNS O
, , O
their PRP$ O
mean JJ O
weight NN O
was VBD O
193 CD O
. . O
9 CD O
pounds NNS O
, , O
and CC O
they PRP O
smoked VBD O
a DT O
mean NN O
of IN O
25 CD O
. . O
2 CD O
cigarettes NNS O
per IN O
day NN O
at IN O
baseline NN O
. . O

Clinical JJ O
and CC O
experimental JJ O
data NNS O
published VBN O
to IN O
date NN O
suggest VBP O
several JJ O
possible JJ O
mechanisms NNS O
by IN O
which WDT O
cocaine NN B-Chemical
may MD O
result VB O
in IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

These DT O
patients NNS O
had VBD O
Q NN O
- HYPH O
T NN O
prolongation NN O
and CC O
recurrent JJ O
syncope NN O
due IN O
to IN O
polymorphous JJ O
ventricular JJ O
tachycardia NN O
. . O

Catalepsy NN O
was VBD O
induced VBN O
by IN O
haloperidol NN B-Chemical
( , O
2 CD O
mg NN O
/ SYM O
kg NN O
p NN O
. . O
o NFP O
. . O
) -RRB- O
, , O
while IN O
apomorphine NN B-Chemical
( , O
1 CD O
. . O
5 CD O
mg NN O
/ SYM O
kg NN O
s NNS O
. . O
c NN O
. . O
) -RRB- O
and CC O
amphetamine NN B-Chemical
( , O
2 CD O
mg NNS O
/ SYM O
kg NN O
s NNS O
. . O
c NN O
. . O
) -RRB- O
were VBD O
used VBN O
for IN O
studying VBG O
climbing NN O
behavior NN O
and CC O
locomotor NN O
activities NNS O
, , O
respectively RB O
. . O

In IN O
each DT O
group NN O
, , O
SNP NNP B-Chemical
infusion NN O
resulted VBD O
in IN O
an DT O
initial JJ O
decrease NN O
in IN O
blood NN O
pressure NN O
from IN O
86 CD O
torr NN O
and CC O
83 CD O
torr NN O
, , O
respectively RB O
, , O
to IN O
48 CD O
torr NN O
. . O

Myopathy NN O
, , O
associated VBN O
in IN O
some DT O
cases NNS O
with IN O
myoglobinuria NN O
, , O
and CC O
in IN O
2 CD O
cases NNS O
with IN O
transient JJ O
renal JJ O
failure NN O
, , O
has VBZ O
been VBN O
rarely RB O
reported VBN O
with IN O
lovastatin NN B-Chemical
, , O
especially RB O
in IN O
patients NNS O
concomitantly RB O
treated VBN O
with IN O
cyclosporin NN B-Chemical
, , O
gemfibrozil NN B-Chemical
or CC O
niacin NN B-Chemical
. . O

PG NNP B-Chemical
was VBD O
well RB O
tolerated VBN O
by IN O
all DT O
54 CD O
patients NNS O
. . O

Findings NNS O
were VBD O
confirmed VBN O
ultrastructurally RB O
. . O

In IN O
the DT O
in IN O
vivo NN O
study NN O
, , O
the DT O
administration NN O
( , O
50 CD O
mg CD O
/ SYM O
kg NN O
, , O
i CD O
. . O
p NN O
. . O
) -RRB- O
of IN O
TET NNP B-Chemical
and CC O
FAN NNP B-Chemical
in IN O
mice NNS O
showed VBD O
the DT O
inhibition NN O
of IN O
thrombosis NN O
by IN O
55 CD O
% NN O
and CC O
35 CD O
% NN O
, , O
respectively RB O
, , O
while IN O
acetylsalicylic NN B-Chemical
acid NN I-Chemical
( , O
ASA NNP B-Chemical
, , O
50 CD O
mg NN O
/ SYM O
kg NN O
, , O
i CD O
. . O
p NN O
. . O
) -RRB- O
, , O
a DT O
positive JJ O
control NN O
, , O
showed VBD O
only RB O
30 CD O
% NN O
inhibition NN O
. . O

Lovastatin NNP B-Chemical
has VBZ O
been VBN O
marketed VBN O
in IN O
the DT O
United NNP O
States NNP O
for IN O
over IN O
6 CD O
months NNS O
. . O

During IN O
nitroprusside JJ B-Chemical
infusion NN O
low JJ O
levels NNS O
of IN O
CPAP NNP O
do VBP O
not RB O
markedly RB O
alter VB O
cardiovascular JJ O
dynamics NNS O
, , O
but CC O
high JJ O
levels NNS O
of IN O
CPAP NNP O
( -LRB- O
10 CD O
cm NN O
H2O NN B-Chemical
) -RRB- O
, , O
while IN O
decreasing VBG O
QS NNP O
/ SYM O
QT NNP O
, , O
produce VBP O
marked JJ O
decreases NNS O
in IN O
arterial JJ O
blood NN O
pressure NN O
and CC O
cardiac JJ O
output NN O
. . O

Also RB O
recorded VBN O
were VBD O
one CD O
case NN O
of IN O
pain NN O
of IN O
the DT O
vein NN O
, , O
which WDT O
required VBD O
treatment NN O
, , O
and CC O
two CD O
cases NNS O
of IN O
hypotension NN O
. . O

The DT O
effects NNS O
of IN O
METH NNP B-Chemical
in IN O
CX3CR1 NNP O
knockout NN O
mice NNS O
were VBD O
not RB O
gender NN O
- HYPH O
dependent JJ O
and CC O
did VBD O
not RB O
extend VB O
beyond IN O
the DT O
striatum NN O
. . O

Fundus NNP O
fluorescein NN B-Chemical
angiography NN O
confirmed VBD O
macular JJ O
capillary NN O
closure NN O
and CC O
telangiectasis NN O
. . O

We PRP O
suggest VBP O
that IN O
our PRP$ O
patient NN O
' '' O
s POS O
tubular JJ O
dysfunction NN O
and CC O
myopathy NN O
may MD O
have VB O
resulted VBN O
from IN O
mitochondrial JJ O
dysfunction NN O
which WDT O
is VBZ O
triggered VBN O
by IN O
tacrolimus NN B-Chemical
and CC O
augmented VBN O
by IN O
lamivudine NN B-Chemical
. . O

Only RB O
five CD O
of IN O
the DT O
controls NNS O
exhibited VBD O
evidence NN O
of IN O
very RB O
slight JJ O
perivascular JJ O
fibrosis NN O
. . O

We PRP O
report VBP O
a DT O
case NN O
of IN O
severe JJ O
hypertension NN O
with IN O
an DT O
occluded VBN O
renal JJ O
artery NN O
to IN O
a DT O
solitary JJ O
kidney NN O
, , O
who WP O
developed VBD O
sudden JJ O
deterioration NN O
of IN O
renal JJ O
function NN O
following VBG O
treatment NN O
with IN O
captopril NN B-Chemical
. . O

The DT O
possibility NN O
of IN O
de FW O
novo FW O
glomerular JJ O
pathology NN O
under IN O
SRL NNP B-Chemical
treatment NN O
requires VBZ O
further JJ O
investigation NN O
by IN O
renal JJ O
biopsy NN O
. . O

METHODS NNS O
: : O
The DT O
Multiple NNP O
Outcomes NNPS O
of IN O
Raloxifene NNP B-Chemical
Evaluation NNP O
, , O
a DT O
multicenter JJ O
, , O
randomized JJ O
, , O
double JJ O
- HYPH O
blind JJ O
trial NN O
, , O
enrolled VBD O
7 CD O
, , O
705 CD O
postmenopausal JJ O
women NNS O
with IN O
osteoporosis NN O
. . O

The DT O
second JJ O
episode NN O
was VBD O
more RBR O
severe JJ O
than IN O
the DT O
first JJ O
; : O
and CC O
although IN O
both DT O
were VBD O
treated VBN O
with IN O
intensive JJ O
corticosteroid NN O
therapy NN O
, , O
renal JJ O
function NN O
remained VBD O
impaired JJ O
. . O

Regular JJ O
audiologic JJ O
evaluation NN O
is VBZ O
imperative JJ O
in IN O
all DT O
thalassemic JJ O
patients NNS O
so IN O
that IN O
early JJ O
changes NNS O
may MD O
be VB O
recognized VBN O
and CC O
treatment NN O
may MD O
be VB O
judiciously RB O
adjusted VBN O
in IN O
order NN O
to TO O
prevent VB O
or CC O
reverse VB O
hearing NN O
impairment NN O
. . O

The DT O
HBV NNP O
viral JJ O
loads NNS O
for IN O
mono NN O
- HYPH O
infected VBN O
and CC O
co NN O
- HYPH O
infected VBN O
patients NNS O
ranged VBD O
from IN O
3 CD O
. . O
32 CD O
x SYM O
10 CD O
( SYM O
2 CD O
) CD O
to IN O
3 CD O
. . O
82 CD O
x SYM O
10 CD O
( SYM O
7 CD O
) SYM O
and CC O
< $ O
200 CD O
to TO O
4 CD O
. . O
40 CD O
x SYM O
10 CD O
( SYM O
3 CD O
) SYM O
copies NNS O
/ SYM O
ml NNS O
, , O
respectively RB O
. . O

Swiss JJ O
albino NN O
mice NN O
prepared VBN O
with IN O
intrajugular JJ O
catheters NNS O
were VBD O
tested VBN O
in IN O
photocell NN O
cages NNS O
after IN O
administration NN O
of IN O
93 CD O
mg NNS O
/ SYM O
kg NNS O
( SYM O
LD50 CD O
) -RRB- O
of IN O
cocaine NN B-Chemical
and CC O
GNC92H2 NNP B-Chemical
infusions NNS O
ranging VBG O
from IN O
30 CD O
to IN O
190 CD O
mg NNS O
/ SYM O
kg NN O
. . O

The DT O
results NNS O
showed VBD O
a DT O
high JJ O
prevalence NN O
of IN O
depression NN O
in IN O
both DT O
groups NNS O
of IN O
patients NNS O
, , O
with IN O
no DT O
preponderance NN O
in IN O
the DT O
hypertensive JJ O
group NN O
. . O

An DT O
80 CD O
- HYPH O
yr NN O
- HYPH O
old JJ O
man NN O
developed VBD O
acute JJ O
hepatitis NN O
shortly RB O
after IN O
ingesting VBG O
oral JJ O
ceftriaxone NN B-Chemical
. . O

To IN O
the DT O
best JJS O
of IN O
our PRP$ O
knowledge NN O
, , O
this DT O
constitutes VBZ O
the DT O
first JJ O
report NN O
of IN O
HBV NNP O
lamivudine NN B-Chemical
- HYPH O
resistant JJ O
strains NNS O
in IN O
therapy NN O
- HYPH O
na NN B-Chemical
ve IN O
HBV NNP O
- HYPH O
HIV NNP O
co NN O
- HYPH O
infected VBN O
patients NNS O
. . O

AV NN O
block NN O
, , O
severe JJ O
hypotension NN O
, , O
and CC O
impairment NN O
of IN O
ventricular JJ O
function NN O
. . O

She PRP O
then RB O
very RB O
rapidly RB O
developed VBD O
acute JJ O
onset NN O
of IN O
severe JJ O
facial JJ O
and CC O
extremity NN O
tetany NN O
. . O

Examinations NNS O
, , O
including VBG O
blood NN O
pressure NN O
, , O
pulse NN O
rate NN O
, , O
conjunctiva NN O
and CC O
cornea NN O
, , O
intraocular JJ O
pressure NN O
( , O
IOP NNP O
) -RRB- O
, , O
pupil NN O
diameter NN O
, , O
basal JJ O
tear NN O
secretion NN O
and CC O
margin NN O
reflex NN O
distance NN O
of IN O
both CC O
upper JJ O
and CC O
lower JJ O
eyelids NNS O
, , O
were VBD O
performed VBN O
prior RB O
to IN O
entry NN O
and CC O
at IN O
1 CD O
, , O
3 CD O
, , O
5 CD O
and CC O
7 CD O
hours NNS O
after IN O
instillation NN O
. . O

Treatment NN O
was VBD O
administered VBN O
every DT O
3 CD O
weeks NNS O
until IN O
disease NN O
progression NN O
. . O

The DT O
plasma NN O
levels NNS O
of IN O
atrial JJ O
natriuretic JJ O
peptide NN O
( -LRB- O
ANP NNP O
) -RRB- O
and CC O
BNP NNP O
were VBD O
measured VBN O
at IN O
the DT O
time NN O
of IN O
radionuclide NN O
angiography NN O
. . O

Controlled VBN O
hypotension NN O
to IN O
an DT O
average JJ O
MAP NNP O
of IN O
50 CD O
- SYM O
55 CD O
mm NN O
Hg NN B-Chemical
was VBD O
induced VBN O
by IN O
increasing VBG O
the DT O
dose NN O
of IN O
isoflurane NN B-Chemical
, , O
and CC O
maintained VBN O
at IN O
an DT O
inspired JJ O
concentration NN O
of IN O
2 CD O
. . O
2 CD O
+ SYM O
/ SYM O
- SYM O
0 CD O
. . O
2 CD O
% NN O
. . O

Furthermore RB O
, , O
adriamycin NN B-Chemical
induced VBD O
the DT O
formation NN O
of IN O
autophagic JJ O
vacuoles NNS O
, , O
and CC O
3MA NNP B-Chemical
strongly RB O
downregulated VBD O
the DT O
expression NN O
of IN O
beclin NN O
1 CD O
in IN O
adriamycin NN B-Chemical
- HYPH O
induced VBN O
failing VBG O
heart NN O
and CC O
inhibited VBD O
the DT O
formation NN O
of IN O
autophagic JJ O
vacuoles NNS O
. . O

The DT O
patient NN O
had VBD O
no DT O
apparent JJ O
associated VBN O
conditions NNS O
which WDT O
might MD O
have VB O
predisposed VBN O
him PRP O
to IN O
the DT O
development NN O
of IN O
bradyarrhythmias NN O
; : O
and CC O
, , O
thus RB O
, , O
this DT O
probably RB O
represented VBD O
a DT O
true JJ O
idiosyncrasy NN O
to IN O
lidocaine NN B-Chemical
. . O

Idraparinux NNP B-Chemical
, , O
a DT O
Factor NNP O
Xa NNP O
inhibitor NN O
, , O
is VBZ O
being VBG O
evaluated VBN O
in IN O
patients NNS O
with IN O
atrial JJ O
fibrillation NN O
. . O

Massive JJ O
urinary JJ O
protein NN O
excretion NN O
has VBZ O
been VBN O
observed VBN O
after IN O
conversion NN O
from IN O
calcineurin NN O
inhibitors NNS O
to IN O
mammalian JJ O
target NN O
of IN O
rapamycin NN B-Chemical
( , O
mToR NNP O
) -RRB- O
inhibitors NNS O
, , O
especially RB O
sirolimus NN B-Chemical
, , O
in IN O
renal JJ O
transplant NN O
recipients NNS O
with IN O
chronic JJ O
allograft NN O
nephropathy NN O
. . O

After IN O
6 CD O
weeks NNS O
of IN O
treatment NN O
, , O
renal JJ O
hemodynamics NNS O
( , O
glomerular JJ O
filtration NN O
rate NN O
and CC O
renal JJ O
plasma NN O
flow NN O
) , O
were VBD O
measured VBN O
in IN O
the DT O
anesthetized VBN O
rats NNS O
. . O

Estradiol NNP B-Chemical
reduces VBZ O
seizure NN O
- HYPH O
induced VBN O
hippocampal JJ O
injury NN O
in IN O
ovariectomized JJ O
female NN O
but CC O
not RB O
in IN O
male JJ O
rats NNS O
. . O

Dipyridamole NNP B-Chemical
- HYPH O
induced VBN O
myocardial JJ O
ischemia NN O
. . O

Randomized JJ O
, , O
double JJ O
- HYPH O
blind JJ O
trial NN O
of IN O
mazindol NN B-Chemical
in IN O
Duchenne NNP O
dystrophy NN O
. . O

These DT O
data NNS O
show VBP O
that IN O
GnRH NNP O
pulse NN O
frequency NN O
is VBZ O
inhibited VBN O
by IN O
chronic JJ O
hyperprolactinemia NN O
in IN O
a DT O
steroid NN B-Chemical
- HYPH O
dependent JJ O
manner NN O
. . O

Bone NN O
pain NN O
after IN O
transplantation NN O
is VBZ O
a DT O
frequent JJ O
complication NN O
that WDT O
can MD O
be VB O
caused VBN O
by IN O
several JJ O
diseases NNS O
. . O

This DT O
observation NN O
, , O
along IN O
with IN O
the DT O
rapid JJ O
rate NN O
of IN O
decline NN O
in IN O
red JJ O
cell NN O
mass NN O
parameters NNS O
of IN O
affected VBN O
dogs NNS O
, , O
suggests VBZ O
that IN O
a DT O
hemolytic JJ O
component NN O
complicated VBD O
the DT O
red JJ O
cell NN O
production NN O
problem NN O
and CC O
that IN O
multiple JJ O
toxicologic JJ O
mechanisms NNS O
contributed VBD O
to IN O
the DT O
cytopenia NN O
. . O

We PRP O
therefore RB O
established VBD O
sensitive JJ O
quantification NN O
methods NNS O
and CC O
provided VBD O
a DT O
rat NN O
ICH NNP O
model NN O
for IN O
detection NN O
of IN O
ICH NNP O
deterioration NN O
. . O

2 LS O
. . O

Furthermore RB O
, , O
it PRP O
appears VBZ O
that IN O
striatal JJ O
- HYPH O
resident NN O
microglia NN O
respond VBP O
to IN O
METH NNP B-Chemical
with IN O
an DT O
activation NN O
cascade NN O
and CC O
then RB O
return VB O
to IN O
a DT O
surveying VBG O
state NN O
without IN O
undergoing VBG O
apoptosis NN O
or CC O
migration NN O
. . O

Analgesic JJ O
effect NN O
of IN O
intravenous JJ O
ketamine NN B-Chemical
in IN O
cancer NN O
patients NNS O
on IN O
morphine NN B-Chemical
therapy NN O
: : O
a DT O
randomized VBN O
, , O
controlled VBN O
, , O
double JJ O
- HYPH O
blind JJ O
, , O
crossover JJ O
, , O
double JJ O
- HYPH O
dose NN O
study NN O
. . O

In IN O
these DT O
62 CD O
patients NNS O
, , O
no DT O
other JJ O
causes NNS O
for IN O
renal JJ O
failure NN O
could MD O
be VB O
identified VBN O
. . O

Competition NN O
binding NN O
assays NNS O
demonstrated VBD O
that IN O
all DT O
three CD O
compounds NNS O
have VBP O
high JJ O
affinities NNS O
for IN O
sigma1 NN O
receptors NNS O
. . O

In IN O
both DT O
cases NNS O
, , O
discontinuation NN O
of IN O
FK506 NNP B-Chemical
and CC O
treatment NN O
with IN O
plasma NN O
exchange NN O
, , O
fresh JJ O
frozen JJ O
plasma NN O
replacement NN O
, , O
corticosteroids NNS B-Chemical
, , O
aspirin NN B-Chemical
, , O
and CC O
dipyridamole NN B-Chemical
led VBD O
to IN O
resolution NN O
of IN O
MAHA NNP O
. . O

Estradiol NNP B-Chemical
is VBZ O
known VBN O
to TO O
influence VB O
expression NN O
of IN O
the DT O
long JJ O
form NN O
of IN O
prolactin JJ O
receptors NNS O
( , O
PRL NN O
- HYPH O
R NN O
) -RRB- O
and CC O
components NNS O
of IN O
prolactin NN O
' '' O
s NNS O
signaling VBG O
pathway NN O
. . O

Administration NN O
of IN O
50 CD O
mg CD O
/ SYM O
kg NNP O
PDTC NNP B-Chemical
( HYPH O
low JJ O
- HYPH O
dose NN O
) -RRB- O
did VBD O
not RB O
exert VB O
major JJ O
effects NNS O
on IN O
the DT O
development NN O
of IN O
a DT O
status NN O
epilepticus NN O
or CC O
the DT O
mortality NN O
rate NN O
. . O

A DT O
lower JJR O
relative JJ O
risk NN O
would MD O
be VB O
expected VBN O
for IN O
acetaminophen NN B-Chemical
if IN O
the DT O
risk NN O
of IN O
both DT O
drugs NNS O
in IN O
combination NN O
with IN O
other JJ O
analgesics NNS O
was VBD O
higher JJR O
than IN O
the DT O
risk NN O
of IN O
either CC O
agent NN O
alone RB O
. . O

No DT O
differences NNS O
were VBD O
observed VBN O
with IN O
respect NN O
to IN O
side NN O
effects NNS O
and CC O
general JJ O
tolerability NN O
. . O

Pimozide NNP B-Chemical
did VBD O
not RB O
affect VB O
the DT O
actions NNS O
of IN O
L NN B-Chemical
- HYPH I-Chemical
dopa NNP I-Chemical
on IN O
blood NN O
pressure NN O
and CC O
heart NN O
rate NN O
but CC O
completely RB O
blocked VBD O
the DT O
enhancement NN O
of IN O
reflexes NNS O
. . O

INTERPRETATION NN O
: : O
Repeated VBN O
exposure NN O
of IN O
human JJ O
beings NNS O
to IN O
HCFCs NNP B-Chemical
123 CD I-Chemical
and CC I-Chemical
124 CD I-Chemical
can MD O
result VB O
in IN O
serious JJ O
liver NN O
injury NN O
in IN O
a DT O
large JJ O
proportion NN O
of IN O
the DT O
exposed JJ O
population NN O
. . O

Jaundice NNP O
disappeared VBD O
within IN O
3 CD O
months NNS O
but CC O
was VBD O
followed VBN O
by IN O
prolonged VBN O
anicteric JJ O
cholestasis NN O
marked VBN O
by IN O
pruritus NN O
and CC O
high JJ O
levels NNS O
of IN O
alkaline NN O
phosphatase NN O
and CC O
gammaglutamyltransferase NN O
activities NNS O
. . O

Following VBG O
intervention NN O
, , O
7 CD O
out IN O
of IN O
21 CD O
affected VBN O
patients NNS O
recovered VBD O
, , O
10 CD O
remained VBD O
stable JJ O
and CC O
4 CD O
demonstrated VBD O
aggravation NN O
. . O

Blood NN O
was VBD O
collected VBN O
from IN O
the DT O
antecubital JJ O
vein NN O
four CD O
times NNS O
: : O
60 CD O
min NN O
before IN O
and CC O
after IN O
the DT O
nitroglycerin NN B-Chemical
application NN O
, , O
and CC O
60 CD O
and CC O
120 CD O
min NN O
after IN O
the DT O
beginning NN O
of IN O
the DT O
migraine NN O
attack NN O
( , O
mean JJ O
344 CD O
and CC O
404 CD O
min NN O
; : O
12 CD O
subjects NNS O
) -RRB- O
. . O

The DT O
present JJ O
study NN O
was VBD O
carried VBN O
out RP O
to TO O
test VB O
the DT O
effects NNS O
of IN O
L NNP B-Chemical
- HYPH I-Chemical
alpha NN I-Chemical
- HYPH I-Chemical
glycerylphosphorylcholine NN I-Chemical
( -LRB- O
L NNP B-Chemical
- HYPH I-Chemical
alpha NN I-Chemical
- HYPH I-Chemical
GFC NNP I-Chemical
) -RRB- O
on IN O
memory NN O
impairment NN O
induced VBN O
by IN O
scopolamine NN B-Chemical
in IN O
man NN O
. . O

CONCLUSIONS NNS O
: : O
The DT O
results NNS O
indicated VBD O
a DT O
favorable JJ O
therapeutic JJ O
profile NN O
for IN O
haloperidol NN B-Chemical
in IN O
doses NNS O
of IN O
2 CD O
- SYM O
3 CD O
mg NN O
/ SYM O
day NN O
, , O
although IN O
a DT O
subgroup NN O
developed VBD O
moderate JJ O
to IN O
severe JJ O
extrapyramidal JJ O
signs NNS O
. . O

Patients NNS O
who WP O
are VBP O
given VBN O
this DT O
drug NN O
regimen NN O
should MD O
be VB O
observed VBN O
very RB O
carefully RB O
for IN O
early JJ O
signs NNS O
of IN O
nephrotoxicity NN O
. . O

BACKGROUND NN O
: : O
The DT O
possible JJ O
role NN O
of IN O
alcohol NN B-Chemical
in IN O
the DT O
development NN O
of IN O
hepatotoxicity NN O
associated VBN O
with IN O
therapeutic JJ O
doses NNS O
of IN O
paracetamol NN B-Chemical
( : O
acetaminophen NN B-Chemical
) -RRB- O
is VBZ O
currently RB O
debated VBN O
. . O

The DT O
appearance NN O
of IN O
nephrotic JJ O
syndromes NNS O
such JJ O
as IN O
proteinuria NN O
, , O
hypoalbuminemia NN O
, , O
hypercholesterolemia NN O
and CC O
increase NN O
in IN O
blood NN B-Chemical
nitrogen NN I-Chemical
urea NN I-Chemical
, , O
induced VBN O
in IN O
rats NNS O
by IN O
injection NN O
of IN O
puromycin NN B-Chemical
aminonucleoside NN I-Chemical
was VBD O
markedly RB O
inhibited VBN O
by IN O
oral JJ O
administration NN O
of IN O
Dup NNP B-Chemical
753 CD I-Chemical
( HYPH O
losartan NN B-Chemical
) -RRB- O
, , O
a DT O
novel JJ O
angiotensin NN B-Chemical
II NNP I-Chemical
receptor NN O
antagonist NN O
, , O
at IN O
a DT O
dose NN O
of IN O
1 CD O
or CC O
2 CD O
mg NNS O
/ SYM O
kg NNS O
per IN O
day NN O
. . O

Two CD O
weeks NNS O
after IN O
terminating VBG O
the DT O
treatment NN O
, , O
the DT O
SBP NNP O
recovered VBD O
to TO O
control VB O
value NN O
. . O

We PRP O
report VBP O
the DT O
case NN O
of IN O
a DT O
70 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
hypertensive JJ O
man NN O
with IN O
a DT O
solitary JJ O
kidney NN O
and CC O
chronic JJ O
renal JJ O
insufficiency NN O
who WP O
developed VBD O
two CD O
episodes NNS O
of IN O
transient JJ O
anuria NN O
after IN O
losartan JJ B-Chemical
administration NN O
. . O

METHOD NN O
: : O
The DT O
response NN O
of IN O
44 CD O
patients NNS O
meeting VBG O
DSM NNP O
- HYPH O
IV NN O
criteria NNS O
for IN O
bipolar JJ O
disorder NN O
to IN O
naturalistic JJ O
treatment NN O
was VBD O
assessed VBN O
for IN O
at RB O
least RBS O
6 CD O
weeks NNS O
using VBG O
the DT O
Montgomery NNP O
- HYPH O
Asberg NNP O
Depression NNP O
Rating NNP O
Scale NNP O
and CC O
the DT O
Bech NNP O
- HYPH O
Rafaelson NNP O
Mania NNP O
Rating NNP O
Scale NNP O
. . O

It PRP O
has VBZ O
been VBN O
consistently RB O
shown VBN O
that IN O
ecstasy NN B-Chemical
users NNS O
display VBP O
impairments NNS O
in IN O
learning NN O
and CC O
memory NN O
performance NN O
. . O

In IN O
particular JJ O
, , O
the DT O
tendency NN O
of IN O
cocaine NN B-Chemical
to TO O
produce VB O
chest NN O
pain NN O
ought MD O
to TO O
be VB O
in IN O
the DT O
mind NN O
of IN O
the DT O
emergency NN O
nurse NN O
when WRB O
faced VBN O
with IN O
a DT O
young JJ O
victim NN O
of IN O
chest NN O
pain NN O
who WP O
is VBZ O
otherwise RB O
at IN O
low JJ O
risk NN O
. . O

We PRP O
conclude VBP O
that IN O
noxious JJ O
stimulation NN O
of IN O
facial JJ O
mucosa NN O
increases VBZ O
intracranial JJ O
blood NN O
flow NN O
and CC O
lacrimation NN O
via IN O
a DT O
trigemino NN O
- HYPH O
parasympathetic JJ O
reflex NN O
. . O

Simultaneous JJ O
administration NN O
of IN O
morphine NN B-Chemical
with IN O
metamizol NN B-Chemical
resulted VBD O
in IN O
a DT O
markedly RB O
antinociceptive JJ O
potentiation NN O
and CC O
an DT O
increasing VBG O
of IN O
the DT O
duration NN O
of IN O
action NN O
after IN O
a DT O
single JJ O
( , O
298 CD O
+ NN O
/ SYM O
- HYPH O
7 CD O
vs NN O
. . O
139 CD O
+ SYM O
/ SYM O
- HYPH O
36 CD O
units NNS O
area NN O
( , O
ua FW O
) -RRB- O
; : O
P NN O
< NN O
0 CD O
. . O
001 CD O
) -RRB- O
and CC O
repeated VBN O
administration NN O
( : O
280 CD O
+ SYM O
/ SYM O
- HYPH O
17 CD O
vs IN O
. . O
131 CD O
+ CD O
/ SYM O
- HYPH O
22 CD O
ua NN O
; : O
P NN O
< NN O
0 CD O
. . O
001 CD O
) -RRB- O
. . O

CONCLUSION NN O
: : O
Autophagic JJ O
cardiomyocyte NN O
death NN O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
heart NN O
failure NN O
in IN O
rats NNS O
induced VBN O
by IN O
adriamycin NN B-Chemical
. . O

High JJ O
- HYPH O
dose NN O
intravenous JJ O
methotrexate NN B-Chemical
is VBZ O
an DT O
effective JJ O
treatment NN O
for IN O
the DT O
induction NN O
of IN O
remission NN O
after IN O
meningeal JJ O
relapse NN O
in IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
. . O

Grade NN O
3 CD O
- HYPH O
4 CD O
adverse JJ O
effects NNS O
included VBD O
myelosuppression NN O
, , O
fatigue NN O
, , O
somnolence NN O
/ SYM O
depressed VBN O
mood NN O
, , O
neuropathy NN O
and CC O
dyspnea NN O
. . O

A DT O
significant JJ O
correlation NN O
was VBD O
found VBN O
between IN O
baseline NN O
TAFI NNP O
antigen NN O
concentrations NNS O
and CC O
the DT O
duration NN O
of IN O
amenorrhea NN O
( , O
P NN O
< SYM O
0 CD O
. . O
05 CD O
; : O
r NN O
= SYM O
0 CD O
. . O
33 CD O
) -RRB- O
. . O

Ketoconazole NNP B-Chemical
- HYPH O
induced VBN O
neurologic JJ O
sequelae NN O
. . O

Nearly RB O
3 CD O
. . O
2 CD O
million CD O
people NNS O
in IN O
this DT O
country NN O
receive VBP O
aminoglycoside NN B-Chemical
antibiotics NNS O
annually RB O
. . O

Generally RB O
, , O
carboplatin NN B-Chemical
is VBZ O
said VBN O
to TO O
have VB O
milder JJR O
side NN O
effects NNS O
than IN O
cisplatin NN B-Chemical
, , O
whose WP$ O
ocular JJ O
and CC O
orbital JJ O
toxicity NN O
are VBP O
well RB O
known JJ O
. . O

The DT O
ventricular JJ O
fibrillation NN O
threshold NN O
was VBD O
measured VBN O
by IN O
passing VBG O
a DT O
gated VBN O
train NN O
of IN O
12 CD O
constant JJ O
current JJ O
pulses NNS O
through IN O
the DT O
ventricular JJ O
myocardium NN O
during IN O
the DT O
vulnerable JJ O
period NN O
of IN O
the DT O
cardiac JJ O
cycle NN O
. . O

In IN O
a DT O
double JJ O
blind JJ O
cross NN O
- HYPH O
over IN O
study NN O
with IN O
control NN O
group NN O
, , O
the DT O
patients NNS O
under IN O
timolol NN B-Chemical
treatment NN O
presented VBD O
higher JJR O
depression NN O
values NNS O
measured VBN O
through IN O
the DT O
Beck NNP O
and CC O
the DT O
Zung NNP O
- HYPH O
Conde NNP O
scales NNS O
( : O
p NN O
< SYM O
0 CD O
. . O
001 CD O
vs IN O
control NN O
) -RRB- O
. . O

Differential JJ O
effects NNS O
of IN O
systemically RB O
administered VBN O
ketamine NN B-Chemical
and CC O
lidocaine NN B-Chemical
on IN O
dynamic JJ O
and CC O
static JJ O
hyperalgesia NN O
induced VBN O
by IN O
intradermal JJ O
capsaicin NN B-Chemical
in IN O
humans NNS O
. . O

Dose NN O
- HYPH O
dependent JJ O
bradycardia NN O
induced VBN O
by IN O
verapamil NN B-Chemical
was VBD O
potentiated VBN O
by IN O
LNa NNP O
, , O
LCa NNP O
, , O
and CC O
HCa NNP O
. . O

Evaluation NN O
of IN O
cardiac JJ O
troponin NN O
I NNP O
and CC O
T NNP O
levels NNS O
as IN O
markers NNS O
of IN O
myocardial JJ O
damage NN O
in IN O
doxorubicin NN B-Chemical
- HYPH O
induced VBN O
cardiomyopathy NN O
rats NNS O
, , O
and CC O
their PRP$ O
relationship NN O
with IN O
echocardiographic JJ O
and CC O
histological JJ O
findings NNS O
. . O

BACKGROUND NN O
: : O
A DT O
72 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
white JJ O
man NN O
with IN O
underlying VBG O
human JJ O
immunodeficiency NN O
virus NN O
, , O
atrial JJ O
fibrillation NN O
, , O
coronary JJ O
artery NN O
disease NN O
, , O
and CC O
hyperlipidemia NN O
presented VBN O
with IN O
generalized VBN O
pain NN O
, , O
fatigue NN O
, , O
and CC O
dark JJ O
orange NN O
urine NN O
for IN O
3 CD O
days NNS O
. . O

Her PRP$ O
medical JJ O
history NN O
included VBD O
coronary JJ O
artery NN O
disease NN O
with IN O
previous JJ O
myocardial JJ O
infarctions NNS O
, , O
hypertension NN O
, , O
and CC O
diabetes NN O
mellitus NN O
. . O

A DT O
complete JJ O
responder NN O
had VBD O
relapse NN O
- HYPH O
free JJ O
survival NN O
up IN O
to TO O
17 CD O
months NNS O
. . O

Peritubular JJ O
capillary NN O
basement NN O
membrane NN O
reduplication NN O
in IN O
allografts NNS O
and CC O
native JJ O
kidney NN O
disease NN O
: : O
a DT O
clinicopathologic JJ O
study NN O
of IN O
278 CD O
consecutive JJ O
renal JJ O
specimens NNS O
. . O

In IN O
addition NN O
, , O
working VBG O
memory NN O
processing NN O
in IN O
ecstasy NN B-Chemical
users NNS O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
associated VBN O
with IN O
neural JJ O
alterations NNS O
in IN O
hippocampal JJ O
and CC O
/ SYM O
or CC O
cortical JJ O
regions NNS O
as IN O
measured VBN O
by IN O
functional JJ O
magnetic JJ O
resonance NN O
imaging NN O
( : O
fMRI NNP O
) -RRB- O
. . O

This DT O
study NN O
provides VBZ O
a DT O
useful JJ O
animal NN O
model NN O
for IN O
understanding VBG O
the DT O
neuropathological JJ O
processes NNS O
underlying VBG O
autism JJ O
spectrum NN O
disorders NNS O
. . O

Further JJ O
testing NN O
in IN O
this DT O
and CC O
other JJ O
tumour NN O
types NNS O
using VBG O
multiple JJ O
daily JJ O
schedules NNS O
is VBZ O
warranted VBN O
. . O

Cerebral JJ O
infarction NN O
with IN O
a DT O
single JJ O
oral JJ O
dose NN O
of IN O
phenylpropanolamine NN B-Chemical
. . O

Given VBN O
the DT O
influx NN O
of IN O
Southeast NNP O
Asians NNPS O
into IN O
the DT O
United NNP O
States NNP O
, , O
oxidant NN O
medications NNS O
should MD O
be VB O
used VBN O
with IN O
caution NN O
, , O
especially RB O
if IN O
an DT O
infection NN O
is VBZ O
present JJ O
, , O
in IN O
individuals NNS O
of IN O
ethnic JJ O
backgrounds NNS O
that WDT O
have VBP O
an DT O
increased VBN O
prevalence NN O
of IN O
hemoglobin NN O
E NN O
. . O

This DT O
case NN O
illustrates VBZ O
the DT O
need NN O
for IN O
close JJ O
vigilance NN O
in IN O
adverse JJ O
drug NN O
reactions NNS O
, , O
particularly RB O
in IN O
the DT O
elderly JJ O
. . O

RESULTS NNS O
: : O
The DT O
mean JJ O
+ CC O
/ SYM O
- HYPH O
SD NN O
duration NN O
of IN O
BZD NN O
/ SYM O
RD NN O
use NN O
was VBD O
7 CD O
+ SYM O
/ SYM O
- SYM O
7 CD O
years NNS O
( : O
range NN O
1 CD O
- HYPH O
31 CD O
) -RRB- O
. . O

The DT O
cardiotoxic JJ O
effects NNS O
of IN O
adriamycin NN B-Chemical
were VBD O
studied VBN O
in IN O
mammalian JJ O
myocardial JJ O
cells NNS O
in IN O
culture NN O
as IN O
a DT O
model NN O
system NN O
. . O

In IN O
other JJ O
individuals NNS O
with IN O
no DT O
underlying VBG O
atherosclerotic JJ O
obstruction NN O
, , O
coronary JJ O
occlusion NN O
may MD O
be VB O
due JJ O
to IN O
spasm NN O
, , O
thrombus NN O
, , O
or CC O
both DT O
. . O

A DT O
case NN O
of IN O
metabolic JJ O
acidosis NN O
, , O
acute JJ O
renal JJ O
failure NN O
and CC O
hepatic JJ O
failure NN O
following VBG O
paracetamol NN B-Chemical
ingestion NN O
is VBZ O
presented VBN O
. . O

At IN O
hippocampal JJ O
Schaeffer NNP O
collateral JJ O
- HYPH O
CA1 NN O
synapses NNS O
, , O
long JJ O
- HYPH O
term NN O
potentiation NN O
was VBD O
preserved VBN O
in IN O
BMC NNP O
- HYPH O
transplanted VBN O
rats NNS O
compared VBN O
to IN O
epileptic JJ O
controls NNS O
. . O

Attention NN O
to IN O
the DT O
possible JJ O
induction NN O
of IN O
specific JJ O
tardive JJ O
dyskinesia NN O
is VBZ O
called VBN O
for IN O
in IN O
the DT O
use NN O
of IN O
this DT O
drug NN O
. . O

We PRP O
also RB O
assessed VBD O
cell NN O
viability NN O
, , O
mitochondrial JJ O
membrane NN O
potential JJ O
changes NNS O
and CC O
counted VBD O
autophagic JJ O
vacuoles NNS O
in IN O
cultured VBN O
cardiomyocytes NNS O
. . O

The DT O
electrocardiograms NNS O
( -LRB- O
ECG NNP O
) -RRB- O
of IN O
99 CD O
cocaine NN B-Chemical
- HYPH O
abusing VBG O
patients NNS O
were VBD O
compared VBN O
with IN O
the DT O
ECGs NNPS O
of IN O
50 CD O
schizophrenic JJ O
controls NNS O
. . O

The DT O
temporal JJ O
relationship NN O
between IN O
lipid NN O
peroxidation NN O
in IN O
the DT O
kidney NN O
and CC O
proteinuria NN O
was VBD O
examined VBN O
in IN O
this DT O
study NN O
. . O

Optimization NN O
of IN O
levodopa NN B-Chemical
therapy NN O
. . O

All DT O
four CD O
agents NNS O
were VBD O
associated VBN O
with IN O
aortic JJ O
arch NN O
branching NN O
variants NNS O
, , O
although IN O
significantly RB O
increased VBD O
only RB O
for IN O
Ro NNP B-Chemical
40 CD I-Chemical
- SYM I-Chemical
5967 CD I-Chemical
and CC O
verapamil NN B-Chemical
. . O

During IN O
the DT O
early JJ O
stages NNS O
of IN O
analgesic JJ O
treatment NN O
, , O
the DT O
changes NNS O
in IN O
urinary JJ O
concentrating NN O
ability NN O
were VBD O
reversible JJ O
, , O
but CC O
after IN O
prolonged JJ O
analgesic JJ O
treatment NN O
, , O
maximum JJ O
urinary JJ O
concentrating NN O
ability NN O
failed VBD O
to TO O
recover VB O
. . O

The DT O
blood NN O
amounts NNS O
and CC O
hematoma NN O
volumes NNS O
were VBD O
significantly RB O
correlated VBN O
, , O
and CC O
the DT O
hematoma NN O
induced VBN O
by IN O
0 CD O
. . O
014 CD O
- HYPH O
unit NN O
collagenase NN O
was VBD O
adequate JJ O
to TO O
detect VB O
ICH NN O
deterioration NN O
. . O

Treatment NN O
of IN O
psoriasis NN O
with IN O
azathioprine NN B-Chemical
. . O

In IN O
one CD O
patient NN O
, , O
the DT O
tinnitus NN O
was VBD O
almost RB O
completely RB O
abolished VBN O
, , O
but CC O
in IN O
all PDT O
the DT O
nine CD O
patients NNS O
the DT O
decompensated JJ O
tinnitus NN O
changed VBD O
to IN O
a DT O
compensated JJ O
one NN O
. . O

Prenatal JJ O
protein NN O
deprivation NN O
alters VBZ O
dopamine NN B-Chemical
- HYPH O
mediated VBN O
behaviors NNS O
and CC O
dopaminergic JJ O
and CC O
glutamatergic JJ O
receptor NN O
binding NN O
. . O

Skin NN O
tests NNS O
with IN O
AX NNP B-Chemical
were VBD O
positive JJ O
in IN O
34 CD O
( SYM O
63 CD O
% NN O
) SYM O
patients NNS O
. . O

Over IN O
a DT O
range NN O
of IN O
1 CD O
- SYM O
150 CD O
days NNS O
of IN O
DES NNP B-Chemical
treatment NN O
, , O
pairs NNS O
of IN O
control NN O
and CC O
DES NN B-Chemical
- HYPH O
treated VBN O
rats NNS O
were VBD O
sacrificed VBN O
, , O
and CC O
their PRP$ O
pituitaries NNS O
dissociated VBN O
enzymatically RB O
into IN O
single JJ O
- HYPH O
cell NN O
preparations NNS O
. . O

The DT O
present JJ O
study NN O
aimed VBD O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
pallidal JJ O
neurotensin NN B-Chemical
on IN O
haloperidol NN B-Chemical
- HYPH O
induced VBN O
parkinsonian JJ O
symptoms NNS O
. . O

The DT O
present JJ O
study NN O
was VBD O
designed VBN O
to TO O
evaluate VB O
two CD O
endogenous JJ O
and CC O
one CD O
synthetic JJ O
neuroactive JJ O
steroid NN B-Chemical
that WDT O
positively RB O
modulate VBP O
the DT O
gamma NN B-Chemical
- HYPH I-Chemical
aminobutyric JJ I-Chemical
acid NN I-Chemical
( -LRB- O
GABA NNP B-Chemical
( -LRB- O
A NN O
) -RRB- O
) -RRB- O
receptor NN O
against IN O
the DT O
increase NN O
in IN O
sensitivity NN O
to IN O
the DT O
convulsant JJ O
effects NNS O
of IN O
cocaine NN B-Chemical
engendered VBN O
by IN O
repeated VBN O
cocaine NN B-Chemical
administration NN O
( , O
seizure NN O
kindling NN O
) -RRB- O
. . O

The DT O
most RBS O
common JJ O
side NN O
- HYPH O
effect NN O
was VBD O
diarrhoea NN O
, , O
which WDT O
resulted VBD O
in IN O
cessation NN O
of IN O
therapy NN O
in IN O
19 CD O
individuals NNS O
. . O

Treatment NN O
, , O
given VBN O
every DT O
21 CD O
days NNS O
for IN O
a DT O
maximum NN O
of IN O
three CD O
cycles NNS O
, , O
consisted VBD O
of IN O
paclitaxel NN B-Chemical
by IN O
3 CD O
- HYPH O
hour NN O
infusion NN O
followed VBN O
the DT O
next JJ O
day NN O
by IN O
a DT O
fixed VBN O
dose NN O
of IN O
cisplatin NN B-Chemical
( : O
75 CD O
mg NNS O
/ SYM O
m2 CD O
) -RRB- O
. . O

Bromocriptine NNP B-Chemical
was VBD O
definitely RB O
effective JJ O
in IN O
cases NNS O
with IN O
prolactin NN O
greater JJR O
than IN O
35 CD O
ng NN O
. . O
/ SYM O
ml UH O
. . O

Individual JJ O
differences NNS O
in IN O
renal JJ O
ACE NN O
activity NN O
in IN O
healthy JJ O
rats NNS O
predict VBP O
susceptibility NN O
to IN O
adriamycin NN B-Chemical
- HYPH O
induced VBN O
renal JJ O
damage NN O
. . O

cTnT NN O
found VBN O
in IN O
rats NNS O
after IN O
12 CD O
mg CD O
/ SYM O
kg NNS O
were VBD O
significantly RB O
greater JJR O
than IN O
that DT O
found VBN O
after IN O
7 CD O
. . O
5 CD O
mg NN O
/ SYM O
kg NN O
DOX NNP B-Chemical
. . O

The DT O
results NNS O
of IN O
this DT O
case NN O
report NN O
support VBP O
the DT O
idea NN O
that IN O
in IN O
contrast NN O
with IN O
carbamazepine NN B-Chemical
oxcarbazepine NN B-Chemical
does VBZ O
not RB O
induce VB O
the DT O
hepatic JJ O
microsomal NN O
enzyme NN O
systems NNS O
regulating VBG O
the DT O
inactivation NN O
of IN O
antipsychotic JJ O
drugs NNS O
. . O

Rabbit NNP O
syndrome NN O
( , O
RS NN O
) -RRB- O
is VBZ O
a DT O
rare JJ O
extrapyramidal JJ O
side NN O
effect NN O
caused VBN O
by IN O
prolonged VBN O
neuroleptic JJ O
medication NN O
. . O

Podocyte NN O
injury NN O
and CC O
focal JJ O
segmental JJ O
glomerulosclerosis NN O
have VBP O
been VBN O
related VBN O
to IN O
mToR NNP O
inhibition NN O
in IN O
some DT O
patients NNS O
, , O
but CC O
the DT O
pathways NNS O
underlying VBG O
these DT O
lesions NNS O
remain VBP O
hypothetic JJ O
. . O

The DT O
overall JJ O
response NN O
rate NN O
is VBZ O
72 CD O
% NN O
. . O

In IN O
patient NN O
2 CD O
, , O
in IN O
addition NN O
to IN O
an DT O
increase NN O
in IN O
both CC O
deoxycorticosterone NN B-Chemical
and CC O
11 CD B-Chemical
- HYPH I-Chemical
deoxycortisol NN I-Chemical
levels NNS O
, , O
plasma NN O
aldosterone NN B-Chemical
values NNS O
were VBD O
raised VBN O
, , O
with IN O
a DT O
concomitant JJ O
suppression NN O
of IN O
renin NN O
levels NNS O
. . O

Vitamin NN B-Chemical
D3 NN I-Chemical
toxicity NN O
in IN O
dairy NN O
cows NNS O
. . O

Treatment NN O
of IN O
tinnitus NN O
by IN O
intratympanic JJ O
instillation NN O
of IN O
lignocaine NN B-Chemical
( , O
lidocaine NN B-Chemical
) -RRB- O
2 CD O
per NN O
cent NN O
through IN O
ventilation NN O
tubes NNS O
. . O

Brain NN O
natriuretic JJ O
peptide NN O
is VBZ O
a DT O
predictor NN O
of IN O
anthracycline NN B-Chemical
- HYPH O
induced VBN O
cardiotoxicity NN O
. . O

Effect NN O
of IN O
fucoidan JJ B-Chemical
treatment NN O
on IN O
collagenase NN O
- HYPH O
induced VBN O
intracerebral JJ O
hemorrhage NN O
in IN O
rats NNS O
. . O

In IN O
high JJ O
doses NNS O
, , O
its PRP$ O
nonhematological JJ O
dose NN O
- HYPH O
limiting VBG O
toxicity NN O
is VBZ O
cardiomyopathy NN O
. . O

CONCLUSIONS NNS O
: : O
In IN O
the DT O
literature NN O
, , O
the DT O
most RBS O
- HYPH O
frequent JJ O
cause NN O
of IN O
hemolytic JJ O
uremic JJ O
syndrome NN O
in IN O
patients NNS O
following VBG O
renal JJ O
transplantation NN O
is VBZ O
recurrence NN O
of IN O
the DT O
hemolytic JJ O
uremic JJ O
syndrome NN O
. . O

In IN O
inflamed JJ O
preparations NNS O
, , O
the DT O
muscarinic JJ O
receptor NN O
antagonism NN O
on IN O
the DT O
phasic JJ O
component NN O
of IN O
the DT O
electrical JJ O
field NN O
stimulation NN O
- HYPH O
evoked VBN O
contraction NN O
was VBD O
decreased VBN O
and CC O
the DT O
pirenzepine NN B-Chemical
and CC O
4 CD B-Chemical
- HYPH I-Chemical
DAMP NN I-Chemical
antagonism NN O
on IN O
the DT O
tonic NN O
component NN O
was VBD O
much RB O
less RBR O
efficient JJ O
than IN O
in IN O
controls NNS O
. . O

In IN O
future NN O
, , O
this DT O
form NN O
of IN O
therapy NN O
can MD O
offer VB O
a DT O
safe JJ O
alternative NN O
in IN O
the DT O
treatment NN O
of IN O
cyclophosphamide NN B-Chemical
- HYPH O
induced VBN O
hemorrhagic JJ O
cystitis NN O
. . O

In IN O
the DT O
Ato NNP B-Chemical
+ SYM O
Dex NNP B-Chemical
group NN O
, , O
SBP NNP O
was VBD O
increased VBN O
from IN O
113 CD O
+ SYM O
/ SYM O
- SYM O
2 CD O
to IN O
119 CD O
+ CD O
/ SYM O
- HYPH O
2 CD O
mmHg NN O
on IN O
Days NNS O
4 CD O
to TO O
14 CD O
, , O
respectively RB O
( : O
P NN O
< SYM O
0 CD O
. . O
001 CD O
) -RRB- O
, , O
but CC O
was VBD O
significantly RB O
lower JJR O
than IN O
SBP NNP O
in IN O
the DT O
group NN O
treated VBN O
with IN O
Dex NNP B-Chemical
alone RB O
( : O
P NN O
< SYM O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

Endothelial JJ O
cell NN O
culture NN O
supernatants NNS O
separated VBN O
by IN O
ultrafiltration NN O
and CC O
ultracentrifugation NN O
from IN O
cells NNS O
treated VBN O
with IN O
EPO NNP O
and CC O
IL NN O
- HYPH O
3 CD O
significantly RB O
reduced VBD O
thymidine NN B-Chemical
incorporation NN O
into IN O
erythroid NN O
cells NNS O
as IN O
compared VBN O
to IN O
identical JJ O
fractions NNS O
obtained VBN O
from IN O
the DT O
media NNS O
of IN O
cells NNS O
cultured VBN O
with IN O
EPO NNP O
alone RB O
. . O

These DT O
are VBP O
nephrotoxic JJ O
, , O
but CC O
SRL NNP B-Chemical
seems VBZ O
to TO O
act VB O
differently RB O
displaying VBG O
only RB O
minor JJ O
nephrotoxic JJ O
effects NNS O
, , O
although IN O
this DT O
question NN O
is VBZ O
still RB O
open JJ O
. . O

Groups NNS O
3 CD O
and CC O
4 CD O
were VBD O
studied VBN O
at IN O
four CD O
and CC O
at IN O
six CD O
months NNS O
to TO O
assess VB O
the DT O
effect NN O
of IN O
enalapril NN B-Chemical
on IN O
progression NN O
of IN O
renal JJ O
injury NN O
in IN O
adriamycin NN B-Chemical
nephrosis NN O
. . O

The DT O
results NNS O
have VBP O
shown VBN O
that IN O
the DT O
degradation NN O
product NN O
p NN B-Chemical
- HYPH I-Chemical
choloroaniline NN I-Chemical
is VBZ O
not RB O
a DT O
significant JJ O
factor NN O
in IN O
chlorhexidine NN B-Chemical
- HYPH I-Chemical
digluconate NN I-Chemical
associated VBN O
erosive JJ O
cystitis NN O
. . O

At RB O
least RBS O
one CD O
episode NN O
of IN O
grade NN O
3 CD O
or CC O
4 CD O
granulocytopenia NN O
was VBD O
seen VBN O
in IN O
59 CD O
% NN O
of IN O
patients NNS O
. . O

BACKGROUND NN O
AND CC O
OBJECTIVE NN O
: : O
Despite IN O
advantages NNS O
of IN O
induction NN O
and CC O
maintenance NN O
of IN O
anaesthesia NN O
with IN O
sevoflurane NN B-Chemical
, , O
postoperative JJ O
nausea NN O
and CC O
vomiting NN O
occurs VBZ O
frequently RB O
. . O

To IN O
date NN O
there EX O
has VBZ O
been VBN O
little JJ O
documentation NN O
of IN O
clinically RB O
significant JJ O
proteinuria NN O
linked VBN O
with IN O
the DT O
use NN O
of IN O
sirolimus NN B-Chemical
. . O

In IN O
the DT O
initial JJ O
6 CD O
months NNS O
since IN O
it PRP O
' '' O
s POS O
introduction NN O
, , O
12 CD O
overdose NN O
cases NNS O
have VBP O
been VBN O
reported VBN O
to IN O
The DT O
National NNP O
Poisons NNPS O
Information NNP O
Centre NNP O
. . O

Further JJ O
studies NNS O
of IN O
specifically RB O
elderly JJ O
patients NNS O
are VBP O
now RB O
required VBN O
to TO O
establish VB O
safer JJR O
and CC O
more RBR O
appropriate JJ O
guidelines NNS O
for IN O
drug NN O
therapy NN O
. . O

Immediate JJ O
allergic JJ O
reactions NNS O
to IN O
amoxicillin NN B-Chemical
. . O

Effects NNS O
of IN O
tetrandrine NN B-Chemical
and CC O
fangchinoline NN B-Chemical
on IN O
experimental JJ O
thrombosis NN O
in IN O
mice NNS O
and CC O
human JJ O
platelet NN O
aggregation NN O
. . O

Using VBG O
this DT O
rationale NN O
, , O
the DT O
8 CD B-Chemical
- HYPH I-Chemical
aminoquinoline NN I-Chemical
WR242511 NNP B-Chemical
, , O
a DT O
potent JJ O
long RB O
- HYPH O
lasting VBG O
MHb NNP O
former NN O
in IN O
rodents NNS O
and CC O
beagle NN O
dogs NNS O
, , O
was VBD O
studied VBN O
in IN O
the DT O
rhesus NN O
monkey NN O
for IN O
advanced JJ O
development NN O
as IN O
a DT O
potential JJ O
CN NNP O
pretreatment NN O
. . O

Sirolimus NNP B-Chemical
is VBZ O
a DT O
novel JJ O
immunosuppressant NN O
with IN O
potent JJ O
antiproliferative JJ O
actions NNS O
through IN O
its PRP$ O
ability NN O
to TO O
inhibit VB O
the DT O
raptor NN O
- HYPH O
containing VBG O
mammalian JJ O
target NN O
of IN O
rapamycin NN B-Chemical
protein NN O
kinase NN O
. . O

Recently RB O
, , O
however RB O
, , O
we PRP O
have VBP O
had VBN O
an DT O
increase NN O
of IN O
patients NNS O
who WP O
are VBP O
presenting VBG O
after IN O
OLTX NNP O
with IN O
end JJ O
- HYPH O
stage NN O
renal JJ O
disease NN O
( , O
ESRD NNP O
) -RRB- O
. . O

SUMMARY NN O
: : O
The DT O
patient NN O
' POS O
s POS O
medical JJ O
and CC O
dental JJ O
histories NNS O
along IN O
with IN O
radiographic JJ O
and CC O
clinical JJ O
findings NNS O
lead VBP O
to IN O
a DT O
diagnosis NN O
of IN O
"""" `` O
meth NN O
mouth NN O
. , O
"""" '' O
Although IN O
three CD O
different JJ O
dental JJ O
treatment NN O
modalities NNS O
( , O
either CC O
conventional JJ O
or CC O
implant NN O
- HYPH O
supported VBN O
) , O
have VBP O
been VBN O
offered VBN O
to IN O
the DT O
patient NN O
since IN O
August NNP O
2007 CD O
, , O
the DT O
patient NN O
has VBZ O
yet RB O
to TO O
initiate VB O
any DT O
treatment NN O
. . O

The DT O
average JJ O
time NN O
of IN O
death NN O
was VBD O
delayed VBN O
. . O

Reports NNS O
of IN O
persistent JJ O
paralysis NN O
after IN O
the DT O
discontinuance NN O
of IN O
these DT O
drugs NNS O
have VBP O
most RBS O
often RB O
involved VBN O
aminosteroid NN O
- HYPH O
based VBN O
NMBAs NNS O
such JJ O
as IN O
vecuronium NN B-Chemical
bromide NN I-Chemical
, , O
especially RB O
when WRB O
used VBN O
in IN O
conjunction NN O
with IN O
corticosteroids NNS O
. . O

w LS O
. . O
once RB O
daily RB O
to IN O
rats NNS O
for IN O
1 CD O
, , O
3 CD O
, , O
6 CD O
, , O
9 CD O
and CC O
12 CD O
months NNS O
revealed VBD O
neurological JJ O
disorders NNS O
indicating VBG O
cerebellum NN O
damage NN O
( : O
"""" `` O
valproate NN B-Chemical
encephalopathy NN O
"""" '' O
) -RRB- O
. . O

Leucovorin NNP B-Chemical
rescue NN O
was VBD O
initiated VBN O
12 CD O
hours NNS O
after IN O
the DT O
end NN O
of IN O
the DT O
infusion NN O
with IN O
a DT O
loading VBG O
dose NN O
of IN O
200 CD O
mg NNS O
/ SYM O
m2 CD O
followed VBN O
by IN O
12 CD O
mg NN O
/ SYM O
m2 CD O
every DT O
three CD O
hours NNS O
for IN O
six CD O
doses NNS O
and CC O
then RB O
every DT O
six CD O
hours NNS O
until IN O
the DT O
plasma NN O
methotrexate NN B-Chemical
level NN O
decreased VBD O
to IN O
less JJR O
than IN O
1 CD O
X NN O
10 CD O
( SYM O
- HYPH O
7 CD O
) SYM O
mol NN O
/ SYM O
L NN O
. . O

The DT O
first JJ O
case NN O
involved VBD O
a DT O
59 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
man NN O
who WP O
used VBD O
Dormex NNP B-Chemical
, , O
which WDT O
contains VBZ O
hydrogen NN B-Chemical
cyanamide NN I-Chemical
, , O
without IN O
protection NN O
after IN O
consuming VBG O
a DT O
large JJ O
amount NN O
of IN O
alcohol NN B-Chemical
during IN O
a DT O
meal NN O
. . O

Dexamethasone NNP O
is VBZ O
frequently RB O
administered VBN O
to IN O
the DT O
developing VBG O
fetus NN O
to TO O
accelerate VB O
pulmonary JJ O
development NN O
. . O

No DT O
histopathological JJ O
alterations NNS O
or CC O
differences NNS O
in IN O
bone NN O
formation NN O
were VBD O
seen VBN O
in IN O
the DT O
limbs NNS O
or CC O
toes NNS O
of IN O
any DT O
chicks NNS O
from IN O
any DT O
group NN O
; , O
however RB O
, , O
extensive JJ O
cranial JJ O
hemorrhage NN O
occurred VBD O
in IN O
all DT O
nicotine NN B-Chemical
sulfate NN O
- HYPH O
treated VBN O
chicks NNS O
. . O

Reduction NN O
in IN O
injection NN O
pain NN O
using VBG O
buffered VBN O
lidocaine NN B-Chemical
as IN O
a DT O
local JJ O
anesthetic NN O
before IN O
cardiac JJ O
catheterization NN O
. . O

Twin NN O
preterm JJ O
neonates NNS O
with IN O
cardiac JJ O
toxicity NN O
related VBN O
to IN O
lopinavir NN B-Chemical
/ SYM I-Chemical
ritonavir NN I-Chemical
therapy NN O
. . O

Effects NNS O
of IN O
calcium NN B-Chemical
channel NN O
blockers NNS O
on IN O
bupivacaine NN B-Chemical
- HYPH O
induced VBN O
toxicity NN O
. . O

At IN O
presentation NN O
, , O
advanced JJ O
encephalopathy NN O
and CC O
cerebral JJ O
edema NN O
were VBD O
present JJ O
in IN O
51 CD O
( SYM O
76 CD O
% NN O
) -RRB- O
and CC O
29 CD O
( SYM O
41 CD O
. . O
4 CD O
% NN O
) SYM O
patients NNS O
, , O
respectively RB O
. . O

Whether IN O
pentoxifylline NN B-Chemical
inhibits VBZ O
dipyridamole NN B-Chemical
- HYPH O
induced VBN O
coronary JJ O
hyperemia NN O
like IN O
other JJ O
methylxanthines NNS B-Chemical
such JJ O
as IN O
theophylline NN B-Chemical
and CC O
should MD O
be VB O
stopped VBN O
prior RB O
to IN O
dipyridamole NN B-Chemical
- HYPH O
thallium NN B-Chemical
- HYPH O
201 CD O
imaging NN O
is VBZ O
unknown JJ O
. . O

METH NNP B-Chemical
depleted VBD O
DA NN B-Chemical
, , O
caused VBD O
microglial JJ O
activation NN O
, , O
and CC O
increased VBN O
body NN O
temperature NN O
in IN O
CX3CR1 NN O
knockout NN O
mice NNS O
to IN O
the DT O
same JJ O
extent NN O
and CC O
over IN O
the DT O
same JJ O
time NN O
course NN O
seen VBN O
in IN O
wild JJ O
- HYPH O
type NN O
controls NNS O
. . O

MR NNP O
imaging NN O
with IN O
quantitative JJ O
diffusion NN O
mapping NN O
of IN O
tacrolimus NN B-Chemical
- HYPH O
induced VBN O
neurotoxicity NN O
in IN O
organ NN O
transplant NN O
patients NNS O
. . O

For IN O
glyburide NN B-Chemical
, , O
a DT O
second JJ O
- HYPH O
generation NN O
sulfonylurea NN B-Chemical
, , O
only RB O
two CD O
brief JJ O
reports NNS O
of IN O
hepatotoxicity NN O
exist VBP O
. . O

null NN O
of IN O
the DT O
patients NNS O
complained VBD O
of IN O
subjective JJ O
hearing NN O
loss NN O
. . O

Over IN O
the DT O
long JJ O
- HYPH O
term NN O
chronic JJ O
phase NN O
( , O
120 CD O
days NNS O
after IN O
transplantation NN O
) -RRB- O
, , O
only RB O
25 CD O
% NN O
of IN O
BMC NNP O
- HYPH O
treated VBN O
epileptic JJ O
animals NNS O
had VBD O
seizures NNS O
, , O
but CC O
with IN O
a DT O
lower JJR O
frequency NN O
and CC O
duration NN O
compared VBN O
to IN O
the DT O
epileptic JJ O
control NN O
group NN O
. . O

We PRP O
conclude VBP O
that IN O
GLEPP1 NNP O
expression NN O
, , O
unlike IN O
podocalyxin NN O
, , O
reflects VBZ O
podocyte NN O
injury NN O
induced VBN O
by IN O
PAN NNP B-Chemical
. . O

Nine CD O
patients NNS O
exhibited VBD O
mild JJ O
to IN O
moderate JJ O
extrapyramidal JJ O
concomitant JJ O
symptoms NNS O
; : O
no DT O
other JJ O
side NN O
effects NNS O
were VBD O
observed VBN O
. . O

Deep JJ O
- HYPH O
tendon NN O
reflexes NNS O
were VBD O
decreased VBN O
especially RB O
in IN O
the DT O
right JJ O
leg NN O
. . O

Skin NN O
tests NNS O
were VBD O
performed VBN O
with IN O
benzylpenicilloyl NN B-Chemical
- HYPH I-Chemical
poly NN I-Chemical
- HYPH I-Chemical
L NN I-Chemical
- HYPH I-Chemical
lysine NN I-Chemical
( , O
BPO NNP B-Chemical
- HYPH I-Chemical
PLL NNP I-Chemical
) -RRB- O
, , O
benzylpenicilloate NN B-Chemical
, , O
benzylpenicillin NN B-Chemical
( , O
PG NNP B-Chemical
) -RRB- O
, , O
ampicillin NN B-Chemical
( , O
AMP NNP B-Chemical
) -RRB- O
, , O
and CC O
AX NNP B-Chemical
. . O

Eighty CD O
- HYPH O
nine CD O
new JJ O
referral NN O
hypertensive JJ O
out IN O
- HYPH O
patients NNS O
and CC O
46 CD O
new JJ O
referral JJ O
non NN O
- HYPH O
hypertensive JJ O
chronically RB O
physically RB O
ill JJ O
out IN O
- HYPH O
patients NNS O
completed VBD O
a DT O
mood NN O
rating NN O
scale NN O
at IN O
regular JJ O
intervals NNS O
for IN O
one CD O
year NN O
. . O

Prolactin NN O
exceeded VBD O
20 CD O
ng NNS O
. . O
/ SYM O
ml UH O
. . O
in IN O
5 CD O
men NNS O
and CC O
was VBD O
normal JJ O
in IN O
2 CD O
at IN O
repeat NN O
determination NN O
. . O

Of IN O
concern NN O
was VBD O
the DT O
occurrence NN O
of IN O
four CD O
thromboembolic JJ O
events NNS O
. . O

Subjects NNS O
were VBD O
able JJ O
to TO O
reliably RB O
discriminate VB O
pain NN O
magnitude NN O
and CC O
duration NN O
across IN O
capsaicin NN B-Chemical
doses NNS O
( : O
both DT O
p NN O
< SYM O
0 CD O
. . O
001 CD O
) -RRB- O
, , O
regardless RB O
of IN O
whether IN O
first JJ O
- HYPH O
time NN O
ratings NNS O
were VBD O
requested VBN O
immediately RB O
, , O
after IN O
one CD O
hour NN O
or CC O
after IN O
one CD O
day NN O
. . O

The DT O
beneficial JJ O
effect NN O
of IN O
Adriamycin NNP B-Chemical
appears VBZ O
obvious JJ O
and CC O
might MD O
be VB O
related VBN O
to IN O
the DT O
drug NN O
itself PRP O
, , O
the DT O
early JJ O
and CC O
repeated VBN O
instillations NNS O
after IN O
TUR NNP O
, , O
or CC O
both DT O
. . O

Introduction NN O
of IN O
the DT O
DSM NNP O
- HYPH O
IV NN O
diagnosis NN O
of IN O
CIMD NNP O
did VBD O
not RB O
substantially RB O
affect VB O
rates NNS O
of IN O
the DT O
other JJ O
depressive JJ O
disorders NNS O
. . O

We PRP O
conclude VBP O
from IN O
these DT O
studies NNS O
that IN O
CX3CR1 NN O
signaling NN O
does VBZ O
not RB O
modulate VB O
METH NN B-Chemical
neurotoxicity NN O
or CC O
microglial JJ O
activation NN O
. . O

Long JJ O
- HYPH O
term NN O
glutamate NN B-Chemical
supplementation NN O
failed VBD O
to TO O
protect VB O
against IN O
peripheral JJ O
neurotoxicity NN O
of IN O
paclitaxel NN B-Chemical
. . O

This DT O
case NN O
documents VBZ O
acute JJ O
drug NN O
- HYPH O
related VBN O
vanishing VBG O
bile NN O
duct NN O
syndrome NN O
in IN O
the DT O
pediatric JJ O
age NN O
group NN O
and CC O
suggests VBZ O
shared VBN O
immune JJ O
mechanisms NNS O
in IN O
the DT O
pathogenesis NN O
of IN O
both CC O
Stevens NNP O
- HYPH O
Johnson NNP O
syndrome NN O
and CC O
vanishing VBG O
bile NN O
duct NN O
syndrome NN O
. . O

Peripheral JJ O
neuropathy NN O
has VBZ O
been VBN O
noted VBN O
as IN O
a DT O
complication NN O
of IN O
therapy NN O
with IN O
perhexiline NN B-Chemical
maleate NN I-Chemical
, , O
a DT O
drug NN O
widely RB O
used VBN O
in IN O
France NNP O
( , O
and CC O
in IN O
clinical JJ O
trials NNS O
in IN O
the DT O
United NNP O
States NNP O
) , O
for IN O
the DT O
prophylactic JJ O
treatment NN O
of IN O
angina NN O
pectoris NN O
. . O

Acute JJ O
normal JJ O
tissue NN O
toxicities NNS O
( : O
i LS O
. . O
e LS O
. . O
, , O
leukopenia NN O
and CC O
thrombocytopenia NN O
) NFP O
and CC O
late JJ O
normal JJ O
tissue NN O
toxicities NNS O
( : O
i LS O
. . O
e LS O
. . O
, , O
myocardial JJ O
and CC O
kidney NN O
injury NN O
) -RRB- O
were VBD O
evaluated VBN O
by IN O
functional JJ O
/ SYM O
physiological JJ O
assays NNS O
and CC O
by IN O
morphological JJ O
techniques NNS O
. . O

To TO O
assess VB O
the DT O
safety NN O
of IN O
the DT O
ACE NNP B-Chemical
inhibitor NN I-Chemical
enalapril NN B-Chemical
a DT O
multicenter NN O
, , O
randomized VBN O
, , O
prazosin NN B-Chemical
- HYPH O
controlled VBN O
trial NN O
was VBD O
designed VBN O
that WDT O
compared VBD O
the DT O
incidence NN O
and CC O
severity NN O
of IN O
symptomatic JJ O
hypotension NN O
on IN O
the DT O
first JJ O
day NN O
of IN O
treatment NN O
. . O

The DT O
area NN O
under IN O
the DT O
plasma NN O
concentration NN O
time NN O
curve NN O
at IN O
90 CD O
min NN O
was VBD O
4 CD O
- SYM O
12 CD O
times NNS O
greater JJR O
than IN O
for IN O
oral JJ O
drug NN O
, , O
suggesting VBG O
the DT O
existence NN O
of IN O
an DT O
absorption NN O
- HYPH O
limiting VBG O
process NN O
in IN O
the DT O
intestine NN O
, , O
and CC O
providing VBG O
an DT O
alternate JJ O
form NN O
of IN O
administration NN O
for IN O
quaternary JJ O
drugs NNS O
. . O

METHODS NNS O
: : O
Fourteen CD O
patients NNS O
chronically RB O
infected VBN O
with IN O
hepatitis NNP O
C NNP O
virus NN O
were VBD O
treated VBN O
by IN O
pegylated JJ B-Chemical
interferon NN I-Chemical
alpha NN I-Chemical
2a NN I-Chemical
and CC O
ribavirin NN B-Chemical
. . O

Steady JJ O
state NN O
arterial JJ O
plasma NN O
concentrations NNS O
of IN O
atrial JJ O
natriuretic JJ O
factor NN O
were VBD O
39 CD O
+ CD O
/ SYM O
- SYM O
10 CD O
pg NN O
/ SYM O
ml CD O
( , O
n CD O
= SYM O
6 CD O
) -RRB- O
during IN O
infusions NNS O
of IN O
saline NN O
and CC O
284 CD O
+ SYM O
/ SYM O
- SYM O
24 CD O
pg NN O
/ SYM O
ml NN O
( , O
n CD O
= SYM O
6 CD O
) SYM O
and CC O
1520 CD O
+ SYM O
/ SYM O
- SYM O
300 CD O
pg NN O
/ SYM O
ml NN O
( , O
n CD O
= SYM O
9 CD O
) -RRB- O
during IN O
0 CD O
. . O
03 CD O
and CC O
0 CD O
. . O
1 CD O
microgram NN O
/ SYM O
kg NNS O
/ SYM O
min NN O
infusions NNS O
of IN O
the DT O
factor NN O
. . O
( , O
ABSTRACT NN O
TRUNCATED VBN O
AT IN O
250 CD O
WORDS NNS O
) -RRB- O

A DT O
17 CD O
- HYPH O
day NN O
- HYPH O
old JJ O
infant NN O
on IN O
isoniazid NN B-Chemical
therapy NN O
13 CD O
mg NN O
/ SYM O
kg NN O
daily RB O
from IN O
birth NN O
because IN O
of IN O
maternal JJ O
tuberculosis NN O
was VBD O
admitted VBN O
after IN O
4 CD O
days NNS O
of IN O
clonic JJ O
fits NNS O
. . O

The DT O
3 CD O
- HYPH O
week NN O
sulphasalazine NN B-Chemical
syndrome NN O
strikes VBZ O
again RB O
. . O

Tremor NNP O
was VBD O
measured VBN O
simultaneously RB O
by IN O
two CD O
independent JJ O
observers NNS O
. . O

The DT O
acute JJ O
toxicity NN O
of IN O
OPs NNS B-Chemical
is VBZ O
the DT O
result NN O
of IN O
their PRP$ O
irreversible JJ O
binding NN O
with IN O
AChEs NNS O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
( -LRB- O
CNS NNP O
) -RRB- O
, , O
which WDT O
elevates VBZ O
acetylcholine NN B-Chemical
( , O
ACh NNP B-Chemical
) -RRB- O
levels NNS O
. . O

These DT O
findings NNS O
reveal VBP O
the DT O
differential JJ O
impact NN O
of IN O
immune JJ O
escape NN O
variants NNS O
on IN O
the DT O
replication NN O
and CC O
drug NN O
susceptibility NN O
of IN O
complex JJ O
HBV NNP O
mutants NNS O
, , O
supporting VBG O
the DT O
need NN O
of IN O
close JJ O
surveillance NN O
and CC O
treatment NN O
adjustment NN O
in IN O
response NN O
to IN O
the DT O
selection NN O
of IN O
distinct JJ O
mutational JJ O
patterns NNS O
. . O

This DT O
was VBD O
followed VBN O
by IN O
ventricular JJ O
fibrillation NN O
in IN O
one CD O
patient NN O
and CC O
sudden JJ O
death NN O
in IN O
another DT O
. . O

Antituberculosis NN B-Chemical
therapy NN O
- HYPH O
induced VBN O
acute JJ O
liver NN O
failure NN O
: : O
magnitude NN O
, , O
profile NN O
, , O
prognosis NN O
, , O
and CC O
predictors NNS O
of IN O
outcome NN O
. . O

Although IN O
the DT O
intraocular JJ O
pressure NN O
elevation NN O
caused VBN O
by IN O
secondary JJ O
acute JJ O
angle NN O
- HYPH O
closure NN O
glaucoma NN O
decreased VBD O
and CC O
ocular JJ O
pain NN O
diminished VBD O
, , O
inexorable JJ O
papilledema NN O
and CC O
exudative JJ O
retinal JJ O
detachment NN O
continued VBD O
for IN O
3 CD O
weeks NNS O
. . O

CONCLUSIONS NNS O
: : O
The DT O
combination NN O
of IN O
GEM NNP B-Chemical
and CC O
VNB NNP B-Chemical
is VBZ O
moderately RB O
active JJ O
and CC O
well RB O
tolerated VBN O
except IN O
in IN O
patients NNS O
age NN O
> SYM O
/ SYM O
= SYM O
75 CD O
years NNS O
. . O

Features NNS O
of IN O
organic JJ O
mental JJ O
disorder NN O
( -LRB- O
delirium NN O
) -RRB- O
were VBD O
not RB O
present JJ O
. . O

This DT O
work NN O
evaluates VBZ O
the DT O
effects NNS O
of IN O
TAM NNP B-Chemical
on IN O
isolated VBN O
human JJ O
erythrocytes NNS O
, , O
attempting VBG O
to TO O
identify VB O
the DT O
underlying VBG O
mechanisms NNS O
on IN O
TAM NNP B-Chemical
- HYPH O
induced VBN O
hemolytic JJ O
anemia NN O
and CC O
the DT O
involvement NN O
of IN O
biomembranes NNS O
in IN O
its PRP$ O
cytostatic JJ O
action NN O
mechanisms NNS O
. . O

GLEPP1 NNP O
receptor NN O
tyrosine NN B-Chemical
phosphatase NN O
( , O
Ptpro NNP O
) -RRB- O
in IN O
rat NN O
PAN NNP B-Chemical
nephrosis NN O
. . O

Paclitaxel NNP B-Chemical
, , O
cisplatin NN B-Chemical
, , O
and CC O
gemcitabine NN B-Chemical
combination NN O
chemotherapy NN O
within IN O
a DT O
multidisciplinary JJ O
therapeutic JJ O
approach NN O
in IN O
metastatic JJ O
nonsmall JJ O
cell NN O
lung NN O
carcinoma NN O
. . O

Cauda NNP O
equina NN O
syndrome NN O
after IN O
epidural JJ O
steroid NN B-Chemical
injection NN O
: : O
a DT O
case NN O
report NN O
. . O

Because IN O
such PDT O
a DT O
compensatory JJ O
mechanism NN O
most RBS O
likely RB O
occurs VBZ O
to TO O
reduce VB O
injury NN O
to IN O
the DT O
brain NN O
from IN O
cytotoxic JJ O
compounds NNS O
, , O
the DT O
present JJ O
data NNS O
substantiate VBP O
the DT O
concept NN O
that IN O
MRP2 NNP O
performs VBZ O
a DT O
protective JJ O
role NN O
in IN O
the DT O
BBB NNP O
. . O

To TO O
test VB O
the DT O
validity NN O
of IN O
the DT O
hypothesis NN O
that IN O
hypomethylation NN O
of IN O
DNA NNP O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
initiation NN O
of IN O
carcinogenic JJ O
process NN O
, , O
5 CD B-Chemical
- HYPH I-Chemical
azacytidine NN I-Chemical
( -LRB- O
5 CD B-Chemical
- HYPH I-Chemical
AzC NN I-Chemical
) -RRB- O
( , O
10 CD O
mg NNS O
/ SYM O
kg NN O
) -RRB- O
, , O
an DT O
inhibitor NN O
of IN O
DNA NN O
methylation NN O
, , O
was VBD O
given VBN O
to IN O
rats NNS O
during IN O
the DT O
phase NN O
of IN O
repair NN O
synthesis NN O
induced VBN O
by IN O
the DT O
three CD O
carcinogens NNS O
, , O
benzo FW B-Chemical
[ -LRB- I-Chemical
a DT I-Chemical
] -RRB- I-Chemical
- HYPH I-Chemical
pyrene NN I-Chemical
( , O
200 CD O
mg NNS O
/ SYM O
kg NN O
) -RRB- O
, , O
N NNP B-Chemical
- HYPH I-Chemical
methyl NN I-Chemical
- HYPH I-Chemical
N NNP I-Chemical
- HYPH I-Chemical
nitrosourea NN I-Chemical
( : O
60 CD O
mg NNS O
/ SYM O
kg CD O
) -RRB- O
and CC O
1 CD B-Chemical
, , I-Chemical
2 CD I-Chemical
- HYPH I-Chemical
dimethylhydrazine NN I-Chemical
( , O
1 CD B-Chemical
, , I-Chemical
2 CD I-Chemical
- HYPH I-Chemical
DMH NN I-Chemical
) -RRB- O
( : O
100 CD O
mg NNS O
/ SYM O
kg NNS O
) -RRB- O
. . O

NX NNP O
caused VBD O
an DT O
additive JJ O
deterioration NN O
in IN O
GFR NNP O
which WDT O
, , O
however RB O
, , O
was VBD O
ameliorated VBN O
by IN O
HP NNP O
. . O

Pulmonary JJ O
shunt NN O
and CC O
cardiovascular JJ O
responses NNS O
to IN O
CPAP NNP O
during IN O
nitroprusside NN B-Chemical
- HYPH O
induced VBN O
hypotension NN O
. . O

An DT O
initial JJ O
dose NN O
of IN O
0 CD O
. . O
1 CD O
microgram NN O
. . O
kg NN O
- HYPH O
1 CD O
. . O
min NN O
- HYPH O
1 CD O
of IN O
PGE1 NNP B-Chemical
( : O
15 CD O
patients NNS O
) -RRB- O
, , O
or CC O
10 CD O
micrograms NNS O
. . O
kg NN O
- HYPH O
1 CD O
. . O
min NN O
- HYPH O
1 CD O
of IN O
TMP NNP B-Chemical
( SYM O
15 CD O
patients NNS O
) -RRB- O
was VBD O
administered VBN O
intravenously RB O
after IN O
the DT O
dural JJ O
opening NN O
and CC O
the DT O
dose NN O
was VBD O
adjusted VBN O
to TO O
maintain VB O
the DT O
mean JJ O
arterial JJ O
blood NN O
pressure NN O
( -LRB- O
MAP NNP O
) -RRB- O
at IN O
about RB O
60 CD O
mmHg NN O
. . O

Effect NN O
of IN O
green JJ B-Chemical
tea NN I-Chemical
and CC O
vitamin NN B-Chemical
E NN I-Chemical
combination NN O
in IN O
isoproterenol NN B-Chemical
induced VBD O
myocardial JJ O
infarction NN O
in IN O
rats NNS O
. . O

6 CD O
courses NNS O
per IN O
patient NN O
. . O

Clinical JJ O
examinations NNS O
and CC O
skin NN O
, , O
oral JJ O
and CC O
parenteral JJ O
challenges NNS O
with IN O
different JJ O
corticosteroids NNS B-Chemical
and CC O
ELISA NNP O
tests NNS O
were VBD O
performed VBN O
. . O

Finally RB O
, , O
6 CD O
weeks NNS O
later RB O
, , O
diffuse JJ O
chorioretinal JJ O
atrophy NN O
with IN O
optic JJ O
atrophy NN O
occurred VBD O
and CC O
the DT O
vision NN O
in IN O
his PRP$ O
left JJ O
eye NN O
was VBD O
lost VBN O
. . O

BACKGROUND NN O
: : O
Cyproterone NN B-Chemical
acetate NN I-Chemical
combined VBN O
with IN O
ethinyl NN B-Chemical
estradiol NN I-Chemical
( , O
CPA NNP B-Chemical
/ SYM O
EE NNP B-Chemical
) -RRB- O
is VBZ O
licensed VBN O
in IN O
the DT O
UK NNP O
for IN O
the DT O
treatment NN O
of IN O
women NNS O
with IN O
acne NN O
and CC O
hirsutism NN O
and CC O
is VBZ O
also RB O
a DT O
treatment NN O
option NN O
for IN O
polycystic JJ O
ovary NN O
syndrome NN O
( -LRB- O
PCOS NNP O
) -RRB- O
. . O

RESULTS NNS O
: : O
Clomipramine NN B-Chemical
exposure NN O
in IN O
immature JJ O
rats NNS O
produced VBD O
significant JJ O
behavioral JJ O
and CC O
biochemical JJ O
changes NNS O
that WDT O
include VBP O
enhanced VBN O
anxiety NN O
( , O
elevated VBN O
plus CC O
maze NN O
and CC O
marble NN O
burying NN O
) -RRB- O
, , O
behavioral JJ O
inflexibility NN O
( , O
perseveration NN O
in IN O
the DT O
spontaneous JJ O
alternation NN O
task NN O
and CC O
impaired JJ O
reversal NN O
learning NN O
) -RRB- O
, , O
working VBG O
memory NN O
impairment NN O
( , O
e LS O
. . O
g LS O
. . O
, , O
win NN O
- HYPH O
shift NN O
paradigm NN O
) -RRB- O
, , O
hoarding NN O
, , O
and CC O
corticostriatal JJ O
dysfunction NN O
. . O

Few JJ O
days NNS O
later RB O
, , O
the DT O
patient NN O
used VBD O
another DT O
200 CD O
mg NN O
ketoconazole NN B-Chemical
tablet NN O
, , O
and CC O
within IN O
an DT O
hour NN O
experienced VBD O
a DT O
similar JJ O
clinical JJ O
picture NN O
, , O
which WDT O
resolved VBD O
again RB O
spontaneously RB O
within IN O
hours NNS O
. . O

Electrical JJ O
recordings NNS O
from IN O
the DT O
hippocampus NN O
showed VBD O
a DT O
rhythmic JJ O
progression NN O
in IN O
EEG NNP O
frequency NN O
and CC O
voltage NN O
with IN O
clinical JJ O
seizure NN O
expression NN O
. . O

Urinary JJ O
sodium NN B-Chemical
excretion NN O
reached VBD O
signficantly RB O
lower JJR O
values NNS O
in IN O
sgk1 NN O
( : O
+ SYM O
/ SYM O
+ CC O
) -RRB- O
mice NNS O
( : O
15 CD O
+ SYM O
/ SYM O
- HYPH O
5 CD O
mumol NN O
/ SYM O
mg NN O
crea NN O
) -RRB- O
than IN O
in IN O
sgk1 NN O
( SYM O
- HYPH O
/ SYM O
- HYPH O
) SYM O
mice NNS O
( , O
35 CD O
+ SYM O
/ SYM O
- HYPH O
5 CD O
mumol NN O
/ SYM O
mg NN O
crea NN O
) -RRB- O
and CC O
was VBD O
associated VBN O
with IN O
a DT O
significantly RB O
higher JJR O
body NN O
weight NN O
gain NN O
in IN O
sgk1 NN O
( : O
+ NFP O
/ SYM O
+ CC O
) NFP O
compared VBN O
with IN O
sgk1 NN O
( : O
- HYPH O
/ SYM O
- HYPH O
) SYM O
mice NNS O
( : O
+ SYM O
6 CD O
. . O
6 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
7 CD O
vs NN O
. . O
+ SYM O
4 CD O
. . O
1 CD O
+ NN O
/ SYM O
- HYPH O
0 CD O
. . O
8 CD O
g NN O
) -RRB- O
. . O

Cardiac JJ O
toxicity NN O
observed VBN O
in IN O
association NN O
with IN O
high JJ O
- HYPH O
dose NN O
cyclophosphamide NN B-Chemical
- HYPH O
based VBN O
chemotherapy NN O
for IN O
metastatic JJ O
breast NN O
cancer NN O
. . O

Since IN O
the DT O
introduction NN O
of IN O
angiotensin NN B-Chemical
converting VBG I-Chemical
enzyme NN I-Chemical
( -LRB- I-Chemical
ACE NNP I-Chemical
) -RRB- I-Chemical
inhibitors NNS I-Chemical
into IN O
the DT O
adjunctive JJ O
treatment NN O
of IN O
patients NNS O
with IN O
congestive JJ O
heart NN O
failure NN O
, , O
cases NNS O
of IN O
severe JJ O
hypotension NN O
, , O
especially RB O
on IN O
the DT O
first JJ O
day NN O
of IN O
treatment NN O
, , O
have VBP O
occasionally RB O
been VBN O
reported VBN O
. . O

These DT O
observations NNS O
indicate VBP O
that IN O
although IN O
the DT O
gamma NN B-Chemical
- HYPH I-Chemical
carboxyglutamate NN I-Chemical
residues NNS O
of IN O
matrix NN O
Gla NNP O
protein NN O
are VBP O
apparently RB O
required VBN O
for IN O
its PRP$ O
function NN O
as IN O
a DT O
calcification NN O
inhibitor NN O
, , O
they PRP O
are VBP O
not RB O
required VBN O
for IN O
its PRP$ O
accumulation NN O
at IN O
calcification NN O
sites NNS O
. . O

RESULTS NNS O
: : O
Sixty CD O
percent NN O
in IN O
Group NNP O
A NNP O
developed VBD O
postoperative JJ O
emetic JJ O
symptoms NNS O
, , O
headache NN O
, , O
or CC O
both DT O
; : O
1 CD O
patient NN O
in IN O
Group NNP O
B NNP O
developed VBD O
symptoms NNS O
. . O

Major JJ O
toxicities NNS O
were VBD O
cardiotoxicity NN O
and CC O
leukopenia NN O
. . O

In IN O
streptozotocin NN B-Chemical
- HYPH O
induced VBN O
hyperalgesia NN O
, , O
inducible JJ O
NO NNP B-Chemical
synthase NN O
participates VBZ O
in IN O
pronociceptive JJ O
activity NN O
of IN O
bradykinin NN B-Chemical
, , O
whereas IN O
in IN O
vincristine NN B-Chemical
- HYPH O
induced VBN O
hyperalgesia NN O
bradykinin NN B-Chemical
seemed VBD O
to TO O
activate VB O
neuronal JJ O
NO NNP B-Chemical
synthase NN O
pathway NN O
. . O

The DT O
lung NN O
weights NNS O
were VBD O
lower JJR O
and CC O
PaO2 NNP O
was VBD O
improved VBN O
in IN O
rats NNS O
given VBN O
this DT O
enzyme NN O
- HYPH O
blocking VBG O
agent NN O
. . O

A DT O
case NN O
of IN O
genuine JJ O
stress NN O
incontinence NN O
due IN O
to IN O
prazosin NN B-Chemical
, , O
a DT O
common JJ O
antihypertensive JJ O
drug NN O
, , O
is VBZ O
presented VBN O
. . O

In IN O
contrast NN O
, , O
in IN O
the DT O
nitrendipine NN B-Chemical
- HYPH O
treated VBN O
group NN O
albuminuria NN O
increased VBD O
from IN O
12 CD O
. . O
8 CD O
+ NN O
/ SYM O
- HYPH O
2 CD O
progressively RB O
to IN O
163 CD O
+ SYM O
/ SYM O
- HYPH O
55 CD O
compared VBN O
with IN O
19 CD O
. . O
2 CD O
+ NN O
/ SYM O
- SYM O
9 CD O
mg NN O
/ SYM O
24 CD O
hr NN O
in IN O
the DT O
hypertensive JJ O
controls NNS O
. . O

It PRP O
was VBD O
found VBN O
that IN O
he PRP O
was VBD O
a DT O
poor JJ O
metabolizer NN O
of IN O
all DT O
four CD O
drugs NNS O
, , O
indicating VBG O
that IN O
their PRP$ O
metabolism NN O
is VBZ O
under IN O
the DT O
same JJ O
genetic JJ O
control NN O
. . O

Components NNS O
of IN O
lemon NN O
essential JJ O
oil NN O
attenuate VBP O
dementia NN O
induced VBN O
by IN O
scopolamine NN B-Chemical
. . O

This DT O
low JJ O
percentage NN O
( : O
5 CD O
% NN O
) -RRB- O
of IN O
TDFS NNP O
must MD O
be VB O
evaluated VBN O
with IN O
respect NN O
to IN O
the DT O
efficacy NN O
of IN O
ifosfamide NN B-Chemical
in IN O
the DT O
treatment NN O
of IN O
mesenchymal JJ O
tumors NNS O
in IN O
children NNS O
. . O

Dopamine NN B-Chemical
D2 NN O
receptors NNS O
were VBD O
elevated VBN O
in IN O
the DT O
striatum NN O
, , O
whereas IN O
serotonin NN B-Chemical
2C NN O
, , O
but CC O
not RB O
serotonin NN B-Chemical
1A NN O
, , O
receptors NNS O
were VBD O
elevated VBN O
in IN O
the DT O
orbital JJ O
frontal JJ O
cortex NN O
. . O

Determining VBG O
testosterone NN B-Chemical
only RB O
in IN O
cases NNS O
of IN O
low JJ O
sexual JJ O
desire NN O
or CC O
abnormal JJ O
physical JJ O
examination NN O
would MD O
have VB O
missed VBN O
40 CD O
% NN O
of IN O
the DT O
cases NNS O
with IN O
low JJ O
testosterone NN B-Chemical
, , O
including VBG O
37 CD O
% NN O
of IN O
those DT O
subsequently RB O
improved VBN O
by IN O
androgen NN O
therapy NN O
. . O

Five CD O
of IN O
8 CD O
patients NNS O
( : O
63 CD O
% NN O
) , O
improved VBD O
during IN O
fusidic JJ B-Chemical
acid NN I-Chemical
treatment NN O
: : O
3 CD O
at IN O
two CD O
weeks NNS O
and CC O
2 CD O
after IN O
four CD O
weeks NNS O
. . O

Crescentic JJ O
fibrillary NN O
glomerulonephritis NN O
associated VBN O
with IN O
intermittent JJ O
rifampin NN B-Chemical
therapy NN O
for IN O
pulmonary JJ O
tuberculosis NN O
. . O

Prolonged JJ O
apnea NN O
in IN O
our PRP$ O
case NN O
ensued VBD O
because IN O
the DT O
information NN O
about IN O
suicidal JJ O
attempt NN O
by IN O
OP NNP B-Chemical
compound NN I-Chemical
was VBD O
concealed VBN O
from IN O
the DT O
treating NN O
team NN O
. . O

The DT O
dose NN O
- HYPH O
limiting VBG O
toxic JJ O
effect NN O
was VBD O
transient JJ O
noncumulative JJ O
granulocytopenia NN O
. . O

The DT O
present JJ O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
carcinogenicity NN O
experiment NN O
suggesting VBG O
that IN O
different JJ O
mechanisms NNS O
are VBP O
involved VBN O
in IN O
FANFT NNP B-Chemical
carcinogenesis NN O
in IN O
the DT O
bladder NN O
and CC O
forestomach NN O
, , O
and CC O
that IN O
aspirin NN B-Chemical
' '' O
s POS O
effect NN O
on IN O
FANFT NNP B-Chemical
in IN O
the DT O
forestomach NN O
is VBZ O
not RB O
due JJ O
to IN O
an DT O
irritant JJ O
effect NN O
associated VBN O
with IN O
increased VBN O
cell NN O
proliferation NN O
. . O

In IN O
patients NNS O
requiring VBG O
the DT O
concurrent JJ O
use NN O
of IN O
statins NNS B-Chemical
and CC O
CYP3A4 NN O
inhibitors NNS O
, , O
pravastatin NN B-Chemical
, , O
fluvastatin NN B-Chemical
, , O
and CC O
rosuvastatin NN B-Chemical
carry VBP O
the DT O
lowest JJS O
risk NN O
of IN O
drug NN O
interactions NNS O
; : O
atorvastatin NN B-Chemical
carries VBZ O
moderate JJ O
risk NN O
, , O
whereas IN O
simvastatin NN B-Chemical
and CC O
lovastatin NN B-Chemical
have VBP O
the DT O
highest JJS O
risk NN O
and CC O
should MD O
be VB O
avoided VBN O
in IN O
patients NNS O
taking VBG O
concomitant JJ O
CYP3A4 NNP O
inhibitors NNS O
. . O

The DT O
most RBS O
important JJ O
findings NNS O
were VBD O
that IN O
compared VBN O
with IN O
values NNS O
in IN O
control NN O
subjects NNS O
, , O
end NN O
- HYPH O
systolic JJ O
left JJ O
ventricular JJ O
posterior NN O
wall NN O
dimension NN O
and CC O
percent NN O
of IN O
left JJ O
ventricular JJ O
posterior NN O
wall NN O
thickening NN O
in IN O
doxorubicin NN B-Chemical
- HYPH O
treated VBN O
patients NNS O
were VBD O
decreased VBN O
at IN O
baseline NN O
study NN O
and CC O
these DT O
findings NNS O
were VBD O
more RBR O
clearly RB O
delineated VBN O
with IN O
dobutamine NN B-Chemical
stimulation NN O
. . O

Mean JJ O
serum NN O
creatinine NN B-Chemical
level NN O
before IN O
conversion NN O
was VBD O
2 CD O
. . O
21 CD O
mg NN O
/ SYM O
dL NN O
and CC O
thereafter RB O
, , O
4 CD O
. . O
93 CD O
mg NN O
/ SYM O
dL NN O
( : O
P NN O
= SYM O
. . O
02 CD O
) -RRB- O
. . O

Importantly RB O
, , O
a DT O
decrease NN O
in IN O
glutamate NN B-Chemical
uptake NN O
correlates VBZ O
negatively RB O
with IN O
an DT O
increase NN O
in IN O
the DT O
incidence NN O
of IN O
orofacial JJ O
diskinesia NN O
. . O

Intracavernous JJ O
epinephrine NN B-Chemical
: : O
a DT O
minimally RB O
invasive JJ O
treatment NN O
for IN O
priapism NN O
in IN O
the DT O
emergency NN O
department NN O
. . O

On IN O
the DT O
next JJ O
day NN O
he PRP O
died VBD O
, , O
probably RB O
as IN O
a DT O
result NN O
of IN O
heart NN O
failure NN O
. . O

Pretreatment NN O
of IN O
TCR NN B-Chemical
, , O
at IN O
a DT O
dose NN O
of IN O
0 CD O
. . O
5 CD O
mL CD O
/ SYM O
100 CD O
g NN O
bodyweight NN O
per IN O
day NN O
, , O
orally RB O
for IN O
30 CD O
days NNS O
, , O
prevented VBN O
the DT O
increase NN O
in IN O
lipid NN O
peroxidation NN O
and CC O
activity NN O
of IN O
marker NN O
enzymes NNS O
observed VBN O
in IN O
isoproterenol NN B-Chemical
- HYPH O
induced VBN O
rats NNS O
( , O
85 CD O
mg CD O
kg NNS O
( SYM O
- HYPH O
1 CD O
) -RRB- O
s NNS O
. . O
c NN O
. . O
for IN O
2 CD O
days NNS O
at IN O
an DT O
interval NN O
of IN O
24 CD O
h NN O
) -RRB- O
. . O

METHODS NNS O
: : O
We PRP O
present VBP O
the DT O
first JJ O
case NN O
report NN O
of IN O
a DT O
woman NN O
with IN O
hyperthyroidism NN O
treated VBN O
with IN O
propylthiouracil NN B-Chemical
in IN O
whom WP O
a DT O
syndrome NN O
of IN O
pericarditis NN O
, , O
fever NN O
, , O
and CC O
glomerulonephritis NN O
developed VBD O
. . O

Hysterosalpingography NN O
was VBD O
performed VBN O
on IN O
both DT O
patients NNS O
and CC O
, , O
in IN O
1 CD O
instance NN O
, , O
an DT O
abnormal JJ O
x NN O
- HYPH O
ray NN O
film NN O
was VBD O
reflected VBN O
by IN O
the DT O
gross JJ O
appearance NN O
of IN O
the DT O
uterine JJ O
cavity NN O
found VBN O
in IN O
the DT O
surgical JJ O
specimen NN O
. . O

BACKGROUND NN O
: : O
Papaverine NN B-Chemical
hydrochloride NN I-Chemical
is VBZ O
a DT O
direct JJ O
- HYPH O
acting VBG O
vasodilator NN O
used VBN O
to TO O
manage VB O
vasospasm NN O
during IN O
various JJ O
neurosurgical JJ O
operations NNS O
. . O

Five CD O
grafts NNS O
were VBD O
lost VBN O
and CC O
the DT O
patients NNS O
returned VBD O
to IN O
dialysis NN O
. . O

Through IN O
30 CD O
years NNS O
of IN O
widespread JJ O
use NN O
, , O
acetaminophen NN B-Chemical
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
remarkably RB O
safe JJ O
medication NN O
in IN O
therapeutic JJ O
dosages NNS O
. . O

Immunohistochemical JJ O
studies NNS O
with IN O
antibodies NNS O
to IN O
neurofilament NN O
proteins NNS O
on IN O
axonal JJ O
damage NN O
in IN O
experimental JJ O
focal JJ O
lesions NNS O
in IN O
rat NN O
. . O

RESULTS NNS O
: : O
As IN O
anticipated VBN O
, , O
adriamycin NN B-Chemical
elicited VBD O
nephrotic JJ O
range NN O
proteinuria NN O
, , O
renal JJ O
interstitial JJ O
damage NN O
and CC O
mild JJ O
focal JJ O
glomerulosclerosis NN O
. . O

It PRP O
was VBD O
determined VBN O
that IN O
the DT O
size NN O
of IN O
the DT O
bruising NN O
was VBD O
smaller JJR O
in IN O
the DT O
30 CD O
- HYPH O
second NN O
injection NN O
. . O

Suxamethonium NN B-Chemical
infusion NN O
rate NN O
and CC O
observed JJ O
fasciculations NNS O
. . O

In IN O
the DT O
vitro JJ O
human JJ O
platelet NN O
aggregations NNS O
induced VBN O
by IN O
the DT O
agonists NNS O
used VBN O
in IN O
tests NNS O
, , O
TET NNP B-Chemical
and CC O
FAN NNP B-Chemical
showed VBD O
the DT O
inhibitions NNS O
dose VBP O
dependently RB O
. . O

Damage NN O
to IN O
the DT O
vascular JJ O
basement NN O
lamina NN O
was VBD O
also RB O
observed VBN O
. . O

Thus RB O
, , O
in IN O
cystitis NN O
substantial JJ O
changes NNS O
of IN O
the DT O
efferent JJ O
functional JJ O
responses NNS O
occur VBP O
. . O

Ecstasy NN B-Chemical
users NNS O
performed VBD O
significantly RB O
worse JJR O
in IN O
learning NN O
and CC O
memory NN O
compared VBN O
to IN O
controls NNS O
and CC O
cannabis NN B-Chemical
users NNS O
. . O

Ifosfamide NNP B-Chemical
encephalopathy NN O
presenting VBG O
with IN O
asterixis NN O
. . O

Although IN O
such PDT O
an DT O
association NN O
is VBZ O
of IN O
practical JJ O
and CC O
theoretical JJ O
importance NN O
, , O
only RB O
one CD O
prospective JJ O
study NN O
has VBZ O
tried VBN O
to TO O
confirm VB O
it PRP O
. . O

METHODS NNS O
: : O
This DT O
was VBD O
a DT O
multicenter JJ O
, , O
randomized JJ O
, , O
open JJ O
- HYPH O
label NN O
study NN O
in IN O
adult NN O
smokers NNS O
with IN O
heart NN O
disease NN O
, , O
hypertension NN O
not RB O
controlled VBN O
by IN O
medication NN O
, , O
and CC O
/ SYM O
or CC O
diabetes NN O
mellitus NN O
. . O

Stroke NN O
followed VBD O
cocaine NN B-Chemical
use NN O
by IN O
inhalation NN O
, , O
intranasal JJ O
, , O
intravenous JJ O
, , O
and CC O
intramuscular JJ O
routes NNS O
. . O

Further JJ O
observations NNS O
on IN O
the DT O
electrophysiologic JJ O
effects NNS O
of IN O
oral JJ O
amiodarone NN B-Chemical
therapy NN O
. . O

The DT O
present JJ O
study NN O
was VBD O
aimed VBN O
to TO O
investigate VB O
the DT O
combined VBN O
effects NNS O
of IN O
green JJ B-Chemical
tea NN I-Chemical
and CC O
vitamin NN B-Chemical
E NN I-Chemical
on IN O
heart NN O
weight NN O
, , O
body NN O
weight NN O
, , O
serum NN O
marker NN O
enzymes NNS O
, , O
lipid JJ O
peroxidation NN O
, , O
endogenous JJ O
antioxidants NNS O
and CC O
membrane NN O
bound VBN O
ATPases NNS O
in IN O
isoproterenol NN B-Chemical
( , O
ISO NNP B-Chemical
) -RRB- O
- HYPH O
induced VBN O
myocardial JJ O
infarction NN O
in IN O
rats NNS O
. . O

Clinical JJ O
characteristics NNS O
, , O
medications NNS O
, , O
and CC O
serum JJ O
chemistries NNS O
at IN O
baseline NN O
and CC O
follow NN O
- HYPH O
up NN O
time NN O
periods NNS O
were VBD O
compared VBN O
. . O

Systematic JJ O
investigations NNS O
of IN O
the DT O
human JJ O
capacity NN O
to TO O
remember VB O
sensory JJ O
features NNS O
of IN O
experimental JJ O
pain NN O
are VBP O
sparse JJ O
. . O

RESULTS NNS O
: : O
The DT O
selected VBN O
doses NNS O
of IN O
WR242511 NN B-Chemical
, , O
which WDT O
produced VBD O
significant JJ O
methemoglobinemia NN O
in IN O
beagle NN O
dogs NNS O
in IN O
earlier JJR O
studies NNS O
conducted VBN O
elsewhere RB O
, , O
produced VBD O
very RB O
little JJ O
MHb NNP O
( , O
mean JJ O
< : O
2 CD O
. . O
0 CD O
% NN O
) -RRB- O
in IN O
the DT O
rhesus NN O
monkey NN O
. . O

Dexamethasone NNP B-Chemical
( : O
Dex NNP B-Chemical
) -RRB- O
- HYPH O
induced VBN O
hypertension NN O
is VBZ O
characterized VBN O
by IN O
endothelial JJ O
dysfunction NN O
associated VBN O
with IN O
nitric JJ B-Chemical
oxide NN I-Chemical
( , O
NO NNP B-Chemical
) -RRB- O
deficiency NN O
and CC O
increased VBN O
superoxide NN B-Chemical
( -LRB- O
O2 NN B-Chemical
- HYPH I-Chemical
) -RRB- O
production NN O
. . O

Thus RB O
, , O
use NN O
of IN O
FS NNP O
containing VBG O
tAMCA NNP B-Chemical
for IN O
surgery NN O
within IN O
or CC O
close RB O
to IN O
the DT O
CNS NNP O
may MD O
pose VB O
a DT O
substantial JJ O
risk NN O
to IN O
the DT O
patient NN O
. . O

Thus RB O
, , O
interference NN O
with IN O
the DT O
central JJ O
venous JJ O
infusion NN O
by IN O
the DT O
dialysis NN O
catheter NN O
was VBD O
suspected VBN O
. . O

Pregnant JJ O
rats NNS O
were VBD O
administered VBN O
one CD O
of IN O
these DT O
calcium NN B-Chemical
channel NN O
blockers NNS O
during IN O
the DT O
period NN O
of IN O
cardiac JJ O
morphogenesis NN O
and CC O
the DT O
offspring NN O
examined VBN O
on IN O
day NN O
20 CD O
of IN O
gestation NN O
for IN O
cardiovascular JJ O
malformations NNS O
. . O

All DT O
rats NNS O
in IN O
the DT O
sodium NN B-Chemical
- HYPH O
depleted VBN O
group NN O
had VBD O
histopathological JJ O
evidence NN O
of IN O
patchy JJ O
tubular JJ O
cytoplasmic JJ O
degeneration NN O
in IN O
tubules NNS O
that WDT O
was VBD O
not RB O
observed VBN O
in IN O
any DT O
normal JJ O
- HYPH O
salt NN O
or CC O
salt NN O
- HYPH O
loaded VBN O
rat NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
influence NN O
of IN O
calcium NN B-Chemical
channel NN O
blockers NNS O
on IN O
bupivacaine NN B-Chemical
- HYPH O
induced VBN O
acute JJ O
toxicity NN O
. . O

It PRP O
was VBD O
concluded VBN O
that IN O
treatment NN O
with IN O
enalapril NN B-Chemical
was VBD O
well RB O
tolerated VBN O
and CC O
it PRP O
is VBZ O
, , O
therefore RB O
, , O
unreasonable JJ O
to TO O
restrict VB O
the DT O
initiation NN O
of IN O
treatment NN O
with IN O
enalapril NN B-Chemical
to IN O
inpatients NNS O
. . O

Serum NN O
samples NNS O
from IN O
the DT O
first JJ O
and CC O
second JJ O
days NNS O
contained VBD O
3 CD O
. . O
6 CD O
and CC O
1 CD O
. . O
9 CD O
mg NN O
/ SYM O
l NN O
carbachol NN B-Chemical
, , O
respectively RB O
. . O

Inhibition NN O
of IN O
NO NNP B-Chemical
synthesis NN O
induces VBZ O
sustained JJ O
hypertension NN O
. . O

Periodic JJ O
withdrawal NN O
of IN O
pyridoxine NN B-Chemical
was VBD O
associated VBN O
with IN O
return NN O
of IN O
the DT O
hyperkinesis NN O
. . O

BACKGROUND NN O
: : O
There EX O
recently RB O
has VBZ O
been VBN O
a DT O
resurgence NN O
in IN O
the DT O
utilization NN O
of IN O
ketamine NN B-Chemical
, , O
a DT O
unique JJ O
anesthetic NN O
, , O
for IN O
emergency NN O
- HYPH O
department NN O
procedures NNS O
requiring VBG O
sedation NN O
. . O

Although IN O
much JJ O
has VBZ O
been VBN O
written VBN O
about IN O
the DT O
management NN O
of IN O
the DT O
more RBR O
common JJ O
adverse JJ O
effects NNS O
of IN O
lithium NN B-Chemical
, , O
such JJ O
as IN O
polyuria NN O
and CC O
tremor NN O
, , O
more RBR O
subtle JJ O
lithium NN B-Chemical
side NN O
effects NNS O
such JJ O
as IN O
cognitive JJ O
deficits NNS O
, , O
loss NN O
of IN O
creativity NN O
, , O
and CC O
functional JJ O
impairments NNS O
remain VBP O
understudied JJ O
. . O

Of IN O
the DT O
patients NNS O
developing VBG O
one CD O
or CC O
more JJR O
recurrences NNS O
during IN O
the DT O
first JJ O
year NN O
, , O
only RB O
50 CD O
% NN O
presented VBN O
with IN O
further JJ O
recurrence NN O
once IN O
the DT O
instillations NNS O
were VBD O
stopped VBN O
. . O

The DT O
aorta NN O
/ SYM O
serum NN O
- HYPH O
ratio NN O
and CC O
the DT O
radioactive JJ O
build NN O
- HYPH O
up NN O
24 CD O
and CC O
48 CD O
hours NNS O
after IN O
injection NN O
of IN O
131I CD O
- HYPH O
HSA NNP O
was VBD O
reduced VBN O
in IN O
animals NNS O
treated VBN O
with IN O
D NN B-Chemical
- HYPH I-Chemical
pen NN I-Chemical
for IN O
42 CD O
days NNS O
, , O
indicating VBG O
an DT O
impeded VBN O
transmural JJ O
transport NN O
of IN O
tracer NN O
which WDT O
may MD O
be VB O
caused VBN O
by IN O
a DT O
steric JJ O
exclusion NN O
effect NN O
of IN O
abundant JJ O
hyaluronate NN B-Chemical
. . O

RESULTS NNS O
: : O
Forty CD O
- HYPH O
four CD O
patients NNS O
were VBD O
enrolled VBN O
in IN O
the DT O
study NN O
of IN O
which WDT O
7 CD O
( SYM O
16 CD O
% NN O
) -RRB- O
were VBD O
ineligible JJ O
. . O

Subsequently RB O
, , O
acute JJ O
cardiac JJ O
arrest NN O
and CC O
fatal JJ O
subarachnoid NN O
hemorrhage NN O
occurred VBD O
. . O

Urotensin NNP B-Chemical
- HYPH I-Chemical
II NNP I-Chemical
( , O
U NNP B-Chemical
- HYPH I-Chemical
II NNP I-Chemical
) -RRB- O
receptors NNS O
are VBP O
widely RB O
distributed VBN O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

When WRB O
discharged VBN O
less JJR O
than IN O
24 CD O
hours NNS O
later RB O
, , O
he PRP O
was VBD O
receiving VBG O
metoprolol NN B-Chemical
and CC O
aspirin NN B-Chemical
, , O
with IN O
follow NN O
- HYPH O
up NN O
plans NNS O
for IN O
echocardiography NN O
and CC O
nuclear JJ O
imaging NN O
to TO O
assess VB O
perfusion NN O
. . O

The DT O
patient NN O
recovered VBD O
spontaneously RB O
in IN O
3 CD O
hours NNS O
under IN O
surveillance NN O
in IN O
the DT O
hospital NN O
. . O

The DT O
rapid JJ O
alternations NNS O
of IN O
rigidity NN O
and CC O
the DT O
signs NNS O
of IN O
dopaminergic JJ O
activation NN O
observed VBN O
in IN O
the DT O
animals NNS O
of IN O
the DT O
AS NNP O
/ SYM O
KS NNP O
group NN O
might MD O
be VB O
due IN O
to IN O
rapid JJ O
shifts NNS O
in IN O
the DT O
predominance NN O
of IN O
various JJ O
DA NN O
- HYPH O
innervated VBN O
structures NNS O
. . O

Flow NN O
and CC O
metabolism NN O
were VBD O
measured VBN O
5 CD O
- SYM O
13 CD O
days NNS O
after IN O
the DT O
subarachnoid NN O
haemorrhage NN O
by IN O
a DT O
modification NN O
of IN O
the DT O
classical JJ O
Kety NNP O
- HYPH O
Schmidt NNP O
technique NN O
using VBG O
xenon NN B-Chemical
- HYPH O
133 CD O
i NN O
. . O
v NN O
. . O
Anaesthesia NN O
was VBD O
maintained VBN O
with IN O
an DT O
inspired VBN O
isoflurane NN B-Chemical
concentration NN O
of IN O
0 CD O
. . O
75 CD O
% NN O
( , O
plus CC O
67 CD O
% NN O
nitrous JJ B-Chemical
oxide NN I-Chemical
in IN O
oxygen NN B-Chemical
) -RRB- O
, , O
during IN O
which WDT O
CBF NNP O
and CC O
CMRO2 NNP O
were VBD O
34 CD O
. . O
3 CD O
+ SYM O
/ SYM O
- SYM O
2 CD O
. . O
1 CD O
ml CD O
/ SYM O
100 CD O
g CD O
min NN O
- HYPH O
1 CD O
and CC O
2 CD O
. . O
32 CD O
+ NN O
/ SYM O
- HYPH O
0 CD O
. . O
16 CD O
ml CD O
/ SYM O
100 CD O
g CD O
min NN O
- HYPH O
1 CD O
at IN O
PaCO2 NN O
4 CD O
. . O
1 CD O
+ NN O
/ SYM O
- HYPH O
0 CD O
. . O
1 CD O
kPa NN O
( : O
mean JJ O
+ NN O
/ SYM O
- HYPH O
SEM NN O
) -RRB- O
. . O

OBJECTIVE NN O
: : O
To TO O
examine VB O
the DT O
effect NN O
of IN O
raloxifene NN B-Chemical
on IN O
major JJ O
adverse JJ O
events NNS O
that WDT O
occur VBP O
with IN O
postmenopausal JJ O
estrogen NN B-Chemical
therapy NN O
or CC O
tamoxifen NN B-Chemical
. . O

Concentrations NNS O
of IN O
coniine NN B-Chemical
and CC O
nicotine NN B-Chemical
sulfate NN O
were VBD O
0 CD O
. . O
015 CD O
% NN O
, , O
0 CD O
. . O
03 CD O
% NN O
, , O
0 CD O
. . O
075 CD O
% NN O
, , O
0 CD O
. . O
15 CD O
% NN O
, , O
0 CD O
. . O
75 CD O
% NN O
, , O
1 CD O
. . O
5 CD O
% NN O
, , O
3 CD O
% NN O
, , O
and CC O
6 CD O
% NN O
and CC O
1 CD O
% NN O
, , O
5 CD O
% NN O
, , O
and CC O
10 CD O
% NN O
, , O
respectively RB O
. . O

Rc NNP O
seemed VBD O
to TO O
be VB O
independent JJ O
of IN O
age NN O
and CC O
decreased VBN O
with IN O
increasing VBG O
serum JJ O
concentration NN O
of IN O
cimetidine NN B-Chemical
, , O
suggesting VBG O
that IN O
secretion NN O
of IN O
cimetidine NN B-Chemical
is VBZ O
a DT O
saturable JJ O
process NN O
. . O

METHODS NNS O
: : O
Drugs NNS O
were VBD O
separately RB O
, , O
orally RB O
once RB O
daily RB O
dosed VBN O
to IN O
pregnant JJ O
rats NNS O
from IN O
day NN O
8 CD O
to IN O
21 CD O
( SYM O
GD1 NNP O
= HYPH O
plug NN O
day NN O
) -RRB- O
. . O

We PRP O
report VBP O
the DT O
first JJ O
case NN O
of IN O
a DT O
serious JJ O
short JJ O
- HYPH O
term NN O
adverse JJ O
reaction NN O
with IN O
the DT O
use NN O
of IN O
omeprazole NN B-Chemical
: : O
hemolytic JJ O
anemia NN O
. . O

Ranitidine NN B-Chemical
- HYPH O
induced VBN O
acute JJ O
interstitial JJ O
nephritis NN O
in IN O
a DT O
cadaveric JJ O
renal JJ O
allograft NN O
. . O

Cross JJ O
- HYPH O
sectional JJ O
echocardiographic JJ O
screening NN O
of IN O
newborns NNS O
exposed VBN O
to IN O
lithium NN B-Chemical
during IN O
gestation NN O
can MD O
provide VB O
highly RB O
accurate JJ O
, , O
noninvasive JJ O
assessment NN O
of IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
lithium NN B-Chemical
- HYPH O
induced VBN O
cardiac JJ O
malformations NNS O
. . O

This DT O
demonstrates VBZ O
the DT O
participation NN O
of IN O
the DT O
renin JJ O
- HYPH O
- HYPH O
angiotensin NN B-Chemical
system NN O
in IN O
antagonizing VBG O
the DT O
combined VBN O
hypotensive JJ O
effects NNS O
of IN O
halothane NN B-Chemical
and CC O
SNP NNP B-Chemical
. . O

Pooled VBN O
data NNS O
from IN O
trials NNS O
comparing VBG O
antithrombotic JJ O
treatment NN O
with IN O
placebo NN O
have VBP O
shown VBN O
that IN O
warfarin NN B-Chemical
reduces VBZ O
the DT O
risk NN O
of IN O
stroke NN O
by IN O
62 CD O
% NN O
, , O
and CC O
that IN O
aspirin NN B-Chemical
alone RB O
reduces VBZ O
the DT O
risk NN O
by IN O
22 CD O
% NN O
. . O

The DT O
amounts NNS O
of IN O
alphaENaC NN O
, , O
betaENaC NN O
and CC O
gammaENaC NN O
proteins NNS O
were VBD O
not RB O
increased VBN O
during IN O
PAN NNP B-Chemical
- HYPH O
induced VBN O
sodium NN B-Chemical
retention NN O
. . O

In IN O
the DT O
antinociceptive JJ O
and CC O
antiamnesic JJ O
dose NN O
range NN O
, , O
( , O
+ NFP O
/ SYM O
- HYPH O
) NFP O
- HYPH O
PG NN B-Chemical
- HYPH I-Chemical
9 CD I-Chemical
did VBD O
not RB O
impair VB O
mouse NN O
performance NN O
evaluated VBN O
by IN O
the DT O
rota JJ O
- HYPH O
rod NN O
test NN O
and CC O
Animex NNP O
apparatus NN O
. . O

Laboratory NN O
evaluation NN O
revealed VBD O
66 CD O
, , O
680 CD O
U NN O
/ SYM O
L NNP O
creatine JJ B-Chemical
kinase NN O
, , O
93 CD O
mg NN O
/ SYM O
dL NN O
blood NN B-Chemical
urea NN I-Chemical
nitrogen NN I-Chemical
, , O
4 CD O
. . O
6 CD O
mg NN O
/ SYM O
dL NN O
creatinine NN B-Chemical
, , O
1579 CD O
U NN O
/ SYM O
L NN O
aspartate NN B-Chemical
aminotransferase NN O
, , O
and CC O
738 CD O
U NN O
/ SYM O
L NN O
alanine NN B-Chemical
aminotransferase NN O
. . O

Recently RB O
, , O
several JJ O
TJ NNP O
- HYPH O
associated VBN O
proteins NNS O
like IN O
ZO NNP O
- HYPH O
1 CD O
and CC O
7H6 CD O
have VBP O
been VBN O
identified VBN O
and CC O
characterized VBN O
. . O

Conversely RB O
, , O
brain NN O
normetanephrine NN B-Chemical
concentration NN O
was VBD O
increased VBN O
from IN O
saline NN O
control NN O
by IN O
amantadine NN B-Chemical
in IN O
the DT O
BALB NNP O
/ SYM O
C NNP O
mice NNS O
. . O

EBFF NNP O
did VBD O
not RB O
change VB O
during IN O
PGE1 NNP B-Chemical
infusion NN O
whereas IN O
in IN O
the DT O
TMP NNP B-Chemical
group NN O
, , O
EBF NNP O
decreased VBD O
significantly RB O
at IN O
30 CD O
and CC O
60 CD O
min NN O
after IN O
the DT O
start NN O
of IN O
TMP NNP B-Chemical
( : O
preinfusion NN O
: : O
45 CD O
. . O
9 CD O
+ SYM O
/ SYM O
- HYPH O
13 CD O
. . O
9 CD O
ml NN O
/ SYM O
100g CD O
/ SYM O
min NN O
. . O
30 CD O
min NN O
: : O
32 CD O
. . O
3 CD O
+ NN O
/ SYM O
- HYPH O
9 CD O
. . O
9 CD O
ml CD O
/ SYM O
100 CD O
g NN O
/ SYM O
min NN O
( : O
P NN O
< NN O
0 CD O
. . O
05 CD O
) NFP O
. . O
60 CD O
min NN O
: : O
30 CD O
+ CD O
/ SYM O
- HYPH O
7 CD O
. . O
5 CD O
ml CD O
/ SYM O
100 CD O
g NN O
/ SYM O
min NN O
( , O
P NN O
< NN O
0 CD O
. . O
05 CD O
) NFP O
) -RRB- O
. . O

Postoperatively RB O
, , O
all DT O
patients NNS O
were VBD O
assessed VBN O
for IN O
symptoms NNS O
of IN O
nausea NN O
, , O
vomiting NN O
, , O
and CC O
headache NN O
. . O

These DT O
defects NNS O
explain VBP O
the DT O
abnormal JJ O
erythrocyte JJ O
shape NN O
and CC O
decreased VBN O
mechanical JJ O
stability NN O
promoted VBN O
by IN O
TAM NNP B-Chemical
, , O
resulting VBG O
in IN O
hemolytic JJ O
anemia NN O
. . O

The DT O
most RBS O
commonly RB O
reported VBN O
toxic JJ O
effects NNS O
of IN O
capecitabine NN B-Chemical
are VBP O
diarrhea NN O
, , O
nausea NN O
, , O
vomiting NN O
, , O
stomatitis NN O
and CC O
hand NN O
- HYPH O
foot NN O
syndrome NN O
. . O

Age NN O
- HYPH O
matched VBN O
controls NNS O
( , O
n CD O
= SYM O
14 CD O
) -RRB- O
were VBD O
given VBN O
only RB O
calcium NN B-Chemical
. . O

Calcineurin NN O
- HYPH O
inhibitor NN O
therapy NN O
can MD O
lead VB O
to IN O
renal JJ O
dysfunction NN O
in IN O
heart NN O
transplantation NN O
patients NNS O
. . O

Renal JJ O
tissue NN O
was VBD O
obtained VBN O
for IN O
determination NN O
of IN O
glomerular JJ O
size NN O
and CC O
sclerosis NN O
. . O

Withdrawal NN O
- HYPH O
emergent JJ O
rabbit NN O
syndrome NN O
during IN O
dose NN O
reduction NN O
of IN O
risperidone NN B-Chemical
. . O

We PRP O
report VBP O
the DT O
case NN O
of IN O
a DT O
patient NN O
in IN O
whom WP O
troleandomycin NN B-Chemical
- HYPH O
induced VBN O
hepatitis NN O
was VBD O
followed VBN O
by IN O
prolonged VBN O
anicteric JJ O
cholestasis NN O
. . O

Recurarization NN O
in IN O
the DT O
recovery NN O
room NN O
. . O

In IN O
addition NN O
, , O
we PRP O
analyzed VBD O
the DT O
expression NN O
of IN O
autophagy NN O
associated VBN O
gene NN O
, , O
beclin NN O
1 CD O
using VBG O
RT NNP O
- HYPH O
PCR NN O
and CC O
Western JJ O
blotting NN O
in IN O
an DT O
animal NN O
model NN O
. . O

In IN O
conclusion NN O
mitochondrial JJ O
toxicity NN O
is VBZ O
an DT O
early JJ O
common JJ O
event NN O
both CC O
in IN O
paclitaxel NN B-Chemical
and CC O
cisplatin NN B-Chemical
induced VBN O
neurotoxicity NN O
. . O

Controls NNS O
were VBD O
age NN O
- HYPH O
and CC O
sex NN O
- HYPH O
matched VBN O
non JJ O
- HYPH O
PD NN O
patients NNS O
referred VBD O
to IN O
the DT O
cardiology NN O
department NN O
. . O

When WRB O
hippocampal JJ O
ACh NNP B-Chemical
was VBD O
measured VBN O
during IN O
testing NN O
for IN O
handling NN O
- HYPH O
induced VBN O
convulsions NNS O
, , O
extracellular JJ O
ACh NNP B-Chemical
was VBD O
significantly RB O
elevated VBN O
( : O
192 CD O
% NN O
) -RRB- O
in IN O
WSP NNP O
mice NNS O
, , O
but CC O
was VBD O
nonsignificantly RB O
elevated VBN O
( : O
59 CD O
% NN O
) -RRB- O
in IN O
WSR NNP O
mice NNS O
. . O

She PRP O
underwent VBD O
liver NN O
transplantation NN O
with IN O
an DT O
uneventful JJ O
postoperative JJ O
course NN O
. . O

Thyroxine NN B-Chemical
abuse NN O
: : O
an DT O
unusual JJ O
case NN O
of IN O
thyrotoxicosis NN O
in IN O
pregnancy NN O
. . O

In IN O
addition NN O
, , O
glomerular JJ O
size NN O
was VBD O
higher JJR O
in IN O
the DT O
nitrendipine NN B-Chemical
- HYPH O
treated VBN O
group NN O
( : O
14 CD O
. . O
9 CD O
+ NN O
/ SYM O
- HYPH O
0 CD O
. . O
17 CD O
10 CD O
( SYM O
- HYPH O
3 CD O
) SYM O
mm2 CD O
) -RRB- O
but CC O
lower JJR O
in IN O
the DT O
enalapril NN B-Chemical
- HYPH O
treated VBN O
group NN O
( : O
11 CD O
. . O
5 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
15 CD O
10 CD O
( SYM O
- HYPH O
3 CD O
) SYM O
mm2 CD O
) , O
compared VBN O
with IN O
the DT O
hypertensive JJ O
controls NNS O
( : O
12 CD O
. . O
1 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
17 CD O
10 CD O
( SYM O
- HYPH O
3 CD O
) SYM O
mm2 CD O
) -RRB- O
. . O
( : O
ABSTRACT NN O
TRUNCATED VBN O
AT IN O
250 CD O
WORDS NNS O
) : O

All DT O
three CD O
cytopenias NNS O
were VBD O
completely RB O
reversible JJ O
following VBG O
cessation NN O
of IN O
treatment NN O
; : O
the DT O
time NN O
required VBN O
for IN O
recovery NN O
of IN O
the DT O
erythron NN O
( : O
approximately RB O
1 CD O
month NN O
) -RRB- O
was VBD O
considerably RB O
longer JJR O
than IN O
that DT O
of IN O
the DT O
granulocytes NNS O
and CC O
platelets NNS O
( , O
hours NNS O
to IN O
a DT O
few JJ O
days NNS O
) -RRB- O
. . O

The DT O
primary JJ O
outcome NN O
was VBD O
a DT O
postdose JJ O
SCr NN O
increase NN O
> : O
or CC O
= SYM O
0 CD O
. . O
5 CD O
mg CD O
/ SYM O
dL CD O
( SYM O
44 CD O
. . O
2 CD O
micromol NN O
/ SYM O
L NN O
) -RRB- O
over IN O
baseline NN O
. . O

PTCR NNP O
also RB O
occurs VBZ O
in IN O
certain JJ O
native JJ O
kidney NN O
diseases NNS O
, , O
though IN O
the DT O
association NN O
is VBZ O
not RB O
as RB O
strong JJ O
as IN O
that DT O
for IN O
TG NNP O
. . O

All DT O
three CD O
had VBD O
been VBN O
diagnosed VBN O
earlier RBR O
with IN O
epilepsy NN O
, , O
and CC O
their PRP$ O
electroencephalogram NN O
( -LRB- O
EEG NNP O
) -RRB- O
findings NNS O
were VBD O
abnormal JJ O
. . O

In IN O
the DT O
following VBG O
report NN O
, , O
a DT O
65 CD O
- HYPH O
year NN O
- HYPH O
old JJ O
critically RB O
ill JJ O
patient NN O
with IN O
a DT O
suspected VBN O
history NN O
of IN O
HITT NNP O
was VBD O
administered VBN O
argatroban NN B-Chemical
for IN O
anticoagulation NN O
on IN O
bypass NN O
during IN O
heart NN O
transplantation NN O
. . O

To TO O
determine VB O
if IN O
routine JJ O
risperidone NN B-Chemical
treatment NN O
is VBZ O
associated VBN O
with IN O
a DT O
unique JJ O
degree NN O
of IN O
D2 NN O
receptor NN O
occupancy NN O
and CC O
pattern NN O
of IN O
clinical JJ O
effects NNS O
, , O
we PRP O
used VBD O
[ -LRB- O
123I CD O
] -RRB- O
IBZM NNP O
SPECT NNP O
to TO O
determine VB O
D2 NN O
occupancy NN O
in IN O
subjects NNS O
treated VBN O
with IN O
routine JJ O
clinical JJ O
doses NNS O
of IN O
risperidone NN B-Chemical
( : O
n NN O
= SYM O
12 CD O
) -RRB- O
or CC O
haloperidol NN B-Chemical
( : O
n NN O
= SYM O
7 CD O
) -RRB- O
. . O

Physicians NNS O
who WP O
prescribe VBP O
molindone NN B-Chemical
should MD O
be VB O
aware JJ O
of IN O
this DT O
reaction NN O
. . O

A DT O
multicenter NN O
study NN O
was VBD O
performed VBN O
in IN O
110 CD O
patients NNS O
with IN O
superficial JJ O
transitional JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
bladder NN O
. . O

Confusion NN O
, , O
a DT O
rather RB O
serious JJ O
adverse JJ O
drug NN O
reaction NN O
with IN O
valproic JJ B-Chemical
acid NN I-Chemical
: : O
a DT O
review NN O
of IN O
the DT O
French NNP O
Pharmacovigilance NNP O
database NN O
. . O

The DT O
orientation NN O
of IN O
the DT O
promoter NN O
and CC O
its PRP$ O
cl NN O
- HYPH O
repressible JJ O
character NN O
raise VBP O
the DT O
possibility NN O
that IN O
cl NN O
expression NN O
is VBZ O
autoregulatory JJ O
. . O

Materials NNS O
and CC O
methods NNS O

The DT O
patient NN B-Species
was VBD O
discharged VBN O
on IN O
the DT O
fifth JJ O
post NN O
- HYPH O
operative NN O
day NN O
with IN O
a DT O
conservative JJ O
management NN O
. . O

EST NNP O
clone NN O
sequences NNS O
from IN O
the DT O
cGRASP NNP O
microarray NN O
were VBD O
used VBN O
to TO O
design VB O
primers NNS O
for IN O
genes NNS O
undergoing VBG O
validation NN O
, , O
along IN O
with IN O
a DT O
beta NN O
- HYPH O
actin NN O
reference NN O
gene NN O
used VBN O
for IN O
normalization NN O
, , O
with IN O
Primer3 NNP O
software NN O
[ -LRB- O
76 CD O
] -RRB- O
and CC O
the DT O
sequence NN O
for IN O
each DT O
primer NN O
pair NN O
is VBZ O
shown VBN O
in IN O
Table NNP O
3 CD O
. . O

In IN O
this DT O
work NN O
, , O
we PRP O
identified VBD O
a DT O
highly RB O
conserved VBN O
GG7 NNP O
motif NN O
in IN O
the DT O
first JJ O
two CD O
tetraspanin JJ O
TM NN O
domains NNS O
. . O

A DT O
32 CD O
year NN O
old JJ O
, , O
primigravida NN O
, , O
was VBD O
admitted VBN O
in IN O
a DT O
District NNP O
General NNP O
Hospital NNP O
for IN O
elective JJ O
Caesarean JJ O
section NN O
at IN O
36 CD O
weeks NNS O
and CC O
6 CD O
days NNS O
with IN O
the DT O
diagnosis NN O
of IN O
preeclampsia NN O
. . O

We PRP O
hypothesized VBD O
that IN O
the DT O
first JJ O
two CD O
transmembrane NN O
domains NNS O
of IN O
tetraspanins NNS O
might MD O
interact VB O
with IN O
each DT O
other JJ O
because IN O
: : O
a DT O
) , O
consecutive JJ O
TM NNP O
domains NNS O
frequently RB O
associate VBP O
in IN O
known VBN O
protein NN O
3D NN O
structures NNS O
[ -LRB- O
35 CD O
] -RRB- O
, , O
and CC O
b LS O
) -RRB- O
they PRP O
both DT O
contain VBP O
a DT O
series NN O
of IN O
highly RB O
conserved VBN O
amino NN O
acids NNS O
- , O
several JJ O
Gly NNP O
residues NNS O
and CC O
an DT O
Asn NNP O
residue NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
. . O

The DT O
sequences NNS O
for IN O
the DT O
five CD O
genes NNS O
of IN O
the DT O
GH NNP O
cluster NN O
identified VBN O
by IN O
Chen NNP O
et FW O
al NNP O
. , O
6 CD O
and CC O
reported VBD O
as IN O
the DT O
GI NNP O
sequence NN O
183148 CD O
were VBD O
aligned VBN O
using VBG O
the DT O
Multalin NNP O
program NN O
. , O
25 CD O
SNPs NNPS O
and CC O
other JJ O
sequence NN O
changes NNS O
identified VBN O
were VBD O
indicated VBN O
using VBG O
their PRP$ O
position NN O
corresponding VBG O
to IN O
GH1 NNP O
. . O

Using VBG O
this DT O
model NN O
we PRP O
have VBP O
recently RB O
shown VBN O
that IN O
, , O
within IN O
granulomas NNS O
, , O
large JJ O
multinucleated JJ O
giant JJ O
cells NNS O
, , O
also RB O
known VBN O
as IN O
Langhans NNP O
giant JJ O
cells NNS O
, , O
result VBP O
from IN O
the DT O
induction NN O
of IN O
granuloma NN O
macrophage NN O
fusion NN O
by IN O
M NN B-Species
. . I-Species
tb NN I-Species
glycolipids NNS O
[ -LRB- O
8 CD O
] -RRB- O
. . O

L NNP O
. . O
, , O
Howard NNP O
, , O
M NNP O
. . O
, , O

Our PRP$ O
preliminary JJ O
results NNS O
indicate VBP O
that IN O
the DT O
5 CD O
' '' O
- HYPH O
flanking VBG O
sequence NN O
of IN O
the DT O
human JJ B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
mediates VBZ O
mitogen NN O
induced VBN O
expression NN O
of IN O
the DT O
gene NN O
in IN O
T NNP O
- HYPH O
lymphocytic JJ O
cells NNS O
( , O
Fujita NNP O
& CC O
Taniguchi NNP O
, , O
unpublished JJ O
observation NN O
) -RRB- O
. . O

The DT O
FMDVs NNPS B-Species
used VBN O
in IN O
the DT O
present JJ O
study NN O
( -LRB- O
Figure NN O
1 CD O
) -RRB- O
are VBP O
( , O
i PRP O
) -RRB- O
the DT O
reference NN O
clone NN O
C NN O
- HYPH O
S8c1 NNP O
, , O
which WDT O
has VBZ O
been VBN O
assigned VBN O
a DT O
relative JJ O
fitness NN O
of IN O
1 CD O
. . O
0 CD O
[ SYM O
11 CD O
] -RRB- O
. . O

* NFP O
p NN O
< SYM O
0 CD O
. . O
5 CD O
and CC O
* NFP O
* NFP O
p NN O
< NN O
0 CD O
. . O
1 CD O
. . O

To TO O
detect VB O
potential JJ O
gene NN O
family NN O
expansion NN O
, , O
we PRP O
decided VBD O
to TO O
identify VB O
Pfam NNP O
motifs NNS O
that WDT O
were VBD O
present JJ O
in IN O
both CC O
phytopathogenic JJ O
and CC O
non JJ O
- HYPH O
pathogenic JJ O
species NNS O
of IN O
filamentous JJ O
ascomycetes NNS O
, , O
but CC O
that DT O
were VBD O
more RBR O
common JJ O
in IN O
the DT O
genomes NNS O
of IN O
the DT O
former JJ O
. . O

Associations NNS O
between IN O
genotypes NNS O
and CC O
standardized VBN O
height NN O
were VBD O
first RB O
studied VBN O
in IN O
the DT O
subpopulation NN O
of IN O
278 CD O
controls NNS O
carrying VBG O
only RB O
the DT O
25 CD O
most RBS O
frequent JJ O
SNPs NNPS O
in IN O
the DT O
GH1 NNP O
gene NN O
( : O
c2 CD O
= SYM O
2 CD O
. . O
59 CD O
; : O
P NN O
= SYM O
0 CD O
. . O
5458 CD O
for IN O
normality NN O
of IN O
height NN O
distribution NN O
) -RRB- O
. . O

Common JJ O
family NN O
- HYPH O
based VBN O
tests NNS O
of IN O
LD NNP O
, , O
such JJ O
as IN O
those DT O
used VBN O
in IN O
this DT O
study NN O
( , O
Genehunter NNP O
) -RRB- O
, , O
measure VB O
transmission NN O
distortion NN O
based VBN O
on IN O
allele JJ O
counts NNS O
rather RB O
than IN O
genotype NN O
counts NNS O
; : O
the DT O
former JJ O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
more RBR O
powerful JJ O
under IN O
additive JJ O
models NNS O
, , O
while IN O
the DT O
latter JJ O
has VBZ O
greater JJR O
power NN O
under IN O
recessive JJ O
or CC O
dominant JJ O
genetic JJ O
models NNS O
[ -LRB- O
27 CD O
] -RRB- O
. . O

Strain NN O
ZH44 NNP O
( -LRB- O
CCT8 NN O
/ SYM O
ST8 CD O
) -RRB- O
contained VBD O
a DT O
type NN O
A NN O
mec NN O
complex NN O
( , O
mecI NN O
- HYPH O
mecR1 NN O
- HYPH O
mecA NN O
) -RRB- O
within IN O
a DT O
type NN O
II NNP O
SCCmec NNP O
, , O
and CC O
had VBD O
no DT O
beta JJ O
- HYPH O
lactamase NN O
locus NN O
; : O
so CC O
mecA NN O
was VBD O
only RB O
under IN O
the DT O
control NN O
of IN O
its PRP$ O
cognate JJ O
regulators NNS O
MecI NNP O
/ SYM O
MecR1 NNP O
. . O

BHK NNP O
- HYPH O
21 CD O
cell NN O
monolayers NNS O
( : O
70 CD O
% NN O
confluent JJ O
, , O
about RB O
1 CD O
x SYM O
106 CD O
cells NNS O
) -RRB- O
were VBD O
transfected VBN O
with IN O
RNA NNP O
transcripts NNS O
( , O
1 CD O
mu NNS O
g NNP O
RNA NNP O
) -RRB- O
using VBG O
lipofectin NN O
as IN O
previously RB O
described VBN O
[ -LRB- O
59 CD O
] -RRB- O
. . O

J NNP O
. . O

Despite IN O
the DT O
growing VBG O
body NN O
of IN O
literature NN O
on IN O
recruitment NN O
and CC O
retention NN O
factors NNS O
in IN O
various JJ O
industries NNS O
, , O
there EX O
is VBZ O
a DT O
minimal JJ O
amount NN O
of IN O
research NN O
studying VBG O
these DT O
factors NNS O
specifically RB O
among IN O
rehabilitation NN O
professionals NNS O
. . O

The DT O
sole JJ O
product NN O
of IN O
each DT O
reaction NN O
is VBZ O
the DT O
5 CD O
' '' O
- HYPH O
O NN O
- HYPH O
dimethoxytritylnucle NN O
as IN O
shown VBN O
by IN O
TLC NNP O
. . O

0 NFP O
. . O
27 CD O
* NFP O
1 CD O
. . O
3 LS O
"""" '' O

The DT O
results NNS O
are VBP O
also RB O
in IN O
line NN O
with IN O
the DT O
intuitive JJ O
expectation NN O
that IN O
genes NNS O
with IN O
higher JJR O
vertex NN O
degree NN O
give VBP O
rise NN O
to IN O
more JJR O
co NN O
- HYPH O
occurrences NNS O
. . O

( -LRB- O
1974 CD O
) -RRB- O
. . O

An DT O
authentic JJ O
MDA NNP O
standard NN O
was VBD O
also RB O
scanned VBN O
as IN O
a DT O
control NN O
( HYPH O
Fig NNP O
. . O
4A NN O
, , O
lower JJR O
section NN O
) -RRB- O
. . O

As IN O
control NN O
we PRP O
performed VBD O
dylt NN O
- HYPH O
1 CD O
( SYM O
RNAi NNP O
) -RRB- O
using VBG O
the DT O
same JJ O
procedure NN O
. . O

Consensus NN O
genomic JJ O
nucleotide NN O
sequences NNS O
of IN O
FMDV NNP B-Species
clones NNS O
were VBD O
obtained VBN O
by IN O
RT NNP O
- HYPH O
PCR NNP O
amplification NN O
of IN O
virion NN O
RNA NNP O
using VBG O
specific JJ O
primers NNS O
[ -LRB- O
7 CD O
, , O
22 CD O
, , O
28 CD O
] -RRB- O
. . O

Expression NN O
cannot MD O
be VB O
absolutely RB O
dependent JJ O
on IN O
cl NN O
- HYPH O
mediated VBN O
activation NN O
, , O
however RB O
, , O
because IN O
the DT O
cloned JJ O
promoter NN O
exhibits VBZ O
significant JJ O
activity NN O
in IN O
the DT O
absence NN O
of IN O
the DT O
cl NN O
gene NN O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

The DT O
comparison NN O
of IN O
the DT O
consensus NN O
nucleotide NN O
sequence NN O
of IN O
the DT O

poly NN O
( , O
dT NN O
) -RRB- O
. . O

After IN O
60 CD O
min NN O
at IN O
room NN O
temperature NN O
, , O
2 CD O
ml NNS O
of IN O
medium NN O
containing VBG O
10 CD O
% NN O
serum NN O
was VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
the DT O
plates NNS O
transferred VBN O
to IN O
25 CD O
degrees NNS O
C NN O
for IN O
up IN O
to TO O
8 CD O
days NNS O
. . O

At IN O
the DT O
same JJ O
time NN O
, , O
since IN O
the DT O
most RBS O
stringent JJ O
permutation NN O
based VBN O
null NN O
- HYPH O
model NN O
predicts VBZ O
non AFX O
- HYPH O
linear JJ O
dependencies NNS O
of IN O
individual JJ O
occurrence NN O
probabilities NNS O
on IN O
vertex NN O
degrees NNS O
, , O
assuming VBG O
such JJ O
linearity NN O
in IN O
statistical JJ O
models NNS O
of IN O
co NN O
- HYPH O
occurrence NN O
will MD O
be VB O
linked VBN O
to IN O
loss NN O
of IN O
stringency NN O
. . O

One CD O
limitation NN O
of IN O
the DT O
available JJ O
evidence NN O
is VBZ O
that IN O
most JJS O
research NN O
has VBZ O
been VBN O
conducted VBN O
in IN O
North NNP O
America NNP O
and CC O
Australia NNP O
[ -LRB- O
9 CD O
, , O
12 CD O
] -RRB- O
, , O
and CC O
it PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
associations NNS O
observed VBN O
in IN O
those DT O
countries NNS O
are VBP O
generalisable JJ O
to IN O
other JJ O
settings NNS O
with IN O
different JJ O
aggregate JJ O
socioeconomic JJ O
characteristics NNS O
( , O
e LS O
. . O
g LS O
. . O
wealth NN O
or CC O
access NN O
to IN O
private JJ O
cars NNS O
) , O
or CC O
environmental JJ O
characteristics NNS O
( : O
e LS O
. . O
g LS O
. . O
climate NN O
, , O
patterns NNS O
of IN O
land NN O
use NN O
, , O
or CC O
availability NN O
of IN O
public JJ O
transport NN O
) -RRB- O
. . O

The DT O
HRP NNP O
- HYPH O
streptavidin NNP O
conjugate NN O
was VBD O
diluted VBN O
to IN O
0 CD O
. . O
5 CD O
micro NN O
g NN O
ml NN O
- HYPH O
1 CD O
in IN O
Assay NNP O
Buffer NNP O
( : O
0 CD O
. . O
15 CD O
M NN O
NaCl NNP O
, , O
10 CD O
mM NN O
NasHPO4 CD O
, , O
1 CD O
. . O
5 CD O
mM NN O
KH2PO4 CD O
, , O
2 CD O
. . O
5 CD O
mM NN O
KCl NN O
, , O
5 CD O
mg NN O
ml CD O
- HYPH O
1 CD O
BSA NN O
, , O
0 CD O
. . O
1 CD O
% NN O
Tween NN O
, , O
pH NN O
7 CD O
. . O
5 CD O
) -RRB- O
, , O
100 CD O
micro NN O
l NN O
was VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
the DT O
plate NN O
incubated VBN O
at IN O
100 CD O
r NN O
. . O
p NN O
. . O
m UH O
. . O
for IN O
1 CD O
h NNS O
at IN O
room NN O
temperature NN O
( , O
RT NN O
) -RRB- O
. . O

For IN O
scp160 CD O
deletion NN O
mutants NNS O
, , O
the DT O
primers NNS O
Scp160PF NNP O
( -LRB- O
5 CD O
' '' O
- HYPH O
GATTTCCTAACTTTCC NNP O
- HYPH O
GTCTA NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
Scp160R5 NNP O
( : O
5 CD O
' '' O
- HYPH O
GCGCAAGCTTCACCGCCTTA NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
that WDT O
flanked VBD O
the DT O
deleted VBN O
region NN O
were VBD O
used VBN O
. . O

Briefly RB O
, , O
ELISA NNP O
plates NNS O
( : O
96 CD O
- HYPH O
well UH O
Immunoplate NNP O
MaxiSorp NNP O
, , O
Nunc NNP O
, , O
Roskilde NNP O
, , O
Denmark NNP O
) , O
were VBD O
coated VBN O
with IN O
IL NN O
- HYPH O
5 CD O
- HYPH O
specific JJ O
monoclonal JJ O
antibody NN O
( , O
TRFK NNP O
- HYPH O
5 CD O
, , O
5 CD O
lag NN O
/ SYM O
ml NN O
in IN O
phosphate NN O
buffered VBN O
saline NN O
, , O
pH NN O
7 CD O
. . O
4 CD O
, , O
PBS NN O
, , O
100 CD O
l NN O
. . O
tl NN O
/ SYM O
well NN O
) -RRB- O
. . O

Since IN O
large JJ O
occurrence NN O
probabilities NNS O
make VBP O
co NN O
- HYPH O
occurrence NN O
more RBR O
likely RB O
, , O
the DT O
analysis NN O
becomes VBZ O
more RBR O
stringent JJ O
. . O

Assays NNS O
using VBG O
synthetic JJ O
template NN O
- HYPH O
initiator NN O
complexes NNS O
were VBD O
carried VBN O
out RP O
at IN O
30 CD O
? . O
C NN O
in IN O
0 CD O
. . O

Thus RB O
, , O
the DT O
FMDV NNP B-Species
- HYPH O
BHK NNP O
- HYPH O
21 CD O
system NN O
offered VBD O
a DT O
means NN O
to TO O
investigate VB O
in IN O
a DT O
direct JJ O
and CC O
comparative JJ O
fashion NN O
the DT O
relationship NN O
between IN O
fitness NN O
and CC O
virulence NN O
of IN O
a DT O
virus NN O
, , O
measured VBN O
in IN O
the DT O
same JJ O
biological JJ O
environment NN O
provided VBN O
by IN O
BHK NNP O
- HYPH O
21 CD O
cells NNS O
. . O

( -LRB- O
1987 CD O
) -RRB- O
. . O

MRB NNP O
participated VBD O
in IN O
study NN O
conception NN O
and CC O
design NN O
, , O
conducted VBD O
gene NN O
expression NN O
experiments NNS O
and CC O
data NN O
analysis NN O
, , O
and CC O
drafted VBD O
the DT O
manuscript NN O
. . O

Analysis NN O

Even RB O
if IN O
one PRP O
takes VBZ O
into IN O
account NN O
the DT O
fact NN O
that IN O
A DT O
enzyme NN O
is VBZ O
less RBR O
active JJ O
on IN O
activated JJ O
DNA NNP O

Estrous JJ O
cycles NNS O
were VBD O
monitored VBN O
by IN O
daily JJ O
vaginal JJ O
smears NNS O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
Ngn2 NNP O
is VBZ O
conserved VBN O
from IN O
development NN O
of IN O
the DT O
DG NNP O
to IN O
postnatal JJ O
hippocampal JJ O
neurogenesis NN O
. . O

In IN O
particular JJ O
, , O
the DT O
identification NN O
of IN O
corresponding VBG O
clusters NNS O
permits VBZ O
the DT O
identification NN O
of IN O
functional JJ O
subunits NNS O
such JJ O
as IN O
gene NN O
clusters NNS O
on IN O
the DT O
one CD O
hand NN O
, , O
and CC O
the DT O
generation NN O
of IN O
hypotheses NNS O
about IN O
the DT O
function NN O
of IN O
those DT O
units NNS O
by IN O
analyzing VBG O
the DT O
corresponding VBG O
list NN O
clusters NNS O
on IN O
the DT O
other JJ O
hand NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
transcription NN O
of IN O
SA1665 NN O
may MD O
respond VB O
in IN O
some DT O
way NN O
to IN O
cell NN O
wall NN O
stress NN O
, , O
rather RB O
than IN O
in IN O
direct JJ O
response NN O
to IN O
the DT O
presence NN O
of IN O
beta NN O
- HYPH O
lactams NNS O
. . O

Since IN O
this DT O
band NN O
appeared VBD O
with IN O
the DT O
cDNA NNP O
probe NN O
extending VBG O
further RB O
upstream RB O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
the DT O
5 CD O
' '' O
region NN O
of IN O
the DT O
gene NN O
is VBZ O
located VBN O
within IN O
this DT O
DNA NNP O
segment NN O
( , O
see VB O
below RB O
) -RRB- O
. . O

There EX O
was VBD O
no DT O
difference NN O
in IN O
the DT O
size NN O
of IN O
the DT O
households NNS O
of IN O
cases NNS O
and CC O
controls NNS O
in IN O
any DT O
of IN O
the DT O
three CD O
settings NNS O
. . O

Lynch NNP O
, , O
R NNP O
. . O
W UH O
. . O

The DT O
ENP1 NNP O
( -LRB- O
Essential NNP O
Nuclear NNP O
Protein NNP O
1 CD O
) -RRB- O
gene NN O
was VBD O
identified VBN O
in IN O
a DT O
genetic JJ O
screen NN O
for IN O
suppressors NNS O
of IN O
an DT O
ost4 NN O
mutation NN O
( , O
oligosaccharide NN O
transferase NN O
4 CD O
) -RRB- O
( SYM O
17 CD O
) -RRB- O
. . O

We PRP O
hypothesized VBD O
that IN O
regulation NN O
of IN O
methicillin NN O
resistance NN O
in IN O
such JJ O
low JJ O
- HYPH O
level NN O
resistant JJ O
clonal JJ O
lineages NNS O
may MD O
differ VB O
qualitatively RB O
from IN O
classical JJ O
heterogeneously RB O
- HYPH O
or CC O
highly RB O
- HYPH O
resistant JJ O
MRSA NNP B-Species
. . O

Similarly RB O
, , O
another DT O
study NN O
using VBG O
chromatin NN O
immunoprecipitation NN O
in IN O
larvae NN O
also RB O
showed VBD O
few JJ O
HP1 NNP O
- HYPH O
positive JJ O
genes NNS O
that WDT O
were VBD O
not RB O
detected VBN O
in IN O
Kc NNP O
cells NNS O
by IN O
the DT O
Dam NNP O
ID NNP O
approach NN O
( : O
21 CD O
) -RRB- O
. . O

Fatty JJ O
acid NN O
analysis NN O
of IN O
cells NNS O
treated VBN O
with IN O
lipoxidase NN O
indicated VBD O
that IN O
host NN O
- HYPH O
derived VBN O
linoleic JJ O
acid NN O
had VBD O
been VBN O
dramatically RB O
reduced VBN O
( : O
50 CD O
- HYPH O
fold NN O
) -RRB- O
in IN O
these DT O
cells NNS O
, , O
with IN O
a DT O
corresponding VBG O
increase NN O
in IN O
the DT O
levels NNS O
of IN O
malondialdehyde NN O
by IN O
- HYPH O
product NN O
( , O
fourfold RB O
) -RRB- O
. . O

Within IN O
each DT O
cluster NN O
from IN O
the DT O
survey NN O
, , O
one CD O
interviewer NN O
was VBD O
asked VBN O
to TO O
be VB O
taken VBN O
to IN O
two CD O
community NN O
members NNS O
aged VBN O
> SYM O
= SYM O
50 CD O
y NN O
with IN O
eye NN O
problems NNS O
, , O
living VBG O
within IN O
the DT O
cluster NN O
boundaries NNS O
but CC O
not RB O
from IN O
the DT O
segments NNS O
selected VBN O
for IN O
the DT O
survey NN O
. . O

Peculiarities NNS O
of IN O
carcinogenesis NN O
under IN O
simultaneous JJ O
oral JJ O
administration NN O
of IN O
benzo NN O
( , O
a DT O
) -RRB- O
pyrene NN O
and CC O
o NN O
- HYPH O
cresol NN O
in IN O
mice NNS B-Species
. . O

The DT O
three CD O
measures NNS O
of IN O
poverty NN O
were VBD O
highly RB O
correlated JJ O
, , O
each DT O
showing VBG O
significant JJ O
correlation NN O
( : O
p NN O
< SYM O
0 CD O
. . O
1 CD O
) -RRB- O
with IN O
the DT O
other JJ O
measure NN O
. . O

Gig UH O
. . O

We PRP O
analyzed VBD O
lymph JJ O
node NN O
biopsies NNS O
from IN O
10 CD O
tuberculous JJ O
patients NNS B-Species
as IN O
a DT O
first JJ O
step NN O
for IN O
evaluating VBG O
the DT O
role NN O
of IN O
FMs NNPS O
within IN O
tuberculous JJ O
granulomas NNS O
. . O

PCR NN O
quality NN O
water NN O
and CC O
Tris NNP O
- HYPH O
EDTA NNP O
buffer NN O
were VBD O
from IN O
BioWhittaker NNP O
. . O

when WRB O
the DT O
mAb NN O
was VBD O
administered VBN O
12 CD O
, , O
17 CD O
or CC O
18 CD O
days NNS O
after IN O
infection NN O
there EX O
was VBD O
no DT O
significant JJ O
inhibition NN O
in IN O
the DT O
numbers NNS O
of IN O
eosinophils NNS O
in IN O
BALF NNP O
( , O
Fig NNP O
. . O
5 CD O
) -RRB- O
, , O
showing VBG O
that IN O
once RB O
established VBN O
, , O
the DT O
eosi18 NN O

The DT O
A2 NNP O

Hofer NNP O
and CC O
Trout NNP O
Lodge NNP O
rainbow NN B-Species
trout NN I-Species
strains NNS O
were VBD O
reared VBN O
in IN O
35 CD O
gallon NN O
aquaria NNS O
with IN O
15 CD O
degrees NNS O
C NN O
flow NN O
- , O
through IN O
well NN O
water NN O
for IN O
nine CD O
weeks NNS O
post NN O
- HYPH O
hatch NN O
, , O
with IN O
each DT O
fish NN O
weighing VBG O
approximately RB O
6 CD O
. . O
5 CD O
grams NNS O
prior RB O
to IN O
pathogen NN O
exposure NN O
. . O

Holmes NNP O
, , O
Department NNP O
of IN O
Biochemistry NNP O
, , O
University NNP O
of IN O
Strathclyde NNP O
, , O
The DT O
Todd NNP O
Centre NNP O
, , O
31 CD O
Taylor NNP O
Street NNP O
, , O
Glasgow NNP O
G4 NNP O
ONR NNP O
, , O
U NNP O
. . O
K NNP O
. . O

Thus RB O
, , O
to TO O
better RBR O
understand VB O
the DT O
eosinophilia NN O
in IN O
the DT O
lungs NNS O
of IN O
infected JJ O
animals NNS O
, , O
we PRP O
monitored VBD O
eosinophil JJ O
numbers NNS O
in IN O
BALF NNP O
after IN O
administration NN O
of IN O
TRFK NNP O
- HYPH O
5 CD O
at IN O
the DT O
same JJ O
time NN O
, , O
or CC O
1 CD O
, , O
3 CD O
, , O
12 CD O
or CC O
17 CD O
days NNS O
after IN O
infection NN O
. . O

different JJ O
mobilities NNS O
( -LRB- O
Lane NNP O
3 CD O
) -RRB- O
. . O

Mezapuke NNP O
, , O
and CC O
O UH O
. . O

Approximately RB O
2 CD O
micro NN O
l NN O
of IN O
viral JJ O
suspension NN O
( : O
1 CD O
x SYM O
10 CD O
^ SYM O
9TU NN O
/ SYM O
ml NN O
) -RRB- O
was VBD O
injected VBN O
into IN O
the DT O
lateral JJ O
ventricle NN O
of IN O
each DT O
embryo NN O
, , O
except IN O
for IN O
the DT O
embryo NN O
closest JJS O
to IN O
the DT O
vagina NN O
. . O

The DT O
containers NNS O
generally RB O
host VBP O
more JJR O
than IN O
one CD O
entity NN O
( , O
otherwise RB O
co NN O
- HYPH O
occurrence NN O
would MD O
be VB O
impossible JJ O
) -RRB- O
and CC O
can MD O
be VB O
conveniently RB O
interpreted VBN O
as IN O
lists NNS O
. . O

This DT O
pattern NN O
is VBZ O
consistent JJ O
with IN O
either CC O
heterozygosity NN O
for IN O
methylation NN O
or CC O
the DT O
co NN O
- HYPH O
existence NN O
of IN O
2 CD O
distinct JJ O
populations NNS O
within IN O
the DT O
cell NN O
line NN O
, , O
one CD O
heavily RB O
methylated JJ O
and CC O
one CD O
unmethylated JJ O
. . O

For IN O
example NN O
, , O
phospholipid NN O
hydroperoxide NN O
glutathione NN O
peroxidase NN O
, , O
a DT O
member NN O
of IN O
the DT O
glutathione NN O
peroxidase NN O
family NN O
, , O
has VBZ O
been VBN O
identified VBN O
in IN O
a DT O
variety NN O
of IN O
higher JJR O
organisms NNS O
. . O

This DT O
is VBZ O
because IN O
each DT O
edge NN O
is VBZ O
linked VBN O
to IN O
either DT O
side NN O
of IN O
the DT O
bipartite NN O
graph NN O
with IN O
certainty NN O
and CC O
therefore RB O
the DT O
sum NN O
of IN O
occurrence NN O
probabilities NNS O
over IN O
all DT O
lists NNS O
( , O
which WDT O
can MD O
be VB O
calculated VBN O
as IN O
the DT O
row NN O
sum NN O
if IN O
genes NNS O
are VBP O
listed VBN O
vertically RB O
or CC O
as IN O
the DT O
column NN O
sum NN O
if IN O
genes NNS O
are VBP O
listed VBN O
horizontally RB O
) , O
followed VBN O
by IN O
summing VBG O
the DT O
results NNS O
over IN O
all DT O
genes NNS O
must MD O
be VB O
1 CD O
for IN O
every DT O
edge NN O
. . O

Diagnosis NN O
of IN O
clinically RB O
suspected VBN O
DVT NNP O
of IN O
the DT O
leg NN O
is VBZ O
based VBN O
on IN O
a DT O
clinical JJ O
score NN O
, , O
serial JJ O
compression NN O
ultrasonography NN O
, , O
and CC O
D NN O
- HYPH O
dimer NN O
assay NN O
. . O

( -LRB- O
1983 CD O
) SYM O
Nucleic NNP O
Acids NNP O
Res NNP O
. . O
, , O
submitted VBN O
for IN O
publ NN O
ication NN O
. . O

This DT O
article NN O
, , O
submitted VBN O
on IN O
disc NN O
, , O
has VBZ O
been VBN O
automatically RB O

As IN O
shown VBN O
in IN O
Figure NNP O
7B NNP O
, , O
the DT O
relatively RB O
low JJ O
level NN O
of IN O
intermolecular JJ O
cross NN O
- HYPH O
linking NN O
of IN O
wild JJ O
- HYPH O
type NN O
CD9 NN O
TM NN O
( , O
1 CD O
+ SYM O
2 CD O
) SYM O
- HYPH O
GFP NNP O
protein NN O
was VBD O
enhanced VBN O
dramatically RB O
in IN O
single JJ O
- HYPH O
cysteine NN O
TM2 NNP O
mutants NNS O
Gly80Cys NNP O
and CC O
Ala81Cys NNP O
. . O

Restriction NN O
endonucleases NNS O
and CC O
Pfu NNP O
DNA NNP O
polymerase NN O
were VBD O
obtained VBN O
New NNP O
England NNP O
Biolabs NNP O
( : O
Beverly NNP O
, , O
MA NNP O
) -RRB- O
and CC O
Stratagene NNP O
( : O
Carlsbad NNP O
, , O
CA NNP O
) -RRB- O
, , O
respectively RB O
. . O

Filled VBN O
blocks NNS O
, , O
dashed VBN O
blocks NNS O
and CC O
open JJ O
blocks NNS O
indicate VBP O
protein NN O
coding VBG O
regions NNS O
, , O
untranslated JJ O
regions NNS O
and CC O
introns NNS O
, , O
respectively RB O
. . O

Background NN O

IL NN O
- HYPH O
5 CD O
drives VBZ O
eosinophils NNS O
in IN O
guinea NN B-Species
- HYPH I-Species
pig NN I-Species

In IN O
particular JJ O
, , O
it PRP O
is VBZ O
not RB O
true JJ O
for IN O
the DT O
GR NNP O
and CC O
the DT O
LVD NNP O
models NNS O
, , O
which WDT O
do VBP O
not RB O
consider VB O
gene NN O
vertex NN O
degrees NNS O
. . O

5 CD O

To TO O
address VB O
these DT O
issues NNS O
, , O
we PRP O
used VBD O
three CD O
behavioral JJ O
paradigms NNS O
, , O
the DT O
open JJ O
field NN O
( , O
OPF NNP O
) -RRB- O
, , O
passive JJ O
avoidance NN O
( , O
PA NNP O
) -RRB- O
, , O
and CC O
Morris NNP O
( -LRB- O
water NN O
) -RRB- O
maze NN O
( , O
MM NN O
) -RRB- O
tests NNS O
, , O
which WDT O
are VBP O
often RB O
used VBN O
in IN O
this DT O
field NN O
and CC O
which WDT O
we PRP O
used VBD O
in IN O
our PRP$ O
previous JJ O
studies NNS O
on IN O
the DT O
effects NNS O
of IN O
Hg NNP O
vapor NN O
( , O
Yoshida NNP O
et FW O
al NNP O
. . O
2004 CD O
, , O
2006 CD O
) -RRB- O
. . O

Although IN O
the DT O
Herzberg NNP O
and CC O
Mottaz NNP O
conceptual JJ O
frameworks NNS O
are VBP O
organized JJ O
differently RB O
, , O
their PRP$ O
job NN O
satisfaction NN O
variables NNS O
are VBP O
very RB O
similar JJ O
( , O
i LS O
. . O
e LS O
. . O
work NN O
conditions NNS O
, , O
pay NN O
, , O
interpersonal JJ O
relationships NNS O
, , O
etc FW O
. . O
) -RRB- O
and CC O
they PRP O
both DT O
classify VBP O
these DT O
factors NNS O
as IN O
having VBG O
intrinsic JJ O
or CC O
extrinsic JJ O
elements NNS O
. . O

However RB O
82 CD O
% NN O
of IN O
employees NNS O
reported VBD O
that IN O
having VBG O
their PRP$ O
partner NN O
move VB O
away RB O
was VBD O
the DT O
number NN O
one CD O
reason NN O
for IN O
leaving VBG O
a DT O
rural JJ O
job NN O
. . O

, , O

12 CD O
. . O

cl NN O
expression NN O
by IN O
cells NNS O
harboring VBG O
either CC O
pBRB7 NNP O
. . O
152 CD O
or CC O
pFA02 NN O
. . O
152 CD O
was VBD O
confirmed VBN O
by IN O
measuring VBG O
their PRP$ O
ability NN O
to TO O
form VB O
chloramphenicol NN O
- HYPH O
resistant JJ O
lysogens NNS O
when WRB O
infected VBN O
with IN O
Plcl NNP O
. . O
245Cm CD O
. . O

16 CD O

Rainbow NN B-Species
trout NN I-Species
are VBP O
highly RB O
susceptible JJ O
to IN O
whirling VBG O
disease NN O
and CC O
the DT O
introduction NN O
of IN O
the DT O
parasite NN O
to IN O
the DT O
U NNP O
. . O
S NNP O
. . O
A NNP O
. . O
in IN O
the DT O
1950s CD O
had VBD O
immediate JJ O
economic JJ O
impacts NNS O
on IN O
salmonid JJ O
hatcheries NNS O
in IN O
both DT O
eastern JJ O
and CC O
western JJ O
states NNS O
[ -LRB- O
2 CD O
] -RRB- O
. . O

mixture NN O
were VBD O
incubated VBN O
with IN O
1 CD O
il NN O
of IN O
1 CD O
M NN O
hydrochloric JJ O
acid NN O
at IN O
37 CD O
? . O
C NN O
for IN O
30 CD O
min NN O
. . O

Neither DT O
enzyme NN O
showed VBD O
a DT O
lag NN O
on IN O
this DT O
template NN O
- HYPH O
initiator NN O
complex NN O
or CC O
on IN O
activated VBN O
DNA NNP O
. . O

was VBD O
evaluated VBN O
as IN O
described VBN O
by IN O
Kayes NNP O
and CC O
Oaks NNP O
, , O
18 CD O
with IN O
minor JJ O
modifications NNS O
. . O

Although IN O
this DT O
event NN O
occurs VBZ O
more RBR O
quickly RB O
than IN O
in IN O
vivo NN O
, , O
or CC O
in IN O
animal NN O
models NNS O
, , O
our PRP$ O
data NNS O
are VBP O
consistent JJ O
with IN O
the DT O
above JJ O
in IN O
vivo NN O
observations NNS O
. . O

224 CD O
. . O

The DT O
deletion NN O
alleles NNS O
of IN O
dylt NN O
- HYPH O
1 CD O
( HYPH O
encoding VBG O
a DT O
Tctex1 NNP O
- HYPH O
type NN O
dynein NN O
light JJ O
chain NN O
) -RRB- O
, , O
and CC O
ufd NN O
- HYPH O
2 CD O
( HYPH O
encoding VBG O
a DT O
ubiquitin NN O
conjugating VBG O
enzyme NN O
) , O
both DT O
recapitulated VBD O
the DT O
suppression NN O
produced VBN O
by IN O
RNAi NNP O
knockdown NN O
( -LRB- O
Figure NN O
3B NN O
) -RRB- O
. . O

The DT O
experimental JJ O
evaluation NN O
of IN O
cytotoxicity NN O
properties NNS O
is VBZ O
presented VBN O
in IN O
Table NNP O
2 CD O
. . O

After IN O
identifying VBG O
the DT O
roles NNS O
of IN O
conserved VBN O
TM1 NNP O
and CC O
TM2 NNP O
residues NNS O
in IN O
CD9 NNP O
dimerization NN O
, , O
we PRP O
next RB O
probed VBD O
whether IN O
residues NNS O
proximal JJ O
to IN O
TM NNP O
domains NNS O
3 CD O
and CC O
4 CD O
are VBP O
also RB O
involved JJ O
. . O

In IN O
order NN O
to TO O
model VB O
the DT O
effect NN O
of IN O
PTPN22 NNP O
on IN O
rheumatoid JJ O
arthritis NN O
( -LRB- O
RA NNP O
) -RRB- O
, , O
we PRP O
determined VBD O
the DT O
combination NN O
of IN O
single JJ O
- HYPH O
nucleotide NN O
- HYPH O
polymorphisms NNS O
( -LRB- O
SNPs NNPS O
) -RRB- O
showing VBG O
the DT O
strongest JJS O
association NN O
with IN O
RA NNP O
. . O

( : O
% NN O
) NFP O
80 CD O

We PRP O
next RB O
investigated VBD O
if IN O
the DT O
cells NNS O
that WDT O
failed VBD O
to TO O
develop VB O
into IN O
neurons NNS O
in IN O
Ngn2GFP NNP O
/ SYM O
GFP NNP O
mutant JJ O
mice NNS B-Species
, , O
became VBD O
glial JJ O
cells NNS O
. . O

derivatives NNS O
( : O
3 CD O
) -RRB- O
. . O

The DT O
monoclonal JJ O
antibody NN O
HP1 NNP O
- HYPH O
CIA9 NNP O
( -LRB- O
5 CD O
) -RRB- O
was VBD O
used VBN O
at IN O
a DT O
dilution NN O
of IN O
1 CD O
: SYM O
20 CD O
in IN O
immunoblotting NN O
assays NNS O
. . O

The DT O
oligomer NN O
was VBD O
desalted VBN O
on IN O
a DT O
Bio NNP O
- HYPH O
Gel NNP O
P NNP O
- HYPH O
2 CD O
gel NN O
filtration NN O
column NN O
. . O

She PRP O
had VBD O
two CD O
normal JJ O
periods NNS O
after IN O
stopping VBG O
breastfeeding VBG O
and CC O
was VBD O
feeling VBG O
well RB O
. . O

5 CD O
: : O
112 CD O
- HYPH O
128 CD O
( SYM O
1933 CD O
) -RRB- O
. . O

Please UH O
note VB O
that IN O
the DT O
choice NN O
of IN O
these DT O
parameters NNS O
is VBZ O
dictated VBN O
by IN O
the DT O
parameters NNS O
used VBN O
in IN O
gene NN O
co NN O
- HYPH O
occurrence NN O
analysis NN O
. . O

After IN O
iAs NNP O
exposure NN O
, , O
we PRP O
harvested VBD O
cells NNS O
and CC O
analyzed VBD O
them PRP O
for IN O
luciferase NN O
activity NN O
using VBG O
a DT O
Dual NNP O
- HYPH O
Luciferase NNP O
Reporter NNP O
Assay NNP O
System NNP O
( -LRB- O
Promega NNP O
) -RRB- O
. . O

This DT O
receptor NN O
is VBZ O
also RB O
involved VBN O
in IN O
the DT O
binding NN O
, , O
transport NN O
and CC O
activation NN O
of IN O
newly RB O
- HYPH O
synthesized VBN O
lysosomal JJ O
enzymes NNS O
, , O
such JJ O
as IN O
cathepsins NNS O
[ -LRB- O
4 CD O
, , O
5 CD O
] -RRB- O
, , O
which WDT O
have VBP O
been VBN O
recently RB O
implicated VBN O
in IN O
the DT O
induction NN O
of IN O
apoptosis NN O
[ -LRB- O
6 CD O
] -RRB- O
. . O

Haplotype NN O
bifurcation NN O
plots NNS O
. . O

These DT O
data NNS O
support VBP O
our PRP$ O
previous JJ O
observations NNS O
( , O
outlined VBN O
above RB O
) , O
of IN O
the DT O
highly RB O
conserved VBN O
nature NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
301 CD O
haplotypes NNS O
in IN O
lupus NN O
. . O

Eighty CD O
- HYPH O
six CD O
SNPs NNS O
were VBD O
chosen VBN O
for IN O
genotyping NN O
in IN O
our PRP$ O
mapping NN O
study NN O
. . O

We PRP O
observed VBD O
that IN O
Pax6 NNP O
expression NN O
persisted VBD O
longer RBR O
than IN O
that DT O
of IN O
Mash1 NNP O
, , O
in IN O
Ngn2 NNP O
- HYPH O
expressing VBG O
cells NNS O
( , O
late JJ O
type NN O
- HYPH O
2a NN O
cells NNS O
) -RRB- O
, , O
in IN O
juvenile NN O
but CC O
not RB O
adult NN O
DG NNP O
( , O
Fig NNP O
. . O
1 CD O
and CC O
figure NN O
S1 NNP O
) -RRB- O
. . O

The DT O
beta JJ O
- HYPH O
2 CD O
- HYPH O
microglobulin NN O
is VBZ O
an DT O
integral JJ O
component NN O
of IN O
MHC NNP O
class NN O
I NN O
proteins NNS O
and CC O
is VBZ O
therefore RB O
involved VBN O
in IN O
antigen NN O
processing NN O
and CC O
presentation NN O
to IN O
cytotoxic JJ O
T NN O
cells NNS O
[ -LRB- O
46 CD O
] -RRB- O
. . O

The DT O
level NN O
of IN O
resolution NN O
used VBN O
for IN O
the DT O
typing NN O
of IN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
15 CD O
alleles NNS O
in IN O
these DT O
healthy JJ O
controls NNS O
resulted VBD O
in IN O
the DT O
ambiguous JJ O
allele NN O
string NN O
HLA NNP O
- HYPH O
DRB1 NNP O
* SYM O
1501 CD O
/ SYM O
1502 CD O
/ SYM O
1504 CD O
/ SYM O
1506 CD O
. . O

It PRP O
is VBZ O
our PRP$ O
hope NN O
that IN O
future JJ O
genome NN O
sequencing NN O
will MD O
enable VB O
the DT O
construction NN O
of IN O
more RBR O
comprehensive JJ O
microarray JJ O
platforms NNS O
for IN O
economically RB O
important JJ O
aquaculture NN O
species NNS O
, , O
such JJ O
as IN O
Atlantic NNP B-Species
salmon NN I-Species
and CC O
rainbow NN B-Species
trout NN I-Species
. . O

Different JJ O
salmonid NN O
microarray NN O
platforms NNS O
, , O
such JJ O
as IN O
those DT O
available JJ O
from IN O
Oregon NNP O
State NNP O
University NNP O
and CC O
Michigan NNP O
State NNP O
University NNP O
, , O
or CC O
different JJ O
tissues NNS O
and CC O
time NN O
points NNS O
may MD O
produce VB O
additional JJ O
candidate NN O
genes NNS O
. . O

Tissue NN O
Hg NNP O
concentration NN O

M6P NNP O
/ SYM O
IGF2R NNP O
transcripts NNS O
were VBD O
amplified VBN O
using VBG O
the DT O
primers NNS O
( -LRB- O
5 CD O
' '' O
- HYPH O
GACAGGCTCGTTCTGACTTA NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
and CC O
( : O
5 CD O
' '' O
- HYPH O
CTTCCACTCTTATCCACAGC NN O
- HYPH O
3 CD O
' '' O
) -RRB- O
specific JJ O
to IN O
the DT O
M6P NNP O
/ SYM O
IGF2R NNP O
. . O

Depletion NN O
of IN O
either CC O
dylt NN O
- HYPH O
1 CD O
( HYPH O
encoding VBG O
a DT O
Tctex1 NNP O
- HYPH O
type NN O
light JJ O
chain NN O
) -RRB- O
or CC O
dyrb NN O
- HYPH O
1 CD O
( HYPH O
encoding VBG O
a DT O
roadblock NN O
- HYPH O
type NN O
light JJ O
chain NN O
) -RRB- O
suppressed VBN O
embryonic JJ O
lethality NN O
in IN O
all DT O
three CD O
ts IN O
dynein NN O
HC NNP O
mutant JJ O
strains NNS O
( -LRB- O
Figure NN O
4 CD O
) -RRB- O
. . O

Concentration NN O
of IN O
NO NNP O
was VBD O
determined VBN O
according VBG O
to IN O
[ $ O
10 CD O
] -RRB- O
. . O

Loss NN O
- HYPH O
and CC O
gain NN O
- HYPH O
of IN O
- HYPH O
function NN O
studies NNS O
indicate VBP O
that IN O
Pax6 NNP O
is VBZ O
involved VBN O
in IN O
regulating VBG O
the DT O
proliferation NN O
of IN O
neocortical JJ O
and CC O
hippocampal JJ O
progenitors NNS O
[ -LRB- O
9 CD O
] -RRB- O
, , O
[ -LRB- O
12 CD O
] -RRB- O
- : O
[ -LRB- O
16 CD O
] -RRB- O
. . O

Therefore RB O
, , O
upon IN O
implementation NN O
of IN O
a DT O
caseload NN O
management NN O
database NN O
for IN O
rehabilitation NN O
, , O
key JJ O
factors NNS O
to TO O
consider VB O
include VB O
workplace JJ O
setting NN O
and CC O
client NN O
service NN O
delivery NN O
models NNS O
. . O

Addition NN O
of IN O
this DT O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
subunit NN O
to IN O
the DT O
polymerase NN O
subunit NN O
does VBZ O
not RB O
aid VB O
the DT O
binding NN O
of IN O
the DT O
enzyme NN O
to IN O
DNA NN O
, , O
but CC O
does VBZ O
have VB O
an DT O
effect NN O
on IN O
the DT O
utilisation NN O
of IN O
synthetic JJ O
template NN O
- HYPH O
initiator NN O
complexes NNS O
by IN O
the DT O
polymerase NN O
subunit NN O
. . O

We PRP O
wish VBP O
to TO O
thank VB O
Mrs NNP O
M NNP O
. . O
A DT O
. . O

Further JJ O
work NN O
should MD O
be VB O
conducted VBN O
to TO O
assess VB O
the DT O
responsiveness NN O
and CC O
to TO O
estimate VB O
the DT O
minimal JJ O
clinical JJ O
important JJ O
difference NN O
of IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
to TO O
more RBR O
fully RB O
understand VB O
the DT O
impact NN O
of IN O
ITP NNP O
and CC O
its PRP$ O
treatments NNS O
on IN O
HRQoL NNP O
. . O

Assumption NN O
of IN O
independence NN O
of IN O
variables NNS O
xi NN O
i -RRB- O
. . O

It PRP O
should MD O
be VB O
noted VBN O
that IN O
rats NNS B-Species
have VBP O
different JJ O
Hg NNP O
kinetics NNS O
( , O
Hirayama NNP O
and CC O
Yasutake NNP O
1986 CD O
; , O
Yasutake NNP O
and CC O
Hirayama NNP O
1990 CD O
) -RRB- O
due IN O
to IN O
the DT O
high JJ O
affinity NN O
of IN O
rat NN O
hemoglobin NN O
for IN O
MeHg NNP O
( : O
Clarkson NNP O
and CC O
Magos NNP O
2006 CD O
) -RRB- O
. . O

It PRP O
contains VBZ O
the DT O
ENP1 NNP O
gene NN O
within IN O
a DT O
2 CD O
. . O
6 CD O
kb NN O
EcoRI NNP O
genomic JJ O
fragment NN O
cloned VBN O
into IN O
pRS426 CD O
( SYM O
18 CD O
) -RRB- O
. . O

The DT O
GFAP NNP O
- : O
and CC O
GLAST NNP O
+ CC O
cells NNS O
are VBP O
defined VBN O
as IN O
type NN O
- HYPH O
1 CD O
cells NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Most JJS O
of IN O
the DT O
studies NNS O
on IN O
TB NNP O
granulomas NNS O
have VBP O
focused VBN O
on IN O
the DT O
contribution NN O
of IN O
host NN O
components NNS O
, , O
but CC O
very RB O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
role NN O
played VBN O
by IN O
bacterial JJ O
constituents NNS O
in IN O
terms NNS O
of IN O
granuloma NN O
formation NN O
and CC O
progression NN O
. . O

Other JJ O
genes NNS O
increase VBP O
beta NN O
- HYPH O
lactam NN O
resistance NN O
upon IN O
overexpression NN O
, , O
such JJ O
as IN O
hmrA NN O
coding NN O
for IN O
a DT O
putative JJ O
amidohydrolase NN O
, , O
hmrB NN O
coding NN O
for IN O
a DT O
putative JJ O
acyl NN O
carrier NN O
protein NN O
[ -LRB- O
31 CD O
] -RRB- O
, , O
or CC O
the DT O
NorG NNP O
- HYPH O
controlled VBN O
abcA NN O
multidrug NN O
efflux NN O
pump NN O
[ -LRB- O
28 CD O
] -RRB- O
. . O

MM NNP O

The DT O
basic JJ O
synthetic JJ O
steps NNS O
which WDT O
are VBP O
shown VBN O
in IN O
Figure NN O
1 CD O
are VBP O
described VBN O
in IN O
detail NN O
in IN O
the DT O
Experimental NNP O
section NN O
. . O

Absence NN O
of IN O
conflicts NNS O
of IN O
interest NN O
, , O
geographic JJ O
diversity NN O
, , O
and CC O
diversity NN O
of IN O
practice NN O
setting NN O
were VBD O
also RB O
considered VBN O
. . O

Individuals NNS O
were VBD O
selected VBN O
randomly RB O
from IN O
different JJ O
areas NNS O
of IN O
the DT O
province NN O
of IN O
Malaga NNP O
, , O
in IN O
southern JJ O
Spain NNP O
, , O
and CC O
from IN O
different JJ O
social JJ O
statuses NNS O
to TO O
avoid VB O
a DT O
selection NN O
bias NN O
. . O

As IN O
in IN O
[ -LRB- O
5 CD O
] -RRB- O
, , O
all PDT O
these DT O
statistics NNS O
are VBP O
evaluated VBN O
using VBG O
transfer NN O
probabilities NNS O
. . O

Analysis NN O
of IN O
the DT O
secondary JJ O
structure NN O
predicted VBN O
by IN O
the DT O
open JJ O
reading NN O
frames NNS O
does VBZ O
not RB O
reveal VB O
the DT O
characteristic JJ O
helix NN O
- HYPH O
turn NN O
- HYPH O
helix NN O
( HYPH O
12 CD O
) , O
or CC O
other JJ O
motifs NNS O
commonly RB O
associated VBN O
with IN O
DNA NN O
binding NN O
proteins NNS O
. . O

P NN O
{ NN O
H1 NN O
| : O
xi NN O
} NFP O
P NN O
{ NN O
H0 NN O
| : O
xi NN O
} NN O
= SYM O
P NN O
{ NN O
xi NN O
0 CD O
= SYM O
1 CD O
| : O
xi NN O
} : O
P NN O
{ NN O
xi NN O
0 CD O
= SYM O
0 CD O
| SYM O
xi NN O
} NFP O
= SYM O
P NN O
{ SYM O
xi NN O
0 CD O
= SYM O
1 CD O
, , O
xi NN O
} NN O
/ : O
P NN O
{ NN O
xi NN O
} : O
P NN O
{ NN O
xi NN O
0 CD O
= SYM O
0 CD O
, , O
xi NN O
} NN O
/ SYM O
P NN O
{ SYM O
xi NN O
} NFP O
= SYM O
P NN O
{ SYM O
xi NN O
| : O
xi NN O
0 CD O
= SYM O
1 CD O
} SYM O
P NN O
{ SYM O
xi NN O
| : O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
. . O
P NN O
{ NN O
xi NN O
0 CD O
= SYM O
1 CD O
} SYM O
P NN O
{ NN O
xi NN O
0 CD O
= SYM O
0 CD O
} NFP O
. . O

The DT O
threshold NN O
value NN O
should MD O
be VB O
selected VBN O
in IN O
such PDT O
a DT O
way NN O
that IN O
the DT O
total JJ O
number NN O
of IN O
incorrect JJ O
predictions NNS O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
the DT O
sum NN O
of IN O
the DT O
number NN O
of IN O
type NN O
1 CD O
errors NNS O
and CC O
the DT O
number NN O
of IN O
type NN O
2 CD O
errors NNS O
) -RRB- O
would MD O
be VB O
minimal JJ O
. . O

CT NNP O
scan NN O
showed VBD O
a DT O
11 CD O
mm CD O
x SYM O
8 CD O
mm NN O
x NN O
6 CD O
mm NN O
tumor NN O
replacing VBG O
the DT O
upper JJ O
half NN O
of IN O
the DT O
left JJ O
kidney NN O
with IN O
extension NN O
into IN O
the DT O
renal JJ O
vein NN O
. . O

resistant JJ O
to IN O
hydrolysis NN O
by IN O
these DT O
conditions NNS O
as IN O
shown VBN O
by IN O
the DT O
stability NN O
of IN O
d NNP O
- HYPH O
TpT NNP O
and CC O
d NNP O
- HYPH O
TpTpT NNP O
. . O

quantitation NN O
and CC O
characterization NN O
of IN O
metallothionein NN O
. . O

* NFP O
- : O
. . O

This DT O
model NN O
is VBZ O
called VBN O
the DT O
binomial NN O
( , O
BN NNP O
) -RRB- O
model NN O
. . O

The DT O
ChIP NNP O
assay NN O
supports VBZ O
the DT O
hypothesis NN O
that IN O
the DT O
loss NN O
of IN O
transcription NN O
of IN O
cell NN O
- HYPH O
cycle NN O
regulator NN O
genes NNS O
is VBZ O
a DT O
direct JJ O
effect NN O
of IN O
the DT O
lack NN O
of IN O
HP1 NNP O
. . O

c LS O
) , O
Circuit NN O
boards NNS O
of IN O
cell NN O
phones NNS O
and CC O
other JJ O
hand NN O
- HYPH O
held VBN O
devices NNS O
were VBD O
taken VBN O
apart RB O
by IN O
a DT O
electrothermal JJ O
machine NN O
( -LRB- O
Figure NNP O
4 CD O
) -RRB- O
, , O
which WDT O
was VBD O
a DT O
particular JJ O
environmental JJ O
and CC O
human JJ B-Species
health NN O
concern NN O
in IN O
the DT O
processing NN O
of IN O
e NN O
- HYPH O
waste NN O
in IN O
Guiyu NNP O
. . O

Eosinophil NNP O
accumulation NN O
induced VBN O
by IN O
human JJ B-Species
interleukin NN O
- HYPH O
8 CD O
in IN O
the DT O
guinea NN B-Species
pig NN I-Species
in IN O
vivo NN O
. . O

68 CD O

Reverse JJ O
transcription NN O
of IN O
FMDV NNP B-Species
RNA NNP O
was VBD O
carried VBN O
out RP O
with IN O
avian JJ B-Species
myeloblastosis NN I-Species
virus NN I-Species
reverse NN O
transcriptase NN O
( , O
Promega NN O
, , O
http NN O
: : O
/ : O
/ : O
www ADD O
. . O
promega NN O
. . O
com NN O
) -RRB- O
or CC O
Transcriptor NN O
reverse JJ O
transcriptase NN O
( : O
Roche NNP O
, , O
http NN O
: : O
/ : O
/ SYM O
www NN O
. . O
roche NN O
. . O
com NN O
) -RRB- O
, , O
and CC O
PCR NN O
amplification NN O
was VBD O
performed VBN O
by IN O
using VBG O
either CC O
Ampli NNP O
- HYPH O
Taq NNP O
polymerase NN O
( : O
PerkinElmer NNP O
, , O
http NNP O
: : O
/ : O
/ : O
las ADD O
. . O
perkinelmer ADD O
. . O
com NN O
) -RRB- O
or CC O
an DT O
Expand NNP O
High NNP O
Fidelity NNP O
polymerase NN O
system NN O
( -LRB- O
Roche NNP O
) -RRB- O
, , O
as IN O
instructed VBN O
by IN O
the DT O
manufacturers NNS O
. . O

Polyribosome NN O
preparation NN O
and CC O
analysis NN O
were VBD O
carried VBN O
out RP O
essentially RB O
as IN O
described VBN O
( SYM O
26 CD O
) -RRB- O
. . O

The DT O
dpy JJ O
- HYPH O
3 CD O
( HYPH O
e27 CD O
) -RRB- O
and CC O
dpy NN O
- HYPH O
10 CD O
( HYPH O
e128 CD O
) -RRB- O
point NN O
mutation NN O
alleles NNS O
[ -LRB- O
28 CD O
] -RRB- O
also RB O
suppressed VBD O
embryonic JJ O
lethality NN O
in IN O
double JJ O
mutants NNS O
( -LRB- O
Figure NNP O
3B NNP O
) -RRB- O
. . O

Methods NNS O

Genotypic JJ O
Risk NN O
for IN O
Class NN O
II NNP O
and CC O
Class NNP O
III NNP O
Association NNP O
Signals NNS O

Cell NN O
killing NN O
assay NN O
. . O

The DT O
resistance NN O
frequency NN O
was VBD O
calculated VBN O
as IN O
the DT O
number NN O
of IN O
colonies NNS O
that WDT O
are VBP O
CouR NNP O
per IN O
total JJ O
number NN O
of IN O
cells NNS O
plated VBN O
. . O

Why WRB O
Was VBD O
This DT O
Study NN O
Done VBN O
? . O

Test NN O
results NNS O
were VBD O
considered VBN O
significant JJ O
if IN O
P NN O
< SYM O
= SYM O
0 CD O
. . O

If IN O
the DT O
observed VBN O
phenotypes NNS O
reproduced VBD O
, , O
the DT O
assay NN O
was VBD O
performed VBN O
with IN O
three CD O
streak NN O
- HYPH O
purified VBN O
E NNP B-Species
. . I-Species
coli NN I-Species
colonies NNS O
, , O
and CC O
a DT O
single JJ O
isolate NN O
that WDT O
again RB O
displayed VBD O
the DT O
interaction NN O
was VBD O
kept VBN O
for IN O
further JJ O
analysis NN O
. . O

The DT O
B NNP B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
includes VBZ O
bacterial JJ O
species NNS O
that WDT O
are VBP O
of IN O
medical JJ O
and CC O
/ SYM O
or CC O
economic JJ O
importance NN O
, , O
such JJ O
as IN O
B NN B-Species
. . I-Species
anthracis NN I-Species
, , O
an DT O
obligate JJ O
mammalian JJ O
pathogen NN O
causing VBG O
the DT O
lethal JJ O
disease NN O
anthrax NN B-Species
, , O
B NN B-Species
. . I-Species
cereus NN I-Species
, , O
an DT O
opportunistic JJ O
human JJ B-Species
pathogen NN O
involved VBN O
in IN O
food NN O
- HYPH O
poisoning VBG O
incidents NNS O
and CC O
contaminations NNS O
in IN O
hospitals NNS O
, , O
B NN B-Species
. . I-Species
thuringiensis NN I-Species
, , O
an DT O
insect NN O
pathogen NN O
and CC O
one CD O
of IN O
the DT O
world NN O
' '' O
s POS O
most RBS O
widely RB O
used VBN O
biopesticide NN O
and CC O
B NN B-Species
. . I-Species
weihenstephanensis NNP I-Species
, , O
a DT O
cold JJ O
- HYPH O
tolerant JJ O
species NN O
known VBN O
for IN O
contaminating VBG O
dairies NNS O
. . O

Although IN O
our PRP$ O
final JJ O
response NN O
rate NN O
was VBD O
low JJ O
, , O
it PRP O
was VBD O
almost RB O
identical JJ O
to IN O
that DT O
achieved VBN O
in IN O
a DT O
recent JJ O
population NN O
- HYPH O
based VBN O
intervention NN O
study NN O
elsewhere RB O
in IN O
Glasgow NNP O
[ -LRB- O
22 CD O
] -RRB- O
. . O

17 CD O
: : O
84 CD O
( SYM O
1973 CD O
) -RRB- O
. . O

MLST NNP O
is VBZ O
based VBN O
on IN O
polymerase NN O
chain NN O
reaction NN O
( , O
PCR NN O
) -RRB- O
amplification NN O
and CC O
sequencing NN O
of IN O
internal JJ O
fragments NNS O
of IN O
usually RB O
seven CD O
essential JJ O
or CC O
housekeeping NN O
genes NNS O
spread VBN O
around IN O
the DT O
bacterial JJ O
chromosome NN O
. . O

Besides IN O
analysis NN O
of IN O
the DT O
available JJ O
data NNS O
, , O
the DT O
user NN O
has VBZ O
the DT O
possibility NN O
to TO O
enter VB O
her PRP$ O
/ SYM O
his PRP$ O
own JJ O
sequences NNS O
and CC O
compare VB O
them PRP O
to IN O
the DT O
database NN O
and CC O
/ SYM O
or CC O
include VB O
them PRP O
into IN O
the DT O
supertree NN O
reconstructions NNS O
. . O

The DT O
culture NN O
was VBD O
split VBN O
into IN O
500 CD O
ml NNS O
aliquots NNS O
, , O
the DT O
first JJ O
was VBD O
treated VBN O
with IN O
1 CD O
mM NN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
, , O
the DT O
second JJ O
with IN O
0 CD O
. . O
25 CD O
mg NN O
of IN O
lipoxidase NN O
( : O
17 CD O
700 CD O
units NNS O
) -RRB- O
and CC O
the DT O
third JJ O
was VBD O
untreated JJ O
. . O

It PRP O
seems VBZ O
likely JJ O
that IN O
secondary JJ O
metabolism NN O
is VBZ O
essential JJ O
in IN O
phytopathogenic JJ O
species NNS O
for IN O
the DT O
synthesis NN O
of IN O
mycotoxins NNS O
, , O
antibiotics NNS O
, , O
siderophores NNS O
and CC O
pigments NNS O
[ -LRB- O
66 CD O
] -RRB- O
, , O
but CC O
it PRP O
may MD O
also RB O
offer VB O
fungal JJ O
pathogens NNS O
a DT O
distinct JJ O
alternative JJ O
means NN O
of IN O
perturbing VBG O
host NN O
metabolism NN O
, , O
cell NN O
signalling NN O
or CC O
plant NN O
defence NN O
, , O
in IN O
contrast NN O
to IN O
bacterial JJ O
pathogens NNS O
that WDT O
rely VBP O
on IN O
protein NN O
secretion NN O
to TO O
achieve VB O
this DT O
. . O

A DT O
review NN O
of IN O
the DT O
literature NN O
was VBD O
conducted VBN O
to TO O
identify VB O
recruitment NN O
and CC O
retention NN O
strategies NNS O
for IN O
rehabilitation NN O
therapists NNS O
. . O

Three CD O
SNPs NNS O
( , O
rs2476601 CD O
- HYPH O
rs12730735 CD O
- HYPH O
rs11102685 CD O
) -RRB- O
were VBD O
selected VBN O
for IN O
which WDT O
we PRP O
estimated VBD O
the DT O
genotypic JJ O
relative JJ O
risks NNS O
( , O
GRRs NNS O
) -RRB- O
of IN O
the DT O
corresponding VBG O
genotypes NNS O
. . O

These DT O
similar JJ O
sequences NNS O
are VBP O
selected VBN O
from IN O
a DT O
certain JJ O
databank NN O
that WDT O
contains VBZ O
annotated JJ O
amino NN O
- HYPH O
acid NN O
sequences NNS O
, , O
e UH O
. . O
g LS O
. . O
, , O
SWISS NNP O
- HYPH O
PROT NN O
. . O

and CC O
hence RB O

Background NN O

Fig NN O
. . O

The DT O
high JJ O
density NN O
of IN O
SNPs NNPS O
and CC O
their PRP$ O
proximity NN O
hamper VBP O
other JJ O
genotyping JJ O
strategies NNS O
for IN O
rapid JJ O
determination NN O
of IN O
the DT O
complete JJ O
GH1 NNP O
SNP NNP O
map NN O
in IN O
large JJ O
control NN O
and CC O
patient JJ B-Species
populations NNS O
. . O

1 CD O
~ SYM O
~ : O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ NFP O
~ SYM O
3 CD O
mouse NN B-Species
myeloma NN O
DNA NN O
polymerase NN O
a DT O
fraction NN O
is VBZ O
not RB O
due JJ O
to IN O
proteolysis NN O
. . O

synthesis NN O
since IN O
large JJ O
excesses NNS O
of IN O
these DT O
materials NNS O
are VBP O
employed VBN O
in IN O
the DT O
coupling NN O
step NN O
. . O

15 CD O

A DT O
QTL NNP O
mapping NN O
approach NN O
could MD O
also RB O
be VB O
used VBN O
to TO O
identify VB O
particular JJ O
chromosomal JJ O
regions NNS O
directly RB O
contributing VBG O
to IN O
the DT O
disease NN O
phenotype NN O
. . O

Quantitative JJ O
PCR NN O
conducted VBN O
on IN O
caudal JJ O
fin NN O
tissues NNS O
at IN O
two CD O
hours NNS O
post NN O
exposure NN O
to IN O
M NNP B-Species
. . I-Species
cerebralis NN I-Species
demonstrated VBD O
each DT O
fish NN O
strain NN O
had VBD O
similar JJ O
initial JJ O
pathogen NN O
loads NNS O
, , O
although IN O
there EX O
was VBD O
substantial JJ O
variation NN O
between IN O
individual JJ O
fish NN O
within IN O
each DT O
strain NN O
. . O

The DT O
tumor NN O
tissues NNS O
were VBD O
considered VBN O
positive JJ O
for IN O
ER NNP O
alpha NN O
by IN O
IHC NNP O
if IN O
> SYM O
5 CD O
% NN O
of IN O
cancer NN O
cells NNS O
showed VBD O
positive JJ O
nuclear JJ O
staining NN O
. . O

36 CD O
. . O

To TO O
extend VB O
this DT O
observation NN O
, , O
we PRP O
surveyed VBD O
all DT O
genes NNS O
encoding VBG O
predicted VBN O
dynein NN O
components NNS O
for IN O
suppression NN O
of IN O
the DT O
three CD O
ts IN O
dhc NN O
- HYPH O
1 CD O
mutants NNS O
( -LRB- O
Figure NNP O
5A NN O
; : O
Table NNP O
S2 NNP O
) -RRB- O
. . O

Table NN O
1 CD O
. . O

ACKNOWLEGMENT NNP O
We PRP O
are VBP O
grateful JJ O
to IN O
Latvian NNP O
Taiho NNP O
Foundation NNP O
for IN O
financial JJ O
support NN O
. . O

300 CD O
350 CD O

Table NNP O
I PRP O
lists VBZ O
some DT O
of IN O
the DT O
oligomers NNS O
which WDT O
have VBP O
been VBN O
synthesized VBN O
on IN O
polystyrene NN O
supports NNS O
. . O

Thus RB O
, , O
the DT O
amino JJ O
acid NN O
composition NN O
indicates VBZ O
that IN O
prokaryotic JJ O
MTs NNS O
are VBP O
not RB O
as RB O
structurally RB O
homologous JJ O
with IN O
eukaryotes NNS O
as IN O
they PRP O
are VBP O
physiologically RB O
homologous JJ O
. . O

RT NNP O
- HYPH O
PCR NNP O
was VBD O
performed VBN O
using VBG O
the DT O
GeneAmp NNP O
EZ NNP O
rTth NNP O
RNA NNP O
PCR NNP O
kit NN O
( : O
Roche NNP O
) -RRB- O
. . O

Here RB O
the DT O
left JJ O
part NN O
is VBZ O
the DT O
posterior JJ O
odds NNS O
, , O
that DT O
is VBZ O
the DT O
ratio NN O
of IN O
a DT O
posteriori JJ O
probabilities NNS O
of IN O
hypotheses NNS O
H1 NN O
and CC O
H0 CD O
( , O
a DT O
posteriori NN O
means VBZ O
that IN O
values NNS O
xi VBP O
1 CD O
, , O
. , O
. , O
. , O
, , O
xi NN O
n CC O
are VBP O
known VBN O
) -RRB- O
. . O

Zool NN O
. . O

Supershift NN O
EMSA NNP O
analysis NN O
using VBG O
an DT O
NRF2 NNP O
antibody NN O
showed VBD O
that IN O
the DT O
iAs NNS O
- HYPH O
induced VBN O
and CC O
iAs NN O
- HYPH O
translocated VBN O
NRF2 NNP O
protein NN O
binds NNS O
to IN O
the DT O
WT NNP O
- HYPH O
K16ARE NNP O
probe NN O
containing VBG O
the DT O
ARE NNP O
sequence NN O
of IN O
the DT O
K16 NNP O
proximal JJ O
promoter NN O
region NN O
( -LRB- O
5 CD O
' '' O
- HYPH O
GGAGTCAGC NNP O
- HYPH O
3 CD O
' '' O
) -RRB- O
that WDT O
comprises VBZ O
an DT O
AP NNP O
- HYPH O
1 CD O
- HYPH O
like JJ O
site NN O
and CC O
a DT O
GC NNP O
box NN O
, , O
whereas IN O
the DT O
supershift NN O
of IN O
c NN O
- HYPH O
Jun NNP O
was VBD O
not RB O
observed VBN O
( : O
Figure NN O
4E CD O
) -RRB- O
. . O

The DT O
experimental JJ O
data NNS O
present JJ O
in IN O
this DT O
report NN O
suggested VBD O
that IN O
this DT O
was VBD O
the DT O
case NN O
. . O

An DT O
increase NN O
in IN O
the DT O
frequency NN O
of IN O
the DT O
T NN O
allele NN O
( , O
0 CD O
. . O
38 CD O
vs IN O
0 CD O
. . O
47 CD O
; : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
and CC O
of IN O
the DT O
TT NNP O
genotype NN O
( , O
0 CD O
. . O
14 CD O
vs IN O
0 CD O
. . O
24 CD O
; : O
p NN O
< NN O
0 CD O
. . O
1 CD O
) -RRB- O
in IN O
subjects NNS O
born VBN O
in IN O
the DT O
last JJ O
quarter NN O
of IN O
the DT O
century NN O
was VBD O
observed VBN O
. . O

Interestingly RB O
, , O
the DT O
absence NN O
of IN O
Ngn2 NNP O
did VBD O
not RB O
alter VB O
the DT O
identity NN O
of IN O
neurons NNS O
in IN O
the DT O
DG NNP O
granule NN O
layer NN O
in IN O
2 CD O
week NN O
- HYPH O
old JJ O
Ngn2 NNP O
null JJ O
mice NN B-Species
. . O

The DT O
BN NNP O
and CC O
HG NNP O
models NNS O
give VBP O
essentially RB O
identical JJ O
results NNS O
. . O

However RB O
, , O
gene NN O
expression NN O
signatures NNS O
are VBP O
composed VBN O
of IN O
distinct JJ O
gene NN O
sets NNS O
and CC O
the DT O
null NN O
- HYPH O
model NN O
must MD O
maintain VB O
this DT O
property NN O
, , O
which WDT O
is VBZ O
not RB O
guaranteed VBN O
using VBG O
these DT O
approaches NNS O
. . O

1 LS O
. . O
58 CD O
"""" '' O

Altogether RB O
, , O
however RB O
, , O
these DT O
results NNS O
strongly RB O
support VBP O
the DT O
notion NN O
that IN O
the DT O
gene NN O
clusters NNS O
in IN O
the DT O
PubLiME NNP O
data NNS O
set NN O
can MD O
be VB O
reproduced VBN O
by IN O
the DT O
more RBR O
fine RB O
- HYPH O
grained JJ O
analysis NN O
that WDT O
considers VBZ O
sublists NNS O
in IN O
each DT O
publication NN O
as IN O
separate JJ O
signatures NNS O
. . O

Substances NNS O
possessing VBG O
cocarcinogenic JJ O
effect NN O
. . O

Large JJ O
- HYPH O
scale NN O
amplification NN O
of IN O
recombinant JJ O
adenovirus NN O
in IN O
293 CD O
cells NNS O
was VBD O
followed VBN O
by IN O
purification NN O
using VBG O
a DT O
discontinuous JJ O
CsCl NNP O
gradient NN O
. . O

Methods NNS O

CACorresponding VBG O
Author NN O

All DT O
three CD O
rs419788 CD O
genotypes NNS O
demonstrated VBD O
significant JJ O
association NN O
in IN O
our PRP$ O
lupus NN O
families NNS O
( -LRB- O
Table NNP O
3 CD O
) -RRB- O
. . O

Peaks NNS O
marked VBD O

Steitz NNP O
, , O
J NNP O
. . O

Additionally RB O
, , O
upstream JJ O
regulators NNS O
of IN O
metallothionein NN O
expression NN O
could MD O
be VB O
the DT O
true JJ O
underlying VBG O
cause NN O
of IN O
the DT O
whirling VBG O
disease NN O
phenotype NN O
since IN O
a DT O
gene NN O
expression NN O
study NN O
alone RB O
cannot MD O
determine VB O
if IN O
a DT O
gene NN O
is VBZ O
directly RB O
contributing VBG O
to IN O
a DT O
phenotype NN O
( : O
i LS O
. . O
e -RRB- O
. . O
, , O
cause NN O
versus IN O
downstream NN O
effect NN O
) -RRB- O
. . O

WS NNP O
conceived VBD O
the DT O
study NN O
, , O
supervised VBD O
the DT O
recruitment NN O
of IN O
participants NNS B-Species
, , O
performed VBD O
the DT O
statistical JJ O
analyses NNS O
, , O
assisted VBN O
in IN O
the DT O
interpretation NN O
of IN O
the DT O
results NNS O
, , O
and CC O
supervised VBD O
the DT O
editing NN O
of IN O
the DT O
manuscript NN O
to IN O
its PRP$ O
final JJ O
form NN O
. . O

Accession NN O
Numbers NNS O

The DT O
cells NNS O
were VBD O
then RB O
resuspended VBN O
in IN O
100 CD O
micro JJ O
l NN O
HN NN O
buffer NN O
and CC O
observed VBN O
by IN O
fluorescence NN O
microscopy NN O
with IN O
excitation NN O
wavelengths NNS O
551 CD O
nm NNS O
( SYM O
Red NNP O
Fluorescent NNP O
) -RRB- O
and CC O
351 CD O
nm NN O
( , O
DPPP NNP O
) -RRB- O
, , O
and CC O
emission NN O
wavelengths NNS O
567 CD O
nm NN O
( -LRB- O
Red NNP O
Fluorescent NNP O
) -RRB- O
and CC O
380 CD O
nm NN O
( -LRB- O
DPPP NNP O
) -RRB- O
. . O

Of IN O
particular JJ O
interests NNS O
is VBZ O
the DT O
presence NN O
of IN O
highly RB O
conserved VBN O
sequences NNS O
in IN O
the DT O
5 CD O
' '' O
- HYPH O
flanking VBG O
region NN O
of IN O
the DT O
human JJ B-Species
and CC O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
gene NN O
( : O
Fig NNP O
. . O
4 CD O
) -RRB- O
. . O

Breakdown NN O
of IN O
material NN O
from IN O
155 CD O
, , O
0 CD O
to IN O
50 CD O
- SYM O
70 CD O
, , O
0 CD O
may MD O
be VB O
partly RB O
responsible JJ O
for IN O
the DT O
contamination NN O
, , O
but CC O
the DT O
presence NN O
of IN O
phenylmethylsulphony NN O
in IN O
samples NNS O
in IN O
preparation NN O
for IN O
sodium NN O
dodecylsulphate NN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
has VBZ O
not RB O
been VBN O
successful JJ O
in IN O
preventing VBG O
it PRP O
. . O

Synergistic JJ O
effects NNS O
of IN O

This DT O
possibility NN O
is VBZ O
supported VBN O
by IN O
a DT O
recent JJ O
study NN O
of IN O
our PRP$ O
group NN O
[ -LRB- O
22 CD O
] -RRB- O
in IN O
which WDT O
we PRP O
found VBD O
that IN O
thrombin NN O
generation NN O
occurred VBD O
in IN O
some DT O
healthy JJ O
volunteers NNS O
after IN O
flying VBG O
for IN O
8 CD O
h NNS O
but CC O
happened VBD O
to IN O
a DT O
far RB O
lesser JJR O
extent NN O
after IN O
being VBG O
immobilized VBN O
for IN O
8 CD O
h NN O
in IN O
a DT O
cinema NN O
. . O

We PRP O
feel VBP O
that IN O
this DT O
device NN O
has VBZ O
great JJ O
potential NN O
in IN O
the DT O
field NN O
of IN O
hand NN O
- HYPH O
and CC O
spinal JJ O
surgery NN O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
21 CD O
B NN B-Species
. . I-Species
cereus NN I-Species
group NN I-Species
strains NNS O
that WDT O
have VBP O
been VBN O
completely RB O
sequenced VBN O
, , O
and CC O
for IN O
which WDT O
the DT O
sequences NNS O
at IN O
all DT O
26 CD O
MLST NNP O
loci NN O
are VBP O
thus RB O
available JJ O
, , O
can MD O
be VB O
used VBN O
to TO O
join VB O
all DT O
five CD O
schemes NNS O
and CC O
provide VB O
the DT O
strain NN O
overlap RB O
necessary JJ O
for IN O
supertree NN O
analysis NN O
. . O

The DT O
culture NN O
was VBD O
incubated VBN O
on IN O
ice NN O
for IN O
15 CD O
min NN O
, , O
and CC O
cells NNS O
were VBD O
harvested VBN O
by IN O
centrifugation NN O
( : O
4000 CD O
r NN O
. . O
p NN O
. . O
m NN O
. . O
/ SYM O
10 CD O
min NN O
) -RRB- O
. . O

Abstract JJ O

Authors NNS O
' POS O
contributions NNS O

RESULTS NNS O
AND CC O
DISCUSSION NN O
Potential JJ O
cytotoxic JJ O
activity NN O
of IN O
synthesized VBN O
fused VBN O
isoxazolines NNS O
1 CD O
and CC O
2 CD O
was VBD O
tested VBN O
in IN O
vitro NN O
on IN O
four CD O
monolayer NN O
tumor NN O
cell NN O
lines NNS O
: : O
MG NNP O
- HYPH O
22A CD O
( HYPH O
mouse NN B-Species
hepatoma NN O
) -RRB- O
, , O
HT NNP O
- HYPH O
1080 CD O
( , O
human JJ B-Species
fibroblastoma NN O
) -RRB- O
, , O
B16 NNP O
( , O
mouse NN B-Species
melanoma NN O
) -RRB- O
, , O
Neuro NNP O
2A NNP O
( , O
mouse NN B-Species
neiroblastoma NN O
) -RRB- O
. . O

Plasmid NN O
DNA NN O
isolated VBN O
from IN O
complementation NN O
- HYPH O
positive JJ O
cells NNS O
was VBD O
shown VBN O
by IN O
agarose NN O
gel NN O
electrophoresis NN O
to TO O
carry VB O
plasmids NNS O
containing VBG O
the DT O
2 CD O
. . O
6 CD O
kb NN O
EcoRIlBamHI NNP O
fragment NN O
from IN O
the DT O
cl JJ O
region NN O
. . O

Biochim NNP O
. . O

Thus RB O
, , O
they PRP O
are VBP O
well RB O
- HYPH O
positioned VBN O
to TO O
participate VB O
in IN O
an DT O
interaction NN O
with IN O
another DT O
molecule NN O
. . O

Biophys NNP O
. . O

Also RB O
, , O
no DT O
increase NN O
in IN O
point NN O
mutations NNS O
was VBD O
observed VBN O
when WRB O
cells NNS O
were VBD O
treated VBN O
with IN O
higher JJR O
concentrations NNS O
of IN O
H2O2 NNP O
( SYM O
10 CD O
mM NN O
) -RRB- O
or CC O
when WRB O
treated VBN O
with IN O
t NN O
- HYPH O
butyl NN O
hydroperoxide NN O
( , O
5 CD O
and CC O
10 CD O
mM NN O
) -RRB- O
( , O
data NNS O
not RB O
shown VBN O
) -RRB- O
. . O

Both DT O
authors NNS O
were VBD O
equally RB O
involved VBN O
in IN O
the DT O
preparation NN O
of IN O
this DT O
manuscript NN O
. . O

The DT O
quantitative JJ O
evaluation NN O
of IN O
the DT O
percentage NN O
of IN O
FMs NNPS O
within IN O
granulomas NNS O
induced VBN O
by IN O
both DT O
strains NNS O
confirmed VBD O
the DT O
differences NNS O
observed VBN O
under IN O
the DT O
light JJ O
microscope NN O
, , O
and CC O
showed VBD O
a DT O
seven CD O
- HYPH O
fold NN O
difference NN O
( : O
44 CD O
% NN O
vs IN O
6 CD O
% NN O
respectively RB O
) -RRB- O
between IN O
M NN B-Species
. . I-Species
tb NN I-Species
and CC O
M NN B-Species
. . I-Species
smegmatis NN I-Species
in IN O
terms NNS O
of IN O
their PRP$ O
ability NN O
to TO O
induce VB O
FM NN O
formation NN O
( -LRB- O
Figure NN O
2D NN O
) -RRB- O
. . O

Ngn2 NNP O
null JJ O
mutant JJ O
animals NNS O
display VBP O
a DT O
reduced VBN O
size NN O
of IN O
the DT O
cornu NN O
ammonis NN O
and CC O
a DT O
malformed VBN O
DG NNP O
( -LRB- O
Figure NNP O
3 CD O
and CC O
4 CD O
; : O
[ -LRB- O
20 CD O
] -RRB- O
) -RRB- O
. . O

1 CD O
M NN O
NaCl NNP O
so RB O
it PRP O
does VBZ O
not RB O
appear VB O
that IN O
the DT O
subunit NN O
enhances VBZ O
the DT O
binding NN O
of IN O
the DT O
DNA NNP O
polymerase NN O
subunit NN O
to IN O
DNA NNP O
. . O

Cells NNS O
were VBD O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
2 CD O
hrs NNS O
in IN O
serum NN O
- HYPH O
free JJ O
F NNP O
- HYPH O
10 CD O
culture NN O
medium NN O
containing VBG O
125I NNP O
- HYPH O
labeled VBN O
IGF NNP O
- HYPH O
II NNP O
( : O
0 CD O
. . O
5 CD O
ng NN O
/ SYM O
ml NN O
) -RRB- O
with IN O
or CC O
without IN O
excess JJ O
unlabeled JJ O
IGF NNP O
- HYPH O
II NN O
( : O
2 CD O
mu NN O
g NN O
/ SYM O
ml NN O
) -RRB- O
. . O

al NNP O
. . O

Not RB O
surprisingly RB O
, , O
they PRP O
included VBD O
many JJ O
proteins NNS O
involved VBN O
in IN O
basic JJ O
cellular JJ O
processes NNS O
, , O
such JJ O
as IN O
ribosomal JJ O
proteins NNS O
, , O
components NNS O
of IN O
transcription NN O
, , O
translation NN O
and CC O
DNA NN O
replication NN O
apparatus NN O
, , O
cytoskeletal JJ O
proteins NNS O
, , O
histones NNS O
, , O
proteins NNS O
involved VBN O
in IN O
the DT O
secretory NN O
pathway NN O
, , O
protein NN O
folding NN O
, , O
protein NN O
sorting NN O
and CC O
ubiquitin NN O
- HYPH O
mediated VBN O
proteolysis NN O
and CC O
enzymes NNS O
involved VBN O
in IN O
primary JJ O
metabolism NN O
. . O

Brief JJ O
restriction NN O
endonuclease NN O
cleavage NN O
map NN O
for IN O
the DT O
mouse NN B-Species
IL NN O
- HYPH O
2 CD O
cDNAs NNS O
is VBZ O
presented VBN O
in IN O
the DT O
lower JJR O
part NN O
of IN O
the DT O
figure NN O
. . O

In IN O
this DT O
case NN O
, , O
measured VBN O
BLyS NNP O
levels NNS O
would MD O
have VB O
been VBN O
spuriously RB O
reduced VBN O
, , O
again RB O
masking VBG O
BLyS NNP O
overproduction NN O
. . O

M UH O
. . O

A DT O
number NN O
of IN O
case NN O
- HYPH O
control NN O
studies NNS O
, , O
however RB O
, , O
have VBP O
shown VBN O
conflicting JJ O
results NNS O
[ -LRB- O
9 CD O
- SYM O
11 CD O
] -RRB- O
. . O

Leu NNP O
Tyr NNP O
Phe NNP O
His PRP$ O
Lys NNP O
Arg NNP O
Pro NNP O

enteral JJ O
zinc NN O
exposure NN O
on IN O
tissue NN O
levels NNS O
of IN O
mice NNS B-Species
on IN O
controlled VBN O
zinc NN O
diets NNS O
. . O

Poly NNP O
- HYPH O
A NN O
+ SYM O
RNA NN O
for IN O
Northern JJ O
blotting NN O
was VBD O
selected VBN O
from IN O
total JJ O
RNA NNP O
using VBG O
Oligotex NNP O
beads NNS O
( , O
Qiagen NNP O
) -RRB- O
. . O

Our PRP$ O
detailed JJ O
molecular JJ O
mapping NN O
of IN O
hippocampal JJ O
neurogenesis NN O
allows VBZ O
for IN O
a DT O
more RBR O
accurate JJ O
analysis NN O
of IN O
how WRB O
new JJ O
factors NNS O
stimulate VBP O
neurogenesis NN O
at IN O
different JJ O
steps NNS O
in IN O
the DT O
development NN O
of IN O
granule NN O
neurons NNS O
. . O

Discussion NN O

256 CD O
: : O
12631268 CD O
( : O
1981 CD O
) -RRB- O
. . O

estimated VBN O
to TO O
be VB O
0 CD O
. . O
13 CD O
mole NN O
% NN O
/ SYM O
hr NN O
. . O

M UH O
. . O
, , O

The DT O
Significance NNP O
Analysis NNP O
of IN O
Microarrays NNP O
( -LRB- O
SAM NNP O
) -RRB- O
software NN O
package NN O
[ -LRB- O
75 CD O
] -RRB- O
was VBD O
used VBN O
to TO O
identify VB O
differentially RB O
expressed VBN O
genes NNS O
between IN O
exposed VBN O
and CC O
unexposed JJ O
control NN O
fish NN O
for IN O
each DT O
rainbow NN B-Species
trout NN I-Species
strain NN O
. . O

P NN O
{ NFP O
xi NN O
i NN O
| NFP O
xi NN O
0 CD O
= SYM O
1 CD O
} NFP O
= NFP O
p0 CD O
| SYM O
1 CD O
( : O
mu NN O
i NN O
) NFP O
= SYM O
1 CD O
- HYPH O
p1 NN O
| SYM O
1 CD O
( : O
mu NN O
i NN O
) -RRB- O
, , O
if IN O
xi NN O
i NN O
= SYM O
0 CD O
, , O

( SYM O
25 CD O
) -RRB- O
. . O

It PRP O
was VBD O
empirically RB O
chosen VBN O
as IN O
a DT O
consensus NN O
from IN O
exploratory JJ O
model NN O
testing NN O
using VBG O
ModelTest NNP O
( , O
32 CD O
, , O
33 CD O
) -RRB- O
, , O
which WDT O
indicated VBD O
that IN O
models NNS O
including VBG O
these DT O
three CD O
factors NNS O
were VBD O
most RBS O
appropriate JJ O
for IN O
the DT O
MLST NNP O
loci NN O
studied VBN O
, , O
although IN O
models NNS O
for IN O
individual JJ O
loci NN O
differed VBD O
slightly RB O
. . O

Volume NN O
12 CD O
Number NNP O
24 CD O
1984 CD O
Nucleic NNP O
Acids NNP O
Research NNP O

DISCUSSION NN O

The DT O
sensitivity NN O
of IN O
the DT O
assay NN O
was VBD O
0 CD O
. . O
15 CD O
ng CD O
/ SYM O
ml NN O
and CC O
the DT O
upper JJ O
limit NN O
100ng CD O
/ SYM O
ml NN O
. . O

For IN O
both DT O
strains NNS O
, , O
response NN O
to IN O
infection NN O
appears VBZ O
to TO O
be VB O
linked VBN O
with IN O
the DT O
interferon NN O
system NN O
. . O

While IN O
probabilities NNS O
smaller JJR O
than IN O
0 CD O
or CC O
bigger JJR O
than IN O
1 CD O
would MD O
still RB O
result VB O
in IN O
a DT O
distribution NN O
with IN O
the DT O
same JJ O
overall JJ O
variance NN O
as IN O
the DT O
original JJ O
distribution NN O
, , O
P NN O
- HYPH O
value NN O
calculation NN O
will MD O
be VB O
imprecise JJ O
because IN O
the DT O
tails NNS O
of IN O
the DT O
distribution NN O
will MD O
deviate VB O
significantly RB O
from IN O
the DT O
original JJ O
distribution NN O
. . O

Resistance NN O
complementation NN O

29 CD O

This DT O
demonstrates VBZ O
the DT O
impact NN O
of IN O
poor JJ O
vision NN O
on IN O
overall JJ O
assessments NNS O
of IN O
health NN O
and CC O
supports VBZ O
our PRP$ O
previous JJ O
finding NN O
of IN O
a DT O
relationship NN O
between IN O
cataract NN O
and CC O
quality NN O
of IN O
life NN O
[ -LRB- O
17 CD O
] -RRB- O
. . O

Here RB O
, , O
we PRP O
provide VBP O
evidence NN O
that IN O
Drosophila NNP B-Species
HP1 NNP O
is VBZ O
essential JJ O
for IN O
the DT O
maintenance NN O
of IN O
active JJ O
transcription NN O
of IN O
euchromatic JJ O
genes NNS O
functionally RB O
involved VBN O
in IN O
cell NN O
- HYPH O
cycle NN O
progression NN O
, , O
including VBG O
those DT O
required VBN O
for IN O
DNA NN O
replication NN O
and CC O
mitosis NN O
. . O

Garlic NNP B-Species
and CC O
Echinacea NNP B-Species
were VBD O
the DT O
preferred VBN O
herbal JJ O
medicines NNS O
in IN O
patients NNS B-Species
with IN O
more JJR O
than IN O
twelve CD O
years NNS O
formal JJ O
education NN O
. . O

If IN O
the DT O
role NN O
of IN O
Ngn1 NNP O
during IN O
hippocampal JJ O
neurogenesis NN O
is VBZ O
to TO O
activate VB O
NeuroD1 NNP O
and CC O
that DT O
of IN O
Ngn2 NNP O
is VBZ O
to TO O
control VB O
granule NN O
neuroblasts NNS O
production NN O
/ SYM O
amplification NN O
, , O
the DT O
DG NN O
of IN O
double JJ O
Ngn1 NNP O
/ SYM O
Ngn2 CD O
knockout NN O
mice NN B-Species
should MD O
resemble VB O
that DT O
of IN O
NeuroD1 NNP O
null JJ O
mutant JJ O
mice NNS B-Species
. . O

A DT O
review NN O
of IN O
the DT O
literature NN O
was VBD O
conducted VBN O
to TO O
identify VB O
recruitment NN O
and CC O
retention NN O
strategies NNS O
for IN O
rehabilitation NN O
professionals NNS O
. . O

Expenditure NN O
data NNS O
were VBD O
not RB O
validated VBN O
through IN O
diaries NNS O
or CC O
other JJ O
means NNS O
, , O
although IN O
assets NNS O
and CC O
self NN O
- HYPH O
rated VBN O
wealth NN O
correlated VBN O
highly RB O
with IN O
PCE NNP O
. . O

This DT O
stands VBZ O
in IN O
direct JJ O
contrast NN O
to IN O
mPR NNP O
and CC O
mANG NNP O
, , O
whose WP$ O
human JJ B-Species
orthologs NNS O
can MD O
be VB O
clearly RB O
distinguished VBN O
on IN O
the DT O
basis NN O
of IN O
their PRP$ O
amino JJ O
acid NN O
sequence NN O
homologies NNS O
. . O

The DT O
most RBS O
active JJ O
isoxazoline NN O
- HYPH O
3 CD O
- HYPH O
( -LRB- O
5 CD O
"""" '' O
- HYPH O
triethylgermyl NN O
- HYPH O
3 CD O
"""" '' O
- HYPH O
isoxazolino NN O
) , O
pyridine NN O
hydrochloride NN O
protected VBD O
the DT O
heart NN O
from IN O
rhythm NN O
disturbances NNS O
and CC O
lethality NN O
during IN O
ischemiareperfusion NN O
[ -LRB- O
7 CD O
] -RRB- O
. . O

Bi JJ O
- HYPH O
binomial JJ O
approximation NN O
of IN O
Poisson NNP O
- HYPH O
binomial JJ O
distribution NN O

High JJ O
- HYPH O
quality NN O
genotype NN O
data NNS O
was VBD O
obtained VBN O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
and CC O
68 CD O
MHC NNP O
SNPs NNPS O
( , O
see VB O
Table NNP O
S1 NNP O
for IN O
quality NN O
control NN O
data NNS O
) -RRB- O
. . O

Hydrolysis NN O
of IN O
Oligonucleoside NNP O
Methylphosphonates NNPS O
by IN O

We PRP O
find VBP O
that IN O
a DT O
lack NN O
of IN O
Ngn2 NNP O
expression NN O
result VBP O
in IN O
a DT O
markedly RB O
smaller JJR O
hippocampus NN O
and CC O
an DT O
almost RB O
complete JJ O
absence NN O
of IN O
the DT O
DG NNP O
. . O

When WRB O
the DT O
cells NNS O
were VBD O
transfected VBN O
with IN O
WT NNP O
- HYPH O
NRF2 NNP O
and CC O
then RB O
treated VBN O
with IN O
or CC O
without IN O
iAs NNP O
, , O
the DT O
expression NN O
of IN O
TXN NNP O
mRNA NNP O
was VBD O
augmented VBN O
markedly RB O
compared VBN O
with IN O
the DT O
empty JJ O
- HYPH O
vector NN O
control NN O
. . O

L NNP O
. . O
, , O
Stuart NNP O
, , O
G NNP O
. . O

The DT O
mannose NN O
6 CD O
- HYPH O
phosphate NN O
/ SYM O
insulin NN O
- HYPH O
like JJ O
growth NN O
factor NN O
- HYPH O
II NN O
receptor NN O
( , O
M6P NNP O
/ SYM O
IGF2R NNP O
) -RRB- O
is VBZ O
a DT O
multi JJ O
- HYPH O
functional JJ O
protein NN O
that WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
regulation NN O
of IN O
cell NN O
growth NN O
and CC O
apoptosis NN O
. . O

Additionally RB O
, , O
subjects NNS O
completed VBD O
the DT O
SF NNP O
- HYPH O
36 CD O
and CC O
the DT O
CES NNP O
- HYPH O
D NNP O
[ -LRB- O
21 CD O
] -RRB- O
for IN O
validation NN O
purposes NNS O
at IN O
both DT O
assessments NNS O
. . O

Tails NNS O
of IN O
the DT O
Ngn2 NNP O
offspring NN O
were VBD O
used VBN O
to TO O
obtain VB O
DNA NN O
for IN O
determination NN O
of IN O
the DT O
genotype NN O
using VBG O
a DT O
polymerase NN O
chain NN O
reaction NN O
( -LRB- O
PCR NN O
) -RRB- O
assay NN O
as IN O
previously RB O
reported VBN O
[ -LRB- O
31 CD O
] -RRB- O
. . O

The DT O
other JJ O
, , O
nonsuppressing JJ O
, , O
accessory NN O
subunits NNS O
might MD O
then RB O
function VB O
in IN O
nonmitotic JJ O
cellular JJ O
processes NNS O
such JJ O
as IN O
neuronal JJ O
transport NN O
or CC O
organelle NN O
positioning NN O
. . O

These DT O
cells NNS O
were VBD O
immunopositive JJ O
for IN O
MAP2 NNP O
( -LRB- O
Figure NNP O
5I1 CD O
and CC O
I2 NNP O
) -RRB- O
and CC O
therefore RB O
represented VBD O
dividing VBG O
neuroblasts NNS O
. . O

SUPERTREE NN O
RECONSTRUCTION NN O

Figure NN O
2 CD O
shows VBZ O
that IN O
the DT O
effects NNS O
of IN O
blocking VBG O
the DT O
cholinergic JJ O
system NN O
of IN O
rats NNS B-Species
with IN O
unilateral JJ O
perforation NN O
of IN O
the DT O
peritoneum NN O
depended VBD O
on IN O
both DT O
, , O
the DT O
side NN O
( , O
left JJ O
or CC O
right JJ O
) -RRB- O
and CC O
the DT O
phase NN O
of IN O
the DT O
estrous NN O
when WRB O
surgery NN O
was VBD O
performed VBN O
. . O

Infection NN O
of IN O
animals NNS O
: : O
T NN B-Species
. . I-Species
canis NN I-Species
eggs NNS O
were VBD O
obtained VBN O
by IN O
the DT O
methods NNS O
of IN O
Olson NNP O
and CC O
Schulz NNP O
, , O
17 CD O
with IN O
minor JJ O
modifications NNS O
. . O

A DT O
quantity NN O
of IN O
survived VBN O
cells NNS O
was VBD O
determined VBN O
using VBG O
crystal NN O
violet NN O
( , O
CV NN O
) , O
or CC O
3 CD O
- HYPH O
( SYM O
4 CD O
, , O
5 CD O
- HYPH O
dimethylthiazol NN O
- HYPH O
2 CD O
- HYPH O
yl NN O
) SYM O
- HYPH O
2 CD O
, , O
5diphenyltetrazolini NN O
bromide NN O
( -LRB- O
MTT NNP O
) -RRB- O
coloration NN O
which WDT O
was VBD O
assayed VBN O
by IN O
multiscan NN O
spectrofotometer NN O
. . O

Roques NNP O
, , O
J NNP O
. . O

However RB O
, , O
in IN O
bacteria NNS O
, , O
it PRP O
is VBZ O
assumed VBN O
that IN O
lipids NNS O
are VBP O
not RB O
subject JJ O
to IN O
the DT O
oxidative JJ O
damage NN O
observed VBN O
in IN O
eukaryotic JJ O
cells NNS O
. . O

To TO O
determine VB O
if IN O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
contains VBZ O
polyunsaturated JJ O
lipids NNS O
, , O
B NN B-Species
. . I-Species
burgdorferi NN I-Species
strain NN O
B31A3 NN O
was VBD O
grown VBN O
under IN O
anaerobic JJ O
conditions NNS O
and CC O
analysed VBN O
for IN O
fatty JJ O
acid NN O
composition NN O
by IN O
Lipid NNP O
Technologies NNP O
( : O
Austin NNP O
, , O
MN NNP O
) -RRB- O
. . O

Many JJ O
Kelch NNP O
domain NN O
- HYPH O
containing VBG O
proteins NNS O
are VBP O
involved VBN O
in IN O
cytoskeletal JJ O
rearrangement NN O
and CC O
cell NN O
morphology NN O
[ -LRB- O
92 CD O
] -RRB- O
, , O
[ -LRB- O
93 CD O
] -RRB- O
. . O

However RB O
, , O
in IN O
contrast NN O
to IN O
normally RB O
distributed VBN O
Z NNP O
- HYPH O
scores NNS O
, , O
binomial NN O
and CC O
Poisson NNP O
- HYPH O
binomial JJ O
Z NNP O
- HYPH O
scores NNS O
do VBP O
not RB O
correspond VB O
to IN O
the DT O
same JJ O
P NN O
- HYPH O
value NN O
for IN O
different JJ O
sets NNS O
of IN O
probabilities NNS O
of IN O
success NN O
. . O

We PRP O
assessed VBD O
the DT O
combined VBN O
effect NN O
of IN O
traveling VBG O
and CC O
the DT O
following VBG O
risk NN O
factors NNS O
for IN O
thrombosis NN O
: : O
factor NN O
V NN O
Leiden NNP O
mutation NN O
, , O
prothrombin NN O
G20210A NN O
mutation NN O
, , O
body NN O
mass NN O
index NN O
( , O
BMI NNP O
, , O
as IN O
kg NN O
/ SYM O
m2 CD O
) -RRB- O
, , O
and CC O
height NN O
. . O

This DT O
number NN O
of IN O
fungal JJ O
- HYPH O
specific JJ O
clusters NNS O
is VBZ O
surprisingly RB O
low JJ O
considering VBG O
the DT O
phylogenetic JJ O
distance NN O
between IN O
the DT O
oomycetes NNS O
and CC O
fungi NN O
[ -LRB- O
30 CD O
] -RRB- O
. . O

Our PRP$ O
results NNS O
, , O
and CC O
those DT O
of IN O
others NNS O
, , O
suggest VBP O
that IN O
stimulating VBG O
on IN O
D2 NNP O
the DT O
sensory NN O
receptors NNS O
located VBN O
on IN O
the DT O
left JJ O
side NN O
of IN O
the DT O
peritoneum NN O
triggers VBZ O
an DT O
E2 NN O
secretion NN O
inhibitory NN O
mechanism NN O
, , O
that IN O
the DT O
sensory JJ O
pathway NN O
arising VBG O
from IN O
the DT O
right JJ O
side NN O
has VBZ O
a DT O
stimulatory JJ O
effect NN O
, , O
and CC O
that IN O
both DT O
are VBP O
mediated VBN O
by IN O
the DT O
cholinergic JJ O
muscarinic JJ O
system NN O
. . O

For IN O
oligomers NNS O
which WDT O
terminate VBP O
with IN O
a DT O
5 CD O
' '' O
- HYPH O
nucleoside NN O
phosphodiester NN O
linkage NN O
( : O
7 CD O
- SYM O
10 CD O
) , O
the DT O
residue NN O
from IN O
step NN O
4 CD O
) -RRB- O
described VBN O
in IN O
the DT O
preceeding VBG O
section NN O
is VBZ O
treated VBN O
with IN O
80 CD O
% NN O
acetic JJ O
acid NN O
in IN O
water NN O
for IN O
15 CD O
min NN O
at IN O
room NN O
temperature NN O
. . O

Two CD O
dsRNAs NNS O
that WDT O
do VBP O
not RB O
suppress VB O
lit VBN O
- HYPH O
1 CD O
or CC O
spn CD O
- HYPH O
4 CD O
mutants NNS O
produced VBN O
suppression NN O
in IN O
the DT O
dhc NN O
- HYPH O
1 CD O
( SYM O
or195 CD O
) -RRB- O
and CC O
dhc NN O
- HYPH O
1 CD O
( SYM O
or283 CD O
) SYM O
strains NNS O
, , O
but CC O
not RB O
in IN O
the DT O
dhc NN O
- HYPH O
1 CD O
( SYM O
or352 CD O
) NN O
strain NN O
, , O
perhaps RB O
indicating VBG O
allele JJ O
specificity NN O
or CC O
variability NN O
in IN O
the DT O
RNAi NNP O
treatments NNS O
. . O

Essentially RB O
, , O
such PDT O
an DT O
analysis NN O
allows VBZ O
assessment NN O
of IN O
positive JJ O
selection NN O
by IN O
mining VBG O
datasets NNS O
for IN O
high JJ O
frequency NN O
extended VBN O
haplotypes NNS O
in IN O
comparison NN O
to IN O
the DT O
other JJ O
core NN O
haplotypes NNS O
at IN O
a DT O
locus NN O
. . O

F NNP O
. . O

Cell NN O
numbers NNS O
and CC O
MT NNP O
concentrations NNS O
as IN O
a DT O
function NN O
of IN O
time NN O
after IN O
inoculation NN O
of IN O
wild JJ O
- HYPH O
type NN O
cyanobacteria NN O
in IN O
the DT O
presence NN O
and CC O
absence NN O

Cells NNS O
were VBD O
harvested VBN O
by IN O
centrifugation NN O
, , O
resuspended VBN O
in IN O
PBS NNP O
pH NN O
7 CD O
. . O
4 CD O
containing VBG O
DNase NNP O
, , O
lysostaphin NN O
and CC O
lysozyme NN O
( : O
150 CD O
mu NNS O
g NN O
/ SYM O
ml NN O
of IN O
each DT O
) -RRB- O
and CC O
incubated VBN O
for IN O
1 CD O
h NNS O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Fig NN O
. . O

The DT O
effects NNS O
of IN O

6230 CD O

Our PRP$ O
ChIP NN O
results NNS O
showed VBD O
that IN O
known VBN O
transposable JJ O
elements NNS O
distributed VBN O
in IN O
heterochromatin NN O
, , O
such JJ O
as IN O
F NNP O
- HYPH O
element NN O
, , O
TART NNP O
and CC O
1360 CD O
( SYM O
7 CD O
, , O
38 CD O
) -RRB- O
, , O
were VBD O
all DT O
enriched VBN O
in IN O
HP1 NN O
binding NN O
( : O
Figure NNP O
4 CD O
) -RRB- O
, , O
which WDT O
is VBZ O
also RB O
consistent JJ O
with IN O
a DT O
previous JJ O
study NN O
( , O
20 CD O
) -RRB- O
. . O

Perforating VBG O
the DT O
left JJ O
peritoneum NN O
on IN O
D1 NNP O
resulted VBD O
in IN O
lower JJR O
E2 NNP O
serum NN O
concentrations NNS O
( , O
55 CD O
% NN O
) -RRB- O
, , O
while IN O
bilateral JJ O
perforation NN O
, , O
or CC O
perforating VBG O
the DT O
right JJ O
side NN O
of IN O
the DT O
peritoneum NN O
, , O
had VBD O
no DT O
apparent JJ O
effects NNS O
( -LRB- O
Table NN O
1 CD O
) -RRB- O
. . O

The DT O
P1 NNP O
and CC O
P7 NN O
sequences NNS O
( -LRB- O
Figure NNP O
3 CD O
) -RRB- O
both DT O
contain VBP O
an DT O
ATG NNP O
initiation NN O
codon NN O
preceded VBN O
by IN O
a DT O
putative JJ O
ribosome NN O
binding NN O
sequence NN O
( : O
29 CD O
) -RRB- O
situated VBN O
211 CD O
bps NNS O
downstream RB O
of IN O
the DT O
EcoRV NNP O
site NN O
. . O

Treatment NN O
of IN O
32pApGpCpApALpG NNP O

A DT O
next JJ O
step NN O
will MD O
be VB O
to TO O
use VB O
simultaneously RB O
the DT O
PTPN22 NNP O
and CC O
HLA NNP O
information NN O
to TO O
evaluate VB O
their PRP$ O
joint JJ O
effects NNS O
while IN O
taking VBG O
into IN O
account NN O
important JJ O
covariables NNS O
such JJ O
as IN O
age NN O
and CC O
gender NN O
. . O

These DT O
analyses NNS O
demonstrated VBD O
that IN O
the DT O
observed VBN O
association NN O
signals VBZ O
at IN O
rs2523589 CD O
, , O
rs1052486 CD O
, , O
and CC O
rs605203 CD O
were VBD O
predominantly RB O
dependent JJ O
upon IN O
the DT O
association NN O
at IN O
rs419788 CD O
, , O
and CC O
suggested VBD O
that IN O
there EX O
are VBP O
two CD O
major JJ O
independent JJ O
association NN O
signals NNS O
in IN O
the DT O
MHC NNP O
in IN O
UK NNP O
SLE NNP O
: : O
HLA NNP O
- HYPH O
DRB1 NNP O
and CC O
rs419788 CD O
. . O

In IN O
this DT O
paper NN O
, , O
we PRP O
present VBP O
the DT O
DNA NN O
sequence NN O
of IN O
the DT O
cl NN O
genes NNS O
of IN O
P1 NN O
and CC O
P7 NN O
and CC O
the DT O
predicted VBN O
amino JJ O
acid NN O
sequence NN O
of IN O
the DT O
cl NN O
repressor NN O
proteins NNS O
. . O

The DT O
high JJ O
response NN O
in IN O
the DT O
fliers NNS O
was VBD O
associated VBN O
with IN O
the DT O
presence NN O
of IN O
risk NN O
factors NNS O
for IN O
thrombosis NN O
, , O
i LS O
. . O
e LS O
. . O
, , O
oral JJ O
contraceptive NN O
use NN O
, , O
the DT O
factor NN O
V NN O
Leiden NNP O
mutation NN O
, , O
and CC O
the DT O
combination NN O
of IN O
the DT O
two CD O
. . O

Kuschner NNP O
, , O
M NNP O
. . O
, , O
and CC O
Laskin NNP O
, , O
S NNP O
. . O

Ovation NNP O
Research NNP O
Group NNP O
provided VBD O
no DT O
additional JJ O
funding NN O
for IN O
this DT O
study NN O
. . O

Co NN O
- HYPH O
occurrence NN O
analysis NN O
, , O
based VBN O
on IN O
the DT O
hypothesis NN O
that IN O
co NN O
- HYPH O
occurring VBG O
entities NNS O
are VBP O
functionally RB O
linked VBN O
, , O
is VBZ O
a DT O
technique NN O
that WDT O
has VBZ O
been VBN O
used VBN O
in IN O
three CD O
main JJ O
areas NNS O
of IN O
biological JJ O
research NN O
: : O

The DT O
overall JJ O
time NN O
of IN O
observation NN O
was VBD O
one CD O
year NN O
. . O

Therefore RB O
, , O
we PRP O
analyzed VBD O
2 CD O
week NN O
- HYPH O
old JJ O
and CC O
younger JJR O
mice NNS B-Species
. . O

Neurons NNS O
are VBP O
born VBN O
not RB O
only RB O
during IN O
development NN O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
but CC O
neurogenesis NN O
also RB O
continues VBZ O
into IN O
adulthood NN O
. . O

Because IN O
the DT O
cl NN O
genes NNS O
of IN O
P1 NN O
and CC O
P7 NN O
are VBP O
genetically RB O
interchangeable JJ O
, , O
it PRP O
is VBZ O
anticipated VBN O
that IN O
the DT O
two CD O
gene NN O
products NNS O
carry VBP O
out RP O
similar JJ O
or CC O
identical JJ O
regulatory JJ O
functions NNS O
. . O

Several JJ O
investigations NNS O
have VBP O
suggested VBN O
that IN O
the DT O
GC NNP O
nucleotides NNS O
within IN O
the DT O
ARE NNP O
are VBP O
essential JJ O
for IN O
both CC O
the DT O
basal JJ O
and CC O
oxidative JJ O
stress NN O
- HYPH O
induced VBN O
activities NNS O
of IN O
the DT O
ARE NNP O
- HYPH O
related VBN O
genes NNS O
, , O
NAD NNP O
( , O
P NNP O
) -RRB- O
H NN O
dehydrogenase NN O
quinone NN O
1 CD O
( , O
NQO1 NN O
) -RRB- O
and CC O
glutamate NN O
- HYPH O
cysteine NN O
ligase NN O
catalytic JJ O
subunit NN O
( , O
GCLC NNP O
) -RRB- O
( , O
Wasserman NNP O
and CC O
Fahl NNP O
1997 CD O
; : O
Wild NNP O
et FW O
al NNP O
. . O
1998 CD O
) -RRB- O
. . O

2 LS O
It PRP O
is VBZ O
apparently RB O
during IN O
this DT O
interval NN O
that IN O
the DT O
worm NN O
provides VBZ O
the DT O
signals NNS O
to IN O
cytokine NN O
- HYPH O
producing VBG O
cells NNS O
, , O
which WDT O
in IN O
turn NN O
trigger VBP O
increased VBN O
serum JJ O
levels NNS O
of IN O
specific JJ O
cytokine NN O
as IN O
demonstrated VBN O
here RB O
for IN O
IL NN O
- HYPH O
5 CD O
, , O
24 CD O
to TO O
72 CD O
h NN O
after IN O
infection NN O
. . O

Comm NNP O
, , O
82 CD O
, , O
255 CD O
- SYM O
264 CD O
. . O

This DT O
observation NN O
provides VBZ O
biochemical JJ O
confirmation NN O
of IN O
the DT O
functional JJ O
identity NN O
predicted VBN O
on IN O
the DT O
basis NN O
of IN O
previous JJ O
genetic JJ O
analysis NN O
( , O
9 CD O
) -RRB- O
. . O

SignalP NNP O
3 CD O
. . O
0 CD O
uses VBZ O
two CD O
different JJ O
algorithms NNS O
to TO O
identify VB O
signal NN O
sequences NNS O
. . O

Trapped VBN O
gas NN O
bubbles NNS O
may MD O
be VB O
removed VBN O
by IN O
gently RB O
tapping VBG O
the DT O
column NN O
. . O

For IN O
the DT O
evaluation NN O
of IN O
p1 NN O
| SYM O
1 CD O
we PRP O
consider VBP O
pairs NNS O
of IN O
similar JJ O
sequences NNS O
pi NN O
i PRP O
, , O
pi NN O
j NN O
that WDT O
satisfy VBP O
the DT O
condition NN O
omega NN O
in IN O
KW NNP O
[ -LRB- O
pi NN O
i PRP O
] -RRB- O
. . O

We PRP O
may MD O
have VB O
expected VBN O
a DT O
different JJ O
outcome NN O
in IN O
asthmatic JJ O
patients NNS B-Species
attending VBG O
private JJ O
institutions NNS O
, , O
where WRB O
their PRP$ O
characteristics NNS O
would MD O
have VB O
been VBN O
slightly RB O
different JJ O
, , O
as IN O
we PRP O
noted VBD O
that IN O
even RB O
in IN O
our PRP$ O
sample NN O
the DT O
small JJ O
number NN O
of IN O
persons NNS O
with IN O
higher JJR O
income NN O
and CC O
educational JJ O
status NN O
tended VBD O
to TO O
use VB O
more JJR O
medicinal JJ O
herbs NNS O
for IN O
symptomatic JJ O
relief NN O
. . O

The DT O
factor NN O
V NN O
Leiden NNP O
mutation NN O
( -LRB- O
G1691A NNP O
) -RRB- O
and CC O
the DT O
prothrombin NN O
mutation NN O
( -LRB- O
G20210A NNP O
) -RRB- O
were VBD O
simultaneously RB O
detected VBN O
by IN O
duplex JJ O
polymerase NN O
chain NN O
reaction NN O
[ -LRB- O
17 CD O
, , O
18 CD O
] -RRB- O
. . O

Overall JJ O
recovery NN O
was VBD O
70 CD O
- SYM O
80 CD O
% NN O
. . O

One CD O
of IN O
the DT O
most RBS O
important JJ O
results NNS O
obtained VBN O
here RB O
was VBD O
the DT O
inhibition NN O
of IN O
circulating VBG O
eosinophil NN O
numbers NNS O
by IN O
the DT O
different JJ O
mAb NN O
treatments NNS O
, , O
even RB O
when WRB O
the DT O
antibody NN O
was VBD O
given VBN O
at IN O
the DT O
peak NN O
of IN O
blood NN O
eosinophilia NN O
, , O
which WDT O
was VBD O
accompanied VBN O
by IN O
an DT O
increase NN O
of IN O
mature JJ O
eosinophils NNS O
in IN O
bone NN O
marrow NN O
. . O

Unfortunately RB O
, , O
we PRP O
did VBD O
not RB O
record VB O
the DT O
exact JJ O
numbers NNS O
of IN O
cases NNS O
and CC O
controls NNS O
who WP O
refused VBD O
to TO O
participate VB O
or CC O
were VBD O
unable JJ O
to TO O
communicate VB O
( , O
believed VBN O
to TO O
be VB O
fewer JJR O
than IN O
five CD O
in IN O
each DT O
country NN O
) -RRB- O
, , O
so CC O
the DT O
response NN O
rate NN O
is VBZ O
unknown JJ O
, , O
but CC O
was VBD O
believed VBN O
to TO O
be VB O
high JJ O
. . O

At IN O
present NN O
, , O
it PRP O
is VBZ O
not RB O
known VBN O
whether IN O
soluble JJ O
Delta NNP O
BLyS NNP O
protein NN O
is VBZ O
present JJ O
in IN O
the DT O
circulation NN O
of IN O
SLE NNP O
patients NNS B-Species
or CC O
of IN O
normal JJ O
individuals NNS O
. . O

( -LRB- O
1999 CD O
) : O
[ -LRB- O
15 CD O
] -RRB- O
. . O

5 CD O
also RB O
show VBP O
that IN O
neither CC O
J NNP O
nor CC O
UC NNP O
can MD O
distinguish VB O
between IN O
positive JJ O
and CC O
negative JJ O
association NN O
while IN O
this DT O
is VBZ O
easy JJ O
with IN O
cumulative JJ O
BBD NN O
P NN O
- HYPH O
values NNS O
: : O
Large JJ O
P NN O
- HYPH O
values NNS O
mean VBP O
positive JJ O
association NN O
and CC O
low JJ O
P NN O
- HYPH O
values NNS O
mean VBP O
negative JJ O
association NN O
. . O

A DT O
copy NN O
of IN O
the DT O
questionnaire NN O
can MD O
be VB O
obtained VBN O
by IN O
contacting VBG O
Janet NNP O
L NNP O
. . O
Nichol NNP O
and CC O
sample NN O
items NNS O
are VBP O
included VBN O
Table NNP O
2 CD O
. . O

This DT O
additional JJ O
heuristic JJ O
, , O
in IN O
particular JJ O
, , O
reduces VBZ O
incorrect JJ O
assignments NNS O
to IN O
subclasses NNS O
as IN O
only RB O
9 CD O
. . O
1 CD O
% NN O
of IN O
hits NNS O
to IN O
subclasses NNS O
score VBP O
above IN O
the DT O
thresholds NNS O
for IN O
those DT O
subclasses NNS O
( -LRB- O
Table NNP O
2 CD O
) -RRB- O
. . O

The DT O
patient NN B-Species
as RB O
well RB O
as IN O
the DT O
surgeons NNS O
were VBD O
fully RB O
satisfied JJ O
with IN O
the DT O
result NN O
. . O

After IN O
incubation NN O
, , O
the DT O
wells NNS O
were VBD O
washed VBN O
four CD O
times NNS O
with IN O
TPBS NNP O
, , O
100 CD O
micro NN O
l NN O
of IN O
substrate NN O
was VBD O
added VBN O
to IN O
each DT O
well NN O
and CC O
incubated VBN O
for IN O
1 CD O
h NN O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

3A NN O
, , O
cells NNS O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
/ SYM O
IGF2R NNP O
- HYPH O
Rz NNP O
showed VBD O
a DT O
54 CD O
% NN O
reduction NN O
in IN O
125I CD O
- HYPH O
IGF NNP O
- HYPH O
II NN O
internalization NN O
when WRB O
compared VBN O
with IN O
the DT O
control NN O
cells NNS O
( , O
infected VBN O
with IN O
Ad NNP O
- HYPH O
GFP NNP O
) -RRB- O
. . O

By IN O
using VBG O
the DT O
suppressor NN O
screening NN O
method NN O
outlined VBN O
in IN O
Figure NNP O
2B NNP O
, , O
we PRP O
have VBP O
isolated VBN O
and CC O
characterized VBN O
49 CD O
genes NNS O
that IN O
when WRB O
reduced VBN O
in IN O
function NN O
can MD O
suppress VB O
a DT O
partial JJ O
loss NN O
of IN O
dynein NN O
HC NN O
function NN O
. . O

Bacteria NNS O
, , O
such JJ O
as IN O
E NNP B-Species
. . I-Species
coli NN I-Species
, , O
harbour VBP O
genes NNS O
encoding VBG O
repair NN O
enzymes NNS O
( , O
i LS O
. . O
e -RRB- O
. . O
MutM NNP O
, , O
MutY NNP O
, , O
Ung NNP O
, , O
AlkA NNP O
, , O
MutS NNP O
, , O
MutL NNP O
, , O
ExoIII NNP O
, , O
EndoVIII NNP O
, , O
PolI NNP O
, , O
RecJ NNP O
) -RRB- O
. . O

( : O
19 CD O
) SYM O
Richards NNP O
, , O
F NNP O
. . O

The DT O
changes NNS O
show VBP O
a DT O
decrease NN O
of IN O
the DT O
CC NNP O
genotype NN O
and CC O
an DT O
increase NN O
of IN O
the DT O
TT NNP O
genotype NN O
in IN O
the DT O
last JJ O
25 CD O
years NNS O
of IN O
the DT O
20th JJ O
century NN O
. . O

The DT O
area NN O
under IN O
the DT O
ROC NNP O
curve NN O
, , O
0 CD O
. . O
89675 CD O
, , O
shows VBZ O
that IN O
the DT O
molecular JJ O
assay NN O
clearly RB O
distinguishes VBZ O
the DT O
positives NNS O
by IN O
IHC NNP O
or CC O
estrogen NN O
binding NN O
from IN O
the DT O
negative JJ O
tissues NNS O
. . O

Discussion NN O

The DT O
subsequent JJ O
oxidation NN O
of IN O
Fe NNP O
- HYPH O
S NNP O
proteins NNS O
by IN O
ROS NNP O
( : O
e LS O
. . O
g LS O
. . O
O2 CD O
- HYPH O
) -RRB- O
leads VBZ O
to IN O
an DT O
increase NN O
in IN O
intracellular JJ O
' `` O
free JJ O
' '' O
Fe2 NN O
+ CC O
which WDT O
triggers VBZ O
the DT O
reduction NN O
of IN O
H2O2 NN O
to IN O
OH NN O
( : O
Fenton NNP O
reaction NN O
) -RRB- O
. . O

In IN O
a DT O
recent JJ O
work NN O
addressing VBG O
this DT O
issue NN O
, , O
Lear NNP O
et FW O
al NNP O
. . O

Francis NNP O
A NNP O
. . O
Osborne NNP O
, , O
Sonja NNP O
R NNP O
. . O
Stovall NNP O
and CC O
Barbara NNP O
R NNP O
. . O
Baumstark NNP O
* NFP O

Within IN O
our PRP$ O
in FW O
vitro FW O
human JJ B-Species
granuloma NN O
model NN O
, , O
M NNP B-Species
. , I-Species
tuberculosis NN I-Species
long JJ O
chain NN O
fatty NN O
acids NNS O
, , O
namely RB O
oxygenated VBN O
mycolic JJ O
acids NNS O
( , O
MA NNP O
) -RRB- O
, , O
triggered VBD O
the DT O
differentiation NN O
of IN O
human JJ B-Species
monocyte NN O
- HYPH O
derived VBN O
macrophages NNS O
into IN O
FMs NNPS O
. . O

At IN O
variance NN O
with IN O
previous JJ O
investigations NNS O
[ -LRB- O
2 CD O
- SYM O
4 CD O
] -RRB- O
, , O
we PRP O
demonstrated VBD O
that IN O
SSc NNP O
patients NNS B-Species
with IN O
diffuse JJ O
subset NN O
are VBP O
characterized VBN O
by IN O
increased VBN O
plasma NN O
D NN O
- HYPH O
dimer NN O
values NNS O
, , O
reflecting VBG O
a DT O
potential JJ O
activation NN O
of IN O
both CC O
the DT O
coagulation NN O
and CC O
fibrinolytic JJ O
pathways NNS O
. . O

RPA NNP O
was VBD O
performed VBN O
using VBG O
the DT O
RPA NNP O
III NNP O
kit NN O
( : O
Ambion NNP O
, , O
Austin NNP O
, , O
TX NNP O
) -RRB- O
. . O

Then RB O
, , O
we PRP O
model VBP O
the DT O
effect NN O
of IN O
PTPN22 NNP O
using VBG O
the DT O
four CD O
genotypic JJ O
groups NNS O
of IN O
risk NN O
defined VBN O
on IN O
the DT O
genotypes NNS O
of IN O
the DT O
combination NN O
of IN O
the DT O
SNPs NNPS O
9 CD O
- SYM O
10 CD O
- SYM O
11 CD O
and CC O
the DT O
IBD NNP O
information NN O
stratified VBN O
on IN O
them PRP O
. . O

These DT O
associations NNS O
persisted VBD O
after IN O
adjustment NN O
for IN O
self NN O
- HYPH O
rated VBN O
health NN O
and CC O
social JJ O
support NN O
indicators NNS O
. . O

To IN O
this DT O
end NN O
, , O
disulfide JJ O
cross NN O
- HYPH O
linking VBG O
of IN O
full JJ O
- HYPH O
length NN O
CD9 NN O
molecules NNS O
containing VBG O
3 CD O
C NN O
- HYPH O
terminal JJ O
cysteines NNS O
( : O
87 CD O
, , O
just RB O
before IN O
TM3 NNP O
; : O
218 CD O
and CC O
219 CD O
in IN O
TM4 CD O
) -RRB- O
or CC O
3 CD O
N CD O
- HYPH O
terminal NN O
cysteines NNS O
( : O
9 CD O
, , O
78 CD O
and CC O
79 CD O
) -RRB- O
was VBD O
compared VBN O
( -LRB- O
Figure NN O
9 CD O
) -RRB- O
. . O

Inhaled VBN O
corticosteroids NNS O
as IN O
prophylaxis NN O
and CC O
' `` O
as IN O
required VBN O
' '' O
bronchodilator NN O
for IN O
symptomatic JJ O
relief NN O
are VBP O
established VBN O
modalities NNS O
for IN O
asthma NN O
management NN O
and CC O
prevention NN O
and CC O
the DT O
Commonwealth NNP O
Caribbean NNP O
Medical NNP O
Research NNP O
Council NNP O
/ SYM O
Global NNP O
Initiative NNP O
for IN O
Asthma NNP O
guidelines NNS O
were VBD O
adopted VBN O
in IN O
the DT O
Caribbean NNP O
in IN O
1997 CD O
[ -LRB- O
4 CD O
] -RRB- O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O

Oxygenated JJ O
mycolic JJ O
acids NNS O
induce VBP O
the DT O
maturation NN O
of IN O
macrophages NNS O
into IN O
FMs NNP O

Breast NN O
tumor NN O
samples NNS O

Testing NN O
results NNS O

Damage NN O
of IN O
these DT O
processes NNS O
may MD O
activate VB O
free JJ O
- HYPH O
radical JJ O
reactions NNS O
, , O
glycolysis NN O
, , O
or CC O
alter VB O
carcinogenic JJ O
metabolism NN O
, , O
which WDT O
promotes VBZ O
the DT O
oncogenic JJ O
effect NN O
. . O

In IN O
support NN O
of IN O
this DT O
view NN O
, , O
physical JJ O
removal NN O
of IN O
the DT O
intermediate JJ O
chains NNS O
of IN O
rat NN B-Species
cytoplasmic JJ O
dynein NN O
increased VBD O
HC NNP O
ATPase NNP O
activity NN O
by IN O
about RB O
4 CD O
- HYPH O
fold NN O
( , O
light JJ O
chains NNS O
were VBD O
not RB O
monitored VBN O
in IN O
this DT O
study NN O
but CC O
were VBD O
likely RB O
removed VBN O
as RB O
well RB O
) : O
[ -LRB- O
73 CD O
] -RRB- O
. . O

Certain JJ O
defects NNS O
in IN O
S NNP O
phase NN O
may MD O
be VB O
a DT O
direct JJ O
consequence NN O
of IN O
the DT O
loss NN O
of IN O
transcription NN O
of IN O
DNA NN O
replication NN O
genes NNS O
such JJ O
as IN O
McM2 NNP O
, , O
McM5 NNP O
, , O
McM6 NNP O
, , O
CDC45L NNP O
, , O
Orc4 NNP O
and CC O
others NNS O
, , O
since IN O
these DT O
genes NNS O
have VBP O
been VBN O
functionally RB O
implicated VBN O
in IN O
the DT O
initiation NN O
of IN O
DNA NN O
replication NN O
and CC O
/ SYM O
or CC O
the DT O
progression NN O
of IN O
replication NN O
forks NNS O
( SYM O
39 CD O
) -RRB- O
. . O

The DT O
geno NN O
- HYPH O
PDT NNP O
was VBD O
performed VBN O
using VBG O
PDT NNP O
version NN O
5 CD O
. . O
1 CD O
with IN O
default NN O
settings NNS O
[ -LRB- O
27 CD O
] -RRB- O
. . O

Scp160p NN O
complexes NNS O
were VBD O
then RB O
isolated VBN O
from IN O
both DT O
of IN O
these DT O
strains NNS O
using VBG O
the DT O
protocol NN O
described VBN O
above RB O
. . O

( -LRB- O
1977 CD O
) -RRB- O
. . O

Financial NNP O
Incentives NNPS O
and CC O
Marketing NNP O

Mol NNP O
. . O

Maxam NNP O
, , O
A NNP O
. . O

However RB O
, , O
no DT O
significant JJ O
difference NN O
in IN O
Hgb NN O
level NN O
or CC O
physical JJ O
indexes NNS O
was VBD O
found VBN O
between IN O
the DT O
two CD O
towns NNS O
. . O

For IN O
example NN O
, , O
all DT O
of IN O
the DT O
10 CD O
clones NNS O
of IN O
amplicon NN O
2 CD O
sequenced VBN O
from IN O
PCI NNP O
- HYPH O
13 CD O
were VBD O
methylated VBN O
at IN O
19 CD O
or CC O
20 CD O
of IN O
their PRP$ O
20 CD O
CpG NN O
dinucleotides NNS O
. . O

Oligonucleoside NN O
methylphosphonates NNS O
have VBP O
been VBN O
used VBN O
to IN O
st RB O
- HYPH O
udy VB O
the DT O
function NN O
of IN O
specific JJ O
RNA NNP O
sequences NNS O
in IN O
biochemical JJ O
and CC O
intact JJ O
cellular JJ O
systems NNS O
( SYM O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

The DT O
coefficients NNS O
ai VBP O
in IN O
( SYM O
15 CD O
) -RRB- O
can MD O
be VB O
calculated VBN O
using VBG O
different JJ O
methods NNS O
- : O
either CC O
formula NN O
( , O
13 CD O
) -RRB- O
can MD O
be VB O
used VBN O
, , O
or CC O
an DT O
iterative JJ O
method NN O
( , O
described VBN O
in IN O
[ -LRB- O
5 CD O
] -RRB- O
) -RRB- O
can MD O
be VB O
applied VBN O
. . O

The DT O
dotted JJ O
line NN O
is VBZ O
the DT O
equilibrium NN O
trace NN O
. . O

5 CD O
ml CD O
0 CD O
. . O

This DT O
indicates VBZ O
that IN O
radial JJ O
glia NN O
- HYPH O
like JJ O
stem NN O
cells NNS O
, , O
neural JJ O
progenitors NNS O
and CC O
mature JJ O
granule NN O
neurons NNS O
are VBP O
present JJ O
in IN O
the DT O
aged VBN O
human JJ B-Species
hippocampus NN O
( -LRB- O
Figure NNP O
8A NNP O
- HYPH O
E NN O
) -RRB- O
. . O

This DT O
low JJ O
correlation NN O
could MD O
be VB O
due IN O
to IN O
the DT O
ITP NNP O
- HYPH O
PAQ NNP O
assessing VBG O
fear NN O
associated VBN O
with IN O
ITP NNP O
( : O
e LS O
. . O
g LS O
. . O
, , O
fear NN O
of IN O
having VBG O
a DT O
bleeding VBG O
episode NN O
) -RRB- O
, , O
while IN O
the DT O
SF NNP O
- HYPH O
36 CD O
provides VBZ O
a DT O
more RBR O
general JJ O
assessment NN O
of IN O
mental JJ O
health NN O
issues NNS O
( : O
e LS O
. . O
g LS O
. . O
, , O
felt VBD O
downhearted JJ O
and CC O
blue JJ O
) -RRB- O
. . O

In IN O
our PRP$ O
study NN O
, , O
we PRP O
successfully RB O
induced VBD O
FM NNP O
formation NN O
from IN O
isolated VBN O
macrophages NNS O
infected VBN O
with IN O
M NNP B-Species
. . I-Species
tb UH I-Species
, , O
i PRP O
. . O
e NFP O
. . O
outside IN O
a DT O
granulomatous JJ O
structure NN O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
Hunter NNP O
' POS O
s POS O
recent JJ O
proposal NN O
. . O

Cytotoxicity NN O
may MD O
not RB O
only RB O
hamper VB O
tumor NN O
growth NN O
, , O
but CC O
also RB O
promote VB O
the DT O
regression NN O
of IN O
inducible JJ O
and CC O
spontaneous JJ O
neoplasms NNS O
( : O
37 CD O
- SYM O
39 CD O
) -RRB- O
. . O

Slides NNS O
were VBD O
then RB O
dried VBN O
by IN O
centrifugation NN O
and CC O
immediately RB O
scanned VBN O
using VBG O
an DT O
Agilent NNP O
G2565BA NNP O
Microarray NNP O
Scanner NNP O
( : O
Agilent NNP O
Technologies NNP O
, , O
Santa NNP O
Clara NNP O
, , O
CA NNP O
) -RRB- O
. . O

CS NN O
: : O
Caesarean JJ O
Section NN O
; : O
FFP NNP O
: : O
Fresh NNP O
Frozen NNP O
Plasma NNP O

Objective NN O

It PRP O
presented VBD O
different JJ O
patterns NNS O
, , O
with IN O
cohesive JJ O
lobules NNS O
or CC O
rosettes NNS O
and CC O
perivascular JJ O
pseudo NN O
- HYPH O
rosettes NNS O
or CC O
, , O
in IN O
some DT O
areas NNS O
, , O
spindle JJ O
cellular JJ O
elements NNS O
( , O
fig NN O
. . O
1 CD O
) -RRB- O
. . O

Discussion NN O

All DT O
tetraspanins NNS O
have VBP O
in IN O
common JJ O
four CD O
hydrophobic JJ O
stretches NNS O
( , O
TM NNP O
domains NNS O
) -RRB- O
of IN O
20 CD O
- SYM O
25 CD O
residues NNS O
, , O
and CC O
contain VBP O
highly RB O
conserved VBN O
residues NNS O
in IN O
the DT O
second JJ O
extracellular JJ O
loop NN O
, , O
in IN O
particular JJ O
the DT O
Cys NNP O
- HYPH O
Cys NNP O
- HYPH O
Gly NNP O
( : O
CCG NNP O
) -RRB- O
motif NN O
. . O

We PRP O
did VBD O
not RB O
assess VB O
whether IN O
patients NNS B-Species
informed VBD O
their PRP$ O
attending VBG O
physician NN O
at IN O
the DT O
clinic NN O
about IN O
their PRP$ O
use NN O
of IN O
herbs NNS O
or CC O
determined VBD O
whether IN O
the DT O
knowledge NN O
or CC O
attitudes NNS O
of IN O
these DT O
physicians NNS O
regarding VBG O
the DT O
use NN O
of IN O
herbs NNS O
influenced VBD O
the DT O
patients NNS B-Species
' POS O
decision NN O
to TO O
use VB O
herbs NNS O
. . O

PCR NN O
products NNS O
were VBD O
resolved VBN O
on IN O
a DT O
1 CD O
. . O
0 CD O
% NN O
agarose NN O
gel NN O
, , O
visualized VBN O
under IN O
UV NNP O
light NN O
and CC O
quantitated VBN O
using VBG O
NIH NNP O
Imager NNP O
. . O

G NNP O
. . O

The DT O
observed JJ O
data NN O
could MD O
not RB O
be VB O
explained VBN O
by IN O
the DT O
role NN O
of IN O
a DT O
single JJ O
variant NN O
but CC O
were VBD O
compatible JJ O
either CC O
with IN O
a DT O
joint JJ O
effect NN O
of IN O
the DT O
three CD O
typed VBN O
SNPs NNPS O
of IN O
PTPN22 NNP O
on IN O
RA NNP O
or CC O
with IN O
the DT O
role NN O
of IN O
two CD O
untyped JJ O
variants NNS O
. . O

For IN O
control NN O
binding NN O
reactions NNS O
, , O
130 CD O
x SYM O
unlabelled JJ O
mec NN O
operator NN O
DNA NNP O
( , O
amplified VBN O
using VBG O
primers NNS O
me36F NNP O
/ SYM O
me36R NNP O
, , O
Table NNP O
2 CD O
) -RRB- O
was VBD O
used VBN O
as IN O
a DT O
specific JJ O
binding VBG O
competitor NN O
and CC O
6 CD O
ng NN O
of IN O
herring NN O
sperm NN O
DNA NNP O
was VBD O
used VBN O
as IN O
unspecific JJ O
competitor NN O
DNA NNP O
. . O

Therefore RB O
, , O
these DT O
results NNS O
suggested VBD O
that IN O
the DT O
amount NN O
of IN O
these DT O
fatty NN O
acids NNS O
in IN O
the DT O
membranes NNS O
would MD O
vary VB O
as IN O
availability NN O
varies VBZ O
. . O

A DT O
modifying VBG O
influence NN O
of IN O
ortho NN O
- HYPH O
cresol NN O
( HYPH O
o NN O
- HYPH O
cresol NN O
) -RRB- O
on IN O
the DT O
carcinogenic JJ O
effect NN O
of IN O
benzo NN O
( , O
a DT O
) -RRB- O
pyrene NN O
( , O
BaP NN O
) -RRB- O
with IN O
combined VBN O
oral JJ O
administration NN O
to IN O
CC57Br NNP O
mice NNS B-Species
had VBD O
been VBN O
found VBN O
. . O

The DT O
third JJ O
most RBS O
frequent JJ O
combined VBN O
genotype NN O
in IN O
the DT O
promoter NN O
region NN O
in IN O
our PRP$ O
population NN O
presented VBD O
, , O
in IN O
addition NN O
, , O
in IN O
heterozygosity NN O
, , O
the DT O
SNP NNP O
at IN O
P6 NN O
in IN O
the DT O
sequence NN O
regulated VBN O
by IN O
Pit NNP O
1 CD O
and CC O
although IN O
mean JJ O
height NN O
of IN O
individuals NNS O
( , O
6 CD O
. . O
1 CD O
% NN O
) -RRB- O
bearing VBG O
this DT O
genotype NN O
was VBD O
around IN O
- HYPH O
0 CD O
. . O
5 CD O
SDS NN O
, , O
this DT O
was VBD O
not RB O
statistically RB O
significant JJ O
. . O

Three CD O
of IN O
these DT O
genes NNS O
( , O
mR NNP O
- HYPH O
3 CD O
, , O
mR NN O
- HYPH O
4 CD O
, , O
mR NN O
- HYPH O
5 CD O
) -RRB- O
include VBP O
complete JJ O
open JJ O
reading NN O
frames NNS O
, , O
encoding VBG O
ribonucleases NNS O
with IN O
eight CD O
cysteines NNS O
and CC O
appropriately RB O
spaced VBN O
histidines NNS O
( -LRB- O
His11 NN O
and CC O
His124 CD O
) -RRB- O
and CC O
lysine NN O
( -LRB- O
Lys35 NNP O
) -RRB- O
that WDT O
are VBP O
characteristic JJ O
of IN O
this DT O
enlarging VBG O
protein NN O
family NN O
; , O
the DT O
fourth JJ O
sequence NN O
encodes VBZ O
a DT O
non JJ O
- HYPH O
functional JJ O
pseudogene NN O
( , O
mR NN O
- HYPH O
6P NN O
) -RRB- O
. . O

More JJR O
than IN O
50 CD O
% NN O
( , O
n CD O
= SYM O
14 CD O
) -RRB- O
of IN O
SNPs NNS O
are VBP O
located VBN O
in IN O
the DT O
promoter NN O
and CC O
5 CD O
' POS O
UTR NNP O
regions NNS O
, , O
thus RB O
confirming VBG O
previous JJ O
reports NNS O
: : O
Giordano NNP O
et FW O
al NNP O
. , O
9 CD O
reported VBD O
eight CD O
SNPs NNS O
in IN O
the DT O
promoter NN O
and CC O
5 CD O
' POS O
UTR NNP O
regions NNS O
, , O
Wagner NNP O
et FW O
al NNP O
. . O
10 CD O
16 CD O
SNPs NNPS O
from IN O
the DT O
promoter NN O
to IN O
intron NN O
1 CD O
and CC O
Horan NNP O
et FW O
al NNP O
. . O
12 CD O
identified VBD O
36 CD O
haplotypes NNS O
in IN O
control NN O
subjects NNS O
of IN O
the DT O
British JJ O
population NN O
, , O
which WDT O
would MD O
result VB O
from IN O
the DT O
combination NN O
of IN O
15 CD O
of IN O
the DT O
previously RB O
reported VBN O
SNPs NNPS O
. . O

As RB O
well RB O
as IN O
domains NNS O
of IN O
unknown JJ O
function NN O
, , O
the DT O
list NN O
of IN O
phytopathogen NN O
- HYPH O
specific JJ O
Pfam NNP O
motifs NN O
includes VBZ O
Allophanate NNP O
hydrolase NN O
( : O
PF02682 CD O
) -RRB- O
which WDT O
is VBZ O
found VBN O
in IN O
an DT O
enzyme NN O
involved VBN O
in IN O
the DT O
ATP NNP O
- HYPH O
dependent JJ O
urea NN O
degradation NN O
pathway NN O
[ -LRB- O
61 CD O
] -RRB- O
, , O
a DT O
peptidase NN O
motif NN O
, , O
an DT O
opioid JJ O
growth NN O
receptor NN O
motif NN O
( , O
PF04664 NN O
) -RRB- O
and CC O
Mnd1 NNP O
( -LRB- O
PF03962 CD O
) -RRB- O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
recombination NN O
and CC O
meiotic JJ O
nuclear JJ O
division NN O
[ -LRB- O
62 CD O
] -RRB- O
. . O

Migration NN O
and CC O
potential JJ O
replication NN O
of IN O
parasite NN O
stages NNS O
in IN O
nervous JJ O
tissue NN O
ensues VBZ O
over IN O
the DT O
next JJ O
16 CD O
d NN O
with IN O
the DT O
first JJ O
parasites NNS O
exiting VBG O
to TO O
invade VB O
cartilage NN O
observed VBN O
at IN O
20 CD O
d NN O
post NN O
infection NN O
[ -LRB- O
16 CD O
] -RRB- O
. . O

The DT O
resulting VBG O
lengths NNS O
of IN O
TM NNP O
domains NNS O
were VBD O
: : O
TM1 NNP O
- HYPH O
23 CD O
residues NNS O
; : O
TM2 NNP O
- HYPH O
21 CD O
residues NNS O
; : O
TM3 NNP O
- HYPH O
25 CD O
residues NNS O
; : O
TM4 NNP O
- HYPH O
25 CD O
residues NNS O
. . O

Blindness NN O
may MD O
also RB O
cause VB O
poverty NN O
, , O
as IN O
the DT O
blind JJ O
individual NN O
, , O
or CC O
the DT O
household NN O
members NNS O
who WP O
care VBP O
for IN O
them PRP O
, , O
have VBP O
a DT O
reduced VBN O
earning NN O
potential NN O
[ -LRB- O
4 CD O
, , O
9 CD O
] -RRB- O
. . O

London NNP O
, , O
1980 CD O
, , O
pp NN O
. . O

The DT O
results NNS O
are VBP O
shown VBN O
in IN O
Fig NNP O
. . O

Uterine NN O
inversion NN O
and CC O
retain VB O
placenta NN O
accreta NN O
can MD O
both DT O
be VB O
fatal JJ O
complications NNS O
[ -LRB- O
3 CD O
] -RRB- O
. . O

Hydrolysis NN O
of IN O
Oligonucleoside NNP O
Methylphosphonates NNP O
in IN O
Acid NNP O
. . O

In IN O
2002 CD O
, , O
a DT O
family NN O
- HYPH O
based VBN O
study NN O
employing VBG O
microsatellites NNS O
as IN O
surrogate NN O
markers NNS O
for IN O
HLA NNP O
- HYPH O
DRB1 NNP O
haplotypes NNS O
in IN O
Caucasian JJ O
lupus NN O
families NNS O
demonstrated VBD O
association NN O
with IN O
DR3 NNP O
- HYPH O
, , O
DR2 NNP O
- , O
, , O
and CC O
DR8 NNP O
( -LRB- O
DRB1 NNP O
* NFP O
801 CD O
) -RRB- O
- , O
containing VBG O
haplotypes NNS O
. . O

Response NN O

The DT O
following VBG O
review NN O
will MD O
outline VB O
the DT O
main JJ O
interactions NNS O
between IN O
the DT O
RPE NNP O
and CC O
photoreceptors NNS O
, , O
describe VB O
the DT O
effects NNS O
of IN O
stimulating VBG O
purinergic JJ O
receptors NNS O
on IN O
both DT O
sides NNS O
of IN O
subretinal JJ O
space NN O
, , O
and CC O
summarize VB O
how WRB O
levels NNS O
of IN O
ATP NNP O
, , O
ADP NNP O
, , O
and CC O
adenosine NN O
are VBP O
manipulated VBN O
in IN O
this DT O
microenvironment NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
relationship NN O
between IN O
the DT O
amount NN O
of IN O
methylation NN O
in IN O
amplicon NN O
1 CD O
and CC O
the DT O
level NN O
of IN O
expression NN O
may MD O
not RB O
be VB O
strictly RB O
quantitative JJ O
. . O

The DT O
reasons NNS O
why WRB O
the DT O
mRNA NNP O
is VBZ O
not RB O
translated VBN O
to IN O
detectable JJ O
protein NN O
are VBP O
not RB O
clear JJ O
. . O

Methods NNS O
and CC O
Findings NNS O

The DT O
resulting VBG O
GH1 NNP O
PCR NNP O
products NNS O
( -LRB- O
2893 CD O
bp NN O
) -RRB- O
were VBD O
used VBN O
as IN O
templates NNS O
for IN O
five CD O
nested VBN O
reactions NNS O
( , O
AN NNP O
, , O
BL NNP O
, , O
CK NNP O
, , O
DI NNP O
, , O
FP NNP O
) -RRB- O
, , O
carried VBN O
out RP O
as IN O
follows VBZ O
: : O
1 CD O
micro JJ O
l NN O
of IN O
each DT O
GH1 NNP O
PCR NNP O
product NN O
was VBD O
added VBN O
to IN O
a DT O
20 CD O
micro JJ O
l NN O
reaction NN O
mixture NN O
of IN O
1 CD O
. . O
5 CD O
mm NN O
MgCl2 CD O
, , O
0 CD O
. . O
2 CD O
mm NN O
dNTPs NNS O
, , O
0 CD O
. . O
3 CD O
micro NN O
m NN O
of IN O
each DT O
primer NN O
and CC O
0 CD O
. . O
4 CD O
U NN O
Eco NNP O
Taq NNP O
DNA NNP O
polymerase NN O
( : O
Ecogen NNP O
S NNP O
. . O
R NNP O
. . O
L NNP O
. . O
, , O
Barcelona NNP O
, , O
Spain NNP O
) -RRB- O
. . O

tag NN O
( : O
cl NN O
. . O
55 CD O
) NFP O

5 CD O
ml NNS O
fractions NNS O
were VBD O
collected VBN O
and CC O
10 CD O
, , O
ul CD O
assayed VBD O
for IN O
5 CD O
minutes NNS O
. . O

The DT O
study NN O
also RB O
drew VBD O
attention NN O
to IN O
ubiquitous JJ O
faculty NN O
shortages NNS O
in IN O
basic JJ O
and CC O
clinical JJ O
sciences NNS O
, , O
weak JJ O
physical JJ O
infrastructure NN O
, , O
and CC O
little JJ O
use NN O
of IN O
external JJ O
accreditation NN O
. . O

The DT O
incidence NN O
of IN O
non JJ O
- HYPH O
albicans NNS O
species NNS O
of IN O
Candida NNP O
is VBZ O
increasing VBG O
compared VBN O
with IN O
that DT O
of IN O
Candida NNP B-Species
albicans NNS I-Species
, , O
and CC O
several JJ O
species NNS O
, , O
such JJ O
as IN O
Candida NNP B-Species
glabrata NN I-Species
and CC O
Candida NNP B-Species
krusei NNP I-Species
, , O
may MD O
be VB O
resistant JJ O
to IN O
azole NN O
antifungal JJ O
therapy NN O
. . O

The DT O
change NN O
of IN O
perspective NN O
on IN O
certain JJ O
community NN O
modules NNS O
may MD O
contribute VB O
to IN O
a DT O
better JJR O
understanding NN O
of IN O
food NN O
web NN O
dynamics NNS O
. . O

Isolates NNS O
of IN O
UCBSV NNP B-Species
from IN O
the DT O
Lake NNP O
Victoria NNP O
zone NN O
were VBD O
placed VBN O
to IN O
two CD O
phylogenetic JJ O
clusters NNS O
in IN O
accordance NN O
with IN O
their PRP$ O
origin NN O
in IN O
Uganda NNP O
or CC O
Tanzania NNP O
, , O
respectively RB O
. . O

* NFP O
One CD O
hundred CD O
and CC O
eighty CD O
- HYPH O
nine CD O
genotypes NNS O
from IN O
the DT O
17 CD O
populations NNS O
were VBD O
grown VBN O
under IN O
uniform NN O
controlled VBN O
conditions NNS O
. . O

The DT O
DNA NNP O
G NNP O
+ NN O
C NN O
content NN O
of IN O
strain NN O
I3 NN O
( -LRB- O
T NNP O
) -RRB- O
was VBD O
69 CD O
. . O
2 CD O
mol NN O
% NN O
. . O

Development NN O
of IN O
a DT O
polyprobe NN O
to TO O
detect VB O
six CD O
viroids NNS O
of IN O
pome NN O
and CC O
stone NN O
fruit NN O
trees NNS O
. . O

5 LS O
. . O

The DT O
recombinant JJ O
enzyme NN O
preferentially RB O
acts VBZ O
on IN O
soluble JJ O
Beta NNP O
- HYPH O
1 CD O
, , O
3 CD O
- HYPH O
glucans NNS O
. . O

Eco NNP O
- HYPH O
immunology NN O
aims VBZ O
to TO O
understand VB O
changes NNS O
in IN O
host NN O
immune JJ O
responses NNS O
in IN O
the DT O
broader JJR O
framework NN O
of IN O
an DT O
organism NN O
' POS O
s NN O
evolutionary JJ O
, , O
ecological JJ O
and CC O
life NN O
- HYPH O
history NN O
contexts NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
investigated VBD O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
the DT O
formation NN O
of IN O
the DT O
SpoIIIAH NNP O
- HYPH O
SpoIIQ NNP O
complex NN O
. . O

The DT O
primary JJ O
objective NN O
of IN O
our PRP$ O
research NN O
was VBD O
to TO O
explore VB O
the DT O
efficacy NN O
of IN O
using VBG O
cox NN O
- HYPH O
1 CD O
barcoding NN O
for IN O
species NNS O
identification NN O
within IN O
the DT O
genus NN O
Tetrahymena NNP O
. . O

The DT O
argC NN O
orthologs NNS O
performed VBD O
differently RB O
in IN O
each DT O
complementation NN O
, , O
reflecting VBG O
the DT O
diverse JJ O
factors NNS O
influencing VBG O
gene NN O
expression NN O
and CC O
the DT O
ability NN O
of IN O
the DT O
ortholog NN O
product NN O
to TO O
function VB O
in IN O
a DT O
foreign JJ O
metabolic JJ O
background NN O
. . O

One CD O
multi JJ O
- HYPH O
microtubular JJ O
structure NN O
, , O
L1 NNP O
, , O
is VBZ O
a DT O
conventional JJ O
microtubular JJ O
root NN O
. . O

Changes NNS O
in IN O
successional JJ O
state NN O
of IN O
testate NN O
amoebae NN O
assemblages NNS O
in IN O
response NN O
to IN O
future JJ O
climate NN O
change NN O
might MD O
thus RB O
be VB O
ephemeral JJ O
, , O
whereas IN O
alterations NNS O
in IN O
density NN O
and CC O
species NNS O
richness NN O
might MD O
be VB O
more RBR O
sustained JJ O
. . O

Hormone NN O
receptor NN O
- HYPH O
like JJ O
in IN O
96 CD O
and CC O
Broad NNP O
- HYPH O
Complex NNP O
modulate VBP O
phenobarbital NN O
induced VBN O
transcription NN O
of IN O
cytochrome NN O
P450 NNP O
CYP6D1 NNP O
in IN O
Drosophila NNP B-Species
S2 NNP O
cells NNS O
. . O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
indicate VBP O
that IN O
polar JJ O
Z NN O
rings NNS O
are VBP O
more RBR O
susceptible JJ O
to IN O
MinC NNP O
/ SYM O
MinD NNP O
than IN O
internal JJ O
Z NN O
rings NNS O
, , O
even RB O
when WRB O
MinE NNP O
is VBZ O
absent JJ O
. . O

Plants NNS O
were VBD O
exposed VBN O
to IN O
a DT O
range NN O
of IN O
water NN O
stresses NNS O
, , O
causing VBG O
up IN O
to TO O
90 CD O
% NN O
leaf JJ O
death NN O
, , O
by IN O
withholding VBG O
water NN O
and CC O
then RB O
rewatering VBG O
to TO O
observe VB O
the DT O
recovery NN O
process NN O
. . O

Sequence NN O
differences NNS O
between IN O
these DT O
orthologs NNS O
, , O
within IN O
and CC O
adjacent JJ O
to IN O
the DT O
amino JJ O
acid NN O
- HYPH O
responsive JJ O
RAM NNP O
domain NN O
, , O
led VBD O
us PRP O
to TO O
test VB O
for IN O
differential JJ O
sensitivity NN O
to IN O
coregulatory JJ O
amino NN O
acids NNS O
. . O

The DT O
DNA NNP O
G NNP O
+ NN O
C NNP O
content NN O
was VBD O
74 CD O
. . O
2 CD O
mol NN O
% NN O
. . O

There EX O
are VBP O
eight CD O
reported VBN O
genotypes NNS O
of IN O
HDV NN B-Species
with IN O
unexplained JJ O
variations NNS O
in IN O
their PRP$ O
geographical JJ O
distribution NN O
and CC O
pathogenicity NN O
. . O

However RB O
, , O
these DT O
results NNS O
were VBD O
based VBN O
on IN O
one CD O
sample NN O
only RB O
, , O
and CC O
extrapolation NN O
to IN O
the DT O
entire JJ O
data NN O
set NN O
is VBZ O
not RB O
possible JJ O
. . O

Protein NN O
alignment NN O
demonstrated VBD O
a DT O
high JJ O
homology NN O
to IN O
that DT O
of IN O
Sarcophaga NN B-Species
crassipalpis NN I-Species
( : O
identity NN O
= : O
51 CD O
% NN O
) -RRB- O
. . O

Transmission NN O
electron NN O
micrographs NNS O
revealed VBD O
that IN O
pit NN O
membranes NNS O
were VBD O
thinner JJR O
in IN O
SH NNP O
, , O
which WDT O
was VBD O
paralleled VBN O
by IN O
lower JJR O
compound NN O
middle JJ O
lamella NN O
thickness NN O
. . O

The DT O
highly RB O
polyphyletic JJ O
nature NN O
of IN O
most JJS O
desmid NN O
genera NN O
corroborated VBN O
in IN O
this DT O
study NN O
using VBG O
a DT O
large JJ O
taxon NN O
set NN O
, , O
calls VBZ O
for IN O
re NN O
- HYPH O
evaluation NN O
of IN O
the DT O
genus NN O
concept NN O
in IN O
the DT O
family NN O
Desmidiaceae NNP O
that WDT O
traditionally RB O
relied VBD O
on IN O
features NNS O
of IN O
cell NN O
morphology NN O
. . O

A DT O
mutant NN O
of IN O
M NNP B-Species
. , I-Species
tuberculosis NN I-Species
lacking VBG O
the DT O
moaA1 NN O
- HYPH O
moaD1 NN O
gene NN O
cluster NN O
and CC O
a DT O
derivative NN O
in IN O
which WDT O
moaD2 NN O
was VBD O
also RB O
deleted VBN O
were VBD O
significantly RB O
impaired VBN O
for IN O
growth NN O
in IN O
media NN O
containing VBG O
nitrate NN O
as IN O
a DT O
sole JJ O
nitrogen NN O
source NN O
, , O
indicating VBG O
a DT O
reduced VBN O
availability NN O
of IN O
MoCo NNP O
to TO O
support VB O
the DT O
assimilatory JJ O
function NN O
of IN O
the DT O
MoCo NNP O
- HYPH O
dependent JJ O
nitrate NN O
reductase NN O
, , O
NarGHI NNP O
. . O

In IN O
leaves NNS O
, , O
although IN O
it PRP O
is VBZ O
accepted VBN O
that IN O
CO NN O
( , O
2 CD O
) -RRB- O
evolved VBN O
by IN O
dark JJ O
respiration NN O
after IN O
illumination NN O
is VBZ O
naturally RB O
( : O
13 CD O
) , O
C NN O
- HYPH O
enriched VBN O
compared VBN O
to IN O
organic JJ O
matter NN O
or CC O
substrate NN O
sucrose NN O
, , O
much JJ O
uncertainty NN O
remains VBZ O
on IN O
whether IN O
day NN O
respiration NN O
produces VBZ O
( , O
13 CD O
) SYM O
C NN O
- HYPH O
depleted VBN O
or CC O
( : O
13 CD O
) SYM O
C NN O
- HYPH O
enriched VBN O
CO NNP O
( SYM O
2 CD O
) -RRB- O
. . O

Disruption NN O
of IN O
the DT O
pptA NN O
gene NN O
abolished VBD O
synthesis NN O
of IN O
all DT O
polyketides NNS O
and CC O
non JJ O
- HYPH O
ribosomal JJ O
peptides NNS O
, , O
while IN O
the DT O
naphtho JJ O
- HYPH O
gamma NN O
- HYPH O
pyrone NN O
subclass NN O
of IN O
polyketides NNS O
were VBD O
specifically RB O
dependent JJ O
on IN O
fwnA NN O
, , O
and CC O
funalenone NN O
on IN O
fwnA NN O
, , O
olvA NN O
and CC O
brnA NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
jasmonates NNS O
are VBP O
not RB O
involved VBN O
in IN O
the DT O
development NN O
and CC O
function NN O
of IN O
root NN O
nodules NNS O
. . O

Globally RB O
, , O
first JJ O
flowering NN O
dates NNS O
( , O
FFDs NNS O
) -RRB- O
have VBP O
advanced VBN O
by IN O
several JJ O
days NNS O
per IN O
decade NN O
in IN O
response NN O
to IN O
recent JJ O
climate NN O
warming NN O
, , O
but CC O
, , O
while IN O
earlier JJR O
flowering NN O
should MD O
allow VB O
plant NN O
distributions NNS O
to TO O
increase VB O
, , O
a DT O
link NN O
between IN O
FFD NN O
and CC O
range NN O
changes NNS O
has VBZ O
not RB O
been VBN O
observed VBN O
. . O

Excision NN O
of IN O
the DT O
Bacteroides NNP O
conjugative JJ O
transposon NN O
CTnDOT NNP O
is VBZ O
stimulated VBN O
by IN O
tetracycline NN O
. . O

* NFP O
Total JJ O
As IN O
concentrations NNS O
of IN O
vegetative JJ O
tissues NNS O
increased VBD O
during IN O
the DT O
2 CD O
wk NN O
after IN O
flowering NN O
. . O

Emerging JJ O
opportunistic JJ O
yeast NN O
infections NNS O
. . O

Iron NN O
acquisition NN O
in IN O
aerobic JJ O
habitats NNS O
is VBZ O
complicated VBN O
by IN O
the DT O
low JJ O
solubility NN O
of IN O
ferric JJ O
hydroxides NNS O
. . O

CbrA NNP O
is VBZ O
a DT O
sensor NN O
kinase NN O
that WDT O
has VBZ O
previously RB O
been VBN O
implied VBN O
to TO O
play VB O
a DT O
role NN O
with IN O
its PRP$ O
cognate JJ O
response NN O
regulator NN O
CbrB NNP O
in IN O
the DT O
metabolic JJ O
regulation NN O
of IN O
carbon NN O
and CC O
nitrogen NN O
utilization NN O
in IN O
P NNP B-Species
. . I-Species
aeruginosa NN I-Species
. . O

Moreover RB O
, , O
the DT O
L98H NNP O
induced VBD O
relocation NN O
of IN O
tyrosine NN O
121 CD O
and CC O
tyrosine NN O
107 CD O
seems VBZ O
to TO O
be VB O
related VBN O
to IN O
the DT O
MAR NNP O
phenotype NN O
, , O
without IN O
affecting VBG O
the DT O
biological JJ O
activity NN O
of IN O
the DT O
CYP51A NNP O
protein NN O
. . O

Consideration NN O
of IN O
functional JJ O
characteristics NNS O
of IN O
individual JJ O
species NNS O
, , O
in IN O
particular JJ O
aspects NNS O
of IN O
habitat NN O
domain NN O
and CC O
hunting NN O
mode NN O
, , O
are VBP O
crucial JJ O
in IN O
predicting VBG O
the DT O
effects NNS O
of IN O
multi JJ O
- HYPH O
predator NN O
systems NNS O
on IN O
the DT O
top NN O
- HYPH O
down RP O
control NN O
of IN O
herbivores NNS O
. . O

( : O
Amoebozoa NNP O
, , O
Dermamoebidae NNP O
) : O
: : O
an DT O
algivorous JJ O
lobose NN O
amoeba NN O
with IN O
complex JJ O
cell NN O
coat NN O
and CC O
unusual JJ O
feeding NN O
mode NN O
. . O

This DT O
study NN O
identifies VBZ O
VZV NNP B-Species
- HYPH I-Species
induced VBN I-Species
CXCL10 NNP O
as IN O
a DT O
potential JJ O
driver NN O
of IN O
T NN O
lymphocyte NN O
recruitment NN O
into IN O
DRG NNP O
during IN O
herpes NNS O
zoster NN O
. . O

SprF NNP O
was VBD O
not RB O
needed VBN O
for IN O
chitinase NN O
secretion NN O
and CC O
may MD O
be VB O
specifically RB O
required VBN O
for IN O
SprB NNP O
secretion NN O
by IN O
the DT O
PorSS NNP O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
P NN O
bodies NNS O
are VBP O
also RB O
disrupted VBN O
during IN O
PV NN B-Species
infection NN O
in IN O
cells NNS O
by IN O
4 CD O
h NN O
postinfection NN O
. . O

HPAEC NNP O
analysis NN O
of IN O
the DT O
products NNS O
formed VBN O
by IN O
Eng2 NNP O
when WRB O
acting VBG O
on IN O
different JJ O
oligo JJ O
- HYPH O
Beta NN O
- HYPH O
1 CD O
, , O
3 CD O
- HYPH O
glucans NNS O
confirmed VBD O
the DT O
predicted VBN O
endoglucanase NN O
activity NN O
and CC O
also RB O
revealed VBD O
a DT O
transferase NN O
activity NN O
for IN O
oligosaccharides NNS O
of IN O
a DT O
low JJ O
degree NN O
of IN O
polymerization NN O
. . O

Our PRP$ O
results NNS O
clearly RB O
demonstrate VBP O
the DT O
need NN O
for IN O
studies NNS O
of IN O
plant NN O
- HYPH O
animal NN O
interactions NNS O
to TO O
include VB O
the DT O
belowground JJ O
fauna NN O
, , O
as IN O
this DT O
might MD O
drastically RB O
alter VB O
our PRP$ O
general JJ O
conception NN O
of IN O
how WRB O
plants NNS O
and CC O
their PRP$ O
associated JJ O
animal NN O
communities NNS O
interact VBP O
and CC O
how WRB O
these DT O
interactions NNS O
shape VBP O
the DT O
process NN O
of IN O
evolution NN O
. . O

Density NN O
- HYPH O
dependent JJ O
processes NNS O
leading VBG O
to IN O
the DT O
regulation NN O
of IN O
local JJ O
population NN O
dynamics NNS O
in IN O
our PRP$ O
experimental JJ O
systems NNS O
were VBD O
strongest JJS O
in IN O
homogeneity NN O
or CC O
temporal JJ O
heterogeneity NN O
treatments NNS O
. . O

Here RB O
, , O
we PRP O
examine VBP O
the DT O
relationship NN O
between IN O
exploration NN O
behaviour NN O
- : O
an DT O
axis NN O
of IN O
personality NN O
that WDT O
appears VBZ O
to TO O
be VB O
important JJ O
in IN O
animals NNS O
generally RB O
- : O
and CC O
a DT O
variety NN O
of IN O
dispersal JJ O
processes NNS O
over IN O
6 CD O
years NNS O
in IN O
a DT O
population NN O
of IN O
the DT O
great JJ B-Species
tit NN I-Species
Parus NNP B-Species
major NN I-Species
. . O

4 LS O
. . O

Some DT O
of IN O
the DT O
transcripts NNS O
encoded VBD O
proteins NNS O
that WDT O
were VBD O
previously RB O
implicated VBN O
in IN O
the DT O
stress NN O
and CC O
defence NN O
responses NNS O
associated VBN O
with IN O
vegetative JJ O
incompatibility NN O
. . O

Using VBG O
phos NNS O
- HYPH O
tag NN O
detection NN O
assays NNS O
, , O
the DT O
present JJ O
study NN O
revealed VBD O
that IN O
the DT O
in IN O
vivo NN O
phosphorylation NN O
level NN O
in IN O
several JJ O
proteins NNS O
[ -LRB- O
33 CD O
kDa NN O
, , O
37 CD O
kDa NN O
, , O
37 CD O
. , O
5 CD O
kDa NN O
, , O
43 CD O
kDa NN O
, , O
47 CD O
kDa NN O
, , O
49 CD O
kDa NN O
, , O
etc FW O
. . O
] -RRB- O
was VBD O
raised VBN O
when WRB O
the DT O
vegetative JJ O
cells NNS O
were VBD O
stimulated VBN O
by IN O
overpopulation NN O
to TO O
encyst VB O
in IN O
a DT O
medium NN O
containing VBG O
0 CD O
. . O
1 CD O
mM NN O
Ca NN O
( , O
2 CD O
+ CC O
) -RRB- O
or CC O
without IN O
the DT O
addition NN O
of IN O
Ca NN O
( SYM O
2 CD O
+ CC O
) -RRB- O
. . O

Its PRP$ O
expression NN O
was VBD O
up RB O
- HYPH O
regulated VBN O
by IN O
20 CD O
- HYPH O
hydroxyecdysone NN O
( SYM O
20E CD O
) -RRB- O
and CC O
the DT O
20E CD O
- HYPH O
induced VBN O
expression NN O
was VBD O
suppressed VBN O
by IN O
juvenile JJ O
hormone NN O
( -LRB- O
JH NNP O
) : O
III NNP O
. . O

8 LS O
. . O

We PRP O
addressed VBD O
the DT O
question NN O
of IN O
which WDT O
intermediate NN O
of IN O
the DT O
cycle NN O
most JJS O
biosynthetic JJ O
routes NNS O
branch VBP O
off RP O
. . O

We PRP O
have VBP O
explored VBN O
the DT O
global JJ O
gene NN O
expression NN O
response NN O
of IN O
S NN B-Species
. . I-Species
cerevisiae NN I-Species
during IN O
that DT O
stimulus NN O
. . O

Bayesian JJ O
analysis NN O
of IN O
16S NNP O
rRNA NNP O
gene NN O
sequences NNS O
suggested VBD O
that IN O
the DT O
newly RB O
identified VBN O
isolates NNS O
belong VBP O
to IN O
distinct JJ O
but CC O
related VBN O
species NNS O
of IN O
the DT O
genus NN O
Neisseria NNP O
, , O
and CC O
are VBP O
members NNS O
of IN O
a DT O
clade NN O
that WDT O
includes VBZ O
N NNP B-Species
. . I-Species
dentiae NN I-Species
, , O
N NNP B-Species
. . I-Species
bacilliformis NN I-Species
and CC O
N NNP B-Species
. . I-Species
canis NN I-Species
. . O

This DT O
study NN O
aimed VBN O
at IN O
providing VBG O
evidence NN O
for IN O
the DT O
domain NN O
structure NN O
of IN O
L NNP O
protein NN O
by IN O
combining VBG O
bioinformatics NNS O
with IN O
a DT O
stepwise JJ O
mutagenesis NN O
approach NN O
using VBG O
the DT O
Lassa NNP B-Species
virus NN I-Species
minireplicon NN O
system NN O
. . O

Insights NNS O
into IN O
the DT O
extracytoplasmic JJ O
stress NN O
response NN O
of IN O
Xanthomonas NNP B-Species
campestris NNP I-Species
pv NN I-Species
. . I-Species
campestris NN I-Species
: : O
role NN O
and CC O
regulation NN O
of IN O
{ : O
sigma NN O
} , O
E NN O
- HYPH O
dependent JJ O
activity NN O
. . O

* NFP O
TFAR1 NNP O
is VBZ O
potentially RB O
involved VBN O
in IN O
cuticular JJ O
wax NN O
formation NN O
during IN O
glandular JJ O
trichome NN O
expansion NN O
in IN O
leaves NNS O
and CC O
flowers NNS O
of IN O
A NN B-Species
. . I-Species
annua NN I-Species
plants NNS I-Species
. . O

Meiotic JJ O
silencing NN O
by IN O
unpaired JJ O
DNA NNP O
is VBZ O
expressed VBN O
more RBR O
strongly RB O
in IN O
the DT O
early JJ O
than IN O
the DT O
late JJ O
perithecia NN O
of IN O
crosses NNS O
involving VBG O
most RBS O
wild JJ O
- HYPH O
isolated VBN O
Neurospora NNP B-Species
crassa NN I-Species
strains NNS O
and CC O
in IN O
self NN O
- HYPH O
crosses NNS O
of IN O
N NNP B-Species
. . I-Species
tetrasperma NN I-Species
. . O

Replicative JJ O
and CC O
transcriptional JJ O
activities NNS O
of IN O
hepatitis NN B-Species
B NN I-Species
virus NN I-Species
in IN O
patients NNS O
coinfected VBN O
with IN O
hepatitis NNP B-Species
B NNP I-Species
and CC O
hepatitis NN B-Species
delta NN I-Species
viruses NNS I-Species
. . O

Previous JJ O
studies NNS O
indicated VBD O
that IN O
most JJS O
of IN O
this DT O
toxicity NN O
is VBZ O
dependent JJ O
on IN O
an DT O
interaction NN O
of IN O
E4orf4 NNP O
protein NN O
with IN O
the DT O
B55 NNP O
class NN O
of IN O
regulatory JJ O
subunits NNS O
of IN O
protein NN O
phosphatase NN O
2A NN O
( , O
PP2A NNP O
) -RRB- O
and CC O
in IN O
yeast NN B-Species
with IN O
the DT O
B55 NNP O
homolog NN O
Cdc55 NN O
. . O

Parasitization NN O
by IN O
C NN B-Species
. . I-Species
plutellae NN I-Species
inhibited VBD O
storage NN O
protein NN O
1 CD O
( HYPH O
SP1 NN O
) -RRB- O
synthesis NN O
of IN O
Plutella NNP B-Species
xylostella NN I-Species
at IN O
post NN O
- HYPH O
transcriptional JJ O
level NN O
. . O

However RB O
, , O
it PRP O
was VBD O
normal JJ O
in IN O
sexual JJ O
reproduction NN O
and CC O
increased VBD O
in IN O
the DT O
production NN O
of IN O
macroconidia NN O
. . O

To TO O
study VB O
whether IN O
JA NNP O
played VBD O
a DT O
regulatory JJ O
role NN O
in IN O
the DT O
nodules NNS O
of IN O
M NNP B-Species
. . I-Species
truncatula NN I-Species
, , O
composite JJ O
plants NNS O
containing VBG O
roots NNS O
expressing VBG O
an DT O
MtAOC1 NNP O
- HYPH O
sense NN O
or CC O
MtAOC1 NNP O
- HYPH O
RNAi NNP O
construct NN O
were VBD O
inoculated VBN O
with IN O
S NNP B-Species
. . I-Species
meliloti NNS I-Species
. . O

Using VBG O
a DT O
collated JJ O
data NNS O
set VBN O
from IN O
several JJ O
different JJ O
populations NNS O
and CC O
species NNS O
of IN O
marine JJ O
turtles NNS O
, , O
we PRP O
then RB O
show VBP O
that IN O
a DT O
single JJ O
relationship NN O
with IN O
water NN O
temperature NN O
explains VBZ O
most JJS O
of IN O
the DT O
variation NN O
in IN O
egg NN O
maturation NN O
rates NNS O
, , O
with IN O
a DT O
slope NN O
that WDT O
is VBZ O
statistically RB O
indistinguishable JJ O
from IN O
the DT O
UTD NNP O
predicted VBN O
by IN O
MTE NNP O
. . O

Transient JJ O
water NN O
deficits NNS O
favoured VBD O
reproductive JJ O
meristem NN O
growth NN O
and CC O
floret NN O
production NN O
. . O

Analysis NN O
of IN O
18 CD O
years NNS O
of IN O
breeding VBG O
data NNS O
from IN O
a DT O
colony NN O
of IN O
the DT O
blue JJ B-Species
- HYPH I-Species
footed JJ I-Species
booby NN I-Species
Sula NNP B-Species
nebouxii NN I-Species
( , O
Milne NNP O
- HYPH O
Edwards NNP O
) -RRB- O
showed VBD O
a DT O
delay NN O
in IN O
onset NN O
of IN O
breeding NN O
when WRB O
the DT O
global JJ O
Southern NNP O
Oscillation NNP O
Index NNP O
was VBD O
negative JJ O
; : O
each DT O
unit NN O
of IN O
the DT O
atmospheric JJ O
pressure NN O
differential NN O
( -LRB- O
hPa NNP O
) -RRB- O
across IN O
the DT O
Pacific NNP O
Ocean NNP O
meant VBD O
a DT O
delay NN O
of IN O
7 CD O
days NNS O
. . O

During IN O
amino JJ O
acid JJ O
starvation NN O
induced VBN O
by IN O
serine NN O
hydroxamate NN O
( , O
SHX NNP O
) -RRB- O
, , O
only RB O
the DT O
strong JJ O
rrnO NN O
and CC O
rrnJ NN O
promoters NNS O
demonstrated VBD O
stringent JJ O
responses NNS O
. . O

As IN O
T NNP B-Species
. . I-Species
ekebladella NNP I-Species
is VBZ O
the DT O
main JJ O
source NN O
of IN O
its PRP$ O
own JJ O
parasitoids NNS O
, , O
we PRP O
expect VBP O
to TO O
find VB O
intraspecific JJ O
density NN O
- HYPH O
dependent JJ O
parasitism NN O
in IN O
this DT O
species NN O
. . O

The DT O
Candida NNP B-Species
albicans NNS I-Species
Rgd1 NNP O
is VBZ O
a DT O
RhoGAP NNP O
protein NN O
involved VBN O
in IN O
the DT O
control NN O
of IN O
filamentous JJ O
growth NN O
. . O

Furthermore RB O
, , O
oncologists NNS O
should MD O
continue VB O
to TO O
use VB O
clinical JJ O
parameters NNS O
when WRB O
making VBG O
decisions NNS O
about IN O
initiation NN O
, , O
continuation NN O
, , O
and CC O
discontinuation NN O
of IN O
HER2 NNP O
- HYPH O
targeted VBN O
treatments NNS O
. . O

One CD O
year NN O
after IN O
removal NN O
, , O
abundances NNS O
of IN O
F NNP B-Species
. . I-Species
aquilonia NN I-Species
at IN O
removal NN O
sites NNS O
were VBD O
similar JJ O
to IN O
those DT O
at IN O
low JJ O
- HYPH O
density NN O
sites NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
microscopic JJ O
and CC O
biochemical JJ O
approaches NNS O
, , O
we PRP O
conclude VBP O
that IN O
death NN O
results VBZ O
from IN O
a DT O
loss NN O
of IN O
membrane NN O
integrity NN O
. . O

The DT O
control NN O
programme NN O
, , O
based VBN O
on IN O
serological JJ O
screening NN O
, , O
has VBZ O
confined VBN O
successfully RB O
AMDV NNP B-Species
to IN O
the DT O
northern JJ O
part NN O
of IN O
Denmark NNP O
. . O

Glaucoma NN O
is VBZ O
mostly RB O
asymptomatic JJ O
until IN O
late RB O
in IN O
the DT O
disease NN O
when WRB O
visual JJ O
problems NNS O
arise VBP O
. . O

Fractal JJ O
analysis NN O
was VBD O
used VBN O
to TO O
quantify VB O
how WRB O
movement NN O
structure NN O
varied VBD O
with IN O
spatial JJ O
scale NN O
and CC O
determine VB O
whether IN O
the DT O
sharks NNS O
were VBD O
using VBG O
patches NNS O
. . O

Changes NNS O
in IN O
the DT O
spatial JJ O
structure NN O
of IN O
mammalian JJ O
populations NNS O
in IN O
response NN O
to IN O
removal NN O
of IN O
individuals NNS O
have VBP O
important JJ O
implications NNS O
for IN O
pest NN O
management NN O
. . O

However RB O
, , O
unlike IN O
in IN O
other JJ O
eukaryota NN O
, , O
the DT O
three CD O
bio NN O
genes NNS O
contributing VBG O
to IN O
the DT O
four CD O
enzymatic JJ O
steps NNS O
from IN O
pimeloyl NN O
- HYPH O
CoA NN O
to IN O
biotin NN O
are VBP O
organized VBN O
in IN O
a DT O
gene NN O
cluster NN O
in IN O
pezizomycotina NN O
. . O

This DT O
transition NN O
requires VBZ O
cellular JJ O
restructuring NN O
to TO O
form VB O
a DT O
filamentous JJ O
dikaryon NN O
. . O

These DT O
results NNS O
highlight VBP O
the DT O
importance NN O
of IN O
considering VBG O
heterogeneity NN O
and CC O
individual JJ O
quality NN O
when WRB O
examining VBG O
trade NN O
- HYPH O
offs NNS O
and CC O
demonstrate VBP O
the DT O
effectiveness NN O
of IN O
using VBG O
detailed JJ O
long JJ O
- HYPH O
term NN O
data NNS O
sets NNS O
to TO O
explore VB O
life NN O
- HYPH O
history NN O
strategies NNS O
using VBG O
multi JJ O
- HYPH O
state NN O
mark NN O
- HYPH O
recapture NN O
models NNS O
. . O

The DT O
metabolic JJ O
theory NN O
of IN O
ecology NN O
( , O
MTE NNP O
) -RRB- O
predicts VBZ O
that IN O
, , O
after IN O
correcting VBG O
for IN O
body NN O
mass JJ O
variation NN O
among IN O
organisms NNS O
, , O
the DT O
rates NNS O
of IN O
most JJS O
biological JJ O
processes NNS O
will MD O
vary VB O
as IN O
a DT O
universal JJ O
function NN O
of IN O
temperature NN O
. . O

The DT O
genes NNS O
involved VBN O
in IN O
the DT O
biosynthesis NN O
of IN O
biotin NN O
were VBD O
identified VBN O
in IN O
the DT O
hyphal NN O
fungus NN O
Aspergillus NNP B-Species
nidulans NNS I-Species
through IN O
homology NN O
searches NNS O
and CC O
complementation NN O
of IN O
Escherichia NNP B-Species
coli NN I-Species
biotin NN O
- HYPH O
auxotrophic JJ O
mutants NNS O
. . O

Several JJ O
of IN O
these DT O
novel JJ O
interactions NNS O
were VBD O
confirmed VBN O
by IN O
coimmunoprecipitation NN O
of IN O
protein NN O
complexes NNS O
from IN O
transfected VBN O
cells NNS O
. . O

Light NN O
exerts VBZ O
multiple JJ O
levels NNS O
of IN O
influence NN O
on IN O
the DT O
Arabidopsis NNP B-Species
wound NN O
response NN O
. . O

Melanomas NNS O
arising VBG O
from IN O
mucosal JJ O
, , O
acral NN O
, , O
chronically RB O
sun NN O
- HYPH O
damaged VBN O
surfaces NNS O
sometimes RB O
have VBP O
oncogenic JJ O
mutations NNS O
in IN O
KIT NNP O
, , O
against IN O
which WDT O
several JJ O
inhibitors NNS O
have VBP O
shown VBN O
clinical JJ O
efficacy NN O
. . O

( -LRB- O
Violales NNS O
: : O
Caricaceae NNP O
) -RRB- O
orchard NN O
known VBN O
to TO O
have VB O
established VBN O
populations NNS O
of IN O
B NN B-Species
. . I-Species
cucurbitae NN I-Species
and CC O
B NN B-Species
. . I-Species
dorsalis NN I-Species
, , O
the DT O
effectiveness NN O
of IN O
M NN B-Species
. , I-Species
esculenta NN I-Species
as IN O
a DT O
roosting NN O
host NN O
was VBD O
assessed VBN O
by IN O
comparing VBG O
its PRP$ O
attractiveness NN O
to IN O
that DT O
of IN O
castor NN B-Species
bean NN I-Species
, , O
Ricinus NNP B-Species
communis NN I-Species
L NNP O
( , O
Malpighiales NNP O
: : O
Euphorbiaceae NNP O
) -RRB- O
, , O
previously RB O
identified VBN O
as IN O
one CD O
of IN O
the DT O
most RBS O
attractive JJ O
roosting VBG O
hosts NNS O
for IN O
B NN B-Species
. . I-Species
cucurbitae NN I-Species
, , O
and CC O
to IN O
corn NN B-Species
, , O
a DT O
crop NN O
which WDT O
has VBZ O
been VBN O
planted VBN O
as IN O
a DT O
roosting VBG O
host NN O
for IN O
help NN O
in IN O
B NN B-Species
. . I-Species
cucurbitae NN I-Species
control NN O
. . O

Plants NNS O
were VBD O
field NN O
grown VBN O
under IN O
well RB O
- HYPH O
watered VBN O
( , O
WW NN O
) -RRB- O
and CC O
water NN O
- HYPH O
stressed VBN O
( , O
WS NNP O
) -RRB- O
treatments NNS O
, , O
with IN O
30 CD O
and CC O
10 CD O
% NN O
of IN O
soil NN O
water NN O
capacity NN O
, , O
respectively RB O
. . O

Moreover RB O
, , O
replacement NN O
of IN O
the DT O
GUG NNP O
translation NN O
initiation NN O
codon NN O
of IN O
bglG NNP O
with IN O
AUG NNP O
was VBD O
effective JJ O
in IN O
relieving VBG O
the DT O
glucose NN O
repression NN O
of IN O
bglF NN O
and CC O
bglG NNP O
. . O

Phylogenetic JJ O
analyses NNS O
based VBN O
on IN O
16S NNP O
rDNA NNP O
and CC O
ITS NNP O
rDNA NNP O
sequences NNS O
demonstrated VBD O
that IN O
all DT O
of IN O
the DT O
endosymbionts NNS O
belonged VBD O
to IN O
the DT O
Betaproteobacteria NNP O
and CC O
revealed VBD O
three CD O
new JJ O
species NNS O
. . O

Dinoflagellates NNS O
are VBP O
a DT O
diverse JJ O
group NN O
of IN O
protists NNS O
that WDT O
are VBP O
common JJ O
in IN O
both CC O
marine JJ O
and CC O
freshwater JJ O
environments NNS O
. . O

The DT O
spectral JJ O
colour NN O
of IN O
population NN O
dynamics NNS O
and CC O
its PRP$ O
causes NNS O
have VBP O
attracted VBN O
much JJ O
interest NN O
. . O

The DT O
immune JJ O
system NN O
, , O
however RB O
, , O
is VBZ O
complex JJ O
and CC O
multifaceted JJ O
and CC O
can MD O
be VB O
intimidating JJ O
for IN O
the DT O
nonimmunologist NN O
interested JJ O
in IN O
incorporating VBG O
immunological JJ O
questions NNS O
into IN O
their PRP$ O
research NN O
. . O

The DT O
heterologous JJ O
expression NN O
of IN O
the DT O
nbtS NN O
gene NN O
revealed VBD O
that IN O
this DT O
gene NN O
encoded VBD O
a DT O
salicylate JJ O
synthase NN O
. . O

In IN O
this DT O
study NN O
we PRP O
demonstrate VBP O
that IN O
, , O
in IN O
contrast NN O
to IN O
earlier JJR O
reports NNS O
, , O
CD81 NNP O
and CC O
the DT O
tight JJ O
- HYPH O
junction NN O
components NNS O
claudin NN O
- HYPH O
1 CD O
and CC O
occludin NN O
are VBP O
all RB O
essential JJ O
for IN O
both CC O
cell NN O
- HYPH O
free JJ O
and CC O
cell NN O
- HYPH O
to IN O
- HYPH O
cell NN O
viral JJ O
transmission NN O
. . O

Thus RB O
, , O
root NN O
- HYPH O
to IN O
- HYPH O
shoot NN O
communication NN O
for IN O
many JJ O
RtS NNP O
genes NNS O
is VBZ O
associated VBN O
with IN O
the DT O
systemic JJ O
production NN O
of IN O
JA NNP O
, , O
OPDA NNP O
and CC O
possibly RB O
ET NNP O
. . O

Although IN O
the DT O
phylum NN O
Cercozoa NNP O
is VBZ O
a DT O
diverse JJ O
group NN O
, , O
gene NN O
data NNS O
for IN O
either CC O
EFL NNP O
or CC O
EF NNP O
- HYPH O
1alpha NNP O
are VBP O
absent JJ O
from IN O
all DT O
cercozoans NNS O
except IN O
chlorarachniophytes NNS O
which WDT O
were VBD O
previously RB O
defined VBN O
as IN O
EFL NNP O
- HYPH O
containing VBG O
members NNS O
. . O

Natural JJ O
mortality NN O
of IN O
ptarmigan NN O
was VBD O
highest JJS O
during IN O
autumn NN O
movements NNS O
and CC O
nesting NN O
by IN O
gyrfalcons NNS B-Species
Falco NNP B-Species
rusticolus NNP I-Species
L NNP O
. . O

While IN O
the DT O
biology NN O
of IN O
Wolbachia NNP O
has VBZ O
been VBN O
extensively RB O
studied VBN O
at IN O
the DT O
ecological JJ O
and CC O
phenotypic JJ O
level NN O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
the DT O
interaction NN O
between IN O
Wolbachia NNP O
and CC O
their PRP$ O
hosts NNS O
. . O

Activity NN O
and CC O
uptake NN O
mutants NNS O
were VBD O
distinguished VBN O
by IN O
osmotic JJ O
shock NN O
, , O
which WDT O
transfers VBZ O
Cma NNP O
into IN O
the DT O
periplasm NN O
independent JJ O
of IN O
the DT O
specific JJ O
FhuA NNP O
receptor NN O
and CC O
the DT O
Ton NNP O
system NN O
. . O

In IN O
this DT O
study NN O
, , O
temperature NN O
reaction NN O
norms NNS O
of IN O
natural JJ O
isolates NNS O
of IN O
the DT O
freshwater NN O
protist NN O
Paramecium NNP B-Species
caudatum NN I-Species
were VBD O
investigated VBN O
, , O
considering VBG O
nearly RB O
the DT O
entire JJ O
temperature NN O
range NN O
. . O

7 LS O
. . O

Membrane NN O
topology NN O
and CC O
DNA NN O
- HYPH O
binding VBG O
ability NN O
of IN O
the DT O
Streptococcal NNP O
CpsA NNP O
protein NN O
. . O

Mating NN O
type NN O
genes NNS O
are VBP O
central JJ O
to IN O
sexual JJ O
reproduction NN O
and CC O
compatibility NN O
in IN O
Ascomycete NNP O
fungi NN O
. . O

The DT O
predominant JJ O
cellular JJ O
fatty NN O
acids NNS O
[ -LRB- O
16 CD O
: SYM O
0 CD O
, , O
summed VBD O
feature NN O
3 CD O
( SYM O
16 CD O
: : O
1omega7c NNS O
and CC O
/ SYM O
or CC O
iso CD O
- HYPH O
15 CD O
: : O
0 CD O
2 CD O
- HYPH O
OH NN O
) -RRB- O
and CC O
18 CD O
: : O
1omega7c NNP O
] -RRB- O
, , O
as RB O
well RB O
as IN O
biochemical JJ O
and CC O
morphological JJ O
analyses NNS O
further RB O
support VBP O
the DT O
designation NN O
of IN O
Neisseria NNP B-Species
wadsworthii NN I-Species
sp NN O
. . O
nov -RRB- O
. . O

In IN O
Loxigilla NNP O
spp NN O
. . O
, , O
we PRP O
found VBD O
a DT O
positive JJ O
correlation NN O
with IN O
geographical JJ O
distance NN O
and CC O
an DT O
unexpected JJ O
negative JJ O
correlation NN O
between IN O
haemosporidian JJ O
beta NN O
diversity NN O
and CC O
host NN O
genetic JJ O
distance NN O
. . O

The DT O
major JJ O
menaquinones NNS O
were VBD O
MK NNP O
- HYPH O
9 CD O
( SYM O
H NNP O
( SYM O
4 CD O
) -RRB- O
) NFP O
, , O
MK NNP O
- HYPH O
10 CD O
( HYPH O
H NNP O
( HYPH O
4 CD O
) SYM O
) -RRB- O
and CC O
MK NNP O
- HYPH O
11 CD O
( HYPH O
H NN O
( HYPH O
4 CD O
) -RRB- O
) -RRB- O
. . O

Single JJ O
mutants NNS O
of IN O
IPMDH2 NNP O
or CC O
IPMDH3 NNP O
lacked VBD O
a DT O
discernible JJ O
phenotype NN O
. . O

We PRP O
describe VBP O
three CD O
new JJ O
orders NNS O
of IN O
filosan NN O
Cercozoa NNP O
, , O
five CD O
new JJ O
deep JJ O
- HYPH O
branching VBG O
genera NN O
, , O
eight CD O
new JJ O
species NNS O
of IN O
Thaumatomonas NNP O
, , O
Reckertia NNP O
, , O
Spongomonas NNP O
, , O
Rhogostoma NNP O
, , O
Agitata NNP O
, , O
Neoheteromita NNP O
and CC O
Paracercomonas NNP O
, , O
sequence VBP O
their PRP$ O
18S CD O
rDNA NN O
, , O
and CC O
construct VBP O
18S CD O
rDNA NNP O
trees NNS O
for IN O
148 CD O
Cercozoa NNP O
. . O

The DT O
corn NN B-Species
planthopper NN I-Species
, , O
Peregrinus NNP B-Species
maidis NN I-Species
, , O
causes VBZ O
direct JJ O
feeding NN O
damage NN O
to IN O
plants NNS O
and CC O
transmits VBZ O
Maize NNP B-Species
mosaic JJ I-Species
rhabdovirus NN I-Species
( , I-Species
MMV NNP I-Species
) -RRB- I-Species
in IN O
a DT O
persistent JJ O
- HYPH O
propagative JJ O
manner NN O
. . O

Fifty CD O
- HYPH O
six CD O
per NN O
cent NN O
of IN O
alligators NNS O
regularly RB O
travelled VBD O
from IN O
the DT O
upstream JJ O
( HYPH O
freshwater NN O
/ SYM O
mid JJ O
- HYPH O
estuary NN O
) -RRB- O
areas NNS O
into IN O
the DT O
downstream NN O
( , O
marine NN O
- HYPH O
influenced VBN O
) , O
areas NNS O
where WRB O
salinities NNS O
exceed VBP O
those DT O
typically RB O
tolerated VBN O
by IN O
alligators NNS O
. . O

Future JJ O
research NN O
must MD O
focus VB O
on IN O
screening NN O
and CC O
interventions NNS O
to TO O
reduce VB O
antepartum NN O
stillbirth NN O
as IN O
a DT O
result NN O
of IN O
placental JJ O
dysfunction NN O
. . O

Although IN O
the DT O
phenotypic JJ O
effects NNS O
of IN O
facultative JJ O
symbionts NNS O
upon IN O
hosts NNS O
have VBP O
been VBN O
studied VBN O
in IN O
some DT O
detail NN O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
molecular JJ O
and CC O
genomic JJ O
basis NN O
of IN O
these DT O
interactions NNS O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
we PRP O
identified VBD O
members NNS O
of IN O
the DT O
insect NN O
IR NN O
chemosensory NN O
receptor NN O
family NN O
in IN O
S NNP B-Species
. . I-Species
littoralis NN I-Species
and CC O
we PRP O
report VBP O
here RB O
the DT O
first JJ O
demonstration NN O
of IN O
IR NN O
expression NN O
in IN O
Lepidoptera NNP O
. . O

Here RB O
, , O
we PRP O
discuss VBP O
current JJ O
evidence NN O
( , O
both CC O
in IN O
vitro JJ O
and CC O
clinical JJ O
studies NNS O
) -RRB- O
, , O
and CC O
focus VBP O
on IN O
a DT O
putative JJ O
role NN O
for IN O
bacterial JJ O
and CC O
viral JJ O
pathogens NNS O
as IN O
a DT O
cause NN O
of IN O
colorectal JJ O
cancer NN O
. . O

Using VBG O
dual JJ O
luciferase NN O
reporter NN O
assays NNS O
in IN O
Drosophila NNP B-Species
Schneider NNP O
( , O
S2 NNP O
) -RRB- O
cells NNS O
, , O
constructs NNS O
containing VBG O
variable JJ O
lengths NNS O
of IN O
the DT O
promoter NN O
of IN O
the DT O
PB NNP O
inducible JJ O
cytochrome NN O
P450 NNP O
CYP6D1 NNP O
were VBD O
evaluated VBN O
in IN O
the DT O
presence NN O
and CC O
absence NN O
of IN O
PB NN O
. . O

Role NN O
of IN O
RNase NNP O
MRP NNP O
in IN O
viral JJ O
RNA NNP O
degradation NN O
and CC O
RNA NN O
recombination NN O
. . O

As IN O
the DT O
tandem NN O
peptide NN O
repeats VBZ O
expand VBP O
, , O
the DT O
Cha NNP O
fiber NN O
becomes VBZ O
longer JJR O
and CC O
Cha NNP O
adherence NN O
activity NN O
decreases VBZ O
. . O

The DT O
dramatic JJ O
discrepancy NN O
between IN O
the DT O
currently RB O
practised VBN O
systematic JJ O
treatment NN O
of IN O
the DT O
family NN O
and CC O
the DT O
composition NN O
of IN O
the DT O
clades NNS O
based VBN O
on IN O
sequence NN O
comparisons NNS O
requires VBZ O
emendation NN O
of IN O
almost RB O
all DT O
existing VBG O
genera NN O
and CC O
description NN O
of IN O
a DT O
larger JJR O
number NN O
of IN O
novel NN O
genera NN O
. . O

The DT O
first JJ O
domain NN O
seems VBZ O
to TO O
mediate VB O
accumulation NN O
of IN O
L NN O
protein NN O
into IN O
cytoplasmic JJ O
dot NN O
- HYPH O
like JJ O
structures NNS O
. . O

We PRP O
present VBP O
a DT O
cryo NN O
- HYPH O
electron NN O
tomographic JJ O
analysis NN O
of IN O
the DT O
three CD O
- HYPH O
dimensional JJ O
architecture NN O
of IN O
a DT O
strain NN O
of IN O
the DT O
Gram NNP O
- HYPH O
negative JJ O
bacterium NN O
Bdellovibrio NNP B-Species
bacteriovorus NN I-Species
in IN O
which WDT O
endogenous JJ O
MreB2 NNP O
was VBD O
replaced VBN O
with IN O
monomeric JJ O
teal NN O
fluorescent NN O
protein NN O
( , O
mTFP NNP O
) -RRB- O
- HYPH O
labeled VBN O
MreB2 NNP O
. . O

Natural JJ O
mortality NN O
was VBD O
mainly RB O
because IN O
of IN O
raptor NN O
predation NN O
, , O
with IN O
two CD O
seasonal JJ O
peaks NNS O
in IN O
fall NN O
and CC O
spring NN O
. . O

New JJ O
contralateral JJ O
tumours NNS O
in IN O
women NNS O
with IN O
breast NN O
cancer NN O
might MD O
be VB O
generally RB O
useful JJ O
as IN O
a DT O
model NN O
for IN O
prevention NN O
, , O
as IN O
has VBZ O
been VBN O
seen VBN O
for IN O
tamoxifen NN O
. . O

1 LS O
. . O

Over IN O
the DT O
past JJ O
decade NN O
, , O
there EX O
has VBZ O
been VBN O
a DT O
substantial JJ O
increase NN O
in IN O
interest NN O
in IN O
the DT O
immune JJ O
system NN O
and CC O
the DT O
role NN O
it PRP O
plays VBZ O
in IN O
the DT O
regulation NN O
of IN O
disease NN O
susceptibility NN O
, , O
giving VBG O
rise NN O
to IN O
the DT O
field NN O
of IN O
eco NN O
- HYPH O
immunology NN O
. . O

For IN O
example NN O
, , O
information NN O
about IN O
effects NNS O
of IN O
wind NN O
on IN O
dispersal JJ O
patterns NNS O
and CC O
heterogeneities NNS O
in IN O
rates NNS O
of IN O
movement NN O
is VBZ O
critical JJ O
to IN O
predicting VBG O
future JJ O
range NN O
expansion NN O
of IN O
biological JJ O
control NN O
agents NNS O
and CC O
determining VBG O
proximity NN O
of IN O
multiple JJ O
releases NNS O
. . O

The DT O
ability NN O
to TO O
unambiguously RB O
marker VB O
classify VB O
10 CD O
- HYPH O
5 CD O
progeny NN O
as IN O
resistant JJ O
( , O
selecting VBG O
for IN O
virulence NN O
) -RRB- O
or CC O
susceptible JJ O
( , O
non RB O
- HYPH O
selecting VBG O
) -RRB- O
permitted VBD O
the DT O
genetic JJ O
mapping NN O
of IN O
the DT O
corresponding VBG O
Avr1 NNP O
gene NN O
by IN O
bulked VBN O
segregant JJ O
analysis NN O
. . O

Four CD O
nests NNS O
of IN O
Mycetagroicus NNP O
cerradensis NN O
near IN O
Uberlandia NNP O
, , O
Minas NNP O
Gerais NNP O
, , O
Brazil NNP O
were VBD O
excavated VBN O
, , O
and CC O
fungus NN O
chambers NNS O
for IN O
one CD O
were VBD O
located VBN O
at IN O
a DT O
depth NN O
of IN O
3 CD O
. . O
5 CD O
meters NNS O
. . O

By IN O
the DT O
1980s NNS O
, , O
Florida NNP B-Species
panthers NNS I-Species
( , O
Puma NNP B-Species
concolor NN I-Species
coryi NN I-Species
) , O
had VBD O
been VBN O
reduced VBN O
to IN O
a DT O
small JJ O
, , O
inbred JJ O
population NN O
that WDT O
appeared VBD O
to TO O
be VB O
on IN O
the DT O
brink NN O
of IN O
extinction NN O
. . O

Heliconius NNP O
butterflies NNS O
are VBP O
known VBN O
to TO O
maximize VB O
fitness NN O
by IN O
feeding VBG O
on IN O
pollen NN O
from IN O
Gurania NNP O
sp NNP O
. . O
and CC O
Psiguria NNP O
sp NNP O
. . O

The DT O
breeding NN O
population NN O
of IN O
the DT O
dipper NN O
does VBZ O
not RB O
seem VB O
yet RB O
to TO O
have VB O
reached VBN O
a DT O
level NN O
where WRB O
all DT O
possible JJ O
territories NNS O
in IN O
the DT O
area NN O
have VBP O
been VBN O
occupied VBN O
, , O
even RB O
after IN O
mild JJ O
winters NNS O
, , O
and CC O
the DT O
estimated VBN O
carrying VBG O
capacity NN O
is VBZ O
also RB O
decidedly RB O
lower JJR O
( : O
66 CD O
breeding NN O
pairs NNS O
) -RRB- O
than IN O
the DT O
number NN O
of IN O
available JJ O
territories NNS O
. . O

We PRP O
also RB O
need VBP O
to TO O
figure VB O
out RP O
how WRB O
best RBS O
to TO O
make VB O
safe JJ O
hygiene NN O
practices NNS O
matters NNS O
of IN O
daily JJ O
routine NN O
that WDT O
are VBP O
sustained VBN O
by IN O
social JJ O
norms NNS O
on IN O
a DT O
mass NN O
scale NN O
. . O

The DT O
protein NN O
encoded VBN O
by IN O
this DT O
gene NN O
, , O
RteC NNP O
, , O
did VBD O
not RB O
have VB O
primary JJ O
amino NN O
acid NN O
sequence NN O
homology NN O
to IN O
any DT O
known VBN O
proteins NNS O
in IN O
the DT O
databases NNS O
. . O

We PRP O
found VBD O
no DT O
interactive JJ O
effect NN O
of IN O
individual JJ O
condition NN O
and CC O
habitat NN O
quality NN O
on IN O
natal JJ O
dispersal NN O
and CC O
habitat NN O
selection NN O
. . O

We PRP O
used VBD O
light NN O
and CC O
electron NN O
microscopy NN O
to TO O
describe VB O
the DT O
isolates NNS O
as IN O
new JJ O
genera NN O
and CC O
species NNS O
Pirum NNP B-Species
gemmata NNP I-Species
and CC O
Abeoforma NNP B-Species
whisleri NNP I-Species
. . O

Our PRP$ O
data NNS O
are VBP O
consistent JJ O
with IN O
a DT O
model NN O
in IN O
which WDT O
InhA1 NNP O
protease NN O
levels NNS O
are VBP O
controlled VBN O
at IN O
the DT O
transcriptional JJ O
level NN O
by IN O
SinR NNP O
and CC O
at IN O
the DT O
posttranslational JJ O
level NN O
by IN O
camelysin NN O
. . O

2 LS O
. . O

Roots NNS O
reacted VBD O
to IN O
soil NN O
acidity NN O
when WRB O
growing VBG O
in IN O
macropores NNS O
, , O
but CC O
elongation NN O
through IN O
high JJ O
- HYPH O
strength NN O
soil NN O
was VBD O
improved VBN O
. . O

Here RB O
we PRP O
combine VBP O
the DT O
hierarchical JJ O
Bayesian JJ O
modelling NN O
approach NN O
with IN O
the DT O
state NN O
- HYPH O
space NN O
formulation NN O
to TO O
extend VB O
the DT O
scope NN O
of IN O
previously RB O
proposed VBN O
models NNS O
of IN O
population NN O
dynamics NNS O
under IN O
climatic JJ O
forcing NN O
to IN O
multi JJ O
- HYPH O
species NNS O
systems NNS O
. . O

Melting VBG O
temperature NN O
and CC O
shape NN O
of IN O
the DT O
melting NN O
peak NN O
were VBD O
analysed VBN O
for IN O
68 CD O
bp NN O
and CC O
148 CD O
bp NN O
coat NN O
protein NN O
gene NN O
amplicons NNS O
using VBG O
SYBR NNP O
( -LRB- O
R NN O
) -RRB- O
GreenER NN O
( -LRB- O
TM NN O
) -RRB- O
fluorescent NN O
dye NN O
. . O

We PRP O
describe VBP O
the DT O
microsatellite NN O
- HYPH O
associated VBN O
interspersed VBN O
nuclear JJ O
element NN O
2 CD O
( HYPH O
MINE NNP O
- HYPH O
2 CD O
) -RRB- O
, , O
that WDT O
integrates VBZ O
at IN O
consensus NN O
WTTTT NNP O
target NN O
sites NNS O
, , O
creates VBZ O
dinucleotide NN O
TT NN O
target NN O
site NN O
duplications NNS O
( , O
TSDs NNP O
) -RRB- O
, , O
and CC O
forms VBZ O
predicted VBN O
MITE NN O
- HYPH O
like JJ O
secondary JJ O
structures NNS O
; : O
a DT O
5 CD O
' '' O
subterminal JJ O
inverted JJ O
repeat NN O
( , O
SIR NN O
; : O
AGGGTTCCGTAG NNP O
) -RRB- O
that WDT O
is VBZ O
partially RB O
complementary JJ O
to IN O
a DT O
5 CD O
' '' O
inverted VBN O
repeat NN O
( , O
IR NN O
; : O
ACGAAGCCCT NNP O
) -RRB- O
and CC O
3 CD O
' '' O
- HYPH O
SIRs NNS O
( -LRB- O
TTACGGAACCCT NNP O
) -RRB- O
. . O

Other JJ O
transcripts NNS O
encoded VBD O
proteins NNS O
known VBN O
to TO O
be VB O
associated VBN O
with IN O
programmed VBN O
cell NN O
death NN O
, , O
but CC O
have VBP O
not RB O
previously RB O
been VBN O
linked VBN O
with IN O
vegetative JJ O
incompatibility NN O
. . O

The DT O
enzyme NN O
product NN O
was VBD O
analyzed VBN O
by IN O
liquid JJ O
chromatography NN O
- HYPH O
mass NN O
spectrometry NN O
( , O
LC NNP O
- HYPH O
MS NNP O
) -RRB- O
, , O
high JJ O
- HYPH O
performance NN O
liquid NN O
chromatography NN O
( , O
HPLC NNP O
) -RRB- O
, , O
nuclear JJ O
magnetic JJ O
resonance NN O
( , O
NMR NNP O
) -RRB- O
, , O
and CC O
galactosidase NN O
digestion NN O
. . O

We PRP O
experimentally RB O
removed VBD O
mothers NNS O
of IN O
independent JJ O
juvenile JJ O
brushtail NN O
possums NNS O
from IN O
the DT O
maternal JJ O
home NN O
range NN O
and CC O
examined VBD O
changes NNS O
in IN O
offspring NN O
space NN O
use NN O
with IN O
global JJ O
positioning NN O
system NN O
collars NNS O
. . O

POPs NNS O
, , O
plant NN O
organellar NN O
DNA NN O
polymerases NNS O
, , O
have VBP O
been VBN O
isolated VBN O
from IN O
various JJ O
photosynthetic JJ O
eukaryotes NNS O
. . O

While IN O
AvrRvi8 NNP O
segregated VBD O
at IN O
1 CD O
: SYM O
1 CD O
ratio NN O
, , O
the DT O
other JJ O
two CD O
Avrs NNP O
segregated VBD O
at IN O
3 CD O
: SYM O
1 CD O
ratios NNS O
. . O

We PRP O
attribute VBP O
such JJ O
developmental JJ O
changes NNS O
to IN O
increasing VBG O
distances NNS O
between IN O
xylem NN O
bundles NNS O
, , O
and CC O
larger JJR O
xylem NN O
lumen NN O
and CC O
heartwood NN O
areas NNS O
as IN O
plants NNS O
age VBP O
. . O

3 LS O
. . O

While IN O
the DT O
biology NN O
of IN O
marine JJ O
dinoflagellates NNS O
has VBZ O
been VBN O
the DT O
focus NN O
of IN O
several JJ O
recent JJ O
studies NNS O
, , O
their PRP$ O
freshwater JJ O
relatives NNS O
remain VBP O
little RB O
- HYPH O
investigated VBN O
. . O

Spider NN O
density NN O
was VBD O
not RB O
affected VBN O
by IN O
ant JJ O
colony NN O
manipulation NN O
, , O
but CC O
species NNS O
richness NN O
of IN O
spiders NNS O
responded VBD O
positively RB O
to IN O
ant JJ O
presence NN O
. . O

However RB O
, , O
the DT O
composition NN O
of IN O
other JJ O
species NNS O
did VBD O
not RB O
change VB O
in IN O
response NN O
to IN O
F NNP B-Species
. . I-Species
aquilonia NN I-Species
removal NN O
. . O

This DT O
finding NN O
offers VBZ O
hope NN O
- HYPH O
inspiring VBG O
news NN O
for IN O
conservation NN O
, , O
but CC O
should MD O
clearly RB O
be VB O
verified VBN O
by IN O
empirical JJ O
studies NNS O
across IN O
both CC O
naturally RB O
and CC O
more RBR O
recently RB O
fragmented VBN O
systems NNS O
. . O

Previously RB O
, , O
in IN O
the DT O
EHEC NNP B-Species
O157 CD I-Species
: : I-Species
H7 CD I-Species
Sakai NNP O
strain NN O
, , O
a DT O
point NN O
mutation NN O
in IN O
ureD NN O
, , O
encoding VBG O
a DT O
urease NN O
chaperone NN O
protein NN O
, , O
was VBD O
identified VBN O
, , O
resulting VBG O
in IN O
a DT O
substitution NN O
of IN O
an DT O
amber NN O
stop NN O
codon NN O
for IN O
glutamine NN O
. . O

Role NN O
of IN O
nitric JJ O
oxide NN O
in IN O
hydrogen NN O
peroxide NN O
- HYPH O
dependent JJ O
induction NN O
of IN O
abiotic JJ O
stress NN O
tolerance NN O
by IN O
brassinosteroids NNS O
in IN O
cucumber NN B-Species
. . O

Biochemical JJ O
characterization NN O
of IN O
UDP NNP O
- HYPH O
Gal NNP O
: : O
GlcNAc NNP O
- HYPH O
pyrophosphate NN O
- HYPH O
lipid NNP O
Beta NNP O
- HYPH O
1 CD O
, , O
4 CD O
- HYPH O
Galactosyltransferase NNP O
WfeD NNP O
, , O
a DT O
new JJ O
enzyme NN O
from IN O
Shigella NNP B-Species
boydii NN I-Species
type NN O
14 CD O
that WDT O
catalyzes VBZ O
the DT O
second JJ O
step NN O
in IN O
O NNP O
- HYPH O
antigen NNP O
repeating NN O
- HYPH O
unit NN O
synthesis NN O
. . O

A DT O
Gram NNP O
- HYPH O
positive JJ O
, , O
non JJ O
- HYPH O
motile NN O
, , O
coccoid NN O
- HYPH O
to IN O
rod NN O
- HYPH O
shaped JJ O
, , O
non JJ O
- HYPH O
spore NN O
- HYPH O
forming VBG O
bacterium NN O
, , O
designated VBN O
strain NN O
YM18 NNP B-Species
- HYPH I-Species
15 CD I-Species
( , O
T NNP O
) -RRB- O
, , O
was VBD O
isolated VBN O
from IN O
sea NN O
sand NN O
and CC O
studied VBD O
using VBG O
a DT O
polyphasic JJ O
taxonomic JJ O
approach NN O
. . O

Our PRP$ O
analysis NN O
revealed VBD O
a DT O
high JJ O
level NN O
of IN O
gene NN O
retention NN O
and CC O
colinearity NN O
, , O
as RB O
well RB O
as IN O
high JJ O
gene NN O
structure NN O
and CC O
sequence NN O
conservation NN O
, , O
with IN O
an DT O
average JJ O
sequence NN O
divergence NN O
of IN O
4 CD O
% NN O
for IN O
exons NNS O
. . O

Metallosphaera NNP B-Species
sedula NN I-Species
( , O
Sulfolobales NNP O
, , O
Crenarchaeota NNP O
) -RRB- O
uses VBZ O
the DT O
3 CD O
- HYPH O
hydroxypropionate NN O
/ SYM O
4 CD O
- HYPH O
hydroxybutyrate NN O
cycle NN O
for IN O
autotrophic JJ O
carbon NN O
fixation NN O
. . O

Based VBN O
on IN O
previous JJ O
experiments NNS O
, , O
we PRP O
hypothesized VBD O
that IN O
changes NNS O
to IN O
the DT O
L NNP O
. , O
crassa FW O
TFL1 NNP O
ortholog NN O
, , O
LcrTFL1 NNP O
, , O
were VBD O
important JJ O
in IN O
the DT O
evolution NN O
of IN O
rosette NN O
flowering NN O
. . O

Interestingly RB O
, , O
the DT O
spatial JJ O
patterns NNS O
of IN O
ABeta NNP O
deposition NN O
in IN O
the DT O
brain NN O
might MD O
correlate VB O
with IN O
increased VBN O
aerobic JJ O
glycolysis NN O
in IN O
those DT O
regions NNS O
. . O

Drivers NNS O
of IN O
age NN O
- HYPH O
specific JJ O
survival NN O
in IN O
a DT O
long RB O
- HYPH O
lived VBN O
seabird NN O
: : O
contributions NNS O
of IN O
observed JJ O
and CC O
hidden VBN O
sources NNS O
of IN O
heterogeneity NN O
. . O

Application NN O
of IN O
MboII NNP O
PRA NNP O
to IN O
samples NNS O
from IN O
241 CD O
Korean JJ O
patients NNS O
with IN O
chronic JJ O
liver NN O
diseases NNS O
of IN O
different JJ O
clinical JJ O
stages NNS O
confirmed VBD O
that IN O
F141L NN O
mutants NNS O
were VBD O
significantly RB O
related VBN O
to IN O
HCC NNP O
, , O
even RB O
in IN O
comparison NN O
to IN O
liver NN O
cirrhosis NN O
( , O
HCC NNP O
, , O
26 CD O
. . O
3 CD O
% NN O
of IN O
patients NNS O
, , O
or CC O
26 CD O
/ SYM O
99 CD O
; : O
liver NN O
cirrhosis NN O
, , O
3 CD O
. . O
8 CD O
% NN O
of IN O
patients NNS O
, , O
or CC O
2 CD O
/ SYM O
52 CD O
; : O
P NN O
= SYM O
0 CD O
. . O
1 CD O
) -RRB- O
. . O

Many JJ O
of IN O
these DT O
bioinformatically RB O
newly RB O
discovered VBN O
secondary JJ O
metabolism NN O
gene NN O
clusters NNS O
are VBP O
silent JJ O
under IN O
standard JJ O
laboratory NN O
conditions NNS O
. . O

is VBZ O
proposed VBN O
. . O

Venosa NNP O
function NN O
was VBD O
examined VBN O
using VBG O
in IN O
situ NN O
hybridization NN O
and CC O
transient JJ O
overexpression NN O
. . O

Furthermore RB O
, , O
the DT O
elephants NNS O
exhibited VBD O
sexual JJ O
habitat NN O
segregation NN O
, , O
mainly RB O
in IN O
relation NN O
to IN O
vegetation NN O
characteristics NNS O
. . O

However RB O
, , O
the DT O
AL9 NNP O
epitope NN O
was VBD O
generally RB O
shown VBN O
to TO O
be VB O
a DT O
weak JJ O
agonist NN O
. . O

We PRP O
demonstrated VBD O
that IN O
CaCdc42 NNP O
, , O
CaRho3 NNP O
and CC O
CaRho4 NNP O
proteins NNS O
had VBD O
an DT O
intrinsic JJ O
GTPase NNP O
activity NN O
and CC O
that IN O
CaRgd1 NNP O
stimulates VBZ O
in FW O
vitro FW O
GTP NNP O
hydrolysis NN O
of IN O
these DT O
GTPases NNS O
. . O

Aged JJ O
animals NNS O
receiving VBG O
VRP NNP O
( , O
3000 CD O
) -RRB- O
- HYPH O
based VBN O
vaccines NNS O
were VBD O
protected VBN O
from IN O
SARS NNP B-Species
- HYPH I-Species
CoV NNP I-Species
disease NN O
, , O
while IN O
animals NNS O
receiving VBG O
the DT O
VRP NNP O
( , O
3014 CD O
) -RRB- O
- HYPH O
based VBN O
vaccines NNS O
were VBD O
not RB O
. . O

Hygiene NN O
: : O
new JJ O
hopes NNS O
, , O
new JJ O
horizons NNS O
. . O

Retroviral JJ B-Species
Gag NNP O
proteins NNS O
contain VBP O
short JJ O
late JJ O
- HYPH O
domain NN O
motifs NNS O
that WDT O
recruit VBP O
cellular JJ O
ESCRT NNP O
pathway NN O
proteins NNS O
to TO O
facilitate VB O
virus NN O
budding NN O
. . O

Contrasting VBG O
cascade NN O
effects NNS O
of IN O
carnivores NNS O
on IN O
plant NN O
fitness NN O
: : O
a DT O
meta JJ O
- HYPH O
analysis NN O
. . O

Food NN O
chain NN O
length NN O
and CC O
omnivory NN O
determine VBP O
the DT O
stability NN O
of IN O
a DT O
marine JJ O
subtidal JJ O
food NN O
web NN O
. . O

8 LS O
. . O

Molecular JJ O
cloning NN O
and CC O
characterization NN O
of IN O
a DT O
thioredoxin NN O
peroxidase NN O
gene NN O
from IN O
Apis NNP B-Species
cerana NN I-Species
cerana NN I-Species
. . O

Moreover RB O
, , O
IDH1 NNP O
and CC O
IDH2 NNP O
mutations NNS O
are VBP O
a DT O
major JJ O
prognostic JJ O
marker NN O
for IN O
overall JJ O
and CC O
progression NN O
- HYPH O
free JJ O
survival NN O
in IN O
grade NN O
II CD O
- HYPH O
IV NN O
gliomas NNS O
. . O

The DT O
importance NN O
of IN O
marine NN O
vs IN O
. , O
human NN B-Species
- HYPH O
induced VBN O
subsidies NNS O
in IN O
the DT O
maintenance NN O
of IN O
an DT O
expanding VBG O
mesocarnivore NN O
in IN O
the DT O
arctic JJ O
tundra NN O
. . O

Expression NN O
of IN O
M NNP B-Species
. , I-Species
tuberculosis NN I-Species
moaX NN O
also RB O
restored VBD O
MoCo NNP O
biosynthesis NN O
in IN O
M NNP B-Species
. . I-Species
smegmatis NN I-Species
mutants NNS O
lacking VBG O
moaD2 NN O
, , O
moaE2 NN O
, , O
or CC O
both DT O
, , O
thus RB O
identifying VBG O
MoaX NNP O
as IN O
a DT O
fused VBN O
MPT NNP O
synthase NN O
. . O

Here RB O
, , O
we PRP O
consider VBP O
insights NNS O
into IN O
the DT O
pathogenesis NN O
of IN O
childhood NN O
arterial JJ O
ischaemic JJ O
stroke NN O
and CC O
cerebral JJ O
arteriopathy NN O
, , O
provided VBN O
by IN O
current JJ O
knowledge NN O
of IN O
Mendelian JJ O
diseases NNS O
that WDT O
are VBP O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
these DT O
conditions NNS O
. . O

Arabidopsis NNP B-Species
thaliana NN I-Species
populations NNS O
show VBP O
clinal JJ O
variation NN O
in IN O
a DT O
climatic JJ O
gradient NN O
associated VBN O
with IN O
altitude NN O
. . O

Furthermore RB O
, , O
host NN O
- HYPH O
plant NN O
preference NN O
experiments NNS O
confirmed VBD O
that IN O
silencing VBG O
PsOr1 NNP O
by IN O
RNAi NNP O
treatment NN O
impaired VBD O
the DT O
host NN O
- HYPH O
plant NN O
preferences NNS O
of IN O
P NN B-Species
. . I-Species
striolata NN I-Species
for IN O
cruciferous JJ O
vegetables NNS O
. . O

Therefore RB O
, , O
we PRP O
named VBD O
NCU00749 NNP O
as IN O
conidiation NN O
at IN O
high JJ O
carbon NN O
dioxide NN O
- HYPH O
1 CD O
( HYPH O
chc NN O
- HYPH O
1 CD O
) -RRB- O
. . O

Growth NN O
- HYPH O
mediated VBN O
stress NN O
escape NN O
: : O
convergence NN O
of IN O
signal NN O
transduction NN O
pathways NNS O
activated VBN O
upon IN O
exposure NN O
to IN O
two CD O
different JJ O
environmental JJ O
stresses NNS O
. . O

4 LS O
. . O

We PRP O
describe VBP O
transcriptional JJ O
analysis NN O
of IN O
two CD O
exceptionally RB O
divergent JJ O
homologues NNS O
( , O
Ra86 CD O
) -RRB- O
of IN O
the DT O
Bm86 NNP O
gut NN O
antigen NN O
from IN O
Rhipicephalus NNP B-Species
appendiculatus NN I-Species
. . O

In IN O
a DT O
recent JJ O
effort NN O
to TO O
find VB O
the DT O
phylogenetic JJ O
positions NNS O
of IN O
the DT O
less RBS O
well RB O
- HYPH O
known VBN O
sorocarpic JJ O
protists NNS O
considered VBN O
to TO O
be VB O
& CC O
quot NN O
; , O
cellular JJ O
slime NN O
molds NNS O
, , O
& CC O
quot NN O
; , O
or CC O
aggregatively RB O
fruiting VBG O
amoebae NN O
, , O
we PRP O
isolated VBD O
C NNP B-Species
. . I-Species
protea NN I-Species
and CC O
sequenced VBD O
the DT O
nuclear NN O
- HYPH O
encoded VBN O
small JJ O
subunit NN O
ribosomal NN O
RNA NNP O
gene NN O
from IN O
four CD O
samples NNS O
collected VBN O
from IN O
cattle NNS B-Species
farms NNS O
in IN O
the DT O
central JJ O
USA NNP O
. . O

We PRP O
focused VBD O
on IN O
Lrp NNP O
from IN O
Proteus NNP B-Species
mirabilis NN I-Species
and CC O
E NN B-Species
. . I-Species
coli NN I-Species
, , O
orthologs NNS O
with IN O
98 CD O
% NN O
identity NN O
overall JJ O
and CC O
identical JJ O
helix NN O
- HYPH O
turn NN O
- HYPH O
helix NN O
motifs NNS O
, , O
for IN O
which WDT O
a DT O
previous JJ O
study NN O
nevertheless RB O
found VBD O
functional JJ O
differences NNS O
. . O

( , O
the DT O
presumed JJ O
area NN O
of IN O
endemism NN O
of IN O
annual JJ O
sunflower NN O
species NNS O
in IN O
the DT O
genus NN O
Helianthus NNP O
) -RRB- O
. . O

On IN O
11 CD O
June NNP O
2009 CD O
, , O
the DT O
World NNP O
Health NNP O
Organization NNP O
( -LRB- O
WHO NNP O
) -RRB- O
declared VBD O
that IN O
the DT O
outbreaks NNS O
caused VBN O
by IN O
novel JJ O
swine NN B-Species
- HYPH I-Species
origin NN I-Species
influenza NN I-Species
A NNP I-Species
( , I-Species
H1N1 NNP I-Species
) -RRB- I-Species
virus NN I-Species
had VBD O
reached VBN O
pandemic JJ O
proportions NNS O
. . O

Children NNS O
with IN O
cancer NN O
are VBP O
increasingly RB O
benefiting VBG O
from IN O
new JJ O
treatment NN O
strategies NNS O
and CC O
advances NNS O
in IN O
supportive JJ O
care NN O
, , O
as IN O
shown VBN O
by IN O
improvements NNS O
in IN O
both CC O
survival NN O
and CC O
quality NN O
- HYPH O
of IN O
- HYPH O
life NN O
. . O

An DT O
analytical JJ O
model NN O
of IN O
non JJ O
- HYPH O
photorespiratory JJ O
CO2release NN O
in IN O
the DT O
light NN O
and CC O
dark JJ O
in IN O
leaves NNS O
of IN O
C3species NNS O
based VBN O
on IN O
stoichiometric JJ O
flux NN O
balance NN O
. . O

The DT O
map NN O
position NN O
of IN O
12 CD O
avirulence NN O
traits NNS O
was VBD O
determined VBN O
: : O
eight CD O
avirulence NN O
genes NNS O
mapped VBN O
into IN O
two CD O
separate JJ O
clusters NNS O
( , O
1 CD O
: : O
AvrVdg2 NNP O
, , O
AvrVv1 NNP O
, , O
AvrVu1 NNP O
, , O
AvrVrjrd NNP O
; : O
and CC O
2 CD O
: : O
AvrVu2 NNP O
, , O
AvrVh3 NNP O
. , O
2 CD O
, , O
AvrVs1 NNP O
, , O
AvrVu4 NNP O
) -RRB- O
, , O
while IN O
four CD O
avirulence NN O
genes NNS O
( , O
AvrRvi8 NNP O
, , O
AvrVv2 NNP O
, , O
AvrVt57 NNP O
and CC O
AvrVsv NNP O
) -RRB- O
mapped VBN O
to IN O
different JJ O
LGs NNS O
. . O

3 LS O
. . O

A DT O
simple JJ O
, , O
programme NN O
- HYPH O
relevant JJ O
stillbirth NN O
classification NN O
that WDT O
can MD O
be VB O
used VBN O
with IN O
verbal JJ O
autopsy NN O
would MD O
provide VB O
a DT O
basis NN O
for IN O
comparable JJ O
national JJ O
estimates NNS O
. . O

Harvest NN O
mortality NN O
increased VBD O
linearly RB O
from IN O
0 CD O
* SYM O
8 CD O
+ CD O
/ SYM O
- HYPH O
0 CD O
* SYM O
5 CD O
, , O
0 CD O
* NFP O
27 CD O
+ CD O
/ SYM O
- HYPH O
0 CD O
* SYM O
5 CD O
and CC O
0 CD O
* SYM O
42 CD O
+ NN O
/ SYM O
- HYPH O
0 CD O
* SYM O
6 CD O
from IN O
0 CD O
% NN O
to TO O
30 CD O
% NN O
harvest NN O
, , O
whereas IN O
natural JJ O
mortality NN O
was VBD O
0 CD O
* SYM O
38 CD O
+ CD O
/ SYM O
- HYPH O
0 CD O
* SYM O
8 CD O
, , O
0 CD O
* SYM O
25 CD O
+ CD O
/ SYM O
- HYPH O
0 CD O
* SYM O
5 CD O
and CC O
0 CD O
* SYM O
28 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
* SYM O
6 CD O
under IN O
the DT O
same JJ O
treatments NNS O
. . O

Individual JJ O
specialization NN O
may MD O
be VB O
an DT O
important JJ O
feature NN O
of IN O
trophic JJ O
dynamics NNS O
of IN O
highly RB O
mobile JJ O
marine JJ O
top JJ O
predators NNS O
and CC O
should MD O
be VB O
explicitly RB O
considered VBN O
in IN O
studies NNS O
of IN O
marine JJ O
food NN O
webs NNS O
and CC O
the DT O
ecological JJ O
role NN O
of IN O
top JJ O
predators NNS O
. . O

The DT O
strain NN O
produced VBD O
greyish JJ O
white JJ O
aerial JJ O
mycelia NN O
, , O
lactic NN O
acid NN O
and CC O
a DT O
large JJ O
quantity NN O
of IN O
double JJ O
diamond NN O
- HYPH O
shaped JJ O
crystals NNS O
on IN O
potato NN B-Species
dextrose NN O
agar NN O
and CC O
yeast NN B-Species
extract NN O
- HYPH O
malt NN O
extract NN O
agar NN O
. . O

Disruption NN O
of IN O
lysosomal JJ O
membranes NNS O
and CC O
the DT O
release NN O
of IN O
cathepsin NN O
B NN O
into IN O
the DT O
cytoplasm NN O
are VBP O
required VBN O
for IN O
Ad NNP B-Species
- HYPH O
induced VBN O
NLRP3 NNP O
activation NN O
. . O

Plasma NN O
membrane NN O
Ca NN O
^ NN O
2 CD O
+ NN O
transporters NNS O
mediate VBP O
virus NN O
- HYPH O
induced VBN O
acquired VBN O
resistance NN O
to IN O
oxidative JJ O
stress NN O
. . O

Thus RB O
, , O
the DT O
present JJ O
study NN O
assesses VBZ O
general JJ O
responses NNS O
of IN O
functional JJ O
and CC O
taxonomic JJ O
components NNS O
of IN O
biodiversity NN O
to IN O
a DT O
specific JJ O
human NN B-Species
- HYPH O
driven VBN O
process NN O
. . O

The DT O
cyanobacterium NN O
Synechocystis NNP B-Species
sp NN I-Species
. . I-Species
strain NN I-Species
PCC NNP I-Species
6803 CD I-Species
encodes VBZ O
nine CD O
sigma NN O
factors NNS O
, , O
all DT O
belonging VBG O
to IN O
the DT O
sigma NN O
( HYPH O
70 CD O
) -RRB- O
family NN O
. . O

Although IN O
the DT O
general JJ O
ecological JJ O
conditions NNS O
that WDT O
lead VBP O
to IN O
dispersal NN O
have VBP O
been VBN O
well RB O
studied VBN O
, , O
the DT O
causes NNS O
of IN O
individual JJ O
variation NN O
in IN O
dispersal NN O
are VBP O
less RBR O
well RB O
understood VBN O
. . O

In IN O
this DT O
first JJ O
paper NN O
of IN O
The DT O
Lancet NNP O
' POS O
s '' O
Stillbirths NNPS O
Series NNP O
we PRP O
explore VBP O
the DT O
present JJ O
status NN O
of IN O
stillbirths NNS O
in IN O
the DT O
world NN O
- : O
from IN O
global JJ O
health NN O
policy NN O
to IN O
a DT O
survey NN O
of IN O
community NN O
perceptions NNS O
in IN O
135 CD O
countries NNS O
. . O

They PRP O
contain VBP O
a DT O
large JJ O
, , O
double JJ O
stranded VBN O
DNA NNP O
genome NN O
of IN O
120 CD O
- SYM O
190 CD O
kbp NN O
. . O

Though IN O
some DT O
of IN O
the DT O
larvae NN O
that WDT O
were VBD O
prevented VBN O
from IN O
post NN O
- HYPH O
egression NN O
feeding NN O
did VBD O
undergo VB O
cocoon NN O
formation NN O
, , O
pupation NN O
, , O
and CC O
adult NN O
emergence NN O
they PRP O
were VBD O
inferior JJ O
in IN O
terms NNS O
of IN O
size NN O
, , O
body NN O
mass NN O
, , O
and CC O
survival NN O
to IN O
those DT O
that WDT O
developed VBD O
from IN O
larvae NN O
allowed VBN O
to IN O
feeding VBG O
after IN O
egression NN O
. . O

Complete JJ O
genome NN O
sequence NN O
of IN O
Corynebacterium NNP B-Species
pseudotuberculosis NN I-Species
I19 NNP I-Species
, , O
a DT O
strain NN O
isolated VBN O
from IN O
a DT O
cow NN B-Species
in IN O
Israel NNP O
with IN O
bovine JJ O
mastitis NN O
. . O

This DT O
information NN O
correlates VBZ O
with IN O
immunohistochemical JJ O
analysis NN O
, , O
where WRB O
positive JJ O
staining NN O
of IN O
the DT O
yeasts NNS O
' POS O
cell NN O
wall NN O
was VBD O
observed VBN O
. . O

Together RB O
with IN O
previously RB O
reported VBN O
data NNS O
, , O
these DT O
findings NNS O
show VBP O
that IN O
transposable JJ O
elements NNS O
disrupt VBP O
eight CD O
of IN O
12 CD O
cadherin NN O
alleles NNS O
linked VBN O
with IN O
resistance NN O
to IN O
Cry1Ac NNP O
in IN O
three CD O
lepidopteran JJ O
species NNS O
, , O
indicating VBG O
that IN O
the DT O
cadherin NN O
locus NN O
is VBZ O
a DT O
common JJ O
target NN O
for IN O
disruption NN O
by IN O
transposable JJ O
elements NNS O
. . O

During IN O
a DT O
culture NN O
- HYPH O
based VBN O
survey NN O
of IN O
opisthokonts NNS O
living VBG O
in IN O
marine JJ O
invertebrate NN O
digestive JJ O
tracts NNS O
, , O
we PRP O
isolated VBD O
two CD O
new JJ O
eukaryotes NNS O
that WDT O
differed VBD O
from IN O
described VBN O
taxa NN O
by IN O
more JJR O
than IN O
10 CD O
% NN O
in IN O
their PRP$ O
small JJ O
subunit NN O
ribosomal JJ O
DNA NNP O
sequences NNS O
. . O

Data NNS O
from IN O
this DT O
assessment NN O
of IN O
the DT O
short JJ O
term NN O
redistribution NN O
pattern NN O
of IN O
P NN B-Species
. . I-Species
tricuspis NN I-Species
could MD O
be VB O
useful JJ O
in IN O
determining VBG O
proximity NN O
of IN O
releases NNS O
of IN O
this DT O
, , O
and CC O
other JJ O
fire NN O
ant CC O
parasitoids NNS O
. . O

1 LS O
. . O

Expression NN O
of IN O
diverse JJ O
midgut NN O
serine NN O
proteinases NNS O
in IN O
the DT O
sericigenous JJ O
Lepidoptera NNP O
Antheraea NNP B-Species
assamensis NN I-Species
( -LRB- O
Helfer NNP O
) -RRB- O
is VBZ O
influenced VBN O
by IN O
choice NN O
of IN O
host NN O
plant NN O
species NNS O
. . O

The DT O
development NN O
of IN O
this DT O
rapid JJ O
assay NN O
should MD O
aid VB O
in IN O
quarantine NN O
and CC O
post NN O
- HYPH O
border NN O
surveys NNS O
for IN O
regulatory JJ O
agencies NNS O
. . O

The DT O
mitogen NN O
- HYPH O
activated VBN O
protein NN O
kinase NN O
( -LRB- O
MAPK NNP O
) -RRB- O
pathways NNS O
control VBP O
diverse JJ O
cellular JJ O
functions NNS O
in IN O
pathogenic JJ O
fungi NN O
, , O
including VBG O
sexual JJ O
differentiation NN O
, , O
stress NN O
response NN O
, , O
and CC O
maintenance NN O
of IN O
cell NN O
wall NN O
integrity NN O
. . O

The DT O
results NNS O
obtained VBN O
from IN O
the DT O
multiplex JJ O
RT NNP O
- HYPH O
PCR NNP O
for IN O
a DT O
total NN O
of IN O
67 CD O
NDV NNP B-Species
field NN O
isolates NNS O
obtained VBN O
in IN O
2009 CD O
were VBD O
consistent JJ O
with IN O
those DT O
obtained VBN O
by IN O
nucleotide NN O
sequencing NN O
and CC O
phylogenetic JJ O
analysis NN O
. . O

We PRP O
also RB O
assessed VBD O
the DT O
phenotypic JJ O
contribution NN O
to IN O
this DT O
rate NN O
, , O
by IN O
using VBG O
radio NN O
telemetry NN O
to TO O
make VB O
repeated VBN O
measurements NNS O
of IN O
interclutch JJ O
intervals NNS O
for IN O
individual JJ O
green JJ B-Species
turtles NNS I-Species
( , O
Chelonia NNP B-Species
mydas NNP I-Species
) -RRB- O
. . O

New JJ O
driver NN O
mutations NNS O
in IN O
non JJ O
- HYPH O
small JJ O
- HYPH O
cell NN O
lung NN O
cancer NN O
. . O

With IN O
habitat NN O
fragmentation NN O
spreading VBG O
around IN O
the DT O
world NN O
, , O
there EX O
is VBZ O
a DT O
pressing VBG O
need NN O
to TO O
understand VB O
its PRP$ O
impacts NNS O
on IN O
local JJ O
food NN O
webs NNS O
. . O

Warming VBG O
of IN O
local JJ O
waters NNS O
during IN O
the DT O
winter NN O
was VBD O
associated VBN O
with IN O
decline NN O
in IN O
ocean NN O
productivity NN O
in IN O
the DT O
current JJ O
year NN O
and CC O
the DT O
following JJ O
year NN O
, , O
consistent JJ O
with IN O
ENSO NNP O
impacts NNS O
on IN O
breeding NN O
parameters NNS O
being VBG O
mediated VBN O
by IN O
effects NNS O
on IN O
local JJ O
productivity NN O
and CC O
prey NN O
availability NN O
. . O

Strain NNP O
V2M29 NNP O
( -LRB- O
T NNP O
) -RRB- O
contained VBN O
MK NNP O
- HYPH O
8 CD O
( SYM O
H NNP O
( , O
4 CD O
) -RRB- O
) -RRB- O
as IN O
the DT O
major JJ O
respiratory JJ O
quinone NN O
and CC O
iso NN O
- HYPH O
C NN O
( : O
15 CD O
: SYM O
0 CD O
) SYM O
( : O
20 CD O
. . O
9 CD O
% NN O
) -RRB- O
, , O
iso CD O
- HYPH O
C NN O
( : O
16 CD O
: : O
0 CD O
) SYM O
( : O
18 CD O
. . O
5 CD O
% NN O
) -RRB- O
, , O
C NN O
( : O
17 CD O
: : O
1 CD O
) SYM O
omega8c NN O
( : O
16 CD O
. . O
7 CD O
% NN O
) -RRB- O
and CC O
10 CD O
- HYPH O
methyl NN O
- HYPH O
C NN O
( : O
17 CD O
: : O
0 CD O
) -RRB- O
( : O
9 CD O
. . O
2 CD O
% NN O
) -RRB- O
as IN O
the DT O
major JJ O
cellular JJ O
fatty NN O
acids NNS O
. . O

The DT O
genetic JJ O
basis NN O
for IN O
3 CD O
- HYPH O
ADON NNP O
and CC O
15 CD O
- HYPH O
ADON NN O
trichothecene NN O
chemotypes NNS O
in IN O
Fusarium NNP O
. . O

2 LS O
. . O

A DT O
few JJ O
diapausing JJ O
females NNS O
( : O
- : O
10 CD O
% NN O
) -RRB- O
will MD O
take VB O
a DT O
blood NN O
meal NN O
when WRB O
placed VBN O
in IN O
close JJ O
proximity NN O
to IN O
a DT O
host NN O
, , O
but CC O
much JJ O
of IN O
the DT O
blood NN O
is VBZ O
ejected VBN O
and CC O
such JJ O
meals NNS O
do VBP O
not RB O
result VB O
in IN O
mature JJ O
eggs NNS O
. . O

We PRP O
investigated VBD O
changes NNS O
in IN O
the DT O
Arabidopsis NNP B-Species
transcriptome NN O
following VBG O
a DT O
light JJ O
- HYPH O
dark JJ O
transition NN O
and CC O
the DT O
response NN O
to IN O
wounding VBG O
either CC O
in IN O
the DT O
light NN O
or CC O
in IN O
the DT O
dark NN O
. . O

Thus RB O
, , O
the DT O
development NN O
of IN O
a DT O
vaccine NN O
that WDT O
is VBZ O
effective JJ O
in IN O
multiple JJ O
animal NN O
species NNS O
is VBZ O
urgently RB O
needed VBN O
. . O

The DT O
size NN O
of IN O
the DT O
territory NN O
actually RB O
occupied VBN O
may MD O
be VB O
limited JJ O
during IN O
dry JJ O
weather NN O
, , O
resulting VBG O
in IN O
very RB O
large JJ O
no DT O
- HYPH O
ants NNS O
' POS O
zones NNS O
. . O

Mutshinda NNP O
, , O
O NNP O
' '' O
Hara NNP O
& CC O
amp NNP O
; : O
Woiwod NNP O
( , O
2011 CD O
) -RRB- O
used VBD O
light NN O
- HYPH O
trapping VBG O
data NNS O
for IN O
Lepidoptera NNP O
( , O
moths NNS O
) -RRB- O
to TO O
examine VB O
population NN O
responses NNS O
to IN O
intraspecific JJ O
effects NNS O
and CC O
effects NNS O
of IN O
winter NN O
rainfall NN O
and CC O
temperature NN O
. . O

However RB O
, , O
re IN O
- HYPH O
infections NNS O
and CC O
new JJ O
introductions NNS O
of IN O
virus NN O
into IN O
farms NNS O
require VBP O
a DT O
confirmatory JJ O
virological JJ O
test NN O
to TO O
verify VB O
the DT O
positive JJ O
test NN O
results NNS O
of IN O
single JJ O
animals NNS O
and CC O
ultimately RB O
to TO O
investigate VB O
disease NN O
transmission NN O
. . O

Identification NN O
and CC O
expression NN O
analysis NN O
of IN O
the DT O
genes NNS O
involved VBN O
in IN O
serotonin NN O
biosynthesis NN O
and CC O
transduction NN O
in IN O
the DT O
field NN O
cricket NN O
Gryllus NNP B-Species
bimaculatus NN I-Species
. . O

Factors NNS O
of IN O
susceptibility NN O
of IN O
human JJ B-Species
myiasis NNS O
caused VBN O
by IN O
the DT O
New NNP B-Species
World NNP I-Species
screw NN I-Species
- HYPH I-Species
worm NN I-Species
, , O
Cochliomyia NNP B-Species
hominivorax NN I-Species
in IN O
Sao NNP O
Gonsigmaalo NNP O
, , O
Rio NNP O
de NNP O
Janeiro NNP O
, , O
Brazil NNP O
. . O

Serinicoccus NNP B-Species
profundi FW I-Species
sp FW I-Species
. . I-Species
nov -RRB- I-Species
. . I-Species
, , O
an DT O
actinomycete NN O
isolated VBN O
from IN O
deep JJ O
- HYPH O
sea NN O
sediment NN O
, , O
and CC O
emended VBN O
description NN O
of IN O
the DT O
genus NN O
Serinicoccus NNP O
. . O

The DT O
results NNS O
of IN O
DNA NN O
- HYPH O
DNA NN O
hybridization NN O
and CC O
physiological JJ O
and CC O
biochemical JJ O
tests NNS O
allowed VBD O
genotypic JJ O
and CC O
phenotypic JJ O
differentiation NN O
of IN O
strains NNS O
T NNP B-Species
- HYPH I-Species
11 CD I-Species
( HYPH O
T NNP O
) -RRB- O
and CC O
E NN B-Species
- HYPH I-Species
112 CD I-Species
( HYPH O
T NNP O
) -RRB- O
from IN O
Anoxybacillus NNP O
species NNS O
with IN O
validly RB O
published VBN O
names NNS O
. . O

Members NNS O
of IN O
this DT O
family NN O
, , O
collectively RB O
, , O
respond VBP O
to IN O
a DT O
wide JJ O
range NN O
of IN O
amino NN O
acids NNS O
as IN O
coregulators NNS O
. . O

2 LS O
. . O

The DT O
expansion NN O
and CC O
contraction NN O
of IN O
peptide NN O
repeats NNS O
represent VBP O
a DT O
novel JJ O
mechanism NN O
for IN O
modulating VBG O
adhesive JJ O
capacity NN O
, , O
potentially RB O
balancing VBG O
the DT O
need NN O
of IN O
the DT O
organism NN O
to TO O
colonize VB O
the DT O
genital JJ O
and CC O
respiratory JJ O
tracts NNS O
with IN O
the DT O
ability NN O
to TO O
attach VB O
to IN O
alternative JJ O
substrates NNS O
, , O
disperse VB O
within IN O
the DT O
host NN O
, , O
or CC O
evade VB O
the DT O
host NN O
immune JJ O
system NN O
. . O

The DT O
niche NN O
expansion NN O
hypothesis NN O
argues VBZ O
that IN O
a DT O
positive JJ O
relationship NN O
is VBZ O
expected VBN O
to TO O
exist VB O
between IN O
insular JJ O
body NN O
size NN O
and CC O
prey NN O
size NN O
, , O
which WDT O
varies VBZ O
in IN O
response NN O
to IN O
extinction NN O
due IN O
to IN O
small JJ O
or CC O
large JJ O
competitors NNS O
. . O

Finally RB O
, , O
we PRP O
propose VBP O
a DT O
model NN O
for IN O
the DT O
succession NN O
of IN O
organellar JJ O
DNA NN O
polymerases NNS O
. . O

Effect NN O
of IN O
soil NN O
acidity NN O
, , O
soil NN O
strength NN O
and CC O
macropores NNS O
on IN O
root NN O
growth NN O
and CC O
morphology NN O
of IN O
perennial JJ O
grass NN O
species NNS O
differing VBG O
in IN O
acid NN O
- HYPH O
soil NN O
resistance NN O
. . O

This DT O
suggests VBZ O
these DT O
inclusions NNS O
originated VBD O
from IN O
early JJ O
Cretaceous JJ O
plant NN O
resins NNS O
, , O
probably RB O
secreted VBN O
with IN O
the DT O
resin NN O
by IN O
trees NNS O
that WDT O
did VBD O
not RB O
survive VB O
after IN O
the DT O
Cretaceous NNP O
( , O
such JJ O
as IN O
the DT O
Cheirolepidiaceae NNP O
) -RRB- O
. . O

To IN O
date NN O
the DT O
use NN O
of IN O
fluorescent JJ O
reporter NN O
constructs NNS O
in IN O
analysing VBG O
membrane NN O
transport NN O
has VBZ O
been VBN O
limited VBN O
primarily RB O
to IN O
cell NN O
lines NNS O
expressing VBG O
stably RB O
either CC O
the DT O
tagged VBN O
transporter NN O
protein NN O
( , O
s FW O
) -RRB- O
or CC O
markers NNS O
to TO O
identify VB O
lineages NNS O
of IN O
interest NN O
. . O

Previously RB O
, , O
we PRP O
purified VBD O
the DT O
native JJ O
POP NN O
of IN O
Cyanidioschyzon NNP B-Species
merolae NN I-Species
( , O
CmPOP NNP O
) -RRB- O
from IN O
whole JJ O
cellular JJ O
extracts NNS O
and CC O
showed VBD O
that IN O
CmPOP NNP O
has VBZ O
DNA NN O
polymerase NN O
activity NN O
with IN O
a DT O
high JJ O
processivity NN O
and CC O
a DT O
3 CD O
' '' O
- HYPH O
5 CD O
' '' O
exonuclease JJ O
activity NN O
, , O
and CC O
its PRP$ O
expression NN O
is VBZ O
related VBN O
to IN O
cell NN O
proliferation NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
different JJ O
DMI NNP O
fungicides NNS O
target VBP O
different JJ O
CYP51 NN O
proteins NNS O
in IN O
F NNP B-Species
. . I-Species
graminearum NN I-Species
and CC O
that IN O
a DT O
mixture NN O
of IN O
DMI NNP O
fungicides NNS O
can MD O
result VB O
in IN O
synergistic JJ O
effects NNS O
. . O

Alzheimer NNP O
' POS O
s POS O
disease NN O
is VBZ O
a DT O
neurodegenerative JJ O
disease NN O
that WDT O
is VBZ O
imposing VBG O
an DT O
increasing VBG O
burden NN O
on IN O
society NN O
, , O
and CC O
is VBZ O
the DT O
leading VBG O
cause NN O
of IN O
senile JJ O
dementia NN O
worldwide RB O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
therapeutic JJ O
upregulation NN O
of IN O
SIRT1 NNP O
might MD O
provide VB O
opportunities NNS O
for IN O
the DT O
amelioration NN O
of IN O
Alzheimer NNP O
' POS O
s NN O
- HYPH O
disease NN O
- HYPH O
type NN O
neuropathology NN O
through IN O
inhibition NN O
of IN O
amyloidogenesis NN O
. . O

ParE VB O
- HYPH O
mediated VBN O
DNA NNP O
damage NN O
activates VBZ O
the DT O
V NN B-Species
. . I-Species
cholerae NN I-Species
SOS NN O
response NN O
, , O
which WDT O
in IN O
turn NN O
likely RB O
accounts VBZ O
for IN O
ParE NNP O
' POS O
s NNS O
inhibition NN O
of IN O
cell NN O
division NN O
. . O

This DT O
study NN O
shows VBZ O
the DT O
utility NN O
of IN O
selectively RB O
purifying VBG O
human JJ B-Species
polyclonal JJ O
antibodies NNS O
from IN O
ascitic JJ O
fluid NN O
. . O

The DT O
N NNP O
- HYPH O
terminal JJ O
domain NN O
is VBZ O
required VBN O
for IN O
stable JJ O
peptidoglycan NN O
binding NN O
, , O
while IN O
the DT O
C NNP O
- HYPH O
terminal JJ O
domain NN O
is VBZ O
the DT O
region NN O
of IN O
peptidoglycan NN O
hydrolytic JJ O
activity NN O
. . O

These DT O
challenges NNS O
include VBP O
an DT O
imbalance NN O
in IN O
resource NN O
allocation NN O
, , O
inadequate JJ O
physical JJ O
access NN O
to IN O
high JJ O
- HYPH O
quality NN O
health NN O
services NNS O
and CC O
human JJ B-Species
resources NNS O
for IN O
health NN O
, , O
high JJ O
out IN O
- HYPH O
of IN O
- HYPH O
pocket NN O
health NN O
expenditures NNS O
, , O
inflation NN O
in IN O
health NN O
spending NN O
, , O
and CC O
behavioural JJ O
factors NNS O
that WDT O
affect VBP O
the DT O
demand NN O
for IN O
appropriate JJ O
health NN O
care NN O
. . O

Redshanks NNS B-Species
most RBS O
commonly RB O
formed VBD O
group NN O
sizes NNS O
that WDT O
gained VBD O
the DT O
maximum JJ O
individual JJ O
predation NN O
risk NN O
reduction NN O
. . O

This DT O
model NN O
assumes VBZ O
that IN O
Z NN O
rings NNS O
formed VBN O
at IN O
different JJ O
cellular JJ O
locations NNS O
have VBP O
equal JJ O
sensitivity NN O
to IN O
MinC NNP O
/ SYM O
MinD NNP O
in IN O
the DT O
absence NN O
of IN O
MinE NNP O
. . O

The DT O
presence NN O
of IN O
a DT O
tumour NN O
( , O
usually RB O
an DT O
ovarian JJ O
teratoma NN O
) , O
is VBZ O
dependent JJ O
on IN O
age NN O
, , O
sex NN O
, , O
and CC O
ethnicity NN O
, , O
being VBG O
more RBR O
frequent JJ O
in IN O
women NNS O
older JJR O
than IN O
18 CD O
years NNS O
, , O
and CC O
slightly RB O
more RBR O
predominant JJ O
in IN O
black JJ O
women NNS O
than IN O
it PRP O
is VBZ O
in IN O
white JJ O
women NNS O
. . O

Although IN O
similar JJ O
to IN O
other JJ O
chlamydiae NN O
, , O
these DT O
transporters NNS O
show VBP O
distinct JJ O
and CC O
unique JJ O
adaptations NNS O
with IN O
respect NN O
to IN O
substrate NN O
specificities NNS O
and CC O
mode NN O
of IN O
transport NN O
. . O

The DT O
spirochaete NN O
required VBD O
sulfide NN O
in IN O
the DT O
growth NN O
medium NN O
and CC O
was VBD O
able JJ O
to TO O
oxidize VB O
it PRP O
non RB O
- HYPH O
enzymically RB O
to IN O
elemental JJ O
sulfur NN O
via IN O
the DT O
interaction NN O
of IN O
H NN O
( SYM O
2 CD O
) SYM O
O NN O
( HYPH O
2 CD O
) -RRB- O
with IN O
sulfide NN O
and CC O
deposit VB O
it PRP O
in IN O
the DT O
periplasmic JJ O
space NN O
. . O

To TO O
identify VB O
maize NN B-Species
genes NNS O
that WDT O
are VBP O
functionally RB O
involved VBN O
in IN O
the DT O
interaction NN O
with IN O
U NNP B-Species
. . I-Species
maydis NNS I-Species
, , O
we PRP O
adapted VBD O
a DT O
virus NN O
- HYPH O
induced VBN O
gene NN O
silencing NN O
( , O
VIGS NNP O
) -RRB- O
system NN O
based VBN O
on IN O
the DT O
brome NN O
mosaic JJ O
virus NN O
( , O
BMV NNP O
) -RRB- O
for IN O
maize NN B-Species
. . O

No DT O
non AFX O
- HYPH O
specific JJ O
PCR NNP O
product NN O
was VBD O
found VBN O
when WRB O
using VBG O
genomic JJ O
DNA NN O
of IN O
infected VBN O
flies NNS O
as IN O
template NN O
DNA NNP O
. . O

Biomarkers NNS O
to TO O
detect VB O
these DT O
histopathological JJ O
changes NNS O
in IN O
life NN O
are VBP O
becoming VBG O
increasingly RB O
important JJ O
with IN O
the DT O
development NN O
of IN O
disease NN O
- HYPH O
modifying VBG O
drugs NNS O
. . O

* NFP O
Biosynthesis NN O
of IN O
the DT O
sesquiterpene NN O
lactone NN O
and CC O
potent JJ O
antimalarial JJ O
drug NN O
artemisinin NN O
occurs VBZ O
in IN O
glandular JJ O
trichomes NNS O
of IN O
Artemisia NNP B-Species
annua NN I-Species
plants NNS I-Species
and CC O
is VBZ O
subjected VBN O
to IN O
a DT O
strict JJ O
network NN O
of IN O
developmental JJ O
and CC O
other JJ O
regulatory JJ O
cues NNS O
. . O

Comparing VBG O
expression NN O
profiles NNS O
in IN O
developing VBG O
buds NNS O
under IN O
long JJ O
day NN O
and CC O
short JJ O
day NN O
conditions NNS O
identified VBD O
possible JJ O
photoperiod NN O
- HYPH O
responsive JJ O
genes NNS O
that WDT O
may MD O
not RB O
be VB O
essential JJ O
for IN O
bud NN O
development NN O
. . O

Dikaryotic JJ O
growth NN O
also RB O
requires VBZ O
tightly RB O
controlled VBN O
nuclear JJ O
migration NN O
to TO O
ensure VB O
faithful JJ O
replication NN O
and CC O
dissemination NN O
of IN O
genetic JJ O
material NN O
to TO O
spore VB O
progeny NN O
. . O

However RB O
, , O
cocoons NNS O
showed VBD O
higher JJR O
emission NN O
for IN O
almost RB O
all DT O
compounds NNS O
, , O
including VBG O
m61 NN O
( , O
acetic JJ O
acid NN O
) -RRB- O
. . O

The DT O
morphology NN O
and CC O
infraciliature NN O
of IN O
four CD O
marine JJ O
cyrtophorid NN O
ciliates NNS O
isolated VBN O
from IN O
Qingdao NNP O
, , O
China NNP O
, , O
were VBD O
investigated VBN O
. . O

* NFP O
We PRP O
propose VBP O
that IN O
the DT O
root NN O
cell NN O
cytoplasm NN O
of IN O
Cd NN O
- HYPH O
overaccumulating VBG O
rice NN B-Species
plants NNS I-Species
has VBZ O
more JJR O
Cd NN O
available JJ O
for IN O
loading VBG O
into IN O
the DT O
xylem NN O
as IN O
a DT O
result NN O
of IN O
the DT O
lack NN O
of IN O
OsHMA3 NNP O
- HYPH O
mediated VBN O
transportation NN O
of IN O
Cd NN O
to IN O
the DT O
vacuoles NNS O
. . O

Gastric JJ O
and CC O
oesophageal JJ O
cancers NNS O
are VBP O
among IN O
the DT O
leading VBG O
causes NNS O
of IN O
cancer NN O
- HYPH O
related VBN O
death NN O
worldwide RB O
. . O

Detection NN O
of IN O
infectious JJ B-Species
myonecrosis NN I-Species
virus NN I-Species
using VBG O
monoclonal JJ O
antibody NN O
specific JJ O
to IN O
N NNP O
and CC O
C NN O
fragments NNS O
of IN O
the DT O
capsid JJ O
protein NN O
expressed VBN O
heterologously RB O
. . O

In IN O
mammals NNS O
, , O
the DT O
nuclear JJ O
receptors NNS O
constitutive JJ O
androstane NN O
receptor NN O
( , O
CAR NN O
) -RRB- O
and CC O
pregnane JJ O
X NN O
receptor NN O
( -LRB- O
PXR NN O
) -RRB- O
have VBP O
been VBN O
identified VBN O
as IN O
key JJ O
transcription NN O
factors NNS O
regulating VBG O
PB NN O
induced VBN O
transcription NN O
of IN O
xenobiotic JJ O
responsive JJ O
genes NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
urbanization NN O
and CC O
behavioural JJ O
adaptation NN O
can MD O
modify VB O
the DT O
role NN O
of IN O
climate NN O
on IN O
bird NN O
ranges NNS O
and CC O
should MD O
be VB O
included VBN O
in IN O
future JJ O
analyses NNS O
of IN O
range NN O
shifts NNS O
because IN O
of IN O
climate NN O
change NN O
. . O

7 LS O
. . O

First RB O
we PRP O
agreed VBD O
that IN O
the DT O
term NN O
chemoprevention NN O
is VBZ O
inappropriate JJ O
and CC O
suggested VBD O
that IN O
the DT O
term NN O
preventive JJ O
therapy NN O
better RBR O
represents VBZ O
this DT O
feature NN O
of IN O
management NN O
. . O

Possible JJ O
contributions NNS O
of IN O
TERMINAL JJ O
FLOWER NN O
1 CD O
to IN O
the DT O
evolution NN O
of IN O
rosette NN O
flowering NN O
in IN O
Leavenworthia NNP O
( -LRB- O
Brassicaceae NNP O
) -RRB- O
. . O

To IN O
date NN O
, , O
few JJ O
studies NNS O
have VBP O
examined VBN O
the DT O
effects NNS O
of IN O
landscape NN O
context NN O
on IN O
multiple JJ O
local JJ O
communities NNS O
in IN O
a DT O
quantitative JJ O
, , O
spatially RB O
realistic JJ O
setting NN O
. . O

Surprisingly RB O
, , O
MreB2 NNP O
- HYPH O
mTFP NNP O
localized VBD O
to IN O
the DT O
interface NN O
between IN O
the DT O
spiral JJ O
nucleoid NN O
and CC O
the DT O
cytoplasm NN O
, , O
suggesting VBG O
an DT O
intimate JJ O
connection NN O
between IN O
nucleoid JJ O
architecture NN O
and CC O
MreB NNP O
arrangement NN O
. . O

6 LS O
. . O

Like IN O
microcin NN O
B17 NN O
and CC O
streptolysin NN O
S NN O
, , O
the DT O
TOMM NN O
from IN O
B NN B-Species
. . I-Species
amyloliquefaciens NNS I-Species
FZB42 NNP I-Species
undergoes VBZ O
extensive JJ O
posttranslational JJ O
modification NN O
to TO O
become VB O
a DT O
bioactive JJ O
natural JJ O
product NN O
. . O

Morphological JJ O
and CC O
molecular JJ O
phylogeny NN O
of IN O
dileptid JJ O
and CC O
tracheliid NN O
ciliates NNS O
: : O
Resolution NN O
at IN O
the DT O
base NN O
of IN O
the DT O
class NN O
Litostomatea NNP O
( , O
Ciliophora NNP O
, , O
Rhynchostomatia NNP O
) -RRB- O
. . O

Many JJ O
plant NN O
species NNS O
are VBP O
susceptible JJ O
to IN O
high JJ O
- HYPH O
temperature NN O
( -LRB- O
HT NN O
) -RRB- O
injury NN O
during IN O
reproductive JJ O
development NN O
. . O

Furthermore RB O
, , O
the DT O
automatic JJ O
, , O
functional JJ O
, , O
and CC O
manual JJ O
annotations NNS O
were VBD O
attained VBN O
with IN O
the DT O
use NN O
of IN O
several JJ O
algorithms NNS O
in IN O
a DT O
multistep NN O
process NN O
. . O

These DT O
patterns NNS O
are VBP O
consistent JJ O
with IN O
neutral JJ O
theory NN O
. . O

The DT O
DeltanbtE NNP O
mutant NN O
was VBD O
found VBN O
to TO O
be VB O
impaired VBN O
in IN O
cytotoxicity NN O
against IN O
J774A NNP O
. , O
1 CD O
cells NNS O
, , O
suggesting VBG O
that IN O
nocobactin NN O
null NNP O
production NN O
is VBZ O
required VBN O
for IN O
virulence NN O
of IN O
N NNP B-Species
. . I-Species
farcinica NN I-Species
. . O

Genetic JJ O
analysis NN O
of IN O
B55alpha NNP O
/ SYM O
Cdc55 NN O
protein NN O
phosphatase NN O
2A NN O
subunits NNS O
: : O
association NN O
with IN O
the DT O
adenovirus NN O
E4orf4 NNP O
protein NN O
. . O

The DT O
theoretical JJ O
concept NN O
of IN O
intraguild JJ O
predation NN O
( -LRB- O
IGP NNP O
) -RRB- O
combines VBZ O
these DT O
key JJ O
interactions NNS O
in IN O
a DT O
single JJ O
community NN O
module NN O
. . O

The DT O
18S NNP O
rRNA NNP O
gene NN O
sequence NN O
of IN O
P NN O
. . O
singularis NN O
sp NN O
. . O
nov NN O
. . O

Cells NNS O
of IN O
strain NN O
V2M29 NNP O
( -LRB- O
T NNP O
) -RRB- O
were VBD O
Gram NNP O
- HYPH O
positive JJ O
, , O
rod NN O
- HYPH O
shaped JJ O
( , O
0 CD O
. . O
5 CD O
- HYPH O
0 CD O
. . O
8 CD O
mum NN O
in IN O
diameter NN O
and CC O
1 CD O
. . O
5 CD O
- SYM O
2 CD O
. . O
0 CD O
mum NN O
in IN O
length NN O
) -RRB- O
, , O
strictly RB O
aerobic JJ O
and CC O
non AFX O
- HYPH O
motile NN O
. . O

These DT O
results NNS O
were VBD O
validated VBN O
by IN O
a DT O
recombinant JJ O
immunoblotting NN O
assay NN O
( , O
two CD O
were VBD O
negative JJ O
, , O
and CC O
one CD O
was VBD O
indeterminate JJ O
) -RRB- O
. . O

Identification NN O
of IN O
binary JJ O
interactions NNS O
between IN O
human JJ B-Species
cytomegalovirus NN I-Species
virion NN O
proteins NNS O
. . O

The DT O
PRP8 NNP O
intein NN O
, , O
the DT O
most RBS O
widespread JJ O
among IN O
fungi NN O
, , O
occurs VBZ O
in IN O
important JJ O
pathogens NNS O
such JJ O
as IN O
Histoplasma NNP B-Species
capsulatum NN I-Species
and CC O
Paracoccidioides NNP B-Species
brasiliensis NN I-Species
, , O
from IN O
the DT O
Ajellomycetaceae NNP O
family NN O
. . O

Ultimately RB O
, , O
further JJ O
analysis NN O
into IN O
both DT O
aspects NNS O
is VBZ O
necessary JJ O
if IN O
any DT O
progress NN O
is VBZ O
to TO O
be VB O
made VBN O
. . O

Moreover RB O
, , O
several JJ O
regulators NNS O
that WDT O
control VBP O
nleA NN O
( SYM O
4795 CD O
) -RRB- O
expression NN O
were VBD O
identified VBN O
. . O

Several JJ O
genes NNS O
putatively RB O
associated VBN O
with IN O
hormone NN O
signalling NN O
were VBD O
identified VBN O
, , O
and CC O
hormone NN O
quantification NN O
revealed VBD O
distinct JJ O
profiles NNS O
for IN O
abscisic JJ O
acid NN O
( -LRB- O
ABA NN O
) -RRB- O
, , O
cytokinins NNS O
, , O
auxin NN O
and CC O
their PRP$ O
metabolites NNS O
that WDT O
can MD O
be VB O
related VBN O
to IN O
morphological JJ O
changes NNS O
to IN O
the DT O
bud NN O
. . O

We PRP O
evaluated VBD O
the DT O
transcriptional JJ O
expression NN O
and CC O
metabolic JJ O
performance NN O
of IN O
ortholog NN O
substitution NN O
complementing VBG O
a DT O
Sinorhizobium NNP B-Species
meliloti NN I-Species
argC NN O
mutant NN O
with IN O
argC NN O
from IN O
Rhizobiales NNP O
( , O
Agrobacterium NN B-Species
tumefaciens NNS I-Species
, , O
Rhizobium NNP B-Species
etli NNP I-Species
, , O
and CC O
Mesorhizobium NN B-Species
loti NN I-Species
) -RRB- O
. . O

Large JJ O
amounts NNS O
of IN O
germplasm NN O
of IN O
entomopathogenic JJ O
fungi NN O
, , O
fundamentally RB O
B NN B-Species
. . I-Species
bassiana NN I-Species
and CC O
M NNP B-Species
. . I-Species
anisopliae NN I-Species
, , O
exist VBP O
in IN O
the DT O
habitats NNS O
sampled VBN O
; : O
pathogenicity NN O
varied VBD O
among IN O
strains NNS O
, , O
and CC O
some DT O
strains NNS O
possessed VBD O
significant JJ O
virulence NN O
. . O

Transcriptional JJ O
analysis NN O
revealed VBD O
that IN O
the DT O
expression NN O
of IN O
comYA NN O
and CC O
comX NN O
was VBD O
dramatically RB O
altered VBN O
in IN O
the DT O
Delta835np NNP O
and CC O
Delta836polar NNP O
mutants NNS O
. . O

This DT O
is VBZ O
a DT O
prerequisite NN O
for IN O
accurately RB O
calculating VBG O
the DT O
critical JJ O
upper JJ O
and CC O
lower JJR O
thermal JJ O
limits NNS O
. . O

All DT O
parents NNS O
should MD O
be VB O
offered VBN O
a DT O
thorough JJ O
investigation NN O
including VBG O
a DT O
high JJ O
- HYPH O
quality NN O
autopsy NN O
and CC O
placental JJ O
histopathology NN O
. . O

We PRP O
tested VBD O
whether IN O
DVM NNP O
of IN O
freshwater NN O
zooplanktivorous JJ O
fish NN O
( , O
Coregonus NNP O
spp NN O
. . O
) -RRB- O
resembles VBZ O
partial JJ O
migrations NNS O
. . O

16S NNP O
rRNA NNP O
gene NN O
sequence NN O
analysis NN O
assigned VBD O
this DT O
actinomycete NN O
to IN O
the DT O
family NN O
Nocardioidaceae NNP O
, , O
but CC O
its PRP$ O
16S NNP O
rRNA NNP O
gene NN O
sequence NN O
shared VBD O
no DT O
more JJR O
than IN O
95 CD O
. . O
5 CD O
% NN O
similarity NN O
with IN O
those DT O
of IN O
other JJ O
members NNS O
of IN O
the DT O
family NN O
. . O

A DT O
wider JJR O
exploration NN O
of IN O
these DT O
effects NNS O
is VBZ O
now RB O
needed VBN O
. . O

These DT O
proteins NNS O
are VBP O
similar JJ O
in IN O
sequence NN O
to IN O
mastigoneme NN O
proteins NNS O
in IN O
other JJ O
stramenopile NN O
protists NNS O
including VBG O
the DT O
algae NN O
Ochromonas NNP B-Species
danica NN I-Species
, , O
Aureococcus NNP B-Species
anophagefferens NNS I-Species
and CC O
Scytosiphon NNP B-Species
lomentaria NN I-Species
and CC O
the DT O
diatoms NNS O
Thalassiosira NNP B-Species
pseudonana NN I-Species
and CC O
T NNP B-Species
. . I-Species
weissflogii NNP I-Species
. . O

1 LS O
. . O

We PRP O
therefore RB O
intended VBD O
to TO O
elucidate VB O
the DT O
underlying VBG O
mechanism NN O
connecting VBG O
light JJ O
response NN O
and CC O
heterotrimeric JJ O
G NN O
- HYPH O
protein NN O
signaling NN O
. . O

However RB O
, , O
virus NN O
isolation NN O
remains VBZ O
the DT O
gold JJ O
standard NN O
for IN O
diagnosis NN O
of IN O
field NN O
outbreaks NNS O
. . O

Overall RB O
, , O
contrasts NNS O
against IN O
null JJ O
models NNS O
indicate VBP O
that IN O
regional JJ O
factors NNS O
determine VBP O
low JJ O
levels NNS O
of IN O
FR NN O
and CC O
redundancy NN O
for IN O
the DT O
vertebrate JJ O
predator NN O
assemblage NN O
studied VBN O
, , O
while IN O
recorded VBN O
linear JJ O
FRSR NN O
indicates VBZ O
proportional JJ O
responses NNS O
of IN O
the DT O
two CD O
biodiversity NN O
components NNS O
to IN O
the DT O
structure NN O
of IN O
forest NN O
fragments NNS O
. . O

More RBR O
importantly RB O
, , O
both CC O
hESC NNP O
- HYPH O
and CC O
iPSC NNP O
- HYPH O
derived VBN O
NK NNP O
cells NNS O
are VBP O
able JJ O
to TO O
inhibit VB O
HIV NNP B-Species
- HYPH I-Species
1 CD I-Species
NL4 NNP O
- HYPH O
3 CD O
infection NN O
of IN O
CEM NNP O
- HYPH O
GFP NNP O
cells NNS O
. . O

2 LS O
. . O

The DT O
cell NN O
- HYPH O
wall NN O
peptidoglycan NN O
type NN O
was VBD O
A4Beta NN O
and CC O
ornithine NN O
was VBD O
the DT O
diagnostic JJ O
diamino NN O
acid NN O
. . O

Prey NNP O
, , O
predators NNS O
, , O
parasites NNS O
: : O
intraguild JJ O
predation NN O
or CC O
simpler JJR O
community NN O
modules NNS O
in IN O
disguise NN O
? . O

We PRP O
present VBP O
some DT O
longer JJR O
term NN O
considerations NNS O
of IN O
ventricular JJ O
septal NN O
defects NNS O
in IN O
adolescents NNS O
and CC O
adults NNS O
, , O
with IN O
particular JJ O
emphasis NN O
on IN O
patients NNS O
with IN O
raised VBN O
pulmonary JJ O
vascular JJ O
resistance NN O
and CC O
Eisenmenger NNP O
' POS O
s NNS O
syndrome NN O
. . O

VV NNP O
caused VBD O
lethal JJ O
disease NN O
in IN O
all DT O
mouse NN B-Species
strains NNS O
. . O

A DT O
new JJ O
method NN O
for IN O
detection NN O
of IN O
pandemic JJ B-Species
influenza NN I-Species
virus NN I-Species
using VBG O
High NNP O
Resolution NNP O
Melting NNP O
analysis NN O
of IN O
the DT O
neuraminidase NN O
gene NN O
. . O

In IN O
this DT O
first JJ O
paper NN O
in IN O
the DT O
Lancet NNP O
Series NNP O
on IN O
health NN O
in IN O
southeast JJ O
Asia NNP O
, , O
we PRP O
present VBP O
an DT O
overview NN O
of IN O
key JJ O
demographic JJ O
and CC O
epidemiological JJ O
changes NNS O
in IN O
the DT O
region NN O
, , O
explore VBP O
challenges NNS O
facing VBG O
health NN O
systems NNS O
, , O
and CC O
draw VBP O
attention NN O
to IN O
the DT O
potential NN O
for IN O
regional JJ O
collaboration NN O
in IN O
health NN O
. . O

Overall RB O
, , O
individual JJ O
trees NNS O
with IN O
EFNs NNPS O
experienced VBD O
higher JJR O
ant CC O
and CC O
other JJ O
( , O
nonant JJ O
) -RRB- O
natural JJ O
enemy NN O
densities NNS O
and CC O
subsequent JJ O
pest NN O
reductions NNS O
, , O
as IN O
compared VBN O
with IN O
trees NNS O
without IN O
EFNs NNS O
. . O

The DT O
RCMV NNP B-Species
miRNAs NNS O
are VBP O
distributed VBN O
across IN O
the DT O
viral JJ O
genome NN O
on IN O
both CC O
the DT O
positive JJ O
and CC O
negative JJ O
strands NNS O
, , O
with IN O
clusters NNS O
of IN O
miRNAs NNS O
at IN O
a DT O
number NN O
of IN O
locations NNS O
, , O
including VBG O
near IN O
viral JJ O
genes NNS O
r1 CD O
and CC O
r111 CD O
. . O

Using VBG O
chromatin NN O
immunoprecipitation NN O
, , O
we PRP O
found VBD O
that IN O
DnaD NNP O
and CC O
DnaB NNP O
, , O
but CC O
not RB O
the DT O
replicative JJ O
helicase NN O
, , O
are VBP O
associated VBN O
with IN O
many JJ O
of IN O
the DT O
chromosomal JJ O
regions NNS O
bound VBN O
by IN O
DnaA NNP O
in IN O
Bacillus NNP B-Species
subtilis NNS I-Species
. . O

The DT O
16S NNP O
rRNA NNP O
gene NN O
sequence NN O
of IN O
strain NN O
F44 CD O
- HYPH O
8 CD O
( SYM O
T NNP O
) -RRB- O
showed VBD O
highest JJS O
similarities NNS O
to IN O
those DT O
of IN O
Flavobacterium NN B-Species
frigoris NN I-Species
LMG NNP I-Species
21922 CD I-Species
( SYM I-Species
T NNP I-Species
) -RRB- I-Species
( : O
93 CD O
. . O
3 CD O
% NN O
) -RRB- O
, , O
Flavobacterium NN B-Species
terrae NN I-Species
R2A1 NNP I-Species
- HYPH I-Species
13 CD I-Species
( SYM I-Species
T NNP I-Species
) -RRB- I-Species
( : O
93 CD O
. . O
3 CD O
% NN O
) -RRB- O
and CC O
Flavobacterium NN B-Species
gelidilacus NNP I-Species
LMG NNP I-Species
21477 CD I-Species
( SYM I-Species
T NNP I-Species
) -RRB- I-Species
( : O
93 CD O
. . O
1 CD O
% NN O
) -RRB- O
. . O

Our PRP$ O
results NNS O
provide VBP O
rare JJ O
empirical JJ O
evidence NN O
for IN O
the DT O
demographic JJ O
consequences NNS O
of IN O
biased VBN O
adult NN O
sex NN O
ratios NNS O
in IN O
the DT O
wild NN O
and CC O
particularly RB O
in IN O
a DT O
conservation NN O
context NN O
. . O

In IN O
insects NNS O
, , O
much RB O
less RBR O
is VBZ O
known VBN O
about IN O
the DT O
transcription NN O
factors NNS O
involved VBN O
in IN O
regulating VBG O
PB NN O
induced VBN O
transcription NN O
, , O
although IN O
CAR NNP O
and CC O
PXR NNP O
have VBP O
a DT O
single JJ O
orthologue NN O
hormone NN O
receptor NN O
- HYPH O
like JJ O
in IN O
96 CD O
( SYM O
HR96 CD O
) -RRB- O
in IN O
Drosophila NNP B-Species
melanogaster NN I-Species
. . O

Identification NN O
of IN O
ways NNS O
to TO O
reduce VB O
maternal JJ O
overweight NN O
and CC O
obesity NN O
is VBZ O
a DT O
high JJ O
priority NN O
for IN O
high JJ O
- HYPH O
income NN O
countries NNS O
. . O

Predator NN O
effects NNS O
were VBD O
positive JJ O
for IN O
plants NNS O
which WDT O
offered VBD O
rewards NNS O
( : O
e LS O
. . O
g LS O
. . O
extrafloral JJ O
nectaries NNS O
) -RRB- O
and CC O
negative JJ O
for IN O
plants NNS O
which WDT O
lacked VBD O
any DT O
attractors NNS O
. . O

Phenotypic JJ O
and CC O
real JJ O
- HYPH O
time NN O
quantitative JJ O
PCR NNP O
( -LRB- O
RT NNP O
- HYPH O
qPCR NNP O
) -RRB- O
analyses NNS O
of IN O
a DT O
PA14 NNP O
cbrB NN O
mutant NN O
suggested VBD O
that IN O
CbrA NNP O
may MD O
be VB O
modulating VBG O
swarming NN O
, , O
biofilm NN O
formation NN O
, , O
and CC O
cytotoxicity NN O
via IN O
CbrB NNP O
and CC O
that IN O
the DT O
CrcZ NNP O
small JJ O
RNA NNP O
is VBZ O
likely JJ O
downstream JJ O
of IN O
this DT O
two CD O
- HYPH O
component NN O
regulator NN O
. . O

Molecular JJ O
diagnostic JJ O
tests NNS O
have VBP O
greatly RB O
increased VBN O
our PRP$ O
understanding NN O
of IN O
the DT O
role NN O
of IN O
viruses NNS O
in IN O
pneumonia NN O
, , O
and CC O
findings NNS O
indicate VBP O
that IN O
the DT O
incidence NN O
of IN O
viral JJ O
pneumonia NN O
has VBZ O
been VBN O
underestimated VBN O
. . O

Thus RB O
, , O
a DT O
very RB O
novel JJ O
relationship NN O
for IN O
protists NNS O
is VBZ O
demonstrated VBN O
, , O
one CD O
in IN O
which WDT O
parasite NN O
and CC O
host NN O
simultaneously RB O
enter VBP O
dormancy NN O
, , O
emerging VBG O
months NNS O
later RB O
to TO O
propagate VB O
both DT O
species NNS O
. . O

Knowledge NN O
of IN O
causes NNS O
and CC O
feasible JJ O
solutions NNS O
for IN O
prevention NN O
is VBZ O
key JJ O
to IN O
health NN O
professionals NNS O
' POS O
priorities NNS O
, , O
to IN O
which WDT O
this DT O
Stillbirths NNPS O
Series NNP O
paper NN O
aims VBZ O
to TO O
contribute VB O
. . O

Haemosporidian JJ O
lineage NN O
beta NN O
diversity NN O
among IN O
nine CD O
islands NNS O
was VBD O
assessed VBN O
using VBG O
the DT O
Chao NNP O
- HYPH O
Jaccard NNP O
, , O
Chao NNP O
- HYPH O
Sorensen NNP O
and CC O
Morisita NNP O
- HYPH O
Horn NNP O
indices NNS O
of IN O
community NN O
similarity NN O
. . O

These DT O
observations NNS O
indicate VBP O
that IN O
Phr1p NNP O
plays VBZ O
a DT O
crucial JJ O
role NN O
in IN O
hyphal NN O
wall NN O
formation NN O
, , O
a DT O
highly RB O
regulated VBN O
process NN O
on IN O
which WDT O
morphogenesis NN O
and CC O
virulence NN O
rely VBP O
. . O

Divergently RB O
transcribed VBN O
from IN O
yqjH NNP O
is VBZ O
the DT O
yqjI NN O
gene NN O
, , O
which WDT O
encodes VBZ O
a DT O
novel JJ O
member NN O
of IN O
the DT O
winged VBN O
- HYPH O
helix NN O
family NN O
of IN O
transcriptional JJ O
regulators NNS O
and CC O
also RB O
contains VBZ O
an DT O
N NNP O
- HYPH O
terminal JJ O
extension NN O
similar JJ O
to IN O
the DT O
Ni NNP O
( HYPH O
2 CD O
+ SYM O
) NFP O
- HYPH O
binding VBG O
C NN O
- HYPH O
terminal JJ O
tail NN O
of IN O
SlyD NNP O
. . O

Four CD O
planktonic JJ O
species NNS O
of IN O
Difflugia NNP O
co NN O
- HYPH O
occurring VBG O
in IN O
a DT O
south JJ O
Chinese JJ O
reservoir NN O
were VBD O
found VBN O
to TO O
be VB O
carnivorous JJ O
, , O
but CC O
the DT O
diet NN O
was VBD O
widest JJS O
in IN O
the DT O
largest JJS O
species NN O
( , O
D NN O
. . O
tuberspinifera NN O
) -RRB- O
and CC O
narrowest JJS O
in IN O
the DT O
smallest JJS O
( , O
D NN O
. . O
hydrostatica NN O
) -RRB- O
. . O

Suppression NN O
of IN O
respiration NN O
is VBZ O
governed VBN O
largely RB O
by IN O
photosynthetic JJ O
adenylate NN O
balance NN O
, , O
although IN O
photorespiratory JJ O
NADH NNP O
may MD O
contribute VB O
at IN O
sub NN O
- HYPH O
saturating VBG O
light NN O
. . O

Plant NN O
adaptive JJ O
responses NNS O
were VBD O
assessed VBN O
by IN O
the DT O
combined VBN O
application NN O
of IN O
a DT O
range NN O
of IN O
electrophysiological JJ O
( , O
non JJ O
- HYPH O
invasive JJ O
microelectrode NN O
ion NN O
flux NN O
measurements NNS O
) -RRB- O
, , O
biochemical NN O
( , O
Ca NN O
^ SYM O
2 CD O
+ SYM O
- HYPH O
and CC O
H NN O
+ SYM O
- HYPH O
ATPase NN O
activity NN O
) -RRB- O
, , O
imaging NN O
( , O
fluorescence NN O
lifetime NN O
imaging NN O
measurements NNS O
of IN O
changes NNS O
in IN O
intracellular JJ O
Ca NN O
^ SYM O
2 CD O
+ SYM O
concentrations NNS O
) -RRB- O
, , O
pharmacological JJ O
and CC O
cytological JJ O
transmission NN O
electrone NN O
microscopy NN O
techniques NNS O
. . O

Strategies NNS O
that WDT O
foster VBP O
greater JJR O
patient JJ O
adherence NN O
are VBP O
also RB O
identified VBN O
. . O

We PRP O
report VBP O
here RB O
the DT O
characterization NN O
of IN O
UreA NNP O
, , O
a DT O
high JJ O
- HYPH O
affinity NN O
urea NN O
/ SYM O
H NN O
+ CC O
symporter NN O
of IN O
Aspergillus NNP B-Species
nidulans NNS I-Species
. . O

Antigen NN O
- HYPH O
specific JJ O
CD8 NNP O
( -LRB- O
+ NFP O
) -RRB- O
T NN O
- HYPH O
lymphocyte NN O
responses NNS O
elicited VBN O
by IN O
these DT O
rAd NNP O
vectors NNS O
were VBD O
significantly RB O
diminished VBN O
in IN O
MyD88 NNP O
( : O
- HYPH O
/ SYM O
- : O
) -RRB- O
mice NNS O
but CC O
not RB O
in IN O
TRIF NNP O
( : O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
or CC O
TLR3 CD O
( SYM O
- HYPH O
/ SYM O
- HYPH O
) -RRB- O
mice NNS O
, , O
suggesting VBG O
the DT O
importance NN O
of IN O
MyD88 NNP O
- HYPH O
dependent JJ O
TLR NNP O
signaling NN O
. . O

In IN O
addition NN O
, , O
strains NNS B-Species
with IN I-Species
the DT I-Species
pga1 NN I-Species
( -LRB- I-Species
G42R NNP I-Species
) -RRB- I-Species
allele NN I-Species
were VBD O
able JJ O
to TO O
bypass VB O
the DT O
carbon NN O
source NN O
( , O
glucose NN O
or CC O
sucrose NN O
) -RRB- O
requirement NN O
for IN O
germination NN O
in IN O
about RB O
64 CD O
% NN O
of IN O
conidia NN O
. . O

The DT O
equivalence NN O
between IN O
the DT O
original JJ O
and CC O
simplified JJ O
community NN O
module NN O
makes VBZ O
it PRP O
possible JJ O
to TO O
take VB O
advantage NN O
from IN O
already RB O
existing JJ O
insights NNS O
. . O

The DT O
projectin JJ O
PEVK NNP O
domains NNS O
of IN O
diverse JJ O
insects NNS O
are VBP O
highly RB O
divergent JJ O
compared VBN O
with IN O
an DT O
otherwise RB O
conserved VBN O
protein NN O
organization NN O
. . O

Third RB O
, , O
the DT O
sequence NN O
was VBD O
shortened VBN O
or CC O
extended VBN O
with IN O
residues NNS O
compatible JJ O
with IN O
helix NN O
formation NN O
. . O

Amyotrophic JJ O
lateral JJ O
sclerosis NN O
( -LRB- O
ALS NNP O
) -RRB- O
is VBZ O
an DT O
idiopathic JJ O
, , O
fatal JJ O
neurodegenerative JJ O
disease NN O
of IN O
the DT O
human JJ B-Species
motor NN O
system NN O
. . O

Infestations NNS O
of IN O
house NN B-Species
flies NNS I-Species
, , O
Musca NNP B-Species
domestica NN I-Species
L NNP O
. . O
, , O
are VBP O
a DT O
continual JJ O
problem NN O
around IN O
poultry NN O
establishments NNS O
. . O

Development NN O
and CC O
validation NN O
of IN O
a DT O
lateral JJ O
flow NN O
immunoassay NN O
using VBG O
colloidal JJ O
gold NN O
for IN O
the DT O
identification NN O
of IN O
serotype NN O
- HYPH O
specific JJ O
foot NN B-Species
- HYPH I-Species
and CC I-Species
- HYPH I-Species
mouth NN I-Species
disease NN I-Species
virus NN I-Species
O NN I-Species
, , O
A NNP B-Species
and CC O
Asia NNP B-Species
1 CD I-Species
. . O

Functional JJ O
and CC O
phylogenetic JJ O
analysis NN O
of IN O
ureD NN O
in IN O
Shiga NNP O
toxin NN O
- HYPH O
producing VBG O
Escherichia NNP B-Species
coli NN I-Species
. . O

In IN O
addition NN O
, , O
antibodies NNS O
and CC O
memory NN O
lymphocytes NNS O
established VBN O
in IN O
the DT O
lungs NNS O
following VBG O
vaccination NN O
were VBD O
required VBN O
for IN O
protection NN O
against IN O
lethal JJ O
challenge NN O
with IN O
homologous JJ O
and CC O
heterologous JJ O
H5N1 NNP B-Species
viruses NNS I-Species
. . O

The DT O
2005 CD O
American NNP O
Thoracic NNP O
Society NNP O
and CC O
Infectious NNP O
Disease NNP O
Society NNP O
of IN O
America NNP O
' POS O
s POS O
guidelines NNS O
for IN O
pneumonia NN O
introduced VBD O
the DT O
new JJ O
category NN O
of IN O
health NN O
- HYPH O
care NN O
- HYPH O
associated VBN O
pneumonia NN O
, , O
which WDT O
increased VBD O
the DT O
number NN O
of IN O
people NNS O
to TO O
whom WP O
the DT O
guidelines NNS O
for IN O
multidrug NN O
- HYPH O
resistant JJ O
pathogens NNS O
applied VBD O
. . O

* NFP O
A DT O
greater JJR O
understanding NN O
of IN O
the DT O
reproductive JJ O
mechanisms NNS O
that WDT O
exist VBP O
in IN O
Tuber NNP O
spp NNP O
. , O
allows VBZ O
for IN O
optimization NN O
of IN O
truffle NN O
plantation NN O
management NN O
strategies NNS O
. . O

We PRP O
found VBD O
two CD O
groups NNS O
of IN O
sequences NNS O
clustering VBG O
within IN O
the DT O
order NN O
Suessiales NNP O
, , O
known VBN O
for IN O
its PRP$ O
symbiotic JJ O
relationships NNS O
with IN O
various JJ O
invertebrates NNS O
. . O

Then RB O
the DT O
cells NNS O
were VBD O
observed VBN O
using VBG O
transmission NN O
electron NN O
microscopy NN O
. . O

Odontoglossum NNP B-Species
ringspot NN I-Species
virus NN I-Species
( , O
ORSV NNP B-Species
) -RRB- O
infects VBZ O
numerous JJ O
commercially RB O
important JJ O
orchids NNS O
and CC O
causes VBZ O
significant JJ O
losses NNS O
worldwide RB O
. . O

In IN O
contrast NN O
to IN O
the DT O
smooth JJ O
colonies NNS O
of IN O
laboratory NN O
strains NNS O
, , O
wild JJ O
Saccharomyces NNP B-Species
cerevisiae NN I-Species
strains NNS O
form VBP O
biofilm NN O
- HYPH O
like JJ O
, , O
strikingly RB O
structured VBN O
colonies NNS O
possessing VBG O
distinctive JJ O
traits NNS O
enabling VBG O
them PRP O
to TO O
better RBR O
survive VB O
in IN O
hostile JJ O
environments NNS O
in IN O
the DT O
wild NN O
. . O

To TO O
obtain VB O
insight NN O
into IN O
the DT O
nature NN O
of IN O
the DT O
death NN O
experienced VBN O
by IN O
ompR JJ O
malT NN O
( , O
Con NNP O
) -RRB- O
mutants NNS O
, , O
we PRP O
described VBD O
the DT O
death NN O
process NN O
. . O

Recruitment NN O
to IN O
food NN O
is VBZ O
initially RB O
very RB O
rapid JJ O
and CC O
local JJ O
from IN O
the DT O
foraging VBG O
tunnels NNS O
, , O
while IN O
sustained JJ O
recruitment NN O
gradually RB O
involves VBZ O
the DT O
recruits NNS O
waiting VBG O
in IN O
the DT O
nest NN O
. . O

Identification NN O
and CC O
characterization NN O
of IN O
genes NNS O
responsible JJ O
for IN O
biosynthesis NN O
of IN O
kojic NN O
acid NN O
, , O
an DT O
industrially RB O
important JJ O
compound NN O
from IN O
Aspergillus NNP B-Species
oryzae NNP I-Species
. . O

In IN O
this DT O
study NN O
, , O
by IN O
screening VBG O
a DT O
set NN O
of IN O
knock VB O
- HYPH O
out RP O
mutants NNS O
corresponding VBG O
to IN O
103 CD O
transcription NN O
factor NN O
encoding VBG O
genes NNS O
in IN O
Neurospora NNP B-Species
crassa NN I-Species
, , O
a DT O
mutant NN O
was VBD O
found VBN O
to TO O
produce VB O
abundant JJ O
conidia NN O
in IN O
race NN O
tubes NNS O
in IN O
which WDT O
conidiation NN O
in IN O
the DT O
wild JJ O
- HYPH O
type NN O
strain NN O
was VBD O
suppressed VBN O
. . O

Different JJ O
breeding NN O
parameters NNS O
were VBD O
sensitive JJ O
to IN O
ENSO NNP O
indices NNS O
in IN O
different JJ O
blocks NNS O
of IN O
months NNS O
. . O

This DT O
review NN O
highlights VBZ O
the DT O
lack NN O
of IN O
interventional JJ O
studies NNS O
addressing VBG O
treatment NN O
adherence NN O
in IN O
TYA NNP O
patients NNS O
with IN O
cancer NN O
, , O
with IN O
only RB O
one CD O
such JJ O
intervention NN O
being VBG O
identified VBN O
: : O
a DT O
video NN O
game NN O
intervention NN O
focusing VBG O
on IN O
behavioural JJ O
issues NNS O
related VBN O
to IN O
cancer NN O
treatment NN O
and CC O
care NN O
. . O

PaCCCH NNP O
( : O
CCCH NNP O
- HYPH O
TYPE NNP O
ZINC NNP O
FINGER NNP O
) -RRB- O
and CC O
PaCBF2 NNP O
& CC O
amp NN O
; : O
3 CD O
( HYPH O
C NN O
- HYPH O
REPEAT NNP O
BINDING NNP O
FACTOR NNP O
2 CD O
& CC O
amp NN O
; : O
3 CD O
) -RRB- O
showed VBD O
a DT O
later JJ O
response NN O
at IN O
20 CD O
SDs NNS O
, , O
with IN O
increased VBN O
and CC O
decreased VBN O
transcript NN O
levels NNS O
, , O
respectively RB O
. . O

Comprehensive JJ O
transcriptome NN O
analyses NNS O
using VBG O
both CC O
reproductive JJ O
organs NNS O
and CC O
vegetative JJ O
tissues NNS O
showed VBD O
high JJ O
and CC O
positive JJ O
pairwise JJ O
correlations NNS O
between IN O
the DT O
expression NN O
profiles NNS O
of IN O
auxin NN O
- HYPH O
induced VBN O
genes NNS O
, , O
DNA NN O
replication NN O
- HYPH O
related VBN O
genes NNS O
and CC O
mitochondrial NN O
- HYPH O
related VBN O
genes NNS O
. . O

Major JJ O
limitations NNS O
of IN O
this DT O
classification NN O
system NN O
are VBP O
absence NN O
of IN O
prognostic JJ O
importance NN O
and CC O
little JJ O
correlation NN O
with IN O
treatment NN O
outcomes NNS O
. . O

Melanoma NN O
is VBZ O
an DT O
aggressive JJ O
disease NN O
with IN O
few JJ O
standard JJ O
treatment NN O
options NNS O
. . O

A DT O
setA NN O
mutant NN O
exhibits VBZ O
a DT O
growth NN O
defect NN O
under IN O
stress NN O
conditions NNS O
that WDT O
can MD O
be VB O
complemented VBN O
by IN O
setA NN O
in IN O
trans NNS O
, , O
suggesting VBG O
that IN O
SetA NNP O
contributes VBZ O
to IN O
the DT O
optimal JJ O
cellular JJ O
recovery NN O
from IN O
stress NN O
. . O

As IN O
mainly RB O
indicated VBN O
by IN O
root NN O
delta NN O
^ SYM O
1 CD O
^ SYM O
5N CD O
signatures NNS O
at IN O
1 CD O
: SYM O
1 CD O
ammonium NN O
/ SYM O
nitrate NN O
ratio NN O
, , O
in IN O
the DT O
drier JJR O
environments NNS O
, , O
plants NNS O
preferred VBD O
nitrate NN O
and CC O
in IN O
the DT O
wetter JJR O
environments NNS O
they PRP O
preferred VBD O
ammonium NN O
. . O

Of IN O
these DT O
tamoxifen NN O
has VBZ O
greater JJR O
efficacy NN O
and CC O
can MD O
be VB O
used VBN O
in IN O
premenopausal JJ O
women NNS O
, , O
but CC O
raloxifene NN O
has VBZ O
fewer JJR O
side NN O
- HYPH O
effects NNS O
. . O

Finally RB O
, , O
we PRP O
are VBP O
only RB O
now RB O
beginning VBG O
to TO O
understand VB O
the DT O
importance NN O
of IN O
cross JJ O
- HYPH O
scale NN O
interactions NNS O
associated VBN O
with IN O
parasitism NN O
. . O

BACKGROUND NN O
: : O
Advances NNS O
in IN O
gerontology NN O
have VBP O
yielded VBN O
crucial JJ O
insights NNS O
into IN O
the DT O
molecular JJ O
and CC O
biochemical JJ O
aspects NNS O
of IN O
the DT O
ageing NN O
process NN O
. . O

Previous JJ O
studies NNS O
showed VBD O
at RB O
least RBS O
eight CD O
species NNS O
of IN O
the DT O
foraminiferal JJ O
genera NN O
Haynesina NNP O
and CC O
Elphidium NNP O
grazing VBG O
on IN O
diatoms NNS O
and CC O
husbanding VBG O
their PRP$ O
chloroplasts NNS O
. . O

Behavioral JJ O
experiments NNS O
using VBG O
plants NNS O
preferred VBN O
by IN O
Heliconius NNP B-Species
erato NN I-Species
suggest VBP O
that IN O
pollen NN O
preference NN O
in IN O
H NN B-Species
. . I-Species
erato NN I-Species
is VBZ O
an DT O
innate JJ O
trait NN O
and CC O
consequently RB O
learning VBG O
of IN O
chemical JJ O
cues NNS O
at IN O
roosting VBG O
aggregations NNS O
is VBZ O
unlikely JJ O
. . O

Why WRB O
are VBP O
some DT O
common JJ O
and CC O
apparently RB O
suitable JJ O
resources NNS O
avoided VBN O
by IN O
potential JJ O
users NNS O
? . O

But CC O
, , O
addition NN O
of IN O
ABA NNP O
strongly RB O
altered VBD O
the DT O
CO2 NNP O
- HYPH O
response NN O
: : O
g NN O
( : O
m NN O
) -RRB- O
was VBD O
high JJ O
( : O
approx NN O
. . O
0 NFP O
. . O
5 CD O
mol NN O
CO2 NN O
m NN O
- HYPH O
^ CC O
2 CD O
s NN O
- HYPH O
^ SYM O
1 CD O
) -RRB- O
at IN O
C NN O
( , O
a DT O
) NN O
& CC O
lt NN O
; : O
200 CD O
mumol NN O
mol NN O
- HYPH O
^ SYM O
1 CD O
and CC O
decreased VBN O
to IN O
& CC O
lt NN O
; : O
0 CD O
. . O
1 CD O
mol NN O
CO2 NN O
m SYM O
- HYPH O
^ CC O
2 CD O
s NNS O
- HYPH O
^ SYM O
1 CD O
at IN O
C NN O
( : O
a DT O
) NFP O
> SYM O
400 CD O
mumol NN O
mol NN O
- HYPH O
^ SYM O
1 CD O
. . O

More RBR O
significantly RB O
, , O
our PRP$ O
experiments NNS O
showed VBD O
that IN O
the DT O
plant NN O
progeny NN O
continued VBD O
to TO O
exhibit VB O
the DT O
same JJ O
nitrogen NN O
preference NN O
as IN O
the DT O
parent NN O
plants NNS O
in IN O
the DT O
field NN O
, , O
even RB O
when WRB O
removed VBN O
from IN O
their PRP$ O
native JJ O
environment NN O
and CC O
the DT O
nitrogen NN O
source NN O
was VBD O
changed VBN O
dramatically RB O
. . O

Several JJ O
traits NNS O
were VBD O
intercorrelated VBN O
and CC O
scores NNS O
based VBN O
on IN O
composite JJ O
traits NNS O
used VBN O
in IN O
a DT O
fourth JJ O
- HYPH O
corner NN O
analysis NN O
found VBD O
significant JJ O
patterns NNS O
, , O
but CC O
slightly RB O
different JJ O
to IN O
those DT O
using VBG O
individual JJ O
traits NNS O
. . O

This DT O
strongly RB O
indicates VBZ O
that IN O
( : O
i PRP O
) -RRB- O
active JJ O
electron NN O
flow NN O
from IN O
metabolites NNS O
to IN O
plastoquinone NN O
is VBZ O
suppressed VBN O
upon IN O
deletion NN O
of IN O
ndhF1 NN O
and CC O
( , O
ii FW O
) -RRB- O
photosystem NN O
1 CD O
- HYPH O
mediated VBN O
cyclic JJ O
electron NN O
transport NN O
is VBZ O
dependent JJ O
on IN O
NdhF3 NNP O
/ SYM O
F4 NNP O
- HYPH O
type NN O
NDH NNP O
- HYPH O
1 CD O
complexes NNS O
. . O

To TO O
identify VB O
Cma NN O
functional JJ O
domains NNS O
, , O
we PRP O
isolated VBD O
54 CD O
point NN O
mutants NNS O
and CC O
small JJ O
deletion NN O
mutants NNS O
and CC O
examined VBD O
their PRP$ O
cytotoxicity NN O
levels NNS O
. . O

These DT O
complex JJ O
virions NNS O
are VBP O
estimated VBN O
to TO O
be VB O
composed VBN O
of IN O
more JJR O
than IN O
50 CD O
viral JJ O
proteins NNS O
. . O

More RBR O
recently RB O
, , O
it PRP O
has VBZ O
been VBN O
hypothesised VBN O
that IN O
a DT O
single JJ O
dimension NN O
may MD O
be VB O
sufficient JJ O
to TO O
explain VB O
the DT O
system NN O
- HYPH O
level NN O
organization NN O
of IN O
trophic JJ O
interactions NNS O
observed VBN O
between IN O
species NNS O
in IN O
a DT O
community NN O
. . O

We PRP O
also RB O
ask VBP O
for IN O
increased VBN O
investment NN O
in IN O
stillbirth NN O
- HYPH O
related VBN O
research NN O
, , O
and CC O
especially RB O
research NN O
aimed VBN O
at IN O
identifying VBG O
and CC O
addressing VBG O
barriers NNS O
to IN O
the DT O
aversion NN O
of IN O
stillbirths NNS O
within IN O
the DT O
maternal JJ O
and CC O
neonatal JJ O
health NN O
systems NNS O
of IN O
low JJ O
- HYPH O
income NN O
and CC O
middle NN O
- HYPH O
income NN O
countries NNS O
. . O

Manifestations NNS O
range VBP O
from IN O
itching NN O
and CC O
minor JJ O
pain NN O
to IN O
neurological JJ O
symptoms NNS O
, , O
cardiac JJ O
collapse NN O
, , O
and CC O
death NN O
. . O

Hepatitis NNP B-Species
B NNP I-Species
virus NN I-Species
( , O
HBV NNP B-Species
) -RRB- O
and CC O
hepatitis NN B-Species
delta NN I-Species
virus NN I-Species
( -LRB- O
HDV NNP B-Species
) -RRB- O
interplay NN O
was VBD O
investigated VBN O
by IN O
examining VBG O
liver NN O
and CC O
serum NN O
samples NNS O
from IN O
21 CD O
coinfected JJ O
and CC O
22 CD O
HBV NN B-Species
- HYPH O
monoinfected VBN O
patients NNS O
with IN O
chronic JJ O
liver NN O
disease NN O
. . O

Expression NN O
of IN O
the DT O
MR NNP O
FreB NNP O
was VBD O
found VBN O
to TO O
be VB O
transcriptionally RB O
repressed VBN O
by IN O
iron NN O
via IN O
SreA NNP O
, , O
a DT O
repressor NN O
of IN O
iron NN O
acquisition NN O
during IN O
iron NN O
sufficiency NN O
, , O
indicating VBG O
a DT O
role NN O
in IN O
iron NN O
metabolism NN O
. . O

Moreover RB O
, , O
16 CD O
/ SYM O
18 CD O
North JJ O
American JJ O
and CC O
13 CD O
/ SYM O
15 CD O
Eurasian JJ O
species NNS O
appeared VBD O
to TO O
exhibit VB O
provincialism NN O
. . O

1 LS O
. . O

Additionally RB O
, , O
other JJ O
measures NNS O
for IN O
patients NNS O
with IN O
brain NN O
tumours NNS O
that WDT O
assess VBP O
outcome NN O
are VBP O
described VBN O
. . O

Characterization NN O
of IN O
cross JJ O
- HYPH O
reactive JJ O
CD8 NNP O
+ CC O
T NNP O
- HYPH O
cell NN O
recognition NN O
of IN O
HLA NNP O
- HYPH O
A2 NNP O
- HYPH O
restricted VBN O
HIV NNP O
- HYPH O
Gag NNP O
( , O
SLYNTVATL NNP O
) -RRB- O
and CC O
HCV NNP O
- HYPH O
NS5b NNP O
( -LRB- O
ALYDVVSKL NNP O
) -RRB- O
epitopes NNS O
in IN O
individuals NNS O
infected VBN O
with IN O
human JJ B-Species
immunodeficiency NN I-Species
and CC O
hepatitis NNP B-Species
C NNP I-Species
viruses NNS I-Species
. . O

To IN O
a DT O
lower JJR O
extent NN O
, , O
crosstalk NN O
to IN O
the DT O
mating NN O
pathway NN O
expressing VBG O
HwSho1 NNP O
proteins NNS O
is VBZ O
conserved VBN O
in IN O
the DT O
PBS2 NN O
deleted VBN O
S NN B-Species
. . I-Species
cerevisiae NN I-Species
strain NN O
. . O

Transcriptional JJ O
analysis NN O
of IN O
the DT O
nickel NN O
transporter NN O
encoding NN O
gene NN O
, , O
tnc NN O
in IN O
N NNP B-Species
. . I-Species
crassa NN I-Species
by IN O
qRT NNP O
- HYPH O
PCR NNP O
showed VBD O
its PRP$ O
constitutive JJ O
expression NN O
in IN O
various JJ O
phases NNS O
of IN O
its PRP$ O
life NN O
cycle NN O
. . O

Under IN O
long JJ O
- HYPH O
term NN O
oxidative JJ O
stress NN O
caused VBN O
by IN O
menadione NN O
sodium NN O
bisulfite NN O
, , O
genome NN O
- HYPH O
wide JJ O
transcriptional JJ O
and CC O
proteome NN O
- HYPH O
wide JJ O
translational JJ O
changes NNS O
were VBD O
compared VBN O
in IN O
Aspergillus NNP B-Species
nidulans NN I-Species
vegetative JJ O
cells NNS O
. . O

By IN O
combining VBG O
suppression NN O
subtractive JJ O
hybridization NN O
and CC O
monitoring NN O
of IN O
gene NN O
expression NN O
by IN O
qRT NN O
- HYPH O
PCR NN O
analysis NN O
, , O
we PRP O
aimed VBD O
to TO O
identify VB O
genes NNS O
involved VBN O
in IN O
photoperiodic JJ O
control NN O
of IN O
growth NN O
cessation NN O
and CC O
bud NN O
set VBN O
in IN O
Norway NNP B-Species
spruce NN I-Species
. . O

Milestones NNS O
in IN O
Candida NNP B-Species
albicans NNS I-Species
gene NN O
manipulation NN O
. . O

Ecologists NNS O
have VBP O
long RB O
been VBN O
interested JJ O
in IN O
the DT O
role NN O
of IN O
climate NN O
in IN O
shaping VBG O
species NNS O
' POS O
ranges NNS O
, , O
and CC O
in IN O
recent JJ O
years NNS O
, , O
this DT O
relationship NN O
has VBZ O
taken VBN O
on RP O
greater JJR O
significance NN O
because IN O
of IN O
the DT O
need NN O
for IN O
accurate JJ O
predictions NNS O
of IN O
the DT O
effects NNS O
of IN O
climate NN O
change NN O
on IN O
wildlife NN O
populations NNS O
. . O

Currently RB O
, , O
the DT O
interaction NN O
between IN O
functional JJ O
and CC O
taxonomic JJ O
components NNS O
of IN O
biodiversity NN O
under IN O
realistic JJ O
scenarios NNS O
of IN O
habitat NN O
degradation NN O
is VBZ O
poorly RB O
understood VBN O
. . O

While IN O
NK NNP O
cells NNS O
have VBP O
been VBN O
shown VBN O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
control NN O
of IN O
HIV NNP B-Species
- HYPH I-Species
1 CD I-Species
replication NN O
, , O
their PRP$ O
functional JJ O
activities NNS O
are VBP O
often RB O
compromised VBN O
in IN O
HIV NNP B-Species
- HYPH I-Species
1 CD I-Species
- HYPH O
infected VBN O
individuals NNS O
. . O

We PRP O
provide VBP O
a DT O
case NN O
for IN O
transformation NN O
of IN O
health NN O
systems NNS O
through IN O
effective JJ O
stewardship NN O
, , O
decentralised JJ O
planning NN O
in IN O
districts NNS O
, , O
a DT O
reasoned JJ O
approach NN O
to IN O
financing NN O
that WDT O
affects VBZ O
demand NN O
for IN O
health NN O
care NN O
, , O
a DT O
campaign NN O
to TO O
create VB O
awareness NN O
and CC O
change VB O
health NN O
and CC O
nutrition NN O
behaviour NN O
, , O
and CC O
revision NN O
of IN O
programmes NNS O
for IN O
child NN O
nutrition NN O
on IN O
the DT O
basis NN O
of IN O
evidence NN O
. . O

Template NN O
recognition NN O
mechanisms NNS O
by IN O
replicase NN O
proteins NNS O
differ VBP O
between IN O
bipartite JJ O
positive JJ O
- HYPH O
strand NN O
genomic JJ O
RNAs NNS O
of IN O
a DT O
plant NN O
virus NN O
. . O

Such JJ O
GB NNP O
- HYPH O
accumulating VBG O
plants NNS O
exhibit VBP O
various JJ O
advantageous JJ O
traits NNS O
, , O
such JJ O
as IN O
enlarged VBN O
fruits NNS O
and CC O
flowers NNS O
and CC O
/ SYM O
or CC O
increased VBN O
seed NN O
number NN O
under IN O
non JJ O
- HYPH O
stress NN O
conditions NNS O
. . O

For IN O
the DT O
most RBS O
southerly RB O
distributed VBN O
species NNS O
, , O
the DT O
A1B NNP O
and CC O
B1 NNP O
emission NN O
scenarios NNS O
were VBD O
respectively RB O
the DT O
most RBS O
and CC O
less RBR O
damaging JJ O
. . O

Lastly RB O
, , O
unobserved JJ O
heterogeneity NN O
across IN O
individuals NNS O
improved VBD O
model NN O
fit NN O
more RBR O
( , O
1 CD O
* SYM O
3 CD O
times NNS O
) -RRB- O
than IN O
fixed JJ O
and CC O
dynamic JJ O
sources NNS O
of IN O
observed VBN O
heterogeneity NN O
in IN O
reproductive JJ O
investment NN O
, , O
demonstrating VBG O
that IN O
it PRP O
is VBZ O
critical JJ O
to TO O
account VB O
for IN O
both DT O
sources NNS O
of IN O
individual JJ O
heterogeneity NN O
when WRB O
studying VBG O
survival NN O
trajectories NNS O
. . O

3 LS O
. . O

is VBZ O
distinguished VBN O
from IN O
its PRP$ O
congeners NNS O
by IN O
the DT O
following VBG O
combination NN O
of IN O
characters NNS O
: : O
body NN O
medium NN O
- HYPH O
sized JJ O
and CC O
slender JJ O
- HYPH O
cylindrical JJ O
; : O
with IN O
a DT O
conspicuous JJ O
prebuccal JJ O
fossa NN O
; : O
28 CD O
- HYPH O
34 CD O
somatic JJ O
kineties NNS O
; : O
about RB O
40 CD O
short JJ O
adoral JJ O
polykineties NNS O
; , O
intrabuccal JJ O
kinety NN O
composed VBN O
of IN O
25 CD O
- SYM O
34 CD O
dikinetids NNS O
; , O
paroral JJ O
kineties NNS O
composed VBN O
of IN O
closely RB O
spaced VBN O
dikinetids NNS O
. . O

This DT O
work NN O
further RB O
defines VBZ O
the DT O
mechanisms NNS O
of IN O
virally RB O
induced VBN O
inflammasome NN O
activation NN O
. . O

* NFP O
Pseudomonas NNP B-Species
syringae NN I-Species
pv NN I-Species
. . I-Species
tomato NN I-Species
DC3000 NN I-Species
( , O
Pst NN B-Species
DC3000 CD I-Species
) -RRB- O
causes VBZ O
an DT O
economically RB O
important JJ O
bacterial JJ O
speck NN O
disease NN O
on IN O
tomato NN B-Species
and CC O
produces VBZ O
symptoms NNS O
with IN O
necrotic JJ O
lesions NNS O
surrounded VBN O
by IN O
chlorosis NN O
. . O

Cleavage NN O
of IN O
resveratrol NN O
in IN O
fungi NN O
: : O
characterization NN O
of IN O
the DT O
enzyme NN O
Rco1 NNP O
from IN O
Ustilago NNP B-Species
maydis NNP I-Species
. . O

The DT O
results NNS O
presented VBN O
here RB O
show VBP O
that IN O
one CD O
of IN O
these DT O
intermediate JJ O
factors NNS O
is VBZ O
SbcCD NNP O
, , O
an DT O
SMC NNP O
- HYPH O
like JJ O
protein NN O
and CC O
an DT O
ATP NNP O
- HYPH O
dependent JJ O
nuclease NN O
. . O

Flavobacterium NN B-Species
johnsoniae NN I-Species
sprB NN O
is VBZ O
part NN O
of IN O
an DT O
operon NN O
spanning VBG O
the DT O
additional JJ O
gliding VBG O
motility NN O
genes NNS O
sprC NN O
, , O
sprD NN O
, , O
and CC O
sprF NN O
. . O

Chromatographic JJ O
and CC O
spectroscopic JJ O
analyses NNS O
revealed VBD O
that IN O
tri5 JJ O
overexpression NN O
led VBD O
to IN O
an DT O
increased VBN O
production NN O
of IN O
trichodermin NN O
and CC O
tyrosol NN O
. . O

It PRP O
is VBZ O
highly RB O
down RB O
- HYPH O
regulated VBN O
in IN O
larvae NN O
and CC O
markedly RB O
up RB O
- HYPH O
regulated VBN O
in IN O
the DT O
pupal JJ O
stage NN O
, , O
suggesting VBG O
that IN O
it PRP O
may MD O
be VB O
related VBN O
to IN O
development NN O
. . O

Several JJ O
new JJ O
insights NNS O
into IN O
the DT O
causes NNS O
of IN O
motor NN O
neuron NN O
death NN O
have VBP O
led VBN O
to IN O
the DT O
identification NN O
of IN O
some DT O
important JJ O
novel JJ O
targets NNS O
for IN O
intervention NN O
. . O

The DT O
sensitivity NN O
of IN O
virus NN O
isolation NN O
was VBD O
combined VBN O
with IN O
nucleic JJ O
acid NN O
based VBN O
detection NN O
methods NNS O
so IN O
that IN O
the DT O
time NN O
taken VBN O
for IN O
confirmatory JJ O
diagnosis NN O
could MD O
be VB O
considerably RB O
reduced VBN O
while IN O
increasing VBG O
sensitivity NN O
. . O

No DT O
native JJ O
residue NN O
was VBD O
obligatory JJ O
for IN O
function NN O
, , O
most RBS O
deleterious JJ O
substitutions NNS O
had VBD O
radically RB O
different JJ O
side NN O
chain NN O
properties NNS O
, , O
and CC O
all DT O
F1 NNP O
mutants NNS O
but CC O
one CD O
were VBD O
functionally RB O
rescued VBN O
by IN O
the DT O
chemoreceptor NN O
Tar NNP O
. . O

Recent JJ O
studies NNS O
from IN O
our PRP$ O
group NN O
suggested VBD O
that IN O
the DT O
actions NNS O
of IN O
D3 NNP O
and CC O
retinoids NNS O
on IN O
myelopoiesis NN O
also RB O
are VBP O
influenced VBN O
by IN O
endogenous JJ O
mechanisms NNS O
involving VBG O
other JJ O
steroid JJ O
hormones NNS O
. . O

Deletion NN O
mutants NNS O
containing VBG O
1 CD B-Gene
. . I-Gene
3 CD I-Gene
, , I-Gene
0 CD I-Gene
. . I-Gene
6 CD I-Gene
, , I-Gene
and CC I-Gene
0 CD I-Gene
. . I-Gene
2 CD I-Gene
kb VBD I-Gene
5 CD I-Gene
' '' I-Gene
- : I-Gene
flanking VBG I-Gene
DNA NN I-Gene
were VBD O
incrementally RB O
less RBR O
transcriptionally RB O
active JJ O
, , O
although IN O
0 CD O
. . O
2 CD O
kb NN O
still RB O
mediated VBD O
a DT O
12 CD O
- : O
fold VBN O
induction NN O
by IN O
PRL NNP B-Gene
. . O

We PRP O
suggest VBP O
that IN O
in IN O
young JJ O
subjects NNS O
Type NNP B-Gene
II NNP I-Gene
receptors NNS I-Gene
are VBP O
initially RB O
up IN O
- : O
regulated VBN O
by IN O
dexamethasone NN O
, , O
and CC O
then RB O
down RP O
- : O
regulated VBN O
, , O
while IN O
in IN O
aged JJ O
subjects NNS O
an DT O
up RP O
- : O
regulation NN O
can MD O
not RB O
be VB O
achieved VBN O
, , O
as IN O
suggested VBN O
by IN O
the DT O
higher JJR O
values NNS O
of IN O
plasma NN O
cortisol NN O
usually RB O
found VBN O
in IN O
aging VBG O
subjects NNS O
. . O

These DT O
data NNS O
collectively RB O
suggest VBP O
that IN O
PAO NNP O
interferes VBZ O
with IN O
the DT O
phosphorylation NN O
and CC O
the DT O
regulated JJ O
degradation NN O
of IN O
IkappaB NNP B-Gene
- : I-Gene
alpha NN I-Gene
, , O
induced VBN O
by IN O
TNF NNP B-Gene
, , O
without IN O
affecting VBG O
the DT O
chymotryptic JJ O
activity NN O
of IN O
the DT O
proteasome NN B-Gene
, , O
independent JJ O
of IN O
age NN O
. . O

2 CD O
) ) O
The DT O
FI NNP O
of IN O
the DT O
chemotactic JJ O
migration NN O
rate NN O
of IN O
PMN NNP O
by IN O
cortisol NN O
also RB O
showed VBD O
diurnal JJ O
changes NNS O
which WDT O
were VBD O
synchronous JJ O
with IN O
that DT O
of IN O
GR NNP B-Gene
. . O

We PRP O
also RB O
discuss VBP O
our PRP$ O
recent JJ O
findings NNS O
that IN O
type NN B-Gene
I PRP I-Gene
and CC I-Gene
type VB I-Gene
II NNP I-Gene
IFNs NNP I-Gene
suppress NN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
/ NN O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
- : O
inducible JJ O
gene NN O
expression NN O
by IN O
inhibiting VBG O
tyrosine JJ O
phosphorylation NN O
and CC O
nuclear JJ O
translocation NN O
of IN O
STAT6 NNP B-Gene
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
by IN O
inhibiting VBG O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
, , O
surface NN O
expression NN O
of IN O
several JJ O
adhesion NN B-Gene
molecules NNS I-Gene
can MD O
be VB O
modulated VBN O
and CC O
that IN O
tepoxalin NN O
may MD O
be VB O
useful JJ O
in IN O
treating VBG O
selected VBN O
adhesion NN O
mediated VBN O
events NNS O
such JJ O
as IN O
leukocyte JJ O
migration NN O
or CC O
atherosclerotic JJ O
plaque NN O
formation NN O
. . O

The DT O
critical JJ O
region NN O
of IN O
THR NNP B-Gene
beta NN O
was VBD O
mapped VBN O
to TO O
3 CD O
amino NN O
acids NNS O
in IN O
the DT O
distal JJ B-Gene
box NN I-Gene
of IN O
the DT O
DNA NNP B-Gene
binding NN I-Gene
domain NN I-Gene
. . O

Here RB O
we PRP O
show VBP O
that IN O
the DT O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
receptor NN I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
12R CD I-Gene
) ) I-Gene
beta NN I-Gene
2 CD I-Gene
subunit NN I-Gene
, , O
a DT O
recently RB O
cloned VBN O
binding NN B-Gene
and CC I-Gene
signal JJ I-Gene
transducing NN I-Gene
component NN I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
12R CD I-Gene
, , O
is VBZ O
expressed VBN O
on IN O
human JJ O
Th1 NNP O
but CC O
not RB O
Th2 NNP O
clones NNS O
and CC O
is VBZ O
induced VBN O
during IN O
differentiation NN O
of IN O
human JJ O
naive JJ O
cells NNS O
along IN O
the DT O
Th1 NNP O
but CC O
not RB O
the DT O
Th2 NNP O
pathway NN O
. . O

The DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
levels NNS O
in IN O
mononuclear JJ O
leukocytes NNS O
correlated VBN O
with IN O
those DT O
in IN O
polymorphonuclear JJ O
leukocytes NNS O
, , O
and CC O
there RB O
was VBD O
a DT O
linear JJ O
relationship NN O
between IN O
the DT O
cellular JJ O
glucocorticoid NN B-Gene
receptor NN I-Gene
levels NNS O
and CC O
glucocorticoid VB O
- : O
mediated VBN O
inhibition NN O
of IN O
the DT O
uptake NN O
of IN O
3 CD O
- : O
O NNP O
- : O
methyl NN O
- : O
D NNP O
- : O
glucose NN O
in IN O
mononuclear JJ O
leukocytes NNS O
. . O

The DT O
mechanisms NN O
by IN O
which WDT O
beta SYM B-Gene
- : I-Gene
catenin NN I-Gene
undergoes VBZ O
this DT O
shift NN O
in IN O
location NN O
and CC O
participates NNS O
in IN O
activation NN O
of IN O
gene NN O
transcription NN O
are VBP O
unknown JJ O
. . O

Changes NNS O
in IN O
c SYM B-Gene
- : I-Gene
fos JJ I-Gene
expression NN O
induced VBN O
by IN O
radiation NN O
therapy NN O
in IN O
tumor NN O
tissues NNS O
have VBP O
not RB O
yet RB O
been VBN O
reported VBN O
. . O

The DT O
core NN B-Gene
elements NNS I-Gene
of IN O
the DT O
SL3 NNP O
virus NN O
are VBP O
important JJ O
genetic JJ O
determinants NNS O
of IN O
the DT O
ability NN O
of IN O
this DT O
virus NN O
to TO O
induce VB O
T NNP O
- : O
cell NN O
lymphomas NN O
and CC O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
viral JJ B-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
in IN O
T NNP O
lymphocytes NNS O
. . O

Polymorphic NNP O
nucleotides NNS O
within IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
that WDT O
mediate JJ O
overexpression NN O
of IN O
the DT O
gene NN O
. . O

Type NNP B-Gene
II NNP I-Gene
estrogen NN I-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
human JJ O
peripheral JJ O
blood NN O
mononuclear JJ O
cells NNS O
: : O
variations NNS O
during IN O
the DT O
menstrual JJ O
cycle NN O
. . O

Level NN O
of IN O
gene NN O
amplification NN O
was VBD O
studied VBN O
by IN O
Southern NNP O
and CC O
/ NNP O
or CC O
slot NN O
blot NN O
techniques NNS O
. . O

Role NNP O
of IN O
EGR1 NNP B-Gene
in IN O
regulation NN O
of IN O
stimulus JJ O
- : O
dependent JJ O
CD44 NNP B-Gene
transcription NN O
in IN O
B NNP O
lymphocytes NNS O
. . O

Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
mediated VBN O
drug NN O
resistance NN O
: : O
inhibition NN O
of IN O
apoptosis NN O
by IN O
blocking VBG O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
lymphocytes NNS I-Gene
( ( O
NFAT NNP B-Gene
) ) O
- : O
induced VBN O
Fas NNP B-Gene
ligand NN O
transcription NN O
. . O

Both DT O
TPCK NNP O
and CC O
TLCK NNP O
inhibited VBD O
LPS NNP O
induction NN O
of IN O
TF NNP B-Gene
protein NN I-Gene
, , O
TF NNP B-Gene
mRNA NN I-Gene
and CC O
TF NNP B-Gene
promoter NN O
activity NN O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
. . O

We PRP O
have VBP O
analyzed VBN O
de IN O
novo FW O
radiation NN O
- : O
induced JJ O
translocations NNS O
between IN O
the DT O
Xi NNP B-Gene
and CC O
autosomes NNS B-Gene
to TO O
study VB O
the DT O
maintenance NN O
and CC O
spreading NN O
of IN O
X NNP B-Gene
- : I-Gene
chromosome NN I-Gene
inactivation NN O
( ( O
X NNP O
inactivation NN O
) ) O
in IN O
relation NN O
to TO O
the DT O
position NN O
of IN O
the DT O
X NNP O
- : O
inactivation NN O
center NN O
( ( B-Gene
XIC NNP I-Gene
) ) I-Gene
/ VBP I-Gene
XIST VBN I-Gene
in IN O
differentiated JJ O
cells NNS O
. . O

From IN O
these DT O
cellular JJ O
changes NNS O
, , O
we PRP O
can MD O
infer VB O
that IN O
the DT O
cell NN O
growth NN O
was VBD O
modulated VBN O
along IN O
with IN O
induction NN O
of IN O
terminal JJ O
differentiation NN O
. . O

Preactivation NN O
of IN O
T NNP O
cells NNS O
resulting VBG O
in IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
nuclear JJ O
translocation NN O
protected VBD O
cells NNS O
from IN O
SN50 NNP O
- : O
induced JJ O
apoptosis NN O
. . O

Genetic JJ O
inactivation NN O
of IN O
JAK3 NNP B-Gene
is VBZ O
manifested VBN O
as IN O
severe JJ O
combined VBN O
immunodeficiency NN O
disease NN O
( ( O
SCID NNP O
) ) O
in IN O
humans NNS O
and CC O
mice NN O
. . O

Scatchard NNP O
analysis NN O
of IN O
[ $ O
3H CD O
] NNP O
dexamethasone NN O
binding VBG O
using VBG O
mixed JJ O
cytosol NN O
showed VBD O
a DT O
diminished JJ O
GR NNP B-Gene
apparent NN O
binding VBG O
affinity NN O
when WRB O
compared VBN O
to TO O
HL NNP O
cytosol NN O
. . O

Levels NNS O
of IN O
other JJ O
nuclear JJ B-Gene
factors NNS I-Gene
involved VBN O
in IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
regulation NN O
were VBD O
not RB O
altered VBN O
by IN O
EC NNP O
, , O
although IN O
NFAT NNP B-Gene
- : I-Gene
DNA NN I-Gene
complexes NNS I-Gene
migrated VBD O
at IN O
a DT O
slightly RB O
different JJ O
mobility NN O
. . O

Transient JJ O
overexpression NN O
of IN O
hTAFII105 NN B-Gene
selectively RB O
squelches VBZ O
the DT O
transcription NN O
of IN O
some DT O
genes NNS O
in IN O
B NNP O
cells NNS O
. . O

Our PRP$ O
laboratory NN O
has VBZ O
shown VBN O
that IN O
RA NNP O
can MD O
enhance VB O
in IN O
vitro JJ O
polyclonal JJ O
B NNP O
cell NN O
immunoglobulin NN B-Gene
( ( O
Ig NNP O
) ) O
response NN O
. . O

However RB O
, , O
the DT O
mechanism NN O
of IN O
the DT O
antiapoptotic JJ O
effects NNS O
is VBZ O
unclear JJ O
. . O

A DT O
sucrose JJ O
gradient NN O
analysis NN O
indicated VBD O
the DT O
simultaneous JJ O
presence NN O
of IN O
two CD O
kinds NNS O
of IN O
receptor NN O
complexes NNS O
: : O
the DT O
steroid JJ B-Gene
- : I-Gene
MR NN I-Gene
complex NN I-Gene
and CC O
the DT O
antibody NN B-Gene
- : I-Gene
MR NNP I-Gene
complex NN I-Gene
. . O

It PRP O
also RB O
abolished VBD O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
- : O
induced JJ O
upregulation NN O
of IN O
CD40 NNP B-Gene
but CC O
promoted VBD O
upregulation NN O
of IN O
CD23 NNP O
. . O

Stimulation NN O
of IN O
HUVEC NNP O
with IN O
thrombin NN B-Gene
resulted VBN O
in IN O
dose JJ O
- : O
and CC O
time NN O
- : O
dependent NN O
increases NNS O
in IN O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNA NN I-Gene
and CC O
cell NN O
surface NN O
expression NN O
and CC O
in IN O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent JJ O
endothelial JJ O
adhesivity NN O
toward IN O
polymorphonuclear JJ O
leukocytes NNS O
. . O

Further JJ O
optimization NN O
of IN O
culture NN O
conditions NNS O
, , O
type NN O
of IN O
Antigen NNP O
Presenting NNP O
Cells NNP O
( ( O
APC NNP O
) ) O
, , O
peptides NNS O
, , O
use NN O
of IN O
stabilizers NNS O
like IN O
beta NN B-Gene
2 CD I-Gene
- : I-Gene
m NN I-Gene
are VBP O
still RB O
needed VBN O
. . O

In IN O
three CD O
families NNS O
the DT O
autosomal JJ O
recessive JJ O
form NN O
was VBD O
characterized VBN O
by IN O
normal JJ B-Gene
receptor NN I-Gene
as RB O
well RB O
as IN O
hormone NN O
data NNS O
in IN O
both DT O
parents NNS O
, , O
while IN O
in IN O
one CD O
family NN O
receptor NN O
levels NNS O
in IN O
both DT O
parents NNS O
were VBD O
greatly RB O
reduced VBN O
, , O
but CC O
hormone NN O
levels NNS O
were VBD O
normal JJ O
. . O

The DT O
affinity NN O
of IN O
glucocorticoid JJ B-Gene
receptors NNS I-Gene
( ( O
Kd NNP O
) ) O
was VBD O
strikingly RB O
decreased VBN O
( ( O
9 CD O
. . O
36 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O
44 CD O
nM NN O
in IN O
group NN O
1 CD O
; : O
3 CD O
. . O
2 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
5 CD O
nM NN O
in IN O
group NN O
2 CD O
; : O
2 CD O
. . O
0 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
8 CD O
nM NN O
in IN O
controls NNS O
; : O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

Regulation NN O
of IN O
B NNP O
- : O
cell NN O
commitment NN O
to TO O
plasma VB O
cells NNS O
or CC O
to TO O
memory NN O
B NNP O
cells NNS O
. . O

Findings NNS O
from IN O
this DT O
analysis NN O
prompted VBD O
sequencing NN O
of IN O
the DT O
gamma NN B-Gene
c SYM I-Gene
gene NN I-Gene
in IN O
this DT O
pedigree NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
used VBN O
the DT O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
with IN O
nested JJ O
primers NNS O
to TO O
analyze VB O
X NNP O
- : O
inactivation NN O
patterns NNS O
of IN O
the DT O
HUMARA NNP B-Gene
loci NN I-Gene
in IN O
purified JJ O
eosinophils NNS O
from IN O
female JJ O
patients NNS O
with IN O
eosinophilia NNS O
. . O

We PRP O
demonstrate VBP O
here RB O
that IN O
the DT O
expression NN O
of IN O
the DT O
lysosomal JJ B-Gene
enzyme NN I-Gene
acid NN B-Gene
sphingomyelinase NN I-Gene
( ( O
ASM NNP O
; : O
E NNP O
. . O
C NNP O
. . O
3 CD O
. . O
1 CD O
. . O
4 CD O
. . O
12 CD O
) ) O
is VBZ O
induced VBN O
during IN O
this DT O
process NN O
and CC O
is VBZ O
strongly RB O
elevated VBN O
in IN O
differentiated JJ O
THP NNP O
- : O
1 CD O
cells NNS O
, , O
as RB O
well RB O
as IN O
in IN O
differentiated JJ O
human JJ O
mononuclear NN O
phagocytes NNS O
. . O

By IN O
coincubating VBG O
the DT O
monocytes NNS O
with IN O
either DT O
the DT O
mineralocorticoid JJ O
antagonist NN O
spironolactone NN O
or CC O
the DT O
glucocorticoid JJ B-Gene
receptor NN I-Gene
antagonist NN O
RU NNP O
38486 CD O
, , O
the DT O
in IN O
vitro NN O
cortisol NN O
- : O
induced JJ O
inhibition NN O
of IN O
LPS NNP O
- : O
stimulated VBD O
IL NNP B-Gene
- : I-Gene
1ra CD I-Gene
secretion NN O
was VBD O
partially RB O
reversed VBN O
. . O

Previously RB O
, , O
we PRP O
demonstrated VBD O
that IN O
Y292 NNP O
negatively RB O
regulates VBZ O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
function NN O
and CC O
that IN O
Y315 NNP O
positively RB O
regulates VBZ O
ZAP NNP B-Gene
- : I-Gene
70 CD I-Gene
function NN O
by IN O
interacting VBG O
with IN O
Vav NNP B-Gene
. . O

ROS NNP O
generation NN O
inhibition NN O
paralleled VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
levels NNS O
in IN O
the DT O
nucleus NN O
. . O

Costimulation NNP O
requirement NN O
for IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
transcription NN O
factor NN O
activation NN O
in IN O
T NNP O
cells NNS O
. . O

The DT O
gene NN O
contains VBZ O
a DT O
CpG NNP B-Gene
- : I-Gene
rich JJ I-Gene
island NN I-Gene
suggesting VBG O
expression NN O
in IN O
the DT O
germ JJ O
line NN O
. . O

The DT O
human JJ O
immunodeficiency NN O
virus NN O
( ( O
HIV NNP O
) ) O
Rev NNP B-Gene
protein NN I-Gene
is VBZ O
essential JJ O
for IN O
viral JJ O
structural JJ O
protein NN O
expression NN O
( ( O
Gag NNP B-Gene
, , O
Pol NNP B-Gene
, , O
and CC O
Env NNP B-Gene
) ) O
and CC O
, , O
hence RB O
, , O
for IN O
viral JJ O
replication NN O
. . O

We PRP O
used VBD O
expression NN O
cloning VBG O
to TO O
identify VB O
interleukin JJ B-Gene
- : I-Gene
6 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
6 CD I-Gene
) ) O
as IN O
one CD O
factor NN O
that WDT O
suppressed VBD O
growth NN O
of IN O
a DT O
pre NN O
- : O
B NNP O
- : O
cell NN O
variant JJ O
line NN O
, , O
1A9 CD O
- : O
M NN O
. . O

We PRP O
measured VBD O
plasma JJ O
hormones NNS O
by IN O
radioimmunoassay NN O
. . O

Alternative JJ O
mechanisms NNS O
include VBP O
the DT O
possibility NN O
that IN O
NF NNP B-Gene
- : I-Gene
ATc NNP I-Gene
operates VBZ O
on IN O
some DT O
cytoplasmic JJ B-Gene
anchor NN I-Gene
or CC O
that IN O
other JJ O
proteins NNS O
that WDT O
are VBP O
controlled VBN O
by IN O
calcineurin NN B-Gene
carry NN O
out IN O
the DT O
nuclear JJ O
import NN O
of IN O
NF NNP B-Gene
- : I-Gene
ATc NN I-Gene
. . O

These DT O
data NNS O
indicate VBP O
that IN O
TCL1 NNP B-Gene
is VBZ O
activated VBN O
in IN O
preleukemic JJ O
clonal JJ O
cells NNS O
as IN O
a DT O
consequence NN O
of IN O
chromosome NN O
translocation NN O
involving VBG O
sequences NNS O
from IN O
the DT O
TCR NNP B-Gene
locus NN I-Gene
at IN O
14q11 CD B-Gene
. . O

Thus RB O
, , O
IVS1 NNP O
- : O
10T CD O
- : O
- : O
> NN O
C NNP O
is VBZ O
not RB O
harmful JJ O
to TO O
BRCA1 NNP B-Gene
function NN O
, , O
and CC O
is VBZ O
classified VBN O
a DT O
benign JJ O
polymorphism NN O
. . O

Histamine NNP O
induced VBD O
mRNA JJ B-Gene
expression NN O
of IN O
an DT O
immediate JJ B-Gene
early JJ I-Gene
gene NN I-Gene
c SYM B-Gene
- : I-Gene
fos NN I-Gene
. . O

This DT O
difference NN O
in IN O
efficacy NN O
, , O
which WDT O
correlates VBZ O
with IN O
the DT O
compounds NNS O
' POS O
anti NNS O
- : O
inflammatory NN O
potency NN O
in IN O
vivo NN O
, , O
may MD O
be VB O
explained VBN O
by IN O
differences NNS O
in IN O
structure NN O
and CC O
conformation NN O
. . O

We PRP O
have VBP O
recently RB O
identified VBN O
and CC O
cloned VBN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
a DT O
T NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
with IN O
specificity NN O
for IN O
the DT O
AACAAAG NNP O
motif NN O
in IN O
the DT O
CD3 NNP O
epsilon NN O
enhancer NN O
and CC O
for IN O
the DT O
TTCAAAG NNP B-Gene
motif NN I-Gene
in IN O
the DT O
TCR NNP B-Gene
alpha NN I-Gene
enhancer NN I-Gene
. . O

We PRP O
propose VBP O
that IN O
neutrophils NNS O
use VBP O
both DT O
ERK NNP O
- : O
dependent NN O
and CC O
ERK NNP O
- : O
independent JJ O
pathways NNS O
to TO O
phosphorylate VB O
Ser NNP O
- : O
727 CD O
on IN O
STAT3 NNP B-Gene
. . O

OBJECTIVE NN O
: : O
The DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
regulates VBZ O
the DT O
expression NN O
of IN O
many JJ O
genes NNS O
involved VBN O
in IN O
the DT O
immune NN O
or CC O
inflammatory JJ O
response NN O
at IN O
the DT O
transcriptional JJ O
level NN O
. . O

The DT O
human JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
leukemia NN I-Gene
virus NN I-Gene
type NN I-Gene
1 CD I-Gene
( ( I-Gene
HTLV NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
transcriptional NN I-Gene
trans NNS I-Gene
- : I-Gene
activator NN I-Gene
Tax NNP B-Gene
has VBZ O
been VBN O
demonstrated VBN O
to TO O
have VB O
transforming VBG O
activity NN O
in IN O
multiple NN O
cell NN O
culture NN O
and CC O
transgenic JJ O
- : O
mouse NN O
models NNS O
. . O

Our PRP$ O
objective NN O
was VBD O
to TO O
identify VB O
the DT O
mechanisms NNS O
underlying VBG O
such JJ O
phenomena NNS O
. . O

In IN O
the DT O
presence NN O
of IN O
ADP NNP O
- : O
activated JJ O
platelets NNS O
, , O
both DT O
MCP NNP B-Gene
- : I-Gene
1 CD I-Gene
secretion NN O
and CC O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
surface NN O
expression NN O
were VBD O
significantly RB O
increased VBN O
compared VBN O
with IN O
nonstimulated JJ O
platelets NNS O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
2 CD O
) ) O
. . O

In IN O
an DT O
open JJ O
- : O
label NN O
study NN O
, , O
adolescents NNS O
( ( O
n JJ O
= NNP O
20 CD O
) ) O
meeting NN O
DSM NNP O
- : O
III NNP O
- : O
R NN O
criteria NNS O
for IN O
MDD NNP O
showed VBD O
baseline JJ O
lymphocyte NN B-Gene
GCII NNP I-Gene
sites VBZ I-Gene
per IN O
cell NN O
( ( O
sites VBZ O
/ NNP O
cell NN O
) ) O
values NNS O
of IN O
793 CD O
+ NNS O
/ SYM O
- : O
106 CD O
versus NN O
2 CD O
, , O
563 CD O
+ NN O
/ NNP O
- : O
499 CD O
( ( O
+ JJ O
/ NNP O
- : O
SEM NN O
) ) O
for IN O
matched VBN O
controls NNS O
( ( O
n JJ O
= NNP O
18 CD O
) ) O
( ( O
t JJ O
= NN O
3 CD O
. . O
5 CD O
; : O
df NN O
= VBZ O
36 CD O
; : O
p NN O
< NN O
. . O
1 CD O
) ) O
. . O

Inhibition NN O
of IN O
adenylyl JJ B-Gene
cyclase NN I-Gene
by IN O
pretreatment NN O
with IN O
2 CD B-Gene
' POS I-Gene
- : I-Gene
deoxy NN I-Gene
- : I-Gene
3 CD I-Gene
' '' I-Gene
- : I-Gene
adenosine NN I-Gene
monophosphate NN I-Gene
partially RB O
reversed VBD O
the DT O
inhibition NN O
of IN O
TF NNP O
activity NN O
promoted VBN O
by IN O
lysoPC NN O
. . O

We PRP O
report VBP O
here RB O
that IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
- : O
mediated VBN O
repression NN O
in IN O
Jurkat NNP O
cells NNS O
is VBZ O
cycloheximide JJ O
resistant NN O
, , O
suggesting VBG O
that IN O
it PRP O
is VBZ O
a DT O
direct JJ O
transcriptional JJ O
repressive JJ O
effect NN O
on IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
by IN O
the DT O
vitamin NN B-Gene
D3 NNP I-Gene
receptor NN I-Gene
( ( O
VDR NNP B-Gene
) ) O
. . O

Arrested VBN O
development NN O
: : O
understanding NN O
v SYM B-Gene
- : I-Gene
abl NN I-Gene
. . O

Granulocyte NNP B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
GM NNP B-Gene
- : I-Gene
CSF NN I-Gene
) ) O
regulates VBZ O
differentiation NN O
, , O
survival NN O
, , O
and CC O
proliferation NN O
of IN O
colony NN O
- : O
forming NN O
unit NN O
- : O
granulocyte NN O
- : O
macrophage NN O
progenitor NN O
cells NNS O
. . O

Inhibition NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
by IN O
sodium NN O
salicylate NN O
and CC O
aspirin JJ O
[ NNP O
see NN O
comments NNS O
] VB O

Establishment NN O
and CC O
characterization NN O
of IN O
EBV NNP O
- : O
positive JJ O
and CC O
EBV NNP O
- : O
negative JJ O
primary JJ O
effusion NN O
lymphoma NN O
cell NN O
lines NNS O
harbouring VBG O
human JJ O
herpesvirus NN O
type NN O
- : O
8 CD O
. . O

We PRP O
have VBP O
found VBN O
that IN O
it PRP O
is VBZ O
phosphorylated VBN O
, , O
predominantly RB O
on IN O
serine NN O
residues NNS O
, , O
when WRB O
transiently RB O
overexpressed VBN O
in IN O
293 CD O
cells NNS O
. . O

Finally RB O
, , O
immunoblot JJ O
analysis NN O
of IN O
nuclear JJ O
extracts NNS O
showed VBD O
decreased JJ O
or CC O
absent JJ O
p65 NN B-Gene
protein NN I-Gene
levels NNS O
. . O

The DT O
genomic JJ O
actions NNS O
of IN O
1 CD O
, , O
25 CD O
- : O
dihydroxyvitamin NN O
D3 NNP O
( ( O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
) ) O
are VBP O
mediated VBN O
by IN O
the DT O
intracellular JJ O
vitamin NN B-Gene
D NNP I-Gene
receptor NN I-Gene
( ( O
VDR NNP B-Gene
) ) O
. . O

Gel NNP O
retardation NN O
and CC O
methylation NN O
interference NN O
studies NNS O
revealed VBD O
that IN O
bacterially RB B-Gene
produced VBN I-Gene
AP NNP I-Gene
- : I-Gene
2 CD I-Gene
bound NN O
specifically RB O
and CC O
with IN O
high JJ O
affinity NN O
to TO O
all DT O
three CD O
21 CD B-Gene
bp NN I-Gene
repeats NNS I-Gene
, , O
and CC O
that IN O
it PRP O
required VBD O
the DT O
core NN B-Gene
sequence NN I-Gene
AGGC NNP O
for IN O
specific JJ O
binding NN O
. . O

Tyrosine NNP O
phosphorylation NN O
of IN O
STAT5 NNP B-Gene
is VBZ O
accompanied VBN O
by IN O
the DT O
translocation NN O
of IN O
activated JJ O
STAT5 NNP B-Gene
to TO O
the DT O
nucleus NN O
as IN O
shown VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay VBP O
( ( O
EMSA NNP O
) ) O
using VBG O
32Pi CD O
- : O
labeled VBN O
STAT5 NNP B-Gene
binding VBG I-Gene
site NN I-Gene
in IN O
the DT O
beta NN B-Gene
- : I-Gene
casein NN I-Gene
promoter NN I-Gene
. . O

These DT O
results NNS O
indicate VBP O
that IN O
LPS NNP O
induction NN O
of IN O
kappaB FW O
- : O
dependent JJ O
gene NN O
expression NN O
in IN O
human JJ O
monocytic JJ O
cells NNS O
requires VBZ O
activation NN O
of IN O
IKK2 NNP B-Gene
. . O

The DT O
enzyme NN O
might MD O
therefore RB O
be VB O
a DT O
potential JJ O
target NN O
for IN O
drug NN O
therapy NN O
under IN O
conditions NNS O
of IN O
active JJ O
DNA NNP O
replication NN O
. . O

In IN O
this DT O
study NN O
the DT O
effects NNS O
of IN O
HIV NNP O
protease NN O
on IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
precursor NN O
activation NN O
were VBD O
examined VBN O
in IN O
Jurkat NNP O
T NNP O
cells NNS O
by IN O
introducing VBG O
a DT O
protease NN B-Gene
expression NN I-Gene
vector NN I-Gene
into IN O
the DT O
cells NNS O
. . O

Similarly RB O
, , O
cycloheximide RB O
prevented VBD O
the DT O
p65 NN B-Gene
and CC O
c SYM B-Gene
- : I-Gene
rel NN I-Gene
translocation NN O
and CC O
consequent JJ O
formation NN O
of IN O
active JJ O
binding NN O
heterodimers NNS O
, , O
at IN O
early RB O
and CC O
late JJ O
times NNS O
. . O

By IN O
contrast NN O
, , O
stimulation NN O
of IN O
calcium NN O
influx NN O
, , O
a DT O
CD3 NNP B-Gene
- : O
dependent JJ O
event NN O
, , O
paralleled VBD O
zap SYM B-Gene
- : I-Gene
70 CD I-Gene
activation NN O
. . O

In IN O
gene NN O
transfection NN O
assays NNS O
, , O
the DT O
effect NN O
of IN O
TNFalpha NNP B-Gene
requires VBZ O
the DT O
presence NN O
of IN O
an DT O
inducible JJ B-Gene
nuclear JJ I-Gene
factor NN I-Gene
- : I-Gene
kappaB NN I-Gene
( ( I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
) ) I-Gene
( ( I-Gene
Rel NNP I-Gene
A NNP I-Gene
) ) I-Gene
binding VBG I-Gene
site NN I-Gene
in IN O
the DT O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
promoter NN I-Gene
. . O

No DT O
significant JJ O
differences NNS O
were VBD O
found VBN O
in IN O
the DT O
immunolabeling NN O
of IN O
the DT O
regulatory JJ B-Gene
subunits NNS I-Gene
( ( O
type NN O
I PRP O
and CC O
type VB O
II NNP O
) ) O
of IN O
cAMP NN B-Gene
- : I-Gene
dependent JJ I-Gene
protein NN I-Gene
kinase NN I-Gene
. . O

To TO O
investigate VB O
the DT O
activity NN O
of IN O
a DT O
single JJ O
transcription NN B-Gene
factor NN I-Gene
in IN O
individual JJ O
viable JJ O
cells NNS O
, , O
we PRP O
have VBP O
applied VBN O
an DT O
assay NN O
that WDT O
uses VBZ O
the DT O
fluorescence NN O
- : O
activated VBN O
cell NN O
sorter NN O
to TO O
quantitate VB O
beta SYM B-Gene
- : I-Gene
galactosidase NN I-Gene
( ( O
beta SYM B-Gene
- : I-Gene
gal NN I-Gene
) ) O
. . O

We PRP O
investigated VBD O
the DT O
pattern NN O
of IN O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
expression NN O
in IN O
purified JJ O
human JJ O
hematopoietic JJ O
cells NNS O
by IN O
in IN O
situ JJ O
hybridization NN O
and CC O
reverse VB B-Gene
transcriptase NN I-Gene
polymerase NN I-Gene
chain NN O
reaction NN O
analysis NN O
. . O

NFAT NNP B-Gene
activation NN O
was VBD O
also RB O
inhibited VBN O
by IN O
agents NNS O
that WDT O
increase VBP O
cAMP JJ O
concentrations NNS O
such JJ O
as IN O
dibutyryl NN O
cAMP NN O
, , O
forskolin NN O
and CC O
prostaglandin NN O
E2 NNP O
. . O

Activation NN O
of IN O
the DT O
CDC42 NNP B-Gene
effector NN I-Gene
N NNP B-Gene
- : I-Gene
WASP NN I-Gene
by IN O
the DT O
Shigella NNP B-Gene
flexneri NN I-Gene
IcsA NNP I-Gene
protein NN I-Gene
promotes VBZ O
actin JJ B-Gene
nucleation NN O
by IN O
Arp2 NNP B-Gene
/ NNP I-Gene
3 CD I-Gene
complex NN I-Gene
and CC O
bacterial JJ O
actin NN B-Gene
- : O
based VBN O
motility NN O
. . O

Furthermore RB O
, , O
in IN O
time NN O
kinetics NNS O
, , O
gangliosides NNS O
were VBD O
effective JJ O
for IN O
up RB O
to TO O
30 CD O
min NNS O
after IN O
addition NN O
of IN O
LPS NNP O
, , O
but CC O
not RB O
thereafter RB O
. . O

To TO O
determine VB O
the DT O
role NN O
of IN O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
in IN O
the DT O
regulation NN O
of IN O
the DT O
HTLV NNP B-Gene
- : I-Gene
I PRP I-Gene
LTR NNP I-Gene
gene NN O
expression NN O
, , O
we PRP O
used VBD O
an DT O
AP NNP B-Gene
- : I-Gene
2 CD I-Gene
cDNA NN I-Gene
in IN O
DNA NNP O
binding NN O
and CC O
transient JJ O
expression NN O
assays NNS O
. . O

One CD O
transformation NN B-Gene
effector NN I-Gene
site NN I-Gene
( ( O
TES1 NNP B-Gene
) ) O
, , O
located VBN O
within IN O
the DT O
membrane NN B-Gene
proximal JJ I-Gene
45 CD I-Gene
residues NNS I-Gene
of IN O
the DT O
cytoplasmic JJ O
tail NN O
, , O
constitutively RB O
engages VBZ O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
receptor NN I-Gene
- : I-Gene
associated JJ I-Gene
factors NNS I-Gene
. . O

A DT O
2 CD B-Gene
. . I-Gene
3 CD I-Gene
- : I-Gene
kb NN I-Gene
LCR NNP I-Gene
in IN O
the DT O
human JJ B-Gene
adenosine NN I-Gene
deaminase NN I-Gene
( ( I-Gene
ADA NNP I-Gene
) ) I-Gene
gene NN I-Gene
first JJ I-Gene
intron NN I-Gene
, , O
which WDT O
controls VBZ O
expression NN O
in IN O
thymocytes NNS O
, , O
is VBZ O
composed VBN O
of IN O
a DT O
200 CD B-Gene
- : I-Gene
bp NN I-Gene
enhancer NN I-Gene
domain NN I-Gene
and CC O
extended VBD O
flanking NN O
sequences NNS O
that WDT O
facilitate VBP O
activation NN O
from IN O
within IN O
chromatin NN B-Gene
. . O

Modifications NNS O
of IN O
the DT O
original JJ O
DDPCR NNP O
protocol NN O
, , O
which WDT O
we PRP O
found VBD O
can MD O
potentially RB O
decrease VB O
the DT O
frequency NN O
of IN O
isolating VBG O
false JJ O
- : O
positive JJ O
DESTs NNP B-Gene
, , O
are VBP O
described VBN O
and CC O
the DT O
merits NNS O
of IN O
DDPCR NNP O
, , O
relative JJ O
to TO O
other JJ O
differential JJ O
cDNA NN O
cloning VBG O
strategies NNS O
, , O
are VBP O
discussed VBN O
. . O

BACKGROUND NN O
: : O
Abnormalities NNS O
in IN O
the DT O
cyclic JJ O
adenosine NN O
monophosphate NN O
( ( O
cAMP NN O
) ) O
- : O
dependent JJ O
phosphorylation NN O
system NN O
have VBP O
been VBN O
recently RB O
reported VBN O
in IN O
patients NNS O
with IN O
bipolar JJ O
disorder NN O
. . O

Moreover RB O
, , O
in IN O
two CD O
in IN O
vivo NN O
models NNS O
, , O
these DT O
compounds NNS O
exerted VBD O
an DT O
antiinflammatory NN O
and CC O
immunosuppressive JJ O
activity NN O
as RB O
potent NN O
as IN O
that DT O
of IN O
the DT O
classic JJ O
glucocorticoid NN O
prednisolone NN O
. . O

The DT O
authors NNS O
conclude VBP O
that IN O
the DT O
microscopic NN O
examination NN O
is VBZ O
the DT O
only JJ O
useful JJ O
tool NN O
for IN O
assessing VBG O
the DT O
risk NN O
of IN O
local JJ O
failure NN O
, , O
which WDT O
is VBZ O
quite RB O
low JJ O
for IN O
the DT O
majority NN O
of IN O
patients NNS O
treated VBN O
with IN O
breast NN O
conservation NN O
. . O

CONCLUSIONS NN O
: : O
Our PRP$ O
results NNS O
demonstrated VBD O
that IN O
HIV NNP O
- : O
1 CD O
infection NN O
can MD O
selectively RB O
influence VB O
the DT O
surface NN O
expression NN O
of IN O
TNF NNP B-Gene
receptors NNS I-Gene
, , O
potentially RB O
influencing VBG O
its PRP$ O
own JJ O
expression NN O
and CC O
altering VBG O
normal JJ O
immunoregulatory JJ B-Gene
signal JJ O
transduction NN O
. . O

We PRP O
found VBD O
that IN O
treatment NN O
with IN O
dexamethasone NN O
induced VBN O
eosinophil JJ O
apoptosis NN O
. . O

They PRP O
propose VBP O
that IN O
BSAP NNP B-Gene
is VBZ O
a DT O
key JJ B-Gene
protein NN I-Gene
of IN O
B NNP O
cells NNS O
and CC O
that IN O
it PRP O
not RB O
only RB O
influence NN O
B NNP O
- : O
cell NN O
development NN O
but CC O
also RB O
influences VBZ O
the DT O
balance NN O
between IN O
B NNP O
- : O
cell NN O
proliferation NN O
and CC O
immunoglobulin JJ B-Gene
secretion NN O
at IN O
later JJ O
stages NNS O
of IN O
B NNP O
- : O
cell NN O
differentiation NN O
. . O

LysoPC NNP O
may MD O
thus RB O
attenuate VB O
activation NN O
of IN O
coagulation NN O
during IN O
inflammation NN O
and CC O
atherosclerosis NN O
. . O

Tat NNP O
also RB O
superactivates VBZ O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
through IN O
a DT O
TAR NNP B-Gene
- : O
independent JJ O
mechanism NN O
, , O
including VBG O
tumor NN O
necrosis NN O
factor NN O
alpha IN O
- : O
induced JJ O
and CC O
protein JJ O
kinase NN O
C NNP O
( ( O
PKC NNP B-Gene
) ) O
- : O
dependent JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
and CC O
inhibitors NNS O
of IN O
Tat NNP B-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
cooperatively RB O
down IN O
- : O
regulate NN O
this DT O
Tat NNP B-Gene
- : O
mediated VBD O
LTR NNP B-Gene
superactivation NN O
. . O

The DT O
present JJ O
data NNS O
, , O
along IN O
with IN O
other JJ O
findings NNS O
of IN O
HPA NNP O
abnormalities NNS O
in IN O
PTSD NNP O
, , O
support NN O
the DT O
possibility NN O
of IN O
a DT O
greater JJR O
negative JJ O
feedback NN O
sensitivity NN O
at IN O
one CD O
or CC O
more JJR O
levels NNS O
of IN O
the DT O
HPA NNP O
axis NN O
. . O

Taken VBN O
together RB O
, , O
these DT O
findings NNS O
suggest VBP O
that IN O
evolutionarily RB O
conserved VBN O
physical JJ O
interactions NNS O
between IN O
Ets NNP B-Gene
and CC I-Gene
NF NNP I-Gene
- : I-Gene
kappaB NN I-Gene
/ JJ I-Gene
NFAT NNP I-Gene
proteins NNS I-Gene
are VBP O
important JJ O
in IN O
regulating VBG O
the DT O
inducible JJ O
expression NN O
of IN O
T NNP B-Gene
- : I-Gene
cell NN I-Gene
genes NNS I-Gene
and CC O
viruses NNS O
. . O

Because IN O
this DT O
region NN O
of IN O
Stat3alpha NNP B-Gene
is VBZ O
involved VBN O
in IN O
transcriptional JJ O
activation NN O
, , O
our PRP$ O
findings NNS O
suggest VBP O
the DT O
possibility NN O
that IN O
Stat3gamma NNP B-Gene
may MD O
be VB O
transcriptionally RB O
inactive JJ O
and CC O
may MD O
compete VB O
with IN O
Stat3alpha NNP B-Gene
for IN O
Stat3 NNP B-Gene
binding VBG I-Gene
sites NNS I-Gene
in IN O
these DT O
terminally RB O
differentiated VBN O
myeloid NN O
cells NNS O

However RB O
, , O
activation NN O
from IN O
a DT O
remote JJ O
position NN O
could MD O
only RB O
be VB O
achieved VBN O
with IN O
the DT O
C NNP B-Gene
- : I-Gene
terminus NN I-Gene
of IN O
Oct NNP B-Gene
- : I-Gene
2a CD I-Gene
in IN O
B NNP O
cells NNS O
. . O

Expression NN O
of IN O
gamma NN B-Gene
- : I-Gene
interferon NN I-Gene
inducible JJ I-Gene
protein NN I-Gene
10 CD I-Gene
( ( O
IP NNP B-Gene
- : I-Gene
10 CD I-Gene
) ) O
, , O
a DT O
STAT1alpha NNP B-Gene
- : I-Gene
responsive JJ I-Gene
gene NN I-Gene
and CC O
mediator NN O
of IN O
inflammatory JJ O
response NN O
, , O
was VBD O
also RB O
abnormally RB O
expressed VBN O
in IN O
the DT O
monocytes NNS O
from IN O
II NNP O
- : O
2 CD O
. . O

In IN O
this DT O
system NN O
, , O
simultaneous JJ O
exposure NN O
to TO O
CD40L VB B-Gene
together RB O
with IN O
either DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
or CC O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
does VBZ O
not RB O
lead VB O
to TO O
the DT O
activation NN O
of IN O
novel JJ O
Rel NNP B-Gene
/ NNP I-Gene
STAT NNP I-Gene
complexes NNS I-Gene
. . O

To TO O
investigate VB O
regulatory JJ O
networks NNS O
in IN O
Legionella NNP O
pneumophila NN O
, , O
the DT O
gene NN O
encoding VBG O
the DT O
homolog NN O
of IN O
the DT O
Escherichia NNP B-Gene
coli NN I-Gene
stress NN I-Gene
and CC I-Gene
stationary JJ I-Gene
- : I-Gene
phase NN I-Gene
sigma NN I-Gene
factor NN I-Gene
RpoS NNP B-Gene
was VBD O
identified VBN O
by IN O
complementation NN O
of IN O
an DT O
E NNP O
. . O
coli NN O
rpoS JJ B-Gene
mutation NN O
. . O

The DT O
glucuronides NNS O
only RB O
inhibited VBD O
NK NNP O
cytotoxicity NN O
at IN O
50 CD O
micromol NN O
/ NNP O
L NNP O
. . O

Prominent JJ O
protein NN B-Gene
kinase NN I-Gene
cascades NNS O
are VBP O
those DT O
that IN O
activate VBP O
mitogen SYM B-Gene
- : I-Gene
activated VBN I-Gene
protein NN I-Gene
( ( I-Gene
MAP NNP I-Gene
) ) I-Gene
kinases VBZ I-Gene
. . O

Altogether RB O
, , O
the DT O
data NNS O
do VBP O
not RB O
provide VB O
any DT O
evidence NN O
to TO O
support VB O
an DT O
assumption NN O
that WDT O
moderately RB O
increased VBD O
body NN O
burdens NNS O
of IN O
PCDDs NNP O
/ NNP O
PCDFs NNP O
in IN O
adults NNS O
induce VBP O
decreases NNS O
in IN O
the DT O
cellular JJ O
components NNS O
of IN O
the DT O
human JJ O
immune NN O
system NN O
. . O

We PRP O
now RB O
show VBP O
that IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
regulation NN O
of IN O
STAT3 NNP B-Gene
proteins NNS I-Gene
in IN O
T NNP O
cells NNS O
is VBZ O
a DT O
complex JJ O
response NN O
involving VBG O
activation NN O
of IN O
two CD O
forms NNS O
of IN O
STAT3 NNP B-Gene
: : O
90 CD O
- : O
kDa NN O
STAT3alpha NNP B-Gene
and CC O
an DT O
83 CD B-Gene
- : I-Gene
kDa NN I-Gene
carboxyl SYM I-Gene
- : I-Gene
terminal NN I-Gene
truncated VBD I-Gene
STAT3beta NNP I-Gene
. . O

Similar JJ O
effects NNS O
were VBD O
obtained VBN O
for IN O
the DT O
c JJ B-Gene
- : I-Gene
fos JJ I-Gene
gene NN I-Gene
. . O

Lymphocytes NNS O
were VBD O
significantly RB O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
more RBR O
sensitive JJ O
to TO O
the DT O
direct JJ O
cytotoxic NN O
effects NNS O
of IN O
SMX NNP O
- : O
NO NN O
than IN O
neutrophils NNS O
. . O

Moreover RB O
, , O
our PRP$ O
data NNS O
provide VB O
evidence NN O
that IN O
the DT O
expression NN O
pattern NN O
of IN O
MHC NNP B-Gene
class NN I-Gene
II NNP I-Gene
mRNA NN I-Gene
is VBZ O
correlated VBN O
with IN O
that DT O
of IN O
the DT O
class NN B-Gene
II NNP I-Gene
transactivator NN I-Gene
( ( O
CIITA NNP B-Gene
) ) O
, , O
suggesting VBG O
that IN O
CIITA NNP B-Gene
is VBZ O
the DT O
actual JJ O
target NN O
of IN O
the DT O
silencing NN O
. . O

We PRP O
used VBD O
histochemical JJ O
markers NNS O
to TO O
define VB O
the DT O
immunophenotype NN O
of IN O
43 CD O
IDCs NNP O
with IN O
respect NN O
to TO O
comedo VB O
versus NN O
noncomedo JJ O
status NN O
and CC O
patterns NNS O
of IN O
angiogenesis NN O
. . O

GM3 NNP O
also RB O
caused VBD O
selective JJ O
inhibition NN O
of IN O
the DT O
human JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
lymphotrophic JJ I-Gene
virus NN I-Gene
- : I-Gene
1 CD I-Gene
Tax NNP I-Gene
transactivator NN O
- : O
induced JJ O
luciferase NN B-Gene
activity NN O
from IN O
a DT O
reporter NN O
construct NN O
driven VBN O
by IN O
the DT O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
promoter NN I-Gene
in IN O
Jurkat NNP O
T NNP O
cells NNS O
. . O

Lt NNP B-Gene
- : I-Gene
4 CD I-Gene
detected VBD O
40 CD O
kd NN O
tax1 NN B-Gene
antigen NN I-Gene
molecules NNS I-Gene
in IN O
most JJS O
HTLV NNP O
- : O
I PRP O
- : O
bearing NN O
cell NN O
lines NNS O
except IN O
one CD O
cell NN O
line NN O
that IN O
expressed VBD O
39 CD B-Gene
kd NN I-Gene
tax1 NN I-Gene
antigen NN I-Gene
. . O

PRE NNP B-Gene
- : I-Gene
I PRP I-Gene
forms VBP O
multiple JJ B-Gene
DNA NNP I-Gene
- : I-Gene
protein NN I-Gene
complexes NNS I-Gene
with IN O
nuclear JJ O
extracts NNS O
from IN O
Jurkat NNP O
cells NNS O
. . O

ICAM NNP B-Gene
- : I-Gene
I PRP I-Gene
mRNA VBP I-Gene
was VBD O
quite RB O
low JJ O
in IN O
MT NNP O
- : O
I PRP O
, , O
but CC O
no DT O
genomic JJ O
changes NNS O
were VBD O
found VBN O
. . O

IL NNP B-Gene
- : I-Gene
2 CD I-Gene
binding NN O
analysis NN O
demonstrated VBD O
that IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
markedly RB O
increased VBD O
the DT O
number NN O
of IN O
low JJ O
affinity NN O
IL NNP B-Gene
- : I-Gene
2Rs CD I-Gene
on IN O
the DT O
leukemia NN O
cells NNS O
, , O
without IN O
an DT O
effect NN O
on IN O
the DT O
number NN O
of IN O
high JJ B-Gene
- : I-Gene
affinity NN I-Gene
IL NNP I-Gene
- : I-Gene
2Rs CD I-Gene
. . O

These DT O
findings NNS O
suggest VBP O
a DT O
mechanism NN O
by IN O
which WDT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
binding NN O
to TO O
its PRP$ O
receptor NN O
may MD O
activate VB O
specific JJ B-Gene
genes NNS I-Gene
involved VBN O
in IN O
immune NN O
cell NN O
function NN O
. . O

NFAT3 NNP B-Gene
protein NN I-Gene
was VBD O
not RB O
observed VBN O
under IN O
any DT O
conditions NNS O
. . O

Immunocytochemistry NN O
60 CD O
minutes NNS O
after IN O
stimulation NN O
revealed VBD O
that IN O
NFkappaB NNP B-Gene
was VBD O
located VBN O
in IN O
the DT O
cytoplasm NN O
in IN O
unstimulated JJ O
cells NNS O
; : O
however RB O
, , O
the DT O
addition NN O
of IN O
TNFalpha NNP B-Gene
caused VBD O
NFkappaB NNP B-Gene
to TO O
translocate VB O
into IN O
the DT O
nucleus NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
cellular JJ O
glucocorticoid NN B-Gene
receptor NN I-Gene
levels NNS O
in IN O
peripheral JJ O
blood NN O
leukocytes NNS O
reflect VBP O
in IN O
vitro NN O
responsiveness NN O
to TO O
glucocorticoids NNS O
in IN O
mononuclear JJ O
leukocytes NNS O
from IN O
healthy JJ O
males NNS O
, , O
and CC O
that IN O
the DT O
individual JJ O
responsiveness NN O
may MD O
alter VB O
upon IN O
changes NNS O
in IN O
the DT O
cellular JJ O
levels NNS O
of IN O
glucocorticoid NN B-Gene
receptor NN I-Gene
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
stoichiometry NN O
of IN O
directly RB O
interacting VBG O
but CC O
opposing VBG O
transcription NN B-Gene
factors NNS I-Gene
may MD O
be VB O
a DT O
crucial JJ O
determinant NN O
governing VBG O
processes NNS O
of IN O
normal JJ O
differentiation NN O
and CC O
malignant JJ O
transformation NN O
. . O

Suppression NN O
of IN O
a DT O
cellular JJ O
differentiation NN O
program NN O
by IN O
phorbol NN O
esters NNS O
coincides NNS O
with IN O
inhibition NN O
of IN O
binding NN O
of IN O
a DT O
cell NN B-Gene
- : I-Gene
specific JJ I-Gene
transcription NN I-Gene
factor NN I-Gene
( ( O
NF NNP B-Gene
- : I-Gene
E2 NN I-Gene
) ) O
to TO O
an DT O
enhancer JJ B-Gene
element NN I-Gene
required VBN O
for IN O
expression NN O
of IN O
an DT O
erythroid JJ B-Gene
- : I-Gene
specific JJ I-Gene
gene NN I-Gene
. . O

PG490 NNP O
inhibits VBZ O
the DT O
induction NN O
of IN O
DNA NNP O
binding VBG O
activity NN O
at IN O
the DT O
purine NN B-Gene
- : I-Gene
box NN I-Gene
/ JJ I-Gene
antigen NN I-Gene
receptor NN I-Gene
response NN I-Gene
element NN I-Gene
( ( I-Gene
ARRE NNP I-Gene
) ) I-Gene
/ VBP I-Gene
nuclear JJ I-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
- : I-Gene
cells NNS I-Gene
( ( I-Gene
NF NNP I-Gene
- : I-Gene
AT NNP I-Gene
) ) I-Gene
target NN I-Gene
sequence NN I-Gene
but CC O
not RB O
at IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
site NN I-Gene
. . O

There EX O
was VBD O
no DT O
significant JJ O
effect NN O
of IN O
BDP NNP O
on IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
tumour JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
alpha RB I-Gene
) ) O
- : O
induced VBN O
changes NNS O
of IN O
gcRs NN B-Gene
. . O

IL NNP B-Gene
- : I-Gene
10 CD I-Gene
inhibits NNS O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
/ NNP I-Gene
Rel NNP I-Gene
nuclear JJ O
activity NN O
in IN O
CD3 NNP O
- : O
stimulated VBD O
human JJ O
peripheral JJ O
T NNP O
lymphocytes NNS O
. . O

LPS NNP B-Gene
- : I-Gene
binding NN I-Gene
protein NN I-Gene
, , O
a DT O
lipid JJ O
transfer NN O
protein NN O
found VBD O
in IN O
serum NN O
, , O
facilitates VBZ O
both DT O
PS NNP O
- : O
and CC O
PtdIns NNP O
- : O
mCD14 NN B-Gene
binding NN O
. . O

Dr NNP O
. . O
Dezube NNP O
of IN O
Beth NNP O
Israel NNP O
Hospital NNP O
( ( O
Boston NNP O
) ) O
concisely RB O
reviews VBZ O
the DT O
state NN O
of IN O
our PRP$ O
knowledge NN O
regarding VBG O
the DT O
effects NNS O
of IN O
pentoxifylline NN O
on IN O
expression NN O
of IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
, , O
a DT O
cytokine NN B-Gene
known VBN O
to TO O
influence VB O
HIV NNP O
- : O
1 CD O
replication NN O
and CC O
to TO O
play VB O
a DT O
possible JJ O
role NN O
in IN O
the DT O
clinical JJ O
manifestations NNS O
of IN O
advanced JJ O
infection NN O
with IN O
this DT O
virus NN O
. . O

Unexpectedly RB O
, , O
the DT O
CD4 NNP B-Gene
silencer NN I-Gene
is VBZ O
also RB O
active JJ O
in IN O
CD4 NNP O
+ NNP O
CD8int NNP O
/ NNP O
- : O
cells NNS O
of IN O
the DT O
thymus NN O
, , O
implying VBG O
that IN O
an DT O
anti JJ O
- : O
silencer NN O
may MD O
be VB O
required VBN O
to TO O
resume VB O
CD4 NNP B-Gene
expression NN O
in IN O
this DT O
cell NN O
population NN O
. . O

These DT O
results NNS O
indicated VBD O
that IN O
salicylates NNS O
inhibited VBD O
LPS NNP O
induction NN O
of IN O
TF NNP B-Gene
gene NN I-Gene
transcription NN O
in IN O
monocytic JJ O
cells NNS O
by IN O
preventing VBG O
nuclear JJ O
translocation NN O
of IN O
c SYM B-Gene
- : I-Gene
Rel NNP I-Gene
/ NNP I-Gene
p65 NN I-Gene
heterodimers NNS I-Gene
. . O

GCR NNP B-Gene
on IN O
MNL NNP O
and CC O
PML NNP O
in IN O
6 CD O
Yang NNP O
deficient NN O
patients NNS O
were VBD O
3473 CD O
+ NNP O
/ NNP O
- : O
413 CD O
and CC O
4433 CD O
+ NN O
/ NNP O
- : O
651 CD O
sites NNS O
/ VBP O
cell NN O
respectively RB O
, , O
statistically RB O
significant JJ O
from IN O
the DT O
normal JJ O
control NN O
group NN O
( ( O
4462 CD O
+ NNP O
/ NNP O
- : O
962 CD O
and CC O
5622 CD O
+ NN O
/ NNP O
- : O
782 CD O
sites NNS O
/ VBP O
cell NN O
respectively RB O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
5 CD O
) ) O
. . O

STAT5 NNP B-Gene
- : I-Gene
and CC I-Gene
STAT1 NNP I-Gene
- : I-Gene
related JJ I-Gene
factors NNS I-Gene
were VBD O
detected VBN O
in IN O
ALL NNP O
and CC O
STAT1 NNP B-Gene
- : I-Gene
, , I-Gene
STAT3 NNP I-Gene
- : I-Gene
, , I-Gene
and CC I-Gene
STAT5 NNP I-Gene
- : I-Gene
related JJ I-Gene
proteins NNS I-Gene
were VBD O
present JJ O
in IN O
nuclear JJ O
cell NN O
extracts NNS O
from IN O
AML NNP O
. . O

Lack NN O
of IN O
IL NNP B-Gene
- : I-Gene
12 CD I-Gene
signaling VBG O
in IN O
human JJ O
allergen NN O
- : O
specific JJ O
Th2 NNP O
cells NNS O
. . O

We PRP O
also RB O
provide VBP O
evidence NN O
for IN O
the DT O
functional JJ O
relationship NN O
between IN O
the DT O
cyclin NN B-Gene
- : I-Gene
like IN I-Gene
UDG NNP I-Gene
gene NN I-Gene
product NN I-Gene
and CC O
E2F NNP B-Gene
. . O

Regulation NN O
of IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
( ( O
GR NNP O
) ) O
expression NN O
by IN O
its PRP$ O
cognate NN O
ligand NN O
was VBD O
examined VBN O
in IN O
the DT O
glucocorticoid JJ O
- : O
sensitive JJ O
human JJ O
leukemic JJ O
T NNP O
- : O
cell NN O
line NN O
6TG1 CD O
. . O
1 CD O
and CC O
in IN O
the DT O
human JJ O
B NNP O
- : O
cell NN O
line NN O
IM NNP O
- : O
9 CD O
. . O

Previous JJ O
studies NNS O
established VBD O
a DT O
potential JJ O
role NN O
for IN O
the DT O
Src NNP B-Gene
- : I-Gene
family NN I-Gene
kinase NN I-Gene
Lck NNP B-Gene
in IN O
JAK NNP B-Gene
- : B-Gene
STAT NN I-Gene
signaling NN O
. . O

The DT O
ratio NN O
of IN O
BCL2 NNP O
+ NNP O
to TO O
CD3 NNP O
+ NNP O
cells NNS O
in IN O
ectopic JJ O
pregnancy NN O
was VBD O
0 CD O
. . O
41 CD O
. . O

Here RB O
, , O
we PRP O
demonstrate VBP O
the DT O
testosterone NN O
responsiveness NN O
of IN O
murine NN O
splenic JJ O
T NNP O
cells NNS O
in IN O
vitro NN O
as RB O
well RB O
as IN O
the DT O
presence NN O
of IN O
unconventional JJ B-Gene
cell NN I-Gene
surface NN I-Gene
receptors NNS I-Gene
for IN O
testosterone NN O
and CC O
classical JJ B-Gene
intracellular NN I-Gene
AR NNP I-Gene
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
paternal JJ B-Gene
X NNP I-Gene
chromosome NN I-Gene
carries VBZ O
the DT O
de FW O
novo FW O
alpha SYM B-Gene
- : I-Gene
galactosidase NN I-Gene
A DT I-Gene
mutation NN O
and CC O
that IN O
uneven JJ O
X NNP O
inactivation NN O
is VBZ O
the DT O
underlying VBG O
mechanism NN O
for IN O
disease NN O
expression NN O
in IN O
this DT O
novel JJ O
female NN O
MZ NNP O
twin NN O
pair NN O
. . O

During IN O
their PRP$ O
first JJ O
year NN O
of IN O
life NN O
, , O
all PDT O
the DT O
PML NNP O
/ NNP O
RARalpha NNP B-Gene
transgenic JJ O
mice NNS O
have VBP O
an DT O
abnormal JJ O
hematopoiesis NN O
that WDT O
can MD O
best VB O
be VB O
described VBN O
as IN O
a DT O
myeloproliferative JJ O
disorder NN O
. . O

Expression NN O
of IN O
the DT O
chemokine NN B-Gene
receptor NN I-Gene
BLR2 NNP B-Gene
/ NNP I-Gene
EBI1 NNP I-Gene
is VBZ O
specifically RB O
transactivated VBN O
by IN O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
nuclear JJ I-Gene
antigen NN I-Gene
2 CD I-Gene
. . O

Selective JJ O
effects NNS O
of IN O
DNA NNP O
damaging VBG O
agents NNS O
on IN O
HIV NNP B-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
activation NN O
and CC O
virus NN O
replication NN O
in IN O
vitro NN O
. . O

Activity NN O
of IN O
the DT O
kappa NN B-Gene
B NNP I-Gene
enhancer NN I-Gene
of IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
chain NN I-Gene
in IN O
somatic JJ O
cell NN O
hybrids NNS O
is VBZ O
accompanied VBN O
by IN O
the DT O
nuclear JJ O
localization NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

The DT O
inactive JJ O
precursor NN O
, , O
lyso SYM B-Gene
- : I-Gene
platelet NN I-Gene
- : I-Gene
activating NN I-Gene
factor NN I-Gene
, , O
at IN O
a DT O
concentration NN O
as RB O
high JJ O
as IN O
10 CD O
( ( O
- : O
7 CD O
) ) O
M NNP O
had VBD O
no DT O
effect NN O
on IN O
any DT O
of IN O
the DT O
membrane NN O
phospholipids NNS O
. . O

This DT O
gene NN O
, , O
originally RB O
named VBN O
AML1 NNP B-Gene
, , O
is VBZ O
a DT O
human JJ O
homologue NN O
of IN O
the DT O
Drosophila NNP B-Gene
gene NN I-Gene
runt NN I-Gene
that WDT O
controls VBZ O
early JJ O
events NNS O
in IN O
fly JJ O
embryogenesis NN O
. . O

In IN O
contrast NN O
, , O
stimuli NNS O
such JJ O
as IN O
hyperosmotic JJ O
shock NN O
or CC O
phosphatase NN O
inhibitors NNS O
, , O
which WDT O
use VBP O
PDTC NNP O
- : O
insensitive JJ O
pathways NNS O
, , O
induce VBP O
I PRP B-Gene
kappaB VBP I-Gene
alpha JJ O
degradation NN O
in IN O
1 CD O
. . O
300 CD O
. . O

Most JJS O
New NNP O
World NNP O
primate NN O
( ( O
NWP NNP O
) ) O
genera NN O
evolved VBN O
to TO O
require VB O
high JJ O
circulating NN O
levels NNS O
of IN O
steroid JJ O
hormones NNS O
and CC O
vitamin NN O
D NNP O
. . O

The DT O
Fc NNP B-Gene
epsilon NN I-Gene
RI NNP I-Gene
- : I-Gene
gamma NN I-Gene
chains NNS I-Gene
are VBP O
expressed VBN O
in IN O
a DT O
variety NN O
of IN O
hematopoietic JJ O
cells NNS O
where WRB O
they PRP O
play VBP O
a DT O
critical JJ O
role NN O
in IN O
signal JJ O
transduction NN O
. . O

Oral JJ O
administration NN O
of IN O
276 CD O
mumol NNS O
cortisol VBP O
to TO O
normal JJ O
subjects NNS O
also RB O
decreased VBD O
LPS NNP O
- : O
induced VBD O
IL NNP B-Gene
- : I-Gene
1ra CD I-Gene
synthesis NN O
in IN O
cultured JJ O
monocytes NNS O
. . O

This DT O
effect NN O
was VBD O
paralleled VBN O
by IN O
a DT O
reduction NN O
in IN O
the DT O
expression NN O
of IN O
MSR NNP B-Gene
protein NN O
and CC O
mRNA NN B-Gene
. . O

The DT O
coding VBG O
region NN O
of IN O
VDR NNP B-Gene
messenger NN I-Gene
RNA NNP I-Gene
was VBD O
also RB O
normal JJ O
, , O
as IN O
determined VBN O
by IN O
both DT O
DNA NNP B-Gene
sequence NN I-Gene
analysis NN O
and CC O
chemical NN O
mismatch NN O
cleavage NN O
analysis NN O
of IN O
copy NN O
DNA NN O
from IN O
11 CD O
index NN O
absorptive JJ O
hypercalciuric NN O
patients NNS O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kB NN I-Gene
, , O
activation NN B-Gene
protein NN I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
OCT NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
NF NNP B-Gene
- : I-Gene
IL NNP I-Gene
- : I-Gene
2B CD I-Gene
binding NN O
activity NN O
were VBD O
normal JJ O
. . O

[ JJ O
Regulation NNP O
of IN O
transcription NN O
of IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
gene NN I-Gene
in IN O
B NNP O
- : O
lymphocytes VBZ O
] NNS O

Differential JJ O
induction NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
complex JJ I-Gene
during IN O
restimulation NN O
and CC O
the DT O
induction NN O
of IN O
T NNP O
- : O
cell NN O
anergy NN O
. . O

We PRP O
have VBP O
previously RB O
demonstrated VBN O
that IN O
interaction NN O
of IN O
infected JJ O
thymocytes NNS O
with IN O
autologous JJ O
thymic JJ O
epithelial JJ O
cells NNS O
( ( O
TEC NNP O
) ) O
is VBZ O
a DT O
prerequisite NN O
for IN O
a DT O
high JJ O
level NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( ( O
HIV NNP O
- : O
1 CD O
) ) O
replication NN O
in IN O
thymocytes NNS O
( ( O
M NNP O
. . O
Rothe NNP O
, , O
L NNP O
. . O
Chene NNP O
, , O
M NNP O
. . O
Nugeyre NNP O
, , O
F NNP O
. . O
Barre NNP O
- : O
Sinoussi NN O
, , O
and CC O
N NNP O
. . O
Israel NNP O
, , O
J NNP O
. . O
Virol NNP O
. . O
72 CD O
: : O
5852 CD O
- : O
5861 CD O
, , O
1998 CD O
) ) O
. . O

Inhibition NN O
of IN O
the DT O
gut JJ O
inflammatory NN O
response NN O
by IN O
the DT O
antisense JJ O
oligonucleotide NN O
or CC O
the DT O
depletion NN O
of IN O
neutrophils NNS O
from IN O
SCID NNP O
- : O
HU NNP O
- : O
INT NNP O
mice NN O
blocked VBD O
the DT O
increase NN O
in IN O
intestinal JJ O
permeability NN O
observed VBN O
with IN O
amebic JJ O
infection NN O
. . O

Estrogen NNP O
exhibits VBZ O
a DT O
variety NN O
of IN O
actions NNS O
, , O
including VBG O
immuno JJ O
- : O
modulatory NN O
effects NNS O
, , O
in IN O
vivo NN O
and CC O
in IN O
vitro NN O
. . O

However RB O
, , O
the DT O
molecular JJ O
basis NN O
for IN O
the DT O
interplay NN O
between IN O
these DT O
distinct JJ O
stimuli NN O
is VBZ O
not RB O
clearly RB O
delineated VBN O
. . O

These DT O
results NNS O
show VBP O
that IN O
immunization NN O
with IN O
synthetic JJ O
peptides NNS O
can MD O
lead VB O
to TO O
the DT O
elimination NN O
of IN O
anti JJ O
- : O
tumor NN O
CTL NNP O
responses NNS O
. . O

Nuclear JJ O
run VBN O
- : O
on IN O
experiments NNS O
showed VBD O
that IN O
E3330 NNP O
decreases VBZ O
transcriptional JJ O
activation NN O
of IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
gene NN I-Gene
induced VBN O
by IN O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
stimulation NN O
in IN O
human JJ O
peripheral JJ O
monocytes NNS O
. . O

The DT O
experiments NNS O
in IN O
this DT O
report NN O
show NN O
that WDT O
cysteine NN O
or CC O
N NNP O
- : O
acetylcysteine NN O
( ( O
NAC NNP O
) ) O
raise VB O
the DT O
intracellular JJ O
glutathione NN O
( ( O
GSH NNP O
) ) O
level NN O
and CC O
inhibit NN O
HIV NNP O
- : O
1 CD O
replication NN O
in IN O
persistently RB O
infected VBN O
Molt NNP O
- : O
4 CD O
and CC O
U937 NNP O
cells NNS O
. . O

E LS B-Gene
- : I-Gene
selectin NN I-Gene
is VBZ O
induced VBN O
within IN O
1 CD O
- : O
2 CD O
h NN O
, , O
peaks NNS O
at IN O
4 CD O
- : O
6 CD O
h NN O
, , O
and CC O
gradually RB O
returns NNS O
to TO O
basal VB O
level NN O
by IN O
24 CD O
h NN O
. . O

We PRP O
then RB O
studied VBD O
the DT O
effect NN O
of IN O
the DT O
antibody NN O
on IN O
aldosterone NN O
and CC O
progesterone NN O
binding NN O
to TO O
the DT O
hMR NN B-Gene
. . O

To TO O
further RBR O
understand VB O
its PRP$ O
mechanism NN O
of IN O
action NN O
, , O
we PRP O
investigated VBD O
the DT O
effects NNS O
of IN O
HU NNP O
on IN O
regulation NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
expression NN O
prior RB O
to TO O
the DT O
onset NN O
of IN O
erythroid JJ O
differentiation NN O
of IN O
K562 NNP O
cells NNS O
. . O

The DT O
B NNP B-Gene
cell NN I-Gene
NFAT NNP I-Gene
complex NN I-Gene
, , O
however RB O
, , O
was VBD O
not RB O
functional JJ O
, , O
since IN O
it PRP O
failed VBD O
to TO O
activate VB O
transcription NN O
from IN O
an DT O
NFAT NNP B-Gene
- : I-Gene
driven NN I-Gene
chloramphenicol NN I-Gene
acetyltransferase NN I-Gene
( ( I-Gene
CAT NNP I-Gene
) ) I-Gene
construct NN I-Gene
. . O

Cell NNP O
activation NN O
and CC O
apoptosis NN O
by IN O
bacterial JJ B-Gene
lipoproteins NNS I-Gene
through IN O
toll NN B-Gene
- : I-Gene
like IN I-Gene
receptor NN I-Gene
- : I-Gene
2 CD I-Gene
. . O

Using VBG O
a DT O
polyclonal JJ O
antibody NN O
to TO O
murine VB B-Gene
NFATp NNP I-Gene
, , O
Western NNP O
blot NN O
analysis NN O
of IN O
various JJ O
mouse NN O
tissues NNS O
demonstrated VBD O
that IN O
the DT O
110 CD O
- : O
130 CD O
- : O
kDa NN O
NFATp NNP B-Gene
protein NN I-Gene
was VBD O
highly RB O
expressed VBN O
in IN O
thymus NN O
and CC O
spleen NN O
. . O

Transcriptional JJ O
efficiency NN O
of IN O
the DT O
MSV NNP B-Gene
LTR NNP I-Gene
promoter NN I-Gene
containing VBG O
this DT O
disrupted VBN O
ets NNS B-Gene
- : I-Gene
1 CD I-Gene
binding VBG I-Gene
site NN I-Gene
was VBD O
compared VBN O
to TO O
the DT O
activity NN O
of IN O
a DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
promoter NN I-Gene
in IN O
mouse NN O
T NNP O
lymphocytes VBZ O
in IN O
culture NN O
, , O
and CC O
15 CD O
- : O
to TO O
20 CD O
- : O
fold NN O
reduction NN O
in IN O
expression NN O
of IN O
a DT O
reporter NN B-Gene
gene NN I-Gene
was VBD O
observed VBN O
. . O

When WRB O
bound NN O
to TO O
cyclophilin VB B-Gene
, , O
cyclosporin VB O
A NNP O
binds NNS O
and CC O
inactivates VBZ O
the DT O
key JJ O
signalling VBG O
intermediate JJ O
calcineurin NN B-Gene
. . O

All DT O
three CD O
cell NN O
lines NNS O
expressed VBD O
vitamin JJ O
D NNP O
receptor NN O
and CC O
had VBD O
increased VBN O
levels NNS O
of IN O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
beta NN I-Gene
mRNA NN I-Gene
in IN O
response NN O
to TO O
LPS NNP O
. . O

As IN O
detected VBN O
by IN O
in IN O
vivo NN O
footprinting NN O
, , O
priming VBG O
markedly RB O
increases VBZ O
the DT O
activation NN O
- : O
dependent JJ O
engagement NN O
of IN O
the DT O
P0 NNP B-Gene
and CC O
P1 NNP B-Gene
NFAT NNP B-Gene
- : I-Gene
binding VBG I-Gene
elements NNS I-Gene
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
. . O

1 CD O
, , O
25 CD O
alpha SYM O
- : O
Dihydroxicholecalcif NNP O
( ( O
VitD3 NNP O
) ) O
and CC O
retinoic JJ O
acid NN O
( ( O
RA NNP O
) ) O
are VBP O
important JJ O
regulators NNS O
of IN O
the DT O
proliferation NN O
and CC O
differentiation NN O
of IN O
several JJ O
cell NN O
types NNS O
. . O

To TO O
gain VB O
some DT O
insight NN O
into IN O
the DT O
maturation NN O
of IN O
M2 NNP O
- : O
type NN O
leukemic JJ O
cells NNS O
, , O
we PRP O
studied VBD O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
monocytic JJ O
differentiation NN O
induced VBN O
by IN O
ATRA NNP O
and CC O
VD NNP O
in IN O
spontaneous JJ O
M2 NNP O
blast NN O
cells NNS O
as RB O
well RB O
as IN O
in IN O
Kasumi NNP O
- : O
1 CD O
cells NNS O
( ( O
an DT O
acute NN O
myeloid NN O
leukemia NN O
M2 NNP O
- : O
type NN O
cell NN O
line NN O
) ) O
. . O

X LS O
- : O
rays VBZ O
- : O
induced JJ O
secretion NN O
of IN O
cellular JJ B-Gene
factor NN I-Gene
( ( O
s NN O
) ) O
that WDT O
enhance NN O
( ( O
s PRP O
) ) O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
transcription NN O
in IN O
various JJ O
non JJ O
- : O
irradiated VBN O
transfected VBD O
cell NN O
lines NNS O
. . O

Progressive JJ O
expression NN O
of IN O
cell NN B-Gene
surface NN I-Gene
maturation NN I-Gene
- : I-Gene
specific JJ I-Gene
antigens NNS I-Gene
of IN O
the DT O
monocyte NN O
/ NNP O
macrophage NN O
lineage NN O
was VBD O
induced VBN O
by IN O
treatment NN O
of IN O
RWLeu NNP O
- : O
4 CD O
cells NNS O
with IN O
VD3 NNP O
for IN O
24 CD O
to TO O
72 CD O
h NN O
at IN O
doses NNS O
that WDT O
inhibited VBD O
cellular JJ O
proliferation NN O
. . O

By IN O
contrast NN O
, , O
memory NN O
cells NNS O
, , O
either RB O
in IN O
vitro NN O
activated VBN O
helper JJ O
T NNP O
cells NNS O
reverting VBG O
to TO O
a DT O
resting VBG O
state NN O
, , O
or CC O
CD4 NNP O
+ NNP O
T NNP O
( ( O
memory NN O
) ) O
clones NNS O
, , O
or CC O
CD4 NNP O
+ NNP O
CD45RO NNP O
+ NNP O
T NNP O
cells NNS O
isolated VBD O
ex JJ O
vivo NN O
, , O
no RB O
longer RB O
have VB O
a DT O
silencer NN B-Gene
. . O

The DT O
inhibition NN O
of IN O
B104 NNP O
cell NN O
growth NN O
induced VBN O
by IN O
anti JJ B-Gene
- : I-Gene
MHC NNP I-Gene
class NN I-Gene
II NNP I-Gene
Ab NNP I-Gene
was VBD O
Ca NNP O
( ( O
2 CD O
+ NN O
) ) O
- : O
independent JJ O
and CC O
not RB O
inhibited VBN O
by IN O
actinomycin JJ O
D NNP O
or CC O
cyclosporin VB O
A NNP O
, , O
and CC O
cell NN O
cycle NN O
arrest NN O
at IN O
the DT O
G2 NNP O
/ NNP O
M NNP O
interphase NN O
was VBD O
not RB O
observed VBN O
. . O

G NNP O
. . O
vaginalis NN O
lysates VBZ O
activated JJ O
HIV NNP O
long RB O
- : O
terminal JJ O
repeat NN O
transcription NN O
in IN O
HIV NNP O
- : O
infected JJ O
cells NNS O
and CC O
increased VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
binding NN O
activity NN O
, , O
indicating VBG O
an DT O
effect NN O
by IN O
G NNP O
. . O
vaginalis NN O
on IN O
HIV NNP O
transcription NN O
. . O

The DT O
diameter NN O
of IN O
the DT O
PCVs NNP O
also RB O
increased VBD O
with IN O
increasing VBG O
inflammatory JJ O
infiltrate NN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
2 CD O
) ) O
. . O

A DT O
model NN O
of IN O
adenovirus JJ O
5 CD O
( ( O
Ad5 NNP O
) ) O
infection NN O
was VBD O
developed VBN O
in IN O
guinea NN O
pigs NNS O
to TO O
begin VB O
to TO O
study VB O
its PRP$ O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
peripheral JJ O
lung NN O
inflammation NN O
. . O

BACKGROUND NNP O
AND CC O
METHODS NNP O
: : O
Because IN O
the DT O
use NN O
of IN O
immunohistochemistry NN O
in IN O
the DT O
diagnosis NN O
of IN O
granulosa NN O
cell NN O
tumor NN O
( ( O
GCT NNP O
) ) O
has VBZ O
not RB O
been VBN O
fully RB O
explored VBN O
, , O
routinely RB O
processed VBN O
( ( O
formalin JJ O
- : O
fixed VBN O
, , O
paraffin SYM O
- : O
embedded VBN O
) ) O
tissue NN O
from IN O
11 CD O
GCT NNP O
, , O
adult NN O
type NN O
, , O
was VBD O
investigated VBN O
immunohistochemicall NN O
( ( O
ABC NNP O
method NN O
) ) O
with IN O
a DT O
broad JJ O
spectrum NN O
of IN O
antibodies NNS O
against IN O
various JJ O
markers NNS O
, , O
including VBG O
p53 NN B-Gene
and CC O
Ki NNP B-Gene
- : I-Gene
67 CD I-Gene
. . O

1 CD O
, , O
25 CD O
- : O
Dihydroxyvitamin NN O
D3 NNP O
( ( O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
) ) O
plays VBZ O
a DT O
major JJ O
role NN O
in IN O
the DT O
stimulation NN O
of IN O
bone NN O
growth NN O
, , O
mineralization NN O
, , O
and CC O
intestinal JJ O
calcium NN O
and CC O
phosphate JJ O
absorption NN O
; : O
it PRP O
also RB O
acts VBZ O
as IN O
a DT O
general JJ O
inhibitor NN O
of IN O
cellular JJ O
proliferation NN O
. . O

Position NNP O
effect NN O
of IN O
translocations NNS O
involving VBG O
the DT O
inactive JJ B-Gene
X NNP I-Gene
chromosome NN I-Gene
: : O
physical JJ O
linkage NN O
to TO O
XIC VB B-Gene
/ JJ I-Gene
XIST NN I-Gene
does VBZ O
not RB O
lead VB O
to TO O
long JJ O
- : O
range NN O
de IN O
novo FW O
inactivation NN O
in IN O
human JJ O
differentiated JJ O
cells NNS O
. . O

Taken VBN O
together RB O
, , O
the DT O
results NNS O
indicate VBP O
that IN O
M NNP B-Gene
- : I-Gene
CSF NNP I-Gene
treatment NN O
is VBZ O
associated VBN O
with IN O
differential JJ O
activation NN O
of IN O
multiple JJ O
members NNS O
of IN O
the DT O
jun NN B-Gene
/ NNP I-Gene
fos VBD I-Gene
family NN I-Gene
and CC O
that DT O
expression NN O
of IN O
these DT O
genes NNS O
could MD O
contribute VB O
to TO O
nuclear JJ O
signaling VBG O
mechanisms NNS O
that WDT O
regulate VBP O
a DT O
specific JJ O
program NN O
of IN O
monocyte JJ O
differentiation NN O
. . O

In IN O
this DT O
communication NN O
, , O
we PRP O
provide VBP O
evidence NN O
that IN O
the DT O
pathway NN O
of IN O
induction NN O
in IN O
the DT O
macrophage NN O
cell NN O
line NN O
U937 NNP O
is VBZ O
different JJ O
from IN O
that DT O
in IN O
Jurkat NNP O
cells NNS O
. . O

Here RB O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
human JJ B-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
receptor NN I-Gene
alpha NN I-Gene
promoter NN I-Gene
directs VBZ O
reporter JJ B-Gene
gene NN I-Gene
activity NN O
in IN O
a DT O
tissue NN O
- : O
specific JJ O
fashion NN O
in IN O
myelomonocytic JJ O
cells NNS O
, , O
which WDT O
correlates VBZ O
with IN O
its PRP$ O
expression NN O
pattern NN O
as IN O
analyzed VBN O
by IN O
reverse JJ O
transcription NN O
PCR NNP O
. . O

It PRP O
is VBZ O
known VBN O
that IN O
sulfated VBD O
polysaccharides NNS O
can MD O
mimic VB O
the DT O
action NN O
of IN O
common JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
mitogens NNS I-Gene
. . O

Like IN O
Esc NNP B-Gene
, , O
Eed NNP B-Gene
contains VBZ O
six CD O
WD NNP B-Gene
- : I-Gene
40 CD I-Gene
repeats NNS I-Gene
in IN O
the DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
half NN I-Gene
of IN O
the DT O
protein NN O
and CC O
is VBZ O
thought VBN O
to TO O
repress VB O
homeotic JJ O
gene NN O
expression NN O
during IN O
mouse NN O
embryogenesis NN O
. . O

IL NNP B-Gene
- : I-Gene
2 CD I-Gene
gene NN O
transcription NN O
in IN O
T NNP O
cells NNS O
requires VBZ O
both DT O
TCR NNP O
and CC O
costimulatory JJ O
signals NNS O
. . O

We PRP O
consider VBP O
the DT O
possible JJ O
consequences NNS O
of IN O
the DT O
reduced JJ O
cellular JJ O
content NN O
of IN O
TFIIH NNP B-Gene
for IN O
the DT O
clinical JJ O
symptoms NNS O
in IN O
XP NNP O
- : O
B NN O
or CC O
XP NNP O
- : O
D NN O
patients NNS O
, , O
and CC O
discuss VB O
a DT O
' POS O
conditional JJ O
phenotype NN O
' POS O
that WDT O
may MD O
involve VB O
an DT O
impairment NN O
of IN O
cellular JJ O
function NN O
only RB O
under IN O
certain JJ O
growth NN O
conditions NNS O
. . O

The DT O
incidence NN O
of IN O
skewing NN O
was VBD O
statistically RB O
significantly RB O
lower JJR O
in IN O
women NNS O
younger JJR O
than IN O
30 CD O
years NNS O
( ( O
2 CD O
/ RB O
73 CD O
) ) O
compared VBN O
with IN O
women NNS O
older JJR O
than IN O
60 CD O
years NNS O
( ( O
10 CD O
/ RB O
53 CD O
) ) O
. . O

The DT O
following JJ O
transcription NN B-Gene
factors NNS I-Gene
were VBD O
studied VBN O
: : O
the DT O
Octamer NNP B-Gene
factors NNS I-Gene
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
members NNS O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
factor NN I-Gene
family NN I-Gene
, , O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
factors NNS I-Gene
, , O
in IN O
particular JJ O
NF NNP B-Gene
- : I-Gene
ATp NNP I-Gene
, , O
and CC O
members NNS O
of IN O
the DT O
Rel NNP B-Gene
/ NNP I-Gene
NF NNP I-Gene
- : I-Gene
kB NN I-Gene
family NN I-Gene
. . O

The DT O
immunodominant NN O
, , O
CD8 NNP O
( ( O
+ NNP O
) ) O
cytotoxic NN O
T NNP O
lymphocyte NN O
( ( O
CTL NNP O
) ) O
response NN O
to TO O
the DT O
HLA NNP O
- : O
B8 NNP O
- : O
restricted VBD O
peptide NN O
, , O
RAKFKQLL NNP O
, , O
located VBN O
in IN O
the DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
immediate JJ I-Gene
- : I-Gene
early JJ I-Gene
antigen NN I-Gene
, , O
BZLF1 NNP B-Gene
, , O
is VBZ O
characterized VBN O
by IN O
a DT O
diverse JJ O
T NNP B-Gene
cell NN I-Gene
receptor NN I-Gene
( ( I-Gene
TCR NNP I-Gene
) ) I-Gene
repertoire NN I-Gene
. . O

X JJ O
inactivation NN O
analysis NN O
in IN O
a DT O
female NN O
with IN O
hypomelanosis NN O
of IN O
Ito NNP O
associated VBN O
with IN O
a DT O
balanced JJ B-Gene
X NN I-Gene
; : I-Gene
17 CD I-Gene
translocation NN I-Gene
: : O
evidence NN O
for IN O
functional JJ O
disomy NN O
of IN O
Xp NNP O
. . O

Inhibition NN O
studies NNS O
were VBD O
used VBN O
to TO O
select VB O
the DT O
monoclonal JJ B-Gene
antibodies NNS I-Gene
( ( O
mAECA NN B-Gene
) ) O
which WDT O
share NN O
the DT O
same JJ O
EC NNP O
epitope NN O
binding VBG O
specificity NN O
as IN O
the DT O
total JJ B-Gene
IgG NNP I-Gene
- : I-Gene
AECA NN I-Gene
from IN O
the DT O
Takayasu NNP O
arteritis NN O
patient NN O
. . O

Our PRP$ O
study NN O
suggests VBZ O
that IN O
the DT O
interaction NN O
of IN O
Tax NNP B-Gene
with IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
TFIIA NNP B-Gene
may MD O
play VB O
a DT O
role NN O
in IN O
Tax NNP B-Gene
- : O
mediated VBD O
transcriptional JJ O
activation NN O
. . O

However RB O
, , O
induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
, , O
which WDT O
has VBZ O
the DT O
same JJ O
signaling NN O
requirements NNS O
as IN O
c JJ B-Gene
- : I-Gene
Rel JJ I-Gene
induction NN O
, , O
was VBD O
not RB O
inhibited VBN O
by IN O
PF NNP O
. . O

Involvement NN O
of IN O
Janus NNP B-Gene
kinase NNP I-Gene
/ NNP B-Gene
signal JJ I-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
and CC O
protein NN B-Gene
kinase NN I-Gene
C NNP I-Gene
signaling NN O
pathways NNS O
. . O

We PRP O
describe VBP O
18 CD O
patients NNS O
from IN O
several JJ O
generations NNS O
of IN O
12 CD O
unrelated JJ O
families NNS O
who WP O
were VBD O
heterozygous JJ O
for IN O
1 CD O
to TO O
5 CD O
overlapping VBG B-Gene
IFNGR1 NNP I-Gene
frameshift NN I-Gene
small JJ I-Gene
deletions NNS I-Gene
and CC O
a DT O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
IFNGR1 NNP I-Gene
allele NN I-Gene
. . O

Furthermore RB O
, , O
the DT O
receptor NN O
changes NNS O
observed VBN O
are VBP O
opposite JJ O
of IN O
those DT O
reported VBN O
in IN O
major JJ O
depressive JJ O
disorder NN O
. . O

HIV NNP B-Gene
glycoprotein VBD I-Gene
120 CD I-Gene
enhances NNS O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
gene NN O
expression NN O
in IN O
glial JJ O
cells NNS O
. . O

The DT O
age NN O
- : O
related JJ O
decline NN O
in IN O
induction NN O
of IN O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
could MD O
not RB O
be VB O
attributed VBN O
to TO O
alteration NN O
in IN O
the DT O
composition NN O
of IN O
subunits NNS O
, , O
p50 NN B-Gene
and CC O
p65 NN B-Gene
were VBD O
found VBN O
to TO O
be VB O
the DT O
predominant JJ O
subunits NNS O
of IN O
induced JJ O
NF NNP B-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
T NNP O
cells NNS O
from IN O
young JJ O
as RB O
well RB O
as IN O
elderly JJ O
donors NNS O
. . O

These DT O
in IN O
vivo NN O
anti SYM O
- : O
inflammatory JJ O
effects NNS O
of IN O
IL NNP B-Gene
- : I-Gene
11 CD I-Gene
were VBD O
associated VBN O
with IN O
reduced JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
in IN O
lung NN O
, , O
reduced VBN O
levels NNS O
of IN O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
in IN O
bronchoalveolar JJ O
lavage NN O
( ( O
BAL NNP O
) ) O
fluids NNS O
, , O
and CC O
diminished VBD O
up RP O
- : O
regulation NN O
of IN O
lung NN B-Gene
vascular NN I-Gene
ICAM NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

This DT O
cooperation NN O
was VBD O
also RB O
required VBN O
to TO O
induce VB O
the DT O
sustained JJ O
proliferation NN O
of IN O
differentiation NN O
- : O
blocked JJ O
erythroblasts NNS O
in IN O
response NN O
to TO O
ligand VB O
activation NN O
of IN O
the DT O
endogenous JJ B-Gene
tyrosine NN I-Gene
kinase NN I-Gene
receptor NN I-Gene
c SYM B-Gene
- : I-Gene
Kit NNP I-Gene
. . O

Inasmuch JJ O
as IN O
these DT O
features NNS O
implicate VBP O
enhanced VBN O
calcitriol JJ O
action NN O
in IN O
gut NN O
and CC O
bone NN O
, , O
we PRP O
analyzed VBD O
the DT O
vitamin NN B-Gene
D NNP I-Gene
receptor NN I-Gene
( ( I-Gene
VDR NNP I-Gene
) ) I-Gene
gene NN I-Gene
to TO O
ascertain VB O
whether IN O
an DT O
abnormality NN O
of IN O
this DT O
gene NN O
marks VBZ O
patients NNS O
with IN O
intestinal JJ O
hyperabsorption NN O
of IN O
calcium NN O
. . O

To TO O
better RBR O
understand VB O
the DT O
regulation NN O
of IN O
this DT O
pivotal JJ O
gene NN O
, , O
we PRP O
have VBP O
analyzed VBN O
the DT O
human JJ B-Gene
genomic JJ I-Gene
DNA NN I-Gene
sequence NN I-Gene
upstream NN O
of IN O
the DT O
B29 NNP B-Gene
ATG NNP B-Gene
start VBP I-Gene
codon NN I-Gene
for IN O
transcriptional JJ O
control NN O
activity NN O
. . O

To TO O
delineate VB O
the DT O
effects NNS O
of IN O
these DT O
motifs NNS O
on IN O
the DT O
replicative JJ O
capacity NN O
of IN O
HIV NNP O
and CC O
to TO O
explore VB O
the DT O
possibility NN O
of IN O
extending VBG O
the DT O
virus NN O
host NN O
range NN O
, , O
known VBN O
heterologous JJ B-Gene
enhancer NN I-Gene
/ NN I-Gene
promoters NNS I-Gene
were VBD O
inserted VBN O
into IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
in IN O
place NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
Sp1 NNP B-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Although IN O
CD28 NNP B-Gene
is VBZ O
constitutively RB O
expressed VBN O
, , O
its PRP$ O
expression NN O
is VBZ O
transiently RB O
down RP O
- : O
regulated VBN O
following VBG O
T NNP O
cell NN O
activation NN O
and CC O
declines NNS O
progressively RB O
with IN O
in IN O
vitro JJ O
senescence NN O
. . O

The DT O
TNF NNP B-Gene
alpha SYM I-Gene
- : O
activated VBN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
was VBD O
transcriptionally RB O
functional JJ O
. . O

The DT O
mechanism NN O
of IN O
reduced JJ O
GR NNP B-Gene
levels NNS O
in IN O
relation NN O
to TO O
age NN O
and CC O
sport NN O
activity NN O
could MD O
involve VB O
a DT O
loss NN O
or CC O
an DT O
involution NN O
of IN O
receptor NN O
synthesis NN O
. . O

IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
transcription NN O
is VBZ O
at IN O
least JJS O
in IN O
part NN O
controlled VBN O
by IN O
two CD O
positive JJ B-Gene
regulatory JJ I-Gene
regions NNS I-Gene
, , O
PRRI NNP B-Gene
and CC O
PRRII NNP B-Gene
. . O

In IN O
an DT O
attempt NN O
to TO O
find VB O
such JJ O
elusive JJ O
Oct2 NNP B-Gene
target NN B-Gene
genes NNS I-Gene
and CC O
to TO O
understand VB O
the DT O
molecular JJ O
function NN O
of IN O
Oct2 NNP B-Gene
in IN O
B NNP O
cell NN O
development NN O
, , O
we PRP O
isolated VBD O
cDNAs NN B-Gene
for IN O
Oct2 NNP B-Gene
target NN B-Gene
genes NNS I-Gene
. . O

The DT O
ability NN O
of IN O
T NNP O
cells NNS O
to TO O
produce VB O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
is VBZ O
a DT O
critical JJ O
control NN O
point NN O
in IN O
T NNP O
lymphocyte JJ O
activation NN O
. . O

There EX O
appears VBZ O
to TO O
be VB O
no DT O
relationship NN O
between IN O
the DT O
number NN O
of IN O
AML1 NNP B-Gene
/ NNP I-Gene
ETO NNP I-Gene
transcripts NNS I-Gene
found VBN O
in IN O
the DT O
infused JJ O
PBSC NNP O
harvests NNS O
and CC O
the DT O
incidence NN O
of IN O
leukemic JJ O
relapse NN O
following VBG O
autologous JJ O
PBSCT NNP O
in IN O
our PRP$ O
study NN O
. . O

Treatment NN O
of IN O
SKW NNP O
6 CD O
. . O
4 CD O
cells NNS O
with IN O
IL NNP B-Gene
6 CD I-Gene
induced VBD O
a DT O
transient NN O
and CC O
early JJ O
stimulation NN O
of IN O
c SYM B-Gene
- : I-Gene
fos NN I-Gene
sense NN I-Gene
mRNA NN I-Gene
expression NN O
. . O

The DT O
activation NN O
of IN O
this DT O
nuclear JJ O
factor NN O
is VBZ O
qualitatively RB O
different JJ O
in IN O
rheumatoid JJ O
synovial JJ O
T NNP O
cells NNS O
to TO O
that DT O
in IN O
other JJ O
forms NNS O
of IN O
non JJ O
- : O
rheumatoid NN O
arthritis NN O
( ( O
for IN O
example NN O
, , O
osteoarthritis NN O
, , O
spondyloarthropathie NN O
) ) O
. . O

The DT O
consequences NNS O
of IN O
EBV NNP O
infection NN O
of IN O
T NNP O
cells NNS O
at IN O
an DT O
early JJ O
stage NN O
of IN O
differentiation NN O
may MD O
lead VB O
to TO O
failure NN O
of IN O
normal JJ O
T NNP O
cell NN O
repertoire NN O
development NN O
, , O
autoimmunity NN O
, , O
or CC O
malignancy NN O
. . O

We PRP O
analyzed VBD O
the DT O
activation NN O
of IN O
STATs NNP B-Gene
in IN O
primary JJ O
human JJ O
T NNP O
and CC O
NK NNP O
cells NNS O
by IN O
a DT O
variety NN O
of IN O
specific JJ O
cytokines NNS B-Gene
. . O

Active JJ O
suppression NN O
of IN O
the DT O
class NN B-Gene
II NNP I-Gene
transactivator NN I-Gene
- : I-Gene
encoding VBG I-Gene
AIR NNP I-Gene
- : I-Gene
1 CD I-Gene
locus NN I-Gene
is VBZ O
responsible JJ O
for IN O
the DT O
lack NN O
of IN O
major JJ B-Gene
histocompatibility NN I-Gene
complex JJ I-Gene
class NN I-Gene
II NNP I-Gene
gene NN I-Gene
expression NN O
observed VBD O
during IN O
differentiation NN O
from IN O
B NNP O
cells NNS O
to TO O
plasma VB O
cells NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
demonstration NN O
of IN O
hormone NN B-Gene
receptor NN I-Gene
proteins NNS I-Gene
in IN O
cells NNS O
from IN O
malignant JJ O
effusions NNS O
is VBZ O
possible JJ O
and CC O
that IN O
there EX O
is VBZ O
a DT O
correlation NN O
with IN O
the DT O
status NN O
of IN O
the DT O
primary JJ O
site NN O
of IN O
cancer NN O
. . O

Both DT O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
CACCC NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
are VBP O
critical JJ O
for IN O
the DT O
developmentally RB O
regulated JJ O
expression NN O
of IN O
erythroid JJ B-Gene
- : I-Gene
specific JJ I-Gene
genes NNS I-Gene
. . O

As IN O
a DT O
functional JJ O
correlate NN O
of IN O
this DT O
finding NN O
, , O
transient NN O
co SYM O
- : O
transfection NN O
of IN O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
reporter NN I-Gene
constructs NNS I-Gene
in IN O
a DT O
different JJ O
T NNP O
cell NN O
line NN O
demonstrated VBD O
that IN O
v FW B-Gene
- : I-Gene
src NN I-Gene
activated VBD O
this DT O
promoter NN B-Gene
in IN O
a DT O
kappa NN O
B NNP O
- : O
dependent JJ O
manner NN O
. . O

A DT O
pair NN O
of IN O
restriction NN B-Gene
fragment NN I-Gene
length NN I-Gene
polymorphisms NN I-Gene
( ( O
RFLPs NNP B-Gene
) ) O
, , O
one CD O
of IN O
which WDT O
hybridizes VBZ O
to TO O
the DT O
TCR NNP B-Gene
constant JJ I-Gene
region NN I-Gene
C NNP I-Gene
beta NN I-Gene
1 CD I-Gene
and CC O
the DT O
other JJ O
to TO O
the DT O
C NNP B-Gene
beta NN I-Gene
2 CD I-Gene
gene NN I-Gene
, , O
has VBZ O
been VBN O
identified VBN O
, , O
suggesting VBG O
these DT O
may MD O
be VB O
genotypic JJ O
markers NNS O
for IN O
an DT O
extended JJ O
region NN O
of IN O
the DT O
TCR NNP B-Gene
beta NN I-Gene
locus NN I-Gene
. . O

Nonspecific NNP O
protein NN B-Gene
kinase NN I-Gene
inhibition NN O
inhibited VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
release NN O
, , O
while IN O
specific JJ O
PKC NNP B-Gene
inhibition NN O
with IN O
Bis NNP O
had VBD O
no DT O
effect NN O
on IN O
LPS NNP O
- : O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
DNA NN O
binding NN O
or CC O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
release NN O
. . O

In IN O
this DT O
review NN O
, , O
we PRP O
describe VBP O
the DT O
host NN B-Gene
- : I-Gene
cell NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
that IN O
interact NN O
with IN O
the DT O
5 CD B-Gene
' POS I-Gene
- : I-Gene
UTR NN I-Gene
and CC O
discuss VB O
their PRP$ O
role NN O
in IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
HIV NNP O
- : O
1 CD O
gene NN O
expression NN O
. . O

Circularization NN O
of IN O
the DT O
EBV NNP B-Gene
genome NN I-Gene
was VBD O
not RB O
detected VBN O
. . O

In IN O
contrast NN O
to TO O
the DT O
MF NNP O
individuals NNS O
where WRB O
no DT O
effect NN O
was VBD O
seen VBN O
, , O
transendothelial JJ O
migration NN O
of IN O
48 CD O
- : O
hr NN O
filarial JJ O
antigen NN O
stimulated VBD O
T NNP O
- : O
cells NNS O
from IN O
LP NNP O
individuals NNS O
was VBD O
significantly RB O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
1 CD O
) ) O
greater JJR O
than IN O
migration NN O
of IN O
48 CD O
- : O
hr NN O
media NNS O
- : O
stimulated VBN O
T NNP O
- : O
cells NNS O
. . O

However RB O
, , O
presentation NN O
of IN O
endogenously RB O
synthesized VBN O
IE1 NNP B-Gene
can MD O
be VB O
restored VBN O
when WRB O
U373 NNP O
MG NNP O
cells NNS O
are VBP O
transfected VBN O
with IN O
CIITA NNP B-Gene
prior RB O
to TO O
infection NN O
with IN O
HCMV NNP O
. . O

However RB O
, , O
TG NNP O
induced VBD O
increases NNS O
in IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha JJ I-Gene
protein NN I-Gene
as RB O
well RB O
as IN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
mRNA NN I-Gene
in IN O
Jurkat NNP O
T NNP O
cells NNS O
in IN O
a DT O
dose JJ O
- : O
dependent JJ O
manner NN O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
the DT O
putative JJ O
GAS NNP B-Gene
element NN I-Gene
in IN O
the DT O
CAEV NNP B-Gene
LTR NNP I-Gene
binds VBZ O
specifically RB O
to TO O
a DT O
cellular JJ B-Gene
factor NN I-Gene
induced VBN O
by IN O
IFN NNP B-Gene
- : I-Gene
gamma NN I-Gene
in IN O
promonocytic JJ O
cells NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
a DT O
single JJ O
cytokine NN B-Gene
receptor NN I-Gene
can MD O
activate VB O
different JJ O
STAT NNP B-Gene
family NN I-Gene
members NNS I-Gene
in IN O
a DT O
cell NN O
- : O
specific JJ O
manner NN O
, , O
which WDT O
might MD O
result VB O
in IN O
cell NN O
- : O
specific JJ O
gene NN O
transcription NN O
. . O

The DT O
c SYM B-Gene
- : I-Gene
rel NN I-Gene
protooncogene NN I-Gene
encodes VBZ O
a DT O
subunit NN O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
like IN I-Gene
family NN I-Gene
of IN I-Gene
transcription NN I-Gene
factors NNS I-Gene
. . O

The DT O
extracellular JJ O
domain NN O
of IN O
the DT O
murine NN B-Gene
G NNP I-Gene
- : I-Gene
CSF NNP I-Gene
receptor NN I-Gene
was VBD O
required VBN O
for IN O
the DT O
activity NN O
of IN O
SB NNP O
247464 CD O
, , O
suggesting VBG O
that IN O
the DT O
compound NN O
acts VBZ O
by IN O
oligomerizing VBG B-Gene
receptor NN I-Gene
chains NNS I-Gene
. . O

The DT O
present JJ O
review NN O
summarizes VBZ O
these DT O
findings NNS O
, , O
with IN O
a DT O
special JJ O
focus NN O
on IN O
our PRP$ O
own JJ O
studies NNS O
on IN O
pluripotent JJ O
endocrine NN O
cultures NNS O
of IN O
rat NN O
pancreas NNS O
. . O

It PRP O
can MD O
only RB O
be VB O
activated VBN O
in IN O
a DT O
tissue NN O
- : O
specific JJ O
manner NN O
by IN O
elements NNS O
that WDT O
lie VBP O
downstream NN O
of IN O
the DT O
initiation NN B-Gene
site NN I-Gene
. . O

Transfection NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
promoter NN I-Gene
constructs NNS I-Gene
confirmed VBD O
the DT O
marked VBN O
difference NN O
between IN O
PMA NNP O
and CC O
okadaic JJ O
acid NN O
in IN O
inducing VBG O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
transcription NN O
. . O

We PRP O
have VBP O
identified VBN O
and CC O
separated VBN O
four CD O
nuclear JJ B-Gene
proteins NNS I-Gene
from IN O
C81 NNP O
- : O
66 CD O
- : O
45 CD O
cells NNS O
, , O
an DT O
HTLV NNP O
- : O
I PRP O
immortalized VBP O
Tax NNP O
- : O
expressing VBG O
human JJ O
T NNP O
- : O
lymphocyte NN O
line NN O
( ( O
Salahuddin NNP O
et RB O
al RB O
. . O
, , O
1983 CD O
) ) O
, , O
that IN O
interact NN O
with IN O
the DT O
TRE NNP B-Gene
- : I-Gene
DNA NN I-Gene
, , O
none NN O
of IN O
which WDT O
are VBP O
identical JJ O
with IN O
the DT O
Tax NNP B-Gene
- : I-Gene
protein NN I-Gene
. . O

Together RB O
, , O
these DT O
findings NNS O
demonstrate VBP O
that IN O
cytokine NN O
or CC O
phorbol NN O
ester JJ O
stimulation NN O
of IN O
KG1 NNP O
is VBZ O
a DT O
model NN O
of IN O
human JJ O
CD34 NNP O
+ NNP O
HPC NNP O
to TO O
DC NNP O
differentiation NN O
and CC O
suggest VBP O
that IN O
specific JJ O
intracellular JJ O
signaling NN O
pathways NNS O
mediate VBP O
specific JJ O
events NNS O
in IN O
DC NNP O
lineage NN O
commitment NN O
. . O

Treatment NN O
of IN O
B NNP O
lymphocytes VBZ O
with IN O
the DT O
cytokine NN B-Gene
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
) ) O
, , O
in IN O
the DT O
absence NN O
of IN O
prior JJ O
activation NN O
, , O
induces VBZ O
a DT O
weak JJ O
up RP O
- : O
regulation NN O
of IN O
VDR NNP B-Gene
expression NN O
but CC O
fails VBZ O
to TO O
generate VB O
vitamin NN B-Gene
D NNP I-Gene
- : I-Gene
responsive JJ I-Gene
element NN I-Gene
( ( I-Gene
VDRE NNP I-Gene
) ) I-Gene
- : I-Gene
reactive JJ I-Gene
nuclear JJ I-Gene
protein NN I-Gene
complexes NNS I-Gene
or CC O
to TO O
initiate VB O
the DT O
genomic JJ O
transcription NN O
of IN O
25 CD B-Gene
- : I-Gene
hydroxyvitamin NN I-Gene
D3 NNP I-Gene
24 CD I-Gene
- : I-Gene
hydroxylase NN I-Gene
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
p38 NN B-Gene
may MD O
influence VB O
host NN O
defence NN O
and CC O
inflammation NN O
by IN O
maintaining VBG O
the DT O
balance NN O
of IN O
c JJ B-Gene
- : I-Gene
Jun NNP I-Gene
protein NN I-Gene
consumed VBD O
during IN O
infection NN O
. . O

The DT O
limited JJ O
activation NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
by IN O
HIV NNP B-Gene
protease NN I-Gene
appears VBZ O
unlikely JJ O
to TO O
have VB O
a DT O
significant JJ O
effect NN O
on IN O
virus NN O
expression NN O
or CC O
T NNP O
cell NN O
function NN O
. . O

GR NNP O
number NN O
in IN O
the DT O
patient NN O
' POS O
s NN O
transformed VBD O
lymphocytes NNS O
was VBD O
approximately RB O
one CD O
half NN O
that IN O
of IN O
control NN O
cells NNS O
with IN O
a DT O
approximately RB O
10 CD O
- : O
fold NN O
reduction NN O
in IN O
binding VBG O
affinity NN O
for IN O
dexamethasone NN O
. . O

As IN O
the DT O
predicted JJ O
protein NN O
is VBZ O
very RB O
similar JJ O
to TO O
the DT O
yeast JJ B-Gene
transcriptional JJ I-Gene
regulator NN I-Gene
Rpd3p NNP B-Gene
, , O
these DT O
results NNS O
support VBD O
a DT O
role NN O
for IN O
histone NN B-Gene
deacetylase NN I-Gene
as IN O
a DT O
key JJ O
regulator NN O
of IN O
eukaryotic JJ O
transcription NN O
. . O

In IN O
an DT O
effort NN O
to TO O
further JJ O
elucidate VB O
the DT O
biological JJ O
effects NNS O
of IN O
A NNP O
beta NN O
towards NNS O
microglia NNS O
, , O
we PRP O
investigated VBD O
the DT O
ability NN O
of IN O
A NNP O
beta NN O
peptides NNS O
to TO O
activate VB O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
in IN O
the DT O
N9 NNP O
murine NN O
microglial NN O
cell NN O
line NN O
. . O

CONCLUSION NN O
: : O
We PRP O
suggest VBP O
that IN O
Oct1 NNP B-Gene
, , O
YY1 NNP B-Gene
, , O
and CC O
octamer SYM B-Gene
- : I-Gene
like IN I-Gene
factors NNS I-Gene
binding VBG O
to TO O
the DT O
- : B-Gene
90 CD I-Gene
/ SYM I-Gene
- : I-Gene
79 CD I-Gene
sequence NN I-Gene
within IN O
the DT O
proximal JJ B-Gene
IL NNP I-Gene
- : I-Gene
5 CD I-Gene
promoter NN I-Gene
are VBP O
involved VBN O
in IN O
suppression NN O
of IN O
IL NNP B-Gene
- : I-Gene
5 CD I-Gene
transcription NN O
in IN O
T NNP O
cells NNS O
. . O

A DT O
germline NN B-Gene
TaqI NNP I-Gene
restriction NN I-Gene
fragment NN I-Gene
length NN I-Gene
polymorphism NN I-Gene
in IN O
the DT O
progesterone NN B-Gene
receptor NN I-Gene
gene NN I-Gene
in IN O
ovarian JJ O
carcinoma NN O
[ NNP O
see VBP O
comments NNS O
] VB O

This DT O
low JJ O
frequency NN O
of IN O
response NN O
was VBD O
no DT O
different JJ O
from IN O
that DT O
previously RB O
detected VBN O
using VBG O
cultures NNS O
of IN O
T NNP O
cells NNS O
and CC O
autologous JJ O
dendritic JJ O
cells NNS O
. . O

Importantly RB O
, , O
jagged1 NN B-Gene
transcripts NNS I-Gene
were VBD O
also RB O
upregulated VBN O
by IN O
endogenous JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
and CC O
this DT O
effect NN O
was VBD O
inhibited VBN O
by IN O
a DT O
dominant JJ O
mutant NN O
of IN O
IkappaBalpha NNP B-Gene
, , O
a DT O
physiological JJ O
inhibitor NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

These DT O
results NNS O
demonstrate VBP O
enhanced JJ O
efficacy NN O
of IN O
local JJ O
immunosuppression NN O
by IN O
targeting VBG O
spleen JJ O
with IN O
liposomal JJ O
MPL NNP O
. . O

Epstein NNP O
- : O
Barr NNP O
virus NN O
replicative JJ O
gene NN O
transcription NN O
during IN O
de FW O
novo FW O
infection NN O
of IN O
human JJ O
thymocytes NNS O
: : O
simultaneous JJ O
early JJ O
expression NN O
of IN O
BZLF NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
its PRP$ O
repressor NN O
RAZ NNP B-Gene
. . O

The DT O
present JJ O
paper NN O
reviews VBZ O
the DT O
data NNS O
supporting VBG O
a DT O
new JJ O
, , O
two CD O
- : O
step NN O
model NN O
for IN O
non JJ O
- : O
genomic NN O
and CC O
genomic JJ O
aldosterone NN O
effects NNS O
. . O

[ JJ O
Glucocorticoid NNP B-Gene
receptors NNS I-Gene
on IN O
human JJ O
peripheral JJ O
mononuclear NN O
and CC O
polymorphonuclear JJ O
leucocytes NNS O
: : O
changes NNS O
in IN O
patients NNS O
with IN O
yang NNP O
- : O
deficiency NN O
] NN O

STAT1 NNP B-Gene
activation NN O
during IN O
monocyte NN O
to TO O
macrophage VB O
maturation NN O
: : O
role NN O
of IN O
adhesion NN B-Gene
molecules NNS I-Gene
. . O

PU NNP B-Gene
. . I-Gene
1 CD I-Gene
represses NNS O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
- : O
mediated VBN O
transcriptional JJ O
activation NN O
. . O

The DT O
BAT NNP B-Gene
box NN I-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
were VBD O
also RB O
implicated VBN O
in IN O
the DT O
induction NN O
of IN O
CD20 NNP B-Gene
in IN O
the DT O
pre NN O
- : O
B NNP O
cell NN O
line NN O
, , O
PB NNP O
- : O
697 CD O
, , O
via IN O
phorbol NN O
esters NNS O
. . O

Activation NN O
of IN O
transcription NN O
factor NN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
by IN O
phagocytic JJ O
stimuli NNS O
in IN O
human JJ O
neutrophils NNS O
. . O

TFIIDs NN B-Gene
from IN O
all DT O
three CD O
organisms NNS O
are VBP O
interchangeable JJ O
among IN O
all DT O
three CD O
systems NNS O
. . O

Interaction NN O
between IN O
protein JJ B-Gene
kinase NN I-Gene
C NNP I-Gene
( ( O
PKC NNP B-Gene
) ) O
- : O
and CC O
glucocorticoid JJ B-Gene
receptor NN I-Gene
( ( O
GR NNP B-Gene
) ) O
- : O
mediated VBN O
signaling NN O
is VBZ O
suggested VBN O
by IN O
the DT O
ability NN O
of IN O
the DT O
PKC NNP B-Gene
activating VBG O
phorbol NN O
ester NN O
12 CD O
- : O
O NNP O
- : O
tetradecanoylphorbol NN O
- : O
13 CD O
- : O
acetate NN O
( ( O
TPA NNP O
) ) O
to TO O
inhibit VB O
GR NNP B-Gene
- : O
dependent JJ O
transcription NN O
of IN O
the DT O
mouse NN O
mammary JJ O
tumor NN O
virus NN O
( ( O
MMTV NNP O
) ) O
long RB B-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
. . O

When WRB O
ordered VBN O
according VBG O
to TO O
stage NN O
of IN O
maturation NN O
, , O
the DT O
amount NN O
of IN O
constitutive JJ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
was VBD O
not RB O
increased VBN O
in IN O
more RBR O
mature NN O
cell NN O
lines NNS O
. . O

Removal NN O
of IN O
the DT O
carboxy JJ B-Gene
terminus NN I-Gene
enables VBZ O
ERP NNP B-Gene
to TO O
interact VB O
with IN O
a DT O
variety NN O
of IN O
ets NNS B-Gene
- : I-Gene
binding VBG I-Gene
sites NNS I-Gene
including VBG O
the DT O
E74 NNP B-Gene
site NN I-Gene
, , O
the DT O
IgH NNP B-Gene
enhancer NN I-Gene
pi NN I-Gene
site NN I-Gene
, , O
and CC O
the DT O
lck NN B-Gene
promoter NN I-Gene
ets NNS I-Gene
site NN I-Gene
, , O
suggesting VBG O
a DT O
carboxy JJ B-Gene
- : I-Gene
terminal JJ I-Gene
negative JJ I-Gene
regulatory JJ I-Gene
domain NN I-Gene
. . O

During IN O
latent JJ O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
EBV NNP O
) ) O
infection NN O
of IN O
human JJ O
B NNP O
lymphocytes NNS O
, , O
six CD B-Gene
viral JJ I-Gene
nuclear JJ I-Gene
antigen NN I-Gene
( ( O
EBNAs NNP B-Gene
) ) O
are VBP O
expressed VBN O
from IN O
long RB B-Gene
primary JJ I-Gene
transcripts NNS I-Gene
by IN O
means NNS O
of IN O
alternative JJ B-Gene
splicing NN I-Gene
and CC O
alternative JJ B-Gene
polyadenylylation NN I-Gene
sites NNS I-Gene
. . O

Together RB O
, , O
our PRP$ O
data NNS O
show VBP O
that IN O
bcl SYM B-Gene
- : I-Gene
xL NN I-Gene
is VBZ O
essential JJ O
for IN O
normal JJ O
erythroid NN O
development NN O
and CC O
suggest VBP O
a DT O
regulatory JJ O
hierarchy NN O
in IN O
which WDT O
bcl SYM B-Gene
- : I-Gene
xL NN I-Gene
is VBZ O
a DT O
critical JJ O
downstream NN O
effector NN O
of IN O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
erythropoietin VB B-Gene
- : O
mediated VBN O
signals NNS O
. . O

The DT O
activity NN O
of IN O
DNA NNP B-Gene
binding VBG I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
dimers NNS I-Gene
is VBZ O
tightly RB O
controlled VBN O
by IN O
accessory NN B-Gene
proteins NNS I-Gene
called VBN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
subunits NNS I-Gene
of IN O
which WDT O
there EX O
are VBP O
also RB O
five CD O
different JJ O
species NNS O
currently RB O
known VBN O
in IN O
vertebrates NNS O
. . O

We PRP O
conclude VBP O
that IN O
CD28 NNP B-Gene
costimulation NN O
can MD O
cause VB O
substantial JJ O
T NNP O
cell NN O
proliferation NN O
in IN O
the DT O
absence NN O
of IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
, , O
which WDT O
is VBZ O
driven VBN O
by IN O
a DT O
soluble JJ B-Gene
factor NN I-Gene
independent JJ O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
transactivation NN O
. . O

Alcoholic JJ O
extracts NNS O
prepared JJ O
form NN O
Arnicae NNP O
flos NN O
, , O
the DT O
collective JJ O
name NN O
for IN O
flowerheads NNS O
from IN O
Arnica NNP O
montana NN O
and CC O
A NNP O
. . O
chamissonis NN O
ssp NN O
. . O
foliosa NN O
, , O
are VBP O
used VBN O
therapeutically RB O
as IN O
anti JJ O
- : O
inflammatory NN O
remedies NNS O
. . O

Quantitative JJ O
assays NNS O
demonstrated VBD O
a DT O
direct JJ O
temporal JJ O
relationship NN O
between IN O
LMP NNP B-Gene
- : I-Gene
1 CD I-Gene
protein NN I-Gene
levels NNS O
and CC O
active JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
during IN O
the DT O
time NN O
course NN O
of IN O
infection NN O
. . O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
interpretation NN O
that IN O
stimulation NN O
of IN O
Bcl NNP B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
is VBZ O
not RB O
the DT O
primary JJ O
target NN O
of IN O
AML1 NNP B-Gene
/ NNP I-Gene
ETO NNP I-Gene
. . O

The DT O
presence NN O
of IN O
mRNA NN B-Gene
for IN O
these DT O
proteins NNS O
in IN O
eosinophils NNS O
and CC O
basophils NNS O
suggests VBZ O
that IN O
gene NN O
transcription NN O
in IN O
these DT O
lineages NNS O
may MD O
be VB O
regulated VBN O
by IN O
GATA NNP B-Gene
- : I-Gene
binding NN I-Gene
proteins NNS I-Gene
. . O

The DT O
human JJ B-Gene
T NNP I-Gene
- : I-Gene
cell NN I-Gene
leukemia NN I-Gene
virus NN I-Gene
type NN I-Gene
I PRP I-Gene
( ( I-Gene
HTLV NNP I-Gene
- : I-Gene
I PRP I-Gene
) ) I-Gene
promoter NN I-Gene
contains NNS O
three CD O
copies NNS O
of IN O
imperfect JJ O
repeats NNS O
of IN O
a DT O
21 CD O
- : O
base NN O
pair NN O
sequence NN O
designated VBN O
here RB O
as IN O
TRE NNP B-Gene
( ( O
Tax NNP B-Gene
- : I-Gene
response NN I-Gene
element NN I-Gene
) ) O
that WDT O
is VBZ O
responsive JJ O
to TO O
the DT O
virally RB B-Gene
encoded JJ I-Gene
transactivator NN I-Gene
protein NN I-Gene
Tax NNP B-Gene
. . O

In IN O
comparison NN O
, , O
PBMC NNP O
from IN O
two CD O
children NNS O
with IN O
fatal JJ O
adenoviral JJ O
infection NN O
were VBD O
both DT O
strongly RB O
positive JJ O
for IN O
adenovirus JJ O
DNA NNP O
. . O

We PRP O
have VBP O
shown VBN O
that IN O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
and CC O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
control NN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( I-Gene
IL NNP I-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
) ) I-Gene
gene NN I-Gene
transcription NN O
in IN O
CD4 NNP O
- : O
CD8 NNP O
- : O
murine NN O
T NNP O
lymphocyte NN O
precursors NNS O
. . O

Differences NNS O
in IN O
pre JJ O
- : O
and CC O
postoperative JJ O
values NNS O
of IN O
cancer NN O
patients NNS O
were VBD O
seen VBN O
in IN O
plasma JJ O
RIA NNP O
values NNS O
: : O
PGE2 NNP O
and CC O
6 CD O
- : O
k NN O
- : O
PGF1 NNP O
alpha NN O
were VBD O
significantly RB O
higher RBR O
preoperatively RB O
when WRB O
compared VBN O
with IN O
postoperatively RB O
, , O
however RB O
, , O
such JJ O
differences NNS O
were VBD O
seen VBN O
in IN O
the DT O
control NN O
groups NNS O
as RB O
well RB O
. . O

The DT O
single JJ O
promoter NN B-Gene
region NN I-Gene
in IN O
the DT O
cloned JJ O
genome NN O
[ NNP O
Noteborn NNP O
et FW O
al NN O
. . O
, , O
J NNP O
. . O
Virol NNP O
. . O
65 CD O
( ( O
1991 CD O
) ) O
3131 CD O
- : O
3139 CD O
] NN O
of IN O
chicken NN O
anemia NN O
virus NN O
( ( O
CAV NNP O
) ) O
in IN O
chicken NN O
T NNP O
- : O
cells NNS O
was VBD O
analysed VBN O
via IN O
CAT NNP B-Gene
assays NNS O
. . O

This DT O
region NN O
is VBZ O
termed VBN O
the DT O
CK NNP B-Gene
- : I-Gene
1 CD I-Gene
or CC O
CD28RE NNP B-Gene
and CC O
appears VBZ O
to TO O
bind VB O
specific JJ O
members NNS O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
. . O

Over IN O
its PRP$ O
3 CD B-Gene
' '' I-Gene
end NN I-Gene
, , O
it PRP O
binds VBZ O
a DT O
factor NN O
that WDT O
is VBZ O
ubiquitously RB O
and CC O
constitutively RB O
expressed VBN O
. . O

We PRP O
report VBP O
here RB O
that IN O
interleukin JJ B-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
acts NNS O
on IN O
human JJ O
blood NN O
monocytes NNS O
by IN O
enhancing VBG O
binding VBG O
activity NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
to TO O
its PRP$ O
consensus NN O
sequence NN O
in IN O
the DT O
5 CD O
' POS O
regulatory JJ O
enhancer JJ O
region NN O
of IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
receptor NN I-Gene
alpha NN I-Gene
chain NN I-Gene
( ( O
p55 NN B-Gene
) ) O
. . O

ICSAT NNP B-Gene
is VBZ O
structurally RB O
most RBS O
closely RB O
related VBN O
to TO O
the DT O
previously RB O
cloned VBN O
ICSBP NNP B-Gene
, , O
a DT O
member NN O
of IN O
the DT O
IFN NNP B-Gene
regulatory JJ I-Gene
factor NN I-Gene
( ( I-Gene
IRF NNP I-Gene
) ) I-Gene
family NN I-Gene
of IN O
proteins NNS O
that WDT O
binds VBZ O
to TO O
interferon VB B-Gene
consensus NN I-Gene
sequences NNS I-Gene
( ( O
ICSs NNP B-Gene
) ) O
found VBD O
in IN O
many JJ O
promoters NNS O
of IN O
the DT O
IFN NNP B-Gene
- : I-Gene
regulated VBN I-Gene
genes NNS I-Gene
. . O

The DT O
exon NN O
: : O
intron NN O
structure NN O
of IN O
chicken NN B-Gene
IL2 NNP I-Gene
corresponds VBZ O
almost RB O
exactly RB O
to TO O
those DT O
of IN O
mammalian JJ O
IL2s NNP B-Gene
with IN O
the DT O
exceptions NNS O
of IN O
exon JJ B-Gene
2 CD I-Gene
and CC O
introns NNS B-Gene
2 CD O
and CC O
3 CD O
which WDT O
are VBP O
shorter JJR O
. . O

This DT O
makes VBZ O
the DT O
identification NN O
of IN O
genetic JJ O
targets NNS O
for IN O
this DT O
transcription NN B-Gene
factor NN I-Gene
pertinent NN O
for IN O
the DT O
understanding NN O
of IN O
early JJ O
B NNP O
- : O
cell NN O
development NN O
. . O

In IN O
addition NN O
, , O
the DT O
65 CD B-Gene
- : I-Gene
kD NN I-Gene
protein NN I-Gene
associated VBN O
with IN O
the DT O
p50 JJ B-Gene
subunit NN I-Gene
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
the DT O
kappa NN B-Gene
B NNP I-Gene
probe NN I-Gene
to TO O
form VB O
a DT O
complex JJ O
with IN O
the DT O
same JJ O
electrophoretic JJ O
mobility NN O
as IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
DNA NN I-Gene
complex NN I-Gene
. . O

In IN O
contrast NN O
, , O
NK NNP O
activity NN O
was VBD O
not RB O
affected VBN O
by IN O
pretreatment NN O
of IN O
the DT O
effector NN O
cells NNS O
with IN O
the DT O
proteasome NN B-Gene
inhibitor NN O
N NNP O
- : O
acetyl NN O
- : O
leu NN O
- : O
leu NN O
- : O
norleucinal JJ O
which WDT O
selectively RB O
inhibits VBZ O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
. . O

To TO O
explore VB O
the DT O
pathogenesis NN O
of IN O
chronic JJ O
lymphocytic JJ O
leukemia NN O
( ( O
CLL NNP O
) ) O
, , O
we PRP O
examined VBD O
whether IN O
phosphorylation NN O
of IN O
one CD O
or CC O
more JJR O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
( ( I-Gene
STAT NNP I-Gene
) ) I-Gene
factors NNS I-Gene
was VBD O
abnormal JJ O
in IN O
cells NNS O
from IN O
CLL NNP O
patients NNS O
. . O

Two CD O
of IN O
these DT O
were VBD O
not RB O
cell JJ O
type NN O
specific NN O
, , O
but CC O
the DT O
third JJ O
was VBD O
detected VBN O
only RB O
in IN O
EBNA2 NNP B-Gene
positive JJ O
cell NN O
extracts NNS O
. . O

p49 NN B-Gene
has VBZ O
a DT O
approximately RB O
18 CD O
- : O
fold NN O
- : O
lower JJR O
affinity NN O
for IN O
the DT O
HIV NNP O
kappa NN B-Gene
B NNP I-Gene
site NN I-Gene
( ( O
KD NNP O
= VBZ O
69 CD O
. . O
1 CD O
pM NN O
) ) O
than IN O
does VBZ O
the DT O
approximately RB O
50 CD O
- : O
kDa NN O
protein NN O
NFKB1 NNP B-Gene
( ( I-Gene
p50 NN I-Gene
) ) I-Gene
derived VBD O
from IN O
p105 NN B-Gene
( ( O
KD NNP O
= VBZ O
3 CD O
. . O
9 CD O
pM NN O
) ) O
. . O

One CD O
group NN O
of IN O
mutants NNS O
replicated VBN O
very RB O
similarly RB O
to TO O
SIVmac239 NNP O
in IN O
kinetics NNS O
and CC O
yield NN O
in IN O
CEMxl74 NNP O
cells NNS O
( ( O
2x CD O
NFKappaB NNP B-Gene
> NN O
or CC O
= VB O
SlVmac239 NNP B-Gene
approximately RB O
deltaNFkappaB VBZ B-Gene
approximately RB O
deltaSpl234 JJ B-Gene
approximately RB O
substNFkappaB VBP B-Gene
approximately RB O
substSpl2 JJ B-Gene
approximately RB O
substSp23 NN B-Gene
) ) O
, , O
while IN O
a DT O
second JJ O
group NN O
replicated VBD O
with IN O
delayed JJ O
or CC O
slightly RB O
delayed VBN O
kinetics NNS O
in IN O
CEMxl74 NNP O
cells NNS O
( ( O
SIVmac239 NNP O
> NNP O
substSp34 VBD B-Gene
> NNP O
deltaNFkappaBdeltaSp NN B-Gene
approximately RB O
deltaNFkappaBdeltaSp JJ B-Gene
> NNP O
substSpl234 NN B-Gene
) ) O
. . O

To TO O
further RBR O
explore VB O
the DT O
involvement NN O
of IN O
PI3 NNP B-Gene
- : I-Gene
K NNP I-Gene
in IN O
T NNP O
cell NN O
activation NN O
, , O
we PRP O
created VBD O
a DT O
set NN O
of IN O
potentially RB O
dominant JJ B-Gene
negative JJ I-Gene
PI3 NNP I-Gene
- : I-Gene
K NNP I-Gene
constructs VBZ I-Gene
comprising VBG O
individual JJ O
or CC O
tandem JJ B-Gene
domains NNS I-Gene
of IN O
the DT O
regulatory JJ B-Gene
p85 NN I-Gene
subunit NN I-Gene
and CC O
tested VBD O
their PRP$ O
effect NN O
on IN O
downstream NN O
signaling VBG O
events NNS O
like IN O
Erk2 NNP B-Gene
activation NN O
and CC O
transcription NN O
from IN O
an DT O
NFAT NNP B-Gene
( ( I-Gene
nuclear JJ I-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
) ) I-Gene
element VBP I-Gene
taken VBN O
from IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
. . O

Induction NN O
of IN O
apoptosis NN O
of IN O
mononucleated JJ O
cells NNS O
is VBZ O
a DT O
physiological JJ O
process NN O
for IN O
regulating VBG O
the DT O
intensity NN O
of IN O
the DT O
immune JJ O
response NN O
. . O

When WRB O
PR NNP B-Gene
is VBZ O
incubated VBN O
in IN O
rabbit NN O
reticulocyte NN O
lysate NN O
, , O
its PRP$ O
association NN O
with IN O
hsp90 NN B-Gene
, , O
hsp70 NN B-Gene
, , O
the DT O
three CD O
immunophilins NNS B-Gene
FKBP54 NNP B-Gene
, , O
FKBP52 NNP B-Gene
and CC O
CyP NNP B-Gene
- : I-Gene
40 CD I-Gene
, , O
and CC O
with IN O
p23 NN B-Gene
is VBZ O
observed VBN O
. . O

We PRP O
have VBP O
examined VBN O
changes NNS O
in IN O
HS1 NNP B-Gene
phosphorylation NN O
after IN O
differential JJ O
stimulation NN O
of IN O
CD3 NNP B-Gene
, , O
CD2 NNP B-Gene
, , O
and CC O
CD28 NNP B-Gene
to TO O
elucidate VB O
its PRP$ O
role NN O
in IN O
T NNP O
cells NNS O
and CC O
to TO O
further RBR O
delineate VB O
the DT O
signaling NN O
pathways NNS O
recruited VBN O
by IN O
these DT O
receptors NNS O
. . O

NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
nuclear JJ O
activation NN O
was VBD O
not RB O
detectable JJ O
before IN O
1 CD O
h NN O
after IN O
cell NN O
contact NN O
and CC O
was VBD O
dependent VBN O
on IN O
protein NN O
synthesis NN O
. . O

Mycobacterium NNP O
tuberculosis NN O
mannose VBD O
- : O
capped VBN O
lipoarabinomannan NN O
can MD O
induce VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : O
dependent JJ O
activation NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
type VBD O
1 CD O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
in IN O
T NNP O
cells NNS O
. . O

These DT O
findings NNS O
are VBP O
consistent JJ O
with IN O
the DT O
postulated JJ O
role NN O
for IN O
TN NNP B-Gene
as IN O
a DT O
natural JJ O
antagonist NN O
to TO O
FN NNP B-Gene
action NN O
, , O
and CC O
suggest VBP O
that IN O
T NNP O
cell NN O
responses NNS O
occurring VBG O
at IN O
tissue NN O
sites NNS O
in IN O
which WDT O
TN NNP B-Gene
is VBZ O
expressed VBN O
could MD O
be VB O
influenced VBN O
by IN O
its PRP$ O
presence NN O
. . O

Although IN O
immunocytochemistry NN O
has VBZ O
shown VBN O
that IN O
disruption NN O
of IN O
microtubular NN O
assembly NN O
prevents NNS O
nuclear JJ O
access NN O
of IN O
the DT O
sterol NN B-Gene
- : I-Gene
VDR NNP I-Gene
complex NN I-Gene
, , O
the DT O
role NN O
of IN O
microtubules NNS B-Gene
in IN O
the DT O
response NN O
to TO O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
has VBZ O
not RB O
been VBN O
studied VBN O
in IN O
viable JJ O
cells NNS O
. . O

Double NNP O
- : O
stimulation NN O
was VBD O
used VBN O
to TO O
demonstrate VB O
that DT O
, , O
in IN O
a DT O
T NNP O
lymphocytic JJ O
cell NN O
line NN O
( ( O
CEM NNP O
) ) O
, , O
phorbol JJ O
myristate NN O
acetate NN O
( ( O
PMA NNP O
) ) O
rapidly RB O
induced VBD O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
through IN O
a DT O
signaling VBG O
pathway NN O
which WDT O
did VBD O
not RB O
involve VB O
reactive JJ O
oxygen NN O
species NNS O
( ( O
ROS NNP O
) ) O
and CC O
was VBD O
different JJ O
from IN O
the DT O
activation NN O
triggered VBN O
by IN O
either DT O
H2O2 NNP O
or CC O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
) ) O
. . O

The DT O
first JJ O
male JJ O
patient NN O
presented VBN O
with IN O
mild JJ O
hypertension NN O
. . O

The DT O
effect NN O
of IN O
antioxidant JJ O
treatment NN O
on IN O
lipopolysaccharide NN O
( ( O
LPS NNP O
) ) O
- : O
induced VBN O
TF NNP B-Gene
expression NN O
was VBD O
examined VBN O
in IN O
murine JJ O
peritoneal NN O
macrophages NNS O
and CC O
human JJ O
monocytes NNS O
. . O

This DT O
phenomenon NN O
, , O
which WDT O
is VBZ O
independent JJ O
of IN O
tumour JJ B-Gene
necrosis NN I-Gene
factor NN I-Gene
, , O
is VBZ O
associated VBN O
with IN O
HIV NNP O
replication NN O
, , O
and CC O
is VBZ O
thus RB O
likely JJ O
to TO O
explain VB O
at IN O
least JJS O
in IN O
part NN O
the DT O
perpetuation NN O
of IN O
HIV NNP O
infection NN O
in IN O
monocytes NNS O
. . O

Activating VBG B-Gene
protein SYM I-Gene
- : I-Gene
1 CD I-Gene
( ( O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
binding NN O
TPA NNP B-Gene
responsive JJ I-Gene
elements NNS I-Gene
( ( O
TRE NNP B-Gene
) ) O
are VBP O
located VBN O
downstream NN O
of IN O
the DT O
transcription NN B-Gene
initiation NN I-Gene
site NN I-Gene
in IN O
the DT O
U5 NNP B-Gene
region NN I-Gene
of IN O
the DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( O
LTR NNP B-Gene
) ) O
. . O

Requirements NNS O
for IN O
induction NN O
of IN O
vitamin NN O
D NNP O
- : O
mediated VBD O
gene NN O
regulation NN O
in IN O
normal JJ O
human JJ O
B NNP O
lymphocytes NNS O
. . O

These DT O
results NNS O
identify VBP O
a DT O
transcriptional JJ B-Gene
regulatory JJ I-Gene
element NN I-Gene
associated VBN O
with IN O
a DT O
nuclease JJ B-Gene
- : I-Gene
hypersensitive JJ I-Gene
site NN I-Gene
in IN O
the DT O
pol JJ B-Gene
gene NN I-Gene
of IN O
HIV NNP O
- : O
1 CD O
and CC O
suggest VB O
that IN O
its PRP$ O
activity NN O
may MD O
be VB O
controlled VBN O
by IN O
a DT O
complex JJ O
interplay NN O
of IN O
cis NN O
- : O
regulatory JJ B-Gene
elements NNS I-Gene
. . O

These DT O
results NNS O
confirm VBP O
that DT O
sequences NNS O
in IN O
the DT O
upstream JJ B-Gene
promoter NN I-Gene
region NN I-Gene
of IN O
the DT O
adult NN B-Gene
beta NN I-Gene
globin NN I-Gene
gene NN I-Gene
contribute NN O
to TO O
its PRP$ O
factor NN O
- : O
mediated VBN O
suppression NN O
early RB O
in IN O
development NN O
and CC O
then RB O
may MD O
modulate VB O
its PRP$ O
expression NN O
at IN O
a DT O
later JJ O
stage NN O
. . O

SCL NNP B-Gene
protein NN I-Gene
was VBD O
detected VBN O
in IN O
erythroid NN O
, , O
megakaryocyte NN O
, , O
mast NN O
and CC O
early JJ O
myeloid NN O
cell NN O
lines NNS O
, , O
as RB O
well RB O
as IN O
in IN O
several JJ O
lymphoid JJ O
leukemia NN O
cell NN O
lines NNS O
which WDT O
are VBP O
known VBN O
to TO O
harbor VB O
SCL NNP B-Gene
gene NN I-Gene
rearrangements NNS I-Gene
. . O

Hence RB O
, , O
it PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
ectopic JJ O
expression NN O
of IN O
TAL1 NNP B-Gene
promotes VBZ O
the DT O
development NN O
of IN O
T NNP O
- : O
ALL DT O
. . O

In IN O
DNA NNP O
- : O
protein NN O
binding VBG O
studies NNS O
, , O
we PRP O
detected VBD O
the DT O
binding NN O
of IN O
transcription NN B-Gene
factors NNS I-Gene
GABP NNP B-Gene
alpha NN I-Gene
and CC I-Gene
- : I-Gene
beta NN I-Gene
to TO O
a DT O
dyad JJ B-Gene
symmetry NN I-Gene
element NN I-Gene
( ( O
DSE NNP B-Gene
) ) O
of IN O
the DT O
distal JJ B-Gene
enhancer NN I-Gene
, , O
which WDT O
is VBZ O
formed VBN O
by IN O
palindromic JJ B-Gene
binding NN I-Gene
sites NNS I-Gene
of IN O
Ets NNP B-Gene
- : I-Gene
like IN I-Gene
factors NNS I-Gene
. . O

Here RB O
we PRP O
show VBP O
that IN O
LMP NNP B-Gene
- : I-Gene
1 CD I-Gene
induces NNS O
the DT O
activity NN O
of IN O
the DT O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN I-Gene
factor NN I-Gene
, , O
a DT O
dimer NN O
of IN O
Jun NNP B-Gene
/ NNP I-Gene
Jun NNP I-Gene
or CC I-Gene
Jun NNP I-Gene
/ NNP I-Gene
Fos NNP I-Gene
proteins VBZ I-Gene
. . O

The DT O
B29 NNP B-Gene
( ( I-Gene
immunoglobulin JJ I-Gene
beta NN I-Gene
- : I-Gene
chain NN I-Gene
) ) I-Gene
gene NN I-Gene
is VBZ O
a DT O
genetic JJ O
target NN O
for IN O
early JJ B-Gene
B NNP I-Gene
- : I-Gene
cell NN I-Gene
factor NN I-Gene
. . O

These DT O
ROI NNP O
- : O
induced JJ O
effects NNS O
can MD O
, , O
to TO O
a DT O
large JJ O
extent NN O
, , O
be VB O
attributed VBN O
to TO O
the DT O
activation NN O
of IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
. . O

Four CD O
specific JJ O
protein SYM B-Gene
- : I-Gene
DNA NN I-Gene
complexes NNS I-Gene
were VBD O
detected VBN O
after IN O
incubation NN O
of IN O
nuclear JJ O
extracts NNS O
( ( O
NE NNP O
) ) O
from IN O
T3 NNP O
- : O
responsive JJ O
pituitary NN O
( ( O
GH3 NNP O
) ) O
cells NNS O
with IN O
a DT O
TREp NNP B-Gene
- : I-Gene
containing VBG I-Gene
DNA NNP I-Gene
fragment NN I-Gene
. . O

Upregulation NN O
of IN O
bcl NN B-Gene
- : I-Gene
2 CD I-Gene
by IN O
the DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
latent NN I-Gene
membrane NN I-Gene
protein NN I-Gene
LMP1 NNP B-Gene
: : O
a DT O
B NNP O
- : O
cell NN O
- : O
specific JJ O
response NN O
that WDT O
is VBZ O
delayed VBN O
relative JJ O
to TO O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activation NN O
and CC O
to TO O
induction NN O
of IN O
cell NN B-Gene
surface NN I-Gene
markers NNS I-Gene
. . O

The DT O
activation NN O
of IN O
signal JJ O
transducer NN O
and CC O
activator NN O
of IN O
transcription NN B-Gene
( ( I-Gene
STAT NNP I-Gene
) ) I-Gene
proteins VBZ I-Gene
in IN O
a DT O
primary JJ O
TCR NNP B-Gene
- : O
mediated VBD O
activation NN O
of IN O
T NNP O
cells NNS O
have VBP O
been VBN O
explored VBN O
. . O

Gel NNP O
electrophoresis NN O
mobility NN O
shift NN O
assays NNS O
and CC O
DNaseI NNP B-Gene
footprinting NN O
assays NNS O
demonstrate VBP O
that IN O
these DT O
negative JJ O
regulatory JJ O
sequences NNS O
are VBP O
recognized VBN O
differently RB O
by IN O
proteins NNS O
present JJ O
in IN O
nuclear JJ O
extracts NNS O
obtained VBN O
from IN O
HeLa NNP O
and CC O
K562 NNP O
cells NNS O
. . O

The DT O
NM23 NNP B-Gene
gene NN I-Gene
has VBZ O
been VBN O
proposed VBN O
as IN O
a DT O
metastasis NN B-Gene
- : I-Gene
suppressor NN I-Gene
gene NN I-Gene
, , O
and CC O
its PRP$ O
use NN O
has VBZ O
been VBN O
suggested VBN O
as IN O
prognostic JJ O
factor NN O
. . O

These DT O
results NNS O
indicated VBD O
that IN O
, , O
in IN O
abdominal JJ O
obesity NN O
, , O
the DT O
GR NNP B-Gene
binding NN O
capacity NN O
in IN O
MNL NNP O
is VBZ O
influenced VBN O
by IN O
the DT O
changes NNS O
in IN O
glucose JJ O
transport NN O
. . O

Murine NNP B-Gene
and CC I-Gene
human JJ I-Gene
MZF NNP I-Gene
- : I-Gene
2 CD I-Gene
proteins NNS I-Gene
consisted VBN O
of IN O
814 CD O
and CC O
775 CD O
amino NN O
acids NNS O
, , O
respectively RB O
, , O
and CC O
have VBP O
identity NN O
of IN O
75 CD O
. . O
3 CD O
% NN O
between IN O
them PRP O
. . O

STAT3 NNP B-Gene
( ( O
signal JJ B-Gene
transducer NN I-Gene
and CC I-Gene
activator NN I-Gene
of IN I-Gene
transcription NN I-Gene
3 CD I-Gene
) ) O
is VBZ O
a DT O
latent JJ O
transcription NN O
factor NN O
that WDT O
is VBZ O
activated VBN O
by IN O
tyrosine JJ O
phosphorylation NN O
( ( O
Tyr NNP O
- : O
705 CD O
) ) O
in IN O
cells NNS O
stimulated VBN O
with IN O
cytokines NNS B-Gene
or CC O
growth NN B-Gene
factors NNS I-Gene
. . O

The DT O
results NNS O
indicate VBP O
that DT O
stimulation NN O
of IN O
NK NNP O
cells NNS O
, , O
either CC O
freshly RB O
isolated VBN O
from IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
( ( O
PBL NNP O
) ) O
or CC O
long JJ O
- : O
term NN O
cultured VBD O
NK NNP O
clones NNS O
, , O
with IN O
specific JJ O
cell NN O
targets NNS O
results NNS O
in IN O
an DT O
increased JJ O
binding NN O
activity NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
transcription NN B-Gene
factors NNS I-Gene
measured VBN O
by IN O
gel JJ O
retardation NN O
. . O

Nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
IL6 NN I-Gene
activates VBZ O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
in IN O
T NNP O
cells NNS O
. . O

This DT O
provides VBZ O
substantial JJ O
evidence NN O
for IN O
an DT O
allosteric JJ O
effect NN O
on IN O
the DT O
catalytic JJ O
cleft NN O
of IN O
VIIa NNP B-Gene
that WDT O
is VBZ O
imparted VBN O
by IN O
binding VBG O
to TO O
TF NNP B-Gene
, , O
its PRP$ O
cognate NN O
catalytic JJ O
cofactor NN B-Gene
. . O

The DT O
Tpl NNP B-Gene
- : I-Gene
2 CD I-Gene
kinase NN I-Gene
activates VBZ O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
of IN I-Gene
activated JJ I-Gene
T NNP I-Gene
cells NNS I-Gene
( ( O
NFAT NNP B-Gene
) ) O
and CC O
induces VBZ O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
expression NN O
in IN O
T NNP O
- : O
cell NN O
lines NNS O
. . O

Spi NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
PU NNP I-Gene
. . I-Gene
1 CD I-Gene
is VBZ O
a DT O
hematopoietic JJ B-Gene
transcription NN I-Gene
factor NN I-Gene
of IN O
the DT O
Ets NNP B-Gene
family NN I-Gene
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
NF NNP B-Gene
- : I-Gene
IL6 NN I-Gene
is VBZ O
involved VBN O
in IN O
transcriptional JJ O
activation NN O
of IN O
the DT O
human JJ B-Gene
IL NNP I-Gene
- : I-Gene
4 CD I-Gene
promoter NN I-Gene
in IN O
T NNP O
cells NNS O
. . O

OBJECTIVE NN O
: : O
The DT O
authors NNS O
' POS O
objective NN O
was VBD O
to TO O
investigate VB O
the DT O
possibility NN O
that IN O
glucocorticoid JJ B-Gene
receptor NN I-Gene
changes NNS O
may MD O
be VB O
involved VBN O
in IN O
the DT O
dysregulation NN O
of IN O
the DT O
hypothalamic JJ O
- : O
pituitary JJ O
- : O
adrenal NN O
( ( O
HPA NNP O
) ) O
axis NN O
in IN O
posttraumatic JJ O
stress NN O
disorder NN O
( ( O
PTSD NNP O
) ) O
. . O

These DT O
findings NNS O
are VBP O
the DT O
first JJ O
to TO O
demonstrate VB O
membrane NN O
binding NN O
of IN O
aldosterone NN O
being VBG O
compatible JJ O
with IN O
major JJ O
aspects NNS O
of IN O
its PRP$ O
nongenomic JJ O
effects NNS O
. . O

Since IN O
the DT O
induction NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
and CC O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
is VBZ O
induced VBN O
by IN O
the DT O
same JJ O
stimuli NN O
that WDT O
stimulate VBP O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
production NN O
, , O
these DT O
results NNS O
indicate VBP O
that IN O
the DT O
immunosuppressant JJ O
action NN O
of IN O
CsA NNP O
and CC O
FK506 NNP O
is VBZ O
exerted VBN O
at IN O
the DT O
level NN O
of IN O
these DT O
trans NNS B-Gene
- : I-Gene
activating VBG I-Gene
factors NNS I-Gene
. . O

In IN O
vivo PDT O
the DT O
Sp1 NNP B-Gene
site NN I-Gene
is VBZ O
bound VBN O
only RB O
in IN O
myeloid NN O
( ( O
U937 NNP O
) ) O
cells NNS O
, , O
not RB O
in IN O
cervical JJ O
carcinoma NN O
( ( O
HeLa NNP O
) ) O
cells NNS O
. . O

Transient JJ O
tranfection NN O
of IN O
a DT O
promyelocyte NN O
cell NN O
line NN O
( ( O
NB4 NNP O
) ) O
with IN O
a DT O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
- : I-Gene
epsilon NN I-Gene
expression NN I-Gene
plasmid NN I-Gene
increased VBD O
cell NN O
growth NN O
by IN O
sevenfold NN O
, , O
while IN O
antisense JJ O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
- : I-Gene
epsilon NN I-Gene
caused VBD O
a DT O
fivefold JJ O
decrease NN O
in IN O
clonal JJ O
growth NN O
of IN O
these DT O
cells NNS O
. . O

Transfection NN O
with IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
alpha NN I-Gene
revealed VBD O
a DT O
massive JJ O
enhancement NN O
of IN O
the DT O
MRP14 NNP B-Gene
promoter NN I-Gene
in IN O
both DT O
, , O
HL NNP O
60 CD O
cells NNS O
( ( O
granulocytic JJ O
differentiated VBN O
) ) O
and CC O
L132 NNP O
fibroblasts NNS O
. . O

Furthermore RB O
, , O
PDTC NNP O
differentially RB O
targeted VBD O
both DT O
NFATp NNP B-Gene
and CC I-Gene
NFATc NNP I-Gene
family NN I-Gene
members NNS I-Gene
, , O
inhibiting VBG O
the DT O
transactivation NN O
functions NNS O
of IN O
NFATp NNP B-Gene
and CC O
mRNA JJ O
induction NN O
of IN O
NFATc NNP B-Gene
. . O

Much JJ O
attention NN O
has VBZ O
been VBN O
focused VBN O
on IN O
the DT O
interaction NN O
of IN O
Tat NNP B-Gene
with IN O
a DT O
specific JJ O
RNA NNP B-Gene
target NN I-Gene
termed VBD O
TAR NNP B-Gene
( ( O
transactivation NN B-Gene
responsive NN I-Gene
) ) O
which WDT O
is VBZ O
present JJ O
in IN O
the DT O
leader NN O
sequence NN O
of IN O
all DT O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
mRNAs NN I-Gene
. . O

The DT O
effects NNS O
of IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
on IN O
two CD O
transcriptional JJ B-Gene
regulatory JJ I-Gene
factors NNS I-Gene
, , O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
nuclear JJ B-Gene
factor NN I-Gene
( ( I-Gene
NF NNP I-Gene
) ) I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
known VBN O
to TO O
be VB O
important JJ O
in IN O
Ig NNP B-Gene
gene NN O
transcription NN O
were VBD O
examined VBN O
. . O

We PRP O
examined VBD O
the DT O
expression NN O
and CC O
modulation NN O
of IN O
expression NN O
of IN O
1 CD B-Gene
, , I-Gene
25 CD I-Gene
( ( I-Gene
OH NNP I-Gene
) ) I-Gene
2D3 CD I-Gene
receptor NN I-Gene
RNA NNP I-Gene
in IN O
various JJ O
proliferating NN O
and CC O
nonproliferating JJ O
hematopoietic JJ O
cells NNS O
. . O

This DT O
region NN O
contains VBZ O
two CD O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
motifs NNS I-Gene
, , O
GM2 NNP B-Gene
and CC O
GC NNP B-Gene
- : I-Gene
box NN I-Gene
. . O

The DT O
effect NN O
of IN O
GH NNP O
appears VBZ O
to TO O
occur VB O
in IN O
an DT O
autocrine JJ O
fashion NN O
, , O
since IN O
the DT O
inhibitory JJ O
effect NN O
on IN O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
secretion NN O
by IN O
constitutive JJ O
GH NNP O
production NN O
could MD O
be VB O
abolished VBN O
in IN O
the DT O
presence NN O
of IN O
anti JJ B-Gene
- : I-Gene
hGH NN I-Gene
mAb NN I-Gene
. . O

The DT O
sophisticated JJ O
control NN O
of IN O
Rel NNP B-Gene
/ NNP I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
activity NN O
is VBZ O
not RB O
surprising JJ O
since IN O
this DT O
transcription NN B-Gene
factor NN I-Gene
is VBZ O
involved VBN O
in IN O
a DT O
wide JJ O
array NN O
of IN O
cellular JJ O
responses NNS O
to TO O
extracellular VB O
cues NNS O
, , O
associated VBN O
with IN O
growth NN O
, , O
development NN O
, , O
apoptosis NN O
, , O
and CC O
pathogen NN O
invasion NN O
. . O

Although IN O
JAK3 NNP B-Gene
is VBZ O
required VBN O
for IN O
proper JJ O
lymphoid NN O
development NN O
, , O
the DT O
precise JJ O
roles NNS O
of IN O
this DT O
kinase NN O
in IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
signaling VBG O
in IN O
lymphocytes NNS O
have VBP O
not RB O
been VBN O
defined VBN O
. . O

The DT O
translocation NN O
found VBD O
in IN O
acute JJ O
promyelocytic JJ O
leukemia NN O
rearranges VBZ O
the DT O
promyelocytic JJ B-Gene
leukemia NN I-Gene
gene NN I-Gene
( ( O
PML NNP B-Gene
) ) O
on IN O
chromosome NN B-Gene
15 CD I-Gene
with IN O
the DT O
retinoic NN B-Gene
acid NN I-Gene
receptor NN I-Gene
alpha NN I-Gene
( ( O
RARalpha NNP B-Gene
) ) O
on IN O
chromosome NN B-Gene
17 CD I-Gene
. . O

Instead RB O
, , O
the DT O
BCS NNP B-Gene
stimulated VBD O
transcription NN O
by IN O
counteracting VBG O
5 CD B-Gene
' '' I-Gene
negative JJ I-Gene
regulatory JJ I-Gene
DNA NNP I-Gene
sequences NNS I-Gene
that WDT O
block VBP O
the DT O
activity NN O
of IN O
the DT O
B29 NNP B-Gene
minimal JJ B-Gene
promoter NN I-Gene
in IN O
its PRP$ O
absence NN O
. . O

Indeed RB O
, , O
the DT O
combination NN O
of IN O
NE NNP B-Gene
and CC O
threshold NN O
of IN O
cathepsin NN B-Gene
G NNP I-Gene
increased VBD O
the DT O
binding NN O
of IN O
PAC NNP B-Gene
- : I-Gene
1 CD I-Gene
approximately RB O
5 CD O
. . O
5 CD O
- : O
fold NN O
over IN O
basal NN O
values NNS O
measured VBN O
on IN O
nontreated JJ O
platelets NNS O
, , O
whereas IN O
this DT O
binding NN O
raised VBD O
only RB O
by IN O
approximately RB O
3 CD O
- : O
fold NN O
in IN O
threshold NN O
of IN O
cathepsin NN O
G NNP O
- : O
stimulated VBN O
platelets NNS O
( ( O
p JJ O
< NN O
0 CD O
. . O
5 CD O
) ) O
. . O

To TO O
investigate VB O
the DT O
effect NN O
of IN O
NAC NNP O
on IN O
the DT O
induction NN O
phase NN O
of IN O
T NNP O
cell NN O
responses NNS O
, , O
we PRP O
analyzed VBD O
its PRP$ O
action NN O
on IN O
human JJ O
dendritic JJ O
cells NNS O
( ( O
DC NNP O
) ) O
derived VBD O
from IN O
adherent JJ O
PBMC NNP O
cultured VBD O
with IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
and CC O
granulocyte JJ B-Gene
- : I-Gene
macrophage NN I-Gene
CSF NNP I-Gene
. . O

To TO O
reconcile VB O
these DT O
observations NNS O
, , O
we PRP O
expressed VBD O
a DT O
hybrid NN B-Gene
CD8 NNP I-Gene
- : I-Gene
Nef NNP I-Gene
protein NN I-Gene
in IN O
Jurkat NNP O
cells NNS O
. . O

Upon IN O
functional JJ O
activation NN O
of IN O
granulocytes NNS O
by IN O
4 CD O
beta NN O
- : O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
, , O
the DT O
levels NNS O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
, , I-Gene
jun NN I-Gene
B NNP I-Gene
and CC I-Gene
jun NN I-Gene
D NNP I-Gene
transcripts NNS I-Gene
were VBD O
increased VBN O
. . O

All DT O
were VBD O
found VBN O
to TO O
selectively RB O
bind VB O
the DT O
consensus NN B-Gene
sequence NN I-Gene
5 CD O
' '' O
- : O
GTTACGTAAT NNP O
- : O
3 CD O
' '' O
with IN O
high JJ O
affinity NN O
. . O

Furthermore RB O
, , O
as IN O
compared VBN O
to TO O
regulation NN O
by IN O
phorbol NN O
ester NN O
, , O
collagenase NN B-Gene
induction NN O
in IN O
monocytic JJ O
cells NNS O
by IN O
cell NN O
wall NN O
derivatives NNS O
of IN O
bacteria NNS O
or CC O
yeast NN O
is VBZ O
largely RB O
independent JJ O
of IN O
upstream JJ B-Gene
promoter NN I-Gene
sequences NNS I-Gene
. . O

Corticosteroid JJ B-Gene
receptors NNS I-Gene
and CC O
lymphocyte JJ O
subsets NNS O
in IN O
mononuclear JJ O
leukocytes NNS O
in IN O
aging VBG O
. . O

The DT O
human JJ O
monocytic JJ O
cell NN O
line NN O
THP NNP O
- : O
1 CD O
mimics NNS O
PAM NNP O
in IN O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
synthesis NN O
and CC O
sensitivity NN O
to TO O
exogenous JJ O
1 CD O
, , O
25 CD O
( ( O
OH NNP O
) ) O
2D3 CD O
. . O

Gangliosides NNS O
appear VBP O
to TO O
act VB O
at IN O
an DT O
early JJ O
step NN O
of IN O
activation NN O
in IN O
that DT O
TNF NNP B-Gene
transcripts NNS I-Gene
were VBD O
reduced VBN O
and CC O
the DT O
mobilization NN O
of IN O
the DT O
nuclear JJ B-Gene
factor NN I-Gene
kappa NN I-Gene
B NNP I-Gene
was VBD O
blocked VBN O
. . O

Interleukin NNP B-Gene
- : I-Gene
13 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
13 CD I-Gene
) ) O
and CC O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
are VBP O
cytokines NNS O
produced VBN O
by IN O
T NNP O
cells NNS O
that WDT O
are VBP O
encoded VBN O
by IN O
the DT O
q23 NN O
- : O
31 CD O
region NN O
of IN O
human JJ O
chromosome NN O
5 CD O
. . O

The DT O
normal JJ O
cell NN O
cycle NN O
activation NN O
program NN O
is VBZ O
exploited VBN O
during IN O
the DT O
infection NN O
of IN O
quiescent NN O
B NNP O
lymphocytes VBZ O
by IN O
Epstein NNP O
- : O
Barr NNP O
virus NN O
. . O

In IN O
contrast NN O
, , O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
was VBD O
expressed VBN O
only RB O
in IN O
a DT O
small JJ O
percentage NN O
of IN O
Hodgkin NNP O
and CC O
Reed NNP O
- : O
Sternberg NNP O
cells NNS O
in IN O
about RB O
30 CD O
% NN O
of IN O
classical JJ O
HD NNP O
cases NNS O
. . O

In IN O
the DT O
absence NN O
of IN O
estrogen NN O
about IN O
half NN O
of IN O
the DT O
cells NNS O
enter VBP O
a DT O
quiescent NN O
non SYM O
- : O
proliferative JJ O
state NN O
whereas VBD O
the DT O
others NNS O
die VBP O
by IN O
apoptosis NN O
. . O

The DT O
c SYM B-Gene
- : I-Gene
Myc NNP I-Gene
oncoprotein NN I-Gene
is VBZ O
important JJ O
in IN O
control NN O
of IN O
cellular JJ O
proliferation NN O
and CC O
differentiation NN O
, , O
while IN O
Yin NNP B-Gene
- : I-Gene
Yang NN I-Gene
1 CD I-Gene
( ( O
YY1 NNP B-Gene
) ) O
has VBZ O
been VBN O
shown VBN O
to TO O
control VB O
the DT O
expression NN O
of IN O
a DT O
number NN O
of IN O
cellular JJ B-Gene
and CC I-Gene
viral JJ I-Gene
genes NNS I-Gene
. . O

Various JJ O
antioxidants NNS O
, , O
such JJ O
as IN O
pyrrolidine NN O
dithiocarbamate NN O
, , O
p SYM O
- : O
bromophenacyl NN O
- : O
bromide NN O
and CC O
nordihydroguaiaretic JJ O
acid NN O
could MD O
strongly RB O
reduce VB O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
translocation NN O
, , O
demonstrating VBG O
the DT O
importance NN O
of IN O
oxidative JJ O
species NNS O
in IN O
the DT O
transduction NN O
mechanism NN O
. . O

Pax NNP B-Gene
- : I-Gene
5 CD I-Gene
codes NNS O
for IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
BSAP NNP B-Gene
which WDT O
is VBZ O
expressed VBN O
throughout IN O
B NNP O
cell NN O
development NN O
except IN O
in IN O
terminally RB O
differentiated VBN O
plasma NN O
cells NNS O
. . O

These DT O
results NNS O
may MD O
lead VB O
to TO O
an DT O
improvement NN O
of IN O
antiinflammatory NN O
and CC O
immunosuppressive JJ O
therapies NNS O
and CC O
provide VB O
a DT O
novel JJ O
concept NN O
for IN O
drug NN O
discovery NN O
. . O

Acute NNP O
promyelocytic JJ O
leukemia NN O
( ( O
APL NNP O
) ) O
is VBZ O
a DT O
specific JJ O
type NN O
of IN O
acute JJ O
myeloid NN O
leukemia NN O
characterized VBN O
by IN O
the DT O
morphology NN O
of IN O
the DT O
blast NN O
cells NNS O
, , O
a DT O
specific JJ O
t NN O
( ( O
15 CD O
; : O
17 CD O
) ) O
translocation NN O
, , O
and CC O
risks NNS O
of IN O
definite JJ O
coagulopathy NN O
. . O

DNA NN O
methylation NN O
changes NNS O
in IN O
hematologic JJ O
malignancies NNS O
: : O
biologic NN O
and CC O
clinical JJ O
implications NNS O
. . O

Induced NNP O
DRA NNP B-Gene
expression NN O
involves VBZ O
activation NN O
of IN O
restricted JJ B-Gene
protein NN I-Gene
kinase NN I-Gene
C NNP I-Gene
( ( I-Gene
PKC NNP I-Gene
) ) I-Gene
isoforms NNS I-Gene
, , O
resulting VBG O
in IN O
activated JJ O
activator NN O
protein VBD B-Gene
- : I-Gene
1 CD I-Gene
- : O
dependent JJ O
transcription NN O
. . O

Using VBG O
a DT O
genetic JJ O
screen NN O
in IN O
yeast NN O
, , O
we PRP O
have VBP O
isolated VBN O
B NNP B-Gene
cell NN I-Gene
- : I-Gene
derived VBN I-Gene
cDNAs NN I-Gene
encoding VBG O
Oct NNP B-Gene
- : I-Gene
binding NN I-Gene
factor NN I-Gene
1 CD I-Gene
( ( O
OBF NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
a DT O
novel JJ O
protein NN O
that WDT O
specifically RB O
associates VBZ O
with IN O
Oct NNP B-Gene
- : I-Gene
1 CD I-Gene
and CC O
Oct NNP B-Gene
- : I-Gene
2 CD I-Gene
. . O

Highly NNP O
polarized VBD O
HLA NNP B-Gene
class NN I-Gene
II NNP I-Gene
antigen NN I-Gene
processing NN O
and CC O
presentation NN O
by IN O
human JJ O
intestinal JJ O
epithelial NN O
cells NNS O
. . O

29 CD O
asthma JJ O
patients NNS O
with IN O
forced JJ O
expiratory NN O
volume NN O
in IN O
1 CD O
s NN O
( ( O
FEV1 NNP O
) ) O
< VBD O
70 CD O
% NN O
predicted VBN O
were VBD O
studied VBN O
. . O

Functional NNP O
association NN O
of IN O
Nmi NNP B-Gene
with IN O
Stat5 NNP B-Gene
and CC O
Stat1 NNP B-Gene
in IN O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
- : O
and CC O
IFNgamma NNP B-Gene
- : O
mediated VBD O
signaling NN O
. . O

Since IN O
the DT O
human JJ B-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
promoter NN I-Gene
has VBZ O
a DT O
base NN O
difference NN O
within IN O
the DT O
GC NNP B-Gene
- : I-Gene
box NN I-Gene
, , O
we PRP O
speculate VBP O
that IN O
this DT O
may MD O
explain VB O
why WRB O
the DT O
human JJ O
promoter NN O
is VBZ O
weak JJ O
and CC O
that IN O
an DT O
upstream JJ B-Gene
enhancer NN I-Gene
is VBZ O
required VBN O
for IN O
the DT O
induction NN O
of IN O
the DT O
human JJ B-Gene
GM NNP I-Gene
- : I-Gene
CSF NNP I-Gene
gene NN I-Gene
. . O

When WRB O
introduced VBN O
in IN O
front NN O
of IN O
a DT O
luciferase NN B-Gene
reporter NN I-Gene
gene NN I-Gene
, , O
this DT O
promoter NN O
is VBZ O
able JJ O
to TO O
direct VB O
a DT O
high JJ O
luciferase NN B-Gene
activity NN O
in IN O
a DT O
human JJ O
B NNP O
- : O
LCL NN O
. . O

Our PRP$ O
results NNS O
support VB O
the DT O
model NN O
proposing VBG O
that IN O
the DT O
N NNP B-Gene
- : I-Gene
terminal NN I-Gene
domain NN I-Gene
confers NNS O
calcium VBP O
- : O
signaling VBG O
dependence NN O
on IN O
NFATx1 NNP B-Gene
transactivation NN O
activity NN O
by IN O
regulating VBG O
its PRP$ O
intracellular JJ O
localization NN O
through IN O
a DT O
protein NN O
module NN O
that WDT O
associates VBZ O
with IN O
calcineurin NN B-Gene
and CC O
is VBZ O
a DT O
target NN O
of IN O
its PRP$ O
phosphatase NN B-Gene
activity NN O
. . O

To TO O
limit VB O
expression NN O
of IN O
a DT O
transduced JJ O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
long JJ I-Gene
terminal JJ I-Gene
repeat NN I-Gene
( ( I-Gene
LTR NNP I-Gene
) ) I-Gene
- : I-Gene
IFNA2 NN I-Gene
( ( O
the DT O
new JJ O
approved JJ O
nomenclature NN O
for IN O
IFN NNP B-Gene
genes NNS I-Gene
is VBZ O
used VBN O
throughout IN O
this DT O
article NN O
) ) O
hybrid JJ B-Gene
gene NN I-Gene
to TO O
the DT O
HIV NNP O
- : O
1 CD O
- : O
infected JJ O
cells NNS O
, , O
HIV NNP B-Gene
- : I-Gene
1 CD I-Gene
LTR NNP I-Gene
was VBD O
modified VBN O
. . O

It PRP O
is VBZ O
known VBN O
that IN O
the DT O
expression NN O
levels NNS O
of IN O
intercellular JJ B-Gene
adhesion NN I-Gene
molecule NN I-Gene
- : I-Gene
1 CD I-Gene
( ( O
ICAM NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
in IN O
adult NN O
T NNP O
cell NN O
leukemia NN O
( ( O
ATL NNP O
) ) O
cells NNS O
are VBP O
high JJ O
, , O
whereas VBP O
those DT O
in IN O
T NNP O
- : O
lymphoid NN O
cells NNS O
are VBP O
not RB O
. . O

The DT O
efficacy NN O
of IN O
the DT O
activated JJ O
LN NNP O
cells NNS O
is VBZ O
augmented VBN O
when WRB O
the DT O
sensitizing NN O
tumor NN O
is VBZ O
a DT O
genetically RB O
modified VBN O
variant NN O
( ( O
designated VBN O
D5G6 NNP O
) ) O
that WDT O
secretes VBZ O
granulocyte JJ B-Gene
/ NNP I-Gene
macrophage NN I-Gene
- : I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
. . O

The DT O
strategy NN O
described VBD O
here RB O
provides VBZ O
a DT O
new JJ O
approach NN O
for IN O
studying VBG O
protein JJ O
- : O
protein NN O
interactions NNS O
that WDT O
govern VBP O
the DT O
complex JJ O
regulation NN O
of IN O
gene NN O
expression NN O
. . O

Interleukin NNP B-Gene
2 CD I-Gene
and CC O
T NNP B-Gene
cell VBP I-Gene
antigen NN I-Gene
receptor NN I-Gene
signals NNS O
converge VBP O
upon IN O
serine NN O
727 CD O
. . O

Cell NNP O
morphology NN O
remained VBD O
essentially RB O
the DT O
same JJ O
in IN O
serum JJ O
- : O
free JJ O
or CC O
serum JJ O
containing VBG O
media NNS O
. . O

Subsequent JJ O
studies NNS O
have VBP O
revealed VBN O
that IN O
( ( O
i NN O
) ) O
cytoplasmic NN B-Gene
RelA NNP I-Gene
is VBZ O
stably RB O
associated VBN O
not RB O
only RB O
with IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
but CC O
also RB O
with IN O
other JJ O
ankyrin NN B-Gene
motif SYM I-Gene
- : I-Gene
rich JJ I-Gene
proteins VBZ I-Gene
including VBG O
the DT O
products NNS O
of IN O
the DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B2 NNP I-Gene
( ( I-Gene
p100 NN I-Gene
) ) I-Gene
and CC I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B1 NNP I-Gene
( ( I-Gene
p105 NN I-Gene
) ) I-Gene
genes NNS I-Gene
; : O
( ( O
ii NN O
) ) O
in IN O
contrast NN O
to TO O
RelA NNP B-Gene
- : B-Gene
I PRP I-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
, , O
RelA NNP B-Gene
- : I-Gene
p100 NN I-Gene
cytoplasmic JJ I-Gene
complexes NNS I-Gene
are VBP O
not RB O
dissociated VBN O
following VBG O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha JJ I-Gene
activation NN O
; : O
( ( O
iii NN O
) ) O
p100 NN B-Gene
functions NNS O
as IN O
a DT O
potent JJ O
inhibitor NN O
of IN O
RelA NNP B-Gene
- : O
mediated VBN O
transcription NN O
in IN O
vivo NN O
; : O
( ( O
iv NN O
) ) O
the DT O
interaction NN O
of IN O
RelA NNP B-Gene
and CC O
p100 NN B-Gene
involves VBZ O
the DT O
conserved JJ B-Gene
Rel NNP I-Gene
homology NN I-Gene
domain NN I-Gene
of IN O
both DT O
proteins NNS O
but CC O
not RB O
the DT O
nuclear JJ B-Gene
localization NN I-Gene
signal NN I-Gene
of IN O
RelA NNP B-Gene
, , O
which WDT O
is VBZ O
required VBN O
for IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
binding NN O
; : O
( ( O
v NN O
) ) O
p100 NN B-Gene
inhibition NN O
of IN O
RelA NNP B-Gene
function NN O
requires VBZ O
the DT O
C NNP B-Gene
- : I-Gene
terminal JJ I-Gene
ankyrin NN I-Gene
motif NN I-Gene
domain NN I-Gene
, , O
which WDT O
mediates VBZ O
cytoplasmic JJ O
retention NN O
of IN O
RelA NNP B-Gene
; : O
and CC O
( ( O
vi NN O
) ) O
as IN O
observed VBN O
with IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
, , O
nuclear JJ O
RelA NNP B-Gene
stimulates VBZ O
p100 JJ B-Gene
mRNA NN I-Gene
and CC O
protein JJ O
expression NN O
. . O

As IN O
an DT O
in IN O
vitro JJ O
model NN O
we PRP O
show VBP O
that DT O
phosphorylation NN O
of IN O
p105 NN B-Gene
impedes VBZ O
its PRP$ O
ability NN O
to TO O
interact VB O
with IN O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
as IN O
has VBZ O
been VBN O
shown VBN O
before IN O
for IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
. . O

These DT O
experiments NNS O
showed VBD O
that IN O
, , O
in IN O
fact NN O
, , O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
was VBD O
translocated VBN O
to TO O
the DT O
nucleus NN O
following VBG O
viral JJ O
binding NN O
or CC O
purified JJ O
viral JJ O
ligand NN O
binding NN O
. . O

In IN O
a DT O
cotransfection NN O
assay NN O
, , O
the DT O
Tax NNP B-Gene
protein NN I-Gene
of IN O
both DT O
HTLV NNP O
- : O
I PRP O
and CC O
HTLV NNP O
- : O
II NNP O
specifically RB O
activated VBD O
transcription NN O
from IN O
the DT O
IL NNP B-Gene
- : I-Gene
1alpha CD I-Gene
promoter NN I-Gene
in IN O
an DT O
uninfected JJ O
Jurkat NNP O
cell NN O
line NN O
. . O

A DT O
new JJ O
protein NN O
- : O
DNA NN O
interaction NN O
has VBZ O
been VBN O
identified VBN O
upstream NN O
of IN O
the DT O
intron NN B-Gene
enhancer NN I-Gene
, , O
within IN O
the DT O
matrix NN B-Gene
- : I-Gene
associated JJ I-Gene
region NN I-Gene
of IN O
the DT O
J NNP B-Gene
- : I-Gene
C NNP I-Gene
intron NN I-Gene
. . O

A DT O
TBP NNP O
mutant NN O
defective NN O
in IN O
interaction NN O
with IN O
TBP NNP B-Gene
- : I-Gene
associated VBN I-Gene
factor NN I-Gene
TAFII250 NNP B-Gene
also RB O
failed VBD O
to TO O
mediate VB O
transactivation NN O
through IN O
the DT O
CIITA NNP B-Gene
activation NN I-Gene
domain NN I-Gene
. . O

Such JJ O
markers NNS O
will MD O
be VB O
useful JJ O
for IN O
linkage NN O
analysis NN O
and CC O
screening NN O
of IN O
cDNA NN B-Gene
libraries NNS I-Gene
. . O

HS NNP B-Gene
I PRP I-Gene
, , I-Gene
IV NNP I-Gene
, , I-Gene
and CC I-Gene
V NNP I-Gene
were VBD O
exclusively RB O
observed VBN O
in IN O
the DT O
erythroid JJ O
/ NNP O
megakaryocytic NN O
cell NN O
lines NNS O
that WDT O
express VBP O
tal JJ B-Gene
- : I-Gene
1 CD I-Gene
from IN O
the DT O
promoters NNS B-Gene
1a CD I-Gene
and CC I-Gene
1b CD I-Gene
. . O

To TO O
identify VB O
such JJ O
target NN B-Gene
genes NNS I-Gene
, , O
we PRP O
established VBD O
Egr NNP O
- : O
1 CD O
- : O
overexpressing VBG O
transfectants NNS O
from IN O
the DT O
murine NN O
B NNP O
cell NN O
line NN O
K46 NNP O
and CC O
from IN O
human JJ O
Ramos NNP O
B NNP O
cells NNS O
. . O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
a DT O
70 CD B-Gene
- : I-Gene
bp NN I-Gene
element NN I-Gene
is VBZ O
necessary JJ O
and CC O
sufficient JJ O
for IN O
the DT O
response NN O
of IN O
the DT O
CAEV NNP B-Gene
LTR NNP I-Gene
to TO O
this DT O
cytokine NN B-Gene
. . O

Cellular JJ O
disposition NN O
of IN O
sulphamethoxazole NN O
and CC O
its PRP$ O
metabolites NNS O
: : O
implications NNS O
for IN O
hypersensitivity NN O
. . O

Moreover RB O
, , O
PMA NNP O
caused VBD O
the DT O
dephosphorylation NN O
of IN O
Tyk2 NNP B-Gene
but CC O
not RB O
of IN O
Jak1 NNP B-Gene
, , O
which WDT O
was VBD O
activated VBN O
by IN O
IFN NNP B-Gene
. . O

The DT O
current JJ O
study NN O
was VBD O
conducted VBN O
to TO O
evaluate VB O
the DT O
cytokine NN B-Gene
modulating VBG O
activity NN O
of IN O
tepoxalin NN O
and CC O
the DT O
role NN O
of IN O
iron NN O
in IN O
these DT O
effects NNS O
. . O

Single NNP O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
of IN O
androgen NN B-Gene
receptor NN I-Gene
gene NN I-Gene
mutations NNS O
in IN O
patients NNS O
with IN O
androgen JJ O
insensitivity NN O
syndromes NNS O
: : O
application NN O
for IN O
diagnosis NN O
, , O
genetic JJ O
counseling NN O
, , O
and CC O
therapy NN O
. . O

The DT O
A6H NNP B-Gene
monoclonal JJ I-Gene
antibody NN I-Gene
( ( O
mAb NN O
) ) O
recognizes VBZ O
a DT O
120 CD B-Gene
, , I-Gene
0 CD I-Gene
- : I-Gene
140 CD I-Gene
, , I-Gene
0 CD I-Gene
MW NNP I-Gene
antigen NN I-Gene
that WDT O
is VBZ O
expressed VBN O
at IN O
similar JJ O
densities NNS O
on IN O
85 CD O
- : O
90 CD O
% NN O
of IN O
human JJ O
CD4 NNP O
+ NNP O
and CC O
CD8 NNP O
+ NNP O
T NNP O
cells NNS O
and CC O
on IN O
renal JJ O
cell NN O
carcinomas NN O
. . O

Thus RB O
, , O
the DT O
transcriptional JJ O
activity NN O
of IN O
TCF NNP B-Gene
- : I-Gene
1 CD I-Gene
alpha NN I-Gene
appears VBZ O
to TO O
depend VB O
on IN O
the DT O
TCF NNP B-Gene
- : I-Gene
2 CD I-Gene
alpha NN I-Gene
and CC O
T NNP B-Gene
alpha VBP I-Gene
1 CD I-Gene
( ( O
CREB NNP B-Gene
) ) O
transcription NN B-Gene
factors NNS I-Gene
and CC O
the DT O
context NN O
of IN O
its PRP$ O
binding NN O
site NN O
within IN O
the DT O
TCR NNP B-Gene
alpha NN I-Gene
enhancer NN I-Gene
. . O

A DT O
missense JJ O
mutation NN O
in IN O
the DT O
region NN O
coding VBG O
for IN O
the DT O
cytoplasmic JJ O
portion NN O
of IN O
the DT O
gamma NN B-Gene
c VBD I-Gene
gene NN I-Gene
was VBD O
found VBN O
in IN O
three CD O
affected JJ O
males NNS O
but CC O
not RB O
in IN O
a DT O
normal JJ O
brother NN O
. . O

A DT O
novel JJ O
mutation NN O
in IN O
the DT O
coding VBG O
sequence NN O
of IN O
the DT O
FY NNP B-Gene
* NNP I-Gene
B NNP I-Gene
allele NN I-Gene
of IN O
the DT O
Duffy NNP B-Gene
chemokine NN I-Gene
receptor NN I-Gene
gene NN I-Gene
is VBZ O
associated VBN O
with IN O
an DT O
altered JJ O
erythrocyte NN O
phenotype NN O
. . O

Hypoxic NNP O
induction NN O
of IN O
interleukin JJ B-Gene
- : I-Gene
8 CD I-Gene
gene NN I-Gene
expression NN O
in IN O
human JJ O
endothelial JJ O
cells NNS O
. . O

Serum NNP O
cortisol NN O
decreased VBD O
after IN O
1 CD O
week NN O
of IN O
treatment NN O
whereas NNS O
urinary JJ O
cortisol NN O
was VBD O
not RB O
affected VBN O
until IN O
the DT O
second JJ O
week NN O
of IN O
treatment NN O
. . O

These DT O
results NNS O
establish VB O
a DT O
crucial JJ O
PI3K NNP B-Gene
/ NNP O
PKB NNP B-Gene
- : O
mediated VBD O
link NN O
between IN O
the DT O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
teceptor NN I-Gene
and CC O
the DT O
cell NN O
cycle NN O
machinery NN O
. . O

Involvement NN O
of IN O
phospholipase NN B-Gene
D NNP I-Gene
in IN O
the DT O
activation NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
AP NNP I-Gene
- : I-Gene
1 CD I-Gene
in IN O
human JJ O
T NNP O
lymphoid NN O
Jurkat NNP O
cells NNS O
. . O

Electrophoretic JJ O
mobility NN O
shift NN O
assays NNS O
revealed VBD O
that IN O
both DT O
thiol JJ O
insufficiency NN O
and CC O
H2O2 NNP O
treatment NN O
suppressed VBD O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
NFAT NNP B-Gene
and CC O
that DT O
addition NN O
of IN O
thiol NN O
- : O
reducing VBG O
compounds NNS O
reversed VBD O
or CC O
even RB O
enhanced VBD O
it PRP O
. . O

The DT O
aim NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
investigate VB O
whether IN O
glucocorticoids NNS O
also RB O
regulate VBP O
the DT O
expression NN O
of IN O
L NNP B-Gene
- : I-Gene
selectin NN I-Gene
and CC O
CD11 NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
integrins VBZ B-Gene
on IN O
human JJ O
neutrophil NN O
granulocytes NNS O
. . O

We PRP O
have VBP O
shown VBN O
earlier RBR O
that IN O
NF NNP B-Gene
- : I-Gene
M NN I-Gene
, , O
the DT O
chicken NN B-Gene
homolog NN I-Gene
of IN O
C NNP B-Gene
/ NNP I-Gene
EBP NNP I-Gene
beta NN I-Gene
, , O
is VBZ O
specifically RB O
expressed VBN O
in IN O
myelomonocytic JJ O
and CC O
eosinophilic JJ O
cells NNS O
of IN O
the DT O
hematopoietic JJ O
system NN O
. . O

Although IN O
no DT O
germ JJ O
- : O
line NN O
BRCA1 NNP B-Gene
mutation NN O
was VBD O
observed VBN O
, , O
6 CD O
of IN O
the DT O
18 CD O
male NN O
breast NN O
cancer NN O
cases NNS O
( ( O
33 CD O
% NN O
) ) O
carried VBD O
truncating VBG O
mutations NNS O
in IN O
the DT O
BRCA2 NNP B-Gene
gene NN O
. . O

It PRP O
suggested VBD O
that IN O
increase NN O
of IN O
ER NNP O
levels NNS O
play VBP O
an DT O
important JJ O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
gynecomastia NN O
. . O

Several JJ O
studies NNS O
have VBP O
pointed VBN O
to TO O
a DT O
link NN O
between IN O
immune NN O
and CC O
endocrine JJ O
systems NNS O
, , O
including VBG O
a DT O
regulatory JJ O
function NN O
of IN O
GH NNP O
on IN O
monocyte NN O
activation NN O
. . O

Although IN O
BCL NNP B-Gene
- : I-Gene
6 CD I-Gene
( ( O
- : O
) ) O
/ VBP O
syn JJ O
- : O
1 CD O
( ( O
+ NN O
) ) O
RS NNP O
cells NNS O
of IN O
HIV NNP O
- : O
HD NNP O
express NN O
CD40 NNP B-Gene
, , O
they PRP O
are VBP O
not RB O
surrounded VBN O
by IN O
CD40 NNP O
ligand SYM O
- : O
positive JJ O
( ( O
CD40L NNP O
+ NNP O
) ) O
reactive VBP O
T NNP O
lymphocytes NNS O
, , O
which WDT O
, , O
in IN O
HD NNP O
of IN O
the DT O
general JJ O
population NN O
, , O
are VBP O
thought VBN O
to TO O
regulate VB O
the DT O
disease NN O
phenotype NN O
through IN O
CD40 NNP B-Gene
/ NNP B-Gene
CD40L NNP I-Gene
interactions NNS O
. . O

The DT O
PAF NNP B-Gene
- : O
induced VBD O
up RP O
- : O
regulation NN O
of IN O
HB NNP B-Gene
- : I-Gene
EGF NNP I-Gene
mRNA NN I-Gene
was VBD O
accompanied VBN O
by IN O
an DT O
increase NN O
in IN O
kappa NN O
B NNP O
binding NN O
activity NN O
. . O

A DT O
critical JJ O
serine NN B-Gene
phosphorylation NN I-Gene
site NN I-Gene
in IN O
STAT3alpha NNP B-Gene
is VBZ O
at IN O
position NN O
727 CD O
. . O

This DT O
complementary JJ B-Gene
DNA NNP I-Gene
encoded VBD O
a DT O
protein NN O
with IN O
structural JJ O
similarities NNS O
to TO O
the DT O
c NN B-Gene
- : I-Gene
jun NN I-Gene
proto NN I-Gene
- : I-Gene
oncogene JJ I-Gene
product NN I-Gene
, , O
and CC O
its PRP$ O
target NN O
sequence NN O
was VBD O
closely RB O
related VBN O
to TO O
the DT O
palindromic JJ B-Gene
target NN I-Gene
sequence NN I-Gene
of IN O
c JJ B-Gene
- : I-Gene
jun NN I-Gene
. . O

We PRP O
provide VBP O
evidence NN O
here RB O
that IN O
virtually RB O
all DT O
human JJ O
CD34 NNP O
( ( O
+ NNP O
) ) O
bone NN O
marrow NN O
cells NNS O
express JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
that WDT O
can MD O
be VB O
activated VBN O
by IN O
exposure NN O
to TO O
phorbol VB O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
and CC O
a DT O
variety NN O
of IN O
cytokines NNS B-Gene
, , O
eg NN O
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
alpha NN I-Gene
, , O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
, , O
and CC O
granulocyte SYM B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
. . O

Pharmacological JJ O
modification NN O
of IN O
cytokine NN B-Gene
dysregulation NN O
, , O
therefore RB O
, , O
has VBZ O
been VBN O
suggested VBN O
as IN O
a DT O
therapeutic JJ O
modality NN O
for IN O
HIV NNP O
- : O
1 CD O
infection NN O
. . O

